Comparison	Comparison	NN	B-NP	O
with	with	IN	B-PP	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatases	phosphatas	NNS	I-NP	I-protein
and	and	CC	O	O
5	5	CD	B-NP	O
-	-	HYPH	I-NP	O
nucleotidase	nucleotidase	NN	I-NP	O


Pharmacologic	Pharmacologic	JJ	B-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
neonatal	neonatal	JJ	B-NP	O
hyperbilirubinemia	hyperbilirubinemia	NN	I-NP	O
.	.	.	O	O


When	When	WRB	B-ADVP	O
CSF	CSF	NN	B-NP	B-protein
[	[	(	O	O
HCO3	HCO3	NN	B-NP	B-protein
-	-	HYPH	B-ADJP	O
]	]	)	O	O
is	be	VBZ	B-VP	O
shown	show	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
CSF	CSF	NN	B-NP	B-protein
PCO2	PCO2	NN	I-NP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
of	of	IN	B-PP	O
K	K	NN	B-NP	O
-	-	HYPH	B-NP	O
depleted	deplete	VBN	I-NP	O
rats	rat	NNS	I-NP	O
are	be	VBP	B-VP	O
no	no	RB	I-VP	O
longer	longer	RB	I-VP	O
displaced	displace	VBD	I-VP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
controls	control	NNS	B-NP	O
but	but	CC	O	O
still	still	RB	B-ADVP	O
have	have	VB	B-VP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
greater	great	JJR	I-NP	O
slope	slope	NN	I-NP	O
(	(	(	O	O
1.21	1.21	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
0.23	0.23	CD	B-NP	O
vs	v	NNS	I-NP	O
.	.	.	O	O


Flurazepam	Flurazepam	NNP	B-NP	O
thus	thus	RB	B-ADVP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
effective	effective	JJ	I-NP	O
hypnotic	hypnotic	JJ	I-NP	O
drug	drug	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
optimum	optimum	JJ	I-NP	O
dose	dose	NN	I-NP	O
for	for	IN	B-PP	O
use	use	NN	B-NP	O
in	in	IN	B-PP	O
general	general	JJ	B-NP	O
practice	practice	NN	I-NP	O
being	be	VBG	B-VP	O
15	15	CD	B-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O


Beta	Beta	NN	B-NP	B-protein
blocking	block	VBG	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O


When	When	WRB	B-ADVP	O
extracorporeal	extracorporeal	JJ	B-NP	O
CO2	CO2	NN	I-NP	O
removal	removal	NN	I-NP	O
approximated	approximate	VBD	B-VP	O
CO2	CO2	NN	B-NP	B-protein
production	production	NN	I-NP	O
(	(	(	O	O
VCO2	VCO2	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
alveolar	alveolar	JJ	B-NP	O
ventilation	ventilation	NN	I-NP	O
almost	almost	RB	B-ADVP	O
ceased	cease	VBD	B-VP	O
.	.	.	O	O


Intravenous	Intravenous	JJ	B-NP	O
administration	administration	NN	I-NP	O
(	(	(	O	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
carbonic	carbonic	JJ	B-NP	O
anhydrase	anhydrase	NN	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
(	(	(	O	O
acetazolamide	acetazolamide	NN	B-NP	O
,	,	,	O	O
methazolamide	methazolamide	NN	B-NP	O
,	,	,	O	O
dichlorphenamide	dichlorphenamide	NN	B-NP	O
,	,	,	O	O
sulthiame	sulthiame	NN	B-NP	O
)	)	)	O	O
induced	induce	VBD	B-VP	O
an	an	DT	B-NP	O
early	early	JJ	I-NP	O
important	important	JJ	I-NP	O
rise	rise	NN	I-NP	O
of	of	IN	B-PP	O
cortical	cortical	JJ	B-NP	O
p	p	NN	I-NP	O
O2	O2	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
increase	increase	NN	B-NP	O
of	of	IN	B-PP	O
p	p	NN	B-NP	O
O2	O2	NN	I-NP	O
and	and	CC	O	O
p	p	NN	B-NP	O
CO2	CO2	NN	I-NP	O
and	and	CC	O	O
decrease	decrease	NN	B-NP	O
of	of	IN	B-PP	O
pH	pH	NN	B-NP	B-protein
in	in	IN	B-PP	O
arterial	arterial	JJ	B-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O


Teratological	Teratological	JJ	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
etoperidone	etoperidone	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
and	and	CC	I-NP	O
rabbit	rabbit	NN	I-NP	O
.	.	.	O	O


Colorectal	Colorectal	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
removed	remove	VBN	I-VP	O
endoscopically	endoscopically	RB	B-ADVP	O
whenever	whenever	WRB	B-ADVP	O
possible	possible	JJ	B-ADJP	O
.	.	.	O	O


The	The	DT	B-NP	O
variable	variable	JJ	I-NP	O
HMG	HMG	NN	I-NP	O
dosage	dosage	NN	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
offer	offer	VB	I-VP	O
no	no	DT	B-NP	O
advantages	advantage	NNS	I-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
our	our	PRP$	B-NP	O
standard	standard	JJ	I-NP	O
daily	daily	JJ	I-NP	O
dosage	dosage	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O


When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
CO2	CO2	NN	I-NP	O
content	content	NN	I-NP	O
reached	reach	VBD	B-VP	O
9	9	CD	B-NP	O
Vol	Vol	NN	I-NP	O
%	%	NN	I-NP	O
the	the	DT	B-NP	O
animals	animal	NNS	I-NP	O
became	become	VBD	B-VP	O
apathic	apathic	JJ	B-ADJP	O
and	and	CC	O	O
lost	lose	VBN	B-VP	O
body	body	NN	B-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O


Serum	Serum	NN	B-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
glutamyltransferase	glutamyltransferase	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
liver	liver	NN	B-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
cattle	cattle	NNS	B-NP	O
.	.	.	O	O


By	By	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
secretory	secretory	JJ	B-NP	B-protein
HI	HI	NN	I-NP	I-protein
antibodies	antibody	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
illness	illness	NN	B-NP	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
their	their	PRP$	B-NP	O
formation	formation	NN	I-NP	O
started	start	VBD	B-VP	O
early	early	RB	B-ADVP	O
and	and	CC	O	O
the	the	DT	B-NP	O
antibodies	antibody	NNS	I-NP	B-protein
reached	reach	VBD	B-VP	O
maximal	maximal	JJ	B-NP	O
levels	level	NNS	I-NP	O
about	about	IN	B-NP	O
10	10	CD	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
onset	onset	NN	B-NP	O
of	of	IN	B-PP	O
illness	illness	NN	B-NP	O
.	.	.	O	O


With	With	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
virus	virus	NN	B-NP	O
assay	assay	NN	I-NP	O
and	and	CC	I-NP	O
quantitation	quantitation	NN	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
methods	method	NNS	I-NP	O
are	be	VBP	B-VP	O
simple	simple	JJ	B-ADJP	O
and	and	CC	O	O
inexpensive	inexpensive	JJ	B-ADJP	O
enough	enough	RB	I-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
done	do	VBN	I-VP	O
in	in	IN	B-PP	O
typical	typical	JJ	B-NP	O
shellfish	shellfish	NN	I-NP	O
microbiology	microbiology	NN	I-NP	O
laboratories	laboratory	NNS	I-NP	O
.	.	.	O	O


Characteristics	Characteristic	NNS	B-NP	O
of	of	IN	B-PP	O
lipase	lipase	NN	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O


Takayasu	Takayasu	NNP	B-NP	O
'	'	POS	B-NP	O
s	s	NNS	I-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
HLA	HLA	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
B5	B5	NN	I-NP	I-protein
.	.	.	O	O


SGPT	SGPT	NN	B-NP	O
,	,	,	O	O
SGOT	SGOT	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
concentrations	concentration	NNS	I-NP	O
were	be	VBD	B-VP	O
essentially	essentially	RB	B-ADJP	O
normal	normal	JJ	I-ADJP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O


Gamma	Gamma	NN	B-NP	B-protein
glutamyl	glutamyl	NN	I-NP	I-protein
transpeptidase	transpeptidase	NN	I-NP	I-protein
(	(	(	O	O
GGTP	GGTP	NN	B-NP	B-protein
)	)	)	O	O
activity	activity	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
seminal	seminal	JJ	I-NP	O
fluid	fluid	NN	I-NP	O


Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
Parkinson	Parkinson	NNP	B-NP	O
'	'	POS	B-NP	O
s	s	NN	I-NP	O
disease	disease	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
high	high	JJ	I-NP	O
incidence	incidence	NN	I-NP	O
to	to	TO	B-PP	O
psychoses	psychos	NNS	B-NP	O
during	during	IN	B-PP	O
drug	drug	NN	B-NP	O
treatment	treatment	NN	I-NP	O
(	(	(	O	O
51.47	51.47	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


Selective	Selective	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
central	central	JJ	B-NP	B-protein
alpha	alpha	SYM	I-NP	I-protein
-	-	HYPH	I-NP	I-protein
autoreceptors	autoreceptor	NNS	B-NP	I-protein
following	follow	VBG	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
alpha	alpha	SYM	O	O
-	-	HYPH	O	O
methyldopa	methyldopa	NN	B-NP	O
and	and	CC	O	O
FLA	FLA	NN	B-NP	B-protein
136	136	CD	I-NP	I-protein
.	.	.	O	O


Anti	Anti	AFX	B-NP	O
-	-	HYPH	I-NP	O
anxiety	anxiety	NN	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
diazepam	diazepam	NN	B-NP	O
after	after	IN	B-PP	O
intra	intra	AFX	B-NP	O
-	-	HYPH	I-NP	O
amygdaloid	amygdaloid	JJ	I-NP	O
application	application	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
.	.	.	O	O


Abstracts	Abstract	NNS	B-NP	O
.	.	.	O	O


Removal	Removal	NN	B-NP	O
of	of	IN	B-PP	O
thick	thick	JJ	B-NP	O
,	,	,	I-NP	O
permanently	permanently	RB	I-NP	O
altered	alter	VBN	I-NP	O
mucoas	mucoa	NNS	I-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
even	even	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
squamous	squamous	JJ	B-NP	O
epithelium	epithelium	NN	I-NP	O
.	.	.	O	O


An	An	DT	B-NP	O
IgG	IgG	NN	I-NP	B-protein
monoclonal	monoclonal	JJ	I-NP	O
gammopathy	gammopathy	NN	I-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
Bence	Bence	NNP	B-NP	O
-	-	HYPH	I-NP	O
Joanes	Joanes	NNP	I-NP	O
proteinuria	proteinuria	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O


Studies	Study	NNS	B-NP	O
on	on	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA
E	E	NN	I-NP	I-DNA
:	:	:	O	O
the	the	DT	B-NP	O
impact	impact	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
sojourn	sojourn	NN	I-NP	O
with	with	IN	B-PP	O
Professor	Professor	NNP	B-NP	O
Dan	Dan	NNP	I-NP	O
H	H	NNP	I-NP	O
.	.	VBD	B-VP	O


Peroxydase	Peroxydase	NN	B-NP	O
reaction	reaction	NN	I-NP	O
stains	stain	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
chloroacetate	chloroacetate	NN	B-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
were	be	VBD	B-VP	O
strongly	strongly	RB	B-ADJP	O
positive	positive	JJ	I-ADJP	O
.	.	.	O	O


Ten	Ten	CD	B-NP	O
out	out	RP	B-PRT	O
-	-	HYPH	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
pustulosis	pustulosis	NN	B-NP	O
palmaris	palmaris	NN	I-NP	O
et	et	FW	B-ADVP	O
plantaris	plantaris	FW	I-ADVP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
with	with	IN	B-PP	O
direct	direct	JJ	B-NP	O
immunofluorescence	immunofluorescence	NN	I-NP	O
(	(	(	O	O
IF	IF	NN	B-NP	O
)	)	)	O	O
technique	technique	NN	B-NP	O
for	for	IN	B-PP	O
deposition	deposition	NN	B-NP	O
of	of	IN	B-PP	O
fibrinogen	fibrinogen	NN	B-NP	B-protein
,	,	,	O	O
fibrin	fibrin	NN	B-NP	B-protein
or	or	CC	O	O
its	its	PRP$	B-NP	O
degradation	degradation	NN	I-NP	O
products	product	NNS	I-NP	O
(	(	(	O	O
FR	FR	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
)	)	)	O	O
in	in	IN	B-PP	O
affected	affect	VBN	B-NP	O
and	and	CC	I-NP	O
unaffected	unaffected	JJ	I-NP	O
skin	skin	NN	I-NP	O
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
heparin	heparin	NN	B-NP	O
-	-	HYPH	B-NP	O
precipitable	precipitable	JJ	I-NP	O
fraction	fraction	NN	I-NP	O
(	(	(	O	O
HPF	HPF	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
cryoglobulin	cryoglobulin	NN	B-NP	B-protein
and	and	CC	O	O
total	total	JJ	B-NP	O
plasma	plasma	NN	I-NP	O
fibrinogen	fibrinogen	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O


Of	Of	IN	B-PP	O
600	600	CD	B-NP	O
mediastinoscopies	mediastinoscopy	NNS	I-NP	O
carried	carry	VBN	B-VP	O
out	out	RP	B-PRT	O
from	from	IN	B-PP	O
1966	1966	CD	B-NP	O
to	to	TO	B-PP	O
1973	1973	CD	B-NP	O
,	,	,	O	O
479	479	CD	B-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
operability	operability	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
mixture	mixture	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
albumin	albumin	NN	I-NP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
hydroxy	hydroxy	NN	I-NP	O
-	-	HYPH	B-NP	O
ethyl	ethyl	NN	I-NP	O
-	-	HYPH	I-NP	O
starch	starch	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
solution	solution	NN	I-NP	O
for	for	IN	B-PP	O
dilution	dilution	NN	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
the	the	DT	B-NP	O
matched	match	VBN	I-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
the	the	DT	B-NP	O
acquisition	acquisition	NN	I-NP	O
-	-	HYPH	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	B-NP	O
symptomatic	symptomatic	JJ	I-NP	O
and	and	CC	I-NP	O
asymptomatic	asymptomatic	JJ	I-NP	O
0acteriuria	0acteriuria	NNS	I-NP	O
was	be	VBD	B-VP	O
over	over	IN	B-NP	O
12	12	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
figure	figure	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
women	woman	NNS	B-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
practice	practice	NN	I-NP	O
population	population	NN	I-NP	O
during	during	IN	B-PP	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
with	with	IN	B-PP	O
transient	transient	JJ	B-NP	O
,	,	,	I-NP	O
symptomatic	symptomatic	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
persistent	persistent	JJ	B-NP	O
A	A	NN	I-NP	O
.	.	.	O	O
B	B	NNP	B-NP	O
.	.	.	O	O


Late	Late	JJ	B-NP	O
complications	complication	NNS	I-NP	O
of	of	IN	B-PP	O
catheterisation	catheterisation	NN	B-NP	O
for	for	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
nutrition	nutrition	NN	I-NP	O
.	.	.	O	O


Prenatal	Prenatal	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
galactosaemia	galactosaemia	NN	B-NP	O
.	.	.	O	O


Sings	Sing	NNS	B-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
indicative	indicative	JJ	B-ADJP	O
of	of	IN	B-PP	O
metaplastic	metaplastic	JJ	B-NP	O
erythropoiesis	erythropoiesis	NN	I-NP	O
are	be	VBP	B-VP	O
absent	absent	JJ	B-ADJP	O
.	.	.	O	O


False	False	JJ	B-NP	O
positive	positive	JJ	I-NP	O
amniotic	amniotic	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
alpha	alpha	NN	I-NP	O
fetoprotein	fetoprotein	NN	I-NP	O
levels	level	NNS	I-NP	O
resulting	result	VBG	B-VP	O
from	from	IN	B-PP	O
contamination	contamination	NN	B-NP	O
with	with	IN	B-PP	O
fetal	fetal	JJ	B-NP	O
blood	blood	NN	I-NP	O
:	:	:	O	O
results	result	NNS	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
experiment	experiment	NN	I-NP	O
.	.	.	O	O


Serum	Serum	NN	B-NP	O
-	-	HYPH	I-NP	O
ferritin	ferritin	NN	I-NP	B-protein
in	in	IN	B-PP	O
diagnosis	diagnosis	NN	B-NP	O
of	of	IN	B-PP	O
haemochromatosis	haemochromatosis	NN	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
2	2	CD	B-NP	O
subjects	subject	NNS	I-NP	O
the	the	DT	B-NP	O
phytomitogen	phytomitogen	NN	I-NP	O
reactivity	reactivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lymphocytes	lymphocyte	NNS	I-NP	B-cell_type
was	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
.	.	.	O	O


Patients	Patient	NNS	B-NP	O
at	at	IN	B-PP	O
risk	risk	NN	B-NP	O
of	of	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
.	.	.	O	O


Albumin	Albumin	NN	B-NP	B-protein
and	and	CC	I-NP	O
cyclic	cyclic	JJ	I-NP	O
AMP	AMP	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
peritoneal	peritoneal	JJ	B-NP	O
fluids	fluid	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
child	child	NN	I-NP	O


Preface	Preface	NNP	B-NP	O
.	.	.	O	O


Thirty	Thirty	CD	B-NP	O
-	-	HYPH	I-NP	O
five	five	CD	I-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
Legionnaires	Legionnaires	NNP	B-NP	O
'	'	POS	B-NP	O
disease	disease	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
belong	belong	VB	I-VP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
serologic	serologic	JJ	I-NP	O
groups	group	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
findings	finding	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
with	with	IN	B-PP	O
direct	direct	JJ	B-NP	O
fluorescent	fluorescent	JJ	I-NP	O
antibody	antibody	NN	I-NP	O
testing	testing	NN	I-NP	O
.	.	.	O	O


On	On	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
factor	factor	NN	I-NP	O
IX	IX	CD	I-NP	O
activity	activity	NN	I-NP	O
is	be	VBZ	B-VP	O
decreased	decrease	VBN	I-VP	O
in	in	IN	B-PP	O
coumarin	coumarin	NN	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
factor	factor	NN	B-NP	O
IX	IX	CD	I-NP	O
antigen	antigen	NN	I-NP	O
remaining	remain	VBG	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O


The	The	DT	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
alpha	alpha	SYM	B-NP	B-protein
2	2	CD	I-NP	I-protein
-	-	HYPH	I-NP	I-protein
macroglobulin	macroglobulin	NN	I-NP	I-protein
,	,	,	O	O
alpha	alpha	SYM	B-NP	B-protein
1	1	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
antitrypsin	antitrypsin	NN	I-NP	B-protein
,	,	,	O	O
plasminogen	plasminogen	NN	B-NP	O
,	,	,	O	O
C3	C3	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
complement	complement	NN	I-NP	O
,	,	,	O	O
fibrinogen	fibrinogen	NN	B-NP	B-protein
degradation	degradation	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
(	(	(	O	O
FDP	FDP	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
fibrinolytic	fibrinolytic	JJ	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
aqueous	aqueous	JJ	I-NP	O
humour	humour	NN	I-NP	O
and	and	CC	I-NP	O
serum	serum	NN	I-NP	O
from	from	IN	B-PP	O
nine	nine	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
Fuchs	Fuchs	NNP	B-NP	O
'	'	POS	B-NP	O
endothelial	endothelial	JJ	I-NP	O
dystrophy	dystrophy	NN	I-NP	O
,	,	,	O	O
17	17	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
uncomplicated	uncomplicated	JJ	B-NP	O
senile	senile	JJ	I-NP	O
cataract	cataract	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
secondary	secondary	JJ	I-NP	O
aqueous	aqueous	JJ	I-NP	O
from	from	IN	B-PP	O
six	six	CD	B-NP	O
cataract	cataract	NN	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O


Only	Only	RB	B-NP	O
17	17	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
patients	patient	NNS	I-NP	O
admitted	admit	VBD	B-VP	O
it	it	PRP	B-NP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
times	time	NNS	I-NP	O
.	.	.	O	O


Prazosin	Prazosin	NN	B-NP	O
alone	alone	RB	B-ADVP	O
was	be	VBD	B-VP	O
effective	effective	JJ	B-ADJP	O
in	in	IN	B-PP	O
volume	volume	NN	B-NP	O
responsive	responsive	JJ	I-NP	O
patients	patient	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1.0	1.0	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O


T4	T4	NN	B-NP	O
and	and	CC	I-NP	O
FT4I	FT4I	NN	I-NP	O
followed	follow	VBD	B-VP	O
parallel	parallel	JJ	B-NP	O
courses	course	NNS	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
;	;	:	O	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
45	45	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
in	in	IN	B-PP	O
premature	premature	JJ	B-NP	O
infants	infant	NNS	I-NP	O
under	under	IN	B-PP	O
34	34	CD	B-NP	O
weeks	week	NNS	I-NP	O
'	'	POS	B-NP	O
EGA	EGA	NN	I-NP	B-protein
than	than	IN	B-PP	O
in	in	IN	B-PP	O
term	term	NN	B-NP	O
infants	infant	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


A	A	DT	B-NP	O
three	three	CD	I-NP	O
-	-	HYPH	I-NP	O
phased	phase	VBN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
plans	plan	NNS	I-NP	O
for	for	IN	B-PP	O
45	45	CD	B-NP	O
patients	patient	NNS	I-NP	O
was	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
.	.	.	O	O


Aspirin	Aspirin	NN	B-NP	O
intolerance	intolerance	NN	I-NP	O
:	:	:	O	O
unaltered	unaltered	JJ	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
of	of	IN	B-PP	O
platelet	platelet	NN	B-NP	B-protein
cyclo	cyclo	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
oxygenase	oxygenase	NN	I-NP	I-protein
to	to	TO	B-PP	O
inhibition	inhibition	NN	B-NP	O
by	by	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O


These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
cynomolgus	cynomolgus	NN	B-NP	O
monkeys	monkey	NNS	I-NP	O
are	be	VBP	B-VP	O
either	either	RB	B-ADJP	O
less	less	RBR	I-ADJP	O
sensitive	sensitive	JJ	I-ADJP	O
or	or	CC	O	O
respond	respond	VBP	B-VP	O
differently	differently	RB	B-ADVP	O
than	than	IN	B-PP	O
rhesus	rhesus	NN	B-NP	O
monkeys	monkey	NNS	I-NP	O
to	to	TO	B-PP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pharmacological	pharmacological	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
norcocaine	norcocaine	NN	B-NP	O
.	.	.	O	O


59	59	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
surgically	surgically	RB	B-NP	O
resectable	resectable	JJ	I-NP	O
cancers	cancer	NNS	I-NP	O
(	(	(	O	O
T1	T1	NN	B-NP	O
,	,	,	O	O
T2	T2	NN	B-NP	B-protein
,	,	,	O	O
T3	T3	NN	B-NP	B-DNA
,	,	,	O	O
N0	N0	NN	B-NP	B-protein
,	,	,	O	O
N1	N1	NN	B-NP	O
)	)	)	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
minimum	minimum	JJ	I-NP	O
followup	followup	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
years	year	NNS	I-NP	O
(	(	(	O	O
average	average	NN	B-NP	O
4	4	CD	B-NP	O
years	year	NNS	I-NP	O
+	+	SYM	B-NP	O
/	/	SYM	B-NP	O
-	-	SYM	B-VP	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
CBZ	CBZ	NN	B-NP	B-protein
and	and	CC	I-NP	O
DPH	DPH	NN	I-NP	B-protein
can	can	MD	B-VP	O
be	be	VB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
interference	interference	NN	B-NP	O
with	with	IN	B-PP	O
thyroid	thyroid	NN	B-NP	O
hormone	hormone	NN	I-NP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
TBG	TBG	NN	B-NP	B-protein
combined	combine	VBN	B-VP	O
with	with	IN	B-PP	O
enzyme	enzyme	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
increased	increase	VBN	I-NP	O
metabolic	metabolic	JJ	I-NP	O
clearance	clearance	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
thyroid	thyroid	JJ	B-NP	O
hormones	hormone	NNS	I-NP	O
without	without	IN	B-PP	O
homeostatic	homeostatic	JJ	B-NP	O
maintenance	maintenance	NN	I-NP	O
of	of	IN	B-PP	O
premedication	premedication	NN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
FT4	FT4	NN	B-NP	B-protein
and	and	CC	I-NP	O
FT3	FT3	NN	I-NP	B-protein
.	.	.	O	O


The	The	DT	B-NP	O
present	present	JJ	I-NP	O
research	research	NN	I-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-SBAR	O
polyethylene	polyethylene	NN	B-NP	O
glycol	glycol	NN	I-NP	O
400	400	CD	I-NP	O
(	(	(	O	O
PEG	PEG	NN	B-NP	B-DNA
400	400	CD	I-NP	I-DNA
)	)	)	O	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
efficacious	efficacious	JJ	B-ADJP	O
,	,	,	O	O
toxic	toxic	JJ	B-ADJP	O
,	,	,	O	O
or	or	CC	O	O
both	both	DT	B-NP	O
.	.	.	O	O


According	Accord	VBG	B-PP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
functional	functional	JJ	I-NP	O
properties	property	NNS	I-NP	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
neurons	neuron	NNS	I-NP	O
were	be	VBD	B-VP	O
subdivided	subdivide	VBN	I-VP	O
into	into	IN	B-PP	O
:	:	:	O	O
(	(	(	B-LST	O
a	a	LS	I-LST	O
)	)	)	O	O
neurons	neuron	NNS	B-NP	O
responding	respond	VBG	B-VP	O
to	to	TO	B-PP	O
stimuli	stimulus	NNS	B-NP	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
eyes	eye	NNS	I-NP	O
;	;	:	O	O
(	(	(	B-LST	O
b	b	LS	I-LST	O
)	)	)	O	O
neurons	neuron	NNS	B-NP	O
triggered	trigger	VBN	B-VP	O
by	by	IN	B-PP	O
complex	complex	JJ	B-NP	O
visual	visual	JJ	I-NP	O
stimuli	stimulus	NNS	I-NP	O
;	;	:	O	O
(	(	(	B-LST	O
c	c	LS	I-LST	O
)	)	)	O	O
neurons	neuron	NNS	B-NP	O
inhibited	inhibit	VBN	B-VP	O
by	by	IN	B-PP	O
visual	visual	JJ	B-NP	O
stimuli	stimulus	NNS	I-NP	O
.	.	.	O	O


Pentobarbital	Pentobarbital	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
,	,	,	I-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
17.5	17.5	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
tested	test	VBN	I-VP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
rate	rate	NN	B-NP	O
-	-	HYPH	O	O
decreasing	decrease	VBG	B-VP	O
doses	dose	NNS	B-NP	O
of	of	IN	B-PP	O
normeperidine	normeperidine	NN	B-NP	O
(	(	(	O	O
17.5	17.5	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
anileridine	anileridine	NN	B-NP	O
(	(	(	O	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
alphaprodine	alphaprodine	NN	B-NP	O
(	(	(	O	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
fentanyl	fentanyl	NN	B-NP	O
(	(	(	O	O
0.3	0.3	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


Pb	Pb	NN	B-NP	O
foil	foil	NN	I-NP	O
(	(	(	O	O
0.55	0.55	CD	B-NP	O
gcm	gcm	NN	I-NP	O
-	-	HYPH	B-NP	O
2	2	CD	I-NP	O
)	)	)	O	O
provided	provide	VBD	B-VP	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
overall	overall	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O


An	An	DT	B-NP	O
anatomical	anatomical	JJ	I-NP	O
and	and	CC	I-NP	O
histochemical	histochemical	JJ	I-NP	O
study	study	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
undertaken	undertake	VBN	I-VP	O
and	and	CC	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
emphasis	emphasis	NN	I-NP	O
is	be	VBZ	B-VP	O
given	give	VBN	I-VP	O
to	to	TO	B-PP	O
recent	recent	JJ	B-NP	O
hypotheses	hypothesis	NNS	I-NP	O
that	that	WDT	B-NP	O
suggest	suggest	VBP	B-VP	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
similarities	similarity	NNS	B-NP	O
with	with	IN	B-PP	O
Type	Type	NN	B-NP	O
IV	IV	CD	I-NP	O
glycogen	glycogen	NN	I-NP	O
storage	storage	NN	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
Andersen	Andersen	NNP	B-NP	O
'	'	POS	B-NP	O
s	s	NNS	I-NP	O
disease	disease	NN	I-NP	O
)	)	)	O	O
which	which	WDT	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
clinically	clinically	RB	B-ADJP	O
distinct	distinct	JJ	I-ADJP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
enzyme	enzyme	NN	I-NP	O
defect	defect	NN	I-NP	O
.	.	.	O	O


All	All	DT	B-NP	O
groups	group	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Hebb	Hebb	NNP	I-NP	O
-	-	HYPH	I-NP	O
Williams	Williams	NNP	I-NP	O
maze	maze	NN	I-NP	O
at	at	IN	B-PP	O
100	100	CD	B-NP	O
approximately	approximately	RB	I-NP	O
10	10	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
.	.	.	O	O


Erythromycin	Erythromycin	NN	B-NP	O
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
resistance	resistance	NN	I-NP	O
in	in	IN	B-PP	O
Corynebacterium	Corynebacterium	NNP	B-NP	O
diphtheriae	diphtheriae	NNP	I-NP	O
from	from	IN	B-PP	O
skin	skin	NN	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O


Imposed	Impose	VBN	B-NP	O
angular	angular	JJ	I-NP	O
displacements	displacement	NNS	I-NP	O
of	of	IN	B-PP	O
monkey	monkey	NN	B-NP	O
'	'	POS	B-NP	O
s	s	NN	I-NP	O
wrist	wrist	NN	I-NP	O
produce	produce	VBP	B-VP	O
three	three	CD	B-NP	O
major	major	JJ	I-NP	O
peaks	peak	NNS	I-NP	O
of	of	IN	B-PP	O
activity	activity	NN	B-NP	O
(	(	(	O	O
terms	term	NNS	B-NP	O
M1	M1	NN	I-NP	O
,	,	,	O	O
M2	M2	NN	B-NP	B-cell_line
,	,	,	O	O
and	and	CC	O	O
M3	M3	NN	B-NP	B-protein
peaks	peak	NNS	I-NP	I-protein
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
averaged	averaged	JJ	I-NP	O
gross	gross	JJ	I-NP	O
EMG	EMG	NN	I-NP	O
activity	activity	NN	I-NP	O
ot	ot	IN	B-PP	O
the	the	DT	B-NP	O
stretched	stretched	JJ	I-NP	O
muscles	muscle	NNS	I-NP	O
.	.	.	O	O


Hemolytic	Hemolytic	JJ	B-NP	O
disease	disease	NN	I-NP	O
of	of	IN	B-PP	O
African	African	JJ	B-NP	O
newborn	newborn	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
this	this	DT	B-NP	O
animal	animal	NN	I-NP	O
,	,	,	O	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
what	what	WP	B-NP	O
was	be	VBD	B-VP	O
judged	judge	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
less	less	RBR	I-NP	O
virulent	virulent	JJ	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
T	T	NN	I-NP	O
.	.	VBD	B-VP	O
cruzi	cruzi	NN	B-NP	O
stocks	stock	NNS	I-NP	O
used	use	VBN	B-VP	O
(	(	(	O	O
'	'	``	O	O
strain	strain	NN	B-NP	O
7	7	CD	I-NP	O
'	'	SYM	B-NP	O
)	)	)	O	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
severe	severe	JJ	B-NP	O
myocarditis	myocarditis	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
myofibre	myofibre	NN	B-NP	O
degeneration	degeneration	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
lesions	lesion	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oesophagus	oesophagus	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
MRF	MRF	NN	B-NP	B-protein
units	unit	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
behaviorally	behaviorally	RB	B-ADJP	O
incongruent	incongruent	JJ	I-ADJP	O
;	;	:	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
frequently	frequently	RB	I-NP	O
observed	observe	VBN	I-NP	O
case	case	NN	I-NP	O
,	,	,	O	O
their	their	PRP$	B-NP	O
activity	activity	NN	I-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
change	change	VB	I-VP	O
reliably	reliably	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
behavior	behavior	NN	B-NP	O
habituated	habituate	VBN	B-VP	O
.	.	.	O	O


Variability	Variability	NN	B-NP	O
within	within	IN	B-PP	O
Down	Down	NN	B-NP	O
'	'	POS	B-NP	O
s	s	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
(	(	(	O	O
trisomy	trisomy	NN	B-NP	O
-	-	HYPH	B-NP	O
21	21	CD	I-NP	O
)	)	)	O	O
:	:	:	O	O
empirically	empirically	RB	B-NP	O
observed	observe	VBN	I-NP	O
sex	sex	NN	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
IQs	IQ	NNS	B-NP	B-protein
.	.	.	O	O


VII	VII	CD	B-NP	O
.	.	.	O	O


Several	Several	JJ	B-NP	O
demographic	demographic	JJ	I-NP	O
indices	index	NNS	I-NP	O
of	of	IN	B-PP	O
isolated	isolate	VBN	B-NP	B-cell_type
populations	population	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
Uzbekistan	Uzbekistan	NNP	B-NP	O


2	2	LS	B-LST	O
.	.	.	O	O
-	-	HYPH	O	O
-	-	HYPH	O	O
concepts	concept	NNS	B-NP	O
of	of	IN	B-PP	O
higher	high	JJR	B-NP	O
nervous	nervous	JJ	I-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
USSR	USSR	NNP	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
maintenance	maintenance	NN	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
myocardial	myocardial	JJ	I-NP	O
capillary	capillary	JJ	I-NP	O
density	density	NN	I-NP	O
required	require	VBD	B-VP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
exercise	exercise	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
1	1	CD	I-NP	O
h	h	NN	I-NP	O
of	of	IN	B-PP	O
exercise	exercise	NN	B-NP	O
once	once	RB	O	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
was	be	VBD	B-VP	O
necessary	necessary	JJ	B-ADJP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
the	the	DT	B-NP	O
enlargement	enlargement	NN	I-NP	O
of	of	IN	B-PP	O
ECA	ECA	NN	B-NP	B-protein
.	.	.	O	O
20	20	CD	B-NP	O


These	These	DT	B-NP	O
observations	observation	NNS	I-NP	O
have	have	VBP	B-VP	O
led	lead	VBN	I-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
conclude	conclude	VB	I-VP	O
that	that	IN	B-SBAR	O
an	an	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
VIII	VIII	CD	I-NP	B-protein
-	-	HYPH	I-NP	O
ratio	ratio	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
sensitive	sensitive	JJ	I-NP	O
indicator	indicator	NN	I-NP	O
of	of	IN	B-PP	O
intravascular	intravascular	JJ	B-NP	O
coagulation	coagulation	NN	I-NP	O
.	.	.	O	O


Eight	Eight	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
colchicine	colchicine	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	O
ceruloplasmin	ceruloplasmin	NN	I-NP	O
level	level	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
rise	rise	VB	I-VP	O
again	again	RB	B-ADVP	O
in	in	IN	B-PP	O
female	female	JJ	B-NP	O
rats	rat	NNS	I-NP	O
,	,	,	B-PP	O
but	but	CC	I-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
male	male	JJ	B-NP	O
rats	rat	NNS	I-NP	O
.	.	.	O	O


Radioimmunoassays	Radioimmunoassay	NNS	B-NP	O
of	of	IN	B-PP	O
pregnenolone	pregnenolone	NN	B-NP	O
,	,	,	O	O
progesterone	progesterone	NN	B-NP	O
,	,	,	O	O
dehydroepiandrosterone	dehydroepiandrosterone	NN	B-NP	B-protein
(	(	(	O	I-protein
DHA	DHA	NN	B-NP	I-protein
)	)	)	O	I-protein
16	16	CD	B-NP	I-protein
alpha	alpha	SYM	O	I-protein
-	-	HYPH	B-NP	O
hydroxy	hydroxy	NN	I-NP	O
-	-	HYPH	O	O
DHA	DHA	NN	B-NP	O
,	,	,	O	O
estriol	estriol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cortisol	cortisol	NN	B-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
0	0	CD	B-NP	O
;	;	:	O	O
1	1	CD	B-NP	O
ml	ml	NN	I-NP	O
;	;	:	O	O
of	of	IN	B-PP	O
fetal	fetal	JJ	B-NP	B-cell_type
plasma	plasma	NN	I-NP	I-cell_type
,	,	,	O	O
collected	collect	VBN	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
vaginal	vaginal	JJ	I-NP	O
delivery	delivery	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
only	only	RB	B-NP	O
two	two	CD	I-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
we	we	PRP	B-NP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
changes	change	NNS	B-NP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
metastases	metastasis	NNS	I-NP	O
any	any	DT	B-ADVP	O
earlier	early	JJR	I-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
99mTc	99mTc	NN	I-NP	O
-	-	HYPH	I-NP	O
EHDP	EHDP	NN	I-NP	O
scan	scan	NN	I-NP	O
than	than	IN	B-PP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
radiographs	radiograph	NNS	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
resolved	resolve	VBN	I-NP	O
spontaneously	spontaneously	RB	B-ADVP	O
.	.	.	O	O


The	The	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
tumors	tumor	NNS	B-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nasal	nasal	JJ	I-NP	O
cavities	cavity	NNS	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
significant	significant	JJ	B-NP	O
incidences	incidence	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
larynx	larynx	NN	I-NP	O
,	,	,	I-NP	O
trachea	trachea	NN	I-NP	O
and	and	CC	I-NP	O
stem	stem	NN	I-NP	O
bronchi	bronchi	NN	I-NP	O
.	.	.	O	O


Prediction	Prediction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
times	time	NNS	I-NP	O
of	of	IN	B-PP	O
sandfly	sandfly	NN	B-NP	O
development	development	NN	I-NP	O


Native	Native	JJ	B-NP	B-protein
human	human	JJ	I-NP	I-protein
fibrinogen	fibrinogen	NN	I-NP	I-protein
was	be	VBD	B-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
coagulation	coagulation	NN	B-NP	O
by	by	IN	B-PP	O
adding	add	VBG	B-VP	O
thrombin	thrombin	NN	B-NP	B-protein
.	.	.	O	O


No	No	DT	B-NP	O
post	post	AFX	I-NP	O
-	-	HYPH	I-NP	O
operative	operative	JJ	I-NP	O
haemorrhages	haemorrhage	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
prostheses	prosthesis	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
Southern	Southern	JJ	I-NP	O
technique	technique	NN	I-NP	O
allowed	allow	VBD	B-VP	O
a	a	DT	B-NP	O
further	further	JJ	I-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
most	most	JJS	B-NP	O
extensive	extensive	JJ	I-NP	O
transcription	transcription	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
1.8	1.8	CD	I-NP	B-DNA
kb	kb	NN	I-NP	I-DNA
HindIII	HindIII	NN	I-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
EcoRI	EcoRI	NN	I-NP	I-DNA
fragment	fragment	NN	I-NP	I-DNA
.	.	.	O	O


Accepting	Accept	VBG	B-VP	O
arbitrarily	arbitrarily	RB	B-NP	O
chosen	choose	VBN	I-NP	O
limits	limit	NNS	I-NP	O
of	of	IN	B-PP	O
maximized	maximized	JJ	B-NP	O
errors	error	NNS	I-NP	O
of	of	IN	B-PP	O
+	+	SYM	B-NP	O
/	/	SYM	B-NP	O
-	-	SYM	B-NP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
system	system	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
work	work	VB	I-VP	O
acceptably	acceptably	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
carbon	carbon	NN	I-NP	O
dioxide	dioxide	NN	I-NP	O
concentration	concentration	NN	I-NP	O
was	be	VBD	B-VP	O
below	below	IN	B-PP	O
1.5	1.5	CD	B-NP	O
vol	vol	NN	I-NP	O
.	.	.	I-NP	O
%	%	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
fresh	fresh	JJ	I-NP	O
gas	gas	NN	I-NP	O
flow	flow	NN	I-NP	O
rates	rate	NNS	I-NP	O
(	(	(	O	O
2.2	2.2	CD	B-NP	O
-	-	HYPH	O	O
-	-	SYM	B-NP	O
7.7	7.7	CD	I-NP	O
1	1	CD	I-NP	O
min	min	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
minute	minute	JJ	B-NP	O
ventilation	ventilation	NN	I-NP	O
(	(	(	O	O
4	4	CD	B-NP	O
-	-	HYPH	O	O
-	-	SYM	B-NP	O
10	10	CD	I-NP	O
1	1	CD	I-NP	O
min	min	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
employed	employ	VBN	B-VP	O
.	.	.	O	O


SV	SV	NN	B-NP	O
increased	increase	VBD	B-VP	O
less	less	RBR	B-ADVP	O
in	in	IN	B-PP	O
SHR	SHR	NN	B-NP	B-protein
,	,	,	O	O
mainly	mainly	RB	B-VP	O
reflecting	reflect	VBG	I-VP	O
the	the	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
diastolic	diastolic	JJ	I-NP	O
compliance	compliance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hypertrophied	hypertrophy	VBN	I-NP	O
SHR	SHR	NN	I-NP	B-protein
left	leave	VBD	B-VP	O
ventricle	ventricle	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
consequent	consequent	JJ	I-NP	O
rightward	rightward	JJ	I-NP	O
shift	shift	NN	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
Frank	Frank	NNP	I-NP	O
-	-	HYPH	I-NP	O
Starling	Starling	NNP	I-NP	O
curve	curve	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
carcass	carcass	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
great	great	JJ	I-NP	O
horned	horned	JJ	I-NP	O
owl	owl	NN	I-NP	O
(	(	(	O	O
Bubo	Bubo	NN	B-NP	O
virginianus	virginianus	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
moribund	moribund	NN	B-NP	O
in	in	IN	B-PP	O
southern	southern	JJ	B-NP	O
Ontario	Ontario	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
presented	present	VBN	I-VP	O
for	for	IN	B-PP	O
necropsy	necropsy	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
inner	inner	JJ	I-NP	O
ears	ear	NNS	I-NP	O
were	be	VBD	B-VP	O
exposed	expose	VBN	I-VP	O
by	by	IN	B-PP	O
microdissection	microdissection	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
vestibular	vestibular	JJ	I-NP	B-DNA
sensory	sensory	JJ	I-NP	I-DNA
regions	region	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
either	either	RB	I-VP	O
sectioned	section	VBN	I-VP	O
and	and	CC	O	O
studied	study	VBN	B-VP	O
with	with	IN	B-PP	O
light	light	NN	B-NP	O
or	or	CC	I-NP	O
electron	electron	NN	I-NP	O
microscopy	microscopy	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
prepared	prepare	VBN	B-VP	O
and	and	CC	I-VP	O
studied	study	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
surface	surface	NN	I-NP	O
specimen	specimen	NN	I-NP	O
technique	technique	NN	I-NP	O
.	.	.	O	O


Patulin	Patulin	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
extracted	extract	VBN	I-VP	O
from	from	IN	B-PP	O
apple	apple	NN	B-NP	O
butter	butter	NN	I-NP	O
samples	sample	NNS	I-NP	O
with	with	IN	B-PP	O
ethyl	ethyl	NN	B-NP	O
acetate	acetate	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
extract	extract	NN	I-NP	O
is	be	VBZ	B-VP	O
cleaned	clean	VBN	I-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
silica	silica	NN	I-NP	O
gel	gel	NN	I-NP	O
column	column	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
benzene	benzene	NN	B-NP	O
-	-	HYPH	O	O
ethyl	ethyl	NN	B-NP	O
acetate	acetate	NN	I-NP	O
(	(	(	O	O
75	75	CD	B-NP	O
+	+	SYM	I-NP	O
25	25	CD	I-NP	O
)	)	)	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
eluant	eluant	NN	I-NP	O
.	.	.	O	O


Steroid	Steroid	JJ	B-NP	O
glucuronides	glucuronide	NNS	I-NP	O
in	in	IN	B-PP	O
amniotic	amniotic	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
at	at	IN	B-PP	O
term	term	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
matrix	matrix	NN	I-NP	O
surrounding	surround	VBG	B-VP	O
the	the	DT	B-NP	O
clusters	cluster	NNS	I-NP	O
either	either	CC	O	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
morphology	morphology	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
homogeneous	homogeneous	JJ	I-NP	O
appearance	appearance	NN	I-NP	O
,	,	,	O	O
within	within	IN	B-PP	O
which	which	WDT	B-NP	O
faint	faint	JJ	B-NP	O
cross	cross	NN	I-NP	O
striations	striation	NNS	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
distinctly	distinctly	RB	I-NP	O
fibrillar	fibrillar	JJ	I-NP	O
outlines	outline	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O


Riboflavin	Riboflavin	NN	B-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
aflatoxin	aflatoxin	NN	B-NP	O
-	-	HYPH	B-NP	O
treated	treat	VBN	I-NP	O
animals	animal	NNS	I-NP	O
with	with	IN	B-PP	O
abnormal	abnormal	JJ	B-NP	O
urinary	urinary	JJ	I-NP	O
excretion	excretion	NN	I-NP	O
patterns	pattern	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
magnitude	magnitude	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
disturbances	disturbance	NNS	I-NP	O
in	in	IN	B-PP	O
elimination	elimination	NN	B-NP	O
of	of	IN	B-PP	O
kynurenic	kynurenic	JJ	B-NP	O
and	and	CC	I-NP	O
xanthurenic	xanthurenic	JJ	I-NP	O
acids	acid	NNS	I-NP	O
.	.	.	O	O


Polyglactin	Polyglactin	NN	B-NP	O
910	910	CD	I-NP	O
suture	suture	JJ	I-NP	O
absorption	absorption	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
DNCB	DNCB	NN	B-NP	O
reactions	reaction	NNS	I-NP	O
was	be	VBD	B-VP	O
78	78	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
for	for	IN	B-PP	O
Stage	Stage	NN	B-NP	O
I	I	CD	I-NP	O
and	and	CC	I-NP	O
II	II	CD	I-NP	O
cancers	cancer	NNS	I-NP	O
(	(	(	O	O
37	37	CD	B-NP	O
patinets	patinet	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
73	73	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
for	for	IN	B-PP	O
resectable	resectable	JJ	B-NP	O
Stage	Stage	NN	I-NP	O
III	III	CD	I-NP	O
cancer	cancer	NN	I-NP	O
(	(	(	O	O
22	22	CD	B-NP	O
patients	patient	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
66	66	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
unresectable	unresectable	JJ	B-NP	O
or	or	CC	I-NP	O
inoperable	inoperable	JJ	I-NP	O
Stage	Stage	NN	I-NP	O
III	III	CD	I-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O


Studies	Study	NNS	B-NP	O
of	of	IN	B-PP	O
lipoproteins	lipoprotein	NNS	B-NP	B-protein
should	should	MD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
be	be	VB	B-VP	O
made	make	VBN	I-VP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
from	from	IN	B-PP	O
families	family	NNS	B-NP	O
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
FH	FH	NN	B-NP	O
or	or	CC	O	O
early	early	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O


Sixteen	Sixteen	CD	B-NP	O
other	other	JJ	I-NP	O
normal	normal	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
g	g	NN	I-NP	O
of	of	IN	B-PP	O
Metyrapone	Metyrapone	NN	B-NP	O
are	be	VBP	B-VP	O
best	good	JJS	B-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O


EEG	EEG	NN	B-NP	O
theta	theta	NN	I-NP	O
waves	wave	NNS	I-NP	O
and	and	CC	O	O
psychological	psychological	JJ	B-NP	O
phenomena	phenomenon	NNS	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
review	review	NN	I-NP	O
and	and	CC	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O


REM	REM	NN	B-NP	O
dream	dream	NN	I-NP	O
content	content	NN	I-NP	O
was	be	VBD	B-VP	O
scored	score	VBN	I-VP	O
for	for	IN	B-PP	O
categories	category	NNS	B-NP	O
suggesting	suggest	VBG	B-VP	O
the	the	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
hemisphere	hemisphere	NN	I-NP	O
,	,	,	O	O
e	e	NN	B-NP	O
.	.	.	I-NP	O
g	g	NN	I-NP	O
.	.	.	O	O
,	,	,	O	O
good	good	JJ	B-NP	O
ego	ego	NN	I-NP	O
functioning	functioning	NN	I-NP	O
,	,	,	O	O
verbalization	verbalization	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hemisphere	hemisphere	NN	I-NP	O
,	,	,	O	O
e	e	NN	B-NP	O
.	.	.	O	O
g	g	NN	B-NP	O
.	.	NN	I-NP	O
,	,	,	O	O
music	music	NN	B-NP	O
,	,	,	O	O
spatial	spatial	JJ	B-NP	O
salience	salience	NN	I-NP	O
,	,	,	O	O
bizarreness	bizarreness	NN	B-NP	O
.	.	.	O	O


Innervation	Innervation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ventral	ventral	JJ	I-NP	O
diaphragm	diaphragm	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
locust	locust	NN	I-NP	O
(	(	(	O	O
Locusta	Locusta	NNP	B-NP	O
migratoria	migratoria	NNP	I-NP	O
)	)	)	O	O
.	.	.	O	O


Ectopic	Ectopic	JJ	B-NP	O
ACTH	ACTH	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
and	and	CC	O	O
medullary	medullary	JJ	B-NP	O
thyroid	thyroid	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
striking	striking	JJ	I-NP	O
finding	finding	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
studies	study	NNS	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
PI	PI	NN	B-NP	O
ACTH	ACTH	NN	I-NP	O
and	and	CC	I-NP	O
MSH	MSH	NN	I-NP	O
contents	content	NNS	I-NP	O
.	.	.	O	O


Chronic	Chronic	JJ	B-NP	O
hypophosphatemia	hypophosphatemia	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
"	"	``	B-NP	O
resistant	resistant	JJ	I-NP	O
"	"	''	I-NP	O
rickets	ricket	NNS	I-NP	O
.	.	.	O	O


There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
serum	serum	NN	B-NP	O
LH	LH	NN	I-NP	O
and	and	CC	O	O
chronological	chronological	JJ	B-NP	O
or	or	CC	I-NP	O
bone	bone	NN	I-NP	O
age	age	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
age	age	NN	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
correlation	correlation	NN	I-NP	O
found	find	VBN	B-VP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
age	age	NN	B-NP	O
-	-	HYPH	I-NP	O
related	relate	VBN	B-VP	O
parallel	parallel	JJ	B-NP	O
phenomena	phenomenon	NNS	I-NP	O
.	.	.	O	O


Molecular	Molecular	JJ	B-NP	O
neurochemistry	neurochemistry	NN	I-NP	O
of	of	IN	B-PP	O
addictive	addictive	JJ	B-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O


Efforts	Effort	NNS	B-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
kidney	kidney	NN	B-NP	O
lesions	lesion	NNS	I-NP	O
to	to	TO	B-VP	O
develop	develop	VB	I-VP	O
and	and	CC	O	O
,	,	,	O	O
if	if	IN	B-SBAR	O
possible	possible	JJ	B-ADJP	O
,	,	,	O	O
to	to	TO	B-VP	O
delineate	delineate	VB	I-VP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
of	of	IN	B-PP	O
PBB	PBB	NN	B-NP	B-protein
.	.	.	O	O


Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
succimer	succimer	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
intensity	intensity	NN	I-NP	O
of	of	IN	B-PP	O
tricarboxylic	tricarboxylic	JJ	B-NP	O
acid	acid	NN	I-NP	O
dehydrogenase	dehydrogenase	NN	I-NP	O
reactions	reaction	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O
poisoned	poison	VBN	B-VP	O
with	with	IN	B-PP	O
mercuric	mercuric	JJ	B-NP	O
chloride	chloride	NN	I-NP	O


Distribution	Distribution	NN	B-NP	O
and	and	CC	I-NP	O
correlations	correlation	NNS	I-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	O
uric	uric	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
French	French	JJ	I-NP	O
adult	adult	JJ	I-NP	O
populations	population	NNS	I-NP	O
:	:	:	O	O
13	13	CD	B-NP	O
,	,	,	O	O
885	885	CD	B-NP	O
men	man	NNS	I-NP	O
and	and	CC	O	O
6	6	CD	B-NP	O
,	,	,	O	O
861	861	CD	B-NP	O
women	woman	NNS	I-NP	O


The	The	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
following	follow	VBG	B-PP	O
transfusion	transfusion	NN	B-NP	O
was	be	VBD	B-VP	O
about	about	IN	B-NP	O
2.8	2.8	CD	I-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
.	.	.	O	O


Technetium	Technetium	NN	B-NP	O
-	-	HYPH	I-NP	O
99m	99m	CD	I-NP	O
stannous	stannous	JJ	I-NP	O
pyrophosphate	pyrophosphate	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
scintigrams	scintigram	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
in	in	IN	B-PP	O
138	138	CD	B-NP	O
clinically	clinically	RB	I-NP	O
stable	stable	JJ	I-NP	O
patients	patient	NNS	I-NP	O
32.7	32.7	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
47.3	47.3	CD	B-NP	O
weeks	week	NNS	I-NP	O
(	(	(	O	O
range	range	NN	B-NP	O
6	6	CD	I-NP	O
to	to	TO	I-NP	O
260	260	CD	I-NP	O
)	)	)	O	O
after	after	IN	B-PP	O
acute	acute	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
similar	similar	JJ	I-NP	O
phenomenon	phenomenon	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
humans	human	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
decline	decline	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
cytochrome	cytochrome	NN	B-NP	B-protein
oxidase	oxidase	NN	I-NP	I-protein
,	,	,	O	O
peroxidase	peroxidase	NN	B-NP	B-protein
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lipid	lipid	NN	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	B-cell_type
neutrophils	neutrophil	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
phagocytic	phagocytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O


Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
pseudohypoparathyroidism	pseudohypoparathyroidism	NN	B-NP	O
type	type	NN	I-NP	O
I	I	CD	I-NP	O
with	with	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
-	-	HYPH	B-NP	O
D	D	NN	I-NP	O
-	-	HYPH	B-NP	O
3	3	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
alpha	alpha	SYM	O	O
-	-	HYPH	O	O
Hydroxycholecalciferol	Hydroxycholecalciferol	NN	B-NP	O
consecutively	consecutively	RB	B-ADVP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
nonuniform	nonuniform	JJ	I-NP	O
response	response	NN	I-NP	O
with	with	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
normalisation	normalisation	NN	I-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	O
-	-	HYPH	B-NP	O
calcium	calcium	NN	I-NP	O
.	.	.	O	O


Workers	Worker	NNS	B-NP	O
with	with	IN	B-PP	O
"	"	``	O	B-cell_type
sensitivity	sensitivity	NN	B-NP	I-cell_type
"	"	''	O	I-cell_type
to	to	TO	B-PP	O
toluene	toluene	NN	B-NP	O
diisocyanate	diisocyanate	NN	I-NP	O
(	(	(	O	O
TDI	TDI	NN	B-NP	O
)	)	)	O	O
studied	study	VBN	B-VP	O
in	in	IN	B-PP	O
depth	depth	NN	B-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
mechanisms	mechanism	NNS	B-NP	O
of	of	IN	B-PP	O
bronchial	bronchial	JJ	B-NP	O
hyperreactivity	hyperreactivity	NN	I-NP	O
.	.	.	O	O


Total	Total	JJ	B-NP	O
VO2	VO2	NN	I-NP	B-protein
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
during	during	IN	B-PP	O
severe	severe	JJ	B-NP	O
hypoxia	hypoxia	NN	I-NP	O
but	but	CC	O	O
limb	limb	NN	B-NP	O
VO2	VO2	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
block	block	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O
beta	beta	SYM	O	O
-	-	HYPH	B-NP	O
Block	Block	NN	I-NP	O
prevented	prevent	VBD	B-VP	O
the	the	DT	B-NP	O
fall	fall	NN	I-NP	O
in	in	IN	B-PP	O
total	total	NN	B-NP	O
and	and	CC	I-NP	O
limb	limb	NN	I-NP	O
peripheral	peripheral	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
seen	see	VBN	B-VP	O
in	in	IN	B-PP	O
severe	severe	JJ	B-NP	O
hypoxia	hypoxia	NN	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
alter	alter	VB	I-VP	O
the	the	DT	B-NP	O
consistently	consistently	RB	I-NP	O
more	more	RBR	I-NP	O
efficient	efficient	JJ	I-NP	O
utilization	utilization	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
O2	O2	NN	I-NP	O
delivery	delivery	NN	I-NP	O
shown	show	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
limb	limb	NN	I-NP	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
whole	whole	JJ	I-NP	O
body	body	NN	I-NP	O
by	by	IN	B-PP	O
higher	high	JJR	B-NP	O
O2	O2	NN	I-NP	O
extraction	extraction	NN	I-NP	O
ratios	ratio	NNS	I-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
venous	venous	JJ	I-NP	B-protein
O2	O2	NN	I-NP	I-protein
pressure	pressure	NN	I-NP	I-protein
.	.	.	O	I-protein
beta	beta	SYM	B-NP	I-protein
-	-	HYPH	B-VP	O
Vasodilator	Vasodilator	NN	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
evidently	evidently	RB	B-VP	O
played	play	VBD	I-VP	O
an	an	DT	B-NP	O
active	active	JJ	I-NP	O
part	part	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
vasodilatation	vasodilatation	NN	I-NP	O
seen	see	VBN	B-VP	O
during	during	IN	B-PP	O
severe	severe	JJ	B-NP	O
hypoxia	hypoxia	NN	I-NP	O
.	.	.	O	O


Phenobarbital	Phenobarbital	NN	B-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
alterations	alteration	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
metabolism	metabolism	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	O	O
vitamin	vitamin	NN	B-NP	O
D3	D3	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
perfused	perfuse	VBN	I-NP	O
rachitic	rachitic	JJ	I-NP	O
rat	rat	NN	I-NP	O
liver	liver	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O


Modulation	Modulation	NN	B-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
hydroxyvitamin	hydroxyvitamin	NN	I-NP	I-protein
D3	D3	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
24	24	CD	I-NP	I-protein
-	-	HYPH	I-NP	I-protein
hydroxylase	hydroxylase	NN	I-NP	I-protein
by	by	IN	B-PP	O
aminophylline	aminophylline	NN	B-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
cytochrome	cytochrome	NN	I-NP	B-protein
P	P	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
450	450	CD	I-NP	I-protein
monooxygenase	monooxygenase	NN	I-NP	I-protein
system	system	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
both	both	PDT	B-NP	O
these	these	DT	B-NP	O
respects	respect	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
DBP	DBP	NN	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
resembles	resemble	VBZ	B-VP	O
the	the	DT	B-NP	O
late	late	JJ	I-NP	O
messengers	messenger	NNS	I-NP	O
of	of	IN	B-PP	O
SV40	SV40	NN	B-NP	B-protein
and	and	CC	I-NP	O
polyoma	polyoma	NN	I-NP	O
viruses	virus	NNS	I-NP	O
.	.	.	O	O


Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
corticosteroid	corticosteroid	NN	B-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
antirheumatic	antirheumatic	JJ	B-NP	O
combination	combination	NN	I-NP	O
drugs	drug	NNS	I-NP	O
on	on	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
ACTH	ACTH	NN	I-NP	O
and	and	CC	O	O
cortisol	cortisol	NN	B-NP	O
production	production	NN	I-NP	O
.	.	.	O	O


Serum	Serum	NN	B-NP	O
ACTH	ACTH	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
insulin	insulin	NN	B-NP	B-protein
and	and	CC	I-NP	O
metyrapone	metyrapone	NN	I-NP	O
.	.	.	O	O


Anatomy	Anatomy	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RNA	RNA	NN	I-NP	O
and	and	CC	I-NP	O
gene	gene	NN	I-NP	O
products	product	NNS	I-NP	O
of	of	IN	B-PP	O
MC29	MC29	NN	B-NP	B-protein
and	and	CC	I-NP	O
MH2	MH2	NN	I-NP	B-protein
,	,	,	O	O
two	two	CD	B-NP	O
defective	defective	JJ	I-NP	O
avian	avian	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
viruses	virus	NNS	I-NP	O
causing	cause	VBG	B-VP	O
acute	acute	JJ	B-NP	O
leukemia	leukemia	NN	I-NP	O
and	and	CC	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
:	:	:	O	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
transforming	transform	VBG	B-VP	B-DNA
genes	gene	NNS	B-NP	I-DNA
.	.	.	O	O


Bertioga	Bertioga	NNP	B-NP	O
(	(	(	O	O
Guama	Guama	NNP	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Anhembi	Anhembi	NNP	B-NP	O
(	(	(	O	O
Bunyamwera	Bunyamwera	NN	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
two	two	CD	B-NP	O
new	new	JJ	I-NP	O
arboviruses	arbovirus	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
in	in	IN	B-PP	O
Sao	Sao	NNP	B-NP	O
Paulo	Paulo	NNP	I-NP	O
,	,	,	O	O
Brazil	Brazil	NNP	B-NP	O
.	.	.	O	O


Gamma	Gamma	NN	B-NP	B-protein
glutamyl	glutamyl	NN	I-NP	I-protein
transpeptidase	transpeptidase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
15	15	CD	I-NP	O
times	time	NNS	I-NP	O
above	above	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
normal	normal	JJ	I-NP	O
limit	limit	NN	I-NP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
received	receive	VBD	B-VP	O
aminopyrine	aminopyrine	NN	B-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
or	or	CC	O	O
longer	long	JJR	B-ADVP	O
.	.	.	O	O


XXI	XXI	LS	B-LST	B-DNA
.	.	.	O	O


A	A	DT	B-NP	O
gas	gas	NN	I-NP	B-DNA
-	-	HYPH	I-NP	O
liquid	liquid	NN	I-NP	O
chromatographic	chromatographic	JJ	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
p	p	NN	B-NP	O
-	-	HYPH	B-NP	O
chlorophenoxyisobutyric	chlorophenoxyisobutyric	JJ	I-NP	O
(	(	(	O	O
CPIB	CPIB	NN	B-NP	B-protein
)	)	)	O	O
acid	acid	NN	B-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
plasma	plasma	NN	I-NP	O
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O
.	.	.	O	O


Dopamine	Dopamine	NN	B-NP	O
receptor	receptor	NN	I-NP	O
blockade	blockade	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
neuroleptics	neuroleptic	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
crystallographic	crystallographic	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O


V	V	NN	B-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
fluorimetric	fluorimetric	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fungicide	fungicide	NN	I-NP	O
5	5	CD	I-NP	O
-	-	HYPH	I-NP	O
fluorocytosine	fluorocytosine	NN	I-NP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
'	'	``	I-NP	O
field	field	NN	I-NP	O
of	of	IN	B-PP	O
stress	stress	NN	B-NP	O
'	'	''	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
supervisory	supervisory	NN	I-NP	O
nurse	nurse	NN	I-NP	O


How	How	WRB	B-ADVP	O
do	do	VBP	O	O
graduates	graduate	NNS	B-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
programs	program	NNS	B-NP	O
perform	perform	VBP	B-VP	O
on	on	IN	B-PP	O
state	state	NN	B-NP	O
boards	board	NNS	I-NP	O
?	?	.	O	O


Similarly	Similarly	RB	B-ADVP	O
,	,	,	O	O
maternal	maternal	JJ	B-NP	O
serum	serum	NN	I-NP	O
somatomedin	somatomedin	NN	I-NP	O
A	A	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
nursing	nurse	VBG	B-VP	O
large	large	JJ	B-NP	O
litters	litter	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
X	X	NN	I-NP	B-DNA
.	.	.	O	I-DNA
borealis	borealis	NN	B-NP	I-DNA
oocyte	oocyte	NN	I-NP	I-DNA
and	and	CC	O	I-DNA
somatic	somatic	JJ	B-NP	I-DNA
5S	5S	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
identical	identical	JJ	B-ADJP	O
in	in	IN	B-PP	O
12	12	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
14	14	CD	I-NP	O
residues	residue	NNS	I-NP	O
and	and	CC	O	O
contain	contain	VBP	B-VP	O
two	two	CD	B-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
T	T	NN	I-NP	B-DNA
clusters	cluster	NNS	I-NP	I-DNA
,	,	,	O	O
as	as	IN	B-SBAR	O
does	do	VBZ	O	O
the	the	DT	B-NP	O
corresponding	corresponding	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
X	X	NN	B-NP	B-DNA
.	.	.	O	I-DNA
laevis	laevis	NN	B-NP	I-DNA
oocyte	oocyte	NN	I-NP	I-DNA
5S	5S	NN	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
.	.	.	O	O


This	This	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
observed	observe	VBN	I-NP	O
grain	grain	NN	I-NP	O
boundary	boundary	JJ	I-NP	O
precipitates	precipitate	NNS	I-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
report	report	NN	I-NP	O
has	have	VBZ	B-VP	O
reviewed	review	VBN	I-VP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
reasons	reason	NNS	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
failures	failure	NNS	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
presented	present	VBN	I-VP	O
a	a	DT	B-NP	O
philosophy	philosophy	NN	I-NP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O


Diagnosis	Diagnosis	NN	B-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
planning	planning	NN	I-NP	O
in	in	IN	B-PP	O
Class	Class	NN	B-NP	O
II	II	CD	I-NP	O
,	,	,	I-NP	O
division	division	NN	I-NP	O
2	2	CD	I-NP	O


Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
serious	serious	JJ	B-NP	O
infections	infection	NNS	I-NP	O
(	(	(	O	O
fever	fever	NN	B-NP	O
larger	large	JJR	B-ADJP	O
than	than	IN	B-PP	O
or	or	CC	O	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
degrees	degree	NNS	I-NP	O
F	F	NN	I-NP	O
.	.	.	O	O
granulocytes	granulocyte	NNS	B-NP	B-cell_type
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
/	/	SYM	I-NP	O
mm	mm	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
and	and	CC	O	O
hospitalization	hospitalization	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
drug	drug	NN	I-NP	O
death	death	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
4	4	CD	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
calcium	calcium	NN	I-NP	O
leucovorin	leucovorin	NN	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
m2	m2	NN	I-NP	O
orally	orally	RB	B-ADVP	O
,	,	,	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
methotrexate	methotrexate	NN	B-NP	O
in	in	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
cycles	cycle	NNS	I-NP	O
.	.	.	O	O


It	It	PRP	B-NP	O
seems	seem	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
drugs	drug	NNS	B-NP	O
modify	modify	VBP	B-VP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
'	'	POS	B-NP	O
s	s	NN	I-NP	O
serum	serum	NN	I-NP	O
chemistry	chemistry	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
efficacy	efficacy	NN	I-NP	O
with	with	IN	B-PP	O
which	which	WDT	B-NP	O
they	they	PRP	B-NP	O
control	control	VBP	B-VP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O


Here	Here	RB	B-ADVP	O
the	the	DT	B-NP	O
conventional	conventional	JJ	I-NP	O
tests	test	NNS	I-NP	O
clearly	clearly	RB	B-ADVP	O
pointed	point	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
retrocochlear	retrocochlear	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
end	end	NN	I-NP	O
-	-	HYPH	I-NP	O
stage	stage	NN	I-NP	O
or	or	CC	I-NP	O
involutional	involutional	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
proliferative	proliferative	JJ	B-NP	O
diabetic	diabetic	JJ	I-NP	O
retinopathy	retinopathy	NN	I-NP	O
may	may	MD	B-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
stabilization	stabilization	NN	B-NP	O
of	of	IN	B-PP	O
vision	vision	NN	B-NP	O
for	for	IN	B-PP	O
long	long	JJ	B-NP	O
periods	period	NNS	I-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
.	.	.	O	O


On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	O
alpha1AT	alpha1AT	NN	I-NP	O
quantitation	quantitation	NN	I-NP	O
,	,	,	O	O
newborn	newborn	JJ	B-NP	O
infants	infant	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
separated	separate	VBN	I-VP	O
into	into	IN	B-PP	O
two	two	CD	B-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
characterized	characterize	VBN	B-VP	O
respectively	respectively	RB	B-ADVP	O
by	by	IN	B-PP	O
concentrations	concentration	NNS	B-NP	O
above	above	IN	B-PP	O
or	or	CC	I-PP	O
below	below	IN	I-PP	O
150	150	CD	B-NP	O
mg	mg	NN	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
patients	patient	NNS	B-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
vented	vent	VBN	I-VP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
overall	overall	JJ	B-NP	O
significant	significant	JJ	I-NP	O
depression	depression	NN	I-NP	O
of	of	IN	B-PP	O
function	function	NN	B-NP	O
(	(	(	O	O
67	67	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	O
;	;	:	O	O
range	range	NN	B-NP	O
,	,	,	O	O
91	91	CD	B-NP	O
-	-	HYPH	I-NP	O
-	-	SYM	I-NP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


Changes	Change	NNS	B-NP	O
in	in	IN	B-PP	O
body	body	NN	B-NP	O
weight	weight	NN	I-NP	O
and	and	CC	O	O
agonistic	agonistic	JJ	B-NP	O
behavior	behavior	NN	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
recorded	record	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
uterine	uterine	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
prostaglandin	prostaglandin	NN	B-NP	O
E2	E2	NN	I-NP	O
(	(	(	O	O
PGE2	PGE2	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
prostaglandin	prostaglandin	NN	B-NP	B-protein
F2alpha	F2alpha	NN	I-NP	I-protein
(	(	(	O	O
administered	administer	VBN	B-VP	O
by	by	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
and	and	CC	I-NP	O
intrauterine	intrauterine	JJ	I-NP	O
routes	route	NNS	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
during	during	IN	B-PP	O
different	different	JJ	B-NP	O
phases	phase	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
menstrual	menstrual	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
in	in	IN	B-PP	O
five	five	CD	B-NP	O
functionally	functionally	RB	I-NP	O
infertile	infertile	JJ	I-NP	O
women	woman	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
26	26	CD	B-NP	O
BCG	BCG	NN	I-NP	O
strains	strain	NNS	I-NP	O
,	,	,	O	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O
10	10	CD	B-NP	O
Czechoslovak	Czechoslovak	JJ	I-NP	O
strains	strain	NNS	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
lyophilized	lyophilize	VBN	I-NP	O
cultures	culture	NNS	I-NP	O
of	of	IN	B-PP	O
BCG	BCG	NN	B-NP	B-protein
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
batch	batch	NN	I-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
strains	strain	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
abscesses	abscess	NNS	B-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
after	after	IN	B-PP	O
BCG	BCG	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
vaccination	vaccination	NN	I-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
strains	strain	NNS	I-NP	O
from	from	IN	B-PP	O
fatal	fatal	JJ	B-NP	O
cases	case	NNS	I-NP	O
after	after	IN	B-PP	O
BCG	BCG	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
vaccination	vaccination	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
16	16	CD	B-NP	O
strains	strain	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
foreign	foreign	JJ	B-NP	O
laboratories	laboratory	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
.	.	.	O	O


High	High	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	B-protein
calcitonin	calcitonin	NN	I-NP	I-protein
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O


Detection	Detection	NN	B-NP	O
of	of	IN	B-PP	O
anti	anti	AFX	B-NP	O
-	-	HYPH	I-NP	O
lymphocyte	lymphocyte	NN	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
immunoperoxidase	immunoperoxidase	NN	I-NP	O
antiglobulin	antiglobulin	NN	I-NP	O
technic	technic	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	O
GH	GH	NN	I-NP	O
to	to	TO	B-PP	O
arginine	arginine	NN	B-NP	O
infusion	infusion	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
that	that	DT	B-NP	O
to	to	TO	B-PP	O
insulin	insulin	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
was	be	VBD	B-VP	O
poor	poor	JJ	B-ADJP	O
.	.	.	O	O


The	The	DT	B-NP	O
mortality	mortality	NN	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
histopathological	histopathological	JJ	B-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
Nocardia	Nocardia	NNP	B-NP	O
asteroides	asteroide	NNS	I-NP	O
and	and	CC	O	O
Nocardia	Nocardia	NNP	B-NP	O
brasiliensis	brasiliensis	NN	I-NP	O
infections	infection	NNS	I-NP	O
in	in	IN	B-PP	O
congenitally	congenitally	RB	O	O
athymic	athymic	JJ	O	O
(	(	(	O	O
nude	nude	JJ	B-ADJP	O
)	)	)	O	O
mice	mouse	NNS	B-NP	O
of	of	IN	B-PP	O
ICR	ICR	NN	B-NP	B-protein
and	and	CC	I-NP	O
C3H	C3H	NN	I-NP	B-protein
/	/	SYM	B-NP	O
eB	eB	NN	B-NP	O
origins	origin	NNS	I-NP	O
were	be	VBD	B-VP	O
quite	quite	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
from	from	IN	B-PP	O
what	what	WP	B-NP	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
for	for	IN	B-PP	O
Swiss	Swiss	JJ	B-NP	O
white	white	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
inbred	inbred	JJ	I-NP	O
mouse	mouse	NN	I-NP	O
strains	strain	NNS	I-NP	O
(	(	(	O	O
namely	namely	RB	B-ADVP	O
,	,	,	O	O
C57	C57	NN	B-NP	B-protein
/	/	SYM	I-NP	O
BL	BL	NN	I-NP	B-protein
/	/	SYM	B-NP	I-protein
6J	6J	NN	I-NP	I-protein
,	,	,	O	O
New	New	NNP	B-NP	O
Zealand	Zealand	NNP	I-NP	O
Black	Black	NNP	I-NP	O
,	,	,	O	O
BALB	BALB	NN	B-NP	B-protein
/	/	SYM	I-NP	O
c	c	NN	I-NP	O
,	,	,	O	O
CBA	CBA	NN	B-NP	B-protein
/	/	SYM	I-NP	O
LAC	LAC	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
C3H	C3H	NN	B-NP	B-protein
/	/	SYM	B-NP	O
eB	eB	NN	I-NP	B-protein
)	)	)	O	O
.	.	.	O	O


Williams	Williams	NNP	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
August	August	NNP	I-NP	O
1977	1977	CD	I-NP	O
.	.	.	O	O


Use	Use	NN	B-NP	O
of	of	IN	B-PP	O
radioactive	radioactive	JJ	B-NP	O
isotopes	isotope	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chemistry	chemistry	NN	I-NP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O


(	(	(	O	O
Emeritus	Emeritus	NNP	B-NP	O
)	)	)	O	O
John	John	NNP	B-NP	O
Henri	Henri	NNP	I-NP	O
Roosegaarde	Roosegaarde	NNP	I-NP	O
Bisschop	Bisschop	NNP	I-NP	O


Disrupted	Disrupted	JJ	B-NP	O
vaccines	vaccine	NNS	I-NP	O
and	and	CC	O	O
whole	whole	JJ	B-NP	O
-	-	HYPH	I-NP	O
virus	virus	NN	I-NP	O
vaccines	vaccine	NNS	I-NP	O
containing	contain	VBG	B-VP	O
type	type	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
only	only	RB	B-ADVP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
cause	cause	VB	I-VP	O
significant	significant	JJ	B-NP	O
reactivity	reactivity	NN	I-NP	O
.	.	.	O	O


255	255	CD	B-NP	O
-	-	HYPH	I-NP	O
61	61	CD	I-NP	O
.	.	.	O	O


Antenatal	Antenatal	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
haematological	haematological	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
-	-	SYM	B-NP	O
-	-	HYPH	B-NP	O
'	'	SYM	I-NP	O
1978	1978	CD	I-NP	O
'	'	SYM	I-NP	O
.	.	.	O	O


Hepatic	Hepatic	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
supply	supply	NN	I-NP	O
and	and	CC	O	O
selected	select	VBN	B-NP	O
blood	blood	NN	I-NP	O
parameters	parameter	NNS	I-NP	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
in	in	IN	B-PP	O
fasted	fast	VBN	B-NP	O
male	male	JJ	I-NP	O
rates	rate	NNS	I-NP	O
given	give	VBN	B-VP	O
20	20	CD	B-NP	O
-	-	HYPH	I-NP	O
-	-	SYM	I-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	B-protein
Escherichia	Escherichia	FW	B-NP	I-protein
coli	coli	FW	I-NP	I-protein
endotoxin	endotoxin	NN	I-NP	I-protein
intraperitoneally	intraperitoneally	RB	B-ADVP	O
.	.	.	O	O


Gonadal	Gonadal	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
ataxia	ataxia	NN	B-NP	O
telangiectasia	telangiectasia	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
maximum	maximum	JJ	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
was	be	VBD	B-VP	O
73	73	CD	B-NP	O
(	(	(	O	O
oral	oral	JJ	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
73	73	CD	B-NP	O
(	(	(	O	O
intraperitoneal	intraperitoneal	JJ	B-ADJP	O
)	)	)	O	O
or	or	CC	O	O
75	75	CD	B-NP	O
(	(	(	O	O
dermal	dermal	JJ	O	O
)	)	)	O	O
weeks	week	NNS	B-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
comparative	comparative	JJ	I-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
diflucortolone	diflucortolone	NN	B-NP	O
valerate	valerate	VBP	B-VP	O
0.3	0.3	CD	B-NP	O
%	%	NN	I-NP	O
ointment	ointment	NN	I-NP	O
and	and	CC	O	O
clobetasol	clobetasol	NN	B-NP	O
propionate	propionate	NN	I-NP	O
0.05	0.05	CD	B-NP	O
%	%	NN	I-NP	O
ointment	ointment	NN	I-NP	O
.	.	.	O	O


Most	Most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
phenomena	phenomena	NN	I-NP	O
of	of	IN	B-PP	O
azotaemic	azotaemic	JJ	B-NP	O
osteodystrophy	osteodystrophy	NN	I-NP	O
are	be	VBP	B-VP	O
encountered	encounter	VBN	I-VP	O
in	in	IN	B-PP	O
simple	simple	JJ	B-NP	O
vitamin	vitamin	NN	I-NP	O
D	D	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
;	;	:	O	O
as	as	IN	B-PP	O
in	in	IN	B-PP	O
that	that	DT	B-NP	O
condition	condition	NN	I-NP	O
,	,	,	O	O
deficiency	deficiency	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
-	-	HYPH	I-NP	O
dihydroxycholecalciferol	dihydroxycholecalciferol	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	O
significance	significance	NN	I-NP	O
in	in	IN	B-PP	O
causing	cause	VBG	B-VP	O
secondary	secondary	JJ	B-NP	O
hyperparathyroidism	hyperparathyroidism	NN	I-NP	O
in	in	IN	B-PP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O


Basal	Basal	JJ	B-NP	O
FSH	FSH	NN	I-NP	O
and	and	CC	I-NP	O
LH	LH	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
in	in	IN	B-PP	O
addicts	addict	NNS	B-NP	O
;	;	:	O	O
after	after	IN	B-PP	O
GnRH	GnRH	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
the	the	DT	B-NP	O
addicts	addict	NNS	I-NP	O
'	'	POS	B-NP	O
FSH	FSH	NN	I-NP	O
and	and	CC	I-NP	O
LH	LH	NN	I-NP	O
values	value	NNS	I-NP	O
increased	increase	VBD	B-VP	O
but	but	CC	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
controls	control	NNS	B-NP	O
.	.	.	O	O


Adriamycin	Adriamycin	NN	B-NP	O
:	:	:	O	O
comparison	comparison	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
5	5	CD	I-NP	O
-	-	HYPH	I-NP	O
week	week	NN	I-NP	O
schedule	schedule	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
3	3	CD	I-NP	O
-	-	HYPH	I-NP	O
week	week	NN	I-NP	O
schedule	schedule	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O


Follow	Follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
controls	control	NNS	B-NP	O
of	of	IN	B-PP	O
luteinizing	luteinize	VBG	B-VP	O
hormone	hormone	NN	B-NP	O
(	(	(	O	O
LH	LH	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
follicle	follicle	NN	B-NP	O
stimulating	stimulate	VBG	B-VP	O
hormone	hormone	NN	B-NP	O
(	(	(	O	O
FSH	FSH	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
prolactin	prolactin	NN	B-NP	O
(	(	(	O	O
HPRL	HPRL	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
oestradiol	oestradiol	NN	B-NP	O
(	(	(	O	O
E2	E2	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
progesterone	progesterone	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
testosterone	testosterone	NN	B-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
catabolic	catabolic	JJ	I-NP	O
and	and	CC	I-NP	O
healing	healing	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
burn	burn	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O


Renin	Renin	NN	B-NP	B-protein
studies	study	NNS	I-NP	O
performed	perform	VBN	B-VP	O
in	in	IN	B-PP	O
34	34	CD	B-NP	O
hypertensive	hypertensive	JJ	I-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
recipients	recipient	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
elevation	elevation	NN	B-NP	O
of	of	IN	B-PP	O
plasma	plasma	NN	B-NP	B-protein
renin	renin	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
and	and	CC	B-PP	O
of	of	IN	B-PP	O
plasma	plasma	NN	B-NP	O
aldosterone	aldosterone	NN	I-NP	O
level	level	NN	I-NP	O
is	be	VBZ	B-VP	O
frequent	frequent	JJ	B-ADJP	O
but	but	CC	I-ADJP	O
difficult	difficult	JJ	I-ADJP	O
to	to	TO	B-VP	O
interpret	interpret	VB	I-VP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
is	be	VBZ	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O


A	A	DT	B-NP	O
randomized	randomize	VBN	I-NP	O
clinical	clinical	JJ	I-NP	O
trial	trial	NN	I-NP	O
in	in	IN	B-PP	O
sixty	sixty	CD	B-NP	O
-	-	HYPH	I-NP	O
two	two	CD	I-NP	O
adult	adult	JJ	I-NP	O
patients	patient	NNS	I-NP	O
suffering	suffer	VBG	B-VP	O
from	from	IN	B-PP	O
typhoid	typhoid	JJ	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
proved	prove	VBN	B-VP	O
by	by	IN	B-PP	O
blood	blood	NN	B-NP	O
and	and	CC	I-NP	O
marrow	marrow	NN	I-NP	O
culture	culture	NN	I-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
amoxycillin	amoxycillin	NN	B-NP	B-protein
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dosage	dosage	NN	I-NP	O
schedule	schedule	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
g	g	NN	I-NP	O
8	8	CD	B-NP	O
-	-	HYPH	I-NP	O
hourly	hourly	RB	B-ADVP	O
orally	orally	RB	I-ADVP	O
for	for	IN	B-PP	O
fourteen	fourteen	CD	B-NP	O
days	day	NNS	I-NP	O
was	be	VBD	B-VP	O
better	good	JJR	B-ADJP	O
than	than	IN	B-PP	O
chloramphenicol	chloramphenicol	NN	B-NP	O
with	with	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
clinical	clinical	JJ	B-NP	O
and	and	CC	I-NP	O
temperature	temperature	NN	I-NP	O
response	response	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
respect	respect	NN	B-NP	O
of	of	IN	B-PP	O
carriers	carrier	NNS	B-NP	O
and	and	CC	O	O
relapse	relapse	NN	B-NP	O
rates	rate	NNS	I-NP	O
.	.	.	O	O


202	202	CD	B-NP	O
-	-	HYPH	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O


Bone	Bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
transplantation	transplantation	NN	I-NP	O
-	-	HYPH	B-NP	O
1979	1979	CD	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
this	this	DT	B-NP	O
article	article	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
actions	action	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
principal	principal	JJ	I-NP	B-protein
dopamine	dopamine	NN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
stimulating	stimulate	VBG	B-VP	O
agents	agent	NNS	B-NP	O
(	(	(	O	O
apomorphine	apomorphine	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
derivatives	derivative	NNS	I-NP	O
;	;	:	O	O
piribedil	piribedil	NN	B-NP	O
,	,	,	O	O
rye	rye	NN	B-NP	O
-	-	HYPH	O	O
ergot	ergot	VBN	B-NP	O
derivatives	derivative	NNS	I-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
biochemical	biochemical	JJ	I-NP	O
and	and	CC	I-NP	O
pharmacological	pharmacological	JJ	I-NP	O
properties	property	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
unilateral	unilateral	JJ	I-NP	O
vestibular	vestibular	JJ	I-NP	O
hypofunction	hypofunction	NN	I-NP	O
.	.	.	O	O


Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
pepsin	pepsin	NN	B-NP	B-protein
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
gastric	gastric	JJ	I-NP	O
juice	juice	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
healing	healing	NN	I-NP	O
of	of	IN	B-PP	O
duodenal	duodenal	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
IDF	IDF	NN	I-NP	O
standard	standard	JJ	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
penicillin	penicillin	NN	B-NP	B-protein
in	in	IN	B-PP	O
milk	milk	NN	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
suitable	suitable	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
sulphonamide	sulphonamide	NN	B-NP	O
residues	residue	NNS	I-NP	O
in	in	IN	B-PP	O
milk	milk	NN	B-NP	O
.	.	.	O	O


Capsular	Capsular	JJ	B-NP	O
antigens	antigen	NNS	I-NP	O
of	of	IN	B-PP	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
aureus	aureus	NN	I-NP	O


The	The	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
endotoxin	endotoxin	NN	B-NP	O
fever	fever	NN	I-NP	O
remained	remain	VBD	B-VP	O
uninfluenced	uninfluenced	JJ	B-ADJP	O
by	by	IN	B-PP	O
ALS	ALS	NN	B-NP	B-protein
.	.	.	O	O


2	2	CD	B-NP	O
new	new	JJ	I-NP	O
Algerian	Algerian	JJ	I-NP	O
cases	case	NNS	I-NP	O


Seventy	Seventy	CD	B-NP	O
-	-	HYPH	I-NP	O
one	one	CD	I-NP	O
percent	percent	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
ticarcillin	ticarcillin	NN	B-NP	B-protein
alone	alone	RB	B-ADVP	O
responded	respond	VBD	B-VP	O
favorably	favorably	RB	B-ADVP	O
.	.	.	O	O


Accurate	Accurate	JJ	B-NP	O
pathologic	pathologic	JJ	I-NP	O
staging	staging	NN	I-NP	O
identifies	identify	VBZ	B-VP	O
patients	patient	NNS	B-NP	O
who	who	WP	B-NP	O
are	be	VBP	B-VP	O
potentially	potentially	RB	B-ADJP	O
curable	curable	JJ	I-ADJP	O
with	with	IN	B-PP	O
radiotherapy	radiotherapy	NN	B-NP	O
.	.	.	O	O


Inherent	Inherent	JJ	B-NP	O
hematology	hematology	NN	I-NP	O
of	of	IN	B-PP	O
old	old	JJ	B-NP	O
age	age	NN	I-NP	O


Neomycin	Neomycin	NN	B-NP	O
is	be	VBZ	B-VP	O
fairly	fairly	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
against	against	IN	B-PP	O
staphylococci	staphylococci	NNS	B-NP	O
,	,	,	O	O
less	less	RBR	B-ADJP	O
effective	effective	JJ	I-ADJP	O
against	against	IN	B-PP	O
streptococci	streptococci	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
fairly	fairly	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
against	against	IN	B-PP	O
gram	gram	NN	B-NP	O
-	-	HYPH	B-NP	O
negative	negative	JJ	I-NP	O
intestinal	intestinal	JJ	I-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O


It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
concluded	conclude	VBN	I-VP	O
,	,	,	O	O
that	that	IN	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
given	give	VBN	I-NP	O
section	section	NN	I-NP	O
,	,	,	O	O
75	75	CD	B-NP	O
,	,	,	I-NP	O
7	7	CD	I-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
trabeculae	trabecula	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
contact	contact	NN	B-NP	O
with	with	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
cavities	cavity	NNS	I-NP	O
.	.	.	O	O


2	2	LS	B-LST	O
.	.	.	O	O


Changes	Change	NNS	B-NP	O
in	in	IN	B-PP	O
tissue	tissue	NN	B-NP	O
PCO2	PCO2	NN	I-NP	O
were	be	VBD	B-VP	O
less	less	RBR	B-ADJP	O
dramatic	dramatic	JJ	I-ADJP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
vary	vary	VB	I-VP	O
significantly	significantly	RB	B-ADVP	O
from	from	IN	B-PP	O
those	those	DT	B-NP	O
recorded	record	VBN	B-VP	O
in	in	IN	B-PP	O
venous	venous	JJ	B-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O


Ultrasonic	Ultrasonic	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
calculi	calculus	NNS	I-NP	O
.	.	.	O	O


Recognition	Recognition	NN	B-NP	O
of	of	IN	B-PP	O
emphysema	emphysema	NN	B-NP	O
was	be	VBD	B-VP	O
poor	poor	JJ	B-ADJP	O
when	when	WRB	B-ADVP	O
radiographs	radiograph	NNS	B-NP	O
of	of	IN	B-PP	O
inadequate	inadequate	JJ	B-NP	O
quality	quality	NN	I-NP	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
(	(	(	O	O
anteroposterior	anteroposterior	JJ	B-NP	O
films	film	NNS	I-NP	O
or	or	CC	O	O
films	film	NNS	B-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
or	or	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


Isolation	Isolation	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	O
.	.	SYM	I-NP	O
gambiense	gambiense	NN	I-NP	O
strains	strain	NNS	I-NP	O
in	in	IN	B-PP	O
Zaire	Zaire	NN	B-NP	B-DNA
and	and	CC	O	O
their	their	PRP$	B-NP	O
adaptation	adaptation	NN	I-NP	O
to	to	TO	B-PP	O
laboratory	laboratory	NN	B-NP	O
animals	animal	NNS	I-NP	O


Pharmacokinetic	Pharmacokinetic	JJ	B-NP	O
profile	profile	NN	I-NP	O
of	of	IN	B-PP	O
clonazepam	clonazepam	NN	B-NP	O
in	in	IN	B-PP	O
rhesus	rhesus	NN	B-NP	O
monkeys	monkey	NNS	I-NP	O
.	.	.	O	O


Immunologic	Immunologic	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
in	in	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
brucellosis	brucellosis	NN	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
.	.	.	O	O


Intestinal	Intestinal	JJ	B-NP	O
adaptation	adaptation	NN	I-NP	O
(	(	(	O	O
first	first	JJ	B-ADVP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
parts	part	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O


In	In	IN	B-PP	O
patients	patient	NNS	B-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
no	no	DT	B-NP	O
previous	previous	JJ	I-NP	O
drug	drug	NN	I-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
log	log	NN	B-NP	B-protein
baseline	baseline	NN	I-NP	I-protein
plasma	plasma	NN	I-NP	I-protein
renin	renin	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
and	and	CC	O	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
mean	mean	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
after	after	IN	B-PP	O
SQ	SQ	NN	B-NP	O
20881	20881	CD	I-NP	O
correlated	correlate	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
0.651	0.651	CD	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


These	These	DT	B-NP	O
techniques	technique	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
used	use	VBN	I-VP	O
by	by	IN	B-PP	O
many	many	JJ	B-NP	O
people	people	NNS	I-NP	O
for	for	IN	B-PP	O
many	many	JJ	B-NP	O
years	year	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
claim	claim	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
made	make	VBN	I-VP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
innovation	innovation	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
regard	regard	NN	I-NP	O
.	.	.	O	O


40	40	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
per	per	IN	B-PP	O
os	o	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
bactericidal	bactericidal	JJ	I-NP	B-protein
beta	beta	SYM	I-NP	I-protein
-	-	HYPH	I-NP	O
lactam	lactam	NN	I-NP	O
-	-	HYPH	I-NP	O
antibiotic	antibiotic	JJ	I-NP	B-protein
cephalexin	cephalexin	NN	I-NP	I-protein
during	during	IN	B-PP	O
3	3	CD	B-NP	O
to	to	TO	I-NP	O
60	60	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
57	57	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
Hodgkin	Hodgkin	NN	B-NP	O
'	'	POS	B-NP	O
s	s	NN	I-NP	O
disease	disease	NN	I-NP	O
limited	limit	VBN	B-VP	O
to	to	TO	I-VP	O
above	above	VB	I-VP	O
the	the	DT	B-NP	O
diaphragm	diaphragm	NN	I-NP	O
(	(	(	O	O
Stages	Stage	NNS	B-NP	O
I	I	CD	B-NP	O
and	and	CC	I-NP	O
II	II	CD	I-NP	O
,	,	,	O	O
A	A	NN	B-NP	O
and	and	CC	O	O
B	B	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
radiation	radiation	NN	B-NP	O
therapy	therapy	NN	I-NP	O
alone	alone	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
University	University	NNP	I-NP	O
of	of	IN	B-PP	O
Florida	Florida	NNP	B-NP	O
between	between	IN	B-PP	O
1964	1964	CD	B-NP	O
and	and	CC	I-NP	O
1974	1974	CD	I-NP	O
.	.	.	O	O


Year	Year	NN	B-NP	O
one	one	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
general	general	JJ	I-NP	O
practitioner	practitioner	NN	I-NP	O
medical	medical	JJ	I-NP	O
unit	unit	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
greater	great	JJR	I-NP	O
Glasgow	Glasgow	NNP	I-NP	O
area	area	NN	I-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
multiple	multiple	JJ	I-NP	O
-	-	HYPH	I-NP	O
electrode	electrode	NN	I-NP	O
array	array	NN	I-NP	O
for	for	IN	B-PP	O
round	round	NN	B-NP	O
window	window	NN	I-NP	O
cochlear	cochlear	JJ	I-NP	O
implantation	implantation	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
robust	robust	JJ	I-NP	O
,	,	,	I-NP	O
reliable	reliable	JJ	I-NP	O
system	system	NN	I-NP	O
for	for	IN	B-PP	O
inserting	insert	VBG	B-VP	O
20	20	CD	B-NP	O
mm	mm	NN	I-NP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
scala	scala	NN	I-NP	O
tympani	tympani	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
trauma	trauma	NN	B-NP	O
and	and	CC	O	O
can	can	MD	B-VP	O
provide	provide	VB	I-VP	O
for	for	IN	B-PP	O
bipolar	bipolar	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
.	.	.	O	O


As	As	IN	B-SBAR	O
authorized	authorize	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
World	World	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Organization	Organization	NNP	I-NP	O
29th	29th	NNP	I-NP	O
Expert	Expert	NNP	I-NP	O
Committee	Committee	NNP	I-NP	O
on	on	IN	B-PP	O
Biological	Biological	NNP	B-NP	O
Standardization	Standardization	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
preparation	preparation	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
prolactin	prolactin	NN	I-NP	I-protein
in	in	IN	B-PP	O
ampoules	ampoule	NNS	B-NP	O
coded	cod	VBD	B-VP	O
75	75	CD	B-NP	O
/	/	SYM	I-NP	O
504	504	CD	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
established	establish	VBN	I-VP	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
International	International	NNP	I-NP	O
Reference	Reference	NNP	I-NP	O
Preparation	Preparation	NNP	I-NP	O
(	(	(	O	O
IRP	IRP	NN	B-NP	B-protein
)	)	)	O	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
prolactin	prolactin	NN	I-NP	O
for	for	IN	B-PP	O
immunoassay	immunoassay	NN	B-NP	O
.	.	.	O	O


i	i	LS	B-LST	O
.	.	.	O	O


Biliary	Biliary	JJ	B-NP	O
-	-	HYPH	I-NP	O
enteric	enteric	JJ	I-NP	O
fistulas	fistula	NNS	I-NP	O


Plasma	Plasma	NN	B-NP	O
ion	ion	NN	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
venous	venous	JJ	B-NP	O
blood	blood	NN	I-NP	O
incubated	incubate	VBN	B-VP	O
with	with	IN	B-PP	O
beta	beta	NN	B-NP	O
receptor	receptor	NN	I-NP	O
blockers	blocker	NNS	I-NP	O
and	and	CC	O	O
subjected	subject	VBN	B-VP	O
to	to	TO	B-PP	O
tonometry	tonometry	NN	B-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O


Such	Such	JJ	B-NP	O
marked	marked	JJ	I-NP	O
differences	difference	NNS	I-NP	O
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
occasionally	occasionally	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
literature	literature	NN	I-NP	O
:	:	:	O	O
heterophile	heterophile	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
against	against	IN	B-PP	O
bovine	bovine	JJ	B-NP	B-protein
gammaglobulin	gammaglobulin	NN	I-NP	I-protein
are	be	VBP	B-VP	O
regarded	regard	VBN	I-VP	O
as	as	IN	B-PP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
interference	interference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Sephadex	Sephadex	NN	I-NP	O
system	system	NN	I-NP	O
of	of	IN	B-PP	O
RIST	RIST	NN	B-NP	B-protein
.	.	.	O	O


"	"	''	O	O
Let	Let	VBD	B-VP	O
the	the	DT	B-NP	O
hundred	hundred	CD	I-NP	O
flowers	flower	NNS	I-NP	O
bloom	bloom	NN	I-NP	O
"	"	''	O	O
.	.	.	O	O


Various	Various	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
modalities	modality	NNS	I-NP	O
are	be	VBP	B-VP	O
reviewed	review	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
psychology	psychology	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
physiology	physiology	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
intractable	intractable	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O


Lethal	Lethal	JJ	B-NP	O
Tachmalcor	Tachmalcor	NNP	I-NP	O
(	(	(	O	O
4	4	CD	B-NP	O
-	-	HYPH	O	O
(	(	(	O	O
3	3	CD	B-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
diethylamino	diethylamino	NN	I-NP	O
-	-	HYPH	I-NP	O
2	2	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
hydroxypropyl	hydroxypropyl	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
ajmaline	ajmaline	NN	I-NP	O
)	)	)	O	O
poisoning	poisoning	NN	B-NP	O
in	in	IN	B-PP	O
childhood	childhood	NN	B-NP	O


Ophthalmosonographic	Ophthalmosonographic	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
flow	flow	NN	I-NP	O
velocity	velocity	NN	I-NP	O
in	in	IN	B-PP	O
arteriocavernous	arteriocavernous	JJ	B-NP	O
fistula	fistula	NNS	I-NP	O


Serum	Serum	NN	B-NP	B-protein
ferritin	ferritin	NN	I-NP	I-protein
concentration	concentration	NN	I-NP	O
and	and	CC	O	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
iron	iron	NN	I-NP	O
stores	store	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
gradient	gradient	NN	I-NP	O
(	(	(	O	O
SPG	SPG	NN	B-NP	O
)	)	)	O	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
(	(	(	O	O
LV	LV	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
left	left	JJ	B-NP	O
atrium	atrium	NN	I-NP	O
(	(	(	O	O
LA	LA	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
fidelity	fidelity	NN	I-NP	O
pressure	pressure	NN	I-NP	O
transducers	transducer	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
trail	trail	NN	I-NP	O
comparing	compare	VBG	B-VP	O
hysterectomy	hysterectomy	NN	B-NP	O
,	,	,	O	O
hysterectomy	hysterectomy	NN	B-NP	O
plus	plus	CC	O	O
vaginal	vaginal	JJ	B-NP	O
radium	radium	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
uterine	uterine	JJ	B-NP	O
radium	radium	NN	I-NP	O
plus	plus	CC	O	O
hysterectomy	hysterectomy	NN	B-NP	O
in	in	IN	B-PP	O
stage	stage	NN	B-NP	O
I	I	CD	I-NP	O
endometrial	endometrial	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O


On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
'	'	POS	B-NP	O
s	s	JJ	I-NP	O
report	report	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
inaccurate	inaccurate	JJ	I-NP	O
Clinitemp	Clinitemp	NNP	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
undertook	undertake	VBD	B-VP	O
to	to	TO	I-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
accuracy	accuracy	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
thermometer	thermometer	NN	I-NP	O
.	.	.	O	O


Cryoglobulinemia	Cryoglobulinemia	NN	B-NP	O
in	in	IN	B-PP	O
Raynaud	Raynaud	NNP	B-NP	O
'	'	POS	B-NP	O
s	s	NNS	I-NP	O
syndrome	syndrome	NN	I-NP	O


Data	Datum	NNS	B-NP	O
were	be	VBD	B-VP	O
processed	process	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
semi	semi	AFX	I-NP	O
-	-	HYPH	I-NP	O
automatic	automatic	JJ	I-NP	O
computer	computer	NN	I-NP	O
program	program	NN	I-NP	O
which	which	WDT	B-NP	O
develops	develop	VBZ	B-VP	O
an	an	DT	B-NP	O
averaged	averaged	JJ	I-NP	O
-	-	HYPH	I-NP	O
volume	volume	NN	I-NP	O
curve	curve	NN	I-NP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
assigned	assign	VBN	I-NP	O
LV	LV	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
-	-	HYPH	B-NP	O
of	of	IN	B-PP	O
-	-	HYPH	B-NP	O
interest	interest	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
preferential	preferential	JJ	I-NP	O
serum	serum	NN	I-NP	O
IgA	IgA	NN	I-NP	O
response	response	NN	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
population	population	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
bronchial	bronchial	JJ	B-NP	O
associated	associate	VBN	I-NP	O
lymphoid	lymphoid	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
diseased	diseased	JJ	I-NP	O
lung	lung	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
circulating	circulate	VBG	B-VP	O
IgA	IgA	NN	B-NP	B-protein
.	.	.	O	O


Ultimate	Ultimate	JJ	B-NP	O
strengthes	strengthe	NNS	I-NP	O
seem	seem	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
reached	reach	VBN	I-VP	O
for	for	IN	B-PP	O
cast	cast	VBN	B-NP	O
cobalt	cobalt	NN	I-NP	O
alloys	alloy	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
titanium	titanium	NN	B-NP	O
alloys	alloy	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Ta	Ta	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
V	V	NN	I-NP	O
,	,	,	O	O
present	present	VBP	B-VP	O
very	very	RB	B-NP	O
high	high	JJ	I-NP	O
fatigue	fatigue	NN	I-NP	O
limit	limit	NN	I-NP	O
under	under	IN	B-PP	O
corrosion	corrosion	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
intracisternal	intracisternal	JJ	B-NP	O
injection	injection	NN	I-NP	O
(	(	(	O	O
i	i	NN	B-NP	O
.	.	.	O	O
c	c	NN	B-NP	O
.	.	.	I-NP	O
i	i	NN	I-NP	O
.	.	.	O	O
)	)	)	O	O
of	of	IN	B-PP	O
clonidine	clonidine	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
microgram	microgram	NN	I-NP	O
kg	kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
conscious	conscious	JJ	B-NP	O
rabbits	rabbit	NNS	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
implanted	implant	VBN	I-NP	O
catheter	catheter	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cisterna	cisterna	NN	I-NP	O
magna	magna	NN	I-NP	O
.	.	.	O	O


Platelet	Platelet	NN	B-NP	O
number	number	NN	I-NP	O
and	and	CC	O	O
life	life	NN	B-NP	O
span	span	NN	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
trimester	trimester	NN	I-NP	O
of	of	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
in	in	IN	B-PP	O
22	22	CD	B-NP	O
women	woman	NNS	I-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
delivered	deliver	VBN	I-VP	O
of	of	IN	B-PP	O
small	small	JJ	B-NP	O
-	-	HYPH	I-NP	O
for	for	IN	B-PP	O
-	-	HYPH	B-NP	O
gestational	gestational	JJ	I-NP	O
age	age	NN	I-NP	O
(	(	(	O	O
SGA	SGA	NN	B-NP	O
)	)	)	O	O
infants	infant	NNS	B-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
21	21	CD	B-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
infants	infant	NNS	B-NP	O
having	have	VBG	B-VP	O
normal	normal	JJ	B-NP	O
birth	birth	NN	I-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O


Serial	Serial	JJ	B-NP	O
measurements	measurement	NNS	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
serum	serum	NN	I-NP	O
IgE	IgE	NN	I-NP	B-protein
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
useful	useful	JJ	I-NP	O
index	index	NN	I-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
ABPA	ABPA	NNP	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
the	the	DT	B-NP	O
8	8	CD	I-NP	O
patients	patient	NNS	I-NP	O
the	the	DT	B-NP	O
difference	difference	NN	I-NP	O
betweent	betweent	IN	B-SBAR	O
he	he	PRP	B-NP	O
mean	mean	VB	B-VP	O
diastolic	diastolic	JJ	B-NP	O
values	value	NNS	I-NP	O
of	of	IN	B-PP	O
delta	delta	NN	B-NP	O
PU	PU	NN	I-NP	O
and	and	CC	I-NP	O
delta	delta	NN	I-NP	O
PM	PM	NN	I-NP	O
was	be	VBD	B-VP	O
-	-	SYM	B-ADJP	O
0.54	0.54	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1.0	1.0	CD	B-NP	O
(	(	(	O	O
SD	SD	NN	B-NP	O
)	)	)	O	O
mmHg	mmHg	NN	B-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
rise	rise	NN	I-NP	O
of	of	IN	B-PP	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
concentration	concentration	NN	I-NP	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
iron	iron	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
serum	serum	NN	I-NP	O
of	of	IN	B-PP	O
white	white	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
under	under	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
atm	atm	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
hour	hour	NN	I-NP	O
(	(	(	O	O
preconvulsive	preconvulsive	JJ	B-NP	O
state	state	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
6	6	CD	B-NP	O
atm	atm	NN	I-NP	O
(	(	(	O	O
convulsive	convulsive	JJ	B-NP	O
state	state	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


Nernst	Nernst	NN	B-NP	O
-	-	HYPH	O	O
-	-	HYPH	B-NP	O
Planck	Planck	NN	I-NP	O
analog	analog	NN	I-NP	O
equations	equation	NNS	I-NP	O
and	and	CC	O	O
stationary	stationary	JJ	B-NP	O
state	state	NN	I-NP	O
membrane	membrane	NN	I-NP	O
electric	electric	JJ	I-NP	O
potentials	potential	NNS	I-NP	O
.	.	.	O	O


Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
methylene	methylene	NN	B-NP	O
chloride	chloride	NN	I-NP	O
,	,	,	O	O
trichloroethane	trichloroethane	NN	B-NP	O
,	,	,	O	O
trichloroethylene	trichloroethylene	NN	B-NP	O
,	,	,	O	O
tetrachloroethylene	tetrachloroethylene	NN	B-NP	O
and	and	CC	I-NP	O
toluene	toluene	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
chick	chick	NN	B-NP	O
embryos	embryo	NNS	I-NP	O
.	.	.	O	O


Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
intraventricular	intraventricular	JJ	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
streptolysin	streptolysin	NN	B-NP	O
O	O	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
electroencephalogram	electroencephalogram	NN	I-NP	O
of	of	IN	B-PP	O
rabbits	rabbit	NNS	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
this	this	DT	B-NP	O
situation	situation	NN	I-NP	O
the	the	DT	B-NP	O
convlusion	convlusion	NN	I-NP	O
threshold	threshold	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
8	8	CD	I-NP	O
substances	substance	NNS	I-NP	O
is	be	VBZ	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
pethidine	pethidine	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	SYM	I-NP	O
kg	kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
I	I	NN	I-NP	O
.	.	.	O	O
V	V	NNP	B-NP	O
.	.	NN	I-NP	O
,	,	,	O	O
piritramide	piritramide	NN	B-NP	O
30	30	CD	I-NP	O
,	,	,	O	O
morphine	morphine	NN	B-NP	O
180	180	CD	I-NP	O
,	,	,	O	O
phenoperidine	phenoperidine	NN	B-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
R	R	NN	B-NP	B-protein
39	39	CD	I-NP	I-protein
209	209	CD	I-NP	I-protein
5	5	CD	I-NP	I-protein
,	,	,	O	O
fentanyl	fentanyl	NN	B-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
sufentanil	sufentanil	NN	B-NP	O
4	4	CD	I-NP	O
and	and	CC	O	O
R	R	NN	B-NP	B-protein
34	34	CD	I-NP	I-protein
995	995	CD	I-NP	I-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
.	.	SYM	I-NP	I-protein
kg	kg	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
I	I	NN	I-NP	O
.	.	.	O	O
V	V	NNP	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
biochemistry	biochemistry	NN	I-NP	O
of	of	IN	B-PP	O
amniotic	amniotic	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
fetal	fetal	JJ	I-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O


Roentgenographically	Roentgenographically	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
lesion	lesion	NN	I-NP	O
was	be	VBD	B-VP	O
usually	usually	RB	B-ADVP	O
a	a	DT	B-NP	O
well	well	RB	I-NP	O
-	-	HYPH	I-NP	O
defined	define	VBN	I-NP	O
and	and	CC	I-NP	O
benign	benign	JJ	I-NP	O
appearing	appear	VBG	I-NP	O
one	one	CD	I-NP	O
,	,	,	O	O
either	either	CC	O	O
purely	purely	RB	B-ADJP	O
lytic	lytic	JJ	I-ADJP	O
(	(	(	O	O
3	3	CD	B-NP	O
cases	case	NNS	I-NP	O
)	)	)	O	O
or	or	CC	O	O
with	with	IN	B-PP	O
central	central	JJ	B-NP	O
radiodensity	radiodensity	NN	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
cases	case	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O


Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
descending	descend	VBG	I-NP	O
tractotomy	tractotomy	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
neurons	neuron	NNS	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
trigeminal	trigeminal	JJ	I-NP	O
nuclei	nucleus	NNS	I-NP	O
principalis	principalis	NN	I-NP	O
and	and	CC	I-NP	O
oralis	oralis	NN	I-NP	O
.	.	.	O	O


Efficacy	Efficacy	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
three	three	CD	I-NP	O
-	-	HYPH	I-NP	O
versus	versus	IN	B-PP	O
a	a	DT	B-NP	O
five	five	CD	I-NP	O
-	-	HYPH	I-NP	O
week	week	NN	I-NP	O
alcohol	alcohol	NN	I-NP	O
treatment	treatment	NN	I-NP	O
program	program	NN	I-NP	O
.	.	.	O	O


Resistance	Resistance	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
simulated	simulated	JJ	I-NP	O
physiologic	physiologic	JJ	I-NP	O
environment	environment	NN	I-NP	O
was	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
by	by	IN	B-PP	O
measured	measure	VBN	B-NP	O
retention	retention	NN	I-NP	O
of	of	IN	B-PP	O
mechanical	mechanical	JJ	B-NP	O
properties	property	NNS	I-NP	O
after	after	IN	B-PP	O
immersion	immersion	NN	B-NP	O
times	time	NNS	I-NP	O
in	in	IN	B-PP	O
pseudo	pseudo	AFX	B-NP	O
-	-	HYPH	I-NP	O
extracellular	extracellular	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
(	(	(	O	O
PECF	PECF	NN	B-NP	B-protein
)	)	)	O	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
for	for	IN	B-PP	O
as	as	RB	B-ADVP	O
long	long	JJ	I-ADVP	O
as	as	IN	B-PP	O
three	three	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O


Isolated	Isolate	VBN	B-NP	O
calcaneal	calcaneal	JJ	I-NP	O
tuberculous	tuberculous	JJ	I-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
.	.	.	O	O


It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
opiate	opiate	JJ	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
bordering	border	VBG	B-VP	O
the	the	DT	B-NP	O
fourth	fourth	JJ	I-NP	O
cerebral	cerebral	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
mediate	mediate	VBP	B-VP	O
the	the	DT	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
and	and	CC	I-NP	O
hypnotic	hypnotic	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
fentanyl	fentanyl	NN	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
case	case	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
pathologically	pathologically	RB	I-NP	O
convoluted	convolute	VBN	I-NP	O
internal	internal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
the	the	DT	B-NP	O
common	common	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
artery	artery	NN	I-NP	O
was	be	VBD	B-VP	O
resected	resecte	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
end	end	NN	I-NP	O
-	-	HYPH	B-ADJP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
end	end	NN	I-NP	O
anastomosis	anastomosis	NN	I-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
expression	expression	NN	I-NP	O
assumes	assume	NNS	I-NP	O
:	:	:	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
a	a	DT	B-NP	O
laminar	laminar	JJ	I-NP	O
flow	flow	NN	I-NP	O
regimen	regimen	NN	I-NP	O
during	during	IN	B-PP	O
expiration	expiration	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
(	(	(	B-LST	O
2	2	LS	I-LST	O
)	)	)	O	O
a	a	DT	B-NP	O
constant	constant	JJ	I-NP	O
CT	CT	NN	I-NP	O
value	value	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
VT	VT	NN	B-NP	B-protein
.	.	.	O	O


These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
confirm	confirm	VBP	B-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
hyperlipemic	hyperlipemic	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
crisis	crisis	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
entity	entity	NN	I-NP	O
and	and	CC	O	O
testify	testify	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
recognizing	recognize	VBG	B-VP	O
this	this	DT	B-NP	O
syndrome	syndrome	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
performance	performance	NN	I-NP	O
of	of	IN	B-PP	O
unnecessary	unnecessary	JJ	B-NP	O
and	and	CC	I-NP	O
potentially	potentially	RB	I-NP	O
harmful	harmful	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
Treatment	Treatment	NN	I-NP	O
X	X	NN	I-NP	O
Strain	Strain	NN	I-NP	O
interaction	interaction	NN	I-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
larger	large	JJR	I-NP	O
defecation	defecation	NN	I-NP	O
numbers	number	NNS	I-NP	O
displayed	display	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
taurine	taurine	NN	I-NP	O
-	-	HYPH	B-VP	O
injected	inject	VBN	B-NP	O
MR	MR	NN	I-NP	O
rats	rat	NNS	I-NP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
saline	saline	NN	I-NP	O
-	-	HYPH	B-VP	O
injected	inject	VBN	B-NP	O
MR	MR	NN	I-NP	O
rats	rat	NNS	I-NP	O
.	.	.	O	O


Their	Their	PRP$	B-NP	O
conduction	conduction	NN	I-NP	O
velocity	velocity	NN	I-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
0.23	0.23	CD	B-NP	O
to	to	TO	I-NP	O
0.98	0.98	CD	I-NP	O
m	m	NN	I-NP	O
/	/	SYM	B-NP	O
sec	sec	NN	B-NP	O
(	(	(	O	O
group	group	NN	B-NP	O
C	C	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
failures	failure	NNS	I-NP	O
frequently	frequently	RB	B-ADVP	O
were	be	VBD	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
intolerance	intolerance	NN	I-NP	O
or	or	CC	O	O
poor	poor	JJ	B-NP	O
mechanical	mechanical	JJ	I-NP	O
fit	fit	NN	I-NP	O
and	and	CC	O	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
or	or	CC	O	O
first	first	JJ	B-NP	O
few	few	JJ	I-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-PP	O
insertion	insertion	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
major	major	JJ	I-NP	O
urinary	urinary	JJ	I-NP	O
metabolites	metabolite	NNS	I-NP	O
were	be	VBD	B-VP	O
3	3	CD	B-NP	O
-	-	HYPH	O	O
(	(	(	O	O
3	3	CD	B-NP	O
-	-	HYPH	I-NP	O
carboxyphenyl	carboxyphenyl	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
5	5	CD	I-NP	O
-	-	HYPH	I-NP	O
hydroxymethyl	hydroxymethyl	NN	I-NP	O
-	-	HYPH	B-NP	O
2	2	CD	I-NP	O
-	-	HYPH	I-NP	O
oxazolidinone	oxazolidinone	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
glucuronide	glucuronide	NN	I-NP	O
of	of	IN	B-PP	O
toloxatone	toloxatone	NN	B-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
characteristics	characteristic	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
the	the	DT	B-NP	O
pronounced	pronounced	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
collagenous	collagenous	JJ	B-NP	O
fiber	fiber	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
matrix	matrix	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
osteoid	osteoid	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
ventilation	ventilation	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
increase	increase	VB	I-VP	O
when	when	WRB	B-ADVP	O
PACO2	PACO2	NN	B-NP	B-protein
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
.	.	.	O	O


Carbohydrate	Carbohydrate	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
semen	seman	NNS	I-NP	O
profile	profile	NN	I-NP	O
:	:	:	O	O
glucose	glucose	NN	B-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
sperm	sperm	NN	B-NP	O
studies	study	NNS	I-NP	O
.	.	.	O	O


It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
come	come	VBN	I-VP	O
out	out	RP	B-PRT	O
that	that	IN	B-SBAR	O
CAEC	CAEC	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
CC	CC	NN	B-NP	O
and	and	CC	I-NP	O
CIEC	CIEC	NN	I-NP	B-protein
and	and	CC	O	O
that	that	IN	B-SBAR	O
attacks	attack	NNS	B-NP	O
of	of	IN	B-PP	O
biliary	biliary	JJ	B-NP	O
fever	fever	NN	I-NP	O
and	and	CC	O	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
and	and	CC	O	O
transaminases	transaminase	NNS	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
helpful	helpful	JJ	I-NP	O
findings	finding	NNS	I-NP	O
for	for	IN	B-PP	O
preoperative	preoperative	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
sub	sub	AFX	I-NP	O
-	-	HYPH	I-NP	O
acute	acute	JJ	I-NP	O
inhalation	inhalation	NN	I-NP	O
toxicity	toxicity	NN	I-NP	O
of	of	IN	B-PP	O
furfural	furfural	JJ	B-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
Syrian	Syrian	JJ	B-NP	O
golden	golden	JJ	I-NP	O
hamsters	hamster	NNS	I-NP	O
.	.	.	O	O


Changes	Change	NNS	B-NP	O
of	of	IN	B-PP	O
thirtynine	thirtynine	NN	B-NP	O
serum	serum	NN	I-NP	O
protein	protein	NN	I-NP	O
components	component	NNS	I-NP	O
following	follow	VBG	B-PP	O
surgical	surgical	JJ	B-NP	O
stress	stress	NN	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
differences	difference	NNS	I-NP	O
are	be	VBP	B-VP	O
smaller	small	JJR	B-ADJP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
described	describe	VBN	B-VP	O
in	in	IN	B-PP	O
standard	standard	JJ	B-NP	O
textbooks	textbook	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
E	E	NNP	I-NP	O
.	.	.	I-NP	O
O	O	NNP	I-NP	O
.	.	.	I-NP	O
R	R	NNP	I-NP	O
.	.	.	I-NP	O
T	T	NNP	I-NP	O
.	.	VBD	B-VP	O
C	C	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
dependence	dependence	NN	I-NP	O
of	of	IN	B-PP	O
difference	difference	NN	B-NP	O
tone	tone	NN	I-NP	O
level	level	NN	I-NP	O
[	[	(	O	O
L	L	NN	B-NP	O
(	(	(	O	O
f2	f2	NN	B-NP	O
-	-	HYPH	O	O
f1	f1	NN	B-NP	O
)	)	)	O	O
]	]	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
parameters	parameter	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
-	-	HYPH	I-NP	O
tone	tone	NN	I-NP	O
input	input	NN	I-NP	O
:	:	:	O	O
f1	f1	NN	B-NP	O
,	,	,	O	O
f2	f2	NN	B-NP	B-protein
/	/	SYM	O	O
f1	f1	NN	B-NP	B-protein
(	(	(	O	O
f2	f2	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
f1	f1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
L1	L1	NN	B-NP	B-DNA
,	,	,	O	O
L2	L2	NN	B-NP	B-DNA
,	,	,	O	O
and	and	CC	O	O
L1	L1	NN	B-NP	B-DNA
=	=	JJ	I-NP	O
L2	L2	NN	I-NP	B-DNA
.	.	.	O	O


An	An	DT	B-NP	O
intravenous	intravenous	JJ	I-NP	O
preparation	preparation	NN	I-NP	O
of	of	IN	B-PP	O
doxycycline	doxycycline	NN	B-NP	O
(	(	(	O	O
DOTC	DOTC	NNP	B-NP	O
,	,	,	O	O
Vibramycin	Vibramycin	NNP	B-NP	O
'	'	POS	B-NP	O
Pfizer	Pfizer	NNP	I-NP	O
'	'	POS	B-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
long	long	RB	I-NP	O
-	-	HYPH	I-NP	O
lasting	last	VBG	B-VP	O
tetracycline	tetracycline	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
mainly	mainly	RB	B-ADVP	O
by	by	IN	B-PP	O
drip	drip	NN	B-NP	O
infusion	infusion	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
study	study	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pediatrics	pediatric	NNS	I-NP	O
field	field	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
)	)	)	O	O
DOTC	DOTC	NN	B-NP	O
(	(	(	O	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
dissolved	dissolve	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
100	100	CD	I-NP	O
ml	ml	NN	I-NP	O
of	of	IN	B-PP	O
glucose	glucose	NN	B-NP	B-protein
solution	solution	NN	I-NP	I-protein
and	and	CC	O	I-protein
2	2	CD	B-NP	I-protein
-	-	HYPH	I-NP	O
-	-	SYM	I-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
intravenously	intravenously	RB	B-ADVP	O
.	.	.	O	O


5	5	LS	B-LST	O
)	)	)	O	O
Before	Before	IN	B-ADVP	O
and	and	CC	O	O
ten	ten	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
DOTC	DOTC	NN	B-NP	O
infusion	infusion	NN	I-NP	O
,	,	,	O	O
laboratory	laboratory	NN	B-NP	O
tests	test	NNS	I-NP	O
for	for	IN	B-PP	O
liver	liver	NN	B-NP	O
and	and	CC	I-NP	O
renal	renal	JJ	I-NP	O
functions	function	NNS	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O


Structural	Structural	JJ	B-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
erythrocyte	erythrocyte	NN	I-NP	O
membrane	membrane	NN	I-NP	O
,	,	,	O	O
peroxidation	peroxidation	NN	B-NP	O
processes	process	NNS	I-NP	O
and	and	CC	O	O
antioxidant	antioxidant	JJ	B-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
diffuse	diffuse	JJ	B-NP	O
glomerulonephritis	glomerulonephritis	NN	I-NP	O


The	The	DT	B-NP	O
enteric	enteric	JJ	I-NP	O
route	route	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
principal	principal	JJ	I-NP	O
mode	mode	NN	I-NP	O
of	of	IN	B-PP	O
transmission	transmission	NN	B-NP	O
for	for	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
maximal	maximal	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
A	A	NN	I-NP	O
virus	virus	NN	I-NP	O
excretion	excretion	NN	I-NP	O
occur	occur	VBP	B-VP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
jaundice	jaundice	NN	B-NP	O
.	.	.	O	O


All	All	DT	B-NP	O
13	13	CD	I-NP	O
patients	patient	NNS	I-NP	O
showed	show	VBD	B-VP	O
endoscopic	endoscopic	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
oesophagitis	oesophagitis	NN	B-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-ADJP	O
in	in	IN	B-PP	O
4	4	CD	B-NP	O
and	and	CC	O	O
severe	severe	JJ	B-ADJP	O
in	in	IN	B-PP	O
9	9	CD	B-NP	O
.	.	.	O	O


Urinary	Urinary	JJ	B-NP	O
excretion	excretion	NN	I-NP	O
of	of	IN	B-PP	O
oestrone	oestrone	NN	B-NP	O
,	,	,	O	O
oestradiol	oestradiol	NN	B-NP	B-protein
-	-	HYPH	O	I-protein
17	17	CD	B-NP	I-protein
beta	beta	SYM	I-NP	I-protein
and	and	CC	I-NP	O
oestriol	oestriol	NN	I-NP	O
in	in	IN	B-PP	O
pregnancies	pregnancy	NNS	B-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
steroid	steroid	NN	B-NP	B-protein
sulphatase	sulphatase	NN	I-NP	I-protein
deficiency	deficiency	NN	I-NP	O
.	.	.	O	O


Both	Both	DT	B-NP	O
reduced	reduce	VBD	B-VP	O
spontaneous	spontaneous	JJ	B-NP	O
locomotor	locomotor	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
,	,	,	O	O
protected	protect	VBD	B-VP	O
them	them	PRP	B-NP	O
from	from	IN	B-PP	O
death	death	NN	B-NP	O
from	from	IN	B-PP	O
amphetamine	amphetamine	NN	B-NP	O
induced	induce	VBD	B-VP	O
toxicity	toxicity	NN	B-NP	O
,	,	,	O	O
prolonged	prolong	VBD	B-VP	O
hexobarbitone	hexobarbitone	NN	B-NP	O
sleeping	sleeping	NN	I-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
depletion	depletion	NN	I-NP	O
of	of	IN	B-PP	O
catecholamines	catecholamine	NNS	B-NP	O
from	from	IN	B-PP	O
various	various	JJ	B-NP	O
organs	organ	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
.	.	.	O	O


On	On	IN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
transferrin	transferrin	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
uptake	uptake	NN	I-NP	O
of	of	IN	B-PP	O
gallium	gallium	NN	B-NP	O
by	by	IN	B-PP	O
tumor	tumor	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O


Irradiation	Irradiation	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
platelets	platelet	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
UV	UV	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
A	A	NN	I-NP	I-protein
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
impairs	impair	VBZ	B-VP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
aggregate	aggregate	VB	I-VP	O
after	after	IN	B-PP	O
challenge	challenge	NN	B-NP	O
with	with	IN	B-PP	O
collagen	collagen	NN	B-NP	B-protein
.	.	.	O	O


With	With	IN	B-PP	O
certain	certain	JJ	B-NP	O
exceptions	exception	NNS	I-NP	O
the	the	DT	B-NP	O
method	method	NN	I-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
suitable	suitable	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
routine	routine	JJ	I-NP	O
intravenous	intravenous	JJ	I-NP	O
cholangiography	cholangiography	NN	I-NP	O
.	.	.	O	O


Following	Follow	VBG	B-PP	O
the	the	DT	B-NP	O
satisfactory	satisfactory	JJ	I-NP	O
results	result	NNS	I-NP	O
and	and	CC	O	O
taking	take	VBG	B-VP	O
into	into	IN	B-PP	O
account	account	NN	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
complications	complication	NNS	I-NP	O
had	have	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
low	low	JJ	I-NP	O
rate	rate	NN	I-NP	O
(	(	(	O	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
cases	case	NNS	I-NP	O
lead	lead	VBP	B-VP	O
tip	tip	NN	B-NP	O
displacement	displacement	NN	I-NP	O
and	and	CC	O	O
pouch	pouch	NN	B-NP	O
haematoma	haematoma	NN	I-NP	O
occurred	occur	VBD	B-VP	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
Authors	Author	NNS	I-NP	O
consider	consider	VBP	B-VP	O
the	the	DT	B-NP	O
adopted	adopt	VBN	I-NP	O
method	method	NN	I-NP	O
an	an	DT	B-NP	O
useful	useful	JJ	I-NP	O
approach	approach	NN	I-NP	O
for	for	IN	B-PP	O
PMK	PMK	NN	B-NP	O
implantation	implantation	NN	I-NP	O
particularly	particularly	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
vena	vena	NN	I-NP	O
cephalica	cephalica	NN	I-NP	O
is	be	VBZ	B-VP	O
deemed	deem	VBN	I-VP	O
impossible	impossible	JJ	B-ADJP	O
.	.	.	O	O


When	When	WRB	B-ADVP	O
two	two	CD	B-NP	O
determinations	determination	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
12	12	CD	B-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
plasma	plasma	NN	B-NP	O
taken	take	VBN	B-VP	O
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	O
adults	adult	NNS	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
22.6	22.6	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
4.8	4.8	CD	B-NP	O
and	and	CC	I-NP	O
21.0	21.0	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
3.6	3.6	CD	B-NP	O
(	(	(	O	O
mean	mean	NN	B-NP	O
+	+	SYM	O	O
/	/	SYM	B-NP	O
-	-	HYPH	B-NP	O
SD	SD	NN	I-NP	O
)	)	)	O	O
ng	ng	NN	B-NP	O
/	/	SYM	B-VP	O
ml	ml	NN	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O


The	The	DT	B-NP	O
six	six	CD	I-NP	O
commonest	commonest	JJ	I-NP	O
causes	cause	NNS	I-NP	O
of	of	IN	B-PP	O
death	death	NN	B-NP	O
varied	vary	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
ethnic	ethnic	JJ	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O


Although	Although	IN	B-SBAR	O
Grice	Grice	NNP	B-NP	O
'	'	POS	B-NP	O
s	s	JJ	I-NP	O
operation	operation	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
used	use	VBN	I-VP	O
all	all	DT	B-ADVP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
world	world	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
systematic	systematic	JJ	I-NP	O
account	account	NN	I-NP	O
of	of	IN	B-PP	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
literature	literature	NN	I-NP	O
(	(	(	O	O
including	include	VBG	B-PP	O
publications	publication	NNS	B-NP	O
dealing	deal	VBG	B-VP	O
with	with	IN	B-PP	O
technique	technique	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
presents	present	VBZ	B-VP	O
it	it	PRP	B-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
basic	basic	JJ	I-NP	O
"	"	``	I-NP	O
classical	classical	JJ	I-NP	O
"	"	''	I-NP	O
principles	principle	NNS	I-NP	O
on	on	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
operation	operation	NN	I-NP	O
was	be	VBD	B-VP	O
conceived	conceive	VBN	I-VP	O
.	.	.	O	O


(	(	(	B-LST	O
5	5	LS	I-LST	O
)	)	)	O	O
No	No	DT	B-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
gastric	gastric	JJ	I-NP	O
venous	venous	JJ	I-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
by	by	IN	B-PP	O
continuous	continuous	JJ	B-NP	O
intravenous	intravenous	JJ	I-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
cimetidine	cimetidine	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
by	by	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
injection	injection	NN	I-NP	O
both	both	CC	O	O
the	the	DT	B-NP	O
flow	flow	NN	I-NP	O
was	be	VBD	B-VP	O
augmented	augmented	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
systemic	systemic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
transiently	transiently	RB	B-ADVP	O
.	.	.	O	O


Study	Study	NN	B-NP	O
on	on	IN	B-PP	O
re	re	AFX	B-NP	B-DNA
-	-	HYPH	I-NP	O
establishment	establishment	NN	I-NP	O
of	of	IN	B-PP	O
ovulation	ovulation	NN	B-NP	O
after	after	IN	B-PP	O
termination	termination	NN	B-NP	O
of	of	IN	B-PP	O
sex	sex	NN	B-NP	O
-	-	HYPH	O	O
steroidal	steroidal	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
-	-	HYPH	B-VP	O
-	-	HYPH	B-ADJP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
re	re	AFX	B-NP	O
-	-	HYPH	I-NP	O
appearance	appearance	NN	I-NP	O
of	of	IN	B-PP	O
ovulation	ovulation	NN	B-NP	O
after	after	IN	B-PP	O
abortion	abortion	NN	B-NP	O
and	and	CC	O	O
premature	premature	JJ	B-NP	O
delivery	delivery	NN	I-NP	O
.	.	.	O	O


Pharmacokinetics	Pharmacokinetic	NNS	B-NP	O
of	of	IN	B-PP	O
Carbamazepine	Carbamazepine	NN	B-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
review	review	NN	I-NP	O
.	.	.	O	O


Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
compounds	compound	NNS	I-NP	O
tested	test	VBN	B-VP	O
,	,	,	O	O
alpha	alpha	SYM	O	O
-	-	HYPH	O	O
(	(	(	O	O
3	3	CD	B-NP	O
-	-	HYPH	I-NP	O
methyl	methyl	NN	I-NP	O
-	-	HYPH	B-NP	O
2	2	CD	I-NP	O
-	-	HYPH	I-NP	O
quinoxalinyl	quinoxalinyl	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	O	O
methylnitrone	methylnitrone	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
4	4	CD	I-NP	O
-	-	HYPH	I-NP	O
dioxide	dioxide	NN	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
active	active	JJ	I-NP	O
agent	agent	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
against	against	IN	B-PP	O
the	the	DT	B-NP	O
gram	gram	NN	I-NP	O
-	-	HYPH	B-VP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
gram	gram	NN	I-NP	O
-	-	HYPH	B-NP	O
positive	positive	JJ	I-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O


Changes	Change	NNS	B-NP	O
in	in	IN	B-PP	O
ionic	ionic	JJ	B-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mucous	mucous	NN	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
cholinergic	cholinergic	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
affect	affect	VBP	B-VP	O
pressure	pressure	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
excretory	excretory	JJ	I-NP	O
duct	duct	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gland	gland	NN	I-NP	O
.	.	.	O	O


Calves	Calf	NNS	B-NP	O
fed	feed	VBN	B-NP	O
MCT	MCT	NN	I-NP	O
-	-	HYPH	B-NP	O
milk	milk	NN	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
lower	low	JJR	I-NP	O
blood	blood	NN	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
than	than	IN	B-PP	O
calves	calf	NNS	B-NP	O
fed	feed	VBN	B-NP	O
T	T	NN	I-NP	O
-	-	HYPH	B-NP	O
or	or	CC	I-NP	O
SBO	SBO	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
milk	milk	NN	I-NP	O
.	.	.	O	O


Delayed	Delay	VBN	B-NP	O
mortality	mortality	NN	I-NP	O
of	of	IN	B-PP	O
mice	mouse	NNS	B-NP	O
following	follow	VBG	B-PP	O
inhalation	inhalation	NN	B-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
CH2O	CH2O	NN	B-NP	B-protein
,	,	,	O	O
SO2Cl2	SO2Cl2	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Br2	Br2	NN	B-NP	B-protein
.	.	.	O	O


Guinea	Guinea	NN	B-NP	B-protein
pigs	pig	NNS	I-NP	I-protein
weighing	weigh	VBG	B-VP	I-protein
300	300	CD	B-NP	I-protein
approximately	approximately	RB	I-NP	O
350	350	CD	I-NP	O
g	g	NN	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
.	.	.	O	O


Under	Under	IN	B-PP	O
halothane	halothane	NN	B-NP	O
anesthesia	anesthesia	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
flow	flow	NN	I-NP	O
pneumocardiogram	pneumocardiogram	NN	I-NP	O
(	(	(	O	O
PnCG	PnCG	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
time	time	NN	I-NP	O
derivative	derivative	NN	I-NP	O
(	(	(	O	O
acceleration	acceleration	NN	B-NP	O
pneumocardiogram	pneumocardiogram	NN	I-NP	O
or	or	CC	O	O
dPn	dPn	NN	B-NP	O
/	/	SYM	B-NP	O
dt	dt	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
transduced	transduce	VBN	I-VP	O
during	during	IN	B-PP	O
apnea	apnea	NN	B-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
high	high	JJ	I-NP	O
-	-	HYPH	I-NP	O
gain	gain	NN	I-NP	O
pneumotachograph	pneumotachograph	NN	I-NP	O
.	.	.	O	O


Sensory	Sensory	JJ	B-NP	O
kindling	kindling	NN	I-NP	O
:	:	:	O	O
implications	implication	NNS	B-NP	O
for	for	IN	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
sensory	sensory	JJ	B-NP	O
prostheses	prosthesis	NNS	I-NP	O
.	.	.	O	O


It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
stereotypy	stereotypy	NN	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
evoked	evoke	VBN	I-VP	O
also	also	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
striatal	striatal	JJ	I-NP	O
dopaminergic	dopaminergic	JJ	I-NP	O
tone	tone	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
or	or	CC	O	O
even	even	RB	B-ADVP	O
below	below	IN	B-PP	O
normal	normal	JJ	B-ADJP	O
:	:	:	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
equilibrium	equilibrium	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
striatal	striatal	JJ	I-NP	O
cholinergic	cholinergic	JJ	I-NP	O
-	-	HYPH	I-NP	O
dopaminergic	dopaminergic	JJ	I-NP	O
systems	system	NNS	I-NP	O
which	which	WDT	B-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
shifted	shift	VBN	I-VP	O
towards	towards	IN	B-PP	O
dopamine	dopamine	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
behavioral	behavioral	JJ	I-NP	O
manifestation	manifestation	NN	I-NP	O
.	.	.	O	O


None	None	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cystometrograms	cystometrogram	NNS	I-NP	O
showed	show	VBD	B-VP	O
uninhibited	uninhibited	JJ	B-NP	O
detrusor	detrusor	NN	I-NP	O
contractions	contraction	NNS	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
the	the	DT	B-NP	O
duodenum	duodenum	NN	I-NP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
administered	administer	VBN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
transformed	transform	VBN	I-VP	O
to	to	TO	B-PP	O
3H	3H	NN	B-NP	B-protein
-	-	HYPH	O	I-protein
alpha	alpha	SYM	O	I-protein
-	-	HYPH	O	O
acetyldigoxin	acetyldigoxin	NN	B-NP	O
.	.	.	O	O


Functional	Functional	JJ	B-NP	O
effects	effect	NNS	I-NP	O
following	follow	VBG	B-PP	O
subacute	subacute	JJ	B-NP	O
administration	administration	NN	I-NP	O
.	.	.	O	O


Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
Graves	Graves	NN	B-NP	O
'	'	POS	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O


Although	Although	IN	B-SBAR	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
possible	possible	JJ	B-ADJP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
orally	orally	RB	B-NP	O
administered	administer	VBN	I-NP	O
testosterone	testosterone	NN	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
se	se	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
T	T	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
male	male	JJ	I-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
convenience	convenience	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
balanced	balance	VBN	I-VP	O
against	against	IN	B-PP	O
the	the	DT	B-NP	O
cost	cost	NN	I-NP	O
and	and	CC	I-NP	O
possible	possible	JJ	I-NP	O
side	side	NN	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	O
doses	dose	NNS	I-NP	O
required	require	VBN	B-VP	O
.	.	.	O	O


Contrary	Contrary	JJ	B-ADJP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
8	8	CD	I-NP	O
-	-	HYPH	I-NP	O
dihydroxy	dihydroxy	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
9	9	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
anthrone	anthrone	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
8	8	CD	I-NP	O
,	,	,	I-NP	O
9	9	CD	I-NP	O
-	-	HYPH	I-NP	O
triacetoxyanthracene	triacetoxyanthracene	NN	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
8	8	CD	I-NP	O
-	-	HYPH	I-NP	O
diacetoxy	diacetoxy	NN	I-NP	O
-	-	HYPH	B-NP	O
9	9	CD	I-NP	O
-	-	HYPH	I-NP	O
anthrone	anthrone	NN	I-NP	O
are	be	VBP	B-VP	O
effective	effective	JJ	B-ADJP	O
against	against	IN	B-PP	O
psoriatic	psoriatic	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
without	without	IN	B-PP	O
accompanying	accompany	VBG	B-VP	O
inflammations	inflammation	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
skin	skin	NN	I-NP	O
.	.	.	O	O


Etiopathogenetic	Etiopathogenetic	JJ	B-NP	O
and	and	CC	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
problems	problem	NNS	I-NP	O
in	in	IN	B-PP	O
acute	acute	JJ	B-NP	O
orbital	orbital	JJ	I-NP	O
inflammation	inflammation	NN	I-NP	O


Nursing	Nurse	VBG	B-VP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
gynecological	gynecological	JJ	B-NP	O
diseases	disease	NNS	I-NP	O


We	We	PRP	B-NP	O
measured	measure	VBD	B-VP	O
basal	basal	JJ	B-NP	O
plasma	plasma	NN	I-NP	O
prolactin	prolactin	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
(	(	(	O	O
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
follicular	follicular	JJ	I-NP	O
phase	phase	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
25	25	CD	B-NP	O
normal	normal	JJ	I-NP	O
(	(	(	O	O
control	control	NN	O	O
)	)	)	O	O
women	woman	NNS	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
-	-	HYPH	I-NP	O
standing	stand	VBG	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
infertility	infertility	NN	B-NP	O
.	.	.	O	O


Ovarian	Ovarian	JJ	B-NP	O
allotransplantation	allotransplantation	NN	I-NP	O
in	in	IN	B-PP	O
human	human	NN	B-NP	O
.	.	.	O	O


Allergic	Allergic	JJ	B-NP	O
reaction	reaction	NN	I-NP	O
to	to	TO	B-PP	O
Patent	Patent	NNP	B-NP	O
Blue	Blue	NNP	I-NP	O
Violet	Violet	NNP	I-NP	O
during	during	IN	B-PP	O
lymphography	lymphography	NN	B-NP	O
.	.	.	O	O


Screening	Screening	NN	B-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
patients	patient	NNS	I-NP	O
by	by	IN	B-PP	O
determination	determination	NN	B-NP	O
of	of	IN	B-PP	O
IgE	IgE	NN	B-NP	B-protein
and	and	CC	B-PP	O
by	by	IN	B-PP	O
comprehension	comprehension	NN	B-NP	O
of	of	IN	B-PP	O
spectrum	spectrum	NN	B-NP	O
of	of	IN	B-PP	O
allergospecific	allergospecific	JJ	B-NP	O
IgE	IgE	NN	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein


The	The	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
seizures	seizure	NNS	B-NP	O
in	in	IN	B-PP	O
"	"	``	O	B-cell_type
Papio	Papio	NNP	B-NP	I-cell_type
papio	papio	NN	I-NP	I-cell_type
"	"	''	O	I-cell_type
following	follow	VBG	B-VP	O
allylglycine	allylglycine	NN	B-NP	O
alone	alone	RB	B-ADVP	O
or	or	CC	O	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
intermittent	intermittent	JJ	B-NP	O
photic	photic	JJ	I-NP	O
stimulation	stimulation	NN	I-NP	O


A	A	DT	B-NP	O
highly	highly	RB	I-NP	O
significant	significant	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
fibrinolytic	fibrinolytic	JJ	B-NP	B-protein
degradation	degradation	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
(	(	(	O	O
FDP	FDP	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
nephropathy	nephropathy	NN	B-NP	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
fibrin	fibrin	NN	B-NP	B-protein
monomers	monomer	NNS	I-NP	I-protein
(	(	(	O	O
Godal	Godal	NNP	B-NP	O
'	'	POS	B-NP	O
s	s	NN	I-NP	O
ethanol	ethanol	NN	I-NP	O
-	-	HYPH	B-NP	O
gelification	gelification	NN	I-NP	O
test	test	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
evolutive	evolutive	JJ	I-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
accelerated	accelerate	VBD	B-VP	O
ESR	ESR	NNP	B-NP	O
)	)	)	O	O
.	.	.	O	O


One	One	CD	B-NP	O
-	-	HYPH	I-NP	O
third	third	JJ	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
men	man	NNS	I-NP	O
with	with	IN	B-PP	O
azoospermia	azoospermia	NN	B-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
sperm	sperm	NN	B-NP	O
density	density	NN	I-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
million	million	CD	I-NP	O
had	have	VBD	B-VP	O
marked	mark	VBN	I-VP	O
FSH	FSH	NN	B-NP	O
elevation	elevation	NN	I-NP	O
and	and	CC	O	O
our	our	PRP$	B-NP	O
experience	experience	NN	I-NP	O
confirms	confirm	VBZ	B-VP	O
the	the	DT	B-NP	O
work	work	NN	I-NP	O
of	of	IN	B-PP	O
others	other	NNS	B-NP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
indicates	indicate	VBZ	B-VP	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
prognosis	prognosis	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
girls	girl	NNS	B-NP	O
prolactin	prolactin	NN	I-NP	O
levels	level	NNS	I-NP	O
rise	rise	VBP	B-VP	O
at	at	IN	B-PP	O
stage	stage	NN	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
are	be	VBP	B-VP	O
higher	high	JJR	B-ADJP	O
after	after	IN	B-PP	O
menarche	menarche	NN	B-NP	O
;	;	:	O	O
in	in	IN	B-PP	O
boys	boy	NNS	B-NP	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
prolactin	prolactin	NN	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O


It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
procedures	procedure	NNS	I-NP	O
were	be	VBD	B-VP	O
as	as	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
as	as	IN	B-PP	O
pinealectomy	pinealectomy	NN	B-NP	O
in	in	IN	B-PP	O
reversing	reverse	VBG	B-VP	O
the	the	DT	B-NP	O
pineal	pineal	NN	I-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
alterations	alteration	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
reproductive	reproductive	JJ	I-NP	O
physiology	physiology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
blind	blind	JJ	I-NP	O
-	-	HYPH	I-NP	O
anosmic	anosmic	JJ	I-NP	O
female	female	JJ	I-NP	O
rat	rat	NN	I-NP	O
.	.	.	O	O


2	2	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
toxic	toxic	JJ	B-NP	O
lymphomononucleosis	lymphomononucleosis	NN	I-NP	O


Such	Such	PDT	B-NP	O
an	an	DT	I-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
solution	solution	NN	I-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
exhibit	exhibit	VB	I-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
Bohr	Bohr	NN	I-NP	O
effect	effect	NN	I-NP	O
(	(	(	O	O
assessed	assess	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
delta	delta	NN	I-NP	B-protein
log	log	NN	I-NP	I-protein
Po2	Po2	NN	I-NP	I-protein
/	/	SYM	O	O
delta	delta	SYM	O	O
pH	pH	NN	B-NP	O
ratio	ratio	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


A	A	DT	B-NP	O
one	one	CD	I-NP	O
-	-	HYPH	I-NP	O
week	week	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
therapy	therapy	NN	I-NP	O
with	with	IN	B-PP	O
atropine	atropine	NN	B-NP	O
and	and	CC	O	O
Vikalin	Vikalin	NN	B-NP	O
(	(	(	O	O
Roter	Roter	NN	B-NP	O
)	)	)	O	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
reduction	reduction	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
proteolytic	proteolytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
one	one	CD	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
the	the	DT	B-NP	O
estriol	estriol	NN	I-NP	O
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
was	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
intestinal	intestinal	JJ	I-NP	O
function	function	NN	I-NP	O
normalised	normalise	VBD	B-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
estriol	estriol	NN	I-NP	O
concentration	concentration	NN	I-NP	O
went	go	VBD	B-VP	O
up	up	RP	B-PRT	O
exactly	exactly	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
stopped	stop	VBD	B-VP	O
.	.	.	O	O


Serum	Serum	NN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
IgG	IgG	NN	B-NP	B-protein
and	and	CC	I-NP	O
IgM	IgM	NN	I-NP	B-protein
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
raised	raise	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
contrary	contrary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
observers	observer	NNS	I-NP	O
IgA	IgA	NN	I-NP	B-protein
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O


Experimental	Experimental	JJ	B-NP	O
ischemic	ischemic	JJ	I-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
thromboxane	thromboxane	NN	B-NP	B-protein
A2	A2	NN	I-NP	I-protein
in	in	IN	B-PP	O
rabbits	rabbit	NNS	B-NP	O
.	.	.	O	O


Vitrectomy	Vitrectomy	NN	B-NP	O
in	in	IN	B-PP	O
ocular	ocular	JJ	B-NP	O
traumatology	traumatology	NN	I-NP	O


To	To	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
central	central	JJ	I-NP	O
brain	brain	NN	I-NP	O
structures	structure	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
electromagnetic	electromagnetic	JJ	I-NP	O
field	field	NN	I-NP	O
of	of	IN	B-PP	O
decimeter	decimeter	NN	B-NP	O
waves	wave	NNS	I-NP	O
(	(	(	O	O
EMF	EMF	NN	B-NP	O
of	of	IN	B-PP	O
DW	DW	NN	B-NP	O
)	)	)	O	O
a	a	DT	B-NP	O
dynamic	dynamic	JJ	I-NP	O
investigation	investigation	NN	I-NP	O
of	of	IN	B-PP	O
single	single	JJ	B-NP	O
unit	unit	NN	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
.	.	.	O	O


No	No	DT	B-NP	O
systematic	systematic	JJ	I-NP	O
L	L	NN	I-NP	O
-	-	HYPH	B-NP	O
R	R	NN	I-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O


A	A	DT	B-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lysozyme	lysozyme	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
coincided	coincide	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
meningitis	meningitis	NN	I-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
implies	imply	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
groups	group	NNS	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
just	just	RB	I-VP	O
differ	differ	VB	I-VP	O
along	along	IN	B-PP	O
one	one	CD	B-NP	O
dimension	dimension	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
along	along	IN	B-PP	O
three	three	CD	B-NP	O
dimensions	dimension	NNS	I-NP	O
.	.	.	O	O


Deep	Deep	NN	B-NP	O
tans	tan	NNS	I-NP	O
were	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
backs	back	NNS	I-NP	O
of	of	IN	B-PP	O
volunteers	volunteer	NNS	B-NP	O
with	with	IN	B-PP	O
repeated	repeat	VBN	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-VP	O
longwave	longwave	VB	I-VP	O
ultraviolet	ultraviolet	JJ	B-NP	O
radiation	radiation	NN	I-NP	O
(	(	(	O	O
UV	UV	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O


1	1	LS	B-LST	O
The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
oral	oral	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Motival	Motival	NNP	B-NP	O
(	(	(	O	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
,	,	,	O	O
containing	contain	VBG	B-VP	O
fluphenazine	fluphenazine	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
and	and	CC	I-NP	O
nortriptyline	nortriptyline	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
contingent	contingent	JJ	I-NP	O
negative	negative	JJ	I-NP	O
variation	variation	NN	I-NP	O
(	(	(	O	O
CNV	CNV	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
reaction	reaction	NN	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
self	self	NN	I-NP	O
-	-	HYPH	O	O
rating	rat	VBG	B-VP	O
scales	scale	NNS	B-NP	O
for	for	IN	B-PP	O
alertness	alertness	NN	B-NP	O
,	,	,	I-NP	O
anxiety	anxiety	NN	I-NP	O
,	,	,	I-NP	O
tension	tension	NN	I-NP	O
,	,	,	I-NP	O
detachment	detachment	NN	I-NP	O
and	and	CC	I-NP	O
depression	depression	NN	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
diazepam	diazepam	NN	B-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
and	and	CC	O	O
7.5	7.5	CD	B-NP	O
mg	mg	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
placebo	placebo	NN	B-NP	O
or	or	CC	I-NP	O
propranolol	propranolol	NN	I-NP	O
(	(	(	O	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


Stress	Stress	NN	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
affiliation	affiliation	NN	B-NP	O
preferences	preference	NNS	I-NP	O
among	among	IN	B-PP	O
subjects	subject	NNS	B-NP	O
possessing	possess	VBG	B-VP	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
A	A	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
-	-	HYPH	I-NP	O
prone	prone	JJ	I-NP	O
behavior	behavior	NN	I-NP	O
pattern	pattern	NN	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
collagen	collagen	NN	I-NP	B-protein
in	in	IN	B-PP	O
this	this	DT	B-NP	O
tissue	tissue	NN	I-NP	O
is	be	VBZ	B-VP	O
modified	modify	VBN	I-VP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
tendon	tendon	NN	B-NP	O
.	.	.	O	O


Smoking	Smoking	NN	B-NP	O
was	be	VBD	B-VP	O
regarded	regard	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
contribution	contribution	NN	I-NP	O
to	to	TO	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
malignity	malignity	NN	I-NP	O
of	of	IN	B-PP	O
nevoid	nevoid	JJ	B-NP	O
lentigo	lentigo	NN	I-NP	O
.	.	.	O	O


Elimination	Elimination	NN	B-NP	O
of	of	IN	B-PP	O
bagassosis	bagassosis	NN	B-NP	O
in	in	IN	B-PP	O
Louisiana	Louisiana	NNP	B-NP	O
paper	paper	NN	I-NP	O
manufacturing	manufacturing	NN	I-NP	O
plant	plant	NN	I-NP	O
workers	worker	NNS	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
responses	response	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
others	other	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
antihypertensive	antihypertensive	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
labetalol	labetalol	NN	B-NP	O
is	be	VBZ	B-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
concurrent	concurrent	JJ	B-NP	O
blockade	blockade	NN	I-NP	O
of	of	IN	B-PP	O
alpha	alpha	SYM	B-NP	B-protein
-	-	HYPH	B-ADJP	I-protein
and	and	CC	O	I-protein
beta	beta	SYM	B-NP	I-protein
-	-	HYPH	B-VP	O
adrenoceptors	adrenoceptor	NNS	B-NP	O
.	.	.	O	O


Diuretics	Diuretic	NNS	B-NP	O
:	:	:	O	O
basic	basic	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
pharmacology	pharmacology	NN	I-NP	O
and	and	CC	O	O
therapeutic	therapeutic	JJ	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O


Three	Three	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
four	four	CD	B-NP	O
renoureteral	renoureteral	JJ	I-NP	O
units	unit	NNS	I-NP	O
have	have	VBP	B-VP	O
undergone	undergo	VBN	I-VP	O
single	single	JJ	B-NP	O
-	-	HYPH	I-NP	O
stage	stage	NN	I-NP	O
reconstruction	reconstruction	NN	I-NP	O
involving	involve	VBG	B-VP	O
ureteroureterostomy	ureteroureterostomy	NN	B-NP	O
and	and	CC	O	O
ipsilateral	ipsilateral	JJ	B-NP	O
ureteroneocystostomy	ureteroneocystostomy	NN	I-NP	O
following	follow	VBG	B-PP	O
temporary	temporary	JJ	B-NP	O
loop	loop	NN	I-NP	O
cutaneous	cutaneous	JJ	I-NP	O
ureterostomy	ureterostomy	NN	I-NP	O
.	.	.	O	O


Evaluation	Evaluation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Du	Du	NNP	I-NP	O
Pont	Pont	NNP	I-NP	O
aca	aca	NN	I-NP	O
ammonia	ammonia	NN	I-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O


Internally	Internally	RB	B-NP	O
oriented	orient	VBN	I-NP	O
patients	patient	NNS	I-NP	O
'	'	POS	B-NP	O
scores	score	NNS	I-NP	O
on	on	IN	B-PP	O
Rotter	Rotter	NNP	B-NP	O
'	'	POS	B-NP	O
s	s	JJ	I-NP	O
Internal	Internal	NNP	I-NP	O
-	-	HYPH	I-NP	O
External	External	JJ	I-NP	O
Locus	Locus	NNP	I-NP	O
of	of	IN	B-PP	O
Control	Control	NNP	B-NP	O
Scale	Scale	NNP	I-NP	O
remained	remain	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
over	over	IN	B-PP	O
treatment	treatment	NN	B-NP	O
but	but	CC	O	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
externally	externally	RB	B-NP	O
oriented	orient	VBN	I-NP	O
patients	patient	NNS	I-NP	O
shifted	shift	VBD	B-VP	O
toward	toward	IN	B-PP	O
greater	great	JJR	B-NP	O
internal	internal	JJ	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O


Action	Action	NN	B-NP	O
of	of	IN	B-PP	O
strontium	strontium	NN	B-NP	O
-	-	HYPH	O	O
90	90	CD	B-NP	O
and	and	CC	O	O
metaphos	metapho	NNS	B-NP	O
on	on	IN	B-PP	O
Cyprinus	Cyprinus	NN	B-NP	O
carpio	carpio	NN	I-NP	O


Kodak	Kodak	NNP	B-NP	O
XV	XV	NNP	I-NP	O
-	-	HYPH	B-NP	O
2	2	CD	I-NP	O
film	film	NN	I-NP	O
is	be	VBZ	B-VP	O
wrapped	wrap	VBN	I-VP	O
around	around	IN	B-PP	O
a	a	DT	B-NP	O
cylindrical	cylindrical	JJ	I-NP	O
water	water	NN	I-NP	O
-	-	HYPH	B-VP	O
filled	fill	VBN	B-NP	O
phantom	phantom	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
distribution	distribution	NN	I-NP	O
is	be	VBZ	B-VP	O
recorded	record	VBN	I-VP	O
.	.	.	O	O


Diagnosis	Diagnosis	NN	B-NP	O
and	and	CC	O	O
differential	differential	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O


The	The	DT	B-NP	O
multiple	multiple	JJ	I-NP	O
factors	factor	NNS	I-NP	O
affecting	affect	VBG	B-VP	O
plasma	plasma	NN	B-NP	O
renin	renin	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
essential	essential	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O


Cortisone	Cortisone	NN	B-NP	O
induced	induce	VBD	B-VP	O
bone	bone	NN	B-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
lipid	lipid	NN	B-NP	O
clearing	clearing	NN	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O


2	2	LS	B-LST	O
)	)	)	O	O
The	The	DT	B-NP	O
time	time	NN	I-NP	O
-	-	HYPH	O	O
sharing	share	VBG	B-VP	O
principle	principle	NN	B-NP	O
was	be	VBD	B-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	I-VP	O
gain	gain	VB	I-VP	O
high	high	JJ	B-NP	O
stability	stability	NN	I-NP	O
.	.	.	O	O


When	When	WRB	B-ADVP	O
blood	blood	NN	B-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
hyperbilirubinemia	hyperbilirubinemia	NN	B-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
,	,	,	O	O
direct	direct	JJ	B-NP	O
measurement	measurement	NN	I-NP	O
of	of	IN	B-PP	O
ZPP	ZPP	NN	B-NP	B-protein
by	by	IN	B-PP	O
this	this	DT	B-NP	O
fluorimeter	fluorimeter	NN	I-NP	O
yielded	yield	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
levels	level	NNS	I-NP	O
than	than	IN	B-SBAR	O
did	do	VBD	B-VP	O
an	an	DT	B-NP	O
alternate	alternate	JJ	I-NP	O
extraction	extraction	NN	I-NP	O
method	method	NN	I-NP	O
.	.	.	O	O


Delayed	Delay	VBN	B-NP	O
hypersensitivity	hypersensitivity	NN	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O
:	:	:	O	O
effects	effect	NNS	B-NP	O
of	of	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
three	three	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
seven	seven	CD	I-NP	O
,	,	,	O	O
inhalation	inhalation	NN	B-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
ml	ml	NN	I-NP	O
normal	normal	JJ	I-NP	O
saline	saline	NN	I-NP	O
produced	produce	VBD	B-VP	O
FEV1	FEV1	NN	B-NP	O
falls	fall	NNS	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
these	these	DT	B-NP	O
falls	fall	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
as	as	RB	B-ADJP	O
great	great	JJ	I-ADJP	O
as	as	IN	B-PP	O
each	each	DT	B-NP	O
subject	subject	NN	I-NP	O
'	'	POS	B-NP	O
s	s	NN	I-NP	O
reactions	reaction	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
solutions	solution	NNS	I-NP	O
.	.	.	O	O


Experimental	Experimental	JJ	B-NP	O
studies	study	NNS	I-NP	O
on	on	IN	B-PP	O
virus	virus	NN	B-NP	O
excretion	excretion	NN	I-NP	O
and	and	CC	O	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
arthropod	arthropod	NN	I-NP	O
transmission	transmission	NN	I-NP	O
.	.	.	O	O


Potency	Potency	NN	B-NP	O
of	of	IN	B-PP	O
enflurane	enflurane	NN	B-NP	O
in	in	IN	B-PP	O
dogs	dog	NNS	B-NP	O
:	:	:	O	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
halothane	halothane	NN	B-NP	O
and	and	CC	I-NP	O
isoflurane	isoflurane	NN	I-NP	O
.	.	.	O	O


Prevention	Prevention	NN	B-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
paraquat	paraquat	NN	I-NP	O
toxicity	toxicity	NN	I-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
by	by	IN	B-PP	O
superoxide	superoxide	NN	B-NP	B-protein
dismutase	dismutase	NN	I-NP	I-protein
.	.	.	O	O


Measurement	Measurement	NN	B-NP	O
of	of	IN	B-PP	O
magnesium	magnesium	NN	B-NP	O
absorption	absorption	NN	I-NP	O
in	in	IN	B-PP	O
man	man	NN	B-NP	O
using	use	VBG	B-VP	O
stable	stable	JJ	B-NP	O
26Mg	26Mg	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
tracer	tracer	NN	I-NP	O
.	.	.	O	O


Increased	Increase	VBN	B-NP	O
urinary	urinary	JJ	I-NP	O
riboflavin	riboflavin	NN	I-NP	O
excretion	excretion	NN	I-NP	O
resulting	result	VBG	B-VP	O
from	from	IN	B-PP	O
boric	boric	JJ	B-NP	O
acid	acid	NN	I-NP	O
ingestion	ingestion	NN	I-NP	O
.	.	.	O	O


Radionuclide	Radionuclide	NN	B-NP	O
angiography	angiography	NN	I-NP	O
and	and	CC	O	O
static	static	JJ	B-NP	O
whole	whole	JJ	I-NP	O
body	body	NN	I-NP	O
imaging	imaging	NN	I-NP	O
performed	perform	VBN	B-VP	O
with	with	IN	B-PP	O
technetium	technetium	NN	B-NP	O
-	-	HYPH	B-NP	O
99m	99m	NN	I-NP	O
-	-	HYPH	B-NP	O
labeled	label	VBN	I-NP	O
particulates	particulate	NNS	I-NP	O
can	can	MD	B-VP	O
clearly	clearly	RB	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
differential	differential	JJ	B-NP	O
shunting	shunting	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
patent	patent	NN	B-NP	O
ductus	ductus	NN	I-NP	O
arteriosus	arteriosus	NN	I-NP	O
(	(	(	O	O
PDA	PDA	NN	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
Eisenmenger	Eisenmenger	NN	B-NP	O
physiology	physiology	NN	I-NP	O
.	.	.	O	O


Looming	Loom	VBG	B-VP	O
detectors	detector	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
visual	visual	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O


Escherichia	Escherichia	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
sero	sero	AFX	I-NP	O
-	-	HYPH	I-NP	O
anzymatic	anzymatic	JJ	I-NP	O
type	type	NN	I-NP	O
(	(	(	O	O
06a6b	06a6b	NN	B-NP	O
:	:	:	O	O
K13	K13	NN	B-NP	O
:	:	:	O	O
H1	H1	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
group	group	NN	I-NP	O
affection	affection	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
method	method	NN	I-NP	O
described	describe	VBN	B-VP	O
may	may	MD	B-VP	O
prove	prove	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
in	in	IN	B-PP	O
studying	study	VBG	B-VP	O
the	the	DT	B-NP	O
physiology	physiology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nasal	nasal	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O


At	At	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
we	we	PRP	B-NP	O
obtained	obtain	VBD	B-VP	O
easily	easily	RB	B-NP	O
understandable	understandable	JJ	I-NP	O
EEG	EEG	NN	I-NP	O
-	-	HYPH	B-NP	O
information	information	NN	I-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
never	never	RB	I-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
available	available	JJ	B-ADJP	O
to	to	TO	B-PP	O
us	us	PRP	B-NP	O
.	.	.	O	O


Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
liver	liver	NN	B-NP	O
biopsy	biopsy	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
variation	variation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
iron	iron	NN	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	B-protein
ferritin	ferritin	NN	I-NP	I-protein
molecules	molecule	NNS	I-NP	I-protein
.	.	.	O	O


Female	Female	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
infection	infection	NN	B-NP	O
than	than	IN	B-PP	O
males	male	NNS	B-NP	O
.	.	.	O	O


During	During	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
9	9	CD	I-NP	O
1	1	CD	I-NP	O
/	/	SYM	B-NP	O
2	2	CD	B-NP	O
years	year	NNS	I-NP	O
three	three	CD	B-NP	O
sequential	sequential	JJ	I-NP	O
liver	liver	NN	I-NP	O
biopsies	biopsy	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O


Angiotensin	Angiotensin	NN	B-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
kidney	kidney	NN	I-NP	O
.	.	.	O	O


Procion	Procion	NN	B-NP	O
yellow	yellow	JJ	I-NP	O
dye	dye	NN	I-NP	O
was	be	VBD	B-VP	O
injected	inject	VBN	I-VP	O
intracellularly	intracellularly	RB	B-ADVP	O
into	into	IN	B-PP	O
large	large	JJ	B-NP	O
auditory	auditory	JJ	I-NP	O
fibers	fiber	NNS	I-NP	O
of	of	IN	B-PP	O
goldfish	goldfish	NN	B-NP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
fibers	fiber	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
termination	termination	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
saccular	saccular	JJ	I-NP	O
macula	macula	NN	I-NP	O
.	.	.	O	O


Incidental	Incidental	JJ	B-NP	O
findings	finding	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
epidermis	epidermis	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
intraepidermal	intraepidermal	JJ	I-NP	O
eccrine	eccrine	JJ	I-NP	O
sweat	sweat	NN	I-NP	O
duct	duct	NN	I-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O


Silicosis	Silicosis	NN	B-NP	O
mortality	mortality	NN	I-NP	O


These	These	DT	B-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
beading	bead	VBG	B-NP	O
and	and	CC	O	O
strictures	stricture	VBZ	B-VP	O
mainly	mainly	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intrahepatic	intrahepatic	JJ	I-NP	O
biliary	biliary	JJ	I-NP	O
tree	tree	NN	I-NP	O
(	(	(	O	O
IHB	IHB	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O


Pentane	Pentane	NN	B-NP	O
and	and	CC	I-NP	O
ethane	ethane	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
arise	arise	VBP	B-VP	O
during	during	IN	B-PP	O
lipid	lipid	NN	B-NP	O
peroxidation	peroxidation	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
gas	gas	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
in	in	IN	B-PP	O
breath	breath	NN	B-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O
fed	feed	VBN	B-VP	O
for	for	IN	B-PP	O
8	8	CD	B-NP	O
weeks	week	NNS	I-NP	O
a	a	DT	B-NP	O
vitamin	vitamin	NN	I-NP	O
E	E	NN	I-NP	O
-	-	HYPH	B-NP	O
deficient	deficient	JJ	I-NP	O
diet	diet	NN	I-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
added	add	VBN	I-VP	O
0	0	CD	B-NP	O
,	,	,	I-NP	O
11	11	CD	I-NP	O
,	,	,	O	O
or	or	CC	O	O
40	40	CD	B-NP	O
IU	IU	NN	I-NP	O
vitamin	vitamin	NN	I-NP	O
E	E	NN	I-NP	O
acetate	acetate	NN	I-NP	O
per	per	IN	B-PP	O
kg	kg	NN	B-NP	O
.	.	.	O	O


Thromboplastic	Thromboplastic	JJ	B-NP	O
and	and	CC	I-NP	O
fibrynolytic	fibrynolytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
after	after	IN	B-PP	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
intralipid	intralipid	NN	B-NP	O
in	in	IN	B-PP	O
men	man	NNS	B-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
45	45	CD	I-NP	O
year	year	NN	I-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O


The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
clinicopathologic	clinicopathologic	JJ	I-NP	O
findings	finding	NNS	I-NP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
adult	adult	JJ	B-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
rhabdomyosarcomas	rhabdomyosarcoma	NNS	B-NP	O
that	that	WDT	B-NP	O
originated	originate	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
endometrium	endometrium	NN	I-NP	O
or	or	CC	I-NP	O
cervix	cervix	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
both	both	DT	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
pure	pure	JJ	B-NP	B-protein
natural	natural	JJ	I-NP	I-protein
porcine	porcine	JJ	I-NP	I-protein
secretin	secretin	NN	I-NP	I-protein
on	on	IN	B-PP	O
endocrine	endocrine	JJ	B-NP	O
and	and	CC	I-NP	O
exocrine	exocrine	JJ	I-NP	O
pancreatic	pancreatic	JJ	I-NP	O
secretion	secretion	NN	I-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
totally	totally	RB	I-NP	O
isolated	isolate	VBN	I-NP	O
perfused	perfuse	VBN	I-NP	O
porcine	porcine	JJ	I-NP	O
pancreas	pancreas	NN	I-NP	O
.	.	.	O	O


Biometric	Biometric	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
intraocular	intraocular	JJ	B-NP	O
lens	lens	NN	I-NP	O
power	power	NN	I-NP	O
required	require	VBN	B-VP	O
to	to	TO	I-VP	O
produce	produce	VB	I-VP	O
emmetropia	emmetropia	NN	B-NP	O
:	:	:	O	O
results	result	NNS	B-NP	O
of	of	IN	B-PP	O
450	450	CD	B-NP	O
implants	implant	NNS	I-NP	O
.	.	.	O	O


Urine	Urine	NN	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
cases	case	NNS	I-NP	O
.	.	.	O	O


Althoug	Althoug	NN	B-NP	B-protein
RBF	RBF	NN	I-NP	I-protein
tended	tend	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
RBF	RBF	NN	B-NP	B-protein
,	,	,	O	O
GFR	GFR	NN	B-NP	B-protein
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
.	.	.	O	O


99mTc	99mTc	NN	B-NP	O
phytate	phytate	NN	I-NP	O
,	,	,	O	O
198Au	198Au	NNP	B-NP	O
colloid	colloid	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
99mTc	99mTc	NN	B-NP	O
antimony	antimony	JJ	I-NP	O
sulfide	sulfide	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
used	use	VBN	I-VP	O
;	;	:	O	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
satisfactory	satisfactory	JJ	I-NP	O
.	.	.	O	O


Six	Six	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
glomerulonephritis	glomerulonephritis	NN	B-NP	O
in	in	IN	B-PP	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
ventriculovascular	ventriculovascular	JJ	I-NP	O
shunt	shunt	NN	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
basic	basic	JJ	I-NP	O
modes	mode	NNS	I-NP	O
of	of	IN	B-PP	O
therapy	therapy	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
mass	mass	NN	I-NP	O
of	of	IN	B-PP	O
UO2	UO2	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
extrapulmonary	extrapulmonary	JJ	I-NP	O
bronchi	bronchi	NN	I-NP	O
and	and	CC	O	O
first	first	JJ	B-NP	O
bifurcation	bifurcation	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
more	more	RBR	B-ADVP	O
slowly	slowly	RB	I-ADVP	O
over	over	IN	B-NP	O
0	0	CD	I-NP	O
-	-	HYPH	I-NP	O
-	-	SYM	I-NP	O
8	8	CD	I-NP	O
d	d	NN	I-NP	O
after	after	IN	B-PP	O
inhalation	inhalation	NN	B-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
mass	mass	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
trachea	trachea	NN	I-NP	O
.	.	.	O	O


Synovial	Synovial	JJ	B-NP	O
cysts	cyst	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hip	hip	NN	I-NP	O
joint	joint	NN	I-NP	O


A	A	DT	B-NP	O
suspected	suspect	VBN	I-NP	O
hypothalamic	hypothalamic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
impaired	impaired	JJ	I-NP	O
pituitary	pituitary	JJ	I-NP	O
function	function	NN	I-NP	O
manifested	manifest	VBN	B-VP	O
as	as	IN	B-PP	O
GH	GH	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
were	be	VBD	B-VP	O
their	their	PRP$	B-NP	O
common	common	JJ	I-NP	O
endocrinological	endocrinological	JJ	I-NP	O
features	feature	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
sharp	sharp	JJ	I-NP	O
outbreak	outbreak	NN	I-NP	O
of	of	IN	B-PP	O
influenza	influenza	NN	B-NP	O
A	A	NN	I-NP	O
occurred	occur	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
during	during	IN	B-PP	O
February	February	NNP	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
A	A	NN	I-NP	O
/	/	SYM	I-NP	O
Texas	Texas	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
/	/	SYM	I-NP	O
77	77	CD	I-NP	O
-	-	HYPH	I-NP	O
like	like	JJ	I-NP	O
virus	virus	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
variant	variant	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
A	A	NN	I-NP	O
/	/	SYM	I-NP	O
Victoria	Victoria	NN	I-NP	B-protein
/	/	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
/	/	SYM	I-NP	O
75	75	CD	I-NP	O
prototpye	prototpye	NN	I-NP	O
.	.	.	O	O


Because	Because	IN	B-SBAR	O
decreases	decrease	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
disfluency	disfluency	NN	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
stutterers	stutterer	NNS	B-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
presentation	presentation	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
three	three	CD	I-NP	O
stimulus	stimulus	NN	I-NP	O
words	word	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
support	support	VB	I-VP	O
the	the	DT	B-NP	O
operant	operant	JJ	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O


Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
and	and	CC	I-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
alterations	alteration	NNS	B-NP	O
following	follow	VBG	B-PP	O
inhalation	inhalation	NN	B-NP	O
of	of	IN	B-PP	O
plutonium	plutonium	NN	B-NP	O
-	-	HYPH	B-NP	O
239	239	CD	I-NP	O
dioxide	dioxide	NN	I-NP	O
aerosol	aerosol	NN	I-NP	O
in	in	IN	B-PP	O
rat	rat	NN	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
biopsies	biopsy	NNS	B-NP	O
CK	CK	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
CPK	CPK	NN	I-NP	B-protein
was	be	VBD	B-VP	O
37	37	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
-	-	HYPH	I-NP	O
CPK	CPK	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
skeletal	skeletal	JJ	I-NP	O
muscles	muscle	NNS	I-NP	O
still	still	RB	B-ADVP	O
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
5	5	CD	I-NP	O
%	%	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
CK	CK	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
MB	MB	NN	I-NP	I-protein
.	.	.	O	O


Value	Value	NN	B-NP	O
of	of	IN	B-PP	O
determination	determination	NN	B-NP	O
of	of	IN	B-PP	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
isoenzymes	isoenzyme	NNS	I-NP	I-protein
for	for	IN	B-PP	O
differential	differential	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
jaundice	jaundice	NN	I-NP	O
and	and	CC	O	O
biliary	biliary	JJ	B-NP	O
liver	liver	NN	I-NP	O
cirrhosis	cirrhosis	NN	I-NP	O


A	A	DT	B-NP	O
one	one	CD	I-NP	O
-	-	HYPH	I-NP	O
way	way	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
variance	variance	NN	B-NP	O
,	,	,	O	O
performed	perform	VBN	B-VP	O
separately	separately	RB	B-ADVP	O
for	for	IN	B-PP	O
men	man	NNS	B-NP	O
and	and	CC	I-NP	O
women	woman	NNS	I-NP	O
for	for	IN	B-PP	O
differences	difference	NNS	B-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
phobic	phobic	JJ	I-NP	O
groups	group	NNS	I-NP	O
on	on	IN	B-PP	O
field	field	NN	B-NP	O
dependence	dependence	NN	I-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
significance	significance	NN	B-NP	O
(	(	(	O	O
rho	rho	NN	B-NP	B-protein
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
.	.	.	B-NP	O
05	05	CD	I-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
females	female	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
famale	famale	JJ	I-NP	O
agoraphobic	agoraphobic	JJ	I-NP	O
being	be	VBG	B-VP	O
more	more	JJR	B-NP	O
field	field	NN	I-NP	O
dependent	dependent	JJ	B-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
female	female	JJ	I-NP	O
simple	simple	JJ	I-NP	O
phobic	phobic	JJ	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
males	male	NNS	I-NP	O
.	.	.	O	O


Several	Several	JJ	B-NP	O
free	free	JJ	I-NP	O
2nd	2nd	CD	I-NP	O
-	-	HYPH	I-NP	O
generation	generation	NN	I-NP	O
schizonts	schizont	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
varied	vary	VBD	B-VP	O
in	in	IN	B-PP	O
diameter	diameter	NN	B-NP	O
from	from	IN	B-PP	O
11	11	CD	B-NP	O
to	to	TO	I-NP	O
21.6	21.6	CD	I-NP	O
micrometer	micrometer	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
epithelial	epithelial	JJ	I-NP	O
surface	surface	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cecum	cecum	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
calculated	calculate	VBN	I-NP	O
pD2	pD2	NN	I-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
8.8	8.8	CD	B-NP	O
for	for	IN	B-PP	O
E	E	NN	B-NP	O
,	,	,	O	O
8.6	8.6	CD	B-NP	O
for	for	IN	B-PP	O
DHE	DHE	NN	B-NP	O
and	and	CC	O	O
6.6	6.6	CD	B-NP	O
for	for	IN	B-PP	O
M	M	NN	B-NP	O
.	.	.	O	O


Newcastle	Newcastle	JJ	B-NP	O
disease	disease	NN	I-NP	O
virus	virus	NN	I-NP	O
surveillance	surveillance	NN	I-NP	O
in	in	IN	B-PP	O
Hong	Hong	NNP	B-NP	O
Kong	Kong	NNP	I-NP	O
on	on	IN	B-PP	O
local	local	JJ	B-NP	O
and	and	CC	I-NP	O
imported	import	VBN	I-NP	O
poultry	poultry	NN	I-NP	O
.	.	.	O	O


It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
postulated	postulate	VBN	I-VP	O
that	that	IN	B-SBAR	O
persistent	persistent	JJ	B-NP	O
challenge	challenge	NN	I-NP	O
by	by	IN	B-PP	O
M	M	NN	B-NP	O
.	.	.	O	O
leprae	leprae	NN	B-NP	O
or	or	CC	O	O
its	its	PRP$	B-NP	O
antigens	antigen	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
IgA	IgA	NN	I-NP	B-cell_type
immunocytes	immunocyte	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intestinal	intestinal	JJ	I-NP	O
epithelium	epithelium	NN	I-NP	O
might	might	MD	B-VP	O
have	have	VB	I-VP	O
induced	induce	VBN	I-VP	O
tolerance	tolerance	NN	B-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
IgA	IgA	NN	B-NP	B-protein
deficiency	deficiency	NN	I-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
subtotal	subtotal	JJ	I-NP	O
atrophy	atrophy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intestinal	intestinal	JJ	I-NP	O
villi	villus	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
lepromatous	lepromatous	JJ	B-NP	O
leprosy	leprosy	NN	I-NP	O
.	.	.	O	O


Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
adrenergic	adrenergic	JJ	I-NP	O
beta	beta	NN	I-NP	O
receptor	receptor	NN	I-NP	O
blockader	blockader	NN	I-NP	O
,	,	,	O	O
obsidan	obsidan	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
vasodilator	vasodilator	NN	I-NP	O
,	,	,	O	O
apressin	apressin	NN	B-NP	O


Orthop	Orthop	NNP	B-NP	O
.	.	.	O	O


Thyroid	Thyroid	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
pregnancy	pregnancy	NN	B-NP	O
.	.	.	O	O


Residues	Residue	NNS	B-NP	O
removed	remove	VBN	B-VP	O
from	from	IN	B-PP	O
transcripts	transcript	NNS	B-NP	O
by	by	IN	B-PP	O
splicing	splicing	NN	B-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O


To	To	TO	B-VP	O
minimize	minimize	VB	I-VP	O
reflux	reflux	NN	B-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
blind	blind	JJ	I-NP	O
loop	loop	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
technical	technical	JJ	B-NP	O
steps	step	NNS	I-NP	O
are	be	VBP	B-VP	O
considered	consider	VBN	I-VP	O
indispensable	indispensable	JJ	B-ADJP	O
:	:	:	O	O
1	1	LS	B-LST	O
)	)	)	O	O
fluted	fluted	JJ	B-NP	O
section	section	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
jejunal	jejunal	JJ	I-NP	O
stump	stump	NN	I-NP	O
;	;	:	O	O
2	2	LS	B-LST	O
)	)	)	O	O
isoperistaltic	isoperistaltic	JJ	B-NP	O
construction	construction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anastomosis	anastomosis	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
,	,	,	O	O
3	3	LS	B-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
creation	creation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
or	or	CC	I-NP	O
double	double	JJ	I-NP	O
valve	valve	NN	I-NP	O
system	system	NN	I-NP	O
upstream	upstream	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
anastomosis	anastomosis	NN	I-NP	O
by	by	IN	B-PP	O
spiral	spiral	JJ	B-NP	O
introflexion	introflexion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mucosa	mucosa	NN	I-NP	O
using	use	VBG	B-VP	O
seroserous	seroserous	JJ	B-NP	O
stitches	stitch	NNS	I-NP	O
parallel	parallel	JJ	B-ADJP	O
and	and	CC	O	O
perpendicular	perpendicular	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ileal	ileal	JJ	I-NP	O
lumen	lumen	NN	I-NP	O
.	.	.	O	O


At	At	IN	B-PP	O
this	this	DT	B-NP	O
stage	stage	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
eventual	eventual	JJ	I-NP	O
high	high	JJ	I-NP	O
mortality	mortality	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
is	be	VBZ	B-VP	O
established	establish	VBN	I-VP	O
whatever	whatever	WDT	B-NP	O
the	the	DT	B-NP	O
urgency	urgency	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
operation	operation	NN	I-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
skill	skill	NN	I-NP	O
with	with	IN	B-PP	O
which	which	WDT	B-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O


Pathogens	Pathogen	NNS	B-NP	O
(	(	(	O	O
Staphylococcus	Staphylococcus	FW	B-NP	O
aureus	aureus	FW	I-NP	O
or	or	CC	O	O
Gram	Gram	NN	B-NP	O
-	-	HYPH	B-NP	O
negative	negative	JJ	I-NP	O
bacilli	bacilli	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
staff	staff	NN	B-NP	O
in	in	IN	B-PP	O
small	small	JJ	B-NP	O
numbers	number	NNS	I-NP	O
and	and	CC	O	O
irregularly	irregularly	RB	B-VP	O
and	and	CC	I-VP	O
rarely	rarely	RB	I-VP	O
in	in	IN	B-PP	O
large	large	JJ	B-NP	O
numbers	number	NNS	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
histochemistry	histochemistry	NN	I-NP	O
and	and	CC	I-NP	O
ultrastructure	ultrastructure	NN	I-NP	O
of	of	IN	B-PP	O
calcified	calcify	VBN	B-NP	O
cerebellar	cerebellar	JJ	I-NP	O
deposits	deposit	NNS	I-NP	O
described	describe	VBN	B-VP	O
by	by	IN	B-PP	O
Tonge	Tonge	NNP	B-NP	O
et	et	FW	I-NP	O
al	al	FW	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
36	36	CD	I-NP	O
year	year	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
woman	woman	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Ergotamine	Ergotamine	NN	B-NP	O
Tartrate	Tartrate	NN	I-NP	O
4.5	4.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p	p	NN	I-NP	O
.	.	.	I-NP	O
d	d	NN	I-NP	O
.	.	.	O	O
during	during	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
an	an	DT	B-NP	O
abortion	abortion	NN	I-NP	O
(	(	(	O	O
a	a	DT	B-NP	O
still	still	RB	I-NP	O
birth	birth	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


Reaction	Reaction	NN	B-NP	O
times	time	NNS	I-NP	O
to	to	TO	B-PP	O
tachistoscopically	tachistoscopically	RB	B-NP	O
presented	present	VBN	I-NP	O
stimuli	stimulus	NNS	I-NP	O
in	in	IN	B-PP	O
diabetics	diabetic	NNS	B-NP	O


Two	Two	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
patients	patient	NNS	I-NP	O
undergoing	undergo	VBG	B-VP	O
selective	selective	JJ	B-NP	O
spinal	spinal	JJ	I-NP	O
arteriography	arteriography	NN	I-NP	O
developed	develop	VBD	B-VP	O
transient	transient	JJ	B-NP	O
neurological	neurological	JJ	I-NP	O
complications	complication	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
Urografin	Urografin	NN	B-NP	B-protein
310	310	CD	I-NP	I-protein
M	M	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
a	a	DT	B-NP	O
three	three	CD	I-NP	O
-	-	HYPH	I-NP	O
phase	phase	NN	I-NP	O
reaction	reaction	NN	I-NP	O
after	after	IN	B-PP	O
B1	B1	NN	B-NP	O
injection	injection	NN	I-NP	O
:	:	:	O	O
Phase	Phase	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
-	-	HYPH	O	O
-	-	HYPH	O	O
shortly	shortly	RB	B-ADVP	O
after	after	IN	B-PP	O
injection	injection	NN	B-NP	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
drop	drop	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
parameters	parameter	NNS	I-NP	O
lasting	last	VBG	B-VP	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
sec	sec	NN	I-NP	O
.	.	.	O	O


Serum	Serum	NN	B-NP	B-protein
relaxin	relaxin	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
prostaglandin	prostaglandin	NN	B-NP	O
E2	E2	NN	I-NP	O
induced	induced	JJ	I-NP	O
abortions	abortion	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
-	-	SYM	I-NP	O
-	-	HYPH	I-NP	O
A	A	DT	I-NP	O
natural	natural	JJ	I-NP	O
hydrostatic	hydrostatic	JJ	I-NP	O
phenomenon	phenomenon	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ends	end	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
plantar	plantar	NN	I-NP	B-cell_type
arcs	arc	NNS	I-NP	I-cell_type
,	,	,	O	O
diffuses	diffuse	VBZ	B-VP	O
body	body	NN	B-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
PAIN	PAIN	NN	B-NP	B-protein
plays	play	VBZ	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
outsentry	outsentry	NN	B-NP	O
(	(	(	O	O
fig	fig	NN	B-NP	O
.	.	SYM	O	O
-	-	SYM	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
(	(	(	O	O
5	5	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
B	B	NN	B-NP	O
-	-	HYPH	O	O
-	-	HYPH	O	O
Plantar	Plantar	NN	B-NP	O
perforating	perforate	VBG	B-VP	O
ulceration	ulceration	NN	B-NP	O
(	(	(	O	O
PPU	PPU	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
INSENSITIVITY	INSENSITIVITY	NN	B-NP	O
and	and	CC	I-NP	O
TRAUMATIS	TRAUMATIS	NN	I-NP	B-protein
(	(	(	O	I-protein
1	1	CD	B-NP	I-protein
)	)	)	O	I-protein
;	;	:	O	I-protein
C	C	NN	B-NP	I-protein
-	-	HYPH	O	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reposing	repose	VBG	B-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
body	body	NN	B-NP	O
weight	weight	NN	I-NP	O
(	(	(	O	O
traumatism	traumatism	NN	B-NP	O
)	)	)	O	O
effects	effect	NNS	B-NP	O
disappear	disappear	VBP	B-VP	O
,	,	,	O	O
cicatrization	cicatrization	NN	B-NP	O
process	process	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
easily	easily	RB	I-VP	O
observed	observe	VBN	I-VP	O
;	;	:	O	O
D	D	NN	B-NP	O
-	-	HYPH	O	O
-	-	HYPH	B-NP	O
PNEUMATIC	PNEUMATIC	NN	I-NP	O
INSOLE	INSOLE	NN	I-NP	O
,	,	,	O	O
being	be	VBG	B-VP	O
elastic	elastic	JJ	B-ADJP	O
,	,	,	O	O
diffuses	diffuse	VBZ	B-VP	O
localized	localized	JJ	B-NP	O
compression	compression	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
ends	end	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
plantar	plantar	NN	I-NP	B-cell_type
arcs	arc	NNS	I-NP	I-cell_type
,	,	,	O	O
reduces	reduce	VBZ	B-VP	O
attrition	attrition	NN	B-NP	O
,	,	,	O	O
makes	make	VBZ	B-VP	O
easier	easy	JJR	B-NP	O
blood	blood	NN	I-NP	O
circulation	circulation	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
cure	cure	NN	B-NP	O
and	and	CC	I-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
of	of	IN	B-PP	O
PPU	PPU	NN	B-NP	B-protein
(	(	(	O	O
fig	fig	NN	B-NP	O
.	.	SYM	O	O
-	-	SYM	O	O
-	-	SYM	O	O
6	6	CD	B-NP	O
)	)	)	O	O
(	(	(	O	O
3	3	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
indoramin	indoramin	NN	B-NP	O
in	in	IN	B-PP	O
small	small	JJ	B-NP	O
doses	dose	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	B-DNA
vasomotor	vasomotor	NN	I-NP	I-DNA
loci	locus	NNS	I-NP	I-DNA
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
chloralose	chloralose	NN	B-NP	O
anesthetized	anesthetize	VBD	B-VP	O
cats	cat	NNS	B-NP	O
by	by	IN	B-PP	O
localizing	localize	VBG	B-VP	O
it	it	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O


As	As	IN	B-SBAR	O
expected	expect	VBN	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
heparin	heparin	NN	I-NP	O
did	do	VBD	B-VP	O
produce	produce	VB	I-VP	O
increased	increase	VBN	B-NP	O
recalcification	recalcification	NN	I-NP	O
times	time	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
hematomas	hematoma	NNS	I-NP	O
.	.	.	O	O


Contingency	Contingency	NN	B-NP	O
contracting	contracting	NN	I-NP	O
between	between	IN	B-PP	O
clients	client	NNS	B-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
parents	parent	NNS	I-NP	O
/	/	SYM	O	O
caregivers	caregiver	NNS	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
specify	specify	VB	I-VP	O
consequences	consequence	NNS	B-NP	O
for	for	IN	B-PP	O
daily	daily	JJ	B-NP	O
self	self	AFX	I-NP	O
-	-	HYPH	I-NP	O
monitoring	monitoring	NN	I-NP	O
,	,	,	O	O
reduced	reduce	VBD	B-VP	O
caloric	caloric	JJ	B-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
exercise	exercise	NN	B-NP	O
.	.	.	O	O


Dietetics	Dietetic	NNS	B-NP	O
of	of	IN	B-PP	O
childhood	childhood	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
juvenile	juvenile	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O


The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
quantitative	quantitative	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
vasculosyncytial	vasculosyncytial	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
in	in	IN	B-PP	O
123	123	CD	B-NP	O
placentas	placenta	NNS	I-NP	O
are	be	VBP	B-VP	O
presented	present	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
micromethod	micromethod	NN	I-NP	O
uses	use	VBZ	B-VP	O
microcuvettes	microcuvette	NNS	B-NP	O
and	and	CC	O	O
substitutes	substitute	VBZ	B-VP	O
ferrozine	ferrozine	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
bathophenanthroline	bathophenanthroline	NN	I-NP	O
chromogen	chromogen	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ICSH	ICSH	NN	I-NP	B-protein
.	.	.	O	O


Platelet	Platelet	NN	B-NP	B-protein
serotonin	serotonin	NN	I-NP	I-protein
(	(	(	O	I-protein
5	5	CD	B-NP	I-protein
-	-	HYPH	I-NP	I-protein
HT	HT	NN	I-NP	I-protein
)	)	)	O	I-protein
and	and	CC	O	I-protein
5	5	CD	B-NP	I-protein
-	-	HYPH	I-NP	O
HT	HT	NN	I-NP	B-protein
releasing	release	VBG	B-VP	I-protein
factor	factor	NN	B-NP	I-protein
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
of	of	IN	B-PP	O
migrainous	migrainous	JJ	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
overall	overall	JJ	I-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
SIDS	SIDS	NN	B-NP	O
was	be	VBD	B-VP	O
1.43	1.43	CD	B-NP	O
per	per	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
live	live	JJ	I-NP	O
births	birth	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
vigilance	vigilance	NN	I-NP	O
task	task	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
measurement	measurement	NN	I-NP	O
of	of	IN	B-PP	O
attentional	attentional	JJ	B-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
December	December	NNP	I-NP	O
armed	arm	VBD	B-VP	O
revolt	revolt	NN	B-NP	O
in	in	IN	B-PP	O
Moscow	Moscow	NNP	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
paramedical	paramedical	JJ	I-NP	O
personnel	personnel	NNS	I-NP	O


Significant	Significant	JJ	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
mean	mean	JJ	B-NP	O
serum	serum	NN	I-NP	O
E2	E2	NN	I-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
100	100	CD	B-NP	O
to	to	TO	I-NP	O
150	150	CD	I-NP	O
pg	pg	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
at	at	IN	B-PP	O
6	6	CD	B-NP	O
and	and	CC	I-NP	O
8	8	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
administration	administration	NN	B-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
hours	hour	NNS	I-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
motor	motor	NN	I-NP	O
unit	unit	NN	I-NP	O
viewed	view	VBN	B-VP	O
from	from	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O


Avian	Avian	JJ	B-NP	O
reproductive	reproductive	JJ	I-NP	O
system	system	NN	I-NP	O
:	:	:	O	O
daily	daily	JJ	B-NP	O
variations	variation	NNS	I-NP	O
in	in	IN	B-PP	O
responses	response	NNS	B-NP	O
to	to	TO	B-PP	O
hormones	hormone	NNS	B-NP	O
.	.	.	O	O


Biological	Biological	JJ	B-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
sumithion	sumithion	NN	B-NP	O
.	.	.	O	O


Serological	Serological	JJ	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
to	to	TO	B-PP	O
Epstein	Epstein	NNP	B-NP	O
-	-	HYPH	I-NP	O
Barr	Barr	NNP	I-NP	O
virus	virus	NN	I-NP	O
in	in	IN	B-PP	O
infectious	infectious	JJ	B-NP	O
mononucleosis	mononucleosis	NN	I-NP	O


Carcinoembryonic	Carcinoembryonic	JJ	B-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
(	(	(	O	O
CEA	CEA	NN	B-NP	O
)	)	)	O	O
procedures	procedure	NNS	B-NP	O
and	and	CC	O	O
clinical	clinical	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
remain	remain	VBP	B-VP	O
convinced	convinced	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
antilymphocyte	antilymphocyte	NN	B-NP	B-protein
globulin	globulin	NN	I-NP	I-protein
(	(	(	O	O
ALG	ALG	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
immunosuppressive	immunosuppressive	JJ	I-NP	O
agent	agent	NN	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
.	.	.	O	O


On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
global	global	JJ	I-NP	O
assessment	assessment	NN	I-NP	O
patients	patient	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
significant	significant	JJ	I-NP	O
preference	preference	NN	I-NP	O
for	for	IN	B-PP	O
imipramine	imipramine	NN	B-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
placebo	placebo	NN	B-NP	O
as	as	IN	B-PP	O
adjunctive	adjunctive	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O


39	39	CD	B-NP	O
-	-	HYPH	I-NP	O
47	47	CD	I-NP	O
.	.	.	O	O


Patients	Patient	NNS	B-NP	O
were	be	VBD	B-VP	O
subclassified	subclassifie	VBN	I-VP	O
into	into	IN	B-PP	O
age	age	NN	B-NP	O
-	-	HYPH	B-NP	O
matched	match	VBN	I-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	O
untreated	untreated	JJ	I-NP	O
cancer	cancer	NN	I-NP	O
(	(	(	O	O
21	21	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
(	(	(	O	O
18	18	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
"	"	``	O	O
cured	cure	VBN	B-VP	O
"	"	''	O	O
patients	patient	NNS	B-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
free	free	JJ	B-ADJP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
9	9	CD	I-NP	O
months	month	NNS	I-NP	O
(	(	(	O	O
16	16	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


Absorption	Absorption	NN	B-NP	O
varied	vary	VBD	B-VP	O
between	between	IN	B-PP	O
65	65	CD	B-NP	O
and	and	CC	I-NP	O
95	95	CD	I-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	JJ	I-NP	O
absorption	absorption	NN	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
pregnant	pregnant	JJ	I-NP	O
and	and	CC	O	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
pregnant	pregnant	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O


Bacteriostatic	Bacteriostatic	JJ	B-NP	O
and	and	CC	I-NP	O
bacteriacidal	bacteriacidal	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
hydroxy	hydroxy	NN	B-NP	O
-	-	HYPH	O	O
9	9	CD	B-NP	O
ellipticine	ellipticine	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O


Advances	Advance	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
gynecologic	gynecologic	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
-	-	HYPH	O	O
-	-	HYPH	B-NP	O
radiation	radiation	NN	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
clinico	clinico	AFX	I-NP	O
-	-	HYPH	I-NP	O
pathological	pathological	JJ	I-NP	O
data	datum	NNS	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
irreversible	irreversible	JJ	B-NP	O
post	post	AFX	I-NP	O
-	-	HYPH	I-NP	O
partum	partum	NN	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
(	(	(	O	O
IPRF	IPRF	NN	B-NP	B-protein
)	)	)	O	O
are	be	VBP	B-VP	O
presented	present	VBN	I-VP	O
.	.	.	O	O


Personal	Personal	JJ	B-NP	O
satisfaction	satisfaction	NN	I-NP	O
in	in	IN	B-PP	O
nursing	nursing	NN	B-NP	O
:	:	:	O	O
an	an	DT	B-NP	O
encounter	encounter	NN	I-NP	O
with	with	IN	B-PP	O
extremely	extremely	RB	B-NP	O
hostile	hostile	JJ	I-NP	O
patients	patient	NNS	I-NP	O


Dialyzable	Dialyzable	JJ	B-NP	O
transfer	transfer	NN	I-NP	O
factor	factor	NN	I-NP	O
.	.	.	O	O


19	19	CD	B-NP	O
-	-	HYPH	I-NP	O
32	32	CD	I-NP	O
.	.	.	O	O


Rheumatoid	Rheumatoid	JJ	B-NP	O
factor	factor	NN	I-NP	O
and	and	CC	O	O
antinuclear	antinuclear	JJ	B-NP	O
antibody	antibody	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
frequently	frequently	RB	B-ADJP	O
positive	positive	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactions	reaction	NNS	B-NP	O
to	to	TO	B-PP	O
gold	gold	NN	B-NP	O
therapy	therapy	NN	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
frequent	frequent	JJ	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
rheumatoid	rheumatoid	JJ	I-NP	B-cell_type
populations	population	NNS	I-NP	I-cell_type
.	.	.	O	O


The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
hydrostatic	hydrostatic	JJ	B-NP	O
pressure	pressure	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
swimming	swimming	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
hyponeustonic	hyponeustonic	JJ	I-NP	O
crustacea	crustacea	NN	I-NP	O
,	,	,	O	O
Anomalocera	Anomalocera	NNP	B-NP	O
patersoni	patersoni	NNS	I-NP	O
,	,	,	O	O
Pontella	Pontella	NNP	B-NP	O
mediterranea	mediterranea	NNP	I-NP	O
,	,	,	O	O
Labidocera	Labidocera	NNP	B-NP	O
wollastoni	wollastoni	NNS	I-NP	O


This	This	DT	B-NP	O
report	report	NN	I-NP	O
presents	present	VBZ	B-VP	O
an	an	DT	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
vocal	vocal	JJ	I-NP	B-protein
repertoire	repertoire	NN	I-NP	I-protein
of	of	IN	B-PP	O
howler	howler	NN	B-NP	O
monkeys	monkey	NNS	I-NP	O
(	(	(	O	O
Alouatta	Alouatta	NN	B-NP	O
palliata	palliata	NN	I-NP	O
)	)	)	O	O
observed	observe	VBN	B-VP	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
field	field	NN	I-NP	O
study	study	NN	I-NP	O
in	in	IN	B-PP	O
southwestern	southwestern	JJ	B-NP	O
Panama	Panama	NNP	I-NP	O
.	.	.	O	O


Up	Up	IN	B-PP	O
to	to	TO	B-PP	O
now	now	RB	B-ADVP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
examined	examine	VBN	B-VP	O
is	be	VBZ	B-VP	O
about	about	IN	B-NP	O
300	300	CD	I-NP	O
,	,	,	O	O
additionally	additionally	RB	B-NP	O
6	6	CD	I-NP	O
persons	person	NNS	I-NP	O
who	who	WP	B-NP	O
underwent	undergo	VBD	B-VP	O
binephrectomy	binephrectomy	NN	B-NP	O
.	.	.	O	O


Deflunia	Deflunia	NNP	B-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
tolerated	tolerate	VBN	I-VP	O
by	by	IN	B-PP	O
25	25	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
very	very	RB	B-VP	O
well	well	RB	I-VP	O
tolerated	tolerate	VBN	I-VP	O
by	by	IN	B-PP	O
2	2	CD	B-NP	O
.	.	.	O	O


III	III	CD	B-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
new	new	JJ	I-NP	O
instrument	instrument	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
designed	design	VBN	I-VP	O
for	for	IN	B-PP	O
freeze	freeze	NN	B-NP	O
-	-	HYPH	I-NP	O
fracturing	fracturing	NN	I-NP	O
of	of	IN	B-PP	O
biological	biological	JJ	B-NP	O
material	material	NN	I-NP	O
in	in	IN	B-PP	O
ultra	ultra	JJ	B-NP	O
high	high	JJ	I-NP	O
vacuum	vacuum	NN	I-NP	O
.	.	.	O	O


Pancreatic	Pancreatic	JJ	B-NP	O
and	and	CC	I-NP	O
biliary	biliary	JJ	I-NP	O
secretion	secretion	NN	I-NP	O
and	and	CC	O	O
gastric	gastric	JJ	B-NP	O
emptying	emptying	NN	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
liquid	liquid	JJ	I-NP	O
test	test	NN	I-NP	O
meal	meal	NN	I-NP	O
(	(	(	O	O
LTM	LTM	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
persons	person	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
subtotal	subtotal	JJ	B-NP	O
gastrectomy	gastrectomy	NN	I-NP	O
with	with	IN	B-PP	O
gastroduodenostomy	gastroduodenostomy	NN	B-NP	O
(	(	(	O	O
STG	STG	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
BI	BI	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
with	with	IN	B-PP	O
gastrojejunostomy	gastrojejunostomy	NN	B-NP	O
(	(	(	O	O
STG	STG	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
BII	BII	NN	I-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
truncal	truncal	JJ	B-NP	O
vagotomy	vagotomy	NN	I-NP	O
and	and	CC	O	O
pyloroplasty	pyloroplasty	NN	B-NP	O
(	(	(	O	O
V	V	NN	B-NP	O
&	&	CC	I-NP	O
P	P	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


Abnormal	Abnormal	JJ	B-NP	O
calcium	calcium	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
in	in	IN	B-PP	O
normocalcaemic	normocalcaemic	JJ	B-NP	O
sarcoidosis	sarcoidosis	NN	I-NP	O
.	.	.	O	O


Also	Also	RB	B-ADVP	O
,	,	,	O	O
except	except	IN	B-PP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
patient	patient	NN	I-NP	O
who	who	WP	B-NP	O
developed	develop	VBD	B-VP	O
gallstones	gallstone	NNS	B-NP	O
following	follow	VBG	B-PP	O
institution	institution	NN	B-NP	O
of	of	IN	B-PP	O
colestipol	colestipol	NN	B-NP	O
,	,	,	O	O
saturation	saturation	NN	B-NP	O
of	of	IN	B-PP	O
gallbladder	gallbladder	NN	B-NP	O
bile	bile	NN	I-NP	O
with	with	IN	B-PP	O
cholesterol	cholesterol	NN	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
markedly	markedly	RB	I-VP	O
increased	increase	VBN	I-VP	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
drug	drug	NN	I-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O


A	A	DT	B-NP	O
five	five	CD	I-NP	O
-	-	HYPH	I-NP	O
phase	phase	NN	I-NP	O
experiment	experiment	NN	I-NP	O
was	be	VBD	B-VP	O
designed	design	VBN	I-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
(	(	(	O	O
a	a	DT	O	O
)	)	)	O	O
whether	whether	IN	B-SBAR	O
contingent	contingent	JJ	B-NP	O
music	music	NN	I-NP	O
-	-	HYPH	B-NP	O
listening	listening	NN	I-NP	O
would	would	MD	B-VP	O
act	act	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
reinforcer	reinforcer	NN	I-NP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
arithmetic	arithmetic	JJ	B-NP	O
performance	performance	NN	I-NP	O
of	of	IN	B-PP	O
EMR	EMR	NN	B-NP	O
children	child	NNS	I-NP	O
and	and	CC	O	O
(	(	(	O	O
b	b	NN	O	O
)	)	)	O	O
whether	whether	IN	B-SBAR	O
this	this	DT	B-NP	O
contingent	contingent	JJ	I-NP	O
reinforcement	reinforcement	NN	I-NP	O
would	would	MD	B-VP	O
affect	affect	VB	I-VP	O
preference	preference	NN	B-NP	O
for	for	IN	B-PP	O
that	that	DT	B-NP	O
reinforcer	reinforcer	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
of	of	IN	B-PP	O
visual	visual	JJ	B-NP	O
cortex	cortex	NN	I-NP	O
(	(	(	O	O
VC	VC	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
superior	superior	JJ	B-NP	O
colliculus	colliculus	NN	I-NP	O
(	(	(	O	O
SC	SC	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
simultaneously	simultaneously	RB	I-VP	O
compared	compare	VBN	I-VP	O
following	follow	VBG	B-PP	O
conditioning	condition	VBG	B-VP	O
"	"	``	O	O
ON	ON	NNP	B-NP	O
"	"	''	O	O
or	or	CC	O	O
"	"	``	B-NP	B-protein
OFF	OFF	NN	I-NP	I-protein
"	"	''	I-NP	O
stimulation	stimulation	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rabbit	rabbit	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
MS	MS	NN	B-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
subtle	subtle	JJ	B-NP	O
neurologic	neurologic	JJ	I-NP	O
signs	sign	NNS	I-NP	O
,	,	,	O	O
spinal	spinal	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
gamma	gamma	NN	I-NP	O
globulin	globulin	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
abnormalities	abnormality	NNS	B-NP	O
in	in	IN	B-PP	O
neuropsychological	neuropsychological	JJ	B-NP	O
testing	testing	NN	I-NP	O
.	.	.	O	O


If	If	IN	B-SBAR	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
temperature	temperature	NN	I-NP	O
rise	rise	NN	I-NP	O
was	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
(	(	(	O	O
0.57	0.57	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
or	or	CC	O	O
0.69	0.69	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
such	such	PDT	B-NP	O
a	a	DT	I-NP	O
selection	selection	NN	I-NP	O
practically	practically	RB	B-ADVP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
disappearance	disappearance	NN	I-NP	O
of	of	IN	B-PP	O
'	'	``	B-NP	O
passable	passable	JJ	I-NP	O
'	'	''	I-NP	O
qualifications	qualification	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
triplet	triplet	JJ	I-NP	O
groups	group	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
great	great	JJ	I-NP	O
predominance	predominance	NN	I-NP	O
of	of	IN	B-PP	O
'	'	''	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
rejected	reject	VBN	I-VP	O
'	'	''	O	O
qualifications	qualification	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
Viso	Viso	NNP	I-NP	O
V	V	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
RDS	RDS	NN	I-NP	O
group	group	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
small	small	JJ	B-NP	O
airway	airway	NN	I-NP	O
resistance	resistance	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
or	or	CC	B-PP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
psychological	psychological	JJ	I-NP	O
tests	test	NNS	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
free	free	JJ	I-NP	O
-	-	HYPH	I-NP	O
recall	recall	NN	I-NP	O
task	task	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
test	test	NN	I-NP	O
for	for	IN	B-PP	O
visuomotor	visuomotor	NN	B-NP	O
coordination	coordination	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
recognition	recognition	NN	I-NP	O
task	task	NN	I-NP	O
.	.	.	O	O


Selective	Selective	JJ	B-NP	O
bronchial	bronchial	JJ	I-NP	O
intubation	intubation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
unilateral	unilateral	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
interstitial	interstitial	JJ	I-NP	O
emphysema	emphysema	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
background	background	NN	I-NP	O
processes	process	NNS	I-NP	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
etiological	etiological	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
character	character	NN	I-NP	O
of	of	IN	B-PP	O
lesion	lesion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
epithelium	epithelium	NN	I-NP	O
are	be	VBP	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
dyshormonal	dyshormonal	JJ	B-NP	O
,	,	,	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
,	,	,	I-NP	O
and	and	CC	I-NP	O
posttraumatic	posttraumatic	JJ	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
sense	sense	NN	I-NP	O
of	of	IN	B-PP	O
self	self	NN	B-NP	O
.	.	.	O	O


Eleven	Eleven	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
Fusarium	Fusarium	NNP	B-NP	O
poae	poae	NN	I-NP	O
and	and	CC	I-NP	O
F	F	NN	I-NP	O
.	.	.	I-NP	O
sporotrichioides	sporotrichioide	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
U	U	NNP	I-NP	O
.	.	.	I-NP	O
S	S	NNP	I-NP	O
.	.	.	I-NP	O
S	S	NNP	I-NP	O
.	.	.	I-NP	O
R	R	NNP	I-NP	O
.	.	.	O	O
and	and	CC	O	O
7	7	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
species	specie	NNS	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
F	F	NN	B-NP	B-protein
.	.	.	O	O
sporotrichioides	sporotrichioide	NNS	B-NP	O
var	var	VBP	B-VP	O
.	.	.	O	O
tricinctum	tricinctum	NN	B-NP	O
from	from	IN	B-PP	O
U	U	NNP	B-NP	O
.	.	.	I-NP	O
S	S	NNP	I-NP	O
.	.	.	I-NP	O
A	A	NNP	I-NP	O
.	.	.	O	O
and	and	CC	O	O
France	France	NNP	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
compared	compare	VBN	I-VP	O
as	as	IN	B-PP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
capacity	capacity	NN	I-NP	O
to	to	TO	B-VP	O
yield	yield	VB	I-VP	O
T	T	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
2	2	CD	I-NP	I-protein
toxin	toxin	NN	I-NP	I-protein
.	.	.	O	O


Current	Current	JJ	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
uses	use	NNS	I-NP	O
of	of	IN	B-PP	O
computerized	computerized	JJ	B-NP	O
tomography	tomography	NN	I-NP	O
in	in	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
medicine	medicine	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
follow	follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
study	study	NN	B-NP	O
of	of	IN	B-PP	O
22	22	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
Ebstein	Ebstein	NN	B-NP	O
'	'	POS	B-NP	O
s	s	NN	I-NP	O
anomaly	anomaly	RB	B-ADVP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O


Deaths	Death	NNS	B-NP	O
stopped	stop	VBD	B-VP	O
11	11	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
copper	copper	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
decreased	decrease	VBD	B-VP	O
below	below	IN	B-PP	O
0.2	0.2	CD	B-NP	O
ppm	ppm	NN	I-NP	O
and	and	CC	O	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
distress	distress	NN	B-NP	O
stopped	stop	VBD	B-VP	O
in	in	IN	B-PP	O
surviving	survive	VBG	B-VP	O
pinfish	pinfish	NN	B-NP	O
by	by	IN	B-PP	O
approximately	approximately	RB	B-NP	O
6	6	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
death	death	NN	I-NP	O
.	.	.	O	O


Recurrence	Recurrence	NN	B-NP	O
of	of	IN	B-PP	O
bladder	bladder	NN	B-NP	O
tumors	tumor	NNS	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
original	original	JJ	I-NP	O
9	9	CD	I-NP	O
cases	case	NNS	I-NP	O
has	have	VBZ	B-VP	O
occurred	occur	VBN	I-VP	O
only	only	RB	B-ADVP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	O
whose	whose	WP$	I-NP	O
properdin	properdin	NN	I-NP	O
levels	level	NNS	I-NP	O
remained	remain	VBD	B-VP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
median	median	NN	I-NP	O
.	.	.	O	O


Adaptation	Adaptation	NN	B-NP	O
of	of	IN	B-PP	O
taurocholate	taurocholate	JJ	B-NP	O
transport	transport	NN	I-NP	O
maximum	maximum	NN	I-NP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
secretory	secretory	JJ	I-NP	O
load	load	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
.	.	.	O	O


Dangers	Danger	NNS	B-NP	O
in	in	IN	B-PP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
live	live	JJ	B-NP	O
-	-	HYPH	I-NP	O
virus	virus	NN	I-NP	O
vaccines	vaccine	NNS	I-NP	O
.	.	.	O	O


Treatment	Treatment	NN	B-NP	O
with	with	IN	B-PP	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
plasminogen	plasminogen	NN	B-NP	B-protein
activators	activator	NNS	I-NP	I-protein
and	and	CC	O	O
fibrinogenolytic	fibrinogenolytic	JJ	B-NP	O
agents	agent	NNS	I-NP	O
was	be	VBD	B-VP	O
disappointing	disappointing	JJ	B-ADJP	O
although	although	IN	B-SBAR	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
has	have	VBZ	B-VP	O
stabilized	stabilize	VBN	I-VP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
long	long	JJ	B-NP	O
term	term	NN	I-NP	O
oral	oral	JJ	I-NP	O
anticoagulant	anticoagulant	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
diethyl	diethyl	NN	B-NP	O
ether	ether	NN	I-NP	O
solution	solution	NN	I-NP	O
the	the	DT	B-NP	O
main	main	JJ	I-NP	O
peak	peak	NN	I-NP	O
is	be	VBZ	B-VP	O
that	that	DT	O	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
-	-	HYPH	O	O
benzylidenamio	benzylidenamio	AFX	O	B-cell_type
-	-	HYPH	B-NP	B-protein
1	1	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
phenylpropane	phenylpropane	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
retention	retention	NN	I-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
23	23	CD	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
minutes	minute	NNS	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
condition	condition	NN	I-NP	O
delineated	delineate	VBN	B-VP	O
.	.	.	O	O


Amikacin	Amikacin	NN	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
56	56	CD	B-NP	O
serious	serious	JJ	I-NP	O
gram	gram	NN	I-NP	O
-	-	HYPH	B-NP	O
negative	negative	JJ	I-NP	O
infections	infection	NNS	I-NP	O
in	in	IN	B-PP	O
54	54	CD	B-NP	O
patients	patient	NNS	I-NP	O
of	of	IN	B-PP	O
whom	whom	WP	B-NP	O
47	47	CD	B-NP	O
survived	survive	VBD	B-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
normally	normally	RB	B-ADJP	O
available	available	JJ	I-ADJP	O
are	be	VBP	B-VP	O
insufficient	insufficient	JJ	B-ADJP	O
and	and	CC	O	O
take	take	VB	B-VP	O
no	no	DT	B-NP	O
account	account	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
direction	direction	NN	I-NP	O
of	of	IN	B-PP	O
recirculation	recirculation	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
determining	determining	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
.	.	.	O	O


During	During	IN	B-PP	O
activity	activity	NN	B-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
angina	angina	NN	B-NP	O
.	.	.	O	O


Estimation	Estimation	NN	B-NP	O
of	of	IN	B-PP	O
L	L	NN	B-NP	O
-	-	HYPH	O	O
alanine	alanine	NN	B-NP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
or	or	CC	I-NP	O
plasma	plasma	NN	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
LKB	LKB	NN	I-NP	O
reaction	reaction	NN	I-NP	O
rate	rate	NN	I-NP	O
analyser	analyser	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
acids	acid	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
hydrolysis	hydrolysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
corresponding	corresponding	JJ	I-NP	O
esters	ester	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
anti	anti	AFX	I-NP	O
-	-	HYPH	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
.	.	.	O	O


Unrecognized	Unrecognized	JJ	B-NP	O
amnionitis	amnionitis	NN	I-NP	O
and	and	CC	I-NP	O
prematurity	prematurity	NN	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
preliminary	preliminary	JJ	I-NP	O
report	report	NN	I-NP	O
.	.	.	O	O


Evaluation	Evaluation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
Gravigard	Gravigard	NNP	I-NP	O
IUCD	IUCD	NN	I-NP	O
inserter	inserter	NN	I-NP	O
.	.	.	O	O


Bacterial	Bacterial	JJ	B-NP	O
meningitis	meningitis	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
abscess	abscess	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nasal	nasal	JJ	I-NP	O
septum	septum	NN	I-NP	O
.	.	.	O	O


Serum	Serum	NN	B-NP	B-protein
amylase	amylase	NN	I-NP	I-protein
became	become	VBD	B-VP	O
markedly	markedly	RB	B-ADJP	O
elevated	elevate	VBN	I-ADJP	O
(	(	(	O	O
2	2	CD	B-NP	O
,	,	,	O	O
624	624	CD	B-NP	O
CU	CU	NN	I-NP	O
/	/	SYM	B-NP	O
100	100	CD	B-NP	O
ml	ml	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
as	as	IN	B-SBAR	O
did	do	VBD	O	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	O
FFA	FFA	NN	I-NP	O
(	(	(	O	O
29.19	29.19	CD	B-NP	O
mEq	mEq	NN	I-NP	O
/	/	SYM	B-NP	O
liter	liter	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


In	In	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
preparation	preparation	NN	I-NP	O
before	before	IN	B-PP	O
weight	weight	NN	B-NP	O
was	be	VBD	B-VP	O
allowed	allow	VBN	I-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
,	,	,	O	O
isogravimetric	isogravimetric	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
(	(	(	O	O
Pci	Pci	NN	B-NP	B-protein
)	)	)	O	O
averaged	average	VBD	B-VP	O
8	8	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
colloid	colloid	JJ	B-NP	O
osmotic	osmotic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
(	(	(	O	O
IIp	IIp	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O


Infants	Infant	NNS	B-NP	O
who	who	WP	B-NP	O
died	die	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
from	from	IN	B-PP	O
'	'	``	O	O
IVH	IVH	NN	B-NP	O
only	only	RB	B-ADVP	O
'	'	''	O	O
had	have	VBD	B-VP	O
suffered	suffer	VBN	I-VP	O
severe	severe	JJ	B-NP	O
birth	birth	NN	I-NP	O
asphyxia	asphyxia	NN	I-NP	O
but	but	CC	B-PP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
who	who	WP	B-NP	O
died	die	VBD	B-VP	O
later	later	RB	B-ADVP	O
the	the	DT	B-NP	O
main	main	JJ	I-NP	O
symptom	symptom	NN	I-NP	O
was	be	VBD	B-VP	O
recurrent	recurrent	JJ	B-NP	O
apnoea	apnoea	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
morphological	morphological	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
snake	snake	NN	I-NP	O
venoms	venom	NNS	I-NP	O
,	,	,	O	O
N	N	NN	B-NP	O
.	.	.	O	O
naja	naja	NN	B-NP	O
and	and	CC	I-NP	O
A	A	NN	I-NP	O
.	.	.	I-NP	O
piscivorus	piscivorus	NN	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Direct	Direct	JJ	I-NP	O
Lytic	Lytic	JJ	I-NP	B-protein
Factor	Factor	NN	I-NP	I-protein
and	and	CC	I-NP	O
Phospholipase	Phospholipase	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
A	A	NN	I-NP	I-protein
,	,	,	O	O
compounds	compound	NNS	B-NP	O
purified	purify	VBN	B-VP	O
from	from	IN	B-PP	O
N	N	NN	B-NP	O
.	.	.	O	O
naja	naja	NN	B-NP	O
crude	crude	JJ	I-NP	O
venom	venom	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
on	on	IN	B-PP	O
lung	lung	NN	B-NP	O
and	and	CC	I-NP	O
cremaster	cremaster	NN	I-NP	O
vessels	vessel	NNS	I-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O
.	.	.	O	O


Since	Since	IN	B-SBAR	O
GAGs	GAG	NNS	B-NP	B-protein
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
cartilage	cartilage	NN	B-NP	O
matrix	matrix	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
depletion	depletion	NN	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
osteoarthrosis	osteoarthrosis	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
measuring	measure	VBG	B-VP	O
sulphated	sulphate	VBN	B-NP	O
GAG	GAG	NN	I-NP	O
synthesis	synthesis	NN	I-NP	O
in	in	IN	B-PP	O
culture	culture	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
length	length	NN	I-NP	O
scales	scale	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
turbulence	turbulence	NN	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
estimated	estimate	VBN	I-VP	O
:	:	:	O	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
Reynolds	Reynolds	NNP	I-NP	O
number	number	NN	I-NP	O
near	near	IN	B-PP	O
4	4	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
the	the	DT	B-NP	O
macroscale	macroscale	NN	I-NP	O
is	be	VBZ	B-VP	O
about	about	RB	B-NP	O
1.25	1.25	CD	I-NP	O
mm	mm	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Taylor	Taylor	NNP	I-NP	O
microscale	microscale	NN	I-NP	O
is	be	VBZ	B-VP	O
about	about	RB	B-NP	O
0.85	0.85	CD	I-NP	O
mm	mm	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
Kolmogoroff	Kolmogoroff	NNP	I-NP	O
scale	scale	NN	I-NP	O
is	be	VBZ	B-VP	O
near	near	IN	B-NP	O
0.075	0.075	CD	I-NP	O
mm	mm	NN	I-NP	O
.	.	.	O	O


Well	Well	RB	B-ADVP	O
-	-	HYPH	B-NP	O
visualised	visualise	VBN	I-NP	O
arteriograms	arteriogram	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
limbs	limb	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
xeroradiography	xeroradiography	NN	B-NP	O
after	after	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
manual	manual	JJ	I-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
contrast	contrast	NN	B-NP	O
-	-	HYPH	B-NP	O
medium	medium	NN	I-NP	O
into	into	IN	B-PP	O
an	an	DT	B-NP	O
arm	arm	NN	I-NP	O
vein	vein	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
demonstrated	demonstrate	VBN	B-VP	O
in	in	IN	B-PP	O
28	28	CD	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O


No	No	DT	B-NP	O
hypotension	hypotension	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
toxemia	toxemia	NN	B-NP	O
and	and	CC	O	O
only	only	RB	B-NP	O
2	2	CD	I-NP	O
ran	run	VBD	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
above	above	IN	B-PP	O
37.5	37.5	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
.	.	.	O	O


The	The	DT	B-NP	O
sera	serum	NNS	I-NP	O
and	and	CC	O	O
nasal	nasal	JJ	B-NP	O
secretions	secretion	NNS	I-NP	O
of	of	IN	B-PP	O
142	142	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
in	in	IN	B-PP	O
HD	HD	NN	B-NP	O
or	or	CC	I-NP	O
mites	mite	NNS	I-NP	O
skin	skin	NN	I-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
radioallergosorbent	radioallergosorbent	JJ	I-NP	O
test	test	NN	I-NP	O
(	(	(	O	O
RAST	RAST	NN	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
estimating	estimate	VBG	B-VP	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
IgE	IgE	NN	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
to	to	TO	B-PP	O
mites	mite	NNS	B-NP	O
.	.	.	O	O


Wherever	Wherever	WRB	B-ADVP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
conditioning	condition	VBG	I-NP	O
stimulation	stimulation	NN	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
modifications	modification	NNS	I-NP	O
disappeared	disappear	VBD	B-VP	O
after	after	IN	B-PP	O
ischaemia	ischaemia	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O


Diallylnitrosamine	Diallylnitrosamine	NN	B-NP	O
(	(	(	O	O
DAN	DAN	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
few	few	JJ	I-NP	O
nitrosamines	nitrosamine	NNS	I-NP	O
tested	test	VBN	B-VP	O
thus	thus	RB	B-ADVP	O
far	far	RB	I-ADVP	O
that	that	DT	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
induced	induce	VBN	I-VP	O
neoplasms	neoplasm	NNS	B-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
,	,	,	O	O
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
tract	tract	NN	I-NP	O
tumors	tumor	NNS	I-NP	O
in	in	IN	B-PP	O
Syrian	Syrian	JJ	B-NP	O
golden	golden	JJ	I-NP	O
hamsters	hamster	NNS	I-NP	O
treated	treat	VBN	B-VP	O
sc	sc	NN	B-NP	O
with	with	IN	B-PP	O
single	single	JJ	B-NP	O
or	or	CC	I-NP	O
weekly	weekly	JJ	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
compound	compound	NN	I-NP	O
.	.	.	O	O


Near	Near	JJ	B-NP	O
term	term	NN	I-NP	O
,	,	,	O	O
under	under	IN	B-PP	O
experimental	experimental	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
maternal	maternal	JJ	B-NP	O
and	and	CC	I-NP	O
fetal	fetal	JJ	I-NP	B-protein
blood	blood	NN	I-NP	I-protein
gases	gas	NNS	I-NP	I-protein
,	,	,	O	O
pH	pH	NN	B-NP	O
,	,	,	O	O
uterine	uterine	JJ	B-NP	O
and	and	CC	I-NP	O
umbilical	umbilical	JJ	I-NP	O
blood	blood	NN	I-NP	O
flows	flow	NNS	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
or	or	CC	I-VP	O
calculated	calculate	VBN	I-VP	O
.	.	.	O	O


Haemodynamic	Haemodynamic	JJ	B-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
antagonism	antagonism	NN	B-NP	O
of	of	IN	B-PP	O
bocurarine	bocurarine	NN	B-NP	O
block	block	NN	I-NP	O
with	with	IN	B-PP	O
atropine	atropine	NN	B-NP	O
-	-	HYPH	I-NP	O
neostigmine	neostigmine	NN	I-NP	O
mixture	mixture	NN	I-NP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
large	large	JJ	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
diphosphonate	diphosphonate	NN	I-NP	O
99mTc	99mTc	NN	I-NP	O
-	-	HYPH	B-NP	O
labeled	label	VBN	I-NP	O
EHDP	EHDP	NN	I-NP	O
or	or	CC	I-NP	O
99mTc	99mTc	NN	I-NP	O
-	-	HYPH	O	O
labeled	label	VBN	B-VP	O
pyrophosphate	pyrophosphate	NN	B-NP	O
,	,	,	O	O
pass	pass	VBP	B-VP	O
through	through	IN	B-PP	O
capillaries	capillary	NNS	B-NP	O
in	in	IN	B-PP	O
bone	bone	NN	B-NP	O
is	be	VBZ	B-VP	O
by	by	IN	B-PP	O
passive	passive	JJ	B-NP	O
diffusion	diffusion	NN	I-NP	O
.	.	.	O	O


Twenty	Twenty	CD	B-NP	O
-	-	HYPH	I-NP	O
nine	nine	CD	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
injection	injection	NN	B-NP	O
of	of	IN	B-PP	O
5.8	5.8	CD	B-NP	O
mCi	mCi	NN	I-NP	O
of	of	IN	B-PP	O
Tc	Tc	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
99m	99m	CD	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
gives	give	VBZ	B-VP	O
28	28	CD	B-NP	O
rads	rad	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
testis	testis	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
sperm	sperm	NN	B-NP	O
hads	had	NNS	I-NP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
control	control	NN	B-NP	O
.	.	.	O	O


Self	Self	NN	B-NP	O
-	-	HYPH	I-NP	O
emasculation	emasculation	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
unusual	unusual	JJ	I-NP	O
psychiatric	psychiatric	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
initially	initially	RB	B-ADVP	O
requires	require	VBZ	B-VP	O
surgical	surgical	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O


Possibility	Possibility	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
TSH	TSH	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
Screening	Screening	NN	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
detection	detection	NN	B-NP	O
of	of	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
newborn	newborn	NN	I-NP	O


Thus	Thus	RB	B-NP	O
analysis	analysis	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
no	no	DT	B-NP	O
reliable	reliable	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
conscious	conscious	JJ	B-NP	O
presleep	presleep	NN	I-NP	O
suggestions	suggestion	NNS	I-NP	O
become	become	VBP	B-VP	O
incorporated	incorporate	VBN	I-VP	O
into	into	IN	B-PP	O
dream	dream	NN	B-NP	O
content	content	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
surface	surface	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
(	(	(	O	O
HBsAg	HBsAg	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
anti	anti	AFX	B-NP	O
-	-	HYPH	I-NP	O
HBs	HB	NNS	B-NP	B-protein
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
sensitive	sensitive	JJ	I-NP	B-protein
double	double	JJ	I-NP	I-protein
-	-	HYPH	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
radio	radio	AFX	B-NP	O
-	-	HYPH	I-NP	O
immunoassay	immunoassay	NN	I-NP	O
technique	technique	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
liver	liver	NN	I-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O


It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
requiring	require	VBG	B-VP	O
artificial	artificial	JJ	B-NP	O
ventilation	ventilation	NN	I-NP	O
have	have	VBP	B-VP	O
two	two	CD	B-NP	O
componenents	componenent	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
shunt	shunt	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
parallel	parallel	NN	I-NP	O
with	with	IN	B-PP	O
and	and	CC	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
inversely	inversely	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
PAO2	PAO2	NN	I-NP	B-protein
.	.	.	O	O


Decreased	Decrease	VBN	B-NP	O
cardiac	cardiac	JJ	I-NP	O
glycogen	glycogen	NN	I-NP	O
following	follow	VBG	B-PP	O
phenformin	phenformin	NN	B-NP	O
injection	injection	NN	I-NP	O
in	in	IN	B-PP	O
hyperglycemic	hyperglycemic	JJ	B-NP	O
,	,	,	I-NP	O
hyperinsulinemic	hyperinsulinemic	JJ	I-NP	O
anaesthetized	anaesthetize	VBN	I-NP	O
rats	rat	NNS	I-NP	O
.	.	.	O	O


Biological	Biological	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
mibolerone	mibolerone	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
female	female	JJ	I-NP	O
Beagle	Beagle	NNP	I-NP	O
.	.	.	O	O


Levels	Level	NNS	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
PGF	PGF	NN	B-NP	B-protein
and	and	CC	I-NP	O
PGFM	PGFM	NN	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
during	during	IN	B-PP	O
early	early	JJ	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
labour	labour	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
dilatation	dilatation	NN	I-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
4	4	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
than	than	IN	B-PP	O
before	before	RB	O	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
labour	labour	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
deterioration	deterioration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
spinal	spinal	JJ	I-NP	O
cord	cord	NN	I-NP	O
injured	injured	JJ	I-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
irreversible	irreversible	JJ	B-NP	O
vesicoureteral	vesicoureteral	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
.	.	.	O	O


Propranolol	Propranolol	NN	B-NP	O
(	(	(	O	O
Inderal	Inderal	JJ	B-ADJP	O
)	)	)	O	O
administered	administer	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
which	which	WDT	B-NP	O
blocks	block	VBZ	B-VP	O
the	the	DT	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
adrenergic	adrenergic	JJ	I-NP	O
apparatus	apparatus	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
prevents	prevent	VBZ	B-VP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
positive	positive	JJ	I-NP	O
inotropic	inotropic	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
strophanthin	strophanthin	JJ	B-NP	O
K	K	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
hypodynamic	hypodynamic	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
myocardium	myocardium	NN	I-NP	O
.	.	.	O	O


Recent	Recent	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
larynx	larynx	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
organ	organ	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
irritancy	irritancy	NN	B-NP	O
of	of	IN	B-PP	O
inhaled	inhale	VBN	B-NP	O
materials	material	NNS	I-NP	O
.	.	.	O	O


Scanning	Scan	VBG	B-NP	O
electron	electron	NN	I-NP	O
microscopic	microscopic	JJ	I-NP	O
investigations	investigation	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
Reissner	Reissner	NNP	B-NP	O
'	'	POS	B-NP	O
s	s	JJ	I-NP	O
fiber	fiber	NN	I-NP	O
in	in	IN	B-PP	O
Rattus	Rattus	NNP	B-NP	O
rattus	rattus	NN	I-NP	O


Feeding	Feed	VBG	B-NP	O
behavior	behavior	NN	I-NP	O
,	,	,	O	O
circannual	circannual	JJ	B-NP	O
body	body	NN	I-NP	O
weight	weight	NN	I-NP	O
and	and	CC	I-NP	O
hibernation	hibernation	NN	I-NP	O
rhythms	rhythm	NNS	I-NP	O
in	in	IN	B-PP	O
European	European	JJ	B-NP	O
hamsters	hamster	NNS	I-NP	O
lesioned	lesione	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
noradrenergic	noradrenergic	JJ	I-NP	O
ascending	ascend	VBG	I-NP	O
bundles	bundle	NNS	I-NP	O


Role	Role	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
infectious	infectious	JJ	I-NP	O
-	-	HYPH	I-NP	O
disease	disease	NN	I-NP	O
specialist	specialist	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
polyclinic	polyclinic	NN	I-NP	O
in	in	IN	B-PP	O
reducing	reduce	VBG	B-VP	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
communicable	communicable	JJ	B-NP	O
diseases	disease	NNS	I-NP	O


These	These	DT	B-NP	O
observed	observe	VBN	I-NP	O
drug	drug	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
,	,	,	O	O
plus	plus	CC	O	O
the	the	DT	B-NP	O
known	know	VBN	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
probenecid	probenecid	NN	B-NP	O
to	to	TO	B-VP	O
block	block	VB	I-VP	O
secretion	secretion	NN	B-NP	O
of	of	IN	B-PP	O
PZA	PZA	NN	B-NP	B-protein
,	,	,	O	O
have	have	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
in	in	IN	B-PP	O
evaluating	evaluate	VBG	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
drugs	drug	NNS	I-NP	O
given	give	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
drug	drug	NN	I-NP	O
given	give	VBN	B-VP	O
separately	separately	RB	B-ADVP	O
.	.	.	O	O


Circulatory	Circulatory	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O


At	At	IN	B-PP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
(	(	(	O	O
BP	BP	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
,	,	,	O	O
C02	C02	NN	B-NP	O
responsiveness	responsiveness	NN	I-NP	O
was	be	VBD	B-VP	O
abolished	abolish	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
at	at	IN	B-PP	O
higher	high	JJR	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
BP	BP	NN	B-NP	B-protein
.	.	.	O	O


Iodine	Iodine	NN	B-NP	O
-	-	HYPH	O	O
123	123	CD	B-NP	O
was	be	VBD	B-VP	O
satisfactorily	satisfactorily	RB	I-VP	O
imaged	image	VBN	I-VP	O
only	only	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
MEC	MEC	NN	I-NP	O
and	and	CC	I-NP	O
pinhole	pinhole	NN	I-NP	B-protein
collimators	collimator	NNS	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
in	in	IN	B-PP	O
turn	turn	NN	B-NP	O
yielded	yield	VBD	B-VP	O
MTF	MTF	NN	B-NP	O
values	value	NNS	I-NP	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
measured	measure	VBN	B-VP	O
for	for	IN	B-PP	O
99mTc	99mTc	NN	B-NP	O
.	.	.	O	O


Petrous	Petrous	JJ	B-NP	O
meningioma	meningioma	NN	I-NP	O
en	en	IN	B-PP	O
plaque	plaque	NN	B-NP	O
presenting	present	VBG	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
ear	ear	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
difficulties	difficulty	NNS	I-NP	O
to	to	TO	B-VP	O
analyse	analyse	VB	I-VP	O
prostaglandins	prostaglandin	NNS	B-NP	O
(	(	(	O	O
PG	PG	NN	B-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
gas	gas	NN	B-NP	B-DNA
-	-	HYPH	I-NP	O
liquid	liquid	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
are	be	VBP	B-VP	O
mainly	mainly	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
sensitivity	sensitivity	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gas	gas	NN	I-NP	B-DNA
-	-	HYPH	I-NP	O
chromatograph	chromatograph	NN	I-NP	O
itself	itself	PRP	B-NP	O
(	(	(	O	O
higher	high	JJR	B-NP	O
than	than	IN	I-NP	O
200	200	CD	I-NP	O
ng	ng	NN	I-NP	O
)	)	)	O	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
poor	poor	JJ	I-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
packed	packed	JJ	I-NP	O
columns	column	NNS	I-NP	O
.	.	.	O	O


On	On	IN	B-PP	O
cessation	cessation	NN	B-NP	O
of	of	IN	B-PP	O
steroid	steroid	NN	B-NP	O
therapy	therapy	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
radiologic	radiologic	JJ	B-NP	O
manifestations	manifestation	NNS	I-NP	O
of	of	IN	B-PP	O
hypertrophic	hypertrophic	JJ	B-NP	O
osteoarthropathy	osteoarthropathy	NN	I-NP	O
(	(	(	O	O
HOA	HOA	NN	B-NP	O
)	)	)	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
clinical	clinical	JJ	B-NP	O
and	and	CC	I-NP	O
laboratory	laboratory	NN	I-NP	O
features	feature	NNS	I-NP	O
of	of	IN	B-PP	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
(	(	(	O	O
RA	RA	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
food	food	NN	B-NP	O
on	on	IN	B-PP	O
procainamide	procainamide	NN	B-NP	O
absorption	absorption	NN	I-NP	O
.	.	.	O	O


After	After	IN	B-PP	O
giving	give	VBG	B-VP	O
a	a	DT	B-NP	O
survey	survey	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
situation	situation	NN	I-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
Northern	Northern	NNP	B-NP	O
Bavaria	Bavaria	NNP	I-NP	O
during	during	IN	B-PP	O
1973	1973	CD	B-NP	O
/	/	SYM	I-NP	O
74	74	CD	I-NP	O
and	and	CC	O	O
comparing	compare	VBG	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
sulfamethoxazole	sulfamethoxazole	NN	I-NP	O
(	(	(	O	O
SMZ	SMZ	NN	B-NP	B-protein
)	)	)	O	O
trimethoprim	trimethoprim	NN	B-NP	O
(	(	(	O	O
TMP	TMP	NN	B-NP	O
)	)	)	O	O
combination	combination	NN	B-NP	O
to	to	TO	B-PP	O
other	other	JJ	B-NP	O
commonly	commonly	RB	I-NP	O
used	use	VBN	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
and	and	CC	O	O
chemotherapeutic	chemotherapeutic	JJ	B-NP	O
agents	agent	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
tests	test	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
N1	N1	NN	B-NP	B-protein
-	-	HYPH	O	O
(	(	(	O	O
4	4	CD	B-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
-	-	HYPH	I-NP	O
dimethyl	dimethyl	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
oxazolyl	oxazolyl	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
sulfanilamide	sulfanilamide	NN	I-NP	O
)	)	)	O	O
(	(	(	O	O
sulfamoxole	sulfamoxole	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
4	4	CD	I-NP	O
-	-	HYPH	I-NP	O
diamino	diamino	NN	I-NP	O
-	-	HYPH	B-NP	O
5	5	CD	I-NP	O
-	-	HYPH	B-NP	O
(	(	(	I-NP	O
3	3	CD	I-NP	O
,	,	,	I-NP	O
4	4	CD	I-NP	O
,	,	,	I-NP	O
5	5	CD	I-NP	O
-	-	HYPH	I-NP	O
trimethoxy	trimethoxy	AFX	I-NP	O
-	-	HYPH	I-NP	O
benzyl	benzyl	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	O	O
pyrimidine	pyrimidine	NN	B-NP	O
(	(	(	O	O
trimethoprim	trimethoprim	NN	B-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
:	:	SYM	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
CN	CN	NN	B-NP	O
3123	3123	CD	I-NP	O
;	;	:	O	O
Nevin	Nevin	NN	B-NP	O
,	,	,	I-NP	O
Supristol	Supristol	NN	I-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
tests	test	NNS	B-NP	O
with	with	IN	B-PP	O
TMP	TMP	NN	B-NP	B-protein
/	/	SYM	I-NP	O
SMZ	SMZ	NN	I-NP	B-protein
.	.	.	O	O


RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Total	Total	JJ	B-NP	O
IgE	IgE	NN	I-NP	B-protein
levels	level	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
tendency	tendency	NN	I-NP	O
to	to	TO	B-VP	O
diminish	diminish	VB	I-VP	O
.	.	.	O	O


Does	Do	VBZ	O	O
afferent	afferent	JJ	B-NP	O
loop	loop	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
exist	exist	VB	B-VP	O
?	?	.	O	O
]	]	)	O	O
It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
author	author	NN	I-NP	O
'	'	POS	B-NP	O
s	s	JJ	I-NP	O
opinion	opinion	NN	I-NP	O
that	that	IN	B-SBAR	O
diagnosis	diagnosis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
"	"	``	I-NP	B-DNA
adducent	adducent	JJ	I-NP	I-DNA
loop	loop	NN	I-NP	I-DNA
syndrome	syndrome	NN	I-NP	I-DNA
"	"	''	O	I-DNA
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
correct	correct	JJ	B-ADJP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
subjected	subject	VBN	B-VP	O
to	to	TO	B-PP	O
Billroth	Billroth	NNP	B-NP	O
-	-	HYPH	B-NP	O
II	II	CD	I-NP	O
gastrectomy	gastrectomy	NN	I-NP	O
.	.	.	O	O


Letter	Letter	NNP	B-NP	O
:	:	:	O	O
Is	Be	VBZ	O	O
actinic	actinic	JJ	O	O
(	(	(	O	O
solar	solar	JJ	B-ADJP	O
)	)	)	O	O
damage	damage	VBP	B-VP	O
the	the	DT	B-NP	O
provoking	provoke	VBG	I-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
'	'	``	O	O
post	post	AFX	B-NP	O
-	-	HYPH	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
elastolysis	elastolysis	NN	I-NP	O
and	and	CC	I-NP	O
cutis	cutis	NN	I-NP	O
laxa	laxa	NN	I-NP	O
(	(	(	O	O
PECL	PECL	NN	B-NP	O
)	)	)	O	O
'	'	''	O	O
?	?	.	O	O


These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
spontaneous	spontaneous	JJ	B-NP	O
recovery	recovery	NN	I-NP	O
of	of	IN	B-PP	O
central	central	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
function	function	NN	I-NP	O
after	after	IN	B-PP	O
intoxication	intoxication	NN	B-NP	O
with	with	IN	B-PP	O
Soman	Soman	NN	B-NP	O
or	or	CC	I-NP	O
Sarin	Sarin	NN	I-NP	B-protein
may	may	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
return	return	NN	I-NP	O
of	of	IN	B-PP	O
AChE	AChE	NN	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O


Batch	Batch	NN	B-NP	O
cultures	culture	NNS	I-NP	O
of	of	IN	B-PP	O
S	S	NN	B-NP	O
.	.	.	O	O
mutans	mutan	NNS	B-NP	O
serotype	serotype	VBP	B-VP	O
a	a	DT	B-NP	O
demonstrated	demonstrate	VBN	I-NP	O
no	no	DT	I-NP	O
growth	growth	NN	I-NP	O
on	on	IN	B-PP	O
MSB	MSB	NN	B-NP	B-protein
agar	agar	NN	I-NP	I-protein
.	.	.	O	O


Also	Also	RB	B-ADVP	O
,	,	,	O	O
samples	sample	NNS	B-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	O
were	be	VBD	B-VP	O
absorbed	absorb	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
various	various	JJ	I-NP	O
solid	solid	JJ	I-NP	O
-	-	HYPH	I-NP	O
phase	phase	NN	I-NP	O
allergens	allergen	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
reactivity	reactivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
IgE	IgE	NN	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O


Crisis	Crisis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
community	community	NN	I-NP	O
in	in	IN	B-PP	O
Great	Great	NNP	B-NP	O
Britain	Britain	NNP	I-NP	O


Pregnant	Pregnant	JJ	B-NP	O
women	woman	NNS	I-NP	O
at	at	IN	B-PP	O
term	term	NN	B-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
lowest	low	JJS	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
antithrombin	antithrombin	NN	B-NP	B-protein
III	III	CD	I-NP	I-protein
.	.	.	O	O


Hematology	Hematology	NN	B-NP	O
problem	problem	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
month	month	NN	I-NP	O
:	:	:	O	O
band	band	NN	B-NP	O
or	or	CC	I-NP	O
seg	seg	NN	I-NP	O
?	?	.	O	O


It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
possible	possible	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
cyclic	cyclic	JJ	B-NP	O
variations	variation	NNS	I-NP	O
in	in	IN	B-PP	O
heme	heme	NN	B-NP	O
turnover	turnover	NN	I-NP	O
are	be	VBP	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
erythrocyte	erythrocyte	NN	B-NP	O
characteristics	characteristic	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
progesterone	progesterone	NN	I-NP	O
phase	phase	NN	I-NP	O
.	.	.	O	O


Haemodilution	Haemodilution	NN	B-NP	O
in	in	IN	B-PP	O
cardiopulmonary	cardiopulmonary	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
gelatine	gelatine	NN	I-NP	O
derivative	derivative	NN	I-NP	O
for	for	IN	B-PP	O
priming	priming	NN	B-NP	O
.	.	.	O	O


Extramedullary	Extramedullary	JJ	B-NP	O
plasmacytoma	plasmacytoma	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
parotid	parotid	NN	I-NP	O
gland	gland	NN	I-NP	O


I	I	PRP	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
recovered	recover	VBN	I-NP	O
calves	calf	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
immunity	immunity	NN	B-NP	O
to	to	TO	B-PP	O
homologous	homologous	JJ	B-NP	O
severe	severe	JJ	I-NP	O
challenge	challenge	NN	I-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
or	or	CC	I-NP	O
73	73	CD	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
performance	performance	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
commonly	commonly	RB	I-NP	O
used	use	VBN	I-NP	O
chemical	chemical	JJ	I-NP	O
cartridge	cartridge	NN	I-NP	O
respirators	respirator	NNS	I-NP	O
for	for	IN	B-PP	O
SO2	SO2	NN	B-NP	B-protein
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
under	under	IN	B-PP	O
working	work	VBG	B-NP	O
conditions	condition	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
copper	copper	NN	I-NP	O
smelter	smelter	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
neuroleptic	neuroleptic	JJ	I-NP	O
-	-	HYPH	I-NP	O
induced	induce	VBN	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
central	central	JJ	B-NP	O
DA	DA	NN	I-NP	O
turnover	turnover	NN	I-NP	O
(	(	(	O	O
an	an	DT	B-NP	O
indicator	indicator	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
DA	DA	NN	B-NP	O
receptor	receptor	NN	I-NP	O
blocking	blocking	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
positively	positively	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
neuroleptics	neuroleptic	NNS	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
hypokinetic	hypokinetic	JJ	B-NP	O
-	-	HYPH	I-NP	O
rigid	rigid	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O


Rainbow	Rainbow	NN	B-NP	O
trout	trout	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
commercial	commercial	JJ	I-NP	O
trout	trout	NN	I-NP	O
farm	farm	NN	I-NP	O
,	,	,	O	O
kept	keep	VBD	B-VP	O
in	in	IN	B-PP	O
running	running	JJ	B-NP	O
water	water	NN	I-NP	O
and	and	CC	I-NP	O
feeding	feeding	NN	I-NP	O
in	in	IN	B-PP	O
experimental	experimental	JJ	B-NP	O
pellets	pellet	NNS	I-NP	O
for	for	IN	B-PP	O
4	4	CD	B-NP	O
to	to	TO	I-NP	O
8	8	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O


Stimulation	Stimulation	NN	B-NP	O
of	of	IN	B-PP	O
macrophage	macrophage	NN	B-NP	B-cell_type
function	function	NN	I-NP	O
by	by	IN	B-PP	O
killed	kill	VBN	B-NP	B-cell_type
Bordetella	Bordetella	NNP	I-NP	I-cell_type
pertussis	pertussis	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
beneficial	beneficial	JJ	I-NP	O
effect	effect	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
became	become	VBD	B-VP	O
apparent	apparent	JJ	B-ADJP	O
.	.	.	O	O


Primary	Primary	JJ	B-NP	O
amenorrhoea	amenorrhoea	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
phenotypically	phenotypically	RB	I-NP	O
female	female	JJ	I-NP	O
individual	individual	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
karyotype	karyotype	NN	I-NP	O
46	46	CD	I-NP	O
,	,	,	O	O
xy	xy	NN	B-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
gonadoblastoma	gonadoblastoma	NN	I-NP	O


Toward	Toward	IN	B-PP	O
absolute	absolute	JJ	B-NP	O
methods	method	NNS	I-NP	O
in	in	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
chemistry	chemistry	NN	I-NP	O
:	:	:	O	O
application	application	NN	B-NP	O
of	of	IN	B-PP	O
mass	mass	NN	B-NP	O
fragmentography	fragmentography	NN	I-NP	O
to	to	TO	B-PP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
accuracy	accuracy	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
.	.	.	O	O


Application	Application	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
2	2	CD	I-NP	O
-	-	HYPH	I-NP	O
deoxy	deoxy	NN	I-NP	O
-	-	HYPH	B-NP	O
D	D	NN	I-NP	O
-	-	HYPH	I-NP	O
glucose	glucose	NN	I-NP	O
method	method	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
coupling	coupling	NN	I-NP	O
of	of	IN	B-PP	O
cerebral	cerebral	JJ	B-NP	O
metabolism	metabolism	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
.	.	.	O	O


Serum	Serum	NN	B-NP	O
gastrin	gastrin	NN	I-NP	O
levels	level	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
change	change	VB	I-VP	O
in	in	IN	B-PP	O
either	either	CC	O	O
group	group	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
background	background	NN	B-NP	O
serum	serum	NN	I-NP	O
gastrin	gastrin	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
for	for	IN	B-PP	O
V	V	NNP	B-NP	O
&	&	CC	I-NP	O
P	P	NN	I-NP	O
patients	patient	NNS	I-NP	O
than	than	IN	B-PP	O
V	V	NNP	B-NP	O
&	&	CC	I-NP	O
A	A	NNP	I-NP	O
patients	patient	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O


Efferent	Efferent	JJ	B-NP	O
projections	projection	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ventral	ventral	JJ	I-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
putamen	putaman	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
frontal	frontal	JJ	I-NP	O
,	,	,	I-NP	O
parietal	parietal	JJ	I-NP	O
and	and	CC	I-NP	O
temporal	temporal	JJ	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cat	cat	NN	I-NP	O
cerebral	cerebral	JJ	I-NP	O
cortex	cortex	NN	I-NP	O


Preflight	Preflight	NN	B-NP	O
,	,	,	O	O
inflight	inflight	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
postflight	postflight	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
response	response	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
astronauts	astronaut	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
Skylab	Skylab	NN	I-NP	O
mission	mission	NN	I-NP	O
(	(	(	O	O
Skylab	Skylab	NN	B-NP	O
3	3	CD	I-NP	O
)	)	)	O	O
as	as	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
physiological	physiological	JJ	B-NP	O
adaptation	adaptation	NN	I-NP	O
to	to	TO	B-PP	O
long	long	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
weightlessness	weightlessness	NN	I-NP	O
.	.	.	O	O


Mean	Mean	JJ	B-NP	O
corpuscular	corpuscular	JJ	I-NP	O
hemoglobin	hemoglobin	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
remained	remain	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
for	for	IN	B-PP	O
48	48	CD	B-NP	O
h	h	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
decreased	decrease	VBD	I-VP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
CO2	CO2	NN	I-NP	O
group	group	NN	I-NP	O
showing	show	VBG	B-VP	O
the	the	DT	B-NP	O
larger	large	JJR	I-NP	O
decrease	decrease	NN	I-NP	O
.	.	.	O	O


All	All	DT	B-NP	O
Cu	Cu	NN	I-NP	O
values	value	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
organs	organ	NNS	I-NP	O
investigated	investigate	VBN	B-VP	O
had	have	VBD	B-VP	O
reached	reach	VBN	I-VP	O
a	a	DT	B-NP	O
saturation	saturation	NN	I-NP	O
level	level	NN	I-NP	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
mug	mug	NN	I-NP	O
Cu	Cu	NN	I-NP	O
/	/	SYM	B-NP	O
g	g	NN	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
values	value	NNS	I-NP	O
for	for	IN	B-PP	O
body	body	NN	B-NP	O
Cu	Cu	NN	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
dams	dam	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
killed	kill	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
delivery	delivery	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
calcitonin	calcitonin	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
calcium	calcium	NN	B-NP	O
given	give	VBN	B-VP	O
orally	orally	RB	B-ADVP	O
,	,	,	O	O
pentagastrin	pentagastrin	NN	B-NP	O
and	and	CC	I-NP	O
glucagon	glucagon	NN	I-NP	O
on	on	IN	B-PP	O
plasma	plasma	NN	B-NP	O
47Ca	47Ca	NN	I-NP	O
radioactivity	radioactivity	NN	I-NP	O
curves	curve	NNS	I-NP	O
in	in	IN	B-PP	O
subjects	subject	NNS	B-NP	O
pretreated	pretreate	VBN	B-VP	O
with	with	IN	B-PP	O
47Ca	47Ca	NN	B-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O


State	State	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
body	body	NN	I-NP	O
in	in	IN	B-PP	O
disorders	disorder	NNS	B-NP	O
of	of	IN	B-PP	O
diurnal	diurnal	JJ	B-NP	O
physiological	physiological	JJ	I-NP	O
rhythms	rhythm	NNS	I-NP	O
and	and	CC	O	O
long	long	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
hypokinesia	hypokinesia	NN	I-NP	O


Oxygen	Oxygen	NN	B-NP	O
tension	tension	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
vessels	vessel	NNS	I-NP	O
(	(	(	O	O
PLO2	PLO2	NN	B-NP	B-protein
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rabbit	rabbit	NN	I-NP	O
hind	hind	NN	I-NP	O
limb	limb	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
with	with	IN	B-PP	O
both	both	CC	O	O
a	a	DT	B-NP	O
flow	flow	NN	I-NP	O
-	-	HYPH	B-VP	O
through	through	IN	B-PP	O
micro	micro	NN	B-NP	O
chamber	chamber	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
polarographic	polarographic	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
-	-	HYPH	I-NP	O
tip	tip	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
electrode	electrode	NN	I-NP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
experimental	experimental	JJ	B-NP	O
data	datum	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lymph	lymph	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
fibrinogen	fibrinogen	NN	I-NP	O
level	level	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
subucutaneous	subucutaneous	JJ	I-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
turpentine	turpentine	NN	B-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
intravenous	intravenous	JJ	I-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
endotoxin	endotoxin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
rabbits	rabbit	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
rabbits	rabbit	NNS	B-NP	O
made	make	VBN	B-VP	O
granulocytopenic	granulocytopenic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
thrombocytopenic	thrombocytopenic	JJ	I-ADJP	O
with	with	IN	B-PP	O
busulfan	busulfan	NN	B-NP	O
.	.	.	O	O


Constantly	Constantly	RB	B-ADVP	O
rectilinear	rectilinear	VB	B-VP	O
pressure	pressure	NN	B-NP	O
curves	curve	NNS	I-NP	O
without	without	IN	B-PP	O
uterine	uterine	JJ	B-NP	O
activities	activity	NNS	I-NP	O
are	be	VBP	B-VP	O
interpreted	interpret	VBN	I-VP	O
as	as	IN	B-PP	O
characteristic	characteristic	JJ	B-NP	O
tocographic	tocographic	JJ	I-NP	O
criteria	criterion	NNS	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
advanced	advanced	JJ	I-NP	O
ectopic	ectopic	JJ	I-NP	O
gravidity	gravidity	NN	I-NP	O
.	.	.	O	O


Since	Since	IN	B-SBAR	O
myoglobin	myoglobin	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
co	co	AFX	B-ADJP	O
-	-	HYPH	O	O
extracted	extract	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
2	2	CD	I-NP	O
heme	heme	NN	I-NP	O
pigments	pigment	NNS	I-NP	O
are	be	VBP	B-VP	O
separated	separate	VBN	I-VP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
extract	extract	NN	I-NP	O
by	by	IN	B-PP	O
precipitating	precipitate	VBG	B-VP	O
the	the	DT	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
in	in	IN	B-PP	O
an	an	DT	B-NP	O
85	85	CD	I-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
NH4	NH4	NN	B-NP	B-protein
)	)	)	O	O
2SO4	2SO4	NN	B-NP	O
solution	solution	NN	I-NP	O
.	.	.	O	O


Considering	Consider	VBG	B-VP	O
these	these	DT	B-NP	O
sources	source	NNS	I-NP	O
of	of	IN	B-PP	O
error	error	NN	B-NP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
variability	variability	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
investigation	investigation	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
avoided	avoid	VBN	I-VP	O
by	by	IN	B-PP	O
systematic	systematic	JJ	B-NP	O
instructions	instruction	NNS	I-NP	O
.	.	.	O	O


E	E	NN	B-NP	B-protein
50	50	CD	I-NP	I-protein
,	,	,	I-NP	O
843	843	CD	I-NP	O
(	(	(	O	O
1994	1994	CD	B-NP	O
)	)	)	O	O
]	]	)	O	O
.	.	.	O	O


Six	Six	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
mania	mania	NN	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
adrenergic	adrenergic	JJ	I-NP	O
blocking	block	VBG	I-NP	O
agent	agent	NN	I-NP	O
propranolol	propranolol	NN	I-NP	O
.	.	.	O	O


Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
trauma	trauma	NN	B-NP	O
on	on	IN	B-PP	O
plasma	plasma	NN	B-NP	O
glucagon	glucagon	NN	I-NP	O
and	and	CC	I-NP	O
insulin	insulin	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
in	in	IN	B-PP	O
sheep	sheep	NN	B-NP	O
.	.	.	O	O


With	With	IN	B-PP	O
the	the	DT	B-NP	O
help	help	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
nomogram	nomogram	NN	I-NP	O
one	one	NN	I-NP	O
can	can	MD	B-VP	O
read	read	VB	I-VP	O
off	off	RP	B-PRT	O
the	the	DT	B-NP	O
refraction	refraction	NN	I-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
axis	axis	NN	B-NP	O
length	length	NN	I-NP	O
and	and	CC	O	O
corneal	corneal	JJ	B-NP	O
curvature	curvature	NN	I-NP	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
.	.	.	O	O


This	This	DT	B-NP	O
up	up	RB	B-ADVP	O
-	-	HYPH	O	O
grading	grading	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
final	final	JJ	I-NP	O
score	score	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
CA	CA	NN	I-NP	B-protein
component	component	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
(	(	(	O	O
3	3	CD	B-NP	O
-	-	HYPH	I-NP	O
8	8	CD	I-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
less	less	RBR	I-NP	O
able	able	JJ	I-NP	O
students	student	NNS	I-NP	O
with	with	IN	B-PP	O
scores	score	NNS	B-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O


Compared	Compare	VBN	B-PP	O
to	to	TO	B-PP	O
controls	control	NNS	B-NP	O
,	,	,	O	O
both	both	CC	O	O
UB	UB	NN	B-NP	B-protein
and	and	CC	I-NP	O
OCS	OCS	NN	I-NP	O
rats	rat	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
but	but	CC	I-NP	O
significant	significant	JJ	I-NP	O
post	post	AFX	I-NP	O
-	-	HYPH	I-NP	O
operative	operative	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nocturnality	nocturnality	NN	I-NP	O
of	of	IN	B-PP	O
drinking	drinking	NN	B-NP	O
.	.	.	O	O


Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
indomethacin	indomethacin	NN	B-NP	O
on	on	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
circulation	circulation	NN	I-NP	O
:	:	:	O	O
effect	effect	NN	B-NP	O
on	on	IN	B-PP	O
ECG	ECG	NN	B-NP	O
tracing	tracing	NN	I-NP	O


Dual	Dual	JJ	B-NP	O
innervation	innervation	NN	I-NP	O
of	of	IN	B-PP	O
fast	fast	JJ	B-NP	O
fibers	fiber	NNS	I-NP	O
in	in	IN	B-PP	O
trunk	trunk	NN	B-NP	O
muscles	muscle	NNS	I-NP	O
of	of	IN	B-PP	O
lamprey	lamprey	NN	B-NP	O
larvae	larva	NNS	I-NP	O


The	The	DT	B-NP	O
feed	feed	NN	I-NP	O
consumed	consume	VBD	B-VP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
lowered	lower	VBN	I-VP	O
by	by	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
initially	initially	RB	B-ADVP	O
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
alter	alter	VB	I-VP	O
later	later	RB	B-ADVP	O
.	.	.	O	O


Certain	Certain	JJ	B-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
eye	eye	NN	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
pheochromocytoma	pheochromocytoma	NN	B-NP	O
including	include	VBG	B-PP	O
Sipple	Sipple	NNP	B-NP	O
'	'	POS	B-NP	O
s	s	NNS	I-NP	O
syndrome	syndrome	NN	I-NP	O


The	The	DT	B-NP	O
color	color	NN	I-NP	O
-	-	HYPH	I-NP	O
word	word	NN	I-NP	O
interference	interference	NN	I-NP	O
effect	effect	NN	I-NP	O
previously	previously	RB	B-VP	O
reported	report	VBN	I-VP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
populations	population	NNS	I-NP	I-cell_type
when	when	WRB	B-ADVP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
Stroop	Stroop	NNP	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
retarded	retard	VBN	I-NP	O
sample	sample	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
special	special	JJ	I-NP	O
format	format	NN	I-NP	O
.	.	.	O	O


It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
selected	select	VBN	I-NP	O
conditions	condition	NNS	I-NP	O
a	a	DT	B-NP	O
linear	linear	JJ	I-NP	O
dependence	dependence	NN	I-NP	O
exists	exist	VBZ	B-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
betaI	betaI	NN	I-NP	O
%	%	NN	I-NP	O
value	value	NN	I-NP	O
and	and	CC	I-NP	O
lgC	lgC	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
-	-	HYPH	I-NP	O
-	-	SYM	I-NP	O
10	10	CD	I-NP	O
mug	mug	NN	I-NP	O
ruscogenin	ruscogenin	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
adrenergic	adrenergic	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	B-cell_type
vessels	vessel	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rabbit	rabbit	NN	I-NP	O
ear	ear	NN	I-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
-	-	HYPH	O	O
-	-	HYPH	B-NP	O
phenylalanine	phenylalanine	NN	I-NP	O
-	-	HYPH	B-NP	O
8	8	CD	I-NP	O
-	-	HYPH	I-NP	O
lysine	lysine	NN	I-NP	O
vasopressin	vasopressin	NN	I-NP	O
(	(	(	O	O
Octapressin	Octapressin	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O


Potscoital	Potscoital	JJ	B-NP	O
test	test	NN	I-NP	O


I	I	PRP	B-NP	O
.	.	.	O	O


When	When	WRB	B-ADVP	O
a	a	DT	B-NP	O
tumour	tumour	NN	I-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-NP	O
nipple	nipple	NN	I-NP	O
discharge	discharge	NN	I-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
little	little	JJ	B-NP	O
importance	importance	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O


Studies	Study	NNS	B-NP	O
of	of	IN	B-PP	O
biochemical	biochemical	JJ	B-NP	O
and	and	CC	I-NP	O
morphological	morphological	JJ	I-NP	O
changes	change	NNS	I-NP	O
(	(	(	O	O
between	between	IN	B-PP	O
normal	normal	JJ	B-NP	O
and	and	CC	I-NP	O
treated	treat	VBN	I-NP	O
animals	animal	NNS	I-NP	O
)	)	)	O	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
chrysotile	chrysotile	NN	B-NP	O
induces	induce	VBZ	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
free	free	JJ	I-NP	O
cell	cell	NN	I-NP	O
population	population	NN	I-NP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
surfactant	surfactant	JJ	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O


Infrared	Infrared	JJ	B-NP	O
measurements	measurement	NNS	I-NP	O
of	of	IN	B-PP	O
temperature	temperature	NN	B-NP	O
changes	change	NNS	I-NP	O
and	and	CC	I-NP	O
estimates	estimate	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heating	heating	NN	I-NP	O
produced	produce	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
mical	mical	JJ	I-NP	O
.	.	.	O	O


Who	Who	WP	B-NP	O
says	say	VBZ	B-VP	O
'	'	''	O	O
National	National	NNP	B-NP	O
Health	Health	NNP	I-NP	O
Dis	Dis	NNP	I-NP	O
-	-	HYPH	I-NP	O
service	service	NN	I-NP	O
'	'	''	O	O
.	.	.	O	O


Is	Be	VBZ	O	O
criticism	criticism	NN	B-NP	O
of	of	IN	B-PP	O
patient	patient	NN	B-NP	O
care	care	NN	I-NP	O
justified	justified	JJ	B-ADJP	O
and	and	CC	O	O
does	do	VBZ	O	O
it	it	PRP	B-NP	O
have	have	VB	B-VP	O
educational	educational	JJ	B-NP	O
value	value	NN	I-NP	O
?	?	.	O	O
Patients	Patient	NNS	B-NP	O
'	'	''	I-NP	O
criticism	criticism	NN	I-NP	O
contributes	contribute	VBZ	B-VP	O
to	to	TO	B-PP	O
improved	improve	VBN	B-NP	O
patient	patient	NN	I-NP	O
care	care	NN	I-NP	O


Critique	Critique	NN	B-NP	O
of	of	IN	B-PP	O
"	"	``	O	O
Interactive	Interactive	JJ	B-NP	O
Effects	Effect	NNS	I-NP	O
of	of	IN	B-PP	O
Test	Test	NN	B-NP	O
Anxiety	Anxiety	NN	I-NP	O
and	and	CC	I-NP	O
Credit	Credit	NN	I-NP	O
/	/	SYM	I-NP	O
No	No	NN	I-NP	O
Credit	Credit	NN	I-NP	O
or	or	CC	I-NP	O
A	A	NN	I-NP	O
-	-	HYPH	I-NP	O
F	F	NN	I-NP	O
Grade	Grade	NN	I-NP	O
Condition	Condition	NN	I-NP	O
upon	upon	IN	B-PP	O
Short	Short	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
and	and	CC	I-NP	O
Long	Long	JJ	I-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
Recall	Recall	NN	I-NP	O
of	of	IN	B-PP	O
Course	Course	NN	B-NP	O
Information	Information	NN	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
tested	test	VBN	B-NP	O
staphylococci	staphylococci	NNS	I-NP	O
were	be	VBD	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	O
G	G	NN	I-NP	O
,	,	,	O	O
erythromycin	erythromycin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
produced	produce	VBD	B-VP	O
beta	beta	SYM	B-NP	O
-	-	HYPH	B-VP	O
lactamase	lactamase	NN	B-NP	O
.	.	.	O	O


Since	Since	IN	B-PP	O
1968	1968	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
steep	steep	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
strains	strain	NNS	B-NP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
three	three	CD	B-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
(	(	(	O	O
multiple	multiple	JJ	B-NP	O
-	-	HYPH	I-NP	O
resistant	resistant	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
strains	strain	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
83A	83A	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
was	be	VBD	B-VP	O
noticed	notice	VBN	I-VP	O
.	.	.	O	O


Improvement	Improvement	NN	B-NP	O
of	of	IN	B-PP	O
nursing	nurse	VBG	B-VP	O
instruction	instruction	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ward	ward	NN	I-NP	O
for	for	IN	B-PP	O
premature	premature	JJ	B-NP	O
infants	infant	NNS	I-NP	O


No	No	DT	B-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
acceptability	acceptability	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
ascertained	ascertain	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O


After	After	IN	B-PP	O
90	90	CD	B-NP	O
d	d	NN	I-NP	O
a	a	DT	B-NP	O
subsurface	subsurface	NN	I-NP	O
,	,	,	O	O
radiolucent	radiolucent	JJ	B-NP	O
caries	cary	NNS	I-NP	O
-	-	HYPH	O	O
like	like	JJ	B-NP	O
lesion	lesion	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
specimens	specimen	NNS	I-NP	O
only	only	RB	B-ADVP	O
.	.	.	O	O


The	The	DT	B-NP	O
contraceptive	contraceptive	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
157	157	CD	B-NP	O
women	woman	NNS	I-NP	O
was	be	VBD	B-VP	O
analysed	analyse	VBN	I-VP	O
and	and	CC	O	O
13.8	13.8	CD	B-NP	O
percent	percent	NN	I-NP	O
were	be	VBD	B-VP	O
using	use	VBG	I-VP	O
inefficient	inefficient	JJ	B-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O


Plethysmographic	Plethysmographic	JJ	B-NP	O
technique	technique	NN	I-NP	O
and	and	CC	O	O
indirect	indirect	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
recordings	recording	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
.	.	.	O	O


I	I	PRP	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
second	second	JJ	I-NP	O
and	and	CC	I-NP	O
third	third	JJ	I-NP	O
responded	respond	VBD	B-VP	O
similarly	similarly	RB	B-ADVP	O
to	to	TO	B-PP	O
either	either	CC	O	O
a	a	DT	B-NP	O
combined	combine	VBN	I-NP	O
cyclophosphamide	cyclophosphamide	NN	I-NP	O
+	+	SYM	O	O
antilymphocyte	antilymphocyte	NN	B-NP	B-protein
globulin	globulin	NN	I-NP	I-protein
(	(	(	O	O
ALG	ALG	NN	B-NP	O
)	)	)	O	O
treatment	treatment	NN	B-NP	O
or	or	CC	B-PP	O
to	to	TO	B-PP	O
ALG	ALG	NN	B-NP	O
administration	administration	NN	I-NP	O
preceded	precede	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
dosage	dosage	NN	I-NP	O
of	of	IN	B-PP	O
cyclophosphamide	cyclophosphamide	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
proved	prove	VBN	I-VP	O
ineffective	ineffective	JJ	B-ADJP	O
when	when	WRB	B-ADVP	O
administered	administer	VBN	B-VP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O


Evidence	Evidence	NN	B-NP	O
is	be	VBZ	B-VP	O
presented	present	VBN	I-VP	O
that	that	IN	B-SBAR	O
Leber	Leber	NNP	B-NP	O
'	'	POS	B-NP	O
s	s	JJ	I-NP	O
military	military	JJ	I-NP	O
aneurysm	aneurysm	NN	I-NP	O
retinitis	retinitis	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
separate	separate	JJ	I-NP	O
entity	entity	NN	I-NP	O
but	but	CC	O	O
a	a	DT	B-NP	O
special	special	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
Coats	Coats	NNP	B-NP	O
'	'	POS	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O


Fibrin	Fibrin	NN	B-NP	B-protein
cloaking	cloak	VBG	B-VP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
20	20	CD	B-NP	O
patients	patient	NNS	I-NP	O
studied	study	VBN	B-VP	O
by	by	IN	B-PP	O
pull	pull	VB	B-VP	O
-	-	HYPH	O	O
out	out	RP	B-PRT	O
arteriography	arteriography	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
unassociated	unassociated	JJ	B-ADJP	O
with	with	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mobile	mobile	JJ	I-NP	O
pupil	pupil	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
DC	DC	NN	I-NP	B-cell_type
-	-	HYPH	B-NP	O
ERG	ERG	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
.	.	.	O	O


A	A	DT	B-NP	O
newly	newly	RB	I-NP	O
synthesized	synthesize	VBN	I-NP	O
anti	anti	AFX	I-NP	O
-	-	HYPH	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
agent	agent	NN	I-NP	O
,	,	,	O	O
Y	Y	NN	B-NP	O
-	-	HYPH	O	O
8004	8004	CD	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
greater	great	JJR	I-NP	O
inhibition	inhibition	NN	I-NP	O
than	than	IN	B-SBAR	O
did	do	VBD	O	O
indomethacin	indomethacin	NN	B-NP	O
(	(	(	O	O
IM	IM	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O
on	on	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
response	response	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
ultraviolet	ultraviolet	JJ	B-NP	O
erythema	erythema	NN	I-NP	O
in	in	IN	B-PP	O
guinea	guinea	NN	B-NP	O
pigs	pig	NNS	I-NP	O
,	,	,	O	O
carrageenin	carrageenin	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
evans	evan	NNS	B-NP	O
blue	blue	JJ	B-ADJP	O
and	and	CC	O	O
carrageenin	carrageenin	NN	B-NP	B-protein
-	-	HYPH	O	O
induced	induce	VBN	B-NP	O
pleuritis	pleuritis	NN	I-NP	O
and	and	CC	O	O
acetic	acetic	JJ	B-NP	O
acid	acid	NN	I-NP	O
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
peritonitis	peritonitis	NN	I-NP	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
.	.	.	O	O


As	As	IN	B-SBAR	O
stands	stand	NNS	B-NP	O
shifted	shift	VBN	B-VP	O
in	in	IN	B-PP	O
dominance	dominance	NN	B-NP	O
from	from	IN	B-PP	O
pine	pine	NN	B-NP	O
to	to	TO	B-VP	O
fir	fir	VB	I-VP	O
with	with	IN	B-PP	O
age	age	NN	B-NP	O
,	,	,	O	O
subalpine	subalpine	NN	B-NP	O
fir	fir	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
maintain	maintain	VB	I-VP	O
gradually	gradually	RB	B-ADVP	O
increasing	increase	VBG	B-VP	O
rates	rate	NNS	B-NP	O
of	of	IN	B-PP	O
whole	whole	JJ	B-NP	O
-	-	HYPH	I-NP	O
forest	forest	NN	I-NP	O
productivity	productivity	NN	I-NP	O
until	until	IN	B-SBAR	O
stands	stand	NNS	B-NP	O
were	be	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
400	400	CD	I-NP	O
years	year	NNS	I-NP	O
old	old	JJ	B-ADJP	O
.	.	.	O	O


Alpha	Alpha	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
antitrypsin	antitrypsin	NN	I-NP	I-protein
and	and	CC	O	O
Indian	Indian	JJ	B-NP	O
childhood	childhood	NN	I-NP	O
cirrhosis	cirrhosis	NN	I-NP	O
.	.	.	O	O


Lymphocyte	Lymphocyte	NN	B-NP	B-cell_type
subpopulations	subpopulation	NNS	I-NP	I-cell_type
,	,	,	O	O
serum	serum	NN	B-NP	O
IgE	IgE	NN	I-NP	B-protein
and	and	CC	O	O
total	total	JJ	B-NP	O
eosinophil	eosinophil	NN	I-NP	O
counts	count	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
bronchial	bronchial	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
measurements	measurement	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
EMI	EMI	NN	I-NP	O
scan	scan	NN	I-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
.	.	.	O	O


A	A	DT	B-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
physical	physical	JJ	B-NP	O
and	and	CC	I-NP	O
cytogenetic	cytogenetic	JJ	I-NP	O
estimates	estimate	NNS	I-NP	O
of	of	IN	B-PP	O
radiation	radiation	NN	B-NP	O
dose	dose	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
iodine	iodine	NN	B-NP	O
-	-	HYPH	B-NP	O
131	131	NN	I-NP	O
for	for	IN	B-PP	O
thyroid	thyroid	JJ	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O


Technique	Technique	NN	B-NP	O
for	for	IN	B-PP	O
obtaining	obtain	VBG	B-VP	O
refined	refined	JJ	B-NP	O
ceramics	ceramic	NNS	I-NP	O
with	with	IN	B-PP	O
dense	dense	JJ	B-NP	O
mass	mass	NN	I-NP	O


Mean	Mean	JJ	B-NP	O
total	total	JJ	I-NP	O
lung	lung	NN	I-NP	O
capacity	capacity	NN	I-NP	O
,	,	,	O	O
functional	functional	JJ	B-NP	O
residual	residual	JJ	I-NP	O
capacity	capacity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
residual	residual	JJ	B-NP	O
volume	volume	NN	I-NP	O
increased	increase	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
closing	closing	NN	I-NP	O
volume	volume	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
volume	volume	NN	I-NP	O
above	above	IN	B-PP	O
residual	residual	JJ	B-NP	O
volume	volume	NN	I-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
phase	phase	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
begins	begin	VBZ	B-VP	O
,	,	,	O	O
decreased	decrease	VBN	B-VP	O
significantly	significantly	RB	B-ADVP	O
with	with	IN	B-PP	O
11	11	CD	B-NP	O
cm	cm	NN	I-NP	O
H20	H20	NN	I-NP	O
continuous	continuous	JJ	I-NP	O
positive	positive	JJ	I-NP	O
airway	airway	NN	I-NP	O
pressure	pressure	NN	I-NP	O
;	;	:	O	O
differences	difference	NNS	B-NP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
cm	cm	NN	I-NP	O
H20	H20	NN	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
significant	significant	JJ	B-ADJP	O
.	.	.	O	O


Current	Current	JJ	B-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
zinc	zinc	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
neurological	neurological	JJ	B-NP	O
,	,	,	I-NP	O
dermatological	dermatological	JJ	I-NP	O
and	and	CC	I-NP	O
musculoskeletal	musculoskeletal	JJ	I-NP	O
disorders	disorder	NNS	I-NP	O
.	.	.	O	O


Calcium	Calcium	NN	B-NP	O
and	and	CC	I-NP	O
phosphorus	phosphorus	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
in	in	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
uremia	uremia	NN	I-NP	O
.	.	.	O	O


Modern	Modern	JJ	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
conducted	conduct	VBN	B-VP	O
with	with	IN	B-PP	O
Delta	Delta	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
9	9	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
THC	THC	NN	I-NP	B-protein
,	,	,	O	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
voluntaries	voluntary	NNS	I-NP	O
,	,	,	O	O
again	again	RB	B-ADVP	O
suggest	suggest	VBP	B-VP	O
the	the	DT	B-NP	O
comparison	comparison	NN	I-NP	O
or	or	CC	O	O
even	even	RB	B-ADVP	O
the	the	DT	B-NP	O
identity	identity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
modifications	modification	NNS	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
cannabis	cannabis	NN	B-NP	O
with	with	IN	B-PP	O
sleep	sleep	NN	B-NP	O
and	and	CC	I-NP	O
dream	dream	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
correcting	correct	VBG	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
tropatepine	tropatepine	NN	B-NP	O
hydrochloride	hydrochloride	NN	I-NP	O
upon	upon	IN	B-PP	O
the	the	DT	B-NP	O
extrapyramidal	extrapyramidal	JJ	I-NP	O
effects	effect	NNS	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
neuroleptics	neuroleptic	NNS	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
32	32	CD	B-NP	O
acute	acute	JJ	I-NP	O
psychotic	psychotic	JJ	I-NP	O
states	state	NNS	I-NP	O
.	.	.	O	O


Epididymal	Epididymal	JJ	B-NP	O
growth	growth	NN	I-NP	O
was	be	VBD	B-VP	O
retarded	retard	VBN	I-VP	O
in	in	IN	B-PP	O
animals	animal	NNS	B-NP	O
maintained	maintain	VBN	B-VP	O
solely	solely	RB	B-ADVP	O
on	on	IN	B-PP	O
chickpea	chickpea	NN	B-NP	O
haulm	haulm	NN	I-NP	O
and	and	CC	O	O
improved	improve	VBN	B-VP	O
with	with	IN	B-PP	O
supplementation	supplementation	NN	B-NP	O
.	.	.	O	O


Two	Two	CD	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
both	both	DT	B-NP	O
regimens	regimen	NNS	I-NP	O
.	.	.	O	O


Results	Result	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
for	for	IN	B-PP	O
chloramphenicol	chloramphenicol	NN	B-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
preparations	preparation	NNS	B-NP	O
are	be	VBP	B-VP	O
presented	present	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
both	both	DT	B-NP	O
dissolution	dissolution	NN	I-NP	O
curves	curve	NNS	I-NP	O
and	and	CC	O	O
cup	cup	NN	B-NP	O
-	-	HYPH	I-NP	O
plate	plate	NN	B-NP	O
assays	assay	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
chloramphenicol	chloramphenicol	NN	B-NP	O
has	have	VBZ	B-VP	O
far	far	RB	B-NP	O
superior	superior	JJ	I-NP	O
release	release	NN	I-NP	O
(	(	(	O	O
and	and	CC	O	O
hence	hence	RB	B-ADVP	O
activity	activity	NN	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
creams	cream	NNS	B-NP	O
than	than	IN	B-PP	O
from	from	IN	B-PP	O
ophthalmic	ophthalmic	JJ	B-NP	O
ointments	ointment	NNS	I-NP	O
.	.	.	O	O


IgG	IgG	NN	B-NP	B-protein
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
100	100	CD	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
only	only	RB	B-NP	O
four	four	CD	I-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
ten	ten	CD	I-NP	O
samples	sample	NNS	I-NP	O
obtained	obtain	VBD	B-VP	O
150	150	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
onset	onset	NN	I-NP	O
.	.	.	O	O


Letter	Letter	NNP	B-NP	O
:	:	:	O	O
Perspectives	Perspective	NNS	B-NP	O
in	in	IN	B-PP	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
transplantation	transplantation	NN	I-NP	O
.	.	.	O	O


Assessment	Assessment	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
carcinogenicity	carcinogenicity	NN	I-NP	O
of	of	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	B-protein
nutritive	nutritive	JJ	B-NP	I-protein
sweetners	sweetner	NNS	I-NP	I-protein
II	II	CD	B-NP	I-protein
:	:	:	O	O
Cyclamates	Cyclamate	NNS	B-NP	O
and	and	CC	O	O
cyclohexylamine	cyclohexylamine	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
discordant	discordant	JJ	I-NP	O
behaviour	behaviour	NN	I-NP	O
in	in	IN	B-PP	O
weakly	weakly	RB	B-NP	O
infected	infected	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
animals	animal	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
more	more	RBR	B-NP	O
rapid	rapid	JJ	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
parasitemia	parasitemia	NN	I-NP	O
.	.	.	O	O


Residual	Residual	JJ	B-NP	O
amphotericin	amphotericin	NN	I-NP	O
B	B	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
feces	fece	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mice	mouse	NNS	I-NP	O
only	only	RB	B-ADVP	O
while	while	IN	B-SBAR	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
receiving	receive	VBG	I-VP	O
the	the	DT	B-NP	O
0.3	0.3	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
dose	dose	NN	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O


There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
total	total	JJ	B-NP	O
transferrin	transferrin	NN	I-NP	O
2	2	CD	I-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
tablet	tablet	NN	I-NP	O
and	and	CC	I-NP	O
values	value	NNS	I-NP	O
remained	remain	VBD	B-VP	O
high	high	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
experiment	experiment	NN	I-NP	O
.	.	.	O	O


Following	Follow	VBG	B-VP	O
intravenous	intravenous	JJ	B-NP	O
administration	administration	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
tracer	tracer	NN	B-NP	O
thallium	thallium	NN	I-NP	O
-	-	HYPH	O	O
201	201	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
-	-	HYPH	O	O
43	43	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
rubidium	rubidium	NN	B-NP	O
-	-	HYPH	B-NP	O
81	81	CD	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
;	;	:	O	O
thallium	thallium	NN	B-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
greatest	great	JJS	I-NP	O
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
myocardium	myocardium	NN	I-NP	O
(	(	(	O	O
2.08	2.08	CD	B-NP	O
%	%	NN	I-NP	O
compared	compare	VBN	B-PP	O
1.25	1.25	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
potassium	potassium	NN	B-NP	O
and	and	CC	O	O
1.15	1.15	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
rubidium	rubidium	NN	B-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
minutes	minute	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O


Thromboplastin	Thromboplastin	NN	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
partial	partial	JJ	B-NP	O
thromboplastin	thromboplastin	NN	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
thrombin	thrombin	NN	B-NP	B-protein
time	time	NN	I-NP	O
,	,	,	O	O
heat	heat	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
dependent	dependent	JJ	I-NP	I-protein
fibrin	fibrin	NN	I-NP	I-protein
,	,	,	O	O
clot	clot	NN	B-NP	O
retraction	retraction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
clotting	clot	VBG	B-VP	O
factors	factor	NNS	B-NP	O
II	II	CD	I-NP	O
,	,	,	I-NP	O
V	V	CD	I-NP	O
,	,	,	I-NP	O
VIII	VIII	CD	I-NP	B-protein
,	,	,	I-NP	O
IX	IX	CD	I-NP	O
,	,	,	O	O
X	X	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
support	support	VBP	B-VP	O
the	the	DT	B-NP	O
notion	notion	NN	I-NP	O
that	that	IN	B-SBAR	O
suppression	suppression	NN	B-NP	O
of	of	IN	B-PP	O
images	image	NNS	B-NP	O
during	during	IN	B-PP	O
binocular	binocular	JJ	B-NP	O
rivalry	rivalry	NN	I-NP	O
is	be	VBZ	B-VP	O
independent	independent	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
eyes	eye	NNS	I-NP	O
.	.	.	O	O


Glycogen	Glycogen	NN	B-NP	O
utilization	utilization	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
tissue	tissue	NN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
creatine	creatine	NN	B-NP	O
phosphate	phosphate	NN	I-NP	O
,	,	,	O	O
ATP	ATP	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
lactate	lactate	NN	B-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
in	in	IN	B-PP	O
hearts	heart	NNS	B-NP	O
receiving	receive	VBG	B-VP	O
normal	normal	JJ	B-NP	O
flow	flow	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
records	record	NNS	I-NP	O
from	from	IN	B-PP	O
1948	1948	CD	B-NP	O
through	through	IN	B-PP	O
1967	1967	CD	B-NP	O
of	of	IN	B-PP	O
344	344	CD	B-NP	O
previously	previously	RB	I-NP	O
untreated	untreated	JJ	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
squamous	squamous	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
oropharynx	oropharynx	NN	B-NP	O
,	,	,	O	O
supraglottic	supraglottic	JJ	B-NP	O
larynx	larynx	NN	I-NP	O
and	and	CC	I-NP	O
hypopharynx	hypopharynx	NN	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
clinically	clinically	RB	B-NP	O
positive	positive	JJ	I-NP	O
cervical	cervical	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
node	node	NN	I-NP	O
metastases	metastasis	NNS	I-NP	O
staged	stag	VBD	B-VP	O
N1	N1	NN	B-NP	B-protein
,	,	,	O	O
N2A	N2A	NN	B-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
N2B	N2B	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
whose	whose	WP$	B-NP	O
initial	initial	JJ	I-NP	O
neck	neck	NN	I-NP	O
treatment	treatment	NN	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
external	external	JJ	B-NP	O
radiation	radiation	NN	I-NP	O
therapy	therapy	NN	I-NP	O
alone	alone	RB	B-ADVP	O
were	be	VBD	B-VP	O
reviewed	review	VBN	I-VP	O
.	.	.	O	O


With	With	IN	B-PP	O
0.5	0.5	CD	B-NP	O
vol	vol	NN	I-NP	O
.	.	.	O	O
-	-	HYPH	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
345	345	CD	B-NP	O
mumol	mumol	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
5.72	5.72	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
100	100	CD	B-NP	O
ml	ml	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
137	137	CD	B-NP	O
mumol	mumol	NN	I-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
2.25	2.25	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
100	100	CD	B-NP	O
ml	ml	NN	I-NP	O
)	)	)	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O


The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
describe	describe	VBP	B-VP	O
the	the	DT	B-NP	O
technique	technique	NN	I-NP	O
of	of	IN	B-PP	O
transverse	transverse	JJ	B-NP	O
axial	axial	JJ	I-NP	O
tomography	tomography	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
spine	spine	NN	I-NP	O
and	and	CC	O	O
give	give	VB	B-VP	O
a	a	DT	B-NP	O
detailed	detailed	JJ	I-NP	O
description	description	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
axial	axial	JJ	I-NP	O
anatomy	anatomy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
lumbar	lumbar	NN	I-NP	O
spine	spine	NN	I-NP	O
from	from	IN	B-PP	O
L	L	NN	B-NP	B-protein
-	-	HYPH	B-ADVP	I-protein
4	4	CD	B-NP	I-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
sacrum	sacrum	NN	I-NP	O
.	.	.	O	O


Owing	Owe	VBG	B-VP	O
to	to	TO	B-PP	O
parental	parental	JJ	B-NP	O
attitude	attitude	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
protein	protein	NN	I-NP	O
diet	diet	NN	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
5	5	CD	I-NP	O
g	g	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
introduced	introduce	VBN	I-VP	O
only	only	RB	B-ADVP	O
late	late	RB	I-ADVP	O
.	.	.	O	O


In	In	IN	B-PP	O
none	none	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
44	44	CD	I-NP	O
type	type	NN	I-NP	O
I	I	CD	B-NP	O
attacks	attack	NNS	I-NP	O
and	and	CC	O	O
29	29	CD	B-NP	O
type	type	NN	I-NP	O
II	II	CD	B-NP	O
attacks	attack	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
did	do	VBD	B-VP	O
circulatory	circulatory	JJ	B-NP	O
changes	change	NNS	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
were	be	VBD	B-VP	O
different	different	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
clinically	clinically	RB	I-NP	O
useful	useful	JJ	I-NP	O
diagnostic	diagnostic	JJ	I-NP	O
method	method	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
developed	develop	VBN	I-VP	O
for	for	IN	B-PP	O
detecting	detect	VBG	B-VP	O
and	and	CC	I-VP	O
quantitating	quantitate	VBG	I-VP	O
periods	period	NNS	B-NP	O
of	of	IN	B-PP	O
apnea	apnea	NN	B-NP	O
in	in	IN	B-PP	O
pediatric	pediatric	JJ	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
other	other	JJ	I-NP	O
hypoglycaemic	hypoglycaemic	JJ	I-NP	O
patient	patient	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
exaggerated	exaggerated	JJ	I-NP	O
insulin	insulin	NN	I-NP	O
release	release	NN	I-NP	O
in	in	IN	B-PP	O
response	response	NN	I-PP	O
to	to	TO	I-PP	O
tolbutamide	tolbutamide	NN	B-NP	O
.	.	.	O	O


Nerve	Nerve	NN	B-NP	O
stimulation	stimulation	NN	I-NP	O
(	(	(	O	O
1.5	1.5	CD	B-NP	O
-	-	HYPH	I-NP	O
12	12	CD	I-NP	O
cycles	cycle	NNS	I-NP	O
/	/	SYM	B-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
produced	produce	VBD	B-VP	O
frequency	frequency	NN	B-NP	O
-	-	HYPH	O	O
dependent	dependent	JJ	B-NP	O
reductions	reduction	NNS	I-NP	O
in	in	IN	B-PP	O
CBF	CBF	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
percent	percent	NN	I-NP	O
occurring	occur	VBG	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
frequency	frequency	NN	I-NP	O
.	.	.	O	O


Effect	Effect	NN	B-NP	O
of	of	IN	B-PP	O
ingestion	ingestion	NN	B-NP	O
of	of	IN	B-PP	O
Norbiogest	Norbiogest	NNP	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
quiescent	quiescent	JJ	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genital	genital	JJ	I-NP	O
organs	organ	NNS	I-NP	O


Risk	Risk	NN	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
fractures	fracture	NNS	B-NP	O


Bulbar	Bulbar	NN	B-NP	O
pouches	pouch	NNS	I-NP	O
were	be	VBD	B-VP	O
perfused	perfuse	VBN	I-VP	O
with	with	IN	B-PP	O
solutions	solution	NNS	B-NP	O
of	of	IN	B-PP	O
0.9	0.9	CD	B-NP	O
%	%	NN	I-NP	O
Na	Na	NN	I-NP	O
C1	C1	NN	I-NP	O
,	,	,	O	O
0.1	0.1	CD	B-NP	O
N	N	NN	I-NP	B-protein
HC1	HC1	NN	I-NP	I-protein
,	,	,	O	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
glucose	glucose	NN	I-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
NaC1	NaC1	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
peptone	peptone	NN	I-NP	O
or	or	CC	B-PP	O
with	with	IN	B-PP	O
0.1	0.1	CD	B-NP	O
%	%	NN	I-NP	O
solutions	solution	NNS	I-NP	O
of	of	IN	B-PP	O
acetylcholine	acetylcholine	NN	B-NP	O
chloride	chloride	NN	I-NP	O
.	.	.	O	O


Liver	Liver	NN	B-NP	O
microsomes	microsome	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
shag	shag	NN	I-NP	O
showed	show	VBD	B-VP	O
smaller	small	JJR	B-NP	O
than	than	IN	I-NP	O
8	8	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
epoxide	epoxide	NN	I-NP	O
hydrase	hydrase	NN	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
smaller	small	JJR	B-ADJP	O
than	than	IN	B-PP	O
14	14	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hydroxylating	hydroxylate	VBG	I-NP	O
capacity	capacity	NN	I-NP	O
of	of	IN	B-PP	O
liver	liver	NN	B-NP	O
microsomes	microsome	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
.	.	.	O	O


Prolonged	Prolong	VBN	B-NP	O
heavy	heavy	JJ	I-NP	O
work	work	NN	I-NP	O
effected	effect	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
10.3	10.3	CD	B-NP	O
plus	plus	CC	B-NP	O
or	or	CC	O	O
minus	minus	CC	O	O
0.9	0.9	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
in	in	IN	B-PP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
P50	P50	NN	I-NP	O
(	(	(	O	O
7.30	7.30	CD	B-NP	O
PH	PH	NN	I-NP	O
-	-	HYPH	B-NP	O
v	v	NN	I-NP	O
,	,	,	O	O
41	41	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-NP	O
-	-	HYPH	I-NP	O
v	v	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
45	45	CD	B-NP	O
Pv	Pv	NN	I-NP	O
-	-	HYPH	B-NP	O
CO2	CO2	NN	I-NP	B-protein
)	)	)	O	O
;	;	:	O	O
due	due	JJ	B-ADJP	O
entirely	entirely	RB	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
additive	additive	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
venous	venous	JJ	I-NP	O
temperature	temperature	NN	I-NP	O
and	and	CC	O	O
[	[	(	O	O
H	H	NN	B-NP	O
+	+	SYM	B-ADJP	O
]	]	)	O	O
.	.	.	O	O


A	A	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
,	,	,	I-NP	O
serological	serological	JJ	I-NP	O
and	and	CC	I-NP	O
prognostic	prognostic	JJ	I-NP	O
study	study	NN	I-NP	O


The	The	DT	B-NP	O
American	American	NNP	I-NP	O
Burkitt	Burkitt	NNP	I-NP	O
Lymphoma	Lymphoma	NNP	I-NP	O
Registry	Registry	NNP	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
progress	progress	NN	I-NP	O
report	report	NN	I-NP	O
.	.	.	O	O


Vitrectomy	Vitrectomy	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
alternative	alternative	JJ	I-NP	O
instrument	instrument	NN	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
metabolic	metabolic	JJ	I-NP	O
clearance	clearance	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
progesterone	progesterone	NN	B-NP	O
was	be	VBD	B-VP	O
295	295	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
49	49	CD	B-NP	O
(	(	(	O	O
S	S	NN	B-NP	O
.	.	.	O	O
E	E	NNP	B-NP	O
.	.	.	O	O
)	)	)	O	O
1	1	CD	B-NP	O
/	/	SYM	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
sequence	sequence	NN	I-NP	O
is	be	VBZ	B-VP	O
almost	almost	RB	B-ADJP	O
identical	identical	JJ	I-ADJP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
luteinizing	luteinizing	NN	I-NP	O
hormone	hormone	NN	I-NP	O
(	(	(	O	O
Sairam	Sairam	NN	B-NP	O
,	,	,	O	O
M	M	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
mean	mean	JJ	I-NP	O
plasma	plasma	NN	I-NP	O
sodium	sodium	NN	I-NP	O
concentration	concentration	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
135.95	135.95	CD	B-NP	O
(	(	(	O	O
+	+	SYM	B-NP	O
/	/	SYM	O	O
-	-	SYM	O	O
SD	SD	NN	B-NP	O
4.14	4.14	CD	I-NP	O
)	)	)	O	O
mEq	mEq	NN	B-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
before	before	IN	B-PP	O
diuretic	diuretic	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
during	during	IN	B-PP	O
treatment	treatment	NN	B-NP	O
to	to	TO	B-PP	O
129.19	129.19	CD	B-NP	O
(	(	(	O	O
+	+	SYM	B-NP	O
/	/	SYM	O	O
-	-	SYM	O	O
SD	SD	NN	B-NP	O
2.77	2.77	CD	I-NP	O
)	)	)	O	O
mEq	mEq	NN	B-NP	O
/	/	SYM	B-VP	O
kg	kg	NN	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.001	0.001	CD	B-NP	O
.	.	.	O	O


Editorial	Editorial	NNP	B-NP	O
:	:	:	O	O
Low	Low	JJ	B-NP	O
-	-	HYPH	I-NP	O
dose	dose	NN	I-NP	O
heparin	heparin	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
prevention	prevention	NN	I-NP	O
of	of	IN	B-PP	O
venous	venous	JJ	B-NP	O
thromboembolic	thromboembolic	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O


At	At	IN	B-PP	O
the	the	DT	B-NP	O
very	very	RB	I-NP	O
high	high	JJ	I-NP	O
dose	dose	NN	I-NP	O
levels	level	NNS	I-NP	O
used	use	VBN	B-VP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
saccharin	saccharin	NN	I-NP	O
and	and	CC	O	O
sodium	sodium	NN	B-NP	B-protein
cyclamate	cyclamate	NN	I-NP	I-protein
were	be	VBD	B-VP	I-protein
weak	weak	JJ	B-NP	I-protein
solitary	solitary	JJ	I-NP	I-protein
carcinogens	carcinogen	NNS	I-NP	I-protein
producing	produce	VBG	B-VP	I-protein
4	4	CD	B-NP	I-protein
/	/	SYM	I-NP	I-protein
253	253	CD	I-NP	I-protein
and	and	CC	I-NP	I-protein
3	3	CD	I-NP	I-protein
/	/	SYM	I-NP	O
228	228	CD	I-NP	O
bladder	bladder	NN	I-NP	O
tumours	tumour	NNS	I-NP	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
tumours	tumour	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
for	for	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
80	80	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O


Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
perceptual	perceptual	JJ	B-NP	O
salience	salience	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
matrix	matrix	NN	I-NP	O
task	task	NN	I-NP	O
performance	performance	NN	I-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
six	six	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O


Glucose	Glucose	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
6	6	CD	I-NP	I-protein
-	-	HYPH	I-NP	I-protein
phosphate	phosphate	NN	I-NP	I-protein
dehydrogenase	dehydrogenase	NN	I-NP	I-protein
(	(	(	O	O
G	G	NN	B-NP	O
-	-	HYPH	B-NP	O
6	6	CD	I-NP	O
-	-	HYPH	I-NP	O
PD	PD	NN	I-NP	O
)	)	)	I-NP	O
deficiency	deficiency	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
newborn	newborn	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
eluting	elute	VBG	I-NP	O
solvent	solvent	NN	I-NP	O
was	be	VBD	B-VP	O
methanol	methanol	NN	B-NP	O
-	-	HYPH	O	O
chloroform	chloroform	NN	B-NP	O
(	(	(	O	O
10	10	CD	B-NP	O
+	+	SYM	I-NP	O
90	90	CD	I-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
flow	flow	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
2.0	2.0	CD	B-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	B-NP	O
min	min	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
bronchial	bronchial	JJ	I-NP	O
epithelia	epithelia	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
smoke	smoke	NN	I-NP	O
-	-	HYPH	B-NP	O
exposed	expose	VBN	I-NP	O
animals	animal	NNS	I-NP	O
were	be	VBD	B-VP	O
hyperplastic	hyperplastic	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
ultrastructure	ultrastructure	NN	I-NP	O
showed	show	VBD	B-VP	O
invaginations	invagination	NNS	B-NP	O
,	,	,	O	O
tilt	tilt	NN	B-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
axes	ax	NNS	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
and	and	CC	I-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
lysosomes	lysosome	NNS	B-NP	O
and	and	CC	O	O
multivesiculated	multivesiculated	JJ	B-NP	O
bodies	body	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
enlarged	enlarged	JJ	B-NP	O
intramitochondrial	intramitochondrial	JJ	I-NP	O
granules	granule	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
routine	routine	JJ	I-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
fat	fat	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
soluble	soluble	JJ	I-NP	I-protein
vitamins	vitamin	NNS	I-NP	I-protein
appears	appear	VBZ	B-VP	O
unnecessary	unnecessary	JJ	B-ADJP	O
but	but	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
prudent	prudent	JJ	B-ADJP	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
prothrombin	prothrombin	NN	B-NP	O
time	time	NN	I-NP	O
and	and	CC	I-NP	O
serum	serum	NN	I-NP	B-protein
vitamins	vitamin	NNS	I-NP	I-protein
A	A	NN	I-NP	I-protein
and	and	CC	I-NP	O
E	E	NN	I-NP	O
at	at	IN	B-PP	O
intervals	interval	NNS	B-NP	O
.	.	.	O	O


Prostaglandins	Prostaglandin	NNS	B-NP	O
F	F	NN	I-NP	O
(	(	(	O	O
PGF	PGF	NN	B-NP	B-protein
)	)	)	O	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
uterine	uterine	JJ	B-NP	O
vein	vein	NN	I-NP	O
,	,	,	O	O
ovarian	ovarian	JJ	B-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
jugular	jugular	JJ	B-NP	O
vein	vein	NN	I-NP	O
plasma	plasma	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
endometrial	endometrial	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
at	at	IN	B-PP	O
various	various	JJ	B-NP	O
times	time	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
bovine	bovine	JJ	I-NP	O
estrous	estrous	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
peripheral	peripheral	JJ	B-NP	O
plasma	plasma	NN	I-NP	O
progesterone	progesterone	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O


Before	Before	IN	B-SBAR	O
this	this	DT	B-NP	O
date	date	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O
directly	directly	RB	B-VP	O
inhibits	inhibit	VBZ	I-VP	O
fetal	fetal	JJ	B-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
placenta	placenta	NN	I-NP	O
is	be	VBZ	B-VP	O
only	only	RB	B-ADJP	O
transient	transient	JJ	I-ADJP	O
at	at	IN	B-PP	O
day	day	NN	B-NP	O
16	16	CD	I-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
maximum	maximum	JJ	B-NP	O
weight	weight	NN	I-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
organ	organ	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
later	later	RB	B-ADVP	O
.	.	.	O	O


Groups	Group	NNS	B-NP	O
of	of	IN	B-PP	O
ten	ten	CD	B-NP	O
dependent	dependent	JJ	I-NP	O
and	and	CC	O	O
ten	ten	CD	B-NP	O
saline	saline	NN	I-NP	O
mice	mouse	NNS	I-NP	O
were	be	VBD	B-VP	O
singly	singly	RB	I-VP	O
tested	test	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
light	light	JJ	I-NP	O
and	and	CC	I-NP	O
dark	dark	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
covered	cover	VBN	I-NP	O
cylinders	cylinder	NNS	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
-	-	HYPH	O	O
23	23	CD	B-NP	O
in	in	IN	B-PP	O
high	high	JJ	B-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
initiated	initiate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
nucleus	nucleus	NN	I-NP	O
accumbens	accumbens	NN	I-NP	O
septi	septi	NNS	I-NP	O
were	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
marked	marked	JJ	I-ADJP	O
.	.	.	O	O


The	The	DT	B-NP	O
appearance	appearance	NN	I-NP	O
of	of	IN	B-PP	O
dyskinetic	dyskinetic	JJ	B-NP	O
movement	movement	NN	I-NP	O
disorders	disorder	NNS	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
following	follow	VBG	B-PP	O
the	the	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
levodopa	levodopa	NN	B-NP	O
or	or	CC	I-NP	O
amphetamine	amphetamine	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
manifestation	manifestation	NN	I-NP	O
of	of	IN	B-PP	O
similarly	similarly	RB	B-NP	O
increased	increase	VBN	I-NP	O
dopamine	dopamine	NN	I-NP	O
receptor	receptor	NN	I-NP	O
site	site	NN	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
striatum	striatum	NN	I-NP	O
.	.	.	O	O


Association	Association	NN	B-NP	O
with	with	IN	B-PP	O
HL	HL	NN	B-NP	O
-	-	HYPH	O	O
A	A	NN	B-NP	O
W	W	NN	I-NP	O
-	-	HYPH	B-NP	O
27	27	CD	I-NP	O
.	.	.	O	O


Letter	Letter	NNP	B-NP	O
:	:	:	O	O
Lactose	Lactose	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
tests	test	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
predictor	predictor	NN	I-NP	O
of	of	IN	B-PP	O
milk	milk	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
.	.	.	O	O


Retinoblastoma	Retinoblastoma	NN	B-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
natural	natural	JJ	B-NP	O
history	history	NN	I-NP	O
and	and	CC	I-NP	O
prognosis	prognosis	NN	I-NP	O
of	of	IN	B-PP	O
268	268	CD	B-NP	O
cases	case	NNS	I-NP	O
.	.	.	O	O


Like	Like	IN	B-PP	O
pineal	pineal	JJ	B-NP	B-protein
melatonin	melatonin	NN	I-NP	I-protein
,	,	,	O	O
serum	serum	NN	B-NP	B-protein
melatonin	melatonin	NN	I-NP	I-protein
was	be	VBD	B-VP	O
high	high	JJ	B-ADJP	O
at	at	IN	B-PP	O
mid	mid	JJ	B-NP	O
-	-	HYPH	I-NP	O
dark	dark	JJ	I-NP	O
and	and	CC	I-NP	O
low	low	JJ	I-NP	O
at	at	IN	B-PP	O
mid	mid	JJ	B-NP	O
-	-	HYPH	I-NP	O
light	light	NN	I-NP	O
.	.	.	O	O


D	D	NN	B-NP	O
.	.	.	O	O


Atherosclerosis	Atherosclerosis	NNP	B-NP	O


The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
concluded	conclude	VBD	B-VP	O
that	that	IN	B-SBAR	O
ultrasonic	ultrasonic	JJ	B-NP	O
Doppler	Doppler	NNP	I-NP	O
-	-	HYPH	I-NP	O
cardiography	cardiography	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
measuring	measure	VBG	B-VP	O
the	the	DT	B-NP	O
relative	relative	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stroke	stroke	NN	I-NP	O
volume	volume	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
attainment	attainment	NN	I-NP	O
of	of	IN	B-PP	O
sexual	sexual	JJ	B-NP	O
maturity	maturity	NN	I-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
secondary	secondary	JJ	B-NP	O
sexual	sexual	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
spermatozoa	spermatozoa	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
male	male	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
cyclical	cyclical	JJ	I-NP	O
female	female	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
with	with	IN	B-PP	O
release	release	NN	B-NP	O
of	of	IN	B-PP	O
ova	ova	NN	B-NP	O
are	be	VBP	B-VP	O
end	end	NN	B-NP	O
-	-	HYPH	B-VP	O
points	point	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
developmental	developmental	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O


However	However	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
10	10	CD	I-NP	O
-	-	HYPH	I-NP	O
-	-	SYM	I-NP	O
15	15	CD	I-NP	O
%	%	NN	I-NP	O
lengthening	lengthening	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
partial	partial	JJ	I-NP	O
thromboplastin	thromboplastin	NN	I-NP	O
time	time	NN	I-NP	O
is	be	VBZ	B-VP	O
evident	evident	JJ	B-ADJP	O
after	after	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
storage	storage	NN	B-NP	O
.	.	.	O	O


Caution	Caution	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
exercised	exercise	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
dyes	dye	NNS	I-NP	O
for	for	IN	B-PP	O
lymphograms	lymphogram	NNS	B-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
reveals	reveal	VBZ	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
test	test	NN	I-NP	O
for	for	IN	B-PP	O
short	short	JJ	B-NP	O
saphenous	saphenous	JJ	I-NP	O
incompetence	incompetence	NN	I-NP	O
and	and	CC	O	O
shows	show	VBZ	B-VP	O
that	that	IN	B-SBAR	O
14	14	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
of	of	IN	B-PP	O
varices	varix	NNS	B-NP	O
stem	stem	VBP	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
saphenopopliteal	saphenopopliteal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
.	.	.	O	O


Three	Three	CD	B-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
undergone	undergo	VBN	I-VP	O
subtotal	subtotal	JJ	B-NP	O
thyroidectomy	thyroidectomy	NN	I-NP	O
for	for	IN	B-PP	O
Graves	Graves	NN	B-NP	O
'	'	POS	B-NP	O
s	s	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
toxic	toxic	JJ	B-NP	O
multinodular	multinodular	JJ	I-NP	O
goitre	goitre	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
euthyroid	euthyroid	JJ	B-NP	O
multinodular	multinodular	JJ	I-NP	O
goitre	goitre	NN	I-NP	O
12	12	CD	I-NP	O
to	to	TO	I-NP	O
15	15	CD	I-NP	O
years	year	NNS	I-NP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
in	in	IN	I-PP	O
whom	whom	WP	B-NP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
serum	serum	NN	I-NP	O
thyroxine	thyroxine	NN	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
-	-	HYPH	O	O
4	4	CD	O	O
)	)	)	O	O
level	level	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
were	be	VBD	B-VP	O
each	each	DT	O	O
divided	divide	VBN	B-VP	O
into	into	IN	B-PP	O
two	two	CD	B-NP	O
subgroups	subgroup	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
raised	raise	VBN	I-NP	O
serum	serum	NN	I-NP	O
thyrotrophin	thyrotrophin	NN	I-NP	O
concentration	concentration	NN	I-NP	O
.	.	.	O	O


Routine	Routine	NN	B-NP	O
isotope	isotope	NN	I-NP	O
cystography	cystography	NN	I-NP	O
using	use	VBG	B-VP	O
99M	99M	NN	B-NP	O
Tc	Tc	NN	I-NP	O
sulfur	sulfur	NN	I-NP	O
colloid	colloid	NN	I-NP	O
for	for	IN	B-PP	O
detection	detection	NN	B-NP	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
-	-	HYPH	O	O
up	up	RP	B-PRT	O
of	of	IN	B-PP	O
vesico	vesico	AFX	B-NP	O
-	-	HYPH	I-NP	O
ureteral	ureteral	JJ	I-NP	O
reflux	reflux	NN	I-NP	O


Air	Air	NN	B-NP	O
ion	ion	NN	I-NP	O
action	action	NN	I-NP	O
on	on	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O


No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
either	either	CC	B-NP	O
positive	positive	JJ	I-NP	O
or	or	CC	I-NP	O
negative	negative	JJ	I-NP	O
chemography	chemography	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
interpretation	interpretation	NN	I-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
disc	disc	NN	I-NP	O
sensitivities	sensitivity	NNS	I-NP	O
.	.	.	O	O


Following	Follow	VBG	B-PP	O
retransfusion	retransfusion	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
affected	affect	VBN	I-NP	O
epithelial	epithelial	JJ	I-NP	O
lining	lining	NN	I-NP	O
appeared	appear	VBD	B-VP	O
greatly	greatly	RB	I-VP	O
distended	distend	VBN	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
oedematous	oedematous	JJ	I-NP	O
lamina	lamina	NN	I-NP	O
propria	propria	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
almost	almost	RB	B-NP	O
complete	complete	JJ	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
structural	structural	JJ	B-NP	O
detail	detail	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
chromosomes	chromosome	NNS	B-NP	O
of	of	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
hycanthone	hycanthone	NN	B-NP	O
.	.	.	O	O


Characteristics	Characteristic	NNS	B-NP	O
of	of	IN	B-PP	O
anesthesia	anesthesia	NN	B-NP	O
and	and	CC	I-NP	O
resuscitation	resuscitation	NN	I-NP	O
in	in	IN	B-PP	O
emergency	emergency	NN	B-NP	O
lung	lung	NN	I-NP	O
surgery	surgery	NN	I-NP	O


Study	Study	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
physico	physico	NN	I-NP	O
-	-	HYPH	B-NP	O
chemical	chemical	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
plutonium	plutonium	NN	B-NP	O
-	-	HYPH	B-NP	O
239	239	CD	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
citrate	citrate	NN	I-NP	O
solution	solution	NN	I-NP	O
-	-	HYPH	B-NP	O
blood	blood	NN	I-NP	O
system	system	NN	I-NP	O


Tobramycin	Tobramycin	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
remarkable	remarkable	JJ	I-NP	O
effect	effect	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
dibecacin	dibecacin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
produced	produce	VBD	B-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
potentiating	potentiating	NN	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
d	d	NN	B-NP	O
-	-	HYPH	B-NP	O
tubocurarine	tubocurarine	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
about	about	IN	B-NP	O
one	one	CD	I-NP	O
third	third	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cases	case	NNS	I-NP	O
this	this	DT	B-NP	O
operation	operation	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
tonal	tonal	JJ	B-NP	O
and	and	CC	I-NP	O
vocal	vocal	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
for	for	IN	B-PP	O
patients	patient	NNS	B-NP	O
suffering	suffer	VBG	B-VP	O
from	from	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
perceptive	perceptive	JJ	I-NP	O
deafness	deafness	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
specific	specific	JJ	I-NP	O
electrical	electrical	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cerebrospinal	cerebrospinal	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
conductometry	conductometry	NN	B-NP	O
in	in	IN	B-PP	O
14	14	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
meningitis	meningitis	NN	B-NP	O
purulenta	purulenta	NN	I-NP	O
,	,	,	O	O
17	17	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
meningitis	meningitis	NN	B-NP	O
serosa	serosa	NN	I-NP	O
,	,	,	O	O
10	10	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
encephalitis	encephalitis	NN	B-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
32	32	CD	B-NP	O
control	control	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O


2	2	CD	B-NP	O
-	-	HYPH	I-NP	O
Chemical	Chemical	JJ	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
vas	vas	NN	B-NP	O
is	be	VBZ	B-VP	O
quite	quite	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
producing	produce	VBG	B-VP	O
a	a	DT	B-NP	O
block	block	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
vas	vas	NN	I-NP	O
deferens	deferen	NNS	I-NP	O
of	of	IN	B-PP	O
dogs	dog	NNS	B-NP	O
.	.	.	O	O


Besides	Besides	IN	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
patients	patient	NNS	I-NP	O
increased	increase	VBD	B-VP	O
serum	serum	NN	B-NP	B-protein
immunoglobulins	immunoglobulin	NNS	I-NP	I-protein
,	,	,	O	O
chiefly	chiefly	RB	B-NP	O
IgG	IgG	NN	I-NP	B-protein
,	,	,	O	O
as	as	IN	B-SBAR	O
first	first	JJ	B-NP	O
Russe	Russe	NNP	I-NP	O
,	,	,	O	O
Busey	Busey	NNP	B-NP	O
and	and	CC	O	O
Barbeau	Barbeau	NNP	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
French	French	JJ	I-NP	O
-	-	HYPH	I-NP	O
Canadian	Canadian	JJ	I-NP	B-protein
family	family	NN	I-NP	I-protein
.	.	.	O	O


We	We	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
such	such	JJ	B-NP	O
occlusions	occlusion	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O


Streptococcal	Streptococcal	JJ	B-NP	O
preparation	preparation	NN	I-NP	O
(	(	(	O	O
OK	OK	NN	B-NP	B-protein
-	-	HYPH	O	I-protein
432	432	CD	B-NP	I-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
anti	anti	AFX	B-NP	O
-	-	HYPH	I-NP	O
cancer	cancer	NN	I-NP	O
agent	agent	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
advanced	advance	VBN	B-NP	O
cancer	cancer	NN	I-NP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
Mitomycin	Mitomycin	NN	B-NP	O
-	-	HYPH	I-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
-	-	HYPH	I-NP	O
FU	FU	NN	I-NP	O
and	and	CC	I-NP	O
Cytosine	Cytosine	NN	I-NP	O
arabinoside	arabinoside	NN	I-NP	O
.	.	.	O	O


Generally	Generally	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
between	between	IN	B-PP	O
highest	high	JJS	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
CSF	CSF	NN	B-NP	B-protein
immunoglobulins	immunoglobulin	NNS	I-NP	I-protein
and	and	CC	O	O
degree	degree	NN	B-NP	O
of	of	IN	B-PP	O
meningeal	meningeal	JJ	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
even	even	RB	B-SBAR	O
if	if	IN	I-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
neurological	neurological	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O


Maternal	Maternal	JJ	B-NP	O
lactation	lactation	NN	I-NP	O


Experimental	Experimental	JJ	B-NP	O
cardiotoxicity	cardiotoxicity	NN	I-NP	O
of	of	IN	B-PP	O
adriamycin	adriamycin	NN	B-NP	O


Muscular	Muscular	JJ	B-NP	O
pathology	pathology	NN	I-NP	O


Demonstration	Demonstration	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
agent	agent	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
6th	6th	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
11th	11th	JJ	I-NP	O
day	day	NN	I-NP	O
p	p	NN	I-NP	O
.	.	.	I-NP	O
i	i	NN	I-NP	O
.	.	.	O	O
by	by	IN	B-PP	O
direct	direct	JJ	B-NP	O
microscopic	microscopic	JJ	I-NP	O
methods	method	NNS	I-NP	O
(	(	(	O	O
Stamp	Stamp	NN	B-NP	O
and	and	CC	O	O
auramine	auramine	NN	B-NP	O
staining	staining	NN	I-NP	O
,	,	,	O	O
fluorescent	fluorescent	JJ	B-NP	O
antibody	antibody	NN	I-NP	O
technique	technique	NN	I-NP	O
)	)	)	O	O
;	;	:	O	O
the	the	DT	B-NP	O
Coxiella	Coxiella	NNP	I-NP	O
content	content	NN	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
titration	titration	NN	B-NP	O
in	in	IN	B-PP	O
embryonated	embryonate	VBN	B-NP	O
hen	hen	NN	I-NP	O
'	'	POS	B-NP	O
s	s	JJ	I-NP	O
eggs	egg	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
4	4	CD	B-NP	O
groups	group	NNS	I-NP	O
receiving	receive	VBG	B-VP	O
NLA	NLA	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
with	with	IN	B-PP	O
or	or	CC	B-PP	O
without	without	IN	B-PP	O
nalorphine	nalorphine	NN	B-NP	O
,	,	,	I-NP	O
morphine	morphine	NN	I-NP	O
or	or	CC	I-NP	O
Micoren	Micoren	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
alterations	alteration	NNS	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
-	-	HYPH	I-NP	O
HT	HT	NN	I-NP	B-protein
and	and	CC	I-NP	I-protein
5	5	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
HIAA	HIAA	NN	I-NP	B-protein
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
conditions	condition	NNS	I-NP	O
examined	examine	VBN	B-VP	O
may	may	MD	B-VP	O
indicate	indicate	VB	I-VP	O
that	that	IN	B-SBAR	O
IDPN	IDPN	NN	B-NP	B-protein
'	'	POS	B-NP	O
s	s	NN	I-NP	O
neurotoxicity	neurotoxicity	NN	I-NP	O
primarily	primarily	RB	B-ADVP	O
affects	affect	VBZ	B-VP	O
5	5	CD	B-NP	O
-	-	HYPH	I-NP	O
HT	HT	NN	I-NP	O
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
neurones	neurone	NNS	B-NP	O
.	.	.	O	O


(	(	(	B-LST	O
5	5	LS	I-LST	O
)	)	)	O	O
An	An	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
leukocyte	leukocyte	NN	B-NP	B-cell_type
-	-	HYPH	B-NP	O
counts	count	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
rabbit	rabbit	NN	B-NP	B-protein
during	during	IN	B-PP	I-protein
phase	phase	NN	B-NP	I-protein
-	-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
results	result	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
tend	tend	VBP	B-VP	O
to	to	TO	I-VP	O
prove	prove	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
reticuloendothelial	reticuloendothelial	JJ	I-NP	O
system	system	NN	I-NP	O
mainly	mainly	RB	B-ADVP	O
participated	participate	VBD	B-VP	O
in	in	IN	B-PP	O
beryllium	beryllium	NN	B-NP	O
retention	retention	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
both	both	DT	B-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
exposure	exposure	NN	B-NP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	B-protein
carboxyhemoglobin	carboxyhemoglobin	NN	I-NP	I-protein
(	(	(	O	O
COHb	COHb	NN	B-NP	B-protein
)	)	)	O	O
(	(	(	O	O
about	about	RB	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
reached	reach	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
increased	increase	VBN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
with	with	IN	B-PP	O
advancing	advance	VBG	B-VP	O
gestation	gestation	NN	B-NP	O
are	be	VBP	B-VP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
vessels	vessel	NNS	B-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
vasomotor	vasomotor	NN	I-NP	O
reactivity	reactivity	NN	I-NP	O
is	be	VBZ	B-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
smooth	smooth	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
thickness	thickness	NN	I-NP	O
of	of	IN	B-PP	O
muscle	muscle	NN	B-NP	O
in	in	IN	B-PP	O
individual	individual	JJ	B-NP	O
vessels	vessel	NNS	I-NP	O
remains	remain	VBZ	B-VP	O
constant	constant	JJ	B-ADJP	O
.	.	.	O	O


Reduction	Reduction	NN	B-NP	O
in	in	IN	B-PP	O
dosage	dosage	NN	B-NP	O
restored	restore	VBD	B-VP	O
normal	normal	JJ	B-NP	O
taste	taste	NN	I-NP	O
sense	sense	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
three	three	CD	I-NP	O
,	,	,	O	O
but	but	CC	O	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O
had	have	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
because	because	RB	B-PP	O
of	of	IN	I-PP	O
persisting	persist	VBG	B-VP	O
high	high	JJ	B-NP	O
transaminase	transaminase	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
calcium	calcium	NN	I-NP	O
ratio	ratio	NN	I-NP	O
(	(	(	O	O
mean	mean	JJ	B-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
predicted	predict	VBN	I-NP	O
to	to	TO	B-PP	O
measured	measure	VBN	B-NP	O
TBCa	TBCa	NN	I-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
men	man	NNS	B-NP	O
was	be	VBD	B-VP	O
1.000	1.000	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
7.8	7.8	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
women	woman	NNS	B-NP	O
0.996	0.996	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
7.1	7.1	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
late	late	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
retinoblastoma	retinoblastoma	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
unquestionable	unquestionable	JJ	I-NP	O
fact	fact	NN	I-NP	O
that	that	WDT	B-NP	O
allows	allow	VBZ	B-VP	O
its	its	PRP$	B-NP	O
growth	growth	NN	I-NP	O
and	and	CC	O	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
deterioration	deterioration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outlook	outlook	NN	I-NP	O
.	.	.	O	O


Total	Total	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
amniotic	amniotic	JJ	B-NP	O
fluids	fluid	NNS	I-NP	O
collected	collect	VBN	B-VP	O
at	at	IN	B-PP	O
different	different	JJ	B-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
gestation	gestation	NN	B-NP	O
.	.	.	O	O


Her	Her	PRP$	B-NP	O
serum	serum	NN	I-NP	O
FT3	FT3	NN	I-NP	O
concentration	concentration	NN	I-NP	O
was	be	VBD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
much	much	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
ranges	range	NNS	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
or	or	CC	B-PP	O
in	in	IN	B-PP	O
GTD	GTD	NN	B-NP	O
patients	patient	NNS	I-NP	O
without	without	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
hyperthyroidism	hyperthyroidism	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
fear	fear	NN	B-NP	O
and	and	CC	I-NP	O
pugnacity	pugnacity	NN	I-NP	O
all	all	DT	B-NP	O
husband	husband	NN	I-NP	O
-	-	HYPH	B-NP	O
wife	wife	NN	I-NP	O
trait	trait	NN	I-NP	O
correlations	correlation	NNS	I-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
in	in	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
Winch	Winch	NNP	B-NP	O
'	'	POS	B-NP	O
s	s	JJ	I-NP	O
principle	principle	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	O
I	I	CD	I-NP	O
complementarity	complementarity	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
note	note	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
phase	phase	NN	I-NP	O
-	-	HYPH	B-NP	O
plane	plane	NN	I-NP	O
technique	technique	NN	I-NP	O
representation	representation	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
action	action	NN	I-NP	O
potentials	potential	NNS	I-NP	O
.	.	.	O	O


3	3	CD	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
factor	factor	NN	I-NP	B-protein
II	II	CD	I-NP	I-protein
molecule	molecule	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
newborn	newborn	JJ	I-NP	O
infant	infant	NN	I-NP	O
at	at	IN	B-PP	O
term	term	NN	B-NP	O


The	The	DT	B-NP	O
concept	concept	NN	I-NP	O
of	of	IN	B-PP	O
"	"	``	O	B-protein
structural	structural	JJ	B-NP	I-protein
identifiability	identifiability	NN	I-NP	I-protein
"	"	''	O	I-protein
is	be	VBZ	B-VP	O
employed	employ	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
analysis	analysis	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
which	which	WDT	B-NP	O
model	model	NN	I-NP	O
parameters	parameter	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
and	and	CC	O	O
which	which	WDT	B-NP	O
cannot	cannot	MD	B-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O
"	"	``	O	O
uniquely	uniquely	RB	B-ADVP	O
"	"	''	O	O
from	from	IN	B-PP	O
given	give	VBN	B-NP	O
input	input	NN	I-NP	O
-	-	HYPH	B-NP	O
output	output	NN	I-NP	O
data	datum	NNS	I-NP	O
;	;	:	O	O
a	a	DT	B-NP	O
step	step	NN	I-NP	O
-	-	HYPH	B-ADJP	O
by	by	IN	B-PP	O
-	-	HYPH	B-NP	O
step	step	NN	I-NP	O
procedure	procedure	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
extension	extension	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
concept	concept	NN	I-NP	O
is	be	VBZ	B-VP	O
presented	present	VBN	I-VP	O
for	for	IN	B-PP	O
adapting	adapt	VBG	B-VP	O
the	the	DT	B-NP	O
overall	overall	JJ	I-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
design	design	NN	I-NP	O
problem	problem	NN	I-NP	O
.	.	.	O	O


However	However	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
did	do	VBD	B-VP	O
detect	detect	VB	I-VP	O
lot	lot	NN	B-NP	O
-	-	HYPH	B-ADVP	O
to	to	TO	B-PP	O
-	-	HYPH	B-NP	O
lot	lot	NN	I-NP	O
variation	variation	NN	I-NP	O
and	and	CC	O	O
differences	difference	NNS	B-NP	O
in	in	IN	B-PP	O
performance	performance	NN	B-NP	O
between	between	IN	B-PP	O
narrow	narrow	JJ	B-NP	O
bandpass	bandpass	NN	I-NP	O
and	and	CC	O	O
wide	wide	JJ	B-NP	O
bandpass	bandpass	NN	I-NP	O
spectrophotometers	spectrophotometer	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
cochlear	cochlear	JJ	I-NP	O
compromise	compromise	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
case	case	NN	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
Saigon	Saigon	NNP	B-NP	O


Hypertonic	Hypertonic	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
administered	administer	VBN	B-VP	O
intrajejunally	intrajejunally	RB	B-ADVP	O
in	in	IN	B-PP	O
Heidenhain	Heidenhain	NNP	B-NP	O
pouch	pouch	NN	I-NP	O
dogs	dog	NNS	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
equal	equal	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
pentagastrin	pentagastrin	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
acid	acid	NN	I-NP	O
secretion	secretion	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
pouch	pouch	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
main	main	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
hypertonic	hypertonic	JJ	B-NP	O
saline	saline	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O


Acquired	Acquire	VBN	B-NP	O
factor	factor	NN	I-NP	O
VIII	VIII	CD	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
in	in	IN	B-PP	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
hemophilic	hemophilic	JJ	I-NP	O
patients	patient	NNS	I-NP	O


Biohydrogenation	Biohydrogenation	NN	B-NP	O
of	of	IN	B-PP	O
linoleic	linoleic	JJ	B-NP	O
acid	acid	NN	I-NP	O
into	into	IN	B-PP	O
octadecenoic	octadecenoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
calcium	calcium	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O
in	in	IN	B-PP	O
ten	ten	CD	B-NP	O
thalassaemic	thalassaemic	JJ	I-NP	O
children	child	NNS	I-NP	O
comperatively	comperatively	RB	B-ADVP	O
with	with	IN	B-PP	O
controls	control	NNS	B-NP	O
after	after	IN	B-PP	O
oral	oral	JJ	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
47Ca	47Ca	NN	B-NP	O
has	have	VBZ	B-VP	O
shown	show	VBN	I-VP	O
diminished	diminish	VBN	I-VP	O
intestinal	intestinal	JJ	B-NP	O
absorption	absorption	NN	I-NP	O
.	.	.	O	O


Chlamydial	Chlamydial	NN	B-NP	O
agents	agent	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
semen	seman	NNS	I-NP	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chlamydemic	chlamydemic	JJ	I-NP	O
phase	phase	NN	I-NP	O
.	.	.	O	O


Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
increased	increase	VBN	I-NP	O
CPK	CPK	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
newborns	newborn	NNS	I-NP	O
,	,	,	O	O
screening	screen	VBG	B-VP	O
for	for	IN	B-PP	O
Duchenne	Duchenne	NNP	B-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
muscular	muscular	JJ	I-NP	O
dystrophy	dystrophy	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
postponed	postpone	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
delivery	delivery	NN	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
insulin	insulin	NN	I-NP	O
response	response	NN	I-NP	O
had	have	VBD	B-VP	O
returned	return	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
pregnant	pregnant	JJ	I-NP	O
value	value	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
puerperium	puerperium	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
toxicological	toxicological	JJ	B-NP	O
tests	test	NNS	I-NP	O
conducted	conduct	VBN	B-VP	O
on	on	IN	B-PP	O
plastic	plastic	JJ	B-NP	O
materials	material	NNS	I-NP	O
(	(	(	O	O
polyethylene	polyethylene	NN	B-NP	O
)	)	)	O	O
activated	activate	VBN	B-VP	O
with	with	IN	B-PP	O
tetraphenylbutadiene	tetraphenylbutadiene	NN	B-NP	O
(	(	(	O	O
TPB	TPB	NN	B-NP	O
)	)	)	O	O
an	an	DT	B-NP	O
additive	additive	JJ	I-NP	O
recently	recently	RB	I-NP	O
proposed	propose	VBN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
sensitizer	sensitizer	NN	I-NP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
photodegrading	photodegrade	VBG	B-VP	O
plastic	plastic	JJ	B-NP	O
materials	material	NNS	I-NP	O
.	.	.	O	O


Mutational	Mutational	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	B-DNA
homology	homology	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
Mason	Mason	NNP	B-NP	O
-	-	HYPH	I-NP	O
Pfizer	Pfizer	NNP	I-NP	O
monkey	monkey	NN	I-NP	O
virus	virus	NN	I-NP	O
by	by	IN	B-PP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
saturation	saturation	NN	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
.	.	.	O	O


One	One	CD	B-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
PAL	PAL	NN	B-NP	O
,	,	,	O	O
occurs	occur	VBZ	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
10	10	CD	I-NP	B-DNA
bp	bp	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
GGGGAGGAGG	GGGGAGGAGG	NN	I-NP	O
.	.	.	O	O


Nuclear	Nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
both	both	CC	B-NP	O
neural	neural	JJ	I-NP	O
and	and	CC	O	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	B-cell_line
neural	neural	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
mouse	mouse	NN	B-NP	O
brain	brain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mouse	mouse	NN	B-NP	O
liver	liver	NN	I-NP	O
contain	contain	VBP	B-VP	O
proteins	protein	NNS	B-NP	O
that	that	WDT	B-NP	O
recognize	recognize	VBP	B-VP	O
and	and	CC	I-VP	O
bind	bind	VBP	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PROX	PROX	NN	I-NP	B-DNA
and	and	CC	I-NP	O
PAL	PAL	NN	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
proteins	protein	NNS	B-NP	O
which	which	WDT	B-NP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
target	target	NN	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
widespread	widespread	JJ	B-ADJP	O
.	.	.	O	O


To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
NF	NF	NN	I-NP	B-DNA
(	(	(	O	I-DNA
H	H	NN	B-NP	I-DNA
)	)	)	O	I-DNA
promoter	promoter	NN	B-NP	I-DNA
can	can	MD	B-VP	O
be	be	VB	I-VP	O
activated	activate	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
tissue	tissue	NN	I-NP	O
specific	specific	JJ	I-NP	O
manner	manner	NN	I-NP	O
during	during	IN	B-PP	O
development	development	NN	B-NP	O
transgenic	transgenic	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
galactosidase	galactosidase	NN	I-NP	B-DNA
reporter	reporter	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
were	be	VBD	B-VP	O
generated	generate	VBN	I-VP	O
.	.	.	O	O


Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
describe	describe	VBP	B-VP	O
and	and	CC	I-VP	O
map	map	VBP	I-VP	O
two	two	CD	B-NP	O
more	more	RBR	I-NP	O
new	new	JJ	I-NP	O
genes	gene	NNS	I-NP	O
identified	identify	VBN	B-VP	O
as	as	IN	B-PP	O
allele	allele	NN	B-NP	B-DNA
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
suppressors	suppressor	NNS	I-NP	O
that	that	WDT	B-NP	O
compensate	compensate	VBP	B-VP	O
for	for	IN	B-PP	O
carboxy	carboxy	NN	B-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
truncation	truncation	NN	I-NP	O
of	of	IN	B-PP	O
PET122	PET122	NN	B-NP	B-protein
.	.	.	O	O


Previous	Previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
[	[	(	O	O
Hisanaga	Hisanaga	NNP	B-NP	O
,	,	,	O	O
S	S	NNP	B-NP	O
.	.	.	O	O
,	,	,	O	O
Kusubata	Kusubata	NNP	B-NP	O
,	,	,	O	O
M	M	NNP	B-NP	O
.	.	.	O	O
,	,	,	O	O
Okumura	Okumura	NNP	B-NP	O
,	,	,	O	O
E	E	NNP	B-NP	O
.	.	.	I-NP	O
&	&	CC	I-NP	O
Kishimoto	Kishimoto	NNP	I-NP	O
,	,	,	O	O
T	T	NN	B-NP	O
.	.	.	O	O


Treatment	Treatment	NN	B-NP	O
and	and	CC	I-NP	O
staining	staining	NN	I-NP	O
of	of	IN	B-PP	O
smears	smear	NNS	B-NP	O
and	and	CC	I-NP	O
sections	section	NNS	I-NP	O
for	for	IN	B-PP	O
detection	detection	NN	B-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O


The	The	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
Kd	Kd	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MetRS	MetRS	NN	I-NP	B-DNA
/	/	SYM	B-NP	O
CAU	CAU	NN	I-NP	B-protein
operator	operator	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
one	one	CD	B-NP	O
order	order	NN	I-NP	O
magnitude	magnitude	NN	I-NP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ThrRS	ThrRS	NN	I-NP	B-protein
/	/	SYM	B-NP	I-protein
CGU	CGU	NN	I-NP	I-protein
operator	operator	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O


A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
direct	direct	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
percent	percent	NN	I-NP	O
area	area	NN	I-NP	O
density	density	NN	I-NP	O
of	of	IN	B-PP	O
smooth	smooth	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
percent	percent	NN	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
peak	peak	NN	B-NP	O
urinary	urinary	JJ	I-NP	O
flow	flow	NN	I-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O


Rabbit	Rabbit	NN	B-NP	B-protein
skeletal	skeletal	JJ	I-NP	I-protein
muscle	muscle	NN	I-NP	I-protein
glycogenin	glycogenin	NN	I-NP	I-protein
.	.	.	O	O


Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
cytokeratin	cytokeratin	NN	B-NP	B-protein
17	17	CD	I-NP	I-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
expression	expression	NN	I-NP	O
pattern	pattern	NN	I-NP	O
.	.	.	O	O


Animals	Animal	NNS	B-NP	O
that	that	WDT	B-NP	O
received	receive	VBD	B-VP	O
DSP	DSP	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
4	4	CD	I-NP	I-protein
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
retarded	retard	VBN	I-VP	O
in	in	IN	B-PP	O
motor	motor	NN	B-NP	O
recovery	recovery	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
saline	saline	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
prophylactic	prophylactic	JJ	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
medication	medication	NN	I-NP	O
for	for	IN	B-PP	O
patients	patient	NNS	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
and	and	CC	I-NP	O
second	second	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
of	of	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
agreement	agreement	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
estimates	estimate	NNS	I-NP	O
calculated	calculate	VBN	B-VP	O
,	,	,	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
save	save	VB	I-VP	O
health	health	NN	B-NP	O
care	care	NN	I-NP	O
costs	cost	NNS	I-NP	O
but	but	CC	O	O
may	may	MD	B-VP	O
improve	improve	VB	I-VP	O
the	the	DT	B-NP	O
quality	quality	NN	I-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
permit	permit	VB	B-VP	O
the	the	DT	B-NP	O
continuation	continuation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
schedule	schedule	NN	I-NP	O
without	without	IN	B-PP	O
interruption	interruption	NN	B-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
improve	improve	VB	I-VP	O
the	the	DT	B-NP	O
life	life	NN	I-NP	O
expectancy	expectancy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O


AP	AP	NN	B-NP	O
was	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
intraductal	intraductal	JJ	B-NP	O
infusion	infusion	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
glycodeoxycholic	glycodeoxycholic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
GDOC	GDOC	NN	B-NP	O
17	17	CD	I-NP	O
mmol	mmol	NN	I-NP	O
and	and	CC	O	O
34	34	CD	B-NP	O
mmol	mmol	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
isolation	isolation	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
gene	gene	NN	I-NP	O
was	be	VBD	B-VP	O
based	base	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Y	Y	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
231	231	CD	I-NP	I-DNA
cosmid	cosmid	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
CpG	CpG	NN	B-NP	B-DNA
rich	rich	JJ	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
(	(	(	O	O
HTF	HTF	NN	B-NP	B-DNA
islands	island	NNS	I-NP	I-DNA
)	)	)	O	O
in	in	IN	B-PP	O
its	its	PRP$	B-NP	O
human	human	JJ	I-NP	B-protein
insert	insert	NN	I-NP	I-protein
.	.	.	O	O


Tissue	Tissue	NN	B-NP	B-protein
plasminogen	plasminogen	NN	I-NP	I-protein
activator	activator	NN	I-NP	I-protein
,	,	,	O	O
its	its	PRP$	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
of	of	IN	B-PP	O
fibrinolysis	fibrinolysis	NN	B-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
operated	operate	VBN	B-VP	O
for	for	IN	B-PP	O
mild	mild	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prostate	prostate	NN	I-NP	O


Gene	Gene	NN	B-NP	O
constructs	construct	NNS	I-NP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-DNA
growth	growth	NN	I-NP	I-DNA
hormone	hormone	NN	I-NP	I-DNA
(	(	(	O	I-DNA
hGH	hGH	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
driven	drive	VBN	B-VP	O
by	by	IN	B-PP	O
promoter	promoter	NN	B-NP	O
/	/	SYM	B-NP	O
regulatory	regulatory	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
mouse	mouse	NN	B-NP	B-protein
metallothionein	metallothionein	NN	I-NP	I-protein
(	(	(	O	O
mMT	mMT	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
viral	viral	JJ	B-NP	B-protein
thymidine	thymidine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
vTK	vTK	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
rat	rat	NN	B-NP	B-protein
cholecystokinin	cholecystokinin	NN	I-NP	I-protein
(	(	(	O	O
rCCK	rCCK	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
or	or	CC	O	O
chicken	chicken	NN	B-NP	B-protein
beta	beta	SYM	O	I-protein
-	-	HYPH	O	I-protein
actin	actin	NN	B-NP	I-protein
(	(	(	O	O
cBA	cBA	NN	B-NP	O
)	)	)	O	O
gene	gene	NN	B-NP	O
were	be	VBD	B-VP	O
injected	inject	VBN	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
cytoplasm	cytoplasm	NN	I-NP	O
of	of	IN	B-PP	O
fertilized	fertilize	VBN	B-NP	O
medaka	medaka	NN	I-NP	O
eggs	egg	NNS	I-NP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
micropyle	micropyle	NN	I-NP	O
.	.	.	O	O


Serum	Serum	NN	B-NP	O
gastrin	gastrin	NN	I-NP	O
and	and	CC	I-NP	O
AFP	AFP	NN	I-NP	O
levels	level	NNS	I-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
evolution	evolution	NN	I-NP	O
and	and	CC	O	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
interest	interest	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O


Prospects	Prospect	NNS	B-NP	O
for	for	IN	B-PP	O
controlled	control	VBN	B-NP	O
-	-	HYPH	I-NP	O
delivery	delivery	NN	I-NP	O
systems	system	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
mean	mean	JJ	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	HYPH	B-NP	O
SD	SD	NN	I-NP	O
)	)	)	O	O
PaO2	PaO2	NN	B-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
80.8	80.8	CD	B-NP	O
+	+	SYM	B-ADJP	O
/	/	SYM	O	O
-	-	SYM	O	O
26.9	26.9	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
89.8	89.8	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
27.3	27.3	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
infusion	infusion	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
PaCO2	PaCO2	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
from	from	IN	B-PP	O
42.4	42.4	CD	B-NP	O
+	+	SYM	B-ADJP	O
/	/	SYM	O	O
-	-	SYM	O	O
8.3	8.3	CD	B-NP	O
to	to	TO	B-PP	O
39.6	39.6	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
7.9	7.9	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


Though	Though	IN	B-SBAR	O
hepatomegaly	hepatomegaly	NN	B-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
of	of	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
can	can	MD	B-VP	O
be	be	VB	I-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
,	,	,	O	O
involvement	involvement	NN	B-NP	O
of	of	IN	B-PP	O
liver	liver	NN	B-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
or	or	CC	I-NP	O
liver	liver	NN	I-NP	O
cell	cell	NN	I-NP	O
necrosis	necrosis	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
uncommon	uncommon	JJ	I-NP	O
complication	complication	NN	I-NP	O
in	in	IN	B-PP	O
P	P	NN	B-NP	O
.	.	.	O	O
falciparum	falciparum	NN	B-NP	O
malaria	malaria	NN	I-NP	O
.	.	.	O	O


For	For	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
maximal	maximal	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
potassium	potassium	NN	I-NP	O
elicited	elicit	VBN	B-VP	O
by	by	IN	B-PP	O
salbutamol	salbutamol	NN	B-NP	O
was	be	VBD	B-VP	O
0.80	0.80	CD	B-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
0.19	0.19	CD	I-NP	O
,	,	,	I-NP	O
0.48	0.48	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
0.22	0.22	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
0.78	0.78	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
0.46	0.46	CD	B-NP	O
mmol	mmol	NN	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
maximal	maximal	JJ	B-NP	O
decrement	decrement	NN	I-NP	O
was	be	VBD	B-VP	O
1.31	1.31	CD	B-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
0.37	0.37	CD	I-NP	O
,	,	,	I-NP	O
0.70	0.70	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
0.24	0.24	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
0.84	0.84	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
0.17	0.17	CD	B-NP	O
mmol	mmol	NN	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
iv	iv	NN	I-NP	O
,	,	,	O	O
po	po	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
routes	rout	VBZ	B-VP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O


The	The	DT	B-NP	O
two	two	CD	I-NP	O
drugs	drug	NNS	I-NP	O
increase	increase	VBP	B-VP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
diastolic	diastolic	JJ	I-NP	O
filling	filling	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
Bromergon	Bromergon	NNP	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
overreactiveness	overreactiveness	NN	B-NP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
prolactin	prolactin	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
i	i	NN	B-NP	O
.	.	.	O	O
e	e	NN	B-NP	O
.	.	.	O	O
abdominal	abdominal	JJ	B-NP	O
tension	tension	NN	I-NP	O
,	,	,	O	O
edema	edema	NN	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
and	and	CC	O	O
breast	breast	NN	B-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
magnitude	magnitude	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
response	response	NN	I-NP	O
was	be	VBD	B-VP	O
241	241	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
51	51	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
A	A	NN	B-NP	O
(	(	(	O	O
%	%	NN	B-NP	O
baseline	baseline	NN	I-NP	O
RL	RL	NN	I-NP	O
;	;	:	O	O
mean	mean	NN	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	HYPH	O	O
SE	SE	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
significantly	significantly	RB	B-ADJP	O
less	less	JJR	I-ADJP	O
in	in	IN	B-PP	O
B	B	NN	B-NP	O
(	(	(	O	O
119	119	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
7	7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
C	C	NN	B-NP	O
(	(	(	O	O
131	131	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
16	16	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


Most	Most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
Transient	Transient	JJ	B-NP	O
Ischemic	Ischemic	JJ	I-NP	O
Attacks	Attack	NNS	I-NP	O
(	(	(	O	O
64	64	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
Reversible	Reversible	JJ	B-NP	O
Ischemic	Ischemic	JJ	I-NP	O
Neurologic	Neurologic	JJ	I-NP	O
Deficits	Deficit	NNS	I-NP	O
(	(	(	O	O
19	19	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


We	We	PRP	B-NP	O
cloned	clone	VBD	B-VP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
human	human	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
LD78	LD78	NNP	I-NP	B-protein
,	,	,	O	O
termed	term	VBN	B-NP	O
LD78	LD78	NN	I-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
analysis	analysis	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
truncated	truncate	VBN	I-NP	I-DNA
pseudogene	pseudogene	NN	I-NP	I-DNA
.	.	.	O	O


This	This	DT	B-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
consideration	consideration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SCBs	SCB	NNS	I-NP	B-protein
found	find	VBN	B-VP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
known	known	JJ	B-NP	O
SWI4	SWI4	NN	I-NP	B-DNA
,	,	,	O	O
6	6	CD	B-NP	O
-	-	HYPH	I-NP	O
dependent	dependent	JJ	I-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
proposal	proposal	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
revised	revise	VBN	I-NP	O
consensus	consensus	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
for	for	IN	B-PP	O
this	this	DT	B-NP	O
important	important	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O


Mutational	Mutational	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
DNA	DNA	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
linking	link	VBG	B-VP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
natural	natural	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
locoregional	locoregional	JJ	B-NP	O
efficiency	efficiency	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
treatments	treatment	NNS	I-NP	O
used	use	VBN	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
part	part	NN	I-NP	O
played	play	VBN	B-VP	O
by	by	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
,	,	,	O	O
survival	survival	NN	B-NP	O
,	,	,	O	O
causes	cause	VBZ	B-VP	O
of	of	IN	B-PP	O
death	death	NN	B-NP	O
and	and	CC	O	O
therapeutic	therapeutic	JJ	B-NP	O
modalities	modality	NNS	I-NP	O
used	use	VBN	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
last	last	JJ	I-NP	O
measure	measure	NN	I-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
analysed	analyse	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
method	method	NN	I-NP	O
was	be	VBD	B-VP	O
adapted	adapt	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
nadolol	nadolol	NN	B-NP	B-protein
racemate	racemate	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
by	by	IN	B-PP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
mobile	mobile	JJ	B-NP	O
phase	phase	NN	I-NP	O
composition	composition	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
provided	provide	VBD	B-VP	O
little	little	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
supplementation	supplementation	NN	B-NP	O
to	to	TO	B-PP	O
athletic	athletic	JJ	B-NP	O
performance	performance	NN	I-NP	O
for	for	IN	B-PP	O
athletes	athlete	NNS	B-NP	O
consuming	consume	VBG	B-VP	O
the	the	DT	B-NP	O
dietary	dietary	JJ	I-NP	O
RDIs	RDI	NNS	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
histological	histological	JJ	B-NP	O
criteria	criterion	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
demand	demand	VB	I-VP	O
in	in	IN	B-PP	O
view	view	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
variability	variability	NN	I-NP	O
of	of	IN	B-PP	O
results	result	NNS	B-NP	O
and	and	CC	O	O
potential	potential	JJ	B-NP	O
dangers	danger	NNS	I-NP	O
of	of	IN	B-PP	O
endomyocardial	endomyocardial	JJ	B-NP	O
biopsy	biopsy	NN	I-NP	O
involving	involve	VBG	B-VP	O
such	such	JJ	B-NP	O
thin	thin	JJ	I-NP	O
and	and	CC	I-NP	O
fragile	fragile	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
walls	wall	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
ACRV	ACRV	NN	B-NP	O
is	be	VBZ	B-VP	O
based	base	VBN	I-VP	O
upon	upon	IN	B-PP	O
the	the	DT	B-NP	O
concomitant	concomitant	JJ	I-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
:	:	:	O	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
electrophysiological	electrophysiological	JJ	B-NP	O
criteria	criterion	NNS	I-NP	O
:	:	:	O	O
ventricular	ventricular	JJ	B-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
particular	particular	JJ	B-NP	O
sustained	sustained	JJ	I-NP	O
monomorphous	monomorphous	JJ	I-NP	O
VT	VT	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
particular	particular	JJ	I-NP	O
feature	feature	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
high	high	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
sensitivity	sensitivity	NN	B-NP	O
to	to	TO	B-PP	O
adrenergic	adrenergic	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
(	(	(	O	O
exercise	exercise	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
late	late	JJ	B-NP	O
potentials	potential	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
amplification	amplification	NN	I-NP	O
ECG	ECG	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
specific	specific	JJ	I-NP	O
sign	sign	NN	I-NP	O
,	,	,	O	O
though	though	RB	O	O
unfortunately	unfortunately	RB	B-ADVP	O
of	of	IN	B-PP	O
poor	poor	JJ	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
in	in	IN	B-PP	O
localized	localize	VBN	B-NP	O
froms	from	NNS	I-NP	O
,	,	,	O	O
those	those	DT	B-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
most	most	RBS	B-ADJP	O
difficult	difficult	JJ	I-ADJP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
segmentary	segmentary	JJ	B-NP	O
morphological	morphological	JJ	I-NP	O
and	and	CC	I-NP	O
kinetic	kinetic	JJ	I-NP	O
RV	RV	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
often	often	RB	I-ADVP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
localized	localize	VBN	B-NP	O
akinetic	akinetic	JJ	I-NP	O
or	or	CC	I-NP	O
dyskinetic	dyskinetic	JJ	I-NP	O
parietal	parietal	JJ	I-NP	O
vaulting	vaulting	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
stasis	stasis	NN	B-NP	O
"	"	''	O	O
in	in	FW	B-ADVP	O
situ	situ	FW	I-ADVP	O
"	"	``	O	O
.	.	.	O	O


In	In	IN	B-PP	O
7	7	CD	B-NP	O
of	of	IN	B-PP	O
9	9	CD	B-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
enhancer	enhancer	NN	I-NP	B-DNA
is	be	VBZ	B-VP	O
fused	fuse	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
c	c	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
myc	myc	NN	I-NP	I-DNA
bearing	bear	VBG	B-VP	I-DNA
sequences	sequence	NNS	B-NP	I-DNA
of	of	IN	B-PP	O
chromosome	chromosome	NN	B-NP	B-DNA
8	8	CD	I-NP	I-DNA
.	.	.	O	O


These	These	DT	B-NP	O
components	component	NNS	I-NP	O
both	both	DT	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
median	median	JJ	I-NP	O
R2	R2	NN	I-NP	O
of	of	IN	B-PP	O
0.84	0.84	CD	B-NP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
median	median	JJ	B-NP	O
R2s	R2	NNS	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
0.37	0.37	CD	B-NP	O
to	to	TO	B-PP	O
0.83	0.83	CD	B-NP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
commonly	commonly	RB	I-NP	O
used	use	VBN	I-NP	O
ad	ad	NN	I-NP	O
hoc	hoc	NN	I-NP	O
EEG	EEG	NN	I-NP	O
components	component	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
obtained	obtain	VBN	I-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
control	control	NN	B-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
10	10	CD	B-NP	O
female	female	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O


100	100	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
dentistry	dentistry	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Friedrich	Friedrich	NNP	I-NP	O
Schiller	Schiller	NNP	I-NP	O
University	University	NNP	I-NP	O
in	in	IN	B-PP	O
Jena	Jena	NNP	B-NP	O


The	The	DT	B-NP	O
target	target	NN	I-NP	O
contained	contain	VBN	B-VP	O
between	between	IN	B-PP	O
positions	position	NNS	B-NP	O
-	-	SYM	O	B-DNA
403	403	CD	B-NP	I-DNA
and	and	CC	O	I-DNA
-	-	SYM	B-NP	I-DNA
125	125	CD	B-NP	I-DNA
acts	act	VBZ	B-VP	O
independently	independently	RB	B-ADVP	O
of	of	IN	B-PP	O
orientation	orientation	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
and	and	CC	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
heterologous	heterologous	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O


66	66	CD	B-NP	O
:	:	:	O	O
469	469	CD	B-NP	O
-	-	HYPH	I-NP	O
479	479	CD	I-NP	O
,	,	,	I-NP	O
1992	1992	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O


Synergistic	Synergistic	JJ	B-NP	O
transactivation	transactivation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
BMRF1	BMRF1	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Z	Z	NN	I-NP	B-protein
/	/	SYM	B-NP	O
c	c	NN	I-NP	O
-	-	HYPH	B-NP	O
myb	myb	NN	I-NP	O
combination	combination	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
involve	involve	VB	I-VP	O
direct	direct	JJ	B-NP	O
binding	binding	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Z	Z	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
but	but	CC	B-CONJP	O
not	not	RB	I-CONJP	O
the	the	DT	B-NP	O
c	c	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
myb	myb	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
UCR	UCR	NN	I-NP	B-DNA
core	core	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
,	,	,	O	O
CGCCATTTT	CGCCATTTT	NN	B-NP	O
,	,	,	O	O
binds	bind	VBZ	B-VP	O
a	a	DT	B-NP	O
ubiquitous	ubiquitous	JJ	I-NP	B-protein
nuclear	nuclear	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	O	O
mediates	mediate	VBZ	B-VP	O
negative	negative	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
MuLV	MuLV	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
UCRBP	UCRBP	NN	B-NP	B-protein
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
various	various	JJ	B-NP	O
target	target	NN	I-NP	O
motifs	motif	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
UCR	UCR	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
:	:	:	O	O
the	the	DT	B-NP	O
adeno	adeno	AFX	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
associated	associate	VBN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
P5	P5	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
and	and	CC	O	O
elements	element	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-DNA
light	light	NN	I-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
and	and	CC	I-NP	I-DNA
heavy	heavy	JJ	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
chain	chain	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
elements	element	NNS	B-NP	O
in	in	IN	B-PP	O
ribosomal	ribosomal	JJ	B-NP	B-DNA
protein	protein	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O


Possibly	Possibly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
scr1	scr1	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
mutation	mutation	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
signal	signal	NN	B-NP	O
recognition	recognition	NN	I-NP	O
or	or	CC	O	O
translational	translational	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
but	but	CC	O	O
instead	instead	RB	B-VP	O
results	result	VBZ	I-VP	O
in	in	IN	B-PP	O
maintenance	maintenance	NN	B-NP	O
of	of	IN	B-PP	O
translational	translational	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
of	of	IN	B-PP	O
AEP	AEP	NN	B-NP	B-protein
synthesis	synthesis	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
5	5	CD	B-NP	O
'	'	SYM	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	B-DNA
integration	integration	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
exhibited	exhibit	VBD	B-VP	O
85	85	CD	B-NP	O
to	to	TO	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
identity	identity	NN	I-NP	O
to	to	TO	B-PP	O
several	several	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
belonging	belong	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	B-protein
L1	L1	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
of	of	IN	B-PP	O
long	long	JJ	B-NP	B-DNA
interspersed	interspersed	JJ	I-NP	I-DNA
repetitive	repetitive	JJ	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
.	.	.	O	O


Both	Both	CC	O	O
Rep78	Rep78	NN	B-NP	B-protein
and	and	CC	I-NP	O
Rep68	Rep68	NN	I-NP	B-protein
cut	cut	VBD	B-VP	O
the	the	DT	B-NP	O
terminal	terminal	JJ	I-NP	B-DNA
AAV	AAV	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
site	site	NN	I-NP	O
(	(	(	O	O
nucleotide	nucleotide	NN	B-NP	B-DNA
124	124	CD	I-NP	I-DNA
)	)	)	O	O
.	.	.	O	O


Nucleotide	Nucleotide	NN	B-NP	O
sequence	sequence	NN	I-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
TAR	TAR	NN	B-NP	B-protein
-	-	HYPH	B-PP	I-protein
binding	bind	VBG	B-NP	I-protein
protein	protein	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CREB2	CREB2	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
N	N	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	O	O
terminal	terminal	JJ	B-NP	O
mutations	mutation	NNS	I-NP	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
to	to	TO	I-VP	O
inhibit	inhibit	VB	I-VP	O
transrepression	transrepression	NN	B-NP	O
by	by	IN	B-PP	O
FBR	FBR	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
and	and	CC	O	O
that	that	IN	B-SBAR	O
multiple	multiple	JJ	B-NP	O
structural	structural	JJ	I-NP	O
mutations	mutation	NNS	I-NP	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
posttranslational	posttranslational	JJ	B-NP	O
protein	protein	NN	I-NP	O
modification	modification	NN	I-NP	O
alter	alter	VBP	B-VP	O
gene	gene	NN	B-NP	O
regulation	regulation	NN	I-NP	O
by	by	IN	B-PP	O
FBR	FBR	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
JS78	JS78	NNP	I-NP	O
mutation	mutation	NN	I-NP	O
changes	change	VBZ	B-VP	O
Gln243	Gln243	NN	B-NP	B-protein
in	in	IN	B-PP	O
gp0.7	gp0.7	NN	B-NP	B-protein
to	to	TO	B-PP	O
an	an	DT	B-NP	O
amber	amber	NN	I-NP	O
codon	codon	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
explains	explain	VBZ	B-VP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
truncated	truncate	VBN	I-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
gp0.7	gp0.7	NN	I-NP	O
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
polypeptide	polypeptide	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
implicates	implicate	VBZ	B-VP	O
the	the	DT	B-NP	O
11	11	CD	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
kDa	kDa	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
terminal	terminal	JJ	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
in	in	IN	B-PP	O
host	host	NN	B-NP	O
transcription	transcription	NN	I-NP	O
shut	shut	NN	I-NP	O
-	-	HYPH	B-VP	O
off	off	RP	B-PRT	O
.	.	.	O	O


A	A	DT	B-NP	O
patient	patient	NN	I-NP	O
suffering	suffer	VBG	B-VP	O
from	from	IN	B-PP	O
heparin	heparin	NN	B-NP	O
-	-	HYPH	B-NP	O
associated	associate	VBN	I-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
(	(	(	O	O
HAT	HAT	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
arteriothromboses	arteriothrombos	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
standard	standard	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
predicted	predict	VBN	I-NP	O
receptor	receptor	NN	I-NP	O
structure	structure	NN	I-NP	O
includes	include	VBZ	B-VP	O
a	a	DT	B-NP	O
cysteine	cysteine	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
rich	rich	JJ	I-NP	I-protein
extracellular	extracellular	JJ	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
,	,	,	O	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
hydrophobic	hydrophobic	JJ	I-NP	B-protein
transmembrane	transmembrane	JJ	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
predicted	predict	VBN	I-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
serine	serine	NN	I-NP	O
/	/	SYM	B-NP	O
threonine	threonine	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
.	.	.	O	O


Drosophila	Drosophila	FW	B-NP	O
UbcD1	UbcD1	NN	I-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
ubiquitin	ubiquitin	NN	I-NP	B-protein
-	-	HYPH	O	O
conjugating	conjugate	VBG	B-VP	O
enzyme	enzyme	NN	B-NP	B-protein
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
selective	selective	JJ	B-NP	O
protein	protein	NN	I-NP	O
degradation	degradation	NN	I-NP	O
.	.	.	O	O


Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
16.7	16.7	CD	I-NP	O
-	-	HYPH	I-NP	B-DNA
kb	kb	NN	I-NP	I-DNA
mt	mt	NN	I-NP	I-DNA
genome	genome	NN	I-NP	I-DNA
determined	determine	VBD	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
MDP1	MDP1	NN	I-NP	B-protein
mediates	mediate	VBZ	B-VP	O
cleavage	cleavage	NN	B-NP	O
of	of	IN	B-PP	O
chick	chick	NN	B-NP	B-DNA
mtDNA	mtDNA	NN	I-NP	I-DNA
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
at	at	IN	B-PP	O
three	three	CD	B-NP	O
H	H	NN	I-NP	O
-	-	HYPH	B-ADJP	O
and	and	CC	O	O
two	two	CD	B-NP	O
L	L	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
strand	strand	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
specific	specific	JJ	I-NP	I-DNA
target	target	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
located	located	JJ	B-ADJP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
-	-	HYPH	I-NP	O
bp	bp	NN	I-NP	O
A	A	NN	I-NP	O
+	+	SYM	I-NP	O
T	T	NN	I-NP	O
-	-	HYPH	I-NP	O
rich	rich	JJ	I-NP	O
genomic	genomic	JJ	I-NP	O
tract	tract	NN	I-NP	O
,	,	,	O	O
theoretically	theoretically	RB	B-ADJP	O
capable	capable	JJ	I-ADJP	O
of	of	IN	B-PP	O
forming	form	VBG	B-VP	O
stable	stable	JJ	B-NP	O
secondary	secondary	JJ	I-NP	O
structures	structure	NNS	I-NP	O
,	,	,	O	O
approximately	approximately	RB	B-NP	O
200	200	CD	I-NP	B-DNA
bases	base	NNS	I-NP	I-DNA
upstream	upstream	RB	B-ADVP	I-DNA
from	from	IN	B-PP	O
the	the	DT	B-NP	O
H	H	NN	I-NP	O
-	-	HYPH	O	O
strand	strand	NN	B-NP	O
origin	origin	NN	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
replication	replication	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
feasibility	feasibility	NN	I-NP	O
of	of	IN	B-PP	O
retrovirus	retrovirus	NN	B-NP	O
mediated	mediate	VBN	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
rp47phox	rp47phox	NN	B-NP	B-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
HL60	HL60	NN	I-NP	B-cell_line
and	and	CC	I-NP	O
U937	U937	NN	I-NP	B-cell_line
human	human	JJ	I-NP	I-cell_line
hematopoietic	hematopoietic	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
Epstein	Epstein	NNP	I-NP	B-cell_line
-	-	HYPH	I-NP	I-cell_line
Barr	Barr	NNP	I-NP	I-cell_line
virus	virus	NN	I-NP	I-cell_line
transformed	transform	VBD	B-VP	I-cell_line
B	B	NN	B-NP	I-cell_line
-	-	HYPH	B-NP	I-cell_line
lymphocyte	lymphocyte	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
(	(	(	O	O
EBV	EBV	NN	B-NP	B-cell_line
-	-	HYPH	B-NP	I-cell_line
BCL	BCL	NN	I-NP	I-cell_line
)	)	)	O	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
p47phox	p47phox	NN	I-NP	O
-	-	HYPH	I-NP	O
deficient	deficient	JJ	I-NP	O
CGD	CGD	NN	I-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O


Comparison	Comparison	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
databanks	databank	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
Tactile	Tactile	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
superfamily	superfamily	NN	I-NP	I-protein
,	,	,	O	O
with	with	IN	B-PP	O
similarity	similarity	NN	B-NP	O
to	to	TO	B-PP	O
Drosophila	Drosophila	FW	B-NP	O
amalgam	amalgam	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
melanoma	melanoma	NN	I-NP	O
Ag	Ag	NN	I-NP	O
MUC	MUC	NN	I-NP	O
-	-	HYPH	O	O
18	18	CD	B-NP	O
,	,	,	O	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
carcinoembryonic	carcinoembryonic	JJ	I-NP	B-protein
Ag	Ag	NN	I-NP	I-protein
family	family	NN	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
poliovirus	poliovirus	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
neural	neural	JJ	I-NP	B-protein
cell	cell	NN	I-NP	I-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule	molecule	NN	I-NP	I-protein
.	.	.	O	O


A	A	DT	B-NP	O
rather	rather	RB	I-NP	O
similar	similar	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
results	result	NNS	B-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
LMP2B	LMP2B	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
,	,	,	O	O
such	such	JJ	B-NP	O
transcripts	transcript	NNS	I-NP	O
being	be	VBG	B-VP	O
detectable	detectable	JJ	B-ADJP	O
only	only	RB	B-PP	O
in	in	IN	I-PP	O
a	a	DT	B-NP	O
subset	subset	NN	I-NP	O
of	of	IN	B-PP	O
tumors	tumor	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
at	at	IN	B-PP	O
apparently	apparently	RB	B-NP	O
low	low	JJ	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
phenotypes	phenotype	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ICP0	ICP0	NN	I-NP	B-protein
nonsense	nonsense	JJ	I-NP	O
mutants	mutant	NNS	I-NP	O
were	be	VBD	B-VP	O
intermediate	intermediate	JJ	B-ADJP	O
between	between	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
virus	virus	NN	I-NP	O
and	and	CC	O	O
7134	7134	CD	B-NP	O
in	in	IN	B-PP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
more	more	JJR	I-NP	O
ICP0	ICP0	NN	I-NP	B-protein
-	-	HYPH	O	O
coding	cod	VBG	B-VP	B-DNA
sequence	sequence	NN	B-NP	I-DNA
expressed	express	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
given	give	VBN	I-NP	O
nonsense	nonsense	NN	I-NP	O
mutant	mutant	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
more	more	RBR	I-NP	O
wild	wild	JJ	I-NP	O
type	type	NN	I-NP	O
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
was	be	VBD	B-VP	O
its	its	PRP$	B-NP	O
phenotype	phenotype	NN	I-NP	O
.	.	.	O	O


Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
nucleotide	nucleotide	NN	B-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rightmost	rightmost	JJ	I-NP	B-protein
43	43	CD	I-NP	I-protein
kbp	kbp	NN	I-NP	I-protein
of	of	IN	B-PP	O
herpesvirus	herpesvirus	NN	B-NP	B-DNA
saimiri	saimiri	NN	I-NP	I-DNA
(	(	(	O	I-DNA
HVS	HVS	NN	B-NP	I-DNA
)	)	)	O	I-DNA
L	L	NN	B-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
:	:	:	O	O
general	general	JJ	B-NP	O
conservation	conservation	NN	I-NP	O
of	of	IN	B-PP	O
genetic	genetic	JJ	B-NP	O
organization	organization	NN	I-NP	O
between	between	IN	B-PP	O
HVS	HVS	NNP	B-NP	O
and	and	CC	I-NP	O
Epstein	Epstein	NNP	I-NP	O
-	-	HYPH	B-NP	O
Barr	Barr	NNP	I-NP	O
virus	virus	NN	I-NP	O
.	.	.	O	O


Treatment	Treatment	NN	B-NP	O
with	with	IN	B-PP	O
MK	MK	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
801	801	CD	I-NP	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
burst	burst	JJ	I-NP	O
suppression	suppression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
EEG	EEG	NN	I-NP	B-DNA
and	and	CC	O	O
a	a	DT	B-NP	O
transient	transient	JJ	I-NP	O
drop	drop	NN	I-NP	O
(	(	(	O	O
11.4	11.4	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
6.5	6.5	CD	B-NP	O
mm	mm	NN	I-NP	O
Hg	Hg	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
arterial	arterial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
gel	gel	NN	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
have	have	VBP	B-VP	O
failed	fail	VBN	I-VP	O
to	to	TO	I-VP	O
reveal	reveal	VB	I-VP	O
that	that	DT	B-NP	O
HAP2	HAP2	NN	I-NP	B-protein
or	or	CC	I-NP	O
HAP3	HAP3	NN	I-NP	B-protein
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
domain	domain	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
or	or	CC	O	O
that	that	IN	B-SBAR	O
hap3	hap3	NN	B-NP	O
mutations	mutation	NNS	I-NP	O
affect	affect	VBP	B-VP	O
the	the	DT	B-NP	O
complexes	complex	NNS	I-NP	O
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
it	it	PRP	B-NP	O
.	.	.	O	O


Myogenic	Myogenic	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
adenovirus	adenovirus	NN	I-NP	B-protein
E1a	E1a	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	B-cell_line
L6	L6	NN	I-NP	I-cell_line
muscle	muscle	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O


The	The	DT	B-NP	O
experiment	experiment	NN	I-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
:	:	:	O	O
(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
1O2	1O2	NN	B-NP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
free	free	JJ	B-ADVP	O
radicals	radical	NNS	B-NP	O
(	(	(	O	O
O2	O2	NN	B-NP	O
-	-	HYPH	B-ADJP	O
.	.	.	O	O
.	.	.	O	O
OH	OH	NN	B-NP	O
and	and	CC	I-NP	O
YHPD	YHPD	NN	I-NP	B-protein
-	-	HYPH	O	O
.	.	.	O	O
)	)	)	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
formed	form	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
aid	aid	NN	I-NP	O
of	of	IN	B-PP	O
YHPD	YHPD	NN	B-NP	B-protein
;	;	:	O	O
and	and	CC	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
as	as	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
producing	produce	VBG	B-VP	O
1O2	1O2	NN	B-NP	O
,	,	,	O	O
YHPD	YHPD	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
BHPD	BHPD	NN	B-NP	B-protein
,	,	,	O	O
while	while	IN	B-SBAR	O
for	for	IN	B-PP	O
generating	generate	VBG	B-VP	O
O2	O2	NN	B-NP	B-protein
-	-	HYPH	B-ADJP	O
.	.	.	O	O
and	and	CC	O	O
.	.	.	O	O
OH	OH	NN	B-NP	O
,	,	,	O	O
YHPD	YHPD	NN	B-NP	B-protein
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
BHPD	BHPD	NN	B-NP	B-protein
.	.	.	O	O


Two	Two	CD	B-NP	O
points	point	NNS	I-NP	O
are	be	VBP	B-VP	O
indicated	indicate	VBN	I-VP	O
:	:	:	O	O
first	first	JJ	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
photosensitized	photosensitize	VBN	I-NP	O
damage	damage	NN	I-NP	O
of	of	IN	B-PP	O
YHPD	YHPD	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
interrelated	interrelate	VBN	I-VP	O
to	to	TO	B-PP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
1O2	1O2	NN	B-NP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
free	free	JJ	B-ADVP	O
radicals	radical	NNS	B-NP	O
(	(	(	O	O
O2	O2	NN	B-NP	O
-	-	HYPH	B-ADJP	O
.	.	.	O	O
.	.	.	O	O
OH	OH	NN	B-NP	O
and	and	CC	I-NP	O
YHPD	YHPD	NN	I-NP	B-protein
-	-	HYPH	O	O
.	.	.	O	O
)	)	)	O	O
;	;	:	O	O
second	second	JJ	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
photosensitized	photosensitize	VBN	I-NP	O
damage	damage	NN	I-NP	O
of	of	IN	B-PP	O
YHPD	YHPD	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
stronger	strong	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
BHPD	BHPD	NN	B-NP	B-protein
,	,	,	O	O
yet	yet	CC	O	O
the	the	DT	B-NP	O
photosensitized	photosensitize	VBN	I-NP	O
damage	damage	NN	I-NP	O
is	be	VBZ	B-VP	O
negatively	negatively	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
yield	yield	NN	I-NP	O
of	of	IN	B-PP	O
1O2	1O2	NN	B-NP	B-protein
but	but	CC	O	O
positively	positively	RB	B-VP	O
correlated	correlate	VBD	I-VP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
O2	O2	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
.	.	.	O	O
and	and	CC	O	O
OH	OH	NN	B-NP	O
.	.	.	O	O


Acad	Acad	NN	B-NP	O
.	.	.	O	O


Both	Both	DT	B-NP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
-	-	HYPH	B-NP	O
synthesized	synthesize	VBN	I-NP	O
S2	S2	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
and	and	CC	O	O
synthetic	synthetic	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
S2	S2	NN	B-NP	B-protein
are	be	VBP	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
react	react	VB	I-VP	O
positively	positively	RB	B-ADVP	O
with	with	IN	B-PP	O
sera	serum	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
EIAV	EIAV	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
infected	infect	VBN	I-NP	O
horses	horse	NNS	I-NP	O
,	,	,	O	O
providing	provide	VBG	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
direct	direct	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
protein	protein	NN	I-NP	O
in	in	IN	B-PP	O
infected	infected	JJ	B-NP	O
animals	animal	NNS	I-NP	O
.	.	.	O	O


Many	Many	JJ	B-NP	O
canonical	canonical	JJ	I-NP	O
TATA	TATA	NN	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
upstream	upstream	RB	B-ADVP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
VZV	VZV	NN	I-NP	B-DNA
transcriptional	transcriptional	JJ	I-NP	I-DNA
start	start	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
but	but	CC	O	O
,	,	,	O	O
apparently	apparently	RB	B-ADVP	O
,	,	,	O	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
used	use	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
ORF	ORF	NN	I-NP	B-DNA
4	4	CD	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
minimally	minimally	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
ORF	ORF	NN	I-NP	B-DNA
62	62	CD	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
gave	give	VBD	B-VP	O
twofold	twofold	JJ	B-NP	O
induction	induction	NN	I-NP	O
;	;	:	O	O
both	both	DT	B-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
acting	act	VBG	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
gave	give	VBD	B-VP	O
fivefold	fivefold	JJ	B-NP	O
induction	induction	NN	I-NP	O
.	.	.	O	O


Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
IR5	IR5	NN	I-NP	B-protein
ORF	ORF	NN	I-NP	I-protein
of	of	IN	B-PP	O
EHV	EHV	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
possesses	possess	NNS	I-NP	O
a	a	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
13	13	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
(	(	(	O	O
CAYWCCLGHAFAC	CAYWCCLGHAFAC	NN	B-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
perfect	perfect	JJ	I-NP	O
match	match	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	B-DNA
zinc	zinc	NN	I-NP	I-DNA
finger	finger	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
(	(	(	O	O
C	C	NN	B-NP	O
-	-	HYPH	B-NP	O
X2	X2	NN	I-NP	B-DNA
-	-	HYPH	B-NP	O
4	4	CD	I-NP	O
-	-	HYPH	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
X2	X2	NN	I-NP	B-DNA
-	-	HYPH	B-NP	O
15	15	CD	I-NP	O
-	-	HYPH	I-NP	O
C	C	NN	I-NP	O
/	/	SYM	B-NP	O
H	H	NN	I-NP	O
-	-	HYPH	B-NP	O
X2	X2	NN	I-NP	B-DNA
-	-	HYPH	B-NP	O
4	4	CD	I-NP	O
-	-	HYPH	I-NP	O
C	C	NN	I-NP	O
/	/	SYM	B-NP	O
H	H	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
DNA	DNA	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sulfate	sulfate	NN	I-NP	B-DNA
activation	activation	NN	I-NP	I-DNA
locus	locus	NN	I-NP	I-DNA
from	from	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	B-protein
coli	coli	FW	I-NP	I-protein
K	K	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
12	12	CD	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
unphosphorylated	unphosphorylated	JJ	I-NP	B-protein
form	form	NN	I-NP	I-protein
of	of	IN	B-PP	O
RNA	RNA	NN	B-NP	B-protein
polymerase	polymerase	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
is	be	VBZ	B-VP	O
designated	designate	VBN	I-VP	O
IIA	IIA	NNP	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
phosphorylated	phosphorylated	JJ	I-NP	B-protein
form	form	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
designated	designate	VBN	I-VP	O
IIO	IIO	NN	B-NP	B-protein
.	.	.	O	O


RNA	RNA	NN	B-NP	B-protein
polymerase	polymerase	NN	I-NP	I-protein
IIA	IIA	NN	I-NP	I-protein
was	be	VBD	B-VP	O
recovered	recover	VBN	I-VP	O
in	in	IN	B-PP	O
transcriptionally	transcriptionally	RB	B-NP	B-protein
active	active	JJ	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
in	in	IN	B-PP	O
reactions	reaction	NNS	B-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
input	input	NN	I-NP	B-protein
enzyme	enzyme	NN	I-NP	I-protein
was	be	VBD	B-VP	O
RNA	RNA	NN	B-NP	B-protein
polymerase	polymerase	NN	I-NP	I-protein
IIA	IIA	NN	I-NP	I-protein
.	.	.	O	O


Fructokinase	Fructokinase	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
is	be	VBZ	B-VP	O
elevated	elevate	VBN	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-PP	O
twofold	twofold	RB	B-NP	O
when	when	WRB	B-ADVP	O
Z	Z	NN	B-NP	B-protein
.	.	.	O	O
mobilis	mobilis	''	O	O
was	be	VBD	B-VP	O
grown	grow	VBN	I-VP	O
on	on	IN	B-PP	O
fructose	fructose	NN	B-NP	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
glucose	glucose	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
parallel	parallel	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
frk	frk	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
levels	level	NNS	I-NP	O
.	.	.	O	O


Plasma	Plasma	NN	B-NP	O
membranes	membrane	NNS	I-NP	O
of	of	IN	B-PP	O
cultured	culture	VBN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
contain	contain	VBP	B-VP	O
high	high	JJ	B-NP	B-protein
affinity	affinity	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
for	for	IN	B-PP	O
high	high	JJ	B-NP	O
density	density	NN	I-NP	O
lipoprotein	lipoprotein	NN	I-NP	O
(	(	(	O	O
HDL	HDL	NN	B-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
mediate	mediate	VB	I-VP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
excess	excess	JJ	B-NP	O
intracellular	intracellular	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O


After	After	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
28	28	CD	I-NP	O
patients	patient	NNS	I-NP	O
vincristine	vincristine	NN	I-NP	O
was	be	VBD	B-VP	O
replaced	replace	VBN	I-VP	O
by	by	IN	B-PP	O
teniposide	teniposide	NN	B-NP	O
(	(	(	O	O
VM	VM	NN	B-NP	O
-	-	HYPH	B-NP	O
26	26	CD	I-NP	O
)	)	)	O	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
neurotoxicity	neurotoxicity	NN	B-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
an	an	DT	B-NP	O
internal	internal	JJ	I-NP	O
short	short	JJ	I-NP	O
element	element	NN	I-NP	O
located	located	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
very	very	RB	I-NP	O
5	5	CD	I-NP	O
'	'	SYM	I-NP	O
terminal	terminal	NN	I-NP	O
of	of	IN	B-PP	O
L1	L1	NN	B-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
element	element	NN	I-NP	O
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
crucial	crucial	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
L1	L1	NN	I-NP	I-protein
.	.	.	O	O


Tumor	Tumor	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
focally	focally	RB	B-ADJP	O
immunoreactive	immunoreactive	JJ	I-ADJP	O
for	for	IN	B-PP	O
neuron	neuron	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
specific	specific	JJ	I-NP	I-protein
enolase	enolase	NN	I-NP	I-protein
,	,	,	I-NP	O
insulin	insulin	NN	I-NP	B-protein
,	,	,	I-NP	O
glucagon	glucagon	NN	I-NP	O
and	and	CC	I-NP	O
VIP	VIP	NN	I-NP	B-protein
.	.	.	O	O


A	A	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
end	end	NN	I-NP	I-DNA
from	from	IN	B-PP	O
src	src	NN	B-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
3	3	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
end	end	NN	I-NP	I-DNA
from	from	IN	B-PP	O
ros	ro	NNS	B-NP	O
,	,	,	O	O
called	call	VBD	B-VP	O
SRC	SRC	NNP	B-NP	B-protein
x	x	NNP	I-NP	I-protein
ROS	ROS	NNP	I-NP	O
,	,	,	O	O
transformed	transform	VBN	B-NP	B-cell_type
chicken	chicken	NN	I-NP	I-cell_type
embryo	embryo	NN	I-NP	I-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
(	(	(	O	O
CEF	CEF	NN	B-NP	B-protein
)	)	)	O	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
spindle	spindle	NN	I-NP	O
shape	shape	NN	I-NP	O
morphology	morphology	NN	I-NP	O
,	,	,	O	O
mimicking	mimic	VBG	B-VP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
UR2	UR2	NN	B-NP	B-protein
.	.	.	O	O


ROS	ROS	NN	B-NP	O
x	x	SYM	O	O
SRC	SRC	NN	B-NP	B-protein
(	(	(	O	O
R	R	NN	B-NP	O
)	)	)	O	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
16	16	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
deletion	deletion	NN	I-NP	O
that	that	WDT	B-NP	O
includes	include	VBZ	B-VP	O
the	the	DT	B-NP	O
3	3	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
half	half	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transmembrane	transmembrane	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
ros	ro	NNS	B-NP	O
.	.	.	O	O


To	To	TO	B-VP	O
define	define	VB	I-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
and	and	CC	I-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
E6	E6	NN	I-NP	B-DNA
and	and	CC	I-NP	O
E7	E7	NN	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
expressed	express	VBN	B-VP	O
in	in	IN	B-PP	O
BPV	BPV	NN	B-NP	B-cell_line
-	-	HYPH	B-NP	I-cell_line
1	1	CD	I-NP	I-cell_line
-	-	HYPH	I-NP	I-cell_line
transformed	transform	VBN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
we	we	PRP	B-NP	O
performed	perform	VBD	B-VP	O
immunoprecipitation	immunoprecipitation	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
with	with	IN	B-PP	O
antisera	antiserum	NNS	B-NP	O
raised	raise	VBN	B-VP	O
to	to	TO	B-PP	O
bacterially	bacterially	RB	B-NP	O
expressed	express	VBN	I-NP	O
BPV	BPV	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
E6	E6	NN	I-NP	O
and	and	CC	I-NP	O
E7	E7	NN	I-NP	B-protein
fusion	fusion	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O


Transient	Transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
assays	assay	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
site	site	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
sufficient	sufficient	JJ	I-ADJP	O
for	for	IN	B-PP	O
RXR	RXR	NN	B-NP	B-protein
alpha	alpha	SYM	B-NP	I-protein
-	-	HYPH	B-VP	O
mediated	mediate	VBN	B-NP	O
transactivation	transactivation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
apoAI	apoAI	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
basal	basal	JJ	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
hepatoma	hepatoma	NN	I-NP	I-cell_line
HepG2	HepG2	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
RA	RA	NN	B-NP	B-protein
and	and	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
transactivation	transactivation	NN	I-NP	O
is	be	VBZ	B-VP	O
abolished	abolish	VBN	I-VP	O
by	by	IN	B-PP	O
increasing	increase	VBG	B-VP	O
amounts	amount	NNS	B-NP	O
of	of	IN	B-PP	O
cotransfected	cotransfecte	VBN	B-NP	O
ARP	ARP	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
enhancer	enhancer	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
Akv	Akv	NN	B-NP	O
murine	murine	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
virus	virus	NN	I-NP	O
contains	contain	VBZ	B-VP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
motif	motif	NN	I-NP	O
ACAGATGG	ACAGATGG	NN	I-NP	O
.	.	.	O	O


Two	Two	CD	B-NP	O
splice	splice	NN	I-NP	O
variants	variant	NNS	I-NP	O
of	of	IN	B-PP	O
ALF1	ALF1	NN	B-NP	B-protein
cDNA	cDNA	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
,	,	,	O	O
differing	differ	VBG	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
72	72	CD	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
bp	bp	NN	I-NP	I-DNA
insertion	insertion	NN	I-NP	I-DNA
,	,	,	O	O
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
putative	putative	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
of	of	IN	B-PP	O
682	682	CD	B-NP	O
and	and	CC	I-NP	O
706	706	CD	I-NP	O
amino	amino	JJ	I-NP	O
acids	acid	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
third	third	JJ	I-NP	O
prominent	prominent	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
apparent	apparent	JJ	B-NP	O
molecular	molecular	JJ	I-NP	O
mass	mass	NN	I-NP	O
16	16	CD	I-NP	O
kDa	kDa	NN	I-NP	O
displayed	display	VBD	B-VP	O
several	several	JJ	B-NP	O
properties	property	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
ability	ability	NN	B-NP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
45Ca2	45Ca2	NN	B-NP	B-protein
+	+	SYM	B-NP	O
,	,	,	O	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
characteristic	characteristic	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	B-protein
(	(	(	O	I-protein
B	B	NN	B-NP	I-protein
)	)	)	O	I-protein
subunit	subunit	NN	B-NP	I-protein
of	of	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	O
calcineurin	calcineurin	NN	I-NP	B-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
recognized	recognize	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
antiserum	antiserum	NN	I-NP	O
raised	raise	VBN	B-VP	O
against	against	IN	B-PP	O
bovine	bovine	JJ	B-NP	O
calcineurin	calcineurin	NN	I-NP	B-protein
.	.	.	O	O


As	As	IN	B-SBAR	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
for	for	IN	B-PP	O
MATa	MATa	NN	B-NP	B-protein
cna1	cna1	NN	I-NP	I-protein
cna2	cna2	NN	I-NP	I-protein
double	double	JJ	I-NP	I-protein
mutants	mutant	NNS	I-NP	I-protein
,	,	,	O	O
MATa	MATa	NNP	B-NP	O
cnb1	cnb1	NN	I-NP	O
mutants	mutant	NNS	I-NP	O
were	be	VBD	B-VP	O
defective	defective	JJ	B-ADJP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
recover	recover	VB	I-VP	O
from	from	IN	B-PP	O
alpha	alpha	SYM	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
factor	factor	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
growth	growth	NN	I-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O


Antibodies	Antibody	NNS	B-NP	B-protein
against	against	IN	B-PP	O
this	this	DT	B-NP	O
purified	purify	VBN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
localize	localize	VBP	B-VP	O
RIM1	RIM1	NN	B-NP	B-protein
to	to	TO	B-PP	O
mitochondria	mitochondrion	NNS	B-NP	O
.	.	.	O	O


METHODS	METHODS	NNS	B-NP	O
:	:	:	O	O
IgG	IgG	NN	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
vs	vs	IN	B-PP	O
HHV	HHV	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
6	6	CD	I-NP	O
(	(	(	O	O
anti	anti	AFX	B-NP	O
-	-	HYPH	B-NP	B-protein
HHV	HHV	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
6	6	CD	I-NP	O
-	-	HYPH	I-NP	O
IgG	IgG	NN	I-NP	B-protein
)	)	)	O	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
indirect	indirect	JJ	B-NP	O
immunofluorescence	immunofluorescence	NN	I-NP	O
in	in	IN	B-PP	O
100	100	CD	B-NP	O
IVDA	IVDA	NN	I-NP	O
(	(	(	O	O
29	29	CD	B-NP	O
seronegative	seronegative	JJ	I-NP	O
and	and	CC	O	O
71	71	CD	B-NP	O
seropositive	seropositive	JJ	I-NP	O
for	for	IN	B-PP	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
45	45	CD	B-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
stage	stage	NN	B-NP	O
II	II	CD	I-NP	O
and	and	CC	I-NP	O
26	26	CD	I-NP	O
in	in	IN	B-PP	O
IV	IV	CD	B-NP	O
-	-	HYPH	I-NP	O
C1	C1	NN	I-NP	B-protein
of	of	IN	B-PP	O
CDC	CDC	NN	B-NP	B-cell_type
)	)	)	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
100	100	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
age	age	NN	I-NP	O
(	(	(	O	O
control	control	NN	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


A	A	DT	B-NP	O
position	position	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
independent	independent	JJ	I-NP	I-protein
activation	activation	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
which	which	WDT	B-NP	O
contained	contain	VBD	B-VP	O
conserved	conserve	VBN	B-NP	O
regions	region	NNS	I-NP	B-DNA
II	II	CD	I-NP	I-DNA
and	and	CC	I-NP	O
III	III	CD	I-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
carboxyl	carboxyl	NN	I-NP	B-protein
terminus	terminus	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HNF	HNF	NN	I-NP	B-protein
-	-	HYPH	O	I-protein
3	3	CD	B-NP	I-protein
beta	beta	SYM	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
amino	amino	NN	B-NP	B-protein
acids	acid	NNS	I-NP	I-protein
361	361	CD	B-NP	I-protein
to	to	TO	B-PP	I-protein
458	458	CD	B-NP	I-protein
)	)	)	O	O
.	.	.	O	O


HNF	HNF	NN	B-NP	B-DNA
-	-	HYPH	O	I-DNA
3	3	CD	B-NP	I-DNA
beta	beta	SYM	I-NP	I-DNA
amino	amino	JJ	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
terminal	terminal	JJ	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
defined	define	VBN	B-VP	O
by	by	IN	B-PP	O
conserved	conserve	VBN	B-NP	O
region	region	NN	I-NP	O
IV	IV	CD	I-NP	O
also	also	RB	B-ADVP	O
contributed	contribute	VBD	B-VP	O
to	to	TO	B-PP	O
transactivation	transactivation	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
region	region	NN	B-NP	O
IV	IV	CD	I-NP	O
activity	activity	NN	I-NP	O
required	require	VBD	B-VP	O
the	the	DT	B-NP	O
participation	participation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	B-DNA
II	II	CD	I-NP	I-DNA
-	-	HYPH	I-NP	O
III	III	CD	I-NP	O
domain	domain	NN	I-NP	O
.	.	.	O	O


Possible	Possible	JJ	B-NP	O
roles	role	NNS	I-NP	O
of	of	IN	B-PP	O
RAD5	RAD5	NN	B-NP	B-protein
putative	putative	JJ	I-NP	I-protein
ATPase	ATPase	NN	I-NP	I-protein
/	/	SYM	B-NP	O
DNA	DNA	NN	I-NP	O
helicase	helicase	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
DNA	DNA	NN	B-NP	O
repair	repair	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
maintenance	maintenance	NN	I-NP	O
of	of	IN	B-PP	O
wild	wild	JJ	B-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
instability	instability	NN	B-NP	O
of	of	IN	B-PP	O
simple	simple	JJ	B-NP	B-DNA
repetitive	repetitive	JJ	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
.	.	.	O	O


Susceptibilities	Susceptibility	NNS	B-NP	O
of	of	IN	B-PP	O
540	540	CD	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
gram	gram	NN	I-NP	O
-	-	HYPH	B-NP	O
negative	negative	JJ	I-NP	O
bacilli	bacilli	NNS	I-NP	O
to	to	TO	B-PP	O
amoxicillin	amoxicillin	NN	B-NP	O
,	,	,	O	O
amoxicillin	amoxicillin	NN	B-NP	B-protein
-	-	HYPH	O	O
BRL	BRL	NN	B-NP	O
42715	42715	CD	I-NP	O
,	,	,	O	O
amoxicillin	amoxicillin	NN	B-NP	B-protein
-	-	HYPH	O	O
clavulanate	clavulanate	NN	B-NP	O
,	,	,	O	O
temafloxacin	temafloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
clindamycin	clindamycin	NN	B-NP	O
.	.	.	O	O


Nocodazole	Nocodazole	NN	B-NP	O
arrest	arrest	NN	I-NP	O
of	of	IN	B-PP	O
DU249	DU249	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
was	be	VBD	B-VP	O
exploited	exploit	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
M	M	NN	I-NP	O
-	-	HYPH	B-NP	O
phase	phase	NN	I-NP	O
-	-	HYPH	O	O
activated	activate	VBN	B-NP	O
MBP	MBP	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
from	from	IN	B-PP	O
p41	p41	NN	B-NP	B-protein
MAP	MAP	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
by	by	IN	B-PP	O
phenyl	phenyl	NN	B-NP	O
-	-	HYPH	I-NP	O
Superose	Superose	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
hit1	hit1	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
mutation	mutation	NN	I-NP	O
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
synthesis	synthesis	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
74	74	CD	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
kD	kD	NN	I-NP	I-protein
heat	heat	NN	I-NP	I-protein
shock	shock	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
319	319	CD	I-NP	B-DNA
base	base	NN	I-NP	I-DNA
pair	pair	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
immediately	immediately	RB	B-ADVP	O
upstream	upstream	RB	I-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CAP	CAP	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
proximal	proximal	JJ	I-NP	B-DNA
TATA	TATA	NN	I-NP	I-DNA
box	box	NN	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
sequences	sequence	NNS	B-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
GC	GC	NN	B-NP	B-DNA
boxes	box	NNS	I-NP	I-DNA
,	,	,	O	O
CACCC	CACCC	NN	B-NP	O
boxes	box	NNS	I-NP	O
,	,	,	O	O
CCAAT	CCAAT	NN	B-NP	B-DNA
boxes	box	NNS	I-NP	I-DNA
,	,	,	O	O
activator	activator	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
(	(	(	O	O
Ap	Ap	NN	B-NP	O
-	-	HYPH	B-NP	O
2	2	CD	I-NP	O
)	)	)	O	O
sites	site	NNS	B-NP	O
,	,	,	O	O
partial	partial	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	O
response	response	NN	I-NP	O
elements	element	NNS	I-NP	O
(	(	(	O	O
GREs	GRE	NNS	B-NP	B-DNA
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
partial	partial	JJ	B-NP	O
cyclic	cyclic	JJ	I-NP	B-DNA
AMP	AMP	NN	I-NP	I-DNA
response	response	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
(	(	(	O	O
CREs	CRE	NNS	B-NP	B-DNA
)	)	)	O	O
.	.	.	O	O


Cloning	Cloning	NN	B-NP	O
and	and	CC	O	O
primary	primary	JJ	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
neurocan	neurocan	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
developmentally	developmentally	RB	I-NP	O
regulated	regulate	VBN	I-NP	O
,	,	,	O	O
aggregating	aggregate	VBG	B-VP	O
chondroitin	chondroitin	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
proteoglycan	proteoglycan	NN	I-NP	O
of	of	IN	B-PP	O
brain	brain	NN	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
rats	rat	NNS	B-NP	O
anaesthetized	anaesthetize	VBN	B-VP	O
with	with	IN	B-PP	O
+	+	SYM	O	O
-	-	HYPH	O	O
chloralose	chloralose	NN	B-NP	O
the	the	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
extracellular	extracellular	JJ	B-NP	O
pH	pH	NN	I-NP	O
and	and	CC	I-NP	O
K	K	NN	I-NP	O
+	+	SYM	B-NP	O
in	in	IN	B-PP	O
spinal	spinal	JJ	B-NP	O
cord	cord	NN	I-NP	O
dorsal	dorsal	JJ	I-NP	O
horn	horn	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
using	use	VBG	B-VP	O
pH	pH	NN	B-NP	O
and	and	CC	I-NP	O
K	K	NN	I-NP	O
+	+	SYM	B-NP	O
ion	ion	NN	I-NP	O
-	-	HYPH	B-NP	O
selective	selective	JJ	I-NP	O
electrodes	electrode	NNS	I-NP	O
.	.	.	O	O


Replication	Replication	NN	B-NP	O
of	of	IN	B-PP	O
bovine	bovine	JJ	B-NP	O
papillomavirus	papillomavirus	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
BPV	BPV	NN	O	O
-	-	HYPH	O	O
1	1	CD	O	O
)	)	)	O	O
DNA	DNA	NN	B-NP	O
requires	require	VBZ	B-VP	O
two	two	CD	B-NP	O
viral	viral	JJ	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
E1	E1	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
full	full	JJ	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
length	length	NN	I-NP	I-protein
E2	E2	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


Insertional	Insertional	JJ	B-NP	O
inactivation	inactivation	NN	I-NP	O
of	of	IN	B-PP	O
sms	sm	NNS	B-NP	B-protein
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
alkylating	alkylate	VBG	I-NP	O
agent	agent	NN	I-NP	O
methylmethane	methylmethane	NN	I-NP	O
sulfonate	sulfonate	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
requirement	requirement	NN	I-NP	O
for	for	IN	B-PP	O
serine	serine	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
metabolites	metabolite	NNS	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
MAP	MAP	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
activator	activator	NN	I-NP	I-protein
/	/	SYM	B-NP	O
MAP	MAP	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
system	system	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
downstream	downstream	JJ	I-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
ras	ras	NN	B-NP	O
signal	signal	NN	I-NP	O
transduction	transduction	NN	I-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O


NSCL	NSCL	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
larger	large	JJR	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cell	cell	NN	I-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
.	.	.	O	O


Labile	Labile	JJ	B-NP	O
LTR	LTR	NN	I-NP	B-DNA
-	-	HYPH	B-VP	O
binding	bind	VBG	B-NP	O
proteins	protein	NNS	I-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
c	c	NN	B-NP	O
-	-	HYPH	I-NP	O
myc	myc	NN	I-NP	O
hyperexpression	hyperexpression	NN	I-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
both	both	CC	O	O
LTR	LTR	NN	B-NP	B-DNA
-	-	HYPH	O	O
enhanced	enhance	VBN	B-VP	O
transcription	transcription	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
LTR	LTR	NN	B-NP	B-DNA
-	-	HYPH	O	O
binding	bind	VBG	B-NP	O
proteins	protein	NNS	I-NP	O
are	be	VBP	B-VP	O
specifically	specifically	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
after	after	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
.	.	.	O	O


Ruddell	Ruddell	NNP	B-NP	O
,	,	,	O	O
M	M	NNP	B-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
single	single	JJ	I-NP	O
MEF	MEF	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
2	2	CD	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
positive	positive	JJ	I-NP	B-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
muscle	muscle	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
specific	specific	JJ	I-NP	I-protein
subunit	subunit	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
phosphoglycerate	phosphoglycerate	JJ	I-NP	I-DNA
mutase	mutase	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
skeletal	skeletal	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
cardiac	cardiac	JJ	I-NP	I-cell_type
muscle	muscle	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O


Truncation	Truncation	NN	B-NP	O
variants	variant	NNS	I-NP	O
of	of	IN	B-PP	O
peptides	peptide	NNS	B-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
MHC	MHC	NN	B-NP	B-protein
class	class	NN	I-NP	I-protein
II	II	CD	B-NP	I-protein
molecules	molecule	NNS	I-NP	I-protein
suggest	suggest	VBP	B-VP	O
sequence	sequence	NN	B-NP	B-DNA
motifs	motif	NNS	I-NP	I-DNA
.	.	.	O	O


Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
E	E	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
box	box	NN	I-NP	I-DNA
consensus	consensus	NN	I-NP	O
is	be	VBZ	B-VP	O
minimally	minimally	RB	I-VP	O
defined	define	VBN	I-VP	O
as	as	IN	B-PP	O
CANNTG	CANNTG	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
adjacent	adjacent	JJ	I-NP	O
nucleotides	nucleotide	NNS	I-NP	O
of	of	IN	B-PP	O
functional	functional	JJ	B-NP	O
E	E	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
boxes	box	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
variable	variable	JJ	B-ADJP	O
for	for	IN	B-PP	O
genes	gene	NNS	B-NP	O
regulated	regulate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
bHLH	bHLH	JJ	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O


Intermediate	Intermediate	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
activity	activity	NN	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
for	for	IN	B-PP	O
TnI	TnI	NN	B-NP	B-DNA
enhancers	enhancer	NNS	I-NP	I-DNA
containing	contain	VBG	B-VP	O
E	E	NN	B-NP	B-DNA
-	-	HYPH	O	I-DNA
boxes	box	NNS	B-NP	I-DNA
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
MCK	MCK	NN	I-NP	B-protein
left	leave	VBD	B-VP	O
E	E	NN	B-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
box	box	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
or	or	CC	B-PP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Ig	Ig	NN	I-NP	B-DNA
kappa	kappa	NN	I-NP	I-DNA
E2	E2	NN	I-NP	I-DNA
E	E	NN	I-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
box	box	NN	I-NP	I-DNA
.	.	.	O	O


T	T	NN	B-NP	O
-	-	HYPH	I-NP	O
cell	cell	NN	I-NP	O
receptor	receptor	NN	I-NP	O
beta	beta	NN	I-NP	O
(	(	(	O	O
TCR	TCR	NN	B-NP	O
beta	beta	NN	I-NP	O
)	)	)	O	O
gene	gene	NN	B-NP	O
rearrangements	rearrangement	NNS	I-NP	O
occur	occur	VBP	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
third	third	JJ	I-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
B	B	NN	I-NP	O
-	-	HYPH	B-NP	O
cell	cell	NN	I-NP	O
acute	acute	JJ	I-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemias	leukemia	NNS	I-NP	O
(	(	(	O	O
ALLs	ALL	NNS	B-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
CANNTG	CANNTG	NN	I-NP	B-DNA
motifs	motif	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
MyoD	MyoD	NN	B-NP	B-protein
and	and	CC	I-NP	O
myogenin	myogenin	NN	I-NP	B-protein
fusion	fusion	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
and	and	CC	O	O
to	to	TO	B-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
proteins	protein	NNS	B-NP	O
in	in	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
cultured	culture	VBN	B-NP	O
myotubes	myotube	NNS	I-NP	O
.	.	.	O	O


Peripheral	Peripheral	JJ	B-NP	O
polyneuropathy	polyneuropathy	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
myeloma	myeloma	NN	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
cloned	clone	VBN	I-VP	O
and	and	CC	I-VP	O
sequenced	sequence	VBN	I-VP	O
COX12	COX12	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
for	for	IN	B-PP	O
subunit	subunit	NN	B-NP	O
VIb	VIb	NN	I-NP	O
of	of	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O
cytochrome	cytochrome	NN	I-NP	B-protein
c	c	NN	I-NP	I-protein
oxidase	oxidase	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
calcineurin	calcineurin	NN	I-NP	B-DNA
A	A	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
comparison	comparison	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genomic	genomic	JJ	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
.	.	.	O	O


The	The	DT	B-NP	O
basal	basal	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
murine	murine	JJ	B-NP	B-DNA
cytochrome	cytochrome	NN	I-NP	I-DNA
c	c	NN	I-NP	I-DNA
oxidase	oxidase	NN	I-NP	I-DNA
subunit	subunit	NN	I-NP	I-DNA
IV	IV	CD	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
consist	consist	VBP	B-VP	O
of	of	IN	B-PP	O
tandemly	tandemly	RB	B-NP	O
duplicated	duplicate	VBN	I-NP	O
ets	ets	NN	I-NP	B-DNA
motifs	motif	NNS	I-NP	I-DNA
that	that	WDT	B-NP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
GABP	GABP	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
related	relate	VBN	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O


Lastly	Lastly	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
multiple	multiple	JJ	B-NP	O
instances	instance	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
short	short	JJ	B-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
direct	direct	JJ	I-NP	O
repeats	repeat	NNS	I-NP	O
flank	flank	VBP	B-VP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
absent	absent	JJ	B-ADJP	O
from	from	IN	B-PP	O
either	either	CC	O	O
variola	variola	NN	B-NP	O
or	or	CC	O	O
vaccinia	vaccinia	NN	B-NP	O
virus	virus	NN	I-NP	O
.	.	.	O	O


Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
short	short	JJ	B-NP	O
synthetic	synthetic	JJ	I-NP	O
peptides	peptide	NNS	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
pRB	pRB	NN	I-NP	B-protein
-	-	HYPH	O	O
binding	bind	VBG	B-VP	O
sequences	sequence	NNS	B-NP	O
of	of	IN	B-PP	O
E1A	E1A	NN	B-NP	B-protein
are	be	VBP	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
for	for	IN	B-PP	O
interaction	interaction	NN	B-NP	O
with	with	IN	B-PP	O
p107	p107	NN	B-NP	B-protein
,	,	,	O	O
cyclin	cyclin	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
p130	p130	NN	B-NP	B-protein
.	.	.	O	O


These	These	DT	B-NP	O
mutants	mutant	NNS	I-NP	O
grow	grow	VBP	B-VP	O
normally	normally	RB	B-ADVP	O
in	in	IN	B-PP	O
3T6	3T6	NN	B-NP	B-cell_line
mouse	mouse	NN	I-NP	I-cell_line
fibroblast	fibroblast	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
and	and	CC	O	O
they	they	PRP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
complement	complement	VB	I-VP	O
the	the	DT	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
virus	virus	NN	I-NP	O
in	in	IN	B-PP	O
coinfection	coinfection	NN	B-NP	O
experiments	experiment	NNS	I-NP	O
of	of	IN	B-PP	O
C2	C2	NN	B-NP	B-cell_line
myoblasts	myoblast	NNS	I-NP	I-cell_line
.	.	.	O	O


The	The	DT	B-NP	O
MICs	MIC	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
compound	compound	NN	I-NP	O
against	against	IN	B-PP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
organisms	organism	NNS	I-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
methicillin	methicillin	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
resistant	resistant	JJ	I-NP	O
S	S	NN	I-NP	O
.	.	.	I-NP	O
aureus	aureus	NN	I-NP	O
,	,	,	O	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	B-PP	O
or	or	CC	O	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
0.006	0.006	CD	B-NP	O
to	to	TO	B-PP	O
3.13	3.13	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	B-NP	O
ml	ml	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
minimal	minimal	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RII	RII	NN	I-NP	B-DNA
beta	beta	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
composed	compose	VBN	I-VP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
adjacent	adjacent	JJ	I-NP	B-DNA
functional	functional	JJ	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
.	.	.	O	O


Mapping	Map	VBG	B-VP	O
the	the	DT	B-NP	O
cAMP	cAMP	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
contact	contact	NN	I-NP	O
site	site	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
alpha	alpha	NN	I-NP	B-protein
subunit	subunit	NN	I-NP	I-protein
of	of	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	B-protein
coli	coli	FW	I-NP	I-protein
RNA	RNA	NN	I-NP	I-protein
polymerase	polymerase	NN	I-NP	I-protein
.	.	.	O	O


Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
epidermal	epidermal	JJ	B-NP	B-protein
growth	growth	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
or	or	CC	I-NP	O
platelet	platelet	NN	I-NP	B-protein
-	-	HYPH	O	I-protein
derived	derive	VBN	B-NP	I-protein
growth	growth	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
intact	intact	JJ	B-NP	O
human	human	JJ	I-NP	O
or	or	CC	I-NP	O
murine	murine	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
phosphorylation	phosphorylation	NN	B-NP	O
of	of	IN	B-PP	O
Nck	Nck	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
on	on	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	O
,	,	,	O	O
serine	serine	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
threonine	threonine	NN	B-NP	O
residues	residue	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
major	major	JJ	I-NP	B-DNA
mechanism	mechanism	NN	I-NP	I-DNA
whereby	whereby	WRB	B-ADVP	I-DNA
steroid	steroid	NN	B-NP	I-DNA
hydroxylase	hydroxylase	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
transcription	transcription	NN	I-NP	O
is	be	VBZ	B-VP	O
regulated	regulate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
adrenal	adrenal	JJ	I-NP	O
cortex	cortex	NN	I-NP	O
requires	require	VBZ	B-VP	O
the	the	DT	B-NP	O
pituitary	pituitary	JJ	I-NP	O
peptide	peptide	NN	I-NP	O
hormone	hormone	NN	I-NP	O
,	,	,	O	O
ACTH	ACTH	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
acts	act	VBZ	B-VP	O
via	via	IN	B-PP	O
cAMP	cAMP	NN	B-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
comparative	comparative	JJ	B-NP	O
sequence	sequence	NN	I-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	O	O
thermodynamic	thermodynamic	JJ	B-NP	O
methods	method	NNS	I-NP	O
reveals	reveal	VBZ	B-VP	O
the	the	DT	B-NP	O
conservation	conservation	NN	I-NP	O
of	of	IN	B-PP	O
tertiary	tertiary	JJ	B-NP	B-DNA
structure	structure	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
untranslated	untranslated	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
(	(	(	O	O
UTR	UTR	NN	B-NP	B-DNA
)	)	)	O	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
enteroviruses	enterovirus	NNS	I-NP	O
and	and	CC	I-NP	O
rhinoviruses	rhinovirus	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
-	-	SYM	I-NP	B-DNA
64	64	CD	I-NP	I-DNA
/	/	SYM	I-NP	I-DNA
-	-	SYM	I-NP	I-DNA
37	37	CD	B-NP	I-DNA
region	region	NN	I-NP	I-DNA
interacted	interact	VBD	B-VP	O
with	with	IN	B-PP	O
purified	purify	VBN	B-NP	O
Sp1	Sp1	NN	I-NP	B-protein
and	and	CC	O	O
an	an	DT	B-NP	O
unidentified	unidentified	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
proximal	proximal	JJ	B-NP	B-protein
regulatory	regulatory	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
I	I	NN	B-NP	O
(	(	(	O	O
PRF	PRF	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
I	I	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


Km	Km	NN	B-NP	O
and	and	CC	I-NP	O
Vmax	Vmax	NN	I-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
substrates	substrate	NNS	I-NP	O
,	,	,	O	O
src	src	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
peptide	peptide	NN	I-NP	O
and	and	CC	I-NP	O
poly	poly	NN	I-NP	O
(	(	(	O	O
Glu	Glu	NN	B-NP	B-protein
,	,	,	O	O
Tyr	Tyr	NN	B-NP	B-protein
)	)	)	O	O
(	(	(	O	O
4	4	CD	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
were	be	VBD	B-VP	O
2.4	2.4	CD	B-NP	O
mM	mM	NN	I-NP	O
and	and	CC	O	O
2.5	2.5	CD	B-NP	O
mumol	mumol	NN	I-NP	O
min	min	NN	I-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
0.26	0.26	CD	I-NP	O
mM	mM	NN	I-NP	O
and	and	CC	O	O
1.2	1.2	CD	B-NP	O
mumol	mumol	NN	I-NP	O
min	min	NN	I-NP	O
-	-	HYPH	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O


This	This	DT	B-NP	O
soluble	soluble	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HGFr	HGFr	NN	I-NP	B-protein
(	(	(	O	O
sHGFr	sHGFr	NN	B-NP	O
)	)	)	O	O
bound	bind	VBD	B-VP	O
HGF	HGF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
affinity	affinity	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
authentic	authentic	JJ	I-NP	O
,	,	,	I-NP	O
membrane	membrane	NN	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
associated	associate	VBN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O


Strategies	Strategy	NNS	B-NP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
screening	screening	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
C	C	NN	I-NP	O
virus	virus	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
in	in	IN	B-PP	O
high	high	JJ	B-NP	O
risk	risk	NN	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O


Also	Also	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
glycoprotein	glycoprotein	NN	I-NP	I-DNA
alpha	alpha	SYM	B-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
subunit	subunit	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
10	10	CD	B-NP	O
-	-	HYPH	O	O
fold	fold	RB	B-ADVP	O
by	by	IN	B-PP	O
FSK	FSK	NN	B-NP	B-protein
in	in	IN	B-PP	O
GH4	GH4	NN	B-NP	B-cell_line
rat	rat	NN	I-NP	I-cell_line
pituitary	pituitary	JJ	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O
(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-PP	O
400	400	CD	B-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O


Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
data	datum	NNS	B-NP	O
obtained	obtain	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
opioid	opioid	JJ	I-NP	O
antagonist	antagonist	NN	I-NP	O
permits	permit	VBZ	B-VP	O
to	to	TO	I-VP	O
conclude	conclude	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
blockade	blockade	NN	I-NP	O
increases	increase	VBZ	B-VP	O
the	the	DT	B-NP	O
fatiguability	fatiguability	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
great	great	JJ	I-NP	O
extent	extent	NN	I-NP	O
than	than	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
opioid	opioid	JJ	B-NP	O
system	system	NN	I-NP	O
.	.	.	O	O


Laboratory	Laboratory	NN	B-NP	O
studies	study	NNS	I-NP	O
using	use	VBG	B-VP	O
Ca45	Ca45	NN	B-NP	B-protein
labeled	label	VBN	I-NP	O
teeth	tooth	NNS	I-NP	O
and	and	CC	O	O
biologically	biologically	RB	B-NP	O
stained	stain	VBN	I-NP	O
teeth	tooth	NNS	I-NP	O
confirmed	confirm	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
dentifrice	dentifrice	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
decalcify	decalcify	VB	I-VP	O
enamel	enamel	NN	B-NP	O
or	or	CC	O	O
bleach	bleach	JJ	B-NP	O
teeth	tooth	NNS	I-NP	O
.	.	.	O	O


Structure	Structure	NN	B-NP	O
and	and	CC	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
gene	gene	NN	I-NP	O
from	from	IN	B-PP	O
Arabidopsis	Arabidopsis	NNP	B-NP	O
thaliana	thaliana	IN	B-ADVP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
SNF1	SNF1	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
.	.	.	O	O


We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
cloned	clone	VBN	I-VP	O
and	and	CC	I-VP	O
characterized	characterize	VBN	I-VP	O
a	a	DT	B-NP	O
55	55	CD	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
kb	kb	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
surrounding	surround	VBG	B-VP	O
HRAS1	HRAS1	NN	B-NP	B-protein
.	.	.	O	O


The	The	DT	B-NP	O
ORF1	ORF1	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
highly	highly	RB	B-ADJP	O
homologous	homologous	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
potexvirus	potexvirus	NN	I-NP	O
RNA	RNA	NN	I-NP	O
replicases	replicas	NNS	I-NP	O
;	;	:	O	O
ORF2	ORF2	NN	B-NP	B-DNA
,	,	,	O	O
-	-	HYPH	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
-	-	HYPH	B-NP	O
5	5	CD	I-NP	O
and	and	CC	O	O
-	-	HYPH	B-NP	B-protein
6	6	CD	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
also	also	RB	B-ADVP	O
have	have	VBP	B-VP	O
analogues	analogue	NNS	B-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
potex	potex	NN	I-NP	O
-	-	HYPH	B-ADJP	O
and	and	CC	O	O
/	/	SYM	B-NP	O
or	or	CC	O	O
carlavirus	carlavirus	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
encoded	encode	VBN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O


A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
281	281	CD	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
groups	group	NNS	B-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
clinical	clinical	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
using	use	VBG	B-VP	O
capnography	capnography	NN	B-NP	O
,	,	,	I-NP	O
spirometry	spirometry	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
-	-	HYPH	I-NP	O
gas	gas	NN	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
relationships	relationship	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
partial	partial	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
O2	O2	NN	B-NP	B-protein
and	and	CC	I-NP	O
CO2	CO2	NN	I-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
between	between	IN	B-PP	O
their	their	PRP$	B-NP	O
gradients	gradient	NNS	I-NP	O
,	,	,	O	O
become	become	VBP	B-VP	O
stronger	strong	JJR	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ventilation	ventilation	NN	I-NP	O
-	-	HYPH	B-NP	O
perfusion	perfusion	NN	I-NP	O
ratio	ratio	NN	I-NP	O
.	.	.	O	O


No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
correlations	correlation	NNS	I-NP	O
of	of	IN	B-PP	O
peak	peak	NN	B-NP	O
VO2	VO2	NN	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
3	3	CD	I-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O


An	An	DT	B-NP	O
RNA	RNA	NN	I-NP	B-DNA
-	-	HYPH	O	I-DNA
binding	bind	VBG	B-VP	I-DNA
protein	protein	NN	B-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
(	(	(	O	O
rbp1	rbp1	NN	B-NP	B-protein
)	)	)	O	O
from	from	IN	B-PP	O
Drosophila	Drosophila	FW	B-NP	O
melanogaster	melanogaster	NN	I-NP	O
,	,	,	O	O
encoding	encode	VBG	B-VP	O
an	an	DT	B-NP	O
RNA	RNA	NN	I-NP	B-DNA
recognition	recognition	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
and	and	CC	O	O
an	an	DT	B-NP	O
Arg	Arg	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
Ser	Ser	NN	I-NP	B-protein
rich	rich	JJ	B-ADJP	I-protein
(	(	(	O	I-protein
RS	RS	NN	B-NP	I-protein
)	)	)	O	I-protein
domain	domain	NN	B-NP	I-protein
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
characterized	characterize	VBN	I-VP	O
.	.	.	O	O


Some	Some	DT	B-NP	O
research	research	NN	I-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
related	relate	VBN	I-VP	O
this	this	DT	B-NP	O
kind	kind	NN	I-NP	O
of	of	IN	B-PP	O
tumors	tumor	NNS	B-NP	O
with	with	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
ingestion	ingestion	NN	I-NP	O
of	of	IN	B-PP	O
H2	H2	NN	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
and	and	CC	I-NP	O
others	other	NNS	I-NP	O
antacid	antacid	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
comparative	comparative	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
protein	protein	NN	I-NP	O
profiles	profile	NNS	I-NP	O
of	of	IN	B-PP	O
wild	wild	JJ	B-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
S	S	NN	I-NP	O
.	.	.	I-NP	O
entomophila	entomophila	NN	I-NP	O
UC9	UC9	NN	I-NP	O
and	and	CC	I-NP	O
mutant	mutant	JJ	I-NP	O
UC21	UC21	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
mutant	mutant	NN	I-NP	O
lacked	lack	VBD	B-VP	O
an	an	DT	B-NP	O
approximately	approximately	RB	I-NP	O
44	44	CD	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
kDa	kDa	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
and	and	CC	O	O
overexpressed	overexpresse	VBD	B-VP	O
an	an	DT	B-NP	O
approximately	approximately	RB	I-NP	O
20	20	CD	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
kDa	kDa	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
regulon	regulon	NN	I-NP	O
controlled	control	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
leucine	leucine	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
responsive	responsive	JJ	I-NP	I-protein
regulatory	regulatory	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
in	in	IN	B-PP	O
Escherichia	Escherichia	NNP	B-NP	O
coli	coli	NNP	I-NP	O
.	.	.	O	O


Mapping	Mapping	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	B-protein
ornithine	ornithine	NN	I-NP	I-protein
decarboxylase	decarboxylase	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
sequence	sequence	NN	I-NP	O
family	family	NN	I-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
mutation	mutation	NN	I-NP	O
also	also	RB	B-ADVP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
markedly	markedly	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mutant	mutant	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
rationale	rationale	NN	I-NP	O
for	for	IN	B-PP	O
continuous	continuous	JJ	B-NP	O
dopaminergic	dopaminergic	JJ	I-NP	O
stimulation	stimulation	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
Parkinson	Parkinson	NNP	B-NP	O
'	'	POS	B-NP	O
s	s	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O


Mutational	Mutational	JJ	B-NP	O
studies	study	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
homeodomain	homeodomain	NN	I-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
II	II	CD	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
regulation	regulation	NN	I-NP	O
.	.	.	O	O


Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
pol	pol	NN	I-NP	B-protein
alpha	alpha	SYM	B-VP	I-protein
-	-	HYPH	B-NP	I-protein
primase	primase	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
act	act	VB	I-VP	O
processively	processively	RB	B-ADVP	O
for	for	IN	B-PP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
short	short	JJ	I-NP	O
distance	distance	NN	I-NP	O
.	.	.	O	O


Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
positions	position	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
introns	intron	NNS	I-NP	B-DNA
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
genes	gene	NNS	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
other	other	JJ	I-NP	O
transglutaminase	transglutaminase	NN	I-NP	B-protein
-	-	HYPH	B-VP	O
like	like	JJ	B-NP	O
activities	activity	NNS	I-NP	O
described	describe	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
literature	literature	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
TGM1	TGM1	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
by	by	IN	B-PP	O
far	far	RB	B-ADVP	O
the	the	DT	B-NP	O
smallest	small	JJS	I-NP	O
characterized	characterize	VBN	B-VP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
because	because	IN	B-SBAR	O
its	its	PRP$	B-NP	O
introns	intron	NNS	I-NP	B-DNA
are	be	VBP	B-VP	O
relatively	relatively	RB	B-ADJP	O
smaller	small	JJR	I-ADJP	O
.	.	.	O	O


In	In	IN	B-PP	O
a	a	DT	B-NP	O
retrospective	retrospective	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
data	datum	NNS	B-NP	O
from	from	IN	B-PP	O
35	35	CD	B-NP	O
cases	case	NNS	I-NP	O
with	with	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
cohort	cohort	NN	I-NP	O
of	of	IN	B-PP	O
2017	2017	CD	B-NP	O
HIV	HIV	NN	I-NP	O
-	-	HYPH	B-NP	O
infected	infect	VBN	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
stage	stage	NN	I-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
CD4	CD4	NN	I-NP	B-protein
counts	count	VBZ	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
diagnosis	diagnosis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
antineoplastic	antineoplastic	JJ	B-NP	O
agents	agent	NNS	I-NP	O
or	or	CC	O	O
radiotherapy	radiotherapy	NN	B-NP	O
were	be	VBD	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
outcome	outcome	NN	B-NP	O
.	.	.	O	O


1	1	LS	B-LST	O
.	.	.	O	O


Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
dioxins	dioxin	NNS	B-NP	O
on	on	IN	B-PP	O
thyroid	thyroid	NN	B-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
newborn	newborn	JJ	B-NP	O
babies	baby	NNS	I-NP	O
.	.	.	O	O


cDNA	cDNA	NN	B-NP	B-DNA
clones	clone	NNS	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
Arabidopsis	Arabidopsis	NNP	B-NP	O
thaliana	thaliana	NNP	I-NP	O
and	and	CC	O	O
Zea	Zea	NNP	B-NP	B-protein
mays	may	VBZ	B-VP	O
mitochondrial	mitochondrial	JJ	B-NP	B-protein
chaperonin	chaperonin	NN	I-NP	I-protein
HSP60	HSP60	NN	I-NP	I-protein
and	and	CC	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
during	during	IN	B-PP	O
seed	seed	NN	B-NP	O
germination	germination	NN	I-NP	O
and	and	CC	O	O
heat	heat	NN	B-NP	O
shock	shock	NN	I-NP	O
.	.	.	O	O


Amino	Amino	NN	B-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
comparison	comparison	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
significant	significant	JJ	B-NP	O
homology	homology	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	O
and	and	CC	O	O
Escherichia	Escherichia	FW	B-NP	B-protein
coli	coli	FW	I-NP	I-protein
gamma	gamma	SYM	B-NP	I-protein
-	-	HYPH	B-NP	O
glutamyl	glutamyl	NN	I-NP	B-protein
kinases	kinase	NNS	I-NP	I-protein
throughout	throughout	IN	B-PP	O
their	their	PRP$	B-NP	O
lengths	length	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
single	single	JJ	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
glycosylation	glycosylation	NN	B-NP	O
is	be	VBZ	B-VP	O
located	located	JJ	B-ADJP	O
near	near	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
terminus	terminus	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	O	O
glycosylation	glycosylation	NN	B-NP	B-protein
sequon	sequon	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
Asn	Asn	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
Cys	Cys	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
Ser	Ser	NN	I-NP	B-protein
-	-	HYPH	B-ADJP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
Cys	Cys	NN	B-NP	B-protein
forms	form	VBZ	B-VP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
disulphide	disulphide	NN	I-NP	O
bridge	bridge	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
toxic	toxic	JJ	I-NP	O
events	event	NNS	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
acute	acute	JJ	B-NP	O
nitrogen	nitrogen	NN	I-NP	O
dioxide	dioxide	NN	I-NP	O
(	(	(	O	O
NO	NO	NN	B-NP	O
)	)	)	O	O
2	2	CD	B-NP	O
exposure	exposure	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
to	to	TO	B-VP	O
develop	develop	VB	I-VP	O
an	an	DT	B-NP	O
inhalation	inhalation	NN	I-NP	O
model	model	NN	I-NP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
therapeutic	therapeutic	JJ	B-NP	O
measures	measure	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
effects	effect	NNS	I-NP	O
observed	observe	VBN	B-VP	O
,	,	,	O	O
became	become	VBD	B-VP	O
more	more	RBR	B-ADJP	O
pronounced	pronounced	JJ	I-ADJP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
NO2	NO2	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
(	(	(	O	O
0	0	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
,	,	,	I-NP	O
75	75	CD	I-NP	O
,	,	,	I-NP	O
125	125	CD	I-NP	O
,	,	,	I-NP	O
175	175	CD	I-NP	O
or	or	CC	I-NP	O
200	200	CD	I-NP	O
ppm	ppm	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
ppm	ppm	NN	I-NP	O
NO2	NO2	NN	I-NP	O
=	=	SYM	B-VP	O
1.88	1.88	CD	B-NP	O
mg	mg	NN	I-NP	O
m	m	NN	I-NP	O
-	-	HYPH	B-NP	O
3	3	CD	I-NP	O
NO2	NO2	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
exposure	exposure	NN	B-NP	O
times	time	NNS	I-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
,	,	,	I-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
20	20	CD	I-NP	O
or	or	CC	I-NP	O
30	30	CD	I-NP	O
min	min	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


Interaction	Interaction	NN	B-NP	O
of	of	IN	B-PP	O
H	H	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
2Eb	2Eb	NN	I-NP	I-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
IAP	IAP	NN	I-NP	O
retrotransposon	retrotransposon	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
A20	A20	NN	I-NP	B-protein
/	/	SYM	B-NP	O
2J	2J	NN	I-NP	O
B	B	NN	I-NP	O
cell	cell	NN	I-NP	O
lymphoma	lymphoma	NN	I-NP	O
.	.	.	O	O


Gestational	Gestational	JJ	B-NP	O
trophoblastic	trophoblastic	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
:	:	:	O	O
recent	recent	JJ	B-NP	O
advances	advance	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
cytogenetics	cytogenetic	NNS	B-NP	O
,	,	,	O	O
histopathology	histopathology	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
natural	natural	JJ	B-NP	O
history	history	NN	I-NP	O
.	.	.	O	O


With	With	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
mutants	mutant	NNS	B-NP	O
that	that	WDT	B-NP	O
remove	remove	VBP	B-VP	O
the	the	DT	B-NP	O
membrane	membrane	NN	I-NP	B-protein
anchor	anchor	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
,	,	,	O	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mutant	mutant	JJ	I-NP	B-protein
glycoproteins	glycoprotein	NNS	I-NP	I-protein
retained	retain	VBD	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
cause	cause	VB	I-VP	O
fusion	fusion	NN	B-NP	O
of	of	IN	B-PP	O
CD4	CD4	NN	B-NP	B-protein
-	-	HYPH	O	O
bearing	bear	VBG	B-VP	B-cell_type
cells	cell	NNS	B-NP	I-cell_type
.	.	.	O	O


The	The	DT	B-NP	O
subunit	subunit	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
of	of	IN	B-PP	O
curli	curli	NN	B-NP	O
was	be	VBD	B-VP	O
highly	highly	RB	B-ADJP	O
homologous	homologous	JJ	I-ADJP	O
at	at	IN	B-PP	O
its	its	PRP$	B-NP	O
amino	amino	JJ	I-NP	B-protein
terminus	terminus	NN	I-NP	I-protein
to	to	TO	B-PP	O
SEF	SEF	NN	B-NP	B-protein
-	-	HYPH	O	O
17	17	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
subunit	subunit	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
of	of	IN	B-PP	O
thin	thin	JJ	B-NP	O
,	,	,	I-NP	O
aggregative	aggregative	JJ	I-NP	O
fimbriae	fimbria	NNS	I-NP	O
of	of	IN	B-PP	O
Salmonella	Salmonella	NNP	B-NP	O
enteritidis	enteritidi	VBZ	B-VP	O
27655	27655	CD	B-NP	O
strain	strain	NN	I-NP	O
3b	3b	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
fibres	fibre	NNS	I-NP	O
form	form	VBP	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
surface	surface	NN	B-NP	O
organelles	organelle	NNS	I-NP	O
on	on	IN	B-PP	O
enterobacteria	enterobacteria	NNS	B-NP	O
.	.	.	O	O


Substitution	Substitution	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DR1	DR1	NN	I-NP	B-protein
beta	beta	NN	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
with	with	IN	B-PP	O
H	H	NN	B-NP	O
-	-	HYPH	O	O
2E	2E	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
k	k	NN	I-NP	I-protein
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
dramatic	dramatic	JJ	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
recognition	recognition	NN	B-NP	O
;	;	:	O	O
alpha	alpha	SYM	B-NP	O
chain	chain	NN	I-NP	O
substitution	substitution	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
less	less	RBR	I-NP	O
marked	marked	JJ	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
negative	negative	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
determining	determine	VBG	B-VP	O
cell	cell	NN	B-NP	O
fate	fate	NN	I-NP	O
or	or	CC	O	O
maintaining	maintain	VBG	B-VP	O
an	an	DT	B-NP	O
inducible	inducible	JJ	I-NP	O
state	state	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ventroposterior	ventroposterior	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
embryo	embryo	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
distal	distal	JJ	I-NP	B-DNA
portion	portion	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	B-DNA
insulin	insulin	NN	I-NP	I-DNA
I	I	CD	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
5	5	CD	B-NP	I-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
flanking	flank	VBG	B-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
sequence	sequence	NN	I-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
Far	Far	NN	I-NP	B-protein
and	and	CC	I-NP	O
FLAT	FLAT	NN	I-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
,	,	,	O	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
function	function	VB	I-VP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
separately	separately	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
.	.	.	O	O


The	The	DT	B-NP	O
deduced	deduce	VBN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
exhibited	exhibit	VBD	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
identity	identity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
cellular	cellular	JJ	I-NP	I-DNA
transglutaminase	transglutaminase	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
.	.	.	O	O


This	This	DT	B-NP	O
computation	computation	NN	I-NP	O
is	be	VBZ	B-VP	O
performed	perform	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
parallel	parallel	JJ	I-NP	O
network	network	NN	I-NP	O
of	of	IN	B-PP	O
locally	locally	RB	B-NP	O
connected	connect	VBN	I-NP	O
neuron	neuron	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
like	like	JJ	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
.	.	.	O	O


Repeated	Repeat	VBN	B-NP	O
efforts	effort	NNS	I-NP	O
to	to	TO	B-VP	O
isolate	isolate	VB	I-VP	O
recombinant	recombinant	JJ	B-NP	O
baculoviruses	baculovirus	NNS	I-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
wild	wild	JJ	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
type	type	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
failed	fail	VBD	B-VP	O
,	,	,	O	O
whereas	whereas	IN	O	O
recombinants	recombinant	NNS	B-NP	O
expressing	express	VBG	B-VP	O
a	a	DT	B-NP	O
nonfunctional	nonfunctional	JJ	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
catalytic	catalytic	JJ	I-NP	O
domain	domain	NN	I-NP	O
II	II	CD	I-NP	O
mutation	mutation	NN	I-NP	O
were	be	VBD	B-VP	O
readily	readily	RB	I-VP	O
isolated	isolate	VBN	I-VP	O
.	.	.	O	O


Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
determined	determine	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
P68	P68	NN	I-NP	B-protein
amino	amino	JJ	I-NP	I-protein
terminus	terminus	NN	I-NP	I-protein
was	be	VBD	B-VP	O
both	both	CC	O	O
necessary	necessary	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
sufficient	sufficient	JJ	I-ADJP	O
for	for	IN	B-PP	O
binding	bind	VBG	B-NP	O
dsRNA	dsRNA	NN	I-NP	O
as	as	IN	B-SBAR	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
transfer	transfer	VB	I-VP	O
dsRNA	dsRNA	NN	B-NP	B-RNA
-	-	HYPH	O	I-RNA
binding	bind	VBG	B-VP	O
properties	property	NNS	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
reporter	reporter	NN	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
product	product	NN	I-NP	I-protein
previously	previously	RB	B-ADJP	O
unable	unable	JJ	I-ADJP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
RNA	RNA	NN	B-NP	O
.	.	.	O	O


From	From	IN	B-PP	O
August	August	NNP	B-NP	O
1989	1989	CD	I-NP	O
to	to	TO	B-PP	O
October	October	NNP	B-NP	O
1990	1990	CD	I-NP	O
,	,	,	O	O
83	83	CD	B-NP	O
pregnant	pregnant	JJ	I-NP	O
Chinese	Chinese	JJ	I-NP	O
women	woman	NNS	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
for	for	IN	B-PP	O
measuring	measure	VBG	B-VP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
plasma	plasma	NN	B-NP	B-protein
functional	functional	JJ	I-NP	I-protein
antithrombin	antithrombin	NN	I-NP	I-protein
III	III	CD	I-NP	I-protein
(	(	(	O	O
AT	AT	NN	O	B-protein
III	III	CD	O	I-protein
)	)	)	O	O
activity	activity	NN	B-NP	O
.	.	.	O	O


Visual	Visual	JJ	B-NP	O
acuity	acuity	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
by	by	IN	B-PP	O
transient	transient	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
refractive	refractive	JJ	B-NP	O
error	error	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
sulfonamides	sulfonamide	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
antifungal	antifungal	JJ	I-NP	O
agent	agent	NN	I-NP	O
metronidazole	metronidazole	NN	I-NP	O
,	,	,	O	O
thiazide	thiazide	NN	B-NP	O
diuretics	diuretic	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
carbonic	carbonic	JJ	B-NP	O
anhydrase	anhydrase	NN	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
.	.	.	O	O


Currents	Current	NNS	B-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
H2	H2	NN	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
antagonists	antagonist	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
ulcers	ulcer	NNS	B-NP	O


In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
21	21	CD	I-NP	O
-	-	HYPH	I-NP	O
mer	mer	NN	I-NP	O
subrepeat	subrepeat	NN	I-NP	O
structure	structure	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
unit	unit	NN	I-NP	O
.	.	.	O	O


Sequencing	Sequencing	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
one	one	CD	B-NP	O
large	large	JJ	I-NP	O
open	open	JJ	I-NP	B-DNA
reading	reading	NN	I-NP	I-DNA
frame	frame	NN	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
39	39	CD	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
kDa	kDa	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


These	These	DT	B-NP	O
sites	site	NNS	I-NP	O
are	be	VBP	B-VP	O
also	also	RB	B-ADVP	O
potential	potential	JJ	B-NP	O
keratan	keratan	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
attachment	attachment	NN	I-NP	O
sites	site	NNS	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
propose	propose	VBP	B-VP	O
that	that	IN	B-SBAR	O
plasmids	plasmid	NNS	B-NP	B-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pLS1	pLS1	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
(	(	(	O	O
pE194	pE194	NN	B-NP	O
,	,	,	O	O
pADB201	pADB201	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pLB4	pLB4	NN	B-NP	B-protein
)	)	)	O	O
share	share	VBP	B-VP	O
functional	functional	JJ	B-NP	O
and	and	CC	I-NP	O
structural	structural	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
copy	copy	NN	I-NP	O
numbers	number	NNS	I-NP	O
.	.	.	O	O


Perturbation	Perturbation	NN	B-NP	O
of	of	IN	B-PP	O
dNTP	dNTP	NN	B-NP	O
pools	pool	NNS	I-NP	O
also	also	RB	B-ADVP	O
affected	affect	VBD	B-VP	O
the	the	DT	B-NP	O
frameshift	frameshift	NN	I-NP	O
fidelity	fidelity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
replicative	replicative	JJ	I-NP	O
yeast	yeast	NN	I-NP	O
DNA	DNA	NN	I-NP	O
polymerase	polymerase	NN	I-NP	O
alpha	alpha	NN	I-NP	O
.	.	.	O	O


Differential	Differential	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
"	"	``	I-NP	B-protein
B	B	NN	I-NP	I-protein
"	"	''	I-NP	I-protein
subunit	subunit	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
vacuolar	vacuolar	JJ	I-NP	B-protein
H	H	NN	I-NP	I-protein
(	(	(	O	I-protein
+	+	SYM	B-NP	I-protein
)	)	)	O	I-protein
-	-	HYPH	B-NP	I-protein
ATPase	ATPase	NN	I-NP	I-protein
in	in	IN	B-PP	O
bovine	bovine	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
hGCSFR	hGCSFR	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
chromosomally	chromosomally	RB	I-VP	O
localized	localize	VBN	I-VP	O
by	by	IN	B-PP	O
Southern	Southern	JJ	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
segregation	segregation	NN	I-NP	O
pattern	pattern	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
panel	panel	NN	I-NP	O
of	of	IN	B-PP	O
rodent	rodent	NN	B-NP	O
-	-	HYPH	B-NP	O
human	human	JJ	I-NP	B-DNA
hybrid	hybrid	NN	I-NP	I-DNA
DNAs	DNA	NNS	I-NP	I-DNA
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
radiolabeled	radiolabele	VBN	I-NP	B-DNA
cDNA	cDNA	NN	I-NP	I-DNA
probe	probe	NN	I-NP	I-DNA
.	.	.	O	O


We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	I-VP	O
characterised	characterise	VBN	I-VP	O
a	a	DT	B-NP	O
differentially	differentially	RB	I-NP	O
-	-	HYPH	I-NP	O
regulated	regulate	VBN	I-NP	O
gene	gene	NN	I-NP	O
family	family	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
protozoan	protozoan	NN	I-NP	O
parasite	parasite	NN	I-NP	O
Leishmania	Leishmania	NNP	I-NP	O
major	major	JJ	I-NP	O
.	.	.	O	O


At	At	IN	B-PP	O
some	some	DT	B-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
%	%	NN	B-NP	O
T	T	NN	I-NP	O
is	be	VBZ	B-VP	O
greatly	greatly	RB	I-VP	O
increased	increase	VBN	I-VP	O
by	by	IN	B-PP	O
Cl	Cl	NN	B-NP	B-protein
-	-	HYPH	O	O
concentrations	concentration	NNS	B-NP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
1	1	CD	I-NP	O
M	M	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
other	other	JJ	B-NP	O
sites	site	NNS	I-NP	O
%	%	NN	I-NP	O
T	T	NN	I-NP	O
is	be	VBZ	B-VP	O
reduced	reduce	VBN	I-VP	O
or	or	CC	O	O
unaffected	unaffected	JJ	B-ADJP	O
by	by	IN	B-PP	O
these	these	DT	B-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O


Necrosis	Necrosis	NN	B-NP	O
appears	appear	VBZ	B-VP	O
6	6	CD	B-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
TA	TA	NN	B-NP	O
infusion	infusion	NN	I-NP	O
,	,	,	O	O
being	be	VBG	B-VP	O
5.77	5.77	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
extent	extent	NN	B-NP	O
after	after	IN	B-PP	O
12	12	CD	B-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
14.9	14.9	CD	B-NP	O
%	%	NN	I-NP	O
after	after	IN	B-PP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
and	and	CC	I-NP	O
animals	animal	NNS	I-NP	O
die	die	VBP	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
29.5	29.5	CD	B-NP	O
%	%	NN	I-NP	O
necrosis	necrosis	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
segments	segment	NNS	I-NP	O
of	of	IN	B-PP	O
C3	C3	NN	B-NP	B-protein
represented	represent	VBN	B-VP	O
by	by	IN	B-PP	O
amino	amino	JJ	B-NP	O
acid	acid	NN	I-NP	O
residues	residue	NNS	I-NP	O
1082	1082	CD	B-NP	O
-	-	HYPH	I-NP	O
1118	1118	CD	I-NP	O
,	,	,	I-NP	O
1117	1117	CD	I-NP	O
-	-	HYPH	I-NP	O
1155	1155	CD	I-NP	O
,	,	,	I-NP	O
1234	1234	CD	I-NP	O
-	-	HYPH	I-NP	O
1294	1294	CD	I-NP	O
and	and	CC	I-NP	O
1312	1312	CD	I-NP	O
-	-	HYPH	I-NP	O
1404	1404	CD	I-NP	B-protein
accommodate	accommodate	NN	I-NP	I-protein
C3	C3	NN	I-NP	I-protein
(	(	(	O	I-protein
D	D	NN	B-NP	I-protein
)	)	)	O	I-protein
epitopes	epitope	NNS	B-NP	I-protein
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
by	by	IN	B-PP	O
erythrocyte	erythrocyte	NN	B-NP	B-cell_type
-	-	HYPH	O	O
bound	bind	VBN	B-NP	O
C3	C3	NN	I-NP	B-protein
fragments	fragment	NNS	I-NP	I-protein
,	,	,	B-PP	O
but	but	CC	I-PP	O
not	not	RB	I-PP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
fluid	fluid	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
phase	phase	NN	I-NP	I-DNA
fragment	fragment	NN	I-NP	I-DNA
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
segments	segment	NNS	I-NP	O
spanning	span	VBG	B-VP	O
residues	residue	NNS	B-NP	O
973	973	CD	B-NP	O
-	-	HYPH	I-NP	O
1026	1026	CD	I-NP	O
and	and	CC	I-NP	O
1477	1477	CD	I-NP	O
-	-	HYPH	I-NP	O
1510	1510	CD	I-NP	O
contain	contain	VBP	B-VP	O
C3	C3	NN	B-NP	B-protein
(	(	(	O	I-protein
D	D	NN	B-NP	I-protein
)	)	)	O	I-protein
epitopes	epitope	NNS	B-NP	I-protein
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
exposed	expose	VBN	I-VP	O
exclusively	exclusively	RB	B-ADVP	O
in	in	IN	B-PP	O
denatured	denature	VBN	B-NP	O
C3	C3	NN	I-NP	B-protein
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
hidden	hide	VBN	B-VP	O
in	in	IN	B-PP	O
physiological	physiological	JJ	B-NP	O
fragments	fragment	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
exons	exon	NNS	I-NP	B-DNA
,	,	,	O	O
further	further	RB	B-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
exons	exon	NNS	B-NP	B-DNA
9	9	CD	I-NP	I-DNA
,	,	,	I-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
11	11	CD	B-NP	O
,	,	,	O	O
together	together	RB	B-ADVP	O
encode	encode	VBP	B-VP	O
the	the	DT	B-NP	O
37	37	CD	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
residues	residue	NNS	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
alpha	alpha	SYM	B-NP	O
s1	s1	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
casein	casein	NN	I-NP	B-protein
variant	variant	JJ	I-NP	I-protein
A	A	NN	I-NP	I-protein
but	but	CC	O	O
missing	miss	VBG	B-VP	O
in	in	IN	B-PP	O
variant	variant	JJ	B-NP	O
F	F	NN	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
report	report	VBP	B-VP	O
here	here	RB	B-ADVP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
structural	structural	JJ	I-NP	O
organization	organization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
goat	goat	NN	I-NP	B-DNA
alpha	alpha	NN	I-NP	I-DNA
s1	s1	NN	I-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
casein	casein	NN	I-NP	I-DNA
transcription	transcription	NN	I-NP	I-DNA
unit	unit	NN	I-NP	I-DNA
,	,	,	O	O
deduced	deduce	VBN	B-VP	O
from	from	IN	B-PP	O
polymerase	polymerase	NN	B-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
.	.	.	O	O


Homodimers	Homodimer	NNS	B-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
proteins	protein	NNS	I-NP	O
specifically	specifically	RB	B-ADVP	O
recognize	recognize	VBP	B-VP	O
the	the	DT	B-NP	O
G	G	NN	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
box	box	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
,	,	,	O	O
with	with	IN	B-PP	O
GBF1	GBF1	NN	B-NP	B-protein
and	and	CC	I-NP	O
GBF3	GBF3	NN	I-NP	B-protein
binding	binding	NN	I-NP	O
symmetrically	symmetrically	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
palindromic	palindromic	JJ	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
.	.	.	O	O


Neither	Neither	DT	B-NP	O
gene	gene	NN	I-NP	O
possesses	possess	VBZ	B-VP	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	B-DNA
start	start	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
as	as	IN	B-SBAR	O
shown	show	VBN	B-VP	O
by	by	IN	B-PP	O
nuclease	nuclease	NN	B-NP	O
S1	S1	NN	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
hydrophobicity	hydrophobicity	NN	I-NP	O
plot	plot	NN	I-NP	O
of	of	IN	B-PP	O
NHE	NHE	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
3	3	CD	I-NP	I-protein
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
NHE	NHE	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
and	and	CC	I-NP	O
NHE	NHE	NN	I-NP	B-protein
-	-	HYPH	O	I-protein
2	2	CD	B-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
initial	initial	JJ	I-NP	B-protein
translation	translation	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cDNA	cDNA	NN	I-NP	B-DNA
is	be	VBZ	B-VP	O
53	53	CD	B-NP	O
,	,	,	O	O
932	932	CD	B-NP	O
kDa	kDa	NN	I-NP	O
and	and	CC	O	O
possesses	possess	VBZ	B-VP	O
a	a	DT	B-NP	O
hydrophilic	hydrophilic	JJ	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
composition	composition	NN	I-NP	O
with	with	IN	B-PP	O
glutamic	glutamic	JJ	B-NP	O
acid	acid	NN	I-NP	O
comprising	comprise	VBG	B-VP	O
22	22	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
residues	residue	NNS	I-NP	O
.	.	.	O	O


Each	Each	DT	B-NP	O
group	group	NN	I-NP	O
received	receive	VBD	B-VP	O
15	15	CD	B-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	O	O
kg	kg	NN	B-NP	O
of	of	IN	B-PP	O
either	either	CC	B-NP	O
6	6	CD	I-NP	O
%	%	NN	I-NP	O
pentafraction	pentafraction	NN	I-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
%	%	NN	I-NP	O
pentastarch	pentastarch	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
plasma	plasma	NN	B-NP	O
followed	follow	VBD	B-VP	O
two	two	CD	B-NP	O
hours	hour	NNS	I-NP	O
later	later	RB	B-ADVP	O
by	by	IN	B-PP	O
1.5	1.5	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
/	/	SYM	I-NP	O
0.5	0.5	CD	I-NP	O
hr	hr	NN	I-NP	O
E	E	NN	I-NP	O
.	.	.	O	O


Genetic	Genetic	JJ	B-NP	O
and	and	CC	I-NP	O
biochemical	biochemical	JJ	I-NP	O
evidence	evidence	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
v	v	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
Crk	Crk	NN	I-NP	I-protein
can	can	MD	B-VP	O
induce	induce	VB	I-VP	O
transformation	transformation	NN	B-NP	O
of	of	IN	B-PP	O
chicken	chicken	NN	B-NP	B-cell_type
embryo	embryo	NN	I-NP	I-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
influencing	influence	VBG	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
growth	growth	NN	B-NP	O
regulation	regulation	NN	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
constructed	construct	VBN	I-VP	O
,	,	,	O	O
using	use	VBG	B-VP	O
synthetic	synthetic	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
U14	U14	NN	I-NP	B-DNA
snRNA	snRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
positioned	position	VBN	I-VP	O
behind	behind	IN	B-PP	O
a	a	DT	B-NP	O
T7	T7	NN	I-NP	B-DNA
RNA	RNA	NN	I-NP	I-DNA
polymerase	polymerase	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
and	and	CC	O	O
then	then	RB	B-VP	O
inserted	insert	VBN	I-VP	O
into	into	IN	B-PP	O
a	a	DT	B-NP	O
plasmid	plasmid	NN	I-NP	B-DNA
.	.	.	O	O


Gene	Gene	NN	B-NP	O
and	and	CC	I-NP	O
pseudogene	pseudogene	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O
cation	cation	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
mannose	mannose	NN	I-NP	O
6	6	CD	I-NP	O
-	-	HYPH	I-NP	O
phosphate	phosphate	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
chick	chick	NN	I-NP	B-protein
axon	axon	NN	I-NP	I-protein
-	-	HYPH	B-VP	I-protein
associated	associate	VBN	B-NP	I-protein
surface	surface	NN	I-NP	I-protein
glycoprotein	glycoprotein	NN	I-NP	I-protein
neurofascin	neurofascin	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
axonal	axonal	JJ	B-NP	O
growth	growth	NN	I-NP	O
and	and	CC	I-NP	O
fasciculation	fasciculation	NN	I-NP	O
as	as	IN	B-SBAR	O
revealed	reveal	VBN	B-VP	O
by	by	IN	B-PP	O
antibody	antibody	NN	B-NP	O
perturbation	perturbation	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
was	be	VBD	B-VP	O
restricted	restricted	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
epithelium	epithelium	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
mucosal	mucosal	JJ	I-NP	O
layer	layer	NN	I-NP	O
in	in	IN	B-PP	O
five	five	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
submucosal	submucosal	JJ	I-NP	O
layer	layer	NN	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
C	C	NN	B-NP	B-protein
/	/	SYM	I-NP	I-protein
EBP	EBP	NN	I-NP	I-protein
beta	beta	SYM	B-NP	I-protein
and	and	CC	O	O
C	C	NN	B-NP	O
/	/	SYM	I-NP	O
EBP	EBP	NN	I-NP	B-protein
gamma	gamma	SYM	B-VP	I-protein
readily	readily	RB	I-VP	O
heterodimerize	heterodimerize	VB	I-VP	O
with	with	IN	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
with	with	IN	B-PP	O
C	C	NN	B-NP	B-protein
/	/	SYM	B-NP	I-protein
EBP	EBP	NN	I-NP	I-protein
alpha	alpha	SYM	B-NP	I-protein
.	.	.	O	O


In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
tobacco	tobacco	NN	B-NP	B-protein
GS	GS	NN	I-NP	I-protein
-	-	HYPH	O	O
2	2	CD	B-NP	O
is	be	VBZ	B-VP	O
composed	compose	VBN	I-VP	O
of	of	IN	B-PP	O
subunits	subunit	NNS	B-NP	O
of	of	IN	B-PP	O
identical	identical	JJ	B-NP	O
size	size	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
organs	organ	NNS	I-NP	O
examined	examine	VBN	B-VP	O
.	.	.	O	O


Between	Between	IN	B-PP	O
acoR	acoR	NN	B-NP	O
and	and	CC	I-NP	O
acoXABC	acoXABC	NN	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
sequences	sequence	NNS	B-NP	O
with	with	IN	B-PP	O
dual	dual	JJ	B-NP	O
rotational	rotational	JJ	I-NP	O
symmetry	symmetry	NN	I-NP	O
[	[	(	O	O
CAC	CAC	NN	B-NP	B-protein
-	-	HYPH	O	O
(	(	(	O	O
N11	N11	NN	B-NP	B-protein
to	to	TO	B-PP	O
N18	N18	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
GTG	GTG	NN	I-NP	B-protein
and	and	CC	I-NP	O
TGT	TGT	NN	I-NP	B-protein
-	-	HYPH	O	O
(	(	(	O	O
N10	N10	NN	B-NP	B-protein
to	to	TO	B-PP	O
N14	N14	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
ACA	ACA	NN	I-NP	O
]	]	)	O	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
;	;	:	O	O
these	these	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
are	be	VBP	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
NtrC	NtrC	NN	B-NP	B-protein
and	and	CC	I-NP	O
NifA	NifA	NN	I-NP	B-protein
upstream	upstream	JJ	I-NP	O
activator	activator	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O


Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
calcium	calcium	NN	I-NP	O
supplement	supplement	NN	I-NP	O
or	or	CC	O	O
calcium	calcium	NN	B-NP	O
antagonist	antagonist	NN	I-NP	O
alone	alone	RB	B-ADVP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
,	,	,	O	O
such	such	JJ	B-NP	O
hypotensive	hypotensive	JJ	I-NP	O
responses	response	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
optimal	optimal	JJ	B-ADJP	O
or	or	CC	I-ADJP	O
predictable	predictable	JJ	I-ADJP	O
or	or	CC	O	O
clearly	clearly	RB	B-ADVP	O
dose	dose	NN	B-NP	O
-	-	HYPH	B-VP	O
dependent	dependent	JJ	B-ADJP	O
.	.	.	O	O


C	C	NN	B-NP	O
.	.	NN	I-NP	O
,	,	,	O	O
Sun	Sun	NNP	B-NP	O
,	,	,	O	O
J	J	NNP	B-NP	O
.	.	.	O	O
,	,	,	O	O
Hsu	Hsu	NNP	B-NP	O
,	,	,	O	O
M	M	NNP	B-NP	O
.	.	.	O	O
-	-	HYPH	B-NP	O
Y	Y	NN	I-NP	O
.	.	NN	I-NP	O
,	,	,	O	O
Vallejo	Vallejo	NNP	B-NP	O
-	-	HYPH	I-NP	O
Ramirez	Ramirez	NNP	I-NP	O
,	,	,	O	O
J	J	NNP	B-NP	O
.	.	.	O	O
,	,	,	O	O
Inouye	Inouye	NNP	B-NP	O
,	,	,	O	O
S	S	NNP	B-NP	O
.	.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Inouye	Inouye	NNP	B-NP	O
,	,	,	O	O
M	M	NNP	B-NP	O
.	.	.	O	O


Surprisingly	Surprisingly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
full	full	JJ	I-NP	O
-	-	HYPH	I-NP	O
deletion	deletion	NN	I-NP	B-DNA
mutant	mutant	NN	I-NP	I-DNA
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
block	block	NN	I-NP	O
in	in	IN	B-PP	O
virus	virus	NN	B-NP	O
release	release	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
NC	NC	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
virus	virus	NN	B-NP	O
assembly	assembly	NN	I-NP	O
.	.	.	O	O


Furthermore	Furthermore	RB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
FK506	FK506	NN	B-NP	O
plasma	plasma	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
concerned	concern	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
appearance	appearance	NN	I-NP	O
of	of	IN	B-PP	O
side	side	NN	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O


Thirty	Thirty	CD	B-NP	O
percent	percent	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
were	be	VBD	B-VP	O
tapered	taper	VBN	I-VP	O
off	off	RP	B-PRT	O
all	all	DT	B-NP	O
steroids	steroid	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
average	average	JJ	I-NP	O
steroid	steroid	NN	I-NP	O
dose	dose	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O
who	who	WP	B-NP	O
received	receive	VBD	B-VP	O
steroids	steroid	NNS	B-NP	O
was	be	VBD	B-VP	O
8.6	8.6	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O


Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
cibenzoline	cibenzoline	NN	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
effective	effective	JJ	I-NP	O
antiarrhythmic	antiarrhythmic	JJ	I-NP	O
agent	agent	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
favourable	favourable	JJ	I-NP	O
pharmacokinetic	pharmacokinetic	JJ	I-NP	O
profile	profile	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
class	class	NN	I-NP	O
I	I	CD	B-NP	O
drugs	drug	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
requiring	require	VBG	B-VP	O
therapy	therapy	NN	B-NP	O
for	for	IN	B-PP	O
high	high	JJ	B-NP	O
risk	risk	NN	I-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
.	.	.	O	O


T	T	NN	B-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
contains	contain	VBZ	B-VP	O
four	four	CD	B-NP	O
H	H	NN	I-NP	O
-	-	HYPH	B-NP	O
2Db	2Db	NN	I-NP	O
-	-	HYPH	B-VP	O
restricted	restrict	VBN	B-NP	O
cytotoxic	cytotoxic	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
lymphocyte	lymphocyte	NN	I-NP	I-cell_type
(	(	(	O	O
CTL	CTL	NN	B-NP	B-cell_type
)	)	)	O	O
recognition	recognition	NN	B-NP	O
epitopes	epitope	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
targets	target	NNS	B-NP	O
for	for	IN	B-PP	O
CTL	CTL	NN	B-NP	B-cell_line
clones	clone	NNS	I-NP	I-cell_line
Y	Y	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
Y	Y	NN	B-NP	O
-	-	HYPH	O	O
2	2	CD	B-NP	O
,	,	,	O	O
Y	Y	NN	B-NP	O
-	-	HYPH	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Y	Y	NN	B-NP	B-protein
-	-	HYPH	O	I-protein
5	5	CD	B-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
method	method	NN	I-NP	O
requires	require	VBZ	B-VP	O
a	a	DT	B-NP	O
reversed	reverse	VBN	I-NP	O
-	-	HYPH	I-NP	O
phase	phase	NN	I-NP	O
column	column	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
paired	paired	JJ	I-NP	O
-	-	HYPH	I-NP	O
ion	ion	NN	I-NP	O
technique	technique	NN	I-NP	O
to	to	TO	B-PP	O
separate	separate	JJ	B-NP	O
docusate	docusate	NN	I-NP	O
sodium	sodium	NN	I-NP	O
from	from	IN	B-PP	O
other	other	JJ	B-NP	O
components	component	NNS	I-NP	O
.	.	.	O	O


Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	B-protein
product	product	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ref	ref	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
stimulates	stimulate	VBZ	B-VP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
Fos	Fos	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
Jun	Jun	NN	I-NP	B-protein
heterodimers	heterodimer	NNS	I-NP	I-protein
,	,	,	O	O
Jun	Jun	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
Jun	Jun	NN	I-NP	B-protein
homodimers	homodimer	NNS	I-NP	I-protein
and	and	CC	O	O
Hela	Hela	NN	B-NP	B-protein
cell	cell	NN	I-NP	I-protein
AP	AP	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
other	other	JJ	I-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
including	include	VBG	B-PP	O
NF	NF	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
,	,	,	O	O
Myb	Myb	NN	B-NP	B-protein
and	and	CC	O	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ATF	ATF	NN	I-NP	B-protein
/	/	SYM	B-NP	O
CREB	CREB	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
pulpal	pulpal	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
permanent	permanent	JJ	I-NP	O
mandibular	mandibular	JJ	I-NP	O
molars	molar	NNS	I-NP	O
were	be	VBD	B-VP	O
amputated	amputate	VBN	I-VP	O
and	and	CC	O	O
then	then	RB	B-VP	O
dressed	dress	VBN	I-VP	O
with	with	IN	B-PP	O
calcium	calcium	NN	B-NP	O
hydrate	hydrate	NN	I-NP	O
.	.	.	O	O


Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
3.9	3.9	CD	B-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
5	5	CD	I-NP	O
-	-	HYPH	I-NP	O
kilobase	kilobase	NN	I-NP	B-RNA
mRNAs	mRNA	NNS	I-NP	I-RNA
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cDNA	cDNA	NN	I-NP	B-DNA
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
tissues	tissue	NNS	I-NP	O
examined	examine	VBN	B-VP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
it	it	PRP	B-NP	O
encodes	encode	VBZ	B-VP	O
performs	perform	VBZ	B-VP	O
a	a	DT	B-NP	O
housekeeping	housekeeping	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
ARG	ARG	NN	I-NP	B-protein
SH2	SH2	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
exhibited	exhibit	VBD	B-VP	O
relatively	relatively	RB	B-NP	O
weak	weak	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
BCR	BCR	NN	B-NP	B-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
about	about	RB	B-NP	O
10	10	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	RB	I-NP	O
less	less	RBR	I-ADVP	O
strongly	strongly	RB	I-ADVP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
ABL	ABL	NN	I-NP	B-protein
SH2	SH2	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
.	.	.	O	O


We	We	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
an	an	DT	B-NP	O
EBV	EBV	NN	I-NP	B-cell_line
B	B	NN	I-NP	I-cell_line
-	-	HYPH	B-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
clone	clone	NN	I-NP	I-cell_line
,	,	,	O	O
E29.1	E29.1	NN	B-NP	B-protein
,	,	,	O	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
11	11	CD	I-NP	O
week	week	NN	I-NP	O
-	-	HYPH	B-NP	O
old	old	JJ	I-NP	O
embryo	embryo	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
secreting	secrete	VBG	B-VP	O
both	both	CC	O	O
IgM	IgM	NN	B-NP	B-protein
kappa	kappa	NN	I-NP	O
and	and	CC	O	O
IgM	IgM	NN	B-NP	B-protein
lambda	lambda	NN	I-NP	O
.	.	.	O	O


Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
activation	activation	NN	I-NP	O
occurred	occur	VBD	B-VP	O
only	only	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
regions	region	NNS	I-NP	O
were	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
relative	relative	JJ	I-NP	O
orientation	orientation	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
they	they	PRP	B-NP	O
exist	exist	VBP	B-VP	O
on	on	IN	B-PP	O
wild	wild	JJ	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
type	type	NN	I-NP	I-protein
pCF10	pCF10	NN	I-NP	I-protein
.	.	.	O	O


In	In	IN	B-PP	O
rats	rat	NNS	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
omentum	omentum	NN	I-NP	O
wrapping	wrap	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
vascularization	vascularization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
trachea	trachea	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
regeneration	regeneration	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mucosal	mucosal	JJ	I-NP	O
epithelium	epithelium	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
very	very	RB	I-NP	O
early	early	JJ	I-NP	O
stage	stage	NN	I-NP	O
after	after	IN	B-PP	O
free	free	JJ	B-NP	O
tracheal	tracheal	JJ	I-NP	O
grafting	grafting	NN	I-NP	O
.	.	.	O	O


To	To	TO	B-VP	O
study	study	VB	I-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
functional	functional	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
putative	putative	JJ	I-NP	O
chicken	chicken	NN	I-NP	O
ICS	ICS	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
spanning	span	VBG	B-VP	O
the	the	DT	B-NP	O
upstream	upstream	JJ	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
BF	BF	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
IV	IV	CD	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
(	(	(	O	O
-	-	SYM	B-NP	B-DNA
174	174	CD	B-NP	I-DNA
/	/	SYM	I-NP	I-DNA
-	-	SYM	I-NP	I-DNA
194	194	CD	I-NP	I-DNA
)	)	)	O	O
was	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
singly	singly	RB	B-ADVP	O
or	or	CC	O	O
in	in	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
copies	copy	NNS	I-NP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
herpes	herpes	NN	I-NP	B-DNA
TK	TK	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
controlling	control	VBG	B-VP	O
the	the	DT	B-NP	O
chloramphenicol	chloramphenicol	NN	I-NP	B-DNA
acetyl	acetyl	NN	I-NP	I-DNA
transferase	transferase	NN	I-NP	I-DNA
(	(	(	O	I-DNA
CAT	CAT	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
(	(	(	O	O
pBLCAT2	pBLCAT2	NN	B-NP	B-DNA
)	)	)	O	O
.	.	.	O	O


In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
two	two	CD	B-NP	O
separate	separate	JJ	I-NP	O
high	high	JJ	I-NP	O
-	-	HYPH	I-NP	O
performance	performance	NN	I-NP	B-protein
liquid	liquid	JJ	I-NP	I-protein
chromatographic	chromatographic	JJ	I-NP	I-protein
runs	run	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
one	one	CD	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
gamma	gamma	SYM	I-NP	O
-	-	HYPH	I-NP	O
aminobutyric	aminobutyric	JJ	I-NP	O
acid	acid	NN	I-NP	O
determination	determination	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
monoamines	monoamine	NNS	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
successful	successful	JJ	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
electroconvulsive	electroconvulsive	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
young	young	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
adult	adult	JJ	B-NP	O
GM2	GM2	NN	I-NP	O
gangliosidosis	gangliosidosis	NN	I-NP	O
.	.	.	O	O


Entry	Entry	NN	B-NP	O
of	of	IN	B-PP	O
yeast	yeast	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
into	into	IN	B-PP	O
the	the	DT	B-NP	O
mitotic	mitotic	JJ	I-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
(	(	(	O	O
Start	Start	NN	B-NP	O
)	)	)	O	O
involves	involve	VBZ	B-VP	O
a	a	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CDC28	CDC28	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
that	that	WDT	B-NP	O
associates	associate	VBZ	B-VP	O
with	with	IN	B-PP	O
G1	G1	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
specific	specific	JJ	I-NP	I-protein
cyclins	cyclin	NNS	I-NP	I-protein
encoded	encode	VBN	B-VP	O
by	by	IN	B-PP	O
CLN1	CLN1	NN	B-NP	B-protein
and	and	CC	O	O
CLN2	CLN2	NN	B-NP	B-protein
(	(	(	O	O
ref	ref	NN	B-NP	O
.	.	.	O	O


Through	Through	IN	B-PP	O
Southern	Southern	JJ	B-NP	O
blot	blot	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
from	from	IN	B-PP	O
backcross	backcross	NN	B-NP	O
and	and	CC	O	O
cogenic	cogenic	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
recombinant	recombinant	JJ	B-NP	B-protein
inbred	inbred	JJ	I-NP	I-protein
strains	strain	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
somatic	somatic	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
hybrids	hybrid	NNS	I-NP	I-cell_line
,	,	,	O	O
the	the	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
loci	locus	NNS	I-NP	O
that	that	WDT	B-NP	O
produce	produce	VBP	B-VP	O
the	the	DT	B-NP	O
cyclin	cyclin	NN	I-NP	B-DNA
B1	B1	NN	I-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
related	relate	VBN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
(	(	(	O	O
designated	designate	VBN	B-NP	O
loci	locus	NNS	I-NP	O
Cycb1	Cycb1	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
rs1	rs1	NN	I-NP	B-protein
to	to	TO	B-PP	O
Cycb1	Cycb1	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
rs9	rs9	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
mapped	map	VBN	I-VP	O
on	on	IN	B-PP	O
mouse	mouse	NN	B-NP	B-DNA
chromosomes	chromosome	NNS	I-NP	I-DNA
5	5	CD	B-NP	I-DNA
,	,	,	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
17	17	CD	I-NP	O
,	,	,	I-NP	O
4	4	CD	I-NP	O
,	,	,	I-NP	O
14	14	CD	I-NP	O
,	,	,	I-NP	O
13	13	CD	I-NP	O
,	,	,	I-NP	O
7	7	CD	I-NP	O
,	,	,	O	O
X	X	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
8	8	CD	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O


Again	Again	NN	B-NP	O
residue	residue	NN	I-NP	O
Glu	Glu	NN	I-NP	O
-	-	HYPH	O	O
381	381	CD	B-NP	O
of	of	IN	B-PP	O
beta	beta	NN	B-NP	O
was	be	VBD	B-VP	O
notably	notably	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
and	and	CC	O	O
no	no	DT	B-NP	O
missing	missing	JJ	I-NP	O
residue	residue	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
epsilon	epsilon	NN	I-NP	O
peptide	peptide	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
identified	identify	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
peptide	peptide	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
limited	limit	VBD	B-VP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
choices	choice	NNS	I-NP	O
to	to	TO	B-PP	O
Ser	Ser	NN	B-NP	B-protein
-	-	HYPH	O	O
106	106	CD	B-NP	O
,	,	,	O	O
Ser	Ser	NN	B-NP	B-protein
-	-	HYPH	O	O
107	107	CD	B-NP	O
,	,	,	O	O
or	or	CC	O	O
Ser	Ser	NN	B-NP	O
-	-	SYM	B-NP	O
108	108	CD	B-NP	O
.	.	.	O	O


Porcelain	Porcelain	NN	B-NP	O
to	to	TO	B-VP	O
dentin	dentin	VB	I-VP	O
bond	bond	NN	B-NP	O
strength	strength	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
dentin	dentin	NN	I-NP	O
adhesive	adhesive	JJ	B-ADJP	O
.	.	.	O	O


TBPf	TBPf	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
defined	define	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
quotient	quotient	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
difference	difference	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
measurement	measurement	NN	I-NP	O
:	:	:	O	O
TBPf	TBPf	NN	B-NP	B-protein
=	=	SYM	B-NP	O
(	(	(	O	O
P1	P1	NN	B-NP	B-DNA
-	-	HYPH	B-NP	O
P2	P2	NN	I-NP	B-DNA
)	)	)	O	O
/	/	SYM	O	O
(	(	(	O	O
A1	A1	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
A2	A2	NN	I-NP	B-protein
)	)	)	O	O
.	.	.	O	O


It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
Scotchbond	Scotchbond	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
and	and	CC	O	O
Prisma	Prisma	NNP	B-NP	O
Universal	Universal	NNP	I-NP	O
Bond	Bond	NNP	I-NP	B-protein
2	2	CD	I-NP	I-protein
are	be	VBP	B-VP	O
effective	effective	JJ	B-ADJP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
dentine	dentine	JJ	I-NP	O
bonding	bonding	NN	I-NP	O
agents	agent	NNS	I-NP	O
of	of	IN	B-PP	O
choice	choice	NN	B-NP	O
.	.	.	O	O


From	From	IN	B-PP	O
all	all	DT	B-NP	O
clinically	clinically	RB	I-NP	O
important	important	JJ	I-NP	O
yeasts	yeast	NNS	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
ATB	ATB	NN	B-NP	O
method	method	NN	I-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
conventional	conventional	JJ	B-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
neurohypophysial	neurohypophysial	JJ	I-NP	O
vasopressin	vasopressin	NN	I-NP	O
and	and	CC	I-NP	O
oxytocin	oxytocin	NN	I-NP	O
content	content	NN	I-NP	O
was	be	VBD	B-VP	O
bioassayed	bioassay	VBN	I-VP	O
by	by	IN	B-PP	O
pressor	pressor	NN	B-NP	O
effect	effect	NN	I-NP	O
following	follow	VBG	B-PP	O
Dekanski	Dekanski	NNP	B-NP	O
or	or	CC	O	O
milk	milk	NN	B-NP	O
-	-	HYPH	O	O
ejection	ejection	NN	B-NP	O
activity	activity	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
following	follow	VBG	B-PP	O
van	van	NNP	B-NP	O
Dongen	Dongen	NNP	I-NP	O
and	and	CC	O	O
Hays	Hays	NNP	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O


Comments	Comment	NNS	B-NP	O
are	be	VBP	B-VP	O
given	give	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
regulations	regulation	NNS	B-NP	O
concerning	concern	VBG	B-VP	O
water	water	NN	B-NP	O
in	in	IN	B-PP	O
swimming	swimming	NN	B-NP	O
pools	pool	NNS	I-NP	O
and	and	CC	I-NP	O
baths	bath	NNS	I-NP	O
-	-	SYM	B-NP	O
-	-	SYM	B-NP	O
1991	1991	CD	I-NP	O
-	-	HYPH	O	O
-	-	HYPH	O	O
(	(	(	O	O
in	in	IN	B-PP	O
connection	connection	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
KOK	KOK	NN	I-NP	O
regulations	regulation	NNS	I-NP	O
-	-	SYM	B-NP	O
-	-	SYM	B-NP	O
1972	1972	CD	I-NP	O
-	-	HYPH	O	O
-	-	HYPH	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
Federal	Federal	JJ	I-NP	O
German	German	JJ	I-NP	O
standard	standard	NN	I-NP	O
[	[	(	O	O
DIN	DIN	NN	B-NP	O
]	]	)	O	O
No	No	NNP	B-NP	O
.	.	.	O	O


If	If	IN	B-SBAR	O
no	no	DT	B-NP	O
reply	reply	NN	I-NP	O
was	be	VBD	B-VP	O
received	receive	VBN	I-VP	O
,	,	,	O	O
telephone	telephone	NN	B-NP	O
contact	contact	NN	I-NP	O
or	or	CC	I-NP	O
home	home	NN	I-NP	O
visits	visit	NNS	I-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
treatment	treatment	NN	I-NP	O
group	group	NN	I-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
T	T	NN	I-NP	O
-	-	HYPH	B-NP	O
cell	cell	NN	I-NP	O
activation	activation	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
initial	initial	JJ	I-NP	O
lymphopenia	lymphopenia	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
rebound	rebound	NN	I-NP	O
lymphocytosis	lymphocytosis	NN	I-NP	O
and	and	CC	I-NP	O
upregulation	upregulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
subset	subset	NN	I-NP	O
markers	marker	NNS	I-NP	O
CD25	CD25	NN	I-NP	B-protein
(	(	(	O	O
interleukin	interleukin	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
)	)	)	O	O
and	and	CC	O	O
CD45RO	CD45RO	NN	B-NP	B-protein
(	(	(	O	O
T	T	NN	B-NP	O
-	-	HYPH	I-NP	O
memory	memory	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
)	)	)	O	O
.	.	.	O	O


Urease	Urease	NN	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
judged	judge	VBN	B-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
ammonia	ammonia	NN	B-NP	O
production	production	NN	I-NP	O
from	from	IN	B-PP	O
urea	urea	NN	B-NP	O
,	,	,	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
measured	measure	VBN	I-VP	O
at	at	IN	B-PP	O
25	25	CD	B-NP	O
ng	ng	NN	I-NP	O
per	per	IN	B-PP	O
tube	tube	NN	B-NP	O
(	(	(	O	O
S	S	NN	B-NP	B-protein
/	/	SYM	O	I-protein
N	N	NN	B-NP	I-protein
=	=	SYM	B-VP	I-protein
1.5	1.5	CD	B-NP	I-protein
)	)	)	O	O
with	with	IN	B-PP	O
Jack	Jack	NNP	B-NP	O
bean	bean	NN	I-NP	O
meal	meal	JJ	I-NP	O
urease	urease	NN	I-NP	O
.	.	.	O	O


Consequently	Consequently	RB	B-ADVP	O
,	,	,	O	O
significant	significant	JJ	B-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
measured	measure	VBN	I-NP	O
and	and	CC	I-NP	O
calculated	calculate	VBN	I-NP	O
methods	method	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
uptake	uptake	NN	I-NP	O
(	(	(	O	O
213	213	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
41	41	CD	B-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	B-NP	O
min	min	NN	I-NP	O
vs	vs	IN	B-PP	O
193	193	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
25	25	CD	B-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	O	O
min	min	NN	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
0.001	0.001	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
delivery	delivery	NN	I-NP	O
(	(	(	O	O
780	780	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
297	297	CD	B-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	B-NP	O
min	min	NN	I-NP	O
vs	vs	IN	B-PP	O
716	716	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
296	296	CD	B-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	O	O
min	min	NN	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
0.001	0.001	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
(	(	(	O	O
5.8	5.8	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
2.2	2.2	CD	B-NP	O
L	L	NN	I-NP	O
/	/	SYM	O	O
min	min	NN	B-NP	O
vs	vs	IN	B-PP	O
5.3	5.3	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
1.8	1.8	CD	B-NP	O
L	L	NN	I-NP	O
/	/	SYM	O	O
min	min	NN	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
0.001	0.001	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O


Although	Although	IN	B-SBAR	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
cognitive	cognitive	JJ	B-NP	O
functions	function	NNS	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
tested	test	VBN	I-VP	O
,	,	,	O	O
all	all	DT	O	O
but	but	IN	B-PP	O
one	one	CD	B-NP	O
seizure	seizure	NN	I-NP	O
occurred	occur	VBD	B-VP	O
during	during	IN	B-PP	O
assessment	assessment	NN	B-NP	O
of	of	IN	B-PP	O
memory	memory	NN	B-NP	O
performance	performance	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
experiments	experiment	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
micromilieu	micromilieu	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alveoli	alveolus	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
condition	condition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AM	AM	NN	I-NP	O
(	(	(	O	O
certain	certain	JJ	B-NP	O
physiological	physiological	JJ	I-NP	O
activation	activation	NN	I-NP	O
states	state	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
phagocytic	phagocytic	JJ	B-NP	O
activity	activity	NN	I-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
essentially	essentially	RB	B-ADVP	O
determine	determine	VBP	B-VP	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
recovery	recovery	NN	B-NP	O
.	.	.	O	O


Negatively	Negatively	RB	B-NP	O
supercoiled	supercoile	VBN	I-NP	O
plasmid	plasmid	NN	I-NP	O
pUC19	pUC19	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
compete	compete	VB	I-VP	O
,	,	,	O	O
whereas	whereas	IN	O	O
an	an	DT	B-NP	O
otherwise	otherwise	RB	I-NP	O
identical	identical	JJ	I-NP	O
plasmid	plasmid	NN	I-NP	O
pUC19	pUC19	NN	I-NP	O
(	(	(	O	O
CG	CG	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
contained	contain	VBD	B-VP	O
a	a	DT	O	O
(	(	(	O	O
dG	dG	NN	B-NP	O
-	-	HYPH	B-NP	O
dC	dC	NN	I-NP	O
)	)	)	O	O
7	7	CD	B-NP	O
segment	segment	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Z	Z	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
form	form	NN	I-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
excellent	excellent	JJ	I-NP	O
competitor	competitor	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
cDNA	cDNA	NN	I-NP	B-DNA
library	library	NN	I-NP	I-DNA
of	of	IN	B-PP	O
tumour	tumour	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
interleukin	interleukin	NN	I-NP	B-DNA
2	2	CD	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
probe	probe	NN	I-NP	O
.	.	.	O	O


Our	Our	PRP$	B-NP	O
experiments	experiment	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
SCL	SCL	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
can	can	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
target	target	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
erythroid	erythroid	JJ	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
GATA	GATA	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
SCL	SCL	NN	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
product	product	NN	I-NP	I-protein
serves	serve	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	B-protein
regulator	regulator	NN	I-NP	I-protein
of	of	IN	B-PP	O
erythroid	erythroid	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
lumenal	lumenal	JJ	I-NP	B-protein
domains	domain	NNS	I-NP	I-protein
of	of	IN	B-PP	O
Sec12p	Sec12p	NN	B-NP	O
,	,	,	I-NP	O
Stl1p	Stl1p	NN	I-NP	O
and	and	CC	I-NP	O
Stl2p	Stl2p	NN	I-NP	O
are	be	VBP	B-VP	O
very	very	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
and	and	CC	O	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
appreciable	appreciable	JJ	I-NP	O
homology	homology	NN	I-NP	O
.	.	.	O	O


Complexes	Complex	NNS	B-NP	O
containing	contain	VBG	B-VP	O
wild	wild	JJ	B-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
and	and	CC	O	O
either	either	CC	O	O
his175	his175	NN	B-NP	O
or	or	CC	O	O
his273	his273	NN	B-NP	O
mutant	mutant	JJ	I-NP	O
p53	p53	NN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
completely	completely	RB	B-ADJP	O
unable	unable	JJ	I-ADJP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
RGC	RGC	NN	I-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
.	.	.	O	O


These	These	DT	B-NP	O
temperature	temperature	NN	I-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
cold	cold	JJ	I-NP	O
-	-	HYPH	I-NP	O
sensitive	sensitive	JJ	I-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
prepare	prepare	VB	I-VP	O
extracts	extract	NNS	B-NP	O
deficient	deficient	JJ	B-ADJP	O
in	in	IN	B-PP	O
BRF1	BRF1	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
RNA	RNA	NN	B-NP	B-protein
polymerases	polymeras	NNS	I-NP	I-protein
I	I	CD	I-NP	I-protein
,	,	,	I-NP	O
II	II	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
III	III	CD	B-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O


These	These	DT	B-NP	O
results	result	NNS	I-NP	O
lead	lead	VBP	B-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
hypothesize	hypothesize	VB	I-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
multisubunit	multisubunit	JJ	I-NP	B-protein
TFIID	TFIID	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
supports	support	VBZ	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
by	by	IN	B-PP	O
diverse	diverse	JJ	B-NP	B-protein
activation	activation	NN	I-NP	I-protein
domains	domain	NNS	I-NP	I-protein
and	and	CC	B-PP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
TATA	TATA	NN	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
less	less	JJ	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O


The	The	DT	B-NP	O
gene	gene	NN	I-NP	O
sequence	sequence	NN	I-NP	O
also	also	RB	B-ADVP	O
identified	identify	VBD	B-VP	O
a	a	DT	B-NP	O
340	340	CD	I-NP	O
-	-	HYPH	I-NP	O
nucleotide	nucleotide	NN	I-NP	B-RNA
RNA	RNA	NN	I-NP	I-RNA
in	in	IN	B-PP	O
total	total	JJ	B-NP	O
yeast	yeast	NN	I-NP	O
RNA	RNA	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
purified	purify	VBN	B-NP	O
RNase	RNase	NN	I-NP	B-protein
MRP	MRP	NN	I-NP	O
enzyme	enzyme	NN	I-NP	O
preparations	preparation	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
RNase	RNase	NN	I-NP	B-DNA
MRP	MRP	NN	I-NP	I-DNA
RNA	RNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
deleted	delete	VBN	I-VP	O
by	by	IN	B-PP	O
insertional	insertional	JJ	B-NP	O
replacement	replacement	NN	I-NP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
viability	viability	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
RNase	RNase	NN	B-NP	B-protein
MRP	MRP	NN	I-NP	O
.	.	.	O	O


Clone	Clone	NN	B-NP	O
pSRc200	pSRc200	NN	I-NP	O
hybrid	hybrid	NN	I-NP	O
selected	select	VBD	B-VP	O
an	an	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
that	that	IN	B-SBAR	O
on	on	IN	B-PP	O
cell	cell	NN	B-NP	O
-	-	HYPH	B-NP	O
free	free	JJ	I-NP	O
translation	translation	NN	I-NP	O
produced	produce	VBD	B-VP	O
a	a	DT	B-NP	O
38	38	CD	I-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
polypeptide	polypeptide	NN	I-NP	O
.	.	.	O	O


From	From	IN	B-PP	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
,	,	,	O	O
CBF	CBF	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
A	A	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
CArG	CArG	NN	I-NP	B-protein
box	box	NN	I-NP	I-protein
-	-	HYPH	B-ADJP	O
,	,	,	O	O
ssDNA	ssDNA	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
RNA	RNA	NN	I-NP	B-protein
-	-	HYPH	O	I-protein
binding	bind	VBG	B-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
repressive	repressive	JJ	I-NP	B-protein
transcriptional	transcriptional	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
.	.	.	O	O


Cleavage	Cleavage	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
intron	intron	NN	I-NP	B-DNA
-	-	HYPH	B-VP	O
encoded	encode	VBN	B-NP	O
enzyme	enzyme	NN	I-NP	O
(	(	(	O	O
I	I	NN	B-NP	O
-	-	HYPH	B-NP	O
CreI	CreI	NN	I-NP	B-protein
)	)	)	O	O
occurs	occur	VBZ	B-VP	O
5	5	CD	B-NP	O
bp	bp	NN	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
bp	bp	NN	I-NP	O
3	3	CD	I-NP	O
'	'	SYM	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
intron	intron	NN	I-NP	B-DNA
insertion	insertion	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
(	(	(	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
3	3	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
exon	exon	NN	I-NP	I-DNA
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
top	top	JJ	I-NP	O
(	(	(	O	O
/	/	SYM	O	O
)	)	)	O	O
and	and	CC	O	O
bottom	bottom	NN	B-NP	O
(	(	(	O	O
,	,	,	O	O
)	)	)	O	O
strands	strand	NNS	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
4	4	CD	B-NP	O
-	-	HYPH	I-NP	O
nt	nt	NN	I-NP	O
single	single	JJ	I-NP	O
-	-	HYPH	I-NP	O
stranded	stranded	JJ	I-NP	O
overhangs	overhang	NNS	I-NP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	B-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
OH	OH	NN	I-NP	I-DNA
termini	terminus	NNS	I-NP	I-DNA
.	.	.	O	O


Surprisingly	Surprisingly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
Xenopus	Xenopus	NN	I-NP	B-DNA
U7	U7	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
two	two	CD	B-NP	O
adjacent	adjacent	JJ	I-NP	O
octamer	octamer	NN	I-NP	B-DNA
-	-	HYPH	B-VP	I-DNA
binding	bind	VBG	B-NP	I-DNA
motifs	motif	NNS	I-NP	I-DNA
located	locate	VBN	B-VP	O
only	only	RB	B-NP	O
12	12	CD	I-NP	O
and	and	CC	I-NP	O
24	24	CD	I-NP	B-DNA
bp	bp	NN	I-NP	I-DNA
upstream	upstream	RB	B-ADVP	I-DNA
from	from	IN	B-PP	O
the	the	DT	B-NP	O
PSE	PSE	NN	I-NP	B-DNA
,	,	,	O	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
usual	usual	JJ	I-NP	O
location	location	NN	I-NP	O
around	around	RB	B-NP	O
150	150	CD	I-NP	O
-	-	HYPH	I-NP	O
200	200	CD	I-NP	B-DNA
bp	bp	NN	I-NP	I-DNA
upstream	upstream	RB	B-ADVP	I-DNA
.	.	.	O	O


The	The	DT	B-NP	O
results	result	NNS	I-NP	O
support	support	VBP	B-VP	O
earlier	early	JJR	B-NP	O
reports	report	NNS	I-NP	O
that	that	IN	B-SBAR	O
collagenase	collagenase	NN	B-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	O
are	be	VBP	B-VP	O
useful	useful	JJ	B-ADJP	O
in	in	IN	B-PP	O
controlling	control	VBG	B-VP	O
blister	blister	NN	B-NP	O
formation	formation	NN	I-NP	O
in	in	IN	B-PP	O
recessive	recessive	JJ	B-NP	O
dystrophic	dystrophic	JJ	I-NP	O
epidermolysis	epidermolysis	NN	I-NP	O
bullosa	bullosa	NN	I-NP	O
.	.	.	O	O


Mutational	Mutational	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
essential	essential	JJ	B-NP	O
IncP	IncP	NN	I-NP	O
alpha	alpha	NN	I-NP	O
plasmid	plasmid	NN	I-NP	O
transfer	transfer	NN	I-NP	O
genes	gene	NNS	I-NP	O
traF	traF	NN	I-NP	B-protein
and	and	CC	I-NP	O
traG	traG	NN	I-NP	O
and	and	CC	I-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
traF	traF	NN	B-NP	B-protein
in	in	IN	B-PP	O
phage	phage	NN	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
stimulated	stimulate	VBN	I-VP	O
8	8	CD	B-NP	O
-	-	HYPH	I-NP	O
20	20	CD	I-NP	O
-	-	HYPH	B-VP	O
fold	fold	RB	B-ADVP	O
by	by	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
esters	ester	NNS	I-NP	O
accounting	account	VBG	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
observed	observe	VBN	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
C	C	NN	I-NP	I-protein
beta	beta	NN	I-NP	I-protein
.	.	.	O	O


In	In	IN	B-PP	O
humans	human	NNS	B-NP	O
,	,	,	O	O
four	four	CD	B-NP	O
AMP	AMP	NN	I-NP	O
deaminase	deaminase	NN	I-NP	O
variants	variant	NNS	I-NP	O
,	,	,	O	O
termed	term	VBN	B-VP	O
M	M	NN	B-NP	O
(	(	(	O	O
muscle	muscle	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
L	L	NN	B-NP	O
(	(	(	O	O
liver	liver	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
E1	E1	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
E2	E2	NN	B-NP	B-protein
(	(	(	O	O
erythrocyte	erythrocyte	NN	B-NP	B-cell_type
)	)	)	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
distinguished	distinguish	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
biochemical	biochemical	JJ	B-NP	O
and	and	CC	I-NP	O
immunological	immunological	JJ	I-NP	O
criteria	criterion	NNS	I-NP	O
.	.	.	O	O


Western	Western	JJ	B-NP	O
blot	blot	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
detect	detect	VBP	B-VP	O
anti	anti	AFX	O	O
-	-	HYPH	B-NP	B-protein
E	E	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
immunoreactivity	immunoreactivity	NN	I-NP	O
in	in	IN	B-PP	O
affinity	affinity	NN	B-NP	O
-	-	HYPH	B-NP	O
purified	purify	VBN	I-NP	O
extracts	extract	NNS	I-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
truncated	truncate	VBN	I-NP	B-DNA
AMPD3	AMPD3	NN	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
.	.	.	O	O


These	These	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
endogenous	endogenous	JJ	B-NP	B-protein
N	N	NN	I-NP	I-protein
-	-	HYPH	O	O
methylation	methylation	NN	B-NP	O
of	of	IN	B-PP	O
salsolinol	salsolinol	NN	B-NP	O
into	into	IN	B-PP	O
N	N	NN	B-NP	O
-	-	HYPH	B-NP	O
methylsalsolinol	methylsalsolinol	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O


DR1	DR1	NN	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
purified	purify	VBN	B-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
lymphoblastoid	lymphoblastoid	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
could	could	MD	B-VP	O
specifically	specifically	RB	I-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
peptide	peptide	NN	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
expressed	express	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
phage	phage	NN	I-NP	O
surface	surface	NN	I-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
article	article	NN	I-NP	O
describes	describe	VBZ	B-VP	O
the	the	DT	B-NP	O
collaborative	collaborative	JJ	I-NP	O
care	care	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
woman	woman	NN	I-NP	O
participating	participate	VBG	B-VP	O
in	in	IN	B-PP	O
maternal	maternal	JJ	B-NP	O
blood	blood	NN	I-NP	O
donation	donation	NN	I-NP	O
for	for	IN	B-PP	O
intrauterine	intrauterine	JJ	B-NP	O
transfusion	transfusion	NN	I-NP	O
.	.	.	O	O


Chronic	Chronic	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
in	in	IN	B-PP	O
adopted	adopt	VBN	B-NP	O
Romanian	Romanian	JJ	I-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O


Behind	Behind	IN	B-PP	O
the	the	DT	B-NP	O
ATPase	ATPase	NN	I-NP	B-DNA
cluster	cluster	NN	I-NP	I-DNA
,	,	,	O	O
two	two	CD	B-NP	O
open	open	JJ	I-NP	B-DNA
reading	reading	NN	I-NP	I-DNA
frames	frame	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
any	any	DT	B-NP	O
known	know	VBN	I-NP	O
chloroplast	chloroplast	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O


Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
recombinant	recombinant	JJ	B-NP	O
human	human	JJ	I-NP	O
Ads	Ad	NNS	I-NP	O
that	that	WDT	B-NP	O
express	express	VBP	B-VP	O
noninfectious	noninfectious	JJ	B-NP	O
HIV	HIV	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
microbial	microbial	JJ	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
attractive	attractive	JJ	B-NP	O
vaccine	vaccine	NN	I-NP	O
candidates	candidate	NNS	I-NP	O
.	.	.	O	O


Alignment	Alignment	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
selected	select	VBN	I-NP	O
sequences	sequence	NNS	I-NP	O
allowed	allow	VBD	B-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
predict	predict	VB	I-VP	O
a	a	DT	B-NP	O
consensus	consensus	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
for	for	IN	B-PP	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
individual	individual	JJ	I-NP	O
homodimeric	homodimeric	JJ	I-NP	B-protein
Rel	Rel	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
related	relate	VBN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
DNA	DNA	NN	B-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
binding	binding	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
selected	select	VBN	I-NP	O
DNA	DNA	NN	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
revealed	reveal	VBD	B-VP	O
sequence	sequence	NN	B-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proteins	protein	NNS	I-NP	O
.	.	.	O	O


Using	Use	VBG	B-VP	O
either	either	CC	O	O
a	a	DT	B-NP	O
p50	p50	NN	I-NP	B-protein
-	-	HYPH	B-VP	O
or	or	CC	O	O
p65	p65	NN	B-NP	B-protein
-	-	HYPH	O	O
selected	select	VBN	B-NP	O
kappa	kappa	NN	I-NP	B-DNA
B	B	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
displayed	display	VBD	B-VP	O
differential	differential	JJ	B-NP	O
binding	binding	NN	I-NP	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
little	little	JJ	B-NP	O
to	to	TO	B-PP	O
no	no	DT	B-NP	O
binding	binding	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
heterodimeric	heterodimeric	JJ	I-NP	B-protein
NF	NF	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O


However	However	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
cosmid	cosmid	NN	I-NP	B-DNA
clone	clone	NN	I-NP	I-DNA
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	B-DNA
mouse	mouse	NN	I-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
(	(	(	O	I-DNA
I	I	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
,	,	,	O	O
including	include	VBG	B-PP	O
3.7	3.7	CD	B-NP	O
kb	kb	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
and	and	CC	O	O
4	4	CD	B-NP	O
kb	kb	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	B-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
flanking	flank	VBG	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
,	,	,	O	O
was	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
at	at	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
fibroblasts	fibroblast	NNS	B-NP	B-cell_type
overexpressing	overexpresse	VBG	B-VP	O
oncogenic	oncogenic	JJ	B-NP	O
ras	ras	NN	I-NP	O
.	.	.	O	O


To	To	TO	B-VP	O
define	define	VB	I-VP	O
transcriptional	transcriptional	JJ	B-NP	B-DNA
control	control	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
muscle	muscle	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
myoglobin	myoglobin	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
we	we	PRP	B-NP	O
performed	perform	VBD	B-VP	O
mutational	mutational	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
upstream	upstream	JJ	B-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
(	(	(	O	O
nucleotide	nucleotide	NN	B-NP	O
positions	position	NNS	I-NP	O
-	-	SYM	O	O
373	373	CD	B-NP	O
to	to	TO	B-PP	O
+	+	SYM	B-NP	O
7	7	CD	I-NP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-DNA
start	start	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
)	)	)	O	O
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
firefly	firefly	JJ	I-NP	B-DNA
luciferase	luciferase	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O


Sequencing	Sequencing	NN	B-NP	O
analysis	analysis	NN	I-NP	O
has	have	VBZ	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
each	each	DT	B-NP	O
rap1t	rap1t	NN	I-NP	B-DNA
allele	allele	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
nonsense	nonsense	JJ	I-NP	O
mutation	mutation	NN	I-NP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
region	region	NN	I-NP	O
between	between	IN	B-PP	O
amino	amino	NN	B-NP	B-protein
acids	acid	NNS	I-NP	I-protein
663	663	CD	B-NP	I-protein
and	and	CC	I-NP	I-protein
684	684	CD	I-NP	I-protein
.	.	.	O	O


By	By	IN	B-PP	O
screening	screen	VBG	B-VP	O
a	a	DT	B-NP	O
Y1	Y1	NN	I-NP	B-DNA
cell	cell	NN	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
library	library	NN	I-NP	I-DNA
with	with	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	B-DNA
-	-	HYPH	B-PP	I-DNA
binding	bind	VBG	B-NP	I-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
H	H	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
2RIIBP	2RIIBP	NN	I-NP	I-DNA
nuclear	nuclear	JJ	I-NP	I-DNA
hormone	hormone	NN	I-NP	I-DNA
receptor	receptor	NN	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
,	,	,	O	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
a	a	DT	B-NP	O
cDNA	cDNA	NN	I-NP	B-DNA
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
selectively	selectively	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
steroidogenic	steroidogenic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O


Autopsy	Autopsy	NN	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
good	good	JJ	B-NP	O
survival	survival	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transplanted	transplant	VBN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
integration	integration	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
recipient	recipient	NN	I-NP	O
and	and	CC	I-NP	O
traces	trace	NNS	I-NP	O
of	of	IN	B-PP	O
positive	positive	JJ	B-NP	O
immunocytochemical	immunocytochemical	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
for	for	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	B-protein
hydroxylase	hydroxylase	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
technique	technique	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TEE	TEE	NN	I-NP	O
visualization	visualization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
shows	show	VBZ	B-VP	O
high	high	JJ	B-NP	O
G	G	NN	I-NP	O
+	+	SYM	B-VP	O
C	C	NN	B-NP	O
content	content	NN	I-NP	O
(	(	(	O	O
62	62	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
particularly	particularly	RB	I-VP	O
emphasized	emphasize	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
200	200	CD	I-NP	B-DNA
bp	bp	NN	I-NP	I-DNA
upstream	upstream	RB	B-ADVP	I-DNA
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
start	start	NN	I-NP	O
(	(	(	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
G	G	NN	I-NP	O
+	+	SYM	B-NP	O
C	C	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


In	In	IN	B-PP	O
the	the	DT	B-NP	O
eight	eight	CD	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
generalized	generalize	VBN	I-NP	O
lymph	lymph	NN	I-NP	O
-	-	HYPH	O	O
adenopathy	adenopathy	NN	B-NP	O
(	(	(	O	O
PGL	PGL	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
nontender	nontender	JJ	B-NP	O
,	,	,	I-NP	O
nonenlarging	nonenlarging	JJ	I-NP	O
nodes	node	NNS	I-NP	O
,	,	,	O	O
pathologic	pathologic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
lymphoid	lymphoid	JJ	B-NP	O
hyperplasia	hyperplasia	NN	I-NP	O
.	.	.	O	O


PaO2	PaO2	NN	B-NP	O
threshold	threshold	NN	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
through	through	IN	B-PP	O
an	an	DT	B-NP	O
indwelling	indwell	VBG	I-NP	O
O2	O2	NN	I-NP	O
sensor	sensor	NN	I-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
the	the	DT	B-NP	O
E26	E26	NN	I-NP	B-protein
virus	virus	NN	I-NP	O
-	-	HYPH	B-VP	O
encoded	encode	VBN	B-NP	O
v	v	NN	I-NP	O
-	-	HYPH	B-NP	O
ets	ets	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
myeloid	myeloid	JJ	I-NP	O
/	/	SYM	I-NP	O
B	B	NN	I-NP	B-cell_type
-	-	HYPH	B-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
factor	factor	NN	I-NP	O
PU	PU	NN	I-NP	B-protein
.	.	.	O	I-protein
1	1	CD	B-NP	I-protein
bind	bind	VBP	B-VP	O
efficiently	efficiently	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
site	site	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O


By	By	IN	B-PP	O
using	use	VBG	B-VP	O
lambda	lambda	NN	B-NP	O
gt11	gt11	NN	I-NP	O
expression	expression	NN	I-NP	O
cloning	clone	VBG	B-VP	O
with	with	IN	B-PP	O
oligonucleotides	oligonucleotide	NNS	B-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
immunodeficiency	immunodeficiency	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
TATA	TATA	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cellular	cellular	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
calculated	calculate	VBN	I-NP	O
molecular	molecular	JJ	I-NP	O
mass	mass	NN	I-NP	O
of	of	IN	B-PP	O
123	123	CD	B-NP	B-protein
kDa	kDa	NN	I-NP	I-protein
that	that	IN	B-NP	O
we	we	PRP	B-NP	O
designate	designate	VBP	B-VP	O
TATA	TATA	NN	B-NP	B-DNA
element	element	NN	I-NP	I-DNA
modulatory	modulatory	JJ	I-NP	O
factor	factor	NN	I-NP	O
(	(	(	O	O
TMF	TMF	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O


Blood	Blood	NN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
melatonin	melatonin	NN	B-NP	O
,	,	,	O	O
serotonin	serotonin	NN	B-NP	O
,	,	,	O	O
cortisol	cortisol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
prolactin	prolactin	NN	B-NP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
circadian	circadian	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
of	of	IN	B-PP	O
platelet	platelet	NN	B-NP	O
serotonin	serotonin	NN	I-NP	O
uptake	uptake	NN	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
couldn	couldn	VBP	B-VP	O
'	'	``	O	O
t	t	NN	B-NP	O
detect	detect	VB	B-VP	O
any	any	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
n	n	NN	B-NP	O
-	-	HYPH	I-NP	O
3	3	CD	I-NP	O
FA	FA	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
on	on	IN	B-PP	O
total	total	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
HDL	HDL	NN	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
LDL	LDL	NN	B-NP	B-protein
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
apo	apo	NN	B-NP	B-protein
A1	A1	NN	I-NP	I-protein
,	,	,	O	O
Lp	Lp	NN	B-NP	O
(	(	(	O	O
a	a	DT	O	O
)	)	)	O	O
,	,	,	O	O
HbA1C	HbA1C	NN	B-NP	B-protein
,	,	,	O	O
glucose	glucose	NN	B-NP	O
,	,	,	O	O
fibrinogen	fibrinogen	NN	B-NP	B-protein
,	,	,	O	O
factor	factor	NN	B-NP	O
VIII	VIII	CD	I-NP	O
,	,	,	O	O
antithrombin	antithrombin	NN	B-NP	B-protein
III	III	CD	I-NP	I-protein
,	,	,	O	O
plasminogen	plasminogen	NN	B-NP	B-protein
activator	activator	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	I-protein
,	,	,	O	O
tissue	tissue	NN	B-NP	B-protein
plasminogen	plasminogen	NN	I-NP	I-protein
activator	activator	NN	I-NP	I-protein
and	and	CC	O	O
von	von	NN	B-NP	B-protein
Willebrand	Willebrand	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
concentration	concentration	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
time	time	NN	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
or	or	CC	I-NP	O
diastolic	diastolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
8	8	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
AUC	AUC	NN	B-NP	O
,	,	,	O	O
peak	peak	JJ	B-NP	O
plasma	plasma	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
or	or	CC	O	O
time	time	NN	B-NP	O
to	to	TO	B-PP	O
peak	peak	JJ	B-NP	O
concentration	concentration	NN	I-NP	O
when	when	WRB	B-ADVP	O
OXC	OXC	NN	B-NP	B-protein
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
either	either	CC	B-PP	O
with	with	IN	I-PP	O
or	or	CC	B-PP	O
without	without	IN	I-PP	O
ERY	ERY	NN	B-NP	O
.	.	.	O	O


Using	Use	VBG	B-VP	O
5	5	CD	B-NP	O
ng	ng	NN	I-NP	O
/	/	SYM	B-NP	O
mL	mL	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
cutoff	cutoff	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
CEA	CEA	NN	B-NP	B-protein
was	be	VBD	B-VP	O
68	68	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O


Rolandic	Rolandic	JJ	B-NP	O
spikes	spike	NNS	I-NP	O
and	and	CC	O	O
cognitive	cognitive	JJ	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	B-protein
18	18	CD	I-NP	I-protein
beta	beta	SYM	O	I-protein
-	-	HYPH	O	O
glycyrrhetate	glycyrrhetate	NN	B-NP	O
(	(	(	O	O
SGA	SGA	NN	B-NP	B-protein
)	)	)	O	O
on	on	IN	B-PP	O
experimental	experimental	JJ	B-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O


Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
decrease	decrease	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
H	H	NN	B-NP	O
or	or	CC	I-NP	O
P	P	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
fall	fall	NN	I-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
control	control	NN	B-NP	O
(	(	(	O	O
201	201	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
3	3	CD	B-NP	O
v	v	SYM	I-NP	O
175	175	CD	I-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
4	4	CD	I-NP	O
,	,	,	I-NP	O
167	167	CD	I-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	O
-	-	SYM	I-NP	O
4	4	CD	I-NP	O
mm	mm	NN	I-NP	O
Hg	Hg	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
;	;	:	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
.	.	.	I-NP	O
05	05	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
diltiazem	diltiazem	NN	B-NP	O
were	be	VBD	B-VP	O
stereoselective	stereoselective	JJ	B-ADJP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
the	the	DT	B-NP	O
potentiation	potentiation	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
d	d	NN	B-NP	O
-	-	HYPH	I-NP	O
cis	cis	NN	I-NP	O
diltiazem	diltiazem	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
cases	case	NNS	I-NP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
l	l	NN	B-NP	O
-	-	HYPH	I-NP	O
cis	cis	NN	I-NP	O
diltiazem	diltiazem	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
calcium	calcium	NN	B-NP	O
channel	channel	NN	I-NP	O
blockade	blockade	NN	I-NP	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
interactions	interaction	NNS	I-NP	O
.	.	.	O	O


Localization	Localization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brachial	brachial	JJ	I-NP	O
plexus	plexus	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
nerve	nerve	NN	I-NP	O
stimulator	stimulator	NN	I-NP	O
is	be	VBZ	B-VP	O
equally	equally	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
interscalene	interscalene	NN	I-NP	O
,	,	,	O	O
supraclavicular	supraclavicular	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
axillary	axillary	JJ	B-NP	O
sites	site	NNS	I-NP	O
.	.	.	O	O


Substitution	Substitution	NN	B-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
Val33	Val33	NN	B-NP	B-protein
(	(	(	O	O
by	by	IN	B-PP	O
Gly	Gly	NN	B-NP	B-protein
)	)	)	O	O
or	or	CC	O	O
Gly28	Gly28	NN	B-NP	B-protein
(	(	(	O	O
by	by	IN	B-PP	O
Ser	Ser	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
two	two	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
conserved	conserve	VBN	I-NP	O
residues	residue	NNS	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
protein	protein	NN	I-NP	B-protein
kinases	kinase	NNS	I-NP	I-protein
,	,	,	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
enzyme	enzyme	NN	B-NP	O
with	with	IN	B-PP	O
marginally	marginally	RB	B-NP	O
detectable	detectable	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O


Significance	Significance	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
biopsy	biopsy	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
latissimus	latissimus	JJ	I-NP	O
dorsi	dorsi	NN	I-NP	O
muscle	muscle	NN	I-NP	O
for	for	IN	B-PP	O
fiber	fiber	NN	B-NP	O
typing	typing	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
TIMP	TIMP	NN	I-NP	B-DNA
(	(	(	O	I-DNA
-	-	SYM	B-NP	I-DNA
59	59	CD	B-NP	I-DNA
/	/	SYM	I-NP	I-DNA
-	-	SYM	I-NP	I-DNA
53	53	CD	I-NP	I-DNA
)	)	)	O	I-DNA
AP1	AP1	NN	B-NP	I-DNA
site	site	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
promiscuous	promiscuous	JJ	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
c	c	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
Fos	Fos	NN	I-NP	I-protein
/	/	SYM	B-NP	O
c	c	NN	I-NP	O
-	-	HYPH	B-NP	O
Jun	Jun	NN	I-NP	B-protein
AP1	AP1	NN	I-NP	B-protein
translated	translate	VBN	B-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
effective	effective	JJ	I-NP	O
competitor	competitor	NN	I-NP	O
for	for	IN	B-PP	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
AP1	AP1	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	B-DNA
TRE	TRE	NN	I-NP	I-DNA
,	,	,	O	O
but	but	CC	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
it	it	PRP	B-NP	O
binds	bind	VBZ	B-VP	O
factors	factor	NNS	B-NP	O
that	that	WDT	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
associate	associate	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	B-DNA
TRE	TRE	NN	I-NP	I-DNA
.	.	.	O	O


Involvement	Involvement	NN	B-NP	O
of	of	IN	B-PP	O
AP1	AP1	NN	B-NP	B-protein
and	and	CC	I-NP	O
PEA3	PEA3	NN	I-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
murine	murine	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
of	of	IN	B-PP	O
metalloproteinases	metalloproteinas	NNS	B-NP	B-protein
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
TIMP	TIMP	NN	O	B-protein
-	-	HYPH	O	I-protein
1	1	CD	O	I-protein
)	)	)	O	O
transcription	transcription	NN	B-NP	O
.	.	.	O	O


Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	B-protein
neutralizing	neutralizing	NN	I-NP	I-protein
(	(	(	O	I-protein
SN	SN	NN	B-NP	I-protein
)	)	)	O	I-protein
antibody	antibody	NN	B-NP	I-protein
negative	negative	JJ	I-NP	O
calves	calf	NNS	I-NP	O
89.7	89.7	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
26	26	CD	B-NP	O
/	/	SYM	B-NP	O
29	29	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
92.8	92.8	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
90	90	CD	B-NP	O
/	/	SYM	O	O
97	97	CD	B-NP	O
)	)	)	O	O
developed	develop	VBD	B-VP	O
SN	SN	NN	B-NP	O
antibody	antibody	NN	I-NP	O
1	1	CD	I-NP	O
month	month	NN	I-NP	O
after	after	IN	B-PP	O
intranasal	intranasal	JJ	B-NP	O
and	and	CC	I-NP	O
intramuscular	intramuscular	JJ	I-NP	O
vaccination	vaccination	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O


Fractionation	Fractionation	NN	B-NP	O
of	of	IN	B-PP	O
crude	crude	JJ	B-NP	O
nuclear	nuclear	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
by	by	IN	B-PP	O
heparin	heparin	NN	B-NP	O
-	-	HYPH	B-NP	O
agarose	agarose	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
PCAT	PCAT	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
is	be	VBZ	B-VP	O
more	more	RBR	B-ADJP	O
prevalent	prevalent	JJ	I-ADJP	O
in	in	IN	B-PP	O
extracts	extract	NNS	B-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
salt	salt	NN	B-NP	O
-	-	HYPH	B-NP	O
stressed	stress	VBN	I-NP	O
leaf	leaf	NN	I-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
controlled	control	VBN	I-NP	O
trial	trial	NN	I-NP	O
of	of	IN	B-PP	O
recombinant	recombinant	JJ	B-NP	B-protein
human	human	JJ	I-NP	I-protein
granulocyte	granulocyte	NN	I-NP	I-protein
-	-	HYPH	O	I-protein
macrophage	macrophage	NN	B-NP	I-protein
colony	colony	NN	I-NP	I-protein
-	-	HYPH	O	I-protein
stimulating	stimulate	VBG	B-VP	I-protein
factor	factor	NN	B-NP	I-protein
after	after	IN	B-PP	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
irradiation	irradiation	NN	I-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
dose	dose	NN	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
autologous	autologous	JJ	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
transplantation	transplantation	NN	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
or	or	CC	O	O
malignant	malignant	JJ	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
DMVA	DMVA	NN	B-NP	B-protein
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
cause	cause	VB	I-VP	O
more	more	RBR	B-NP	O
myocardial	myocardial	JJ	I-NP	O
trauma	trauma	NN	I-NP	O
than	than	IN	B-PP	O
CPB	CPB	NN	B-NP	B-protein
when	when	WRB	B-ADVP	O
used	use	VBN	B-VP	O
to	to	TO	B-VP	O
provide	provide	VB	I-VP	O
resuscitative	resuscitative	JJ	B-NP	O
circulatory	circulatory	JJ	I-NP	O
support	support	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
IgG	IgG	NN	I-NP	O
subclass	subclass	NN	I-NP	O
profile	profile	NN	I-NP	O
of	of	IN	B-PP	O
untreated	untreated	JJ	B-NP	O
coeliac	coeliac	JJ	I-NP	O
disease	disease	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
as	as	IN	B-PP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
controls	control	NNS	I-NP	O
(	(	(	O	O
IgG1	IgG1	NN	B-NP	O
approximately	approximately	RB	B-NP	O
IgG2	IgG2	NN	I-NP	B-protein
>	>	SYM	B-NP	O
IgG3	IgG3	NN	I-NP	O
>	>	SYM	B-NP	O
IgG4	IgG4	NN	I-NP	B-protein
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
only	only	RB	B-NP	O
the	the	DT	I-NP	O
magnitude	magnitude	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
individual	individual	JJ	I-NP	O
subclass	subclass	NN	I-NP	O
responses	response	NNS	I-NP	O
being	be	VBG	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
coeliac	coeliac	JJ	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O


Examination	Examination	NN	B-NP	O
of	of	IN	B-PP	O
ANCA	ANCA	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
contribution	contribution	NN	I-NP	O
towards	towards	IN	B-PP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
accurate	accurate	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
vasculitis	vasculitis	NN	I-NP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
an	an	DT	B-NP	O
indicator	indicator	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
effectiveness	effectiveness	NN	I-NP	O
of	of	IN	B-PP	O
immunosuppressive	immunosuppressive	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O


On	On	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
pinealectomy	pinealectomy	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
already	already	RB	I-NP	O
sympathectomized	sympathectomize	VBN	I-NP	O
blinded	blind	VBN	I-NP	O
rabbits	rabbit	NNS	I-NP	O
always	always	RB	B-ADVP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
substantial	substantial	JJ	I-NP	O
deceleration	deceleration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rhythms	rhythm	NNS	I-NP	O
(	(	(	O	O
mean	mean	NN	B-NP	O
delta	delta	SYM	O	O
tau	tau	SYM	B-NP	O
=	=	SYM	B-VP	O
+	+	SYM	B-NP	O
0.23	0.23	CD	B-NP	O
h	h	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


Cicatricial	Cicatricial	JJ	B-NP	O
pemphigoid	pemphigoid	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
autoimmune	autoimmune	JJ	I-NP	O
systemic	systemic	JJ	I-NP	O
disease	disease	NN	I-NP	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
conjunctival	conjunctival	JJ	I-NP	O
cicatrization	cicatrization	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
caffeine	caffeine	NN	B-NP	O
ingestion	ingestion	NN	I-NP	O
on	on	IN	B-PP	O
excess	excess	JJ	B-NP	O
postexercise	postexercise	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
consumption	consumption	NN	I-NP	O
in	in	IN	B-PP	O
untrained	untrained	JJ	B-NP	O
women	woman	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
distinguishing	distinguishing	JJ	I-NP	O
features	feature	NNS	I-NP	O
involved	involve	VBD	B-VP	O
eight	eight	CD	B-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
lysine	lysine	NN	I-NP	O
deletion	deletion	NN	I-NP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
primate	primate	JJ	I-NP	B-DNA
consensus	consensus	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
complementary	complementary	JJ	I-NP	O
-	-	HYPH	I-NP	O
determing	determe	VBG	B-VP	O
region	region	NN	B-NP	O
of	of	IN	B-PP	O
V1J1	V1J1	NN	B-NP	B-protein
.	.	.	O	O


4	4	LS	B-LST	O
.	.	.	O	O


The	The	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
profile	profile	NN	I-NP	O
of	of	IN	B-PP	O
ZFH	ZFH	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
larval	larval	JJ	I-NP	O
CNS	CNS	NN	I-NP	B-protein
shows	show	VBZ	B-VP	O
intriguing	intriguing	JJ	B-NP	O
overlap	overlap	NN	I-NP	O
with	with	IN	B-PP	O
DDC	DDC	NN	B-NP	B-protein
in	in	IN	B-PP	O
specific	specific	JJ	B-NP	O
serotonin	serotonin	NN	I-NP	O
and	and	CC	I-NP	O
dopamine	dopamine	NN	I-NP	O
neurons	neuron	NNS	I-NP	O
.	.	.	O	O


Unlike	Unlike	IN	B-PP	O
the	the	DT	B-NP	O
introns	intron	NNS	I-NP	B-DNA
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
duplicated	duplicate	VBN	I-NP	O
ribosomal	ribosomal	JJ	I-NP	B-DNA
protein	protein	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
highly	highly	RB	I-VP	O
diverged	diverge	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
duplicated	duplicate	VBN	I-NP	O
S13	S13	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
have	have	VBP	B-VP	O
two	two	CD	B-NP	O
nearly	nearly	RB	I-NP	O
identical	identical	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
31	31	CD	I-NP	I-DNA
bp	bp	NN	I-NP	I-DNA
in	in	IN	B-PP	O
length	length	NN	B-NP	O
within	within	IN	B-PP	O
their	their	PRP$	B-NP	O
introns	intron	NNS	I-NP	B-DNA
.	.	.	O	O


In	In	IN	B-PP	O
a	a	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
,	,	,	O	O
randomized	randomize	VBN	B-VP	O
clinical	clinical	JJ	B-NP	O
trial	trial	NN	I-NP	O
we	we	PRP	B-NP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
subcutaneously	subcutaneously	RB	B-NP	O
(	(	(	O	O
SC	SC	NN	B-NP	O
)	)	)	O	O
administered	administer	VBN	B-VP	O
(	(	(	O	O
every	every	DT	B-NP	O
8	8	CD	I-NP	O
h	h	NN	I-NP	O
)	)	)	O	O
calcium	calcium	NN	B-NP	O
heparin	heparin	NN	I-NP	O
to	to	TO	B-PP	O
intravenous	intravenous	JJ	B-NP	O
(	(	(	O	O
IV	IV	CD	O	O
)	)	)	O	O
sodium	sodium	NN	B-NP	O
heparin	heparin	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
proximal	proximal	JJ	B-NP	O
deep	deep	JJ	I-NP	O
-	-	HYPH	I-NP	O
vein	vein	NN	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
(	(	(	O	O
DVT	DVT	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
highest	high	JJS	I-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
reported	report	VBN	B-NP	O
pet	pet	NN	I-NP	O
allergy	allergy	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
wheeze	wheeze	NN	B-NP	O
,	,	,	O	O
attacks	attack	NNS	B-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
wheezing	wheezing	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
doctor	doctor	NN	B-NP	O
-	-	HYPH	O	O
diagnosed	diagnose	VBN	B-NP	O
asthma	asthma	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
pets	pet	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-ADVP	O
anymore	anymore	RB	I-ADVP	O
.	.	.	O	O


Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
advantageous	advantageous	JJ	B-ADJP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
such	such	JJ	B-NP	O
persons	person	NNS	I-NP	O
and	and	CC	O	O
treat	treat	VB	B-VP	O
them	them	PRP	B-NP	O
preferentially	preferentially	RB	B-ADVP	O
.	.	.	O	O


On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
unique	unique	JJ	I-NP	O
properties	property	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
newly	newly	RB	I-NP	O
characterized	characterize	VBN	I-NP	O
hemagglutinin	hemagglutinin	NN	I-NP	B-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
termed	term	VBN	I-VP	O
Limulus	Limulus	NN	B-NP	B-protein
18K	18K	NN	I-NP	I-protein
agglutination	agglutination	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
aggregation	aggregation	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
18K	18K	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
LAF	LAF	NN	I-NP	B-protein
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
shift	shift	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nonpermissive	nonpermissive	JJ	I-NP	O
temperature	temperature	NN	I-NP	O
is	be	VBZ	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
guanyl	guanyl	NN	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
adenylylcyclase	adenylylcyclase	NN	B-NP	B-protein
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O


Clin	Clin	NN	B-NP	B-protein
.	.	.	O	O


The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
minimal	minimal	JJ	I-NP	B-protein
catalytic	catalytic	JJ	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
Nmt1p	Nmt1p	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
located	located	JJ	B-ADJP	O
between	between	IN	B-PP	O
Ile59	Ile59	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
-	-	SYM	I-NP	O
>	>	SYM	I-NP	O
Phe96	Phe96	NN	I-NP	B-protein
and	and	CC	I-NP	O
Gly451	Gly451	NN	I-NP	O
-	-	SYM	B-NP	O
-	-	HYPH	B-NP	O
>	>	SYM	I-NP	O
Leu455	Leu455	NN	I-NP	O
.	.	.	O	O


It	It	PRP	B-NP	O
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
mitochondrial	mitochondrial	JJ	I-NP	O
presequence	presequence	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
lipoyl	lipoyl	NN	I-NP	B-protein
-	-	HYPH	O	I-protein
bearing	bear	VBG	B-VP	I-protein
domain	domain	NN	B-NP	I-protein
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
encoded	encode	VBN	I-VP	O
by	by	IN	B-PP	O
exons	exon	NNS	B-NP	B-DNA
I	I	CD	B-NP	I-DNA
through	through	IN	B-PP	O
IV	IV	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	B-DNA
E2	E2	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O


Human	Human	JJ	B-NP	O
neutrophil	neutrophil	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
short	short	JJ	B-NP	O
-	-	HYPH	I-NP	O
term	term	NN	I-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
F	F	NN	B-NP	B-protein
-	-	HYPH	O	O
75	75	CD	B-NP	O
cobalt	cobalt	NN	I-NP	O
-	-	HYPH	O	O
based	base	VBN	B-NP	O
alloy	alloy	NN	I-NP	O
.	.	.	O	O


Disruption	Disruption	NN	B-NP	O
of	of	IN	B-PP	O
microtubules	microtubule	NNS	B-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
fidelity	fidelity	NN	I-NP	O
or	or	CC	I-NP	O
kinetics	kinetic	NNS	I-NP	O
of	of	IN	B-PP	O
vacuolar	vacuolar	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
sorting	sorting	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
Vps1p	Vps1p	NN	B-NP	O
function	function	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
microtubules	microtubule	NNS	B-NP	B-protein
.	.	.	O	O


A	A	DT	B-NP	O
mutant	mutant	JJ	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
Vps1p	Vps1p	NN	B-NP	B-protein
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
GTP	GTP	NN	I-NP	B-protein
-	-	HYPH	B-PP	I-protein
binding	bind	VBG	B-NP	I-protein
domain	domain	NN	I-NP	I-protein
interfered	interfere	VBD	B-VP	O
with	with	IN	B-PP	O
vacuolar	vacuolar	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
sorting	sorting	NN	I-NP	O
in	in	IN	B-PP	O
wild	wild	JJ	B-NP	B-cell_line
-	-	HYPH	I-NP	I-cell_line
type	type	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O


According	Accord	VBG	B-PP	O
to	to	TO	B-PP	O
out	out	RP	B-PRT	O
field	field	NN	B-NP	O
research	research	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
tick	tick	NN	I-NP	O
fauna	fauna	NN	I-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
rich	rich	JJ	I-ADJP	O
throughout	throughout	IN	B-PP	O
that	that	DT	B-NP	O
area	area	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
permissible	permissible	JJ	B-ADJP	O
enough	enough	RB	I-ADJP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
ticks	tick	NNS	B-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
vectors	vector	NNS	I-NP	O
,	,	,	O	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
arising	arise	VBG	B-VP	O
of	of	IN	B-PP	O
anti	anti	AFX	B-NP	O
-	-	HYPH	I-NP	B-protein
SF	SF	NN	I-NP	I-protein
group	group	NN	I-NP	I-protein
rickettsiae	rickettsiae	NN	I-NP	I-protein
(	(	(	O	I-protein
SFGR	SFGR	NN	B-NP	I-protein
)	)	)	O	I-protein
antibody	antibody	NN	B-NP	I-protein
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
inoculated	inoculate	VBN	B-VP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
tick	tick	NN	I-NP	O
emulsions	emulsion	NNS	I-NP	O
,	,	,	O	O
findings	finding	NNS	B-NP	O
of	of	IN	B-PP	O
rickettsiae	rickettsia	NNS	B-NP	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
sera	serum	NNS	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
species	species	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
monoclonal	monoclonal	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
to	to	TO	B-PP	O
JSFR	JSFR	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hemolymph	hemolymph	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
some	some	DT	B-NP	O
ticks	tick	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
electron	electron	NN	B-NP	O
microscopical	microscopical	JJ	I-NP	O
observations	observation	NNS	I-NP	O
of	of	IN	B-PP	O
SFGR	SFGR	NN	B-NP	B-protein
in	in	IN	B-PP	O
various	various	JJ	B-NP	O
internal	internal	JJ	I-NP	O
organs	organ	NNS	I-NP	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
salivary	salivary	JJ	I-NP	O
gland	gland	NN	I-NP	O
of	of	IN	B-PP	O
ticks	tick	NNS	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
second	second	JJ	I-NP	O
method	method	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
"	"	``	I-NP	O
macro	macro	NN	I-NP	O
"	"	''	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
0.03	0.03	CD	B-NP	O
-	-	HYPH	I-NP	O
5.0	5.0	CD	I-NP	O
micrograms	microgram	NNS	I-NP	O
phosphorus	phosphorus	NN	I-NP	O
with	with	IN	B-PP	O
100	100	CD	B-NP	O
-	-	HYPH	I-NP	O
500	500	CD	I-NP	O
microliters	microliter	NNS	I-NP	O
HClO4	HClO4	NN	I-NP	O
.	.	.	O	O


Nucleotide	Nucleotide	NN	B-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
and	and	CC	O	O
transcriptional	transcriptional	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
polyhedrin	polyhedrin	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
of	of	IN	B-PP	O
Spodoptera	Spodoptera	NN	B-NP	O
exigua	exigua	NN	I-NP	O
nuclear	nuclear	JJ	I-NP	O
polyhedrosis	polyhedrosis	NN	I-NP	O
virus	virus	NN	I-NP	O
.	.	.	O	O


Validation	Validation	NN	B-NP	O
of	of	IN	B-PP	O
automated	automated	JJ	B-NP	O
systems	system	NNS	I-NP	O
-	-	HYPH	B-NP	O
-	-	HYPH	I-NP	O
system	system	NN	I-NP	O
definition	definition	NN	I-NP	O
.	.	.	O	O


As	As	IN	B-PP	O
a	a	DT	B-NP	O
consequence	consequence	NN	I-NP	O
of	of	IN	B-PP	O
dark	dark	JJ	B-NP	O
rearing	rearing	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
numerical	numerical	JJ	I-NP	O
density	density	NN	I-NP	O
of	of	IN	B-PP	O
cortical	cortical	JJ	B-NP	O
neurons	neuron	NNS	I-NP	O
in	in	IN	B-PP	O
area	area	NN	B-NP	O
17	17	CD	I-NP	O
amounted	amounte	VBD	B-VP	O
to	to	TO	B-PP	O
about	about	RB	B-NP	O
double	double	JJ	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
value	value	NN	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
normally	normally	RB	B-NP	O
reared	rear	VBN	I-NP	O
kittens	kitten	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
area	area	NN	B-NP	O
18	18	CD	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
decreased	decrease	VBN	B-NP	O
class	class	NN	I-NP	B-DNA
I	I	CD	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
Ad12	Ad12	NN	B-NP	B-cell_line
-	-	HYPH	B-NP	I-cell_line
transformed	transform	VBN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
may	may	MD	B-VP	O
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
,	,	,	O	O
be	be	VB	B-VP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
higher	high	JJR	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
enhancer	enhancer	NN	I-NP	B-DNA
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
factor	factor	NN	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADVP	O
acting	act	VBG	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
repressor	repressor	NN	I-NP	B-protein
.	.	.	O	O


A	A	DT	B-NP	O
second	second	JJ	I-NP	O
domain	domain	NN	I-NP	O
,	,	,	O	O
located	located	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
terminal	terminal	JJ	I-NP	I-protein
437	437	CD	I-NP	I-protein
amino	amino	NN	I-NP	I-protein
acids	acid	NNS	I-NP	I-protein
of	of	IN	B-PP	O
IE1	IE1	NN	B-NP	B-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
inhibitory	inhibitory	JJ	B-NP	O
and	and	CC	I-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-NP	O
activities	activity	NNS	I-NP	O
.	.	.	O	O


In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
compatibility	compatibility	NN	I-NP	O
of	of	IN	B-PP	O
autogenous	autogenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
(	(	(	O	O
AVG	AVG	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
prostacyclin	prostacyclin	NN	B-NP	O
(	(	(	O	O
PGI2	PGI2	NN	B-NP	B-protein
)	)	)	O	O
production	production	NN	B-NP	O
following	follow	VBG	B-PP	O
harvesting	harvesting	NN	B-NP	O
and	and	CC	O	O
arterial	arterial	JJ	B-NP	O
implantation	implantation	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
experimentally	experimentally	RB	B-ADVP	O
.	.	.	O	O


Subcutaneous	Subcutaneous	JJ	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
somatostatin	somatostatin	NN	I-NP	O
analogue	analogue	NN	I-NP	O
,	,	,	O	O
octreotide	octreotide	NN	B-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
thrice	thrice	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
sustained	sustained	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
diarrhoea	diarrhoea	NN	B-NP	O
and	and	CC	I-NP	O
disappearance	disappearance	NN	I-NP	O
of	of	IN	B-PP	O
faecal	faecal	JJ	B-NP	O
incontinence	incontinence	NN	I-NP	O
without	without	IN	B-PP	O
reducing	reduce	VBG	B-VP	O
calcitonin	calcitonin	NN	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O


Anti	Anti	AFX	B-NP	O
-	-	HYPH	I-NP	B-protein
CRK	CRK	NN	I-NP	I-protein
antibodies	antibody	NNS	I-NP	I-protein
detect	detect	VBP	B-VP	O
a	a	DT	B-NP	O
53kDa	53kDa	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
in	in	IN	B-PP	O
extracts	extract	NNS	B-NP	O
of	of	IN	B-PP	O
C	C	NN	B-NP	O
.	.	.	O	O
fasciculata	fasciculata	NN	B-NP	O
in	in	IN	B-PP	O
agreement	agreement	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
size	size	NN	I-NP	O
predicted	predict	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cloned	clone	VBN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O


205	205	CD	B-NP	O
,	,	,	I-NP	O
285	285	CD	I-NP	O
-	-	HYPH	I-NP	O
290	290	CD	I-NP	O
]	]	)	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
cloned	clone	VBN	I-VP	O
and	and	CC	O	O
sequenced	sequence	VBN	B-VP	O
[	[	(	O	O
J	J	NN	B-NP	O
.	.	.	O	O


Nonreplicating	Nonreplicate	VBG	B-VP	O
vaccinia	vaccinia	NN	B-NP	O
vector	vector	NN	I-NP	O
efficiently	efficiently	RB	B-ADVP	O
expresses	express	VBZ	B-VP	O
recombinant	recombinant	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O


Use	Use	NN	B-NP	O
of	of	IN	B-PP	O
free	free	JJ	B-NP	O
-	-	HYPH	I-NP	O
access	access	NN	I-NP	O
minerals	mineral	NNS	I-NP	O
.	.	.	O	O


Interferon	Interferon	NN	B-NP	B-protein
type	type	NN	I-NP	I-protein
I	I	CD	I-NP	I-protein
in	in	IN	B-PP	O
protective	protective	JJ	B-NP	O
body	body	NN	I-NP	O
reactions	reaction	NNS	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
Klebsiella	Klebsiella	NN	I-NP	O
infection	infection	NN	I-NP	O


No	No	DT	B-NP	O
other	other	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	O
differentiation	differentiation	NN	I-NP	O
status	status	NN	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
Id	Id	NN	B-NP	B-protein
-	-	HYPH	O	O
SCL	SCL	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
.	.	.	O	O


Respiratory	Respiratory	JJ	B-NP	O
interaction	interaction	NN	I-NP	O
after	after	IN	B-PP	O
spinal	spinal	JJ	B-NP	O
anesthesia	anesthesia	NN	I-NP	O
and	and	CC	I-NP	O
sedation	sedation	NN	I-NP	O
with	with	IN	B-PP	O
midazolam	midazolam	NN	B-NP	O
.	.	.	O	O


For	For	IN	B-PP	O
pressure	pressure	NN	B-NP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
121	121	CD	I-NP	B-protein
atm	atm	NN	I-NP	I-protein
abs	ab	NNS	I-NP	I-protein
,	,	,	O	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
excitability	excitability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tadpoles	tadpole	NNS	I-NP	O
made	make	VBD	B-VP	O
it	it	PRP	B-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
distinguish	distinguish	VB	I-VP	O
the	the	DT	B-NP	O
righting	righting	JJ	I-NP	O
reflex	reflex	NN	I-NP	O
from	from	IN	B-PP	O
involuntary	involuntary	JJ	B-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O


One	One	CD	B-NP	O
air	air	NN	I-NP	O
embolism	embolism	NN	I-NP	O
occurred	occur	VBD	B-VP	O
;	;	:	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
filter	filter	NN	I-NP	O
-	-	HYPH	B-NP	O
or	or	CC	I-NP	O
retrieval	retrieval	NN	I-NP	O
-	-	HYPH	O	O
related	relate	VBN	B-NP	O
complication	complication	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
ADH5	ADH5	NN	B-NP	B-protein
contains	contain	VBZ	B-VP	O
consensus	consensus	NN	B-NP	B-DNA
binding	binding	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-protein
regulatory	regulatory	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
Sp1	Sp1	NN	B-NP	B-protein
,	,	,	O	O
AP2	AP2	NN	B-NP	B-protein
,	,	,	O	O
LF	LF	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
A1	A1	NN	I-NP	I-protein
,	,	,	O	O
NF	NF	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
NF	NF	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
A2	A2	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
NF	NF	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
E1	E1	NN	I-NP	I-protein
.	.	.	O	O


V	V	NN	B-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
RNK	RNK	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
Met	Met	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
serine	serine	NN	I-NP	B-protein
protease	protease	NN	I-NP	I-protein
with	with	IN	B-PP	O
unique	unique	JJ	B-NP	O
activity	activity	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
granules	granule	NNS	I-NP	O
of	of	IN	B-PP	O
large	large	JJ	B-NP	B-cell_type
granular	granular	JJ	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
.	.	.	O	O


Purification	Purification	NN	B-NP	O
and	and	CC	I-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
serine	serine	NN	I-NP	B-protein
protease	protease	NN	I-NP	I-protein
,	,	,	O	O
RNK	RNK	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
Met	Met	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
granules	granule	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
rat	rat	NN	I-NP	O
natural	natural	JJ	I-NP	O
killer	killer	NN	I-NP	O
cell	cell	NN	I-NP	O
leukemia	leukemia	NN	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
describe	describe	VBP	B-VP	O
here	here	RB	B-ADVP	O
17	17	CD	B-NP	O
dominant	dominant	JJ	I-NP	O
GCN2	GCN2	NN	I-NP	O
mutations	mutation	NNS	I-NP	O
that	that	WDT	B-NP	O
lead	lead	VBP	B-VP	O
to	to	TO	B-PP	O
derepression	derepression	NN	B-NP	O
of	of	IN	B-PP	O
GCN4	GCN4	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
amino	amino	JJ	B-NP	O
acid	acid	NN	I-NP	O
starvation	starvation	NN	I-NP	O
.	.	.	O	O


Administration	Administration	NN	B-NP	O
of	of	IN	B-PP	O
growth	growth	NN	B-NP	O
hormone	hormone	NN	I-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
faster	fast	JJR	B-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
faster	fast	JJR	B-NP	O
bone	bone	NN	I-NP	O
maturation	maturation	NN	I-NP	O
.	.	.	O	O


Comparisons	Comparison	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
available	available	JJ	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
residue	residue	NN	I-NP	O
(	(	(	O	O
aa	aa	NN	B-NP	O
)	)	)	O	O
sequence	sequence	NN	B-NP	O
information	information	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
CPMV	CPMV	NN	I-NP	B-DNA
RNA	RNA	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
partial	partial	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
red	red	JJ	B-NP	B-protein
clover	clover	NN	I-NP	I-protein
mottle	mottle	NN	I-NP	I-protein
virus	virus	NN	I-NP	I-protein
RNA	RNA	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
CPSMV	CPSMV	NN	B-NP	B-protein
RNA	RNA	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
specifies	specify	VBZ	B-VP	O
the	the	DT	B-NP	O
expected	expect	VBN	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
mature	mature	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
:	:	:	O	O
32K	32K	NN	B-NP	B-protein
proteinase	proteinase	NN	I-NP	I-protein
cofactor	cofactor	NN	I-NP	I-protein
,	,	,	O	O
58K	58K	NN	B-NP	B-protein
presumed	presume	VBD	B-VP	O
helicase	helicase	NN	B-NP	O
,	,	,	O	O
VPg	VPg	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
'	'	SYM	B-NP	I-protein
-	-	HYPH	B-VP	I-protein
linked	link	VBN	B-NP	I-protein
protein	protein	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genomic	genomic	JJ	I-NP	B-RNA
RNAs	RNA	NNS	I-NP	I-RNA
,	,	,	O	O
24K	24K	NN	B-NP	B-protein
proteinase	proteinase	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
87K	87K	NN	B-NP	B-protein
presumed	presume	VBD	B-VP	I-protein
polymerase	polymerase	NN	B-NP	I-protein
,	,	,	O	O
separated	separate	VBN	B-VP	O
by	by	IN	B-PP	O
four	four	CD	B-NP	O
cleavage	cleavage	NN	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O


Rice	Rice	NN	B-NP	B-RNA
dwarf	dwarf	NN	I-NP	I-RNA
phytoreovirus	phytoreovirus	NN	I-NP	I-RNA
segment	segment	NN	I-NP	I-RNA
S12	S12	NN	I-NP	I-RNA
transcript	transcript	NN	I-NP	I-RNA
is	be	VBZ	B-VP	O
tricistronic	tricistronic	JJ	B-ADJP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O


In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
utility	utility	NN	I-NP	O
of	of	IN	B-PP	O
beta	beta	SYM	B-NP	O
2	2	CD	I-NP	O
transferrin	transferrin	NN	I-NP	O
assay	assay	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
cerebrospinal	cerebrospinal	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
otorrhea	otorrhea	NN	I-NP	O
is	be	VBZ	B-VP	O
presented	present	VBN	I-VP	O
.	.	.	O	O


Cold	Cold	JJ	B-NP	O
cardioplegia	cardioplegia	NN	I-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
at	at	IN	B-PP	O
45	45	CD	B-NP	O
mm	mm	NN	I-NP	O
Hg	Hg	NN	I-NP	O
every	every	DT	B-NP	O
20	20	CD	I-NP	O
minutes	minute	NNS	I-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
diatrizoate	diatrizoate	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
IPRK	IPRK	NN	I-NP	B-protein
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
biphasic	biphasic	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
RPF	RPF	NN	B-NP	B-protein
and	and	CC	I-NP	O
GFR	GFR	NN	I-NP	B-protein
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
initial	initial	JJ	I-NP	O
transient	transient	JJ	I-NP	O
increase	increase	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
and	and	CC	I-NP	O
sustained	sustained	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
.	.	.	O	O


To	To	TO	B-VP	O
prepare	prepare	VB	I-VP	O
for	for	IN	B-PP	O
analyses	analysis	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
variables	variable	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
next	next	JJ	B-NP	O
present	present	JJ	I-NP	O
descriptive	descriptive	JJ	I-NP	O
data	datum	NNS	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
separate	separate	JJ	B-NP	O
principal	principal	JJ	I-NP	O
components	component	NNS	I-NP	O
analysis	analysis	NN	I-NP	O
(	(	(	O	O
PCA	PCA	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
multidimensional	multidimensional	JJ	B-NP	O
scaling	scaling	NN	I-NP	O
analysis	analysis	NN	I-NP	O
(	(	(	O	O
MDS	MDS	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
self	self	NN	I-NP	O
-	-	HYPH	O	O
reported	report	VBN	B-NP	O
health	health	NN	I-NP	O
scores	score	NNS	I-NP	O
for	for	IN	B-PP	O
husbands	husband	NNS	B-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
wives	wife	NNS	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
structural	structural	JJ	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
glyceraldehyde	glyceraldehyde	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
3	3	CD	I-NP	I-protein
-	-	HYPH	I-NP	I-protein
phosphate	phosphate	NN	I-NP	I-protein
dehydrogenase	dehydrogenase	NN	I-NP	I-protein
(	(	(	O	O
GAPDH	GAPDH	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
3	3	CD	B-NP	O
-	-	HYPH	I-NP	O
phosphoglycerate	phosphoglycerate	NN	I-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
(	(	(	O	O
PGK	PGK	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
N	N	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
terminal	terminal	JJ	I-NP	I-protein
part	part	NN	I-NP	I-protein
of	of	IN	B-PP	O
triosephosphate	triosephosphate	NN	B-NP	B-protein
isomerase	isomerase	NN	I-NP	I-protein
(	(	(	O	O
TIM	TIM	NN	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
mesophilic	mesophilic	JJ	B-NP	O
Bacillus	Bacillus	NN	I-NP	O
megaterium	megaterium	NN	I-NP	O
DSM319	DSM319	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
cloned	clone	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
gene	gene	NN	I-NP	O
cluster	cluster	NN	I-NP	O
(	(	(	O	O
gap	gap	NN	B-NP	O
operon	operon	NN	I-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
complementation	complementation	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
Escherichia	Escherichia	FW	I-NP	B-protein
coli	coli	FW	I-NP	I-protein
gap	gap	NN	I-NP	I-protein
amber	amber	NN	I-NP	I-protein
mutant	mutant	NN	I-NP	I-protein
.	.	.	O	O


Pseudomonas	Pseudomonas	NN	B-NP	B-protein
aeruginosa	aeruginosa	NN	I-NP	I-protein
exotoxin	exotoxin	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
:	:	:	O	O
its	its	PRP$	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
retardation	retardation	NN	B-NP	O
of	of	IN	B-PP	O
wound	wound	NN	B-NP	O
healing	healing	NN	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
1992	1992	CD	I-NP	O
Lindberg	Lindberg	NNP	I-NP	O
Award	Award	NNP	I-NP	O
.	.	.	O	O


Laboratory	Laboratory	NN	B-NP	O
studies	study	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
direct	direct	JJ	I-NP	O
fluorescent	fluorescent	JJ	I-NP	O
-	-	HYPH	I-NP	O
antibody	antibody	NN	I-NP	O
kits	kit	NNS	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
least	least	JJS	I-NP	O
sensitive	sensitive	JJ	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
case	case	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
detect	detect	VB	I-VP	O
fewer	few	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
4	4	CD	B-NP	O
)	)	)	O	O
elementary	elementary	JJ	B-NP	O
bodies	body	NNS	I-NP	O
per	per	IN	B-PP	O
ml	ml	NN	B-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
most	most	JJS	B-NP	O
ELISA	ELISA	NN	I-NP	O
kits	kit	NNS	I-NP	O
detected	detect	VBN	B-VP	O
between	between	IN	B-PP	O
130	130	CD	B-NP	O
and	and	CC	I-NP	O
600	600	CD	I-NP	O
elementary	elementary	JJ	I-NP	O
bodies	body	NNS	I-NP	O
per	per	IN	B-PP	O
ml	ml	NN	B-NP	O
.	.	.	O	O


To	To	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
domains	domain	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
overall	overall	JJ	I-NP	O
evolutionary	evolutionary	JJ	I-NP	O
conservation	conservation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
homolog	homolog	NN	I-NP	O
from	from	IN	B-PP	O
Drosophila	Drosophila	FW	B-NP	O
melanogaster	melanogaster	NN	I-NP	O
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
by	by	IN	B-PP	O
low	low	JJ	B-NP	O
stringency	stringency	NN	I-NP	O
hybridizations	hybridization	NNS	I-NP	O
using	use	VBG	B-VP	O
two	two	CD	B-NP	O
flanking	flanking	NN	I-NP	O
probes	probe	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
ERCC3	ERCC3	NN	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
.	.	.	O	O


Mono	Mono	AFX	B-NP	B-cell_type
-	-	HYPH	I-NP	O
ADP	ADP	NN	I-NP	B-protein
-	-	HYPH	O	O
ribosylation	ribosylation	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
reversible	reversible	JJ	I-NP	O
modification	modification	NN	I-NP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
NAD	NAD	NN	B-NP	O
:	:	:	O	O
arginine	arginine	NN	B-NP	B-protein
ADP	ADP	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
ribosyltransferases	ribosyltransferas	NNS	I-NP	I-protein
(	(	(	O	O
EC	EC	NNP	B-NP	B-cell_type
2.4	2.4	CD	I-NP	O
.	.	.	I-NP	O
2.31	2.31	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
ADP	ADP	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
ribosylarginine	ribosylarginine	NN	I-NP	B-protein
hydrolases	hydrolas	NNS	I-NP	I-protein
(	(	(	O	O
EC	EC	NNP	B-NP	B-cell_type
3.2	3.2	CD	I-NP	O
.	.	.	I-NP	O
2.19	2.19	CD	I-NP	O
)	)	)	O	O
catalyzing	catalyze	VBG	B-VP	O
the	the	DT	B-NP	O
opposing	oppose	VBG	I-NP	O
reactions	reaction	NNS	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
ADP	ADP	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
ribosylation	ribosylation	NN	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O


For	For	IN	B-PP	O
this	this	DT	B-NP	O
reason	reason	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
particle	particle	NN	I-NP	O
forming	form	VBG	B-VP	O
capacity	capacity	NN	B-NP	O
of	of	IN	B-PP	O
derivatives	derivative	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HIV	HIV	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
group	group	NN	I-NP	O
specific	specific	JJ	I-NP	O
core	core	NN	I-NP	O
antigen	antigen	NN	I-NP	O
p55	p55	NN	I-NP	O
gag	gag	NN	I-NP	O
was	be	VBD	B-VP	O
assayed	assay	VBN	I-VP	O
and	and	CC	O	O
compared	compare	VBN	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
various	various	JJ	B-NP	O
expression	expression	NN	I-NP	O
systems	system	NNS	I-NP	O
:	:	:	O	O
recombinant	recombinant	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
vaccinia	vaccinia	NN	B-NP	O
-	-	HYPH	B-ADJP	O
and	and	CC	O	O
baculoviruses	baculovirus	NNS	B-NP	O
were	be	VBD	B-VP	O
established	establish	VBN	I-VP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
core	core	NN	I-NP	O
protein	protein	NN	I-NP	O
p55	p55	NN	I-NP	B-protein
either	either	CC	B-PP	O
in	in	IN	B-PP	O
its	its	PRP$	B-NP	O
authentic	authentic	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
or	or	CC	O	O
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
myristylation	myristylation	NN	I-NP	O
consensus	consensus	NN	I-NP	O
signal	signal	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
tramtrack	tramtrack	NN	I-NP	B-DNA
(	(	(	O	I-DNA
ttk	ttk	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
of	of	IN	B-PP	O
Drosophila	Drosophila	NNP	B-NP	O
encodes	encode	VBZ	B-VP	O
69	69	CD	B-NP	O
-	-	HYPH	I-NP	O
kDa	kDa	NN	I-NP	O
and	and	CC	I-NP	O
88	88	CD	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
kDa	kDa	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
through	through	IN	B-PP	O
alternative	alternative	JJ	B-NP	O
splicing	splicing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	B-RNA
ttk	ttk	NN	I-NP	I-RNA
transcript	transcript	NN	I-NP	I-RNA
.	.	.	O	O


Removal	Removal	NN	B-NP	O
of	of	IN	B-PP	O
beta	beta	SYM	B-NP	B-protein
2	2	CD	I-NP	I-protein
-	-	HYPH	I-NP	I-protein
microglobulin	microglobulin	NN	I-NP	I-protein
by	by	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
and	and	CC	I-NP	O
hemofiltration	hemofiltration	NN	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
four	four	CD	I-NP	O
year	year	NN	I-NP	O
follow	follow	VB	B-VP	O
up	up	IN	B-PRT	O
.	.	.	O	O


Removal	Removal	NN	B-NP	O
of	of	IN	B-PP	O
beta	beta	SYM	B-NP	B-protein
2	2	CD	I-NP	I-protein
-	-	HYPH	I-NP	I-protein
microglobulin	microglobulin	NN	I-NP	I-protein
by	by	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
and	and	CC	I-NP	O
hemofiltration	hemofiltration	NN	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
four	four	CD	I-NP	O
year	year	NN	I-NP	O
follow	follow	VB	B-VP	O
up	up	IN	B-PRT	O
.	.	.	O	O


Adapromine	Adapromine	NN	B-NP	O
was	be	VBD	B-VP	O
established	establish	VBN	I-VP	O
to	to	TO	I-VP	O
evoke	evoke	VB	I-VP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
amplitude	amplitude	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
peak	peak	NN	I-NP	O
and	and	CC	O	O
dominant	dominant	JJ	B-NP	B-protein
theta	theta	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
power	power	NN	B-NP	O
spectra	spectrum	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
EEG	EEG	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cortex	cortex	NN	I-NP	O
and	and	CC	I-NP	O
hippocamp	hippocamp	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
wave	wave	NN	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
beta	beta	SYM	I-NP	O
2	2	CD	I-NP	O
range	range	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
cortex	cortex	NN	I-NP	O
and	and	CC	I-NP	O
hippocamp	hippocamp	NN	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
were	be	VBD	B-VP	O
then	then	RB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
clone	clone	VB	I-VP	O
the	the	DT	B-NP	O
full	full	JJ	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
length	length	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
from	from	IN	B-PP	O
a	a	DT	B-NP	O
yeast	yeast	NN	I-NP	B-DNA
genomic	genomic	JJ	I-NP	I-DNA
library	library	NN	I-NP	I-DNA
.	.	.	O	O


GAL4	GAL4	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
VP16	VP16	NN	I-NP	B-protein
-	-	HYPH	O	O
mediated	mediate	VBN	B-NP	O
antirepression	antirepression	NN	I-NP	O
required	require	VBD	B-VP	O
an	an	DT	B-NP	O
auxiliary	auxiliary	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
denoted	denote	VBN	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
co	co	AFX	I-NP	O
-	-	HYPH	I-NP	B-protein
antirepressor	antirepressor	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
partially	partially	RB	I-VP	O
purified	purify	VBN	I-VP	O
from	from	IN	B-PP	O
Drosophila	Drosophila	FW	B-NP	O
embryos	embryo	NNS	I-NP	O
.	.	.	O	O


After	After	IN	B-PP	O
28	28	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
haloperidol	haloperidol	NN	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
similar	similar	JJ	B-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
for	for	IN	B-PP	O
delta	delta	NN	B-NP	B-protein
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
alpha	alpha	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
fast	fast	JJ	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
.	.	.	O	O


Four	Four	CD	B-NP	O
ruminally	ruminally	RB	I-NP	O
and	and	CC	O	O
duodenally	duodenally	RB	B-NP	O
cannulated	cannulate	VBN	I-NP	O
Hampshire	Hampshire	NNP	I-NP	O
wethers	wether	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
4	4	CD	I-NP	O
x	x	NN	I-NP	O
4	4	CD	B-NP	O
Latin	Latin	NN	I-NP	O
square	square	JJ	I-NP	O
experiment	experiment	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
linoleoyl	linoleoyl	NN	B-NP	O
methionine	methionine	NN	I-NP	O
and	and	CC	O	O
calcium	calcium	NN	B-NP	O
linoleate	linoleate	NN	I-NP	O
would	would	MD	B-VP	O
increase	increase	VB	I-VP	O
duodenal	duodenal	JJ	B-NP	O
flow	flow	NN	I-NP	O
of	of	IN	B-PP	O
unsaturated	unsaturated	JJ	B-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
(	(	(	O	O
C18	C18	NN	B-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
cis	cis	NN	I-NP	O
C18	C18	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
)	)	)	O	O
.	.	.	O	O


Truncated	Truncate	VBN	B-NP	O
ICSBP	ICSBP	NN	I-NP	B-protein
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
33	33	CD	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
amino	amino	JJ	I-NP	O
acids	acid	NNS	I-NP	O
fails	fail	VBZ	B-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ICS	ICS	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	B-protein
binding	binding	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
located	located	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
well	well	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
amino	amino	JJ	I-NP	B-protein
terminus	terminus	NN	I-NP	I-protein
.	.	.	O	O


Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
ICSBP	ICSBP	NN	B-NP	B-protein
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
maintaining	maintain	VBG	B-VP	O
submaximal	submaximal	JJ	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
IFN	IFN	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O


A	A	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
C	C	NN	I-NP	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
manifested	manifest	VBN	B-VP	O
during	during	IN	B-PP	O
interferon	interferon	NN	B-NP	O
treatment	treatment	NN	I-NP	O


Dynamic	Dynamic	JJ	B-NP	O
decision	decision	NN	I-NP	O
making	making	NN	I-NP	O
:	:	:	O	O
human	human	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
complex	complex	JJ	B-NP	O
systems	system	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
coiled	coil	VBN	I-NP	O
-	-	HYPH	I-NP	O
coil	coil	NN	I-NP	O
related	relate	VBN	I-NP	O
protein	protein	NN	I-NP	O
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
synapsed	synapse	VBN	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
meiotic	meiotic	JJ	B-NP	B-DNA
prophase	prophase	NN	I-NP	I-DNA
chromosomes	chromosome	NNS	I-NP	I-DNA
.	.	.	O	O


Comparable	Comparable	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
alpha	alpha	SYM	B-NP	B-protein
5	5	CD	B-NP	I-protein
beta	beta	SYM	I-NP	I-protein
1	1	CD	I-NP	I-protein
integrin	integrin	NN	I-NP	I-protein
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
by	by	IN	B-PP	O
chromatography	chromatography	NN	B-NP	O
of	of	IN	B-PP	O
detergent	detergent	JJ	B-NP	O
extracts	extract	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
fibronectin	fibronectin	NN	I-NP	O
cell	cell	NN	I-NP	O
-	-	HYPH	B-VP	O
binding	bind	VBG	I-VP	O
fragment	fragment	NN	B-NP	O
affinity	affinity	NN	I-NP	O
column	column	NN	I-NP	O
and	and	CC	O	O
elution	elution	NN	B-NP	O
with	with	IN	B-PP	O
EDTA	EDTA	NN	B-NP	B-protein
.	.	.	O	O


Abstracts	Abstract	NNS	B-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
opioid	opioid	JJ	I-NP	O
peptides	peptide	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
effects	effect	NNS	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
myocardial	myocardial	JJ	B-NP	O
ischaemia	ischaemia	NN	I-NP	O
and	and	CC	I-NP	O
reperfusion	reperfusion	NN	I-NP	O
,	,	,	O	O
mediated	mediate	VBN	B-VP	O
by	by	IN	B-PP	O
opiate	opiate	JJ	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
through	through	IN	B-PP	O
opiate	opiate	NN	B-NP	O
antagonism	antagonism	NN	I-NP	O
.	.	.	O	O


From	From	IN	B-PP	O
this	this	DT	B-NP	O
library	library	NN	I-NP	O
,	,	,	O	O
LEU2	LEU2	NN	B-NP	B-protein
and	and	CC	I-NP	O
HIS3	HIS3	NN	I-NP	B-DNA
cDNAs	cDNA	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
recovered	recover	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
4	4	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
12	12	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
13	13	CD	B-NP	O
cases	case	NNS	I-NP	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
galactose	galactose	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O


Among	Among	IN	B-PP	O
these	these	DT	B-NP	O
,	,	,	O	O
ACT1	ACT1	NN	B-NP	B-protein
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
NSR1	NSR1	NN	B-NP	B-protein
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
.	.	.	O	O


Since	Since	IN	B-SBAR	O
CENP	CENP	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
B	B	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
conserved	conserve	VBN	I-VP	O
in	in	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	O
species	specie	NNS	I-NP	O
and	and	CC	O	O
CENP	CENP	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
B	B	NN	I-NP	B-DNA
boxes	box	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
also	also	RB	B-ADVP	O
in	in	IN	B-PP	O
mouse	mouse	NN	B-NP	O
centromere	centromere	NN	I-NP	O
satellite	satellite	NN	I-NP	O
DNA	DNA	NN	I-NP	O
(	(	(	O	O
minor	minor	JJ	B-NP	O
satellite	satellite	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
this	this	DT	B-NP	O
sequence	sequence	NN	I-NP	O
-	-	HYPH	O	O
specific	specific	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
interaction	interaction	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
some	some	DT	B-NP	O
kind	kind	NN	I-NP	O
of	of	IN	B-PP	O
common	common	JJ	B-NP	O
centromere	centromere	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O


Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tail	tail	NN	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
(	(	(	O	O
aa	aa	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
094	094	CD	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
830	830	CD	I-NP	O
)	)	)	O	O
shares	share	NNS	B-NP	O
58	58	CD	B-NP	O
%	%	NN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
723	723	CD	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
aa	aa	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
from	from	IN	B-PP	O
mouse	mouse	NN	B-NP	O
brain	brain	NN	I-NP	O
reported	report	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
glutamic	glutamic	JJ	I-NP	B-protein
acid	acid	NN	I-NP	I-protein
decarboxylase	decarboxylase	NN	I-NP	I-protein
.	.	.	O	O


However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
subgroup	subgroup	NN	I-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
Ht	Ht	NN	I-NP	O
(	(	(	O	O
<	<	SYM	B-NP	O
0.45	0.45	CD	B-NP	O
l	l	NN	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
;	;	:	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
201	201	CD	B-NP	O
)	)	)	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mortality	mortality	NN	I-NP	O
after	after	IN	B-PP	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
(	(	(	O	O
27	27	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
16	16	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
independence	independence	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
(	(	(	O	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
48	48	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
viscosity	viscosity	NN	I-NP	O
by	by	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
haemodilution	haemodilution	NN	B-NP	O
with	with	IN	B-PP	O
albumin	albumin	NN	B-NP	O
(	(	(	O	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
viscosity	viscosity	NN	I-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normovolaemic	normovolaemic	JJ	I-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


Distribution	Distribution	NN	B-NP	O
and	and	CC	O	O
changing	change	VBG	B-VP	O
morphological	morphological	JJ	B-NP	O
course	course	NN	I-NP	O


The	The	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
use	use	NN	I-NP	O
and	and	CC	I-NP	O
benefits	benefit	NNS	I-NP	O
of	of	IN	B-PP	O
bile	bile	NN	B-NP	O
acid	acid	NN	I-NP	O
sequestrants	sequestrant	NNS	I-NP	O
,	,	,	O	O
nicotinic	nicotinic	JJ	B-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
fibric	fibric	JJ	B-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
-	-	HYPH	I-NP	O
hydroxy	hydroxy	NN	I-NP	O
-	-	HYPH	B-NP	O
3	3	CD	I-NP	O
-	-	HYPH	I-NP	O
methylglutaryl	methylglutaryl	NN	I-NP	O
coenzyme	coenzyme	NN	I-NP	O
A	A	NN	I-NP	O
(	(	(	O	O
HMG	HMG	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
CoA	CoA	NN	I-NP	O
)	)	)	O	O
reductase	reductase	NN	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
probucol	probucol	NN	B-NP	O
are	be	VBP	B-VP	O
individually	individually	RB	I-VP	O
discussed	discuss	VBN	I-VP	O
,	,	,	O	O
whereas	whereas	IN	O	O
nonpharmacologic	nonpharmacologic	JJ	B-NP	O
approaches	approach	NNS	I-NP	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
conjunction	conjunction	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
drugs	drug	NNS	I-NP	O
are	be	VBP	B-VP	O
recommended	recommend	VBN	I-VP	O
emphatically	emphatically	RB	B-ADVP	O
.	.	.	O	O


This	This	DT	B-NP	O
may	may	MD	B-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
more	more	JJR	B-NP	O
reabsorption	reabsorption	NN	I-NP	O
and	and	CC	O	O
hence	hence	RB	B-NP	O
reduced	reduce	VBN	I-NP	O
renal	renal	JJ	I-NP	O
clearance	clearance	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
major	major	JJ	I-NP	O
pathological	pathological	JJ	I-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
placenta	placenta	NN	I-NP	O
were	be	VBD	B-VP	O
prematuration	prematuration	NN	B-NP	O
and	and	CC	I-NP	O
hypoplasia	hypoplasia	NN	I-NP	O
.	.	.	O	O


Green	Green	JJ	B-NP	O
pepper	pepper	NN	I-NP	O
significantly	significantly	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
N	N	NN	B-NP	O
-	-	HYPH	B-NP	O
nitrosothiazolidine	nitrosothiazolidine	NN	I-NP	O
-	-	HYPH	I-NP	O
carboxylic	carboxylic	JJ	I-NP	O
acid	acid	NN	I-NP	O
formation	formation	NN	I-NP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
ascorbic	ascorbic	JJ	B-NP	O
acid	acid	NN	I-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O


A	A	DT	B-NP	O
genomic	genomic	JJ	I-NP	B-DNA
clone	clone	NN	I-NP	I-DNA
,	,	,	O	O
pTt21	pTt21	NN	B-NP	B-protein
,	,	,	O	O
containing	contain	VBG	B-VP	O
DNA	DNA	NN	B-NP	O
apparently	apparently	RB	B-VP	O
transcribed	transcribe	VBN	I-VP	O
specifically	specifically	RB	B-ADVP	O
in	in	IN	B-PP	O
Trypanosoma	Trypanosoma	NN	B-NP	O
cruzi	cruzi	NN	I-NP	O
trypomastigotes	trypomastigote	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
differentially	differentially	RB	B-VP	O
screening	screen	VBG	I-VP	O
a	a	DT	B-NP	O
genomic	genomic	JJ	I-NP	O
library	library	NN	I-NP	O
with	with	IN	B-PP	O
trypomastigote	trypomastigote	NN	B-NP	O
and	and	CC	I-NP	O
epimastigote	epimastigote	NN	I-NP	B-DNA
cDNA	cDNA	NN	I-NP	I-DNA
.	.	.	O	O


Brucellosis	Brucellosis	NN	B-NP	O
-	-	HYPH	O	O
-	-	SYM	B-NP	O
1990	1990	CD	B-NP	O


Assay	Assay	NN	B-NP	O
of	of	IN	B-PP	O
urea	urea	NN	B-NP	O
by	by	IN	B-PP	O
immobilized	immobilize	VBN	B-NP	O
urease	urease	NN	I-NP	O
coupled	couple	VBN	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
differential	differential	JJ	I-NP	O
pH	pH	NN	I-NP	O
-	-	HYPH	B-NP	O
meter	meter	NN	I-NP	O
.	.	.	O	O


RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
the	the	DT	B-NP	O
AGA	AGA	NNP	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
fetal	fetal	JJ	I-NP	O
and	and	CC	I-NP	O
maternal	maternal	JJ	I-NP	O
serum	serum	NN	I-NP	O
prolactin	prolactin	NN	I-NP	O
concentration	concentration	NN	I-NP	O
increased	increase	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
with	with	IN	B-PP	O
gestation	gestation	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	JJR	B-NP	O
0.001	0.001	CD	I-NP	O
and	and	CC	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
.	.	.	O	O


One	One	CD	B-NP	O
phage	phage	NN	I-NP	O
clone	clone	NN	I-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
junction	junction	NN	I-NP	O
between	between	IN	B-PP	O
alpha	alpha	NN	B-NP	B-DNA
satellite	satellite	NN	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
and	and	CC	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	B-DNA
low	low	JJ	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
copy	copy	NN	I-NP	I-DNA
repeated	repeat	VBN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
.	.	.	O	O


The	The	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
flanking	flank	VBG	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
lactoferrin	lactoferrin	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
placental	placental	JJ	I-NP	I-DNA
genomic	genomic	JJ	I-NP	I-DNA
library	library	NN	I-NP	I-DNA
.	.	.	O	O


Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
estrogen	estrogen	NN	I-NP	O
action	action	NN	I-NP	O
that	that	WDT	B-NP	O
govern	govern	VBP	B-VP	O
the	the	DT	B-NP	O
lactoferrin	lactoferrin	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
expression	expression	NN	I-NP	O
differ	differ	VBP	B-VP	O
between	between	IN	B-PP	O
mouse	mouse	NN	B-NP	O
and	and	CC	O	O
human	human	NN	B-NP	O
.	.	.	O	O


BiP670	BiP670	NN	B-NP	O
retains	retain	VBZ	B-VP	O
basal	basal	JJ	B-NP	O
and	and	CC	I-NP	O
Ca2	Ca2	NN	I-NP	B-protein
+	+	SYM	O	O
ionophore	ionophore	NN	B-NP	O
A23187	A23187	NN	I-NP	O
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	O
activities	activity	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
CEM	CEM	NN	I-NP	B-cell_line
receives	receive	VBZ	B-VP	O
registration	registration	NN	B-NP	O
updates	update	NNS	I-NP	O
via	via	IN	B-PP	O
an	an	DT	B-NP	O
HL7	HL7	NN	I-NP	O
message	message	NN	I-NP	O
and	and	CC	O	O
evaluates	evaluate	VBZ	B-VP	O
data	datum	NNS	B-NP	O
dependencies	dependency	NNS	I-NP	O
in	in	IN	B-PP	O
rules	rule	NNS	B-NP	O
via	via	IN	B-PP	O
an	an	DT	B-NP	O
interface	interface	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
relational	relational	JJ	I-NP	O
database	database	NN	I-NP	O
.	.	.	O	O


Magnetic	Magnetic	JJ	B-NP	O
resonance	resonance	NN	I-NP	O
spectroscopy	spectroscopy	NN	I-NP	O
(	(	(	O	O
MRS	MRS	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
imaging	imaging	NN	B-NP	O
(	(	(	O	O
MRI	MRI	NN	B-NP	B-protein
)	)	)	O	O
are	be	VBP	B-VP	O
now	now	RB	I-VP	O
well	well	RB	I-VP	O
established	establish	VBN	I-VP	O
techniques	technique	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
metabolism	metabolism	NN	I-NP	O
and	and	CC	O	O
gross	gross	JJ	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
muscle	muscle	NN	B-NP	O
.	.	.	O	O


Simultaneously	Simultaneously	RB	B-ADVP	O
a	a	DT	B-NP	O
greater	great	JJR	I-NP	O
NA	NA	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	O
epinephrine	epinephrine	NN	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
Pharmacia	Pharmacia	NNP	B-NP	O
CAP	CAP	NNP	I-NP	O
System	System	NNP	I-NP	O
(	(	(	O	O
Pharmacia	Pharmacia	NNP	B-NP	O
Diagnostics	Diagnostics	NNP	I-NP	O
AB	AB	NNP	I-NP	O
,	,	,	O	O
Uppsala	Uppsala	NNP	B-NP	O
,	,	,	O	O
Sweden	Sweden	NNP	B-NP	O
)	)	)	O	O
,	,	,	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
quantitative	quantitative	JJ	I-NP	O
measurement	measurement	NN	I-NP	O
of	of	IN	B-PP	O
allergen	allergen	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
IgE	IgE	NN	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
by	by	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
RAST	RAST	NN	B-NP	B-protein
in	in	IN	B-PP	O
2	2	CD	B-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
,	,	,	O	O
71	71	CD	B-NP	O
atopic	atopic	JJ	I-NP	O
and	and	CC	O	O
48	48	CD	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	O
atopic	atopic	JJ	I-NP	O
.	.	.	O	O


Patients	Patient	NNS	B-NP	O
receiving	receive	VBG	B-VP	O
VPA	VPA	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
differences	difference	NNS	B-NP	O
in	in	IN	B-PP	O
attention	attention	NN	B-NP	O
,	,	,	O	O
visuomotor	visuomotor	NN	B-NP	O
performance	performance	NN	I-NP	O
,	,	,	O	O
verbal	verbal	JJ	B-NP	O
span	span	NN	I-NP	O
and	and	CC	O	O
sensory	sensory	JJ	B-NP	O
discrimination	discrimination	NN	I-NP	O
tasks	task	NNS	I-NP	O
at	at	IN	B-PP	O
T1	T1	NN	B-NP	B-DNA
,	,	,	O	O
in	in	IN	B-PP	O
visuomotor	visuomotor	NN	B-NP	O
performance	performance	NN	I-NP	O
at	at	IN	B-PP	O
T2	T2	NN	B-NP	B-DNA
and	and	CC	O	O
in	in	IN	B-PP	O
spatial	spatial	JJ	B-NP	O
span	span	NN	I-NP	O
at	at	IN	B-PP	O
T3	T3	NN	B-NP	B-DNA
,	,	,	O	O
whereas	whereas	IN	O	O
no	no	DT	B-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
at	at	IN	B-PP	O
T4	T4	NN	B-NP	B-DNA
.	.	.	O	O


We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
segment	segment	NN	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
mu	mu	NN	I-NP	O
m	m	NN	I-NP	O
poly	poly	NN	I-NP	O
(	(	(	O	O
A	A	NN	B-NP	O
)	)	)	O	O
signals	signal	NNS	B-NP	O
,	,	,	O	O
along	along	IN	B-ADVP	O
with	with	IN	B-PP	O
536	536	CD	B-NP	O
bp	bp	NN	I-NP	O
of	of	IN	B-PP	O
downstream	downstream	JJ	B-NP	B-DNA
flanking	flanking	JJ	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
,	,	,	O	O
acted	act	VBD	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
transcription	transcription	NN	I-NP	O
terminator	terminator	NN	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
myeloma	myeloma	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
L	L	NN	B-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
.	.	.	O	O


As	As	IN	B-PP	O
a	a	DT	B-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
examination	examination	NN	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
and	and	CC	I-NP	O
free	free	JJ	I-NP	O
serum	serum	NN	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
lipid	lipid	NN	I-NP	O
and	and	CC	I-NP	O
triglyceride	triglyceride	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O


Alena	Alena	NNP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
nurse	nurse	NN	I-NP	O
in	in	IN	B-PP	O
Prague	Prague	NN	B-NP	O
-	-	HYPH	O	O
-	-	HYPH	O	O
she	she	PRP	B-NP	O
dreams	dream	NNS	I-NP	O
of	of	IN	B-PP	O
higher	high	JJR	B-NP	O
wages	wage	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
trip	trip	NN	I-NP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
ocean	ocean	NN	I-NP	O


Dopamine	Dopamine	NN	B-NP	O
neurons	neuron	NNS	I-NP	O
in	in	IN	B-PP	O
subjects	subject	NNS	B-NP	O
that	that	WDT	B-NP	O
received	receive	VBD	B-VP	O
6	6	CD	B-NP	O
-	-	HYPH	I-NP	O
OHDA	OHDA	NN	I-NP	B-protein
were	be	VBD	B-VP	O
protected	protect	VBN	I-VP	O
by	by	IN	B-PP	O
pre	pre	AFX	B-NP	B-DNA
-	-	HYPH	I-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
GBR	GBR	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
12909	12909	CD	I-NP	O
.	.	.	O	O


DIBA	DIBA	NN	B-NP	B-protein
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
sensitive	sensitive	JJ	I-ADJP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
better	well	RBR	I-NP	O
negative	negative	JJ	I-NP	O
predictive	predictive	JJ	I-NP	O
value	value	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
false	false	JJ	I-NP	O
negative	negative	JJ	I-NP	O
percentage	percentage	NN	I-NP	O
than	than	IN	B-PP	O
DFAT	DFAT	NN	B-NP	B-protein
.	.	.	O	O


Caries	Cary	NNS	B-NP	O
and	and	CC	I-NP	O
parodontitis	parodontitis	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
spread	spread	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
of	of	IN	B-PP	O
mankind	mankind	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
strongyloidiasis	strongyloidiasis	NN	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
sudden	sudden	JJ	B-NP	O
death	death	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
second	second	JJ	I-NP	O
large	large	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
disorders	disorder	NNS	B-NP	O
in	in	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
is	be	VBZ	B-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
effects	effect	NNS	B-NP	O
of	of	IN	B-PP	O
infections	infection	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mother	mother	NN	I-NP	O
without	without	IN	B-PP	O
pathogens	pathogen	NNS	B-NP	O
being	be	VBG	B-VP	O
transmitted	transmit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
embryo	embryo	NN	I-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
placenta	placenta	NN	I-NP	O
.	.	.	O	O


Four	Four	CD	B-NP	O
short	short	JJ	I-NP	B-DNA
nucleotide	nucleotide	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
(	(	(	O	O
boxes	box	NNS	B-NP	O
I	I	CD	B-NP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
)	)	)	O	O
contribute	contribute	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
light	light	JJ	I-NP	O
responsiveness	responsiveness	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
parsley	parsley	NN	I-NP	B-DNA
chalcone	chalcone	NN	I-NP	I-DNA
synthase	synthase	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
.	.	.	O	O


The	The	DT	B-NP	O
case	case	NN	I-NP	O
described	describe	VBN	B-VP	O
is	be	VBZ	B-VP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
72	72	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
ochronosis	ochronosis	NN	B-NP	O
who	who	WP	B-NP	O
suffered	suffer	VBD	B-VP	O
a	a	DT	B-NP	O
hyperextension	hyperextension	NN	I-NP	O
injury	injury	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
spine	spine	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
fall	fall	NN	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
fracture	fracture	NN	I-NP	O
through	through	IN	B-PP	O
an	an	DT	B-NP	O
ankylosed	ankylose	VBN	I-NP	O
L2	L2	NN	I-NP	B-DNA
-	-	HYPH	I-NP	O
L3	L3	NN	I-NP	B-DNA
disk	disk	NN	I-NP	O
space	space	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
mean	mean	JJ	I-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
penile	penile	JJ	I-NP	O
foreskin	foreskin	NN	I-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
15	15	CD	B-NP	O
ml	ml	NN	I-NP	O
/	/	SYM	I-NP	O
min	min	NN	I-NP	O
/	/	SYM	O	O
100	100	CD	B-NP	O
g	g	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
150	150	CD	B-NP	O
-	-	HYPH	I-NP	O
200	200	CD	I-NP	O
%	%	NN	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
anesthesia	anesthesia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-VP	O
decreased	decrease	VBD	I-VP	O
to	to	TO	B-PP	O
72	72	CD	B-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
tip	tip	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
created	create	VBN	I-NP	O
parameatal	parameatal	JJ	I-NP	O
foreskin	foreskin	NN	I-NP	O
flap	flap	NN	I-NP	O
.	.	.	O	O


ME1a1	ME1a1	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
16	16	CD	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
base	base	NN	I-NP	I-DNA
-	-	HYPH	B-VP	I-DNA
pair	pair	NN	B-NP	I-DNA
nuclear	nuclear	JJ	I-NP	I-DNA
factor	factor	NN	I-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
residing	reside	VBG	B-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
c	c	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
MYC	MYC	NN	I-NP	I-DNA
P1	P1	NN	I-NP	I-DNA
and	and	CC	O	I-DNA
P2	P2	NN	B-NP	I-DNA
transcription	transcription	NN	I-NP	I-DNA
initiation	initiation	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
,	,	,	O	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
P2	P2	NN	B-NP	B-DNA
activity	activity	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
next	next	JJ	I-NP	O
twenty	twenty	CD	I-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
prevention	prevention	NN	B-NP	O
in	in	IN	B-PP	O
Indian	Indian	JJ	B-NP	O
country	country	NN	I-NP	O
:	:	:	O	O
visionary	visionary	JJ	B-NP	O
,	,	,	I-NP	O
complex	complex	JJ	I-NP	O
,	,	,	I-NP	O
and	and	CC	I-NP	O
practical	practical	JJ	I-NP	O
.	.	.	O	O


Exogenous	Exogenous	JJ	B-NP	O
LHRH	LHRH	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
facilitate	facilitate	VB	I-VP	O
mating	mat	VBG	B-NP	O
behavior	behavior	NN	I-NP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
first	first	JJ	I-NP	O
146	146	CD	I-NP	O
consecutive	consecutive	JJ	I-NP	O
patients	patient	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
EVL	EVL	NN	B-NP	B-protein
during	during	IN	B-PP	O
the	the	DT	B-NP	O
period	period	NN	I-NP	O
from	from	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
1986	1986	CD	B-NP	O
to	to	TO	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
1989	1989	CD	B-NP	O
are	be	VBP	B-VP	O
reported	report	VBN	I-VP	O
.	.	.	O	O


Replacing	Replace	VBG	B-VP	O
the	the	DT	B-NP	O
aspartic	aspartic	JJ	I-NP	O
acid	acid	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
lysine	lysine	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
with	with	IN	I-PP	O
an	an	DT	B-NP	O
alanine	alanine	NN	I-NP	O
or	or	CC	I-NP	O
valine	valine	NN	I-NP	O
residue	residue	NN	I-NP	O
allowed	allow	VBD	B-VP	O
formation	formation	NN	B-NP	O
of	of	IN	B-PP	O
disulfide	disulfide	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
linked	link	VBN	I-NP	I-protein
dimers	dimer	NNS	I-NP	I-protein
.	.	.	O	O


During	During	IN	B-PP	O
V	V	NN	B-NP	O
-	-	HYPH	B-NP	O
A	A	NN	I-NP	O
bypass	bypass	NN	I-NP	O
,	,	,	O	O
hemodynamics	hemodynamic	NNS	B-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O


Greater	Greater	JJ	B-NP	O
rupture	rupture	NN	I-NP	O
force	force	NN	I-NP	O
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
adult	adult	JJ	I-NP	O
pigs	pig	NNS	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
young	young	JJ	I-NP	O
pigs	pig	NNS	I-NP	O
.	.	.	O	O


At	At	IN	B-PP	O
rest	rest	NN	B-NP	O
AFF	AFF	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
UT	UT	NN	B-NP	O
(	(	(	O	O
29	29	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
AT	AT	NN	B-NP	O
(	(	(	O	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
UEA	UEA	NN	B-NP	B-protein
(	(	(	O	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
smoking	smoking	NN	I-NP	O
habits	habit	NNS	I-NP	O
of	of	IN	B-PP	O
relapsers	relapser	NNS	B-NP	O
1	1	CD	B-NP	O
year	year	NN	I-NP	O
after	after	IN	B-PP	O
quitting	quit	VBG	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
smoking	smoking	NN	I-NP	O
cessation	cessation	NN	I-NP	O
trial	trial	NN	I-NP	O
using	use	VBG	B-VP	O
nicotine	nicotine	NN	B-NP	O
or	or	CC	I-NP	O
placebo	placebo	NN	I-NP	O
patches	patch	NNS	I-NP	O
.	.	.	O	O


Exposure	Exposure	NN	B-NP	O
to	to	TO	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
virus	virus	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
general	general	JJ	I-NP	O
population	population	NN	I-NP	O
of	of	IN	B-PP	O
Hisayama	Hisayama	NNP	B-NP	O
,	,	,	O	O
Japan	Japan	NNP	B-NP	O
:	:	:	O	O
significance	significance	NN	B-NP	O
of	of	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
antibody	antibody	NN	I-NP	O
to	to	TO	B-PP	O
hepatitis	hepatitis	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
surface	surface	NN	I-NP	I-protein
antigen	antigen	NN	I-NP	I-protein
in	in	IN	B-PP	O
general	general	JJ	B-NP	O
population	population	NN	I-NP	O
.	.	.	O	O


Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
this	this	DT	B-NP	O
latter	latter	JJ	I-NP	O
phenomenon	phenomenon	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
a	a	DT	B-NP	O
particular	particular	JJ	I-NP	O
cysteine	cysteine	NN	I-NP	O
motif	motif	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
repeated	repeat	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
times	time	NNS	I-NP	O
in	in	IN	B-PP	O
Dfurin2	Dfurin2	NN	B-NP	O
but	but	CC	O	O
present	present	VBP	B-VP	O
only	only	RB	B-ADVP	O
twice	twice	RB	I-ADVP	O
in	in	IN	B-PP	O
mammalian	mammalian	JJ	B-NP	B-protein
furin	furin	NN	I-NP	I-protein
.	.	.	O	O


On	On	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
,	,	,	O	O
neither	neither	CC	O	O
phosphate	phosphate	NN	B-NP	O
buffered	buffer	VBD	B-VP	O
saline	saline	NN	B-NP	O
injection	injection	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
ES	ES	NN	I-NP	O
nor	nor	CC	O	O
primary	primary	JJ	B-NP	O
KLH	KLH	NN	I-NP	O
challenges	challenge	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ES	ES	NN	I-NP	O
were	be	VBD	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
elevating	elevate	VBG	B-VP	O
the	the	DT	B-NP	O
threshold	threshold	NN	I-NP	O
level	level	NN	I-NP	O
and	and	CC	O	O
changing	change	VBG	B-VP	O
the	the	DT	B-NP	O
latency	latency	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
newly	newly	RB	I-NP	O
developed	develop	VBN	I-NP	O
broad	broad	JJ	I-NP	O
-	-	HYPH	I-NP	O
spectrum	spectrum	NN	I-NP	O
fluoroquinolone	fluoroquinolone	NN	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
(	(	(	O	O
LVFX	LVFX	NN	B-NP	B-protein
,	,	,	O	O
DR	DR	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
3355	3355	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
(	(	(	O	O
CPFX	CPFX	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
ofloxacin	ofloxacin	NN	B-NP	O
(	(	(	O	O
OFLX	OFLX	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
norfloxacin	norfloxacin	NN	B-NP	O
(	(	(	O	O
NFLX	NFLX	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
mean	mean	JJ	I-NP	O
serum	serum	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
at	at	IN	B-PP	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
(	(	(	O	O
SPK	SPK	NN	B-NP	B-protein
1.8	1.8	CD	I-NP	I-protein
,	,	,	O	O
KTA	KTA	NN	B-NP	O
1.9	1.9	CD	I-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
d	d	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O
(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-PP	O
250	250	CD	B-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O


Model	Model	NN	B-NP	O
predictions	prediction	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
accord	accord	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
nine	nine	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
survival	survival	NN	I-NP	O
experience	experience	NN	I-NP	O
of	of	IN	B-PP	O
women	woman	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
HIP	HIP	NN	I-NP	O
trial	trial	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
women	woman	NNS	B-NP	O
40	40	CD	B-NP	O
-	-	HYPH	I-NP	O
44	44	CD	I-NP	O
years	year	NNS	I-NP	O
old	old	JJ	B-ADJP	O
,	,	,	O	O
with	with	IN	B-SBAR	O
HIP	HIP	NN	B-NP	O
data	datum	NNS	I-NP	O
on	on	IN	B-PP	O
18	18	CD	B-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
survival	survival	NN	I-NP	O
.	.	.	O	O


High	High	JJ	B-NP	O
-	-	HYPH	I-NP	O
resolution	resolution	NN	I-NP	O
computed	compute	VBN	I-NP	O
tomography	tomography	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
miliary	miliary	JJ	B-NP	O
tuberculosis	tuberculosis	NN	I-NP	O
.	.	.	O	O


Previously	Previously	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
SNF2	SNF2	NN	B-NP	B-protein
,	,	,	O	O
SNF5	SNF5	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
SNF6	SNF6	NN	B-NP	B-protein
function	function	NN	I-NP	O
interdependently	interdependently	RB	B-ADVP	O
in	in	IN	B-PP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADVP	O
forming	form	VBG	B-VP	O
a	a	DT	B-NP	O
heteromeric	heteromeric	JJ	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O


We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
LexA	LexA	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
GAL4	GAL4	NN	I-NP	B-protein
and	and	CC	I-NP	O
LexA	LexA	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
Bicoid	Bicoid	NN	I-NP	B-protein
fusion	fusion	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
both	both	DT	O	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
SNF2	SNF2	NN	B-NP	B-protein
,	,	,	O	O
SNF5	SNF5	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
SNF6	SNF6	NN	B-NP	B-protein
for	for	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
target	target	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
containing	contain	VBG	B-VP	O
one	one	CD	B-NP	O
or	or	CC	O	O
multiple	multiple	JJ	B-NP	O
lexA	lexA	NN	I-NP	O
operators	operator	NNS	I-NP	O
.	.	.	O	O


George	George	NNP	B-NP	O
T	T	NNP	I-NP	O
.	.	VBD	B-VP	O


A	A	DT	B-NP	O
lambda	lambda	SYM	I-NP	B-DNA
gt10	gt10	NN	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
library	library	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
constructed	construct	VBN	I-VP	O
from	from	IN	B-PP	O
poly	poly	NN	B-NP	B-RNA
(	(	(	I-NP	I-RNA
A	A	NN	I-NP	I-RNA
)	)	)	I-NP	I-RNA
+	+	JJ	I-NP	I-RNA
RNA	RNA	NN	I-NP	I-RNA
of	of	IN	B-PP	O
young	young	JJ	B-NP	O
green	green	JJ	I-NP	O
leaves	leaf	NNS	I-NP	O
of	of	IN	B-PP	O
spinach	spinach	NN	B-NP	O
.	.	.	O	O


NE	NE	NN	B-NP	B-protein
and	and	CC	I-NP	O
PR3	PR3	NN	I-NP	B-protein
assist	assist	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
destruction	destruction	NN	I-NP	O
of	of	IN	B-PP	O
phagocytosed	phagocytose	VBN	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
,	,	,	O	O
cleave	cleave	VBP	B-VP	O
the	the	DT	B-NP	O
important	important	JJ	I-NP	O
connective	connective	JJ	I-NP	O
-	-	HYPH	I-NP	O
tissue	tissue	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
elastin	elastin	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
generate	generate	VB	B-VP	O
chemotactic	chemotactic	JJ	B-NP	O
activities	activity	NNS	I-NP	O
by	by	IN	B-PP	O
forming	form	VBG	B-VP	O
alpha	alpha	SYM	B-NP	B-protein
1	1	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
proteinase	proteinase	NN	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
and	and	CC	O	O
elastin	elastin	NN	B-NP	O
peptides	peptide	NNS	I-NP	O
.	.	.	O	O


Selected	Select	VBN	B-NP	O
topics	topic	NNS	I-NP	O
in	in	IN	B-PP	O
pediatric	pediatric	JJ	B-NP	O
ultrasonography	ultrasonography	NN	I-NP	O
-	-	HYPH	O	O
-	-	SYM	B-NP	O
1992	1992	CD	B-NP	O
.	.	.	O	O


Methods	Method	NNS	B-NP	O
included	include	VBD	B-VP	O
24	24	CD	B-NP	O
-	-	HYPH	I-NP	O
hour	hour	NN	I-NP	O
dietary	dietary	JJ	I-NP	O
recall	recall	NN	I-NP	O
,	,	,	O	O
menu	menu	NN	B-NP	O
weights	weight	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
recipe	recipe	NN	B-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O


Factors	Factor	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
afterdrop	afterdrop	NN	B-NP	O
included	include	VBD	B-VP	O
age	age	NN	B-NP	O
,	,	,	O	O
end	end	NN	B-NP	O
-	-	HYPH	I-NP	O
of	of	IN	B-PP	O
-	-	HYPH	B-NP	O
surgery	surgery	NN	I-NP	O
temperature	temperature	NN	I-NP	O
(	(	(	O	O
both	both	CC	O	O
positively	positively	RB	B-ADVP	O
)	)	)	O	O
and	and	CC	O	O
body	body	NN	B-NP	O
mass	mass	NN	I-NP	O
(	(	(	O	O
negatively	negatively	RB	B-ADVP	O
)	)	)	O	O
.	.	.	O	O


Both	Both	CC	O	O
GH	GH	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
and	and	CC	O	O
impaired	impaired	JJ	B-NP	O
spinal	spinal	JJ	I-NP	O
growth	growth	NN	I-NP	O
may	may	MD	B-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
short	short	JJ	B-NP	O
stature	stature	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
puberty	puberty	NN	I-NP	O
in	in	IN	B-PP	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
GH	GH	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
reduces	reduce	VBZ	B-VP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
available	available	JJ	B-ADJP	O
for	for	IN	B-PP	O
GH	GH	NN	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O


By	By	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
d	d	NN	B-NP	O
(	(	(	O	O
T2AG3T	T2AG3T	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
d	d	NN	B-NP	O
(	(	(	O	O
T2G4T	T2G4T	NN	B-NP	O
)	)	)	O	O
form	form	VBP	B-VP	O
only	only	RB	B-ADVP	O
the	the	DT	B-NP	O
G	G	NN	I-NP	O
-	-	HYPH	B-NP	O
quadruplex	quadruplex	NN	I-NP	O
monomer	monomer	NN	I-NP	O
structures	structure	NNS	I-NP	O
independent	independent	JJ	B-ADJP	O
of	of	IN	B-PP	O
K	K	NN	B-NP	O
cation	cation	NN	I-NP	O
concentration	concentration	NN	I-NP	O
as	as	IN	B-SBAR	O
reported	report	VBN	B-VP	O
previously	previously	RB	B-ADVP	O
[	[	(	O	O
Sen	Sen	NNP	B-NP	O
,	,	,	O	O
D	D	NNP	B-NP	O
.	.	NN	I-NP	O
,	,	,	B-NP	O
&	&	CC	I-NP	O
Gilbert	Gilbert	NNP	I-NP	O
,	,	,	O	O
W	W	NNP	B-NP	O
.	.	.	O	O


Differentiating	Differentiate	VBG	B-VP	O
among	among	IN	B-PP	O
renal	renal	JJ	B-NP	O
stones	stone	NNS	I-NP	O
.	.	.	O	O


IFI	IFI	NN	B-NP	B-RNA
16	16	CD	I-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
constitutively	constitutively	RB	I-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
lymphoid	lymphoid	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	B-PP	O
in	in	IN	B-PP	O
cell	cell	NN	B-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
of	of	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
lineages	lineage	NNS	I-NP	I-cell_type
.	.	.	O	O


Mitochondria	Mitochondria	NNP	B-NP	O
-	-	HYPH	I-NP	O
lytic	lytic	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
warfarin	warfarin	NN	B-NP	O
in	in	IN	B-PP	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type
.	.	.	O	O


Exon	Exon	NN	B-NP	B-DNA
-	-	HYPH	I-NP	O
intron	intron	NN	I-NP	O
junctions	junction	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
rat	rat	NN	I-NP	I-DNA
AdoMet	AdoMet	NN	I-NP	I-DNA
decarboxylase	decarboxylase	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
identical	identical	JJ	B-NP	O
positions	position	NNS	I-NP	O
except	except	IN	B-PP	O
that	that	IN	B-NP	O
exons	exon	NNS	B-NP	B-DNA
6	6	CD	B-NP	I-DNA
and	and	CC	I-NP	I-DNA
7	7	CD	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
formed	form	VBD	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
exon	exon	NN	I-NP	B-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O


Interferon	Interferon	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
alpha	alpha	SYM	I-NP	I-protein
-	-	HYPH	I-NP	O
induced	induce	VBN	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
:	:	:	O	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
selective	selective	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
ouabain	ouabain	NN	B-NP	O
on	on	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ISGF3	ISGF3	NN	I-NP	B-protein
transcription	transcription	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
cDNA	cDNA	NN	I-NP	B-DNA
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	B-DNA
reading	reading	NN	I-NP	I-DNA
frame	frame	NN	I-NP	I-DNA
of	of	IN	B-PP	O
900	900	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
97	97	CD	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
kDa	kDa	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
LD50	LD50	NN	B-NP	B-protein
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
of	of	IN	B-PP	O
RP	RP	NN	B-NP	B-protein
-	-	HYPH	O	O
170	170	CD	B-NP	O
(	(	(	O	O
4.3	4.3	CD	B-NP	O
g	g	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
on	on	IN	B-PP	O
i	i	NN	B-NP	O
.	.	.	O	O
v	v	NN	B-NP	O
.	.	.	O	O
)	)	)	O	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
5.2	5.2	CD	B-NP	O
g	g	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
by	by	IN	B-PP	O
oral	oral	JJ	B-NP	O
administration	administration	NN	I-NP	O
.	.	.	O	O


Among	Among	IN	B-PP	O
the	the	DT	B-NP	O
few	few	JJ	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
eukaryotic	eukaryotic	JJ	I-NP	O
nucleolus	nucleolus	NN	I-NP	O
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
characterized	characterize	VBN	I-VP	O
,	,	,	O	O
four	four	CD	B-NP	O
proteins	protein	NNS	I-NP	O
,	,	,	O	O
nucleolin	nucleolin	NN	B-NP	B-protein
,	,	,	O	O
fibrillarin	fibrillarin	NN	B-NP	B-protein
,	,	,	O	O
SSB1	SSB1	NN	B-NP	B-protein
and	and	CC	I-NP	O
NSR1	NSR1	NN	I-NP	B-protein
,	,	,	O	O
possess	possess	VBP	B-VP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	B-protein
structural	structural	JJ	I-NP	I-protein
motif	motif	NN	I-NP	I-protein
,	,	,	O	O
the	the	DT	B-NP	O
GAR	GAR	NN	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
rich	rich	JJ	B-ADJP	O
in	in	IN	B-PP	O
glycine	glycine	NN	B-NP	O
and	and	CC	I-NP	O
arginine	arginine	NN	I-NP	O
residues	residue	NNS	I-NP	O
.	.	.	O	O


Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
provides	provide	VBZ	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
,	,	,	I-NP	O
ubiquitous	ubiquitous	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
HF	HF	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
1a	1a	NN	I-NP	I-protein
)	)	)	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
muscle	muscle	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
HF	HF	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
1b	1b	NN	I-NP	O
/	/	SYM	B-NP	O
MEF	MEF	NN	I-NP	B-protein
-	-	HYPH	O	O
2	2	CD	B-NP	O
)	)	)	O	O
can	can	MD	B-VP	O
form	form	VB	I-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
,	,	,	I-NP	O
E	E	NN	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
box	box	NN	I-NP	I-DNA
-	-	HYPH	B-NP	O
independent	independent	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
for	for	IN	B-PP	O
muscle	muscle	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	B-cell_type
cardiac	cardiac	JJ	I-NP	I-cell_type
muscle	muscle	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O


Mutations	Mutation	NNS	B-NP	O
in	in	IN	B-PP	O
either	either	DT	B-NP	O
gene	gene	NN	I-NP	O
block	block	VBP	B-VP	O
some	some	DT	B-NP	O
crucial	crucial	JJ	I-NP	O
late	late	JJ	I-NP	O
step	step	NN	I-NP	O
in	in	IN	B-PP	O
assembly	assembly	NN	B-NP	O
of	of	IN	B-PP	O
F1	F1	NN	B-NP	B-protein
,	,	,	O	O
causing	cause	VBG	B-VP	O
the	the	DT	B-NP	O
alpha	alpha	NN	I-NP	B-protein
and	and	CC	I-NP	I-protein
beta	beta	NN	I-NP	I-protein
subunits	subunit	NNS	I-NP	I-protein
to	to	TO	B-VP	O
accumulate	accumulate	VB	I-VP	O
in	in	IN	B-PP	O
mitochondria	mitochondrion	NNS	B-NP	O
as	as	IN	B-PP	O
inactive	inactive	JJ	B-NP	O
aggregates	aggregate	NNS	I-NP	O
(	(	(	O	O
Ackerman	Ackerman	NNP	B-NP	O
,	,	,	O	O
S	S	NNP	B-NP	O
.	.	.	O	O


Expense	Expense	NN	B-NP	O
limits	limit	VBZ	B-VP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
vaccines	vaccine	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
low	low	JJ	B-NP	O
-	-	HYPH	I-NP	O
dose	dose	NN	I-NP	O
intradermal	intradermal	JJ	I-NP	O
immunization	immunization	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
evaluated	evaluate	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
cost	cost	NN	I-NP	O
-	-	HYPH	O	O
saving	save	VBG	B-VP	O
strategy	strategy	NN	B-NP	O
in	in	IN	B-PP	O
numerous	numerous	JJ	B-NP	O
studies	study	NNS	I-NP	O
.	.	.	O	O


Estrogen	Estrogen	NN	B-NP	O
replacement	replacement	NN	I-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
risk	risk	NN	B-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
:	:	:	O	O
results	result	NNS	B-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
meta	meta	SYM	I-NP	O
-	-	HYPH	I-NP	O
analyses	analysis	NNS	I-NP	O
.	.	.	O	O


Switching	Switch	VBG	B-VP	O
FDC	FDC	NN	B-NP	B-cell_type
-	-	HYPH	I-NP	O
P1	P1	NN	I-NP	B-DNA
/	/	SYM	I-NP	O
MAC	MAC	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
growth	growth	NN	B-NP	O
in	in	IN	B-PP	O
M	M	NN	B-NP	O
-	-	HYPH	B-NP	O
CSF	CSF	NN	I-NP	B-protein
to	to	TO	B-PP	O
GM	GM	NNP	B-NP	O
-	-	HYPH	I-NP	O
CSF	CSF	NN	I-NP	B-protein
caused	cause	VBD	B-VP	O
the	the	DT	B-NP	O
selective	selective	JJ	I-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
c	c	NN	B-NP	B-RNA
-	-	HYPH	O	I-RNA
fms	fms	NN	B-NP	I-RNA
mRNA	mRNA	NN	I-NP	I-RNA
within	within	IN	B-PP	O
6	6	CD	B-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
factor	factor	NN	B-NP	O
switching	switching	NN	I-NP	O
.	.	.	O	O


There	There	EX	B-NP	O
was	be	VBD	B-VP	O
however	however	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
between	between	IN	B-PP	O
animal	animal	NN	B-NP	O
food	food	NN	I-NP	O
workers	worker	NNS	I-NP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
and	and	CC	I-NP	O
negative	negative	JJ	I-NP	O
skin	skin	NN	I-NP	O
tests	test	NNS	I-NP	O
to	to	TO	B-PP	O
house	house	NN	B-NP	O
dust	dust	NN	I-NP	O
or	or	CC	O	O
to	to	TO	B-VP	O
fish	fish	VB	I-VP	O
flour	flour	NN	B-NP	O
or	or	CC	B-PP	O
among	among	IN	B-PP	O
those	those	DT	B-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
or	or	CC	I-NP	O
normal	normal	JJ	I-NP	O
IgE	IgE	NN	I-NP	B-protein
(	(	(	O	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O


An	An	DT	B-NP	O
unexpected	unexpected	JJ	I-NP	O
finding	finding	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
at	at	IN	B-PP	O
position	position	NN	B-NP	B-DNA
-	-	HYPH	O	I-DNA
403	403	CD	B-NP	I-DNA
to	to	TO	B-PP	I-DNA
-	-	SYM	B-NP	I-DNA
385	385	CD	B-NP	I-DNA
of	of	IN	B-PP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	B-DNA
dioxin	dioxin	NN	I-NP	I-DNA
responsive	responsive	JJ	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
,	,	,	O	O
a	a	DT	B-NP	O
sequence	sequence	NN	I-NP	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cytochrome	cytochrome	NN	I-NP	B-DNA
P450IA1	P450IA1	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
(	(	(	O	O
CYPIA1	CYPIA1	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
other	other	JJ	B-NP	O
genes	gene	NNS	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
detoxification	detoxification	NN	B-NP	O
/	/	SYM	O	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
polycyclic	polycyclic	JJ	B-NP	O
aromatic	aromatic	JJ	I-NP	O
hydrocarbons	hydrocarbon	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
TRP	TRP	NN	B-NP	B-protein
-	-	HYPH	O	O
2	2	CD	B-NP	O
maps	map	NNS	I-NP	O
to	to	TO	B-PP	O
mouse	mouse	NN	B-NP	B-DNA
chromosome	chromosome	NN	I-NP	I-DNA
14	14	CD	B-NP	I-DNA
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
coat	coat	NN	I-NP	O
colour	colour	NN	I-NP	O
mutation	mutation	NN	I-NP	O
slaty	slaty	NN	I-NP	O
.	.	.	O	O


Using	Use	VBG	B-VP	O
bovine	bovine	JJ	B-NP	O
and	and	CC	I-NP	O
murine	murine	JJ	I-NP	B-cell_line
c	c	NN	I-NP	I-cell_line
-	-	HYPH	O	I-cell_line
myb	myb	NN	B-NP	I-cell_line
clones	clone	NNS	I-NP	I-cell_line
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
c	c	NN	B-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
myb	myb	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
transcription	transcription	NN	I-NP	O
or	or	CC	O	O
mRNA	mRNA	NN	B-NP	O
stability	stability	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
13	13	CD	I-NP	O
base	base	NN	I-NP	O
-	-	HYPH	I-NP	O
pair	pair	NN	I-NP	O
oligonucleotide	oligonucleotide	NN	I-NP	O
spanning	span	VBG	B-VP	O
nucleotides	nucleotide	NNS	B-NP	O
+	+	SYM	O	O
80	80	CD	B-NP	O
to	to	TO	B-PP	O
+	+	SYM	B-NP	O
92	92	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
S	S	NN	I-NP	I-DNA
RNA	RNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
retained	retain	VBD	B-VP	O
specific	specific	JJ	B-NP	O
and	and	CC	I-NP	O
high	high	JJ	I-NP	O
-	-	HYPH	I-NP	O
affinity	affinity	NN	I-NP	O
binding	binding	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
sixfold	sixfold	RB	B-ADVP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
longer	long	JJR	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
fragments	fragment	NNS	I-NP	I-DNA
.	.	.	O	O


Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
reconstitution	reconstitution	NN	I-NP	O
of	of	IN	B-PP	O
eUSF	eUSF	NN	B-NP	B-protein
and	and	CC	I-NP	O
TFIID	TFIID	NN	I-NP	B-protein
-	-	HYPH	O	O
depleted	deplete	VBN	B-NP	O
transcription	transcription	NN	I-NP	B-protein
complexes	complex	NNS	I-NP	I-protein
with	with	IN	B-PP	O
purified	purify	VBN	B-NP	O
protein	protein	NN	I-NP	O
fractions	fraction	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
TFIID	TFIID	NN	B-NP	B-protein
but	but	CC	B-NP	O
also	also	RB	I-NP	O
eUSF	eUSF	NN	B-NP	B-protein
essentially	essentially	RB	B-ADVP	O
participates	participate	VBZ	B-VP	O
in	in	IN	B-PP	O
complex	complex	NN	B-NP	O
formation	formation	NN	I-NP	O
even	even	RB	B-ADVP	O
on	on	IN	B-PP	O
H5	H5	NN	B-NP	O
promoter	promoter	NN	I-NP	O
mutations	mutation	NNS	I-NP	O
lacking	lack	VBG	B-VP	O
the	the	DT	B-NP	O
TATA	TATA	NN	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
box	box	NN	I-NP	I-DNA
.	.	.	O	O


A	A	DT	B-NP	O
comparison	comparison	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	B-protein
acid	acid	NN	I-NP	I-protein
sequence	sequence	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-protein
.	.	VBD	B-VP	I-protein
thermophilus	thermophilus	NN	B-NP	I-protein
enzyme	enzyme	NN	I-NP	I-protein
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Escherichia	Escherichia	FW	I-NP	B-protein
coli	coli	FW	I-NP	I-protein
enzyme	enzyme	NN	I-NP	I-protein
showed	show	VBD	B-VP	O
(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
a	a	DT	B-NP	O
37	37	CD	I-NP	O
%	%	NN	I-NP	O
overall	overall	JJ	I-NP	O
similarity	similarity	NN	I-NP	O
;	;	:	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
conservation	conservation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ser	Ser	NN	I-NP	O
residue	residue	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
phosphorylated	phosphorylate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
E	E	NN	I-NP	O
.	.	.	O	O
coli	coli	NN	B-NP	B-protein
enzyme	enzyme	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
surrounding	surround	VBG	I-NP	O
sequence	sequence	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
(	(	(	B-LST	O
iii	iii	LS	I-LST	O
)	)	)	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
141	141	CD	B-NP	O
extra	extra	JJ	I-NP	O
residues	residue	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	B-protein
terminus	terminus	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
T	T	NN	I-NP	B-protein
.	.	VBD	B-VP	I-protein
thermophilus	thermophilus	DT	B-NP	I-protein
enzyme	enzyme	NN	I-NP	I-protein
.	.	.	O	O


Radiolabelled	Radiolabelle	VBN	B-NP	O
palmitate	palmitate	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
incorporated	incorporate	VBN	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
mutated	mutate	VBN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
showing	show	VBG	B-VP	O
that	that	IN	B-SBAR	O
lipid	lipid	NN	B-NP	O
modification	modification	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Cys	Cys	NN	I-NP	B-protein
-	-	HYPH	O	I-protein
22	22	CD	B-NP	I-protein
residue	residue	NN	I-NP	I-protein
.	.	.	O	O


17	17	CD	B-NP	O
volunteer	volunteer	NN	I-NP	O
deaf	deaf	NN	I-NP	O
Ss	S	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
18	18	CD	B-NP	O
volunteer	volunteer	NN	I-NP	O
hearing	hearing	NN	I-NP	O
Ss	S	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Stanford	Stanford	NNP	I-NP	O
Hypnotic	Hypnotic	NNP	I-NP	O
Clinical	Clinical	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
(	(	(	O	O
SHCS	SHCS	NNP	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
Morgan	Morgan	NNP	B-NP	O
and	and	CC	I-NP	O
J	J	NNP	I-NP	O
.	.	.	O	O


Mature	Mature	JJ	B-NP	B-protein
tobacco	tobacco	NN	I-NP	I-protein
L12	L12	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
44	44	CD	B-NP	O
%	%	NN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
ribosomal	ribosomal	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
L7	L7	NN	I-NP	I-protein
/	/	SYM	B-VP	O
L12	L12	NN	B-NP	B-protein
of	of	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
.	.	.	O	O


Nuclear	Nuclear	JJ	B-NP	O
-	-	HYPH	I-NP	O
encoded	encode	VBN	I-NP	O
chloroplast	chloroplast	NN	I-NP	O
ribosomal	ribosomal	JJ	I-NP	O
protein	protein	NN	I-NP	O
L12	L12	NN	I-NP	O
of	of	IN	B-PP	O
Nicotiana	Nicotiana	NNP	B-NP	O
tabacum	tabacum	NN	I-NP	O
:	:	:	O	O
characterization	characterization	NN	B-NP	O
of	of	IN	B-PP	O
mature	mature	JJ	B-NP	O
protein	protein	NN	I-NP	O
and	and	CC	I-NP	O
isolation	isolation	NN	I-NP	O
and	and	CC	I-NP	O
sequence	sequence	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
cDNA	cDNA	NN	B-NP	B-DNA
clones	clone	NNS	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
its	its	PRP$	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
precursor	precursor	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
IFN	IFN	NN	B-NP	B-protein
-	-	HYPH	O	O
gamma	gamma	SYM	B-NP	O
was	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
contain	contain	VB	I-VP	O
an	an	DT	B-NP	O
intronic	intronic	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
tissue	tissue	NN	B-NP	O
-	-	HYPH	B-ADJP	O
specific	specific	JJ	I-ADJP	O
in	in	IN	B-PP	O
its	its	PRP$	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
restricted	restricted	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
intact	intact	JJ	I-NP	O
IFN	IFN	NN	I-NP	B-protein
-	-	HYPH	O	I-protein
gamma	gamma	SYM	O	I-protein
-	-	HYPH	O	O
encoding	encode	VBG	B-VP	O
gene	gene	NN	B-NP	O
.	.	.	O	O


Molecular	Molecular	JJ	B-NP	O
cloning	cloning	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Rel	Rel	NN	I-NP	B-protein
-	-	HYPH	O	I-protein
related	relate	VBN	B-NP	I-protein
human	human	JJ	I-NP	I-protein
p75	p75	NN	I-NP	I-protein
nucleoprotein	nucleoprotein	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
revealed	reveal	VBN	I-VP	O
its	its	PRP$	B-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
65	65	CD	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
kDa	kDa	NN	I-NP	I-protein
(	(	(	O	I-protein
p65	p65	NN	B-NP	I-protein
)	)	)	O	I-protein
subunit	subunit	NN	B-NP	I-protein
of	of	IN	B-PP	O
NF	NF	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
kappa	kappa	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
.	.	.	O	O


Because	Because	IN	B-SBAR	O
single	single	JJ	B-NP	O
-	-	HYPH	I-NP	O
chamber	chamber	NN	I-NP	O
rate	rate	NN	I-NP	O
-	-	HYPH	B-NP	O
adaptive	adaptive	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
pacing	pacing	NN	I-NP	O
leaves	leave	VBZ	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
future	future	JJ	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
AV	AV	NN	B-NP	O
block	block	NN	I-NP	O
and	and	CC	O	O
DDD	DDD	NN	B-NP	O
pacing	pacing	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
provide	provide	VB	I-VP	O
chronotropic	chronotropic	JJ	B-NP	O
support	support	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
rate	rate	NN	I-NP	O
-	-	HYPH	B-NP	O
adaptive	adaptive	JJ	I-NP	O
dual	dual	JJ	I-NP	O
-	-	HYPH	I-NP	O
chamber	chamber	NN	I-NP	O
(	(	(	O	O
DDDR	DDDR	NN	B-NP	O
)	)	)	O	O
devices	device	NNS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O
(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-PP	O
250	250	CD	B-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O


When	When	WRB	B-ADVP	O
transiently	transiently	RB	B-VP	O
transfected	transfecte	VBN	I-VP	O
into	into	IN	B-PP	O
K562	K562	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
this	this	DT	B-NP	O
Lg	Lg	NN	I-NP	B-DNA
genomic	genomic	JJ	I-NP	I-DNA
clone	clone	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
actively	actively	RB	I-VP	O
transcribed	transcribe	VBN	I-VP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
possesses	possess	VBZ	B-VP	O
the	the	DT	B-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
processed	process	VBN	I-NP	O
pseudogene	pseudogene	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
correspond	correspond	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
this	this	DT	B-NP	O
new	new	JJ	I-NP	O
ferritin	ferritin	NN	I-NP	B-protein
subunit	subunit	NN	I-NP	I-protein
.	.	.	O	O


Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
drugs	drug	NNS	I-NP	O
orally	orally	RB	B-VP	O
administered	administer	VBN	I-VP	O
,	,	,	O	O
WR	WR	NN	B-NP	B-protein
-	-	HYPH	O	O
168643	168643	CD	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
protector	protector	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
DMF	DMF	NN	I-NP	O
of	of	IN	B-PP	O
1.51	1.51	CD	B-NP	O
.	.	.	O	O


Characterization	Characterization	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
R	R	NN	I-NP	B-protein
subunits	subunit	NNS	I-NP	I-protein
by	by	IN	B-PP	O
their	their	PRP$	B-NP	O
8	8	CD	I-NP	O
-	-	HYPH	I-NP	O
azido	azido	AFX	I-NP	O
-	-	HYPH	I-NP	O
cAMP	cAMP	NN	I-NP	O
photoaffinity	photoaffinity	NN	I-NP	O
labeling	labeling	NN	I-NP	O
and	and	CC	I-NP	O
immunoreactivity	immunoreactivity	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
on	on	IN	B-PP	O
sodium	sodium	NN	B-NP	O
dodecyl	dodecyl	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
-	-	HYPH	B-NP	O
polyacrylamide	polyacrylamide	NN	I-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
(	(	(	O	O
SDS	SDS	NN	B-NP	O
-	-	HYPH	B-NP	O
PAGE	PAGE	NN	I-NP	B-DNA
)	)	)	O	O
,	,	,	O	O
indicated	indicate	VBD	B-VP	O
subunit	subunit	NN	B-NP	O
sizes	size	NNS	I-NP	O
of	of	IN	B-PP	O
RII	RII	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
(	(	(	O	O
53	53	CD	B-NP	O
kDa	kDa	NN	I-NP	O
)	)	)	O	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
RII	RII	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
dephosphoform	dephosphoform	NN	I-NP	O
(	(	(	O	O
51	51	CD	B-NP	O
kDa	kDa	NN	I-NP	O
)	)	)	O	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
RI	RI	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
(	(	(	O	O
49	49	CD	B-NP	B-protein
kDa	kDa	NN	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O


Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genomic	genomic	JJ	I-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
four	four	CD	I-NP	O
different	different	JJ	I-NP	O
mRNAs	mRNA	NNS	I-NP	B-RNA
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
transcripts	transcript	NNS	I-NP	O
are	be	VBP	B-VP	O
produced	produce	VBN	I-VP	O
by	by	IN	B-PP	O
alternative	alternative	JJ	B-NP	O
splicing	splicing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	B-DNA
pre	pre	AFX	O	I-DNA
-	-	HYPH	O	B-RNA
mRNA	mRNA	NN	B-NP	I-RNA
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
cassette	cassette	NN	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O


During	During	IN	B-PP	O
the	the	DT	B-NP	O
1980	1980	CD	I-NP	O
'	'	SYM	I-NP	O
s	s	NNS	I-NP	O
,	,	,	O	O
quantifications	quantification	NNS	B-NP	O
of	of	IN	B-PP	O
immunoserological	immunoserological	JJ	B-NP	O
testings	testing	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
C	C	NN	I-NP	B-protein
reactive	reactive	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
rheumatoid	rheumatoid	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	O	O
antistreptolysin	antistreptolysin	NN	B-NP	B-protein
O	O	NN	I-NP	I-protein
,	,	,	O	O
progressed	progress	VBD	B-VP	O
rapidly	rapidly	RB	B-ADVP	O
.	.	.	O	O


Within	Within	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
enhancer	enhancer	NN	I-NP	I-DNA
,	,	,	O	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
sites	site	NNS	I-NP	O
are	be	VBP	B-VP	O
located	located	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
defined	define	VBN	I-NP	O
DNase	DNase	NN	I-NP	B-protein
I	I	CD	I-NP	I-protein
footprints	footprint	NNS	I-NP	O
,	,	,	O	O
NFAT	NFAT	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
NFIL	NFIL	NN	I-NP	B-protein
-	-	HYPH	O	O
2B	2B	NN	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O


The	The	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	B-DNA
myosin	myosin	NN	I-NP	I-DNA
light	light	JJ	I-NP	I-DNA
chain	chain	NN	I-NP	I-DNA
-	-	HYPH	O	I-DNA
2	2	CD	B-NP	I-DNA
(	(	(	O	I-DNA
MLC	MLC	NN	B-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
2	2	CD	I-NP	I-DNA
)	)	)	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
several	several	JJ	B-NP	O
positive	positive	JJ	I-NP	O
and	and	CC	I-NP	O
negative	negative	JJ	I-NP	O
cis	cis	NN	I-NP	O
-	-	HYPH	O	O
acting	act	VBG	B-VP	O
sequences	sequence	NNS	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O


Deletion	Deletion	NN	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
elements	element	NNS	I-NP	O
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
positive	positive	JJ	I-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
MLC	MLC	NN	B-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
2	2	CD	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
transcription	transcription	NN	I-NP	O
.	.	.	O	O


Disruption	Disruption	NN	B-NP	O
mutations	mutation	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
constructed	construct	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
SLK1	SLK1	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O
slk1	slk1	NN	B-NP	B-protein
null	null	JJ	I-NP	I-protein
mutants	mutant	NNS	I-NP	I-protein
cannot	cannot	MD	B-VP	O
grow	grow	VB	I-VP	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
many	many	JJ	B-NP	O
cells	cell	NNS	I-NP	O
can	can	MD	B-VP	O
grow	grow	VB	I-VP	O
at	at	IN	B-PP	O
30	30	CD	B-NP	O
,	,	,	I-NP	O
24	24	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
17	17	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
.	.	.	O	O


Molecular	Molecular	JJ	B-NP	O
and	and	CC	I-NP	O
genetic	genetic	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	B-DNA
early	early	JJ	I-NP	I-DNA
meiotic	meiotic	JJ	I-NP	I-DNA
recombination	recombination	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
REC102	REC102	NN	I-NP	O
and	and	CC	I-NP	O
REC107	REC107	NN	I-NP	B-protein
/	/	SYM	B-NP	O
MER2	MER2	NN	I-NP	B-protein
.	.	.	O	O


The	The	DT	B-NP	O
p130	p130	NN	I-NP	B-protein
and	and	CC	I-NP	O
p62	p62	NN	I-NP	B-protein
tyrosine	tyrosine	NN	I-NP	O
-	-	HYPH	B-NP	O
phosphorylated	phosphorylate	VBN	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
complexed	complexe	VBD	B-VP	O
v	v	NN	B-NP	O
-	-	HYPH	B-NP	O
Src	Src	NN	I-NP	B-protein
SH2	SH2	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
also	also	RB	B-ADVP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
v	v	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
Src	Src	NN	I-NP	I-protein
in	in	IN	B-PP	O
v	v	NN	B-NP	B-cell_line
-	-	HYPH	B-NP	I-cell_line
src	src	NN	I-NP	I-cell_line
-	-	HYPH	O	I-cell_line
transformed	transform	VBN	B-NP	I-cell_line
Rat	Rat	NN	I-NP	I-cell_line
-	-	HYPH	O	I-cell_line
2	2	CD	B-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
;	;	:	O	O
this	this	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
binding	binding	NN	I-NP	O
was	be	VBD	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
v	v	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
Src	Src	NN	I-NP	I-protein
SH2	SH2	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
.	.	.	O	O


Probable	Probable	JJ	B-NP	O
progressive	progressive	JJ	I-NP	O
multifocal	multifocal	JJ	I-NP	O
leukoencephalopathy	leukoencephalopathy	NN	I-NP	O
(	(	(	O	O
PML	PML	NN	B-NP	B-protein
)	)	)	O	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
picture	picture	NN	I-NP	O
and	and	CC	O	O
magnetic	magnetic	JJ	B-NP	O
resonance	resonance	NN	I-NP	O
imaging	imaging	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
63	63	CD	I-NP	O
-	-	HYPH	I-NP	O
year	year	NN	I-NP	O
-	-	HYPH	O	O
old	old	JJ	B-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
complete	complete	JJ	I-NP	O
remission	remission	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
non	non	AFX	I-NP	B-DNA
-	-	HYPH	I-NP	O
Hodgkin	Hodgkin	NN	I-NP	O
'	'	''	I-NP	O
s	s	JJ	I-NP	O
lymphoma	lymphoma	NN	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
support	support	VBP	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
biological	biological	JJ	I-NP	O
significance	significance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
frameshift	frameshift	NN	I-NP	O
to	to	TO	B-VP	O
occur	occur	VB	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
position	position	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	O
overlap	overlap	NN	I-NP	O
by	by	IN	B-PP	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
template	template	NN	I-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PLRV	PLRV	NN	I-NP	B-protein
replicase	replicase	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ORF2a	ORF2a	NN	I-NP	B-protein
/	/	SYM	B-NP	I-protein
ORF2b	ORF2b	NN	I-NP	I-protein
transframe	transframe	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


Proprotein	Proprotein	NN	B-NP	O
processing	processing	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
intracellularly	intracellularly	RB	B-ADVP	O
.	.	.	O	O


A	A	DT	B-NP	O
32P	32P	NN	I-NP	O
-	-	HYPH	B-VP	O
labeled	label	VBN	I-VP	O
LAP	LAP	NN	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
-	-	HYPH	B-VP	O
binding	bind	VBG	B-NP	O
and	and	CC	I-NP	O
dimerization	dimerization	NN	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
"	"	''	I-NP	O
zipper	zipper	NN	I-NP	O
probe	probe	NN	I-NP	O
"	"	''	O	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
isolate	isolate	VB	I-VP	O
a	a	DT	B-NP	O
clone	clone	NN	I-NP	O
that	that	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
C	C	NN	I-NP	O
/	/	SYM	B-NP	O
EBP	EBP	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
homologous	homologous	JJ	I-NP	O
protein	protein	NN	I-NP	O
:	:	:	O	O
CHOP	CHOP	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
10	10	CD	I-NP	O
.	.	.	O	O


Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
degenerate	degenerate	JJ	I-NP	O
oligodeoxyribonucleotide	oligodeoxyribonucleotide	NN	I-NP	O
(	(	(	O	O
oligo	oligo	NN	B-NP	O
)	)	)	O	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
terminal	terminal	JJ	I-NP	I-DNA
aa	aa	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
,	,	,	O	O
plus	plus	CC	B-PP	O
an	an	DT	B-NP	O
internal	internal	JJ	I-NP	O
oligo	oligo	NN	I-NP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
region	region	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
CYP1	CYP1	NN	B-NP	B-protein
and	and	CC	I-NP	O
CYP2	CYP2	NN	I-NP	B-protein
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
deleted	delete	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
genome	genome	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
CYP3	CYP3	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
DNA	DNA	NN	I-NP	B-DNA
fragment	fragment	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
generated	generate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
PCR	PCR	NN	B-NP	O
)	)	)	O	O
using	use	VBG	B-VP	O
GL81	GL81	NN	B-NP	B-DNA
genomic	genomic	JJ	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
as	as	IN	B-PP	O
a	a	DT	B-NP	O
substrate	substrate	NN	I-NP	O
.	.	.	O	O


Stringent	Stringent	JJ	B-NP	O
hybridization	hybridization	NN	I-NP	O
of	of	IN	B-PP	O
EHS	EHS	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
back	back	RB	B-ADVP	O
to	to	TO	B-VP	O
primate	primate	VB	I-VP	O
genomic	genomic	JJ	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
indicates	indicate	VBZ	B-VP	O
two	two	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
EHS	EHS	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
loci	locus	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
human	human	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
identical	identical	JJ	I-NP	O
band	band	NN	I-NP	O
pattern	pattern	NN	I-NP	O
in	in	IN	B-PP	O
chimpanzee	chimpanzee	NN	B-NP	O
DNA	DNA	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
locus	locus	NN	I-NP	O
in	in	IN	B-PP	O
rhesus	rhesus	NN	B-NP	B-DNA
monkey	monkey	NN	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
.	.	.	O	O


The	The	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
carboxyl	carboxyl	NN	B-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
parathyroid	parathyroid	NN	I-NP	O
hormone	hormone	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
thyroid	thyroid	JJ	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
was	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
without	without	IN	B-PP	O
thyroid	thyroid	JJ	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
Caenorhabditis	Caenorhabditis	NNP	I-NP	B-DNA
elegans	elegans	NNP	I-NP	I-DNA
vitellogenin	vitellogenin	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
are	be	VBP	B-VP	O
subject	subject	JJ	B-ADJP	O
to	to	TO	B-PP	O
sex	sex	NN	B-NP	O
-	-	HYPH	B-ADJP	O
,	,	,	O	O
stage	stage	NN	B-NP	O
-	-	HYPH	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
tissue	tissue	NN	B-NP	O
-	-	HYPH	O	O
specific	specific	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
:	:	:	O	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
expressed	express	VBN	I-VP	O
solely	solely	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
adult	adult	JJ	I-NP	O
hermaphrodite	hermaphrodite	NN	I-NP	O
intestine	intestine	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
MET4	MET4	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
cloned	clone	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
sequence	sequence	NN	I-NP	O
reveals	reveal	VBZ	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bZIP	bZIP	NN	I-NP	B-protein
transcriptional	transcriptional	JJ	I-NP	I-protein
activators	activator	NNS	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
functions	function	NNS	I-NP	O
of	of	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
portions	portion	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
,	,	,	O	O
IAPP	IAPP	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
beta	beta	NN	B-NP	B-DNA
GK	GK	NN	I-NP	I-DNA
promoters	promoter	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
transient	transient	JJ	B-NP	O
expression	expression	NN	B-NP	O
and	and	CC	O	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O


It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
believed	believe	VBN	I-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
domains	domain	NNS	I-NP	O
are	be	VBP	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
directing	direct	VBG	B-VP	O
specific	specific	JJ	B-NP	O
protein	protein	NN	I-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
necessary	necessary	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
proper	proper	JJ	I-NP	O
functioning	functioning	NN	I-NP	O
of	of	IN	B-PP	O
Src	Src	NN	B-NP	B-protein
.	.	.	O	O


The	The	DT	B-NP	O
c	c	NN	I-NP	O
-	-	HYPH	B-NP	O
Ets	Ets	NN	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
1	1	CD	I-NP	I-protein
oncoprotein	oncoprotein	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
transcription	transcription	NN	I-NP	O
activator	activator	NN	I-NP	O
that	that	WDT	B-NP	O
specifically	specifically	RB	B-ADVP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
DNA	DNA	NN	B-NP	O
.	.	.	O	O


Previous	Previous	JJ	B-NP	O
transactivation	transactivation	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
three	three	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
residing	reside	VBG	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
,	,	,	O	O
Gly	Gly	NN	B-NP	B-protein
,	,	,	O	O
Ser	Ser	NN	B-NP	B-protein
and	and	CC	I-NP	O
Val	Val	NN	I-NP	O
,	,	,	O	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
critical	critical	JJ	B-ADJP	O
for	for	IN	B-PP	O
target	target	NN	B-NP	O
-	-	HYPH	I-NP	O
site	site	NN	I-NP	O
discrimination	discrimination	NN	I-NP	O
.	.	.	O	O


GR63178A	GR63178A	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
water	water	NN	I-NP	O
-	-	HYPH	B-NP	O
soluble	soluble	JJ	I-NP	O
analogue	analogue	NN	I-NP	O
of	of	IN	B-PP	O
mitoquidone	mitoquidone	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
pentacyclic	pentacyclic	JJ	I-NP	O
pyrroloquinone	pyrroloquinone	NN	I-NP	O
.	.	.	O	O


Marker	Marker	NN	B-NP	O
rescue	rescue	NN	I-NP	O
analysis	analysis	NN	I-NP	O
has	have	VBZ	B-VP	O
localized	localize	VBN	I-VP	O
ts8	ts8	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
910	910	CD	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
bp	bp	NN	I-NP	I-DNA
internal	internal	JJ	I-NP	I-DNA
segment	segment	NN	I-NP	I-DNA
of	of	IN	B-PP	O
rpoB	rpoB	NN	B-NP	B-DNA
that	that	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
the	the	DT	B-NP	O
Rif	Rif	NNP	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
.	.	.	O	O


This	This	DT	B-NP	O
vector	vector	NN	I-NP	O
transfected	transfecte	VBN	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	O
Saccharomyces	Saccharomyces	NNP	I-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O
directs	direct	VBZ	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
secreted	secrete	VBN	I-NP	O
mature	mature	JJ	I-NP	O
protein	protein	NN	I-NP	O
at	at	IN	B-PP	O
levels	level	NNS	B-NP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
LAPP	LAPP	NN	B-NP	B-protein
/	/	SYM	B-NP	O
liter	liter	NN	I-NP	O
of	of	IN	B-PP	O
culture	culture	NN	B-NP	O
medium	medium	NN	I-NP	O
.	.	.	O	O


Competition	Competition	NN	B-NP	O
analysis	analysis	NN	I-NP	O
by	by	IN	B-PP	O
gel	gel	NN	B-NP	O
mobility	mobility	NN	I-NP	O
shift	shift	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
DNA	DNA	NN	I-NP	O
-	-	HYPH	B-NP	O
protein	protein	NN	I-NP	O
interaction	interaction	NN	I-NP	O
is	be	VBZ	B-VP	O
novel	novel	JJ	B-ADJP	O
and	and	CC	O	O
not	not	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
many	many	JJ	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
previously	previously	RB	B-VP	O
reported	report	VBN	I-VP	O
.	.	.	O	O


This	This	DT	B-NP	O
DNA	DNA	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
-	-	HYPH	B-PP	O
binding	bind	VBG	B-NP	O
sequence	sequence	NN	I-NP	O
.	.	.	O	O


OBJECTIVE	OBJECTIVE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
designed	design	VBN	I-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
alterations	alteration	NNS	B-NP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
psoriasis	psoriasis	NN	B-NP	O
receiving	receive	VBG	B-VP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
kg	kg	NN	I-NP	O
/	/	SYM	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
cyclosporine	cyclosporine	NN	B-NP	O
.	.	.	O	O


Intrapocket	Intrapocket	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
in	in	IN	B-PP	O
adult	adult	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
controlled	controlled	JJ	I-NP	O
-	-	HYPH	I-NP	O
release	release	NN	I-NP	O
insert	insert	NN	I-NP	O
containing	contain	VBG	B-VP	O
ofloxacin	ofloxacin	NN	B-NP	O
(	(	(	O	O
PT	PT	NN	B-NP	O
-	-	HYPH	O	O
01	01	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


Electromagnetic	Electromagnetic	JJ	B-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
(	(	(	O	O
BF	BF	NN	B-NP	O
)	)	)	O	O
probe	probe	NN	B-NP	O
was	be	VBD	B-VP	O
applied	apply	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
(	(	(	O	O
LAD	LAD	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O


Hence	Hence	NN	B-NP	O
temperature	temperature	NN	I-NP	O
and	and	CC	O	O
virF	virF	NN	B-NP	B-protein
are	be	VBP	B-VP	O
both	both	DT	O	O
required	require	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
yop	yop	NN	I-NP	B-DNA
regulon	regulon	NN	I-NP	I-DNA
.	.	.	O	O


Problems	Problem	NNS	B-NP	O
remain	remain	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
resolved	resolve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
quantitative	quantitative	JJ	B-NP	O
risk	risk	NN	I-NP	O
assessment	assessment	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
recently	recently	RB	I-NP	O
developed	develop	VBN	I-NP	O
gamma	gamma	NN	I-NP	O
-	-	HYPH	O	O
interferon	interferon	NN	B-NP	B-protein
(	(	(	O	O
IFN	IFN	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
gamma	gamma	NN	I-NP	I-protein
)	)	)	I-NP	O
assay	assay	NN	I-NP	O
system	system	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
bovine	bovine	JJ	B-NP	O
tuberculosis	tuberculosis	NN	I-NP	O
in	in	IN	B-PP	O
cattle	cattle	NNS	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
accredited	accredit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Standing	Standing	NNP	I-NP	O
Committee	Committee	NNP	I-NP	O
on	on	IN	B-PP	O
Agriculture	Agriculture	NNP	B-NP	O
for	for	IN	B-PP	O
use	use	NN	B-NP	O
in	in	IN	B-PP	O
Australia	Australia	NNP	B-NP	O
.	.	.	O	O


Control	Control	NN	B-NP	O
Tmuscle	Tmuscle	NN	I-NP	O
was	be	VBD	B-VP	O
35.8	35.8	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
0.7	0.7	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
control	control	NN	B-NP	O
Wi	Wi	NNP	I-NP	O
,	,	,	O	O
max	max	NN	B-NP	O
being	be	VBG	B-VP	O
51.6	51.6	CD	B-NP	O
(	(	(	O	O
SD	SD	NN	O	O
8.7	8.7	CD	O	O
)	)	)	O	O
W	W	NNP	B-NP	O
.	.	.	O	O
kg	kg	''	O	B-cell_line
-	-	HYPH	B-NP	I-cell_line
1	1	CD	I-NP	I-cell_line
.	.	.	O	O


The	The	DT	B-NP	O
Klebsiella	Klebsiella	NNP	I-NP	O
aerogenes	aerogene	NNS	I-NP	O
gene	gene	NN	I-NP	O
maoA	maoA	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
monoamine	monoamine	NN	B-NP	B-protein
oxidase	oxidase	NN	I-NP	I-protein
,	,	,	O	O
was	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
tyramine	tyramine	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
related	relate	VBN	I-NP	O
compounds	compound	NNS	I-NP	O
,	,	,	O	O
subjected	subject	VBN	B-VP	O
to	to	TO	B-PP	O
catabolite	catabolite	NN	B-NP	O
and	and	CC	I-NP	O
ammonium	ammonium	NN	I-NP	O
ion	ion	NN	I-NP	O
repression	repression	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cloned	clone	VBN	B-VP	O
.	.	.	O	O


However	However	RB	B-ADVP	O
,	,	,	O	O
other	other	JJ	B-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
plasmid	plasmid	NN	I-NP	B-DNA
are	be	VBP	B-VP	O
also	also	RB	B-ADVP	O
efficiently	efficiently	RB	B-ADJP	O
repaired	repair	VBN	I-ADJP	O
.	.	.	O	O


Eight	Eight	CD	B-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
infectious	infectious	JJ	I-NP	O
or	or	CC	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
scan	scan	NN	I-NP	O
(	(	(	O	O
4	4	CD	B-NP	O
-	-	HYPH	I-NP	O
6	6	CD	I-NP	O
h	h	NN	I-NP	O
p	p	NN	I-NP	O
.	.	.	I-NP	O
i	i	NN	I-NP	O
.	.	.	O	O
)	)	)	O	O
.	.	.	O	O


Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
D1A	D1A	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
belongs	belong	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
category	category	NN	I-NP	O
of	of	IN	B-PP	O
tissue	tissue	NN	B-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
specific	specific	JJ	I-NP	I-DNA
,	,	,	I-NP	I-DNA
regulated	regulated	JJ	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
housekeeping	housekeeping	NN	B-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
type	type	NN	I-NP	I-DNA
promoters	promoter	NNS	I-NP	I-DNA
.	.	.	O	O


Similar	Similar	JJ	B-NP	O
observations	observation	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
made	make	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
for	for	IN	B-PP	O
other	other	JJ	B-NP	O
genes	gene	NNS	I-NP	O
.	.	.	O	O


Preceptorship	Preceptorship	NN	B-NP	O
of	of	IN	B-PP	O
CNS	CNS	NN	B-NP	B-protein
students	student	NNS	I-NP	O
:	:	:	O	O
an	an	DT	B-NP	O
exploratory	exploratory	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O


To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	NN	I-NP	O
and	and	CC	I-NP	O
brain	brain	NN	I-NP	O
AE3	AE3	NN	I-NP	O
variants	variant	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
and	and	CC	O	O
characterized	characterize	VBD	B-VP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O


The	The	DT	B-NP	O
1.7	1.7	CD	I-NP	B-DNA
kb	kb	NN	I-NP	I-DNA
cloned	clone	VBN	I-NP	I-DNA
fragment	fragment	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
sequenced	sequence	VBN	I-VP	O
and	and	CC	O	O
shown	show	VBN	B-VP	O
to	to	TO	I-VP	O
contain	contain	VB	I-VP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	B-DNA
fliA	fliA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O


Institution	Institution	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	B-NP	O
intravenous	intravenous	JJ	I-NP	O
and	and	CC	I-NP	O
intracisternal	intracisternal	JJ	I-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
amphotericin	amphotericin	NN	B-NP	O
B	B	NN	I-NP	O
and	and	CC	O	O
possibly	possibly	RB	B-NP	O
concomitant	concomitant	JJ	I-NP	O
intravenous	intravenous	JJ	I-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
warranted	warrant	VBN	I-VP	O
in	in	IN	B-PP	O
situations	situation	NNS	B-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
C	C	NN	B-NP	O
.	.	.	O	O
immitis	immitis	NN	B-NP	O
with	with	IN	B-PP	O
CNS	CNS	NN	B-NP	B-protein
vasculitis	vasculitis	NN	I-NP	O
or	or	CC	I-NP	O
encephalitis	encephalitis	NN	I-NP	O
appears	appear	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
before	before	IN	B-PP	O
serologic	serologic	JJ	B-NP	O
or	or	CC	I-NP	O
cultural	cultural	JJ	I-NP	O
confirmation	confirmation	NN	I-NP	O
of	of	IN	B-PP	O
C	C	NN	B-NP	O
.	.	.	O	O
immitis	immitis	NN	B-NP	O
infection	infection	NN	I-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
CNS	CNS	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
available	available	JJ	B-ADJP	O
.	.	.	O	O


Lac	Lac	NN	B-NP	O
operators	operator	NNS	I-NP	O
were	be	VBD	B-VP	O
introduced	introduce	VBN	I-VP	O
into	into	IN	B-PP	O
several	several	JJ	B-NP	O
positions	position	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
CAB	CAB	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
and	and	CC	I-NP	O
operator	operator	NN	I-NP	B-DNA
-	-	HYPH	O	I-DNA
free	free	JJ	B-NP	I-DNA
plasmid	plasmid	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
control	control	NN	B-NP	O
.	.	.	O	O


Overproduction	Overproduction	NN	B-NP	O
,	,	,	I-NP	O
purification	purification	NN	I-NP	O
and	and	CC	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
M	M	NN	B-NP	O
.	.	.	O	O
HinfI	HinfI	NN	B-NP	B-protein
methyltransferase	methyltransferase	NN	I-NP	I-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
deletion	deletion	NN	I-NP	B-DNA
mutant	mutant	NN	I-NP	I-DNA
.	.	.	O	O


Various	Various	JJ	B-NP	O
companies	company	NNS	I-NP	O
produce	produce	VBP	B-VP	O
this	this	DT	B-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
lens	lens	NN	B-NP	O
.	.	.	O	O


From	From	IN	B-PP	O
March	March	NNP	B-NP	O
5	5	CD	I-NP	O
through	through	IN	B-PP	O
October	October	NNP	B-NP	O
26	26	CD	I-NP	O
,	,	,	I-NP	O
1991	1991	CD	I-NP	O
,	,	,	I-NP	O
eight	eight	CD	I-NP	O
persons	person	NNS	I-NP	O
were	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
blood	blood	NN	I-NP	O
lead	lead	NN	I-NP	O
levels	level	NNS	I-NP	O
(	(	(	O	O
BLLs	BLL	NNS	B-NP	B-cell_type
)	)	)	O	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
local	local	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
reported	report	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
notifiable	notifiable	JJ	I-NP	O
disease	disease	NN	I-NP	O
surveillance	surveillance	NN	I-NP	O
system	system	NN	I-NP	O
maintained	maintain	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Alabama	Alabama	NNP	I-NP	O
Department	Department	NNP	I-NP	O
of	of	IN	B-PP	O
Public	Public	NNP	B-NP	O
Health	Health	NNP	I-NP	O
(	(	(	O	O
ADPH	ADPH	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O


According	Accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
perfusion	perfusion	NN	B-NP	O
defects	defect	NNS	I-NP	O
between	between	IN	B-PP	O
Ex	Ex	NN	B-NP	O
,	,	,	I-NP	O
RD	RD	NN	I-NP	O
and	and	CC	I-NP	O
ReI	ReI	NN	I-NP	O
images	image	NNS	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
classified	classify	VBN	I-VP	O
into	into	IN	B-PP	O
3	3	CD	B-NP	O
types	type	NNS	I-NP	O
:	:	:	O	O
Type	Type	NN	B-NP	O
I	I	CD	I-NP	O
;	;	:	O	O
perfusion	perfusion	NN	B-NP	O
defect	defect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
RD	RD	NN	I-NP	O
image	image	NN	I-NP	O
was	be	VBD	B-VP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
ReI	ReI	NN	B-NP	O
image	image	NN	I-NP	O
(	(	(	O	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
Type	Type	NN	B-NP	O
I	I	PRP	B-NP	O
was	be	VBD	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
2	2	CD	B-NP	O
subgroups	subgroup	NNS	I-NP	O
whether	whether	IN	B-SBAR	O
perfusion	perfusion	NN	B-NP	O
defect	defect	NN	I-NP	O
at	at	IN	B-PP	O
Ex	Ex	NN	B-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
(	(	(	O	O
Ia	Ia	NN	B-NP	O
,	,	,	O	O
42	42	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
improved	improve	VBN	B-VP	O
(	(	(	O	O
Ib	Ib	NN	B-NP	B-protein
,	,	,	O	O
33	33	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
RD	RD	NN	I-NP	O
image	image	NN	I-NP	O
.	.	.	O	O


Keck	Keck	NNP	B-NP	O
,	,	,	O	O
C	C	NNP	B-NP	O
.	.	.	I-NP	O
J	J	NNP	I-NP	O
.	.	.	O	O


Twenty	Twenty	CD	B-NP	O
-	-	HYPH	I-NP	O
eight	eight	CD	I-NP	O
(	(	(	O	O
7.0	7.0	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
infants	infant	NNS	B-NP	O
without	without	IN	B-PP	O
periventricular	periventricular	JJ	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
were	be	VBD	B-VP	O
revealed	reveal	VBN	I-VP	O
as	as	IN	B-PP	O
having	have	VBG	B-VP	O
spastic	spastic	JJ	B-NP	O
cerebral	cerebral	JJ	I-NP	O
palsy	palsy	NN	I-NP	O
by	by	IN	B-PP	O
neurodevelopmental	neurodevelopmental	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
in	in	IN	B-PP	O
later	later	JJ	B-NP	O
infancy	infancy	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
possible	possible	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
is	be	VBZ	B-VP	O
that	that	IN	B-SBAR	O
elevated	elevated	JJ	B-NP	O
alveolar	alveolar	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
eliminate	eliminate	VB	B-VP	O
blood	blood	NN	B-NP	O
flow	flow	NN	I-NP	O
from	from	IN	B-PP	O
corner	corner	NN	B-NP	O
vessels	vessel	NNS	I-NP	O
in	in	IN	B-PP	O
nondependent	nondependent	JJ	B-NP	O
high	high	JJ	I-NP	O
VA	VA	NN	I-NP	O
/	/	SYM	B-VP	O
Q	Q	NN	B-NP	B-DNA
regions	region	NNS	I-NP	I-DNA
.	.	.	O	O


Computer	Computer	NN	B-NP	O
-	-	HYPH	B-VP	O
aided	aid	VBN	B-NP	O
"	"	``	I-NP	B-DNA
FRAME	FRAME	NN	I-NP	I-DNA
"	"	''	I-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
four	four	CD	B-NP	O
possible	possible	JJ	I-NP	O
open	open	JJ	I-NP	B-DNA
reading	reading	NN	I-NP	I-DNA
frames	frame	NNS	I-NP	I-DNA
(	(	(	O	O
ORFs	ORF	NNS	B-NP	B-DNA
)	)	)	O	O
,	,	,	O	O
three	three	CD	B-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
direction	direction	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
opposite	opposite	JJ	I-NP	O
direction	direction	NN	I-NP	O
.	.	.	O	O


Domain	Domain	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
is	be	VBZ	B-VP	O
highly	highly	RB	B-ADJP	O
homologous	homologous	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LDL	LDL	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
and	and	CC	O	O
contains	contain	VBZ	B-VP	O
four	four	CD	B-NP	O
repeats	repeat	NNS	I-NP	O
with	with	IN	B-PP	O
perfect	perfect	JJ	B-NP	O
conservation	conservation	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
6	6	CD	I-NP	O
consecutive	consecutive	JJ	I-NP	O
cysteines	cysteine	NNS	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
both	both	DT	B-NP	O
cities	city	NNS	I-NP	O
,	,	,	O	O
HTLV	HTLV	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
I	I	NN	I-NP	O
/	/	SYM	I-NP	O
II	II	CD	I-NP	O
prevalence	prevalence	NN	I-NP	O
increased	increase	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
with	with	IN	B-PP	O
age	age	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
New	New	NNP	I-NP	O
Orleans	Orleans	NNP	I-NP	O
age	age	NN	I-NP	O
-	-	HYPH	O	O
and	and	CC	O	O
sex	sex	NN	B-NP	O
-	-	HYPH	O	O
adjusted	adjust	VBN	B-NP	O
HTLV	HTLV	NN	I-NP	O
-	-	HYPH	I-NP	O
I	I	NN	I-NP	O
/	/	SYM	I-NP	O
II	II	CD	I-NP	O
prevalence	prevalence	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
Baltimore	Baltimore	NNP	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
.	.	.	B-NP	O
001	001	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O


Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
present	present	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
mRNA	mRNA	NN	B-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
around	around	IN	B-NP	O
100	100	CD	I-NP	B-DNA
nucleotides	nucleotide	NNS	I-NP	I-DNA
downstream	downstream	RB	B-ADVP	I-DNA
from	from	IN	B-PP	O
the	the	DT	B-NP	O
start	start	NN	I-NP	B-DNA
codon	codon	NN	I-NP	I-DNA
of	of	IN	B-PP	O
21K	21K	NN	B-NP	B-protein
fold	fold	RB	B-ADVP	O
back	back	RB	I-ADVP	O
and	and	CC	O	O
base	base	NN	B-NP	O
-	-	HYPH	O	O
pair	pair	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
21K	21K	NN	I-NP	B-DNA
translation	translation	NN	I-NP	I-DNA
initiation	initiation	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
,	,	,	O	O
thereby	thereby	RB	B-VP	O
decreasing	decrease	VBG	I-VP	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	O
initiation	initiation	NN	I-NP	O
frequency	frequency	NN	I-NP	O
.	.	.	O	O


Hybridization	Hybridization	NN	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
6F6.2	6F6.2	NN	B-NP	B-protein
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
characterized	characterize	VBN	I-NP	O
m6F6	m6F6	NN	I-NP	B-DNA
cDNA	cDNA	NN	I-NP	I-DNA
clone	clone	NN	I-NP	I-DNA
and	and	CC	O	O
that	that	IN	B-SBAR	O
6F6.1	6F6.1	NN	B-NP	B-protein
and	and	CC	I-NP	O
6F6.3	6F6.3	NN	I-NP	B-protein
,	,	,	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
6F6.2	6F6.2	NN	B-NP	B-protein
,	,	,	O	O
are	be	VBP	B-VP	O
adjacent	adjacent	JJ	B-ADJP	O
to	to	TO	B-PP	O
alpha	alpha	SYM	B-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
type	type	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O


The	The	DT	B-NP	O
SEN1	SEN1	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
6	6	CD	I-NP	B-DNA
,	,	,	I-NP	I-DNA
336	336	CD	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
bp	bp	NN	I-NP	I-DNA
open	open	JJ	I-NP	I-DNA
reading	reading	NN	I-NP	I-DNA
frame	frame	NN	I-NP	I-DNA
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
112	112	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
acid	acid	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
molecular	molecular	JJ	B-NP	O
mass	mass	NN	I-NP	O
,	,	,	O	O
239	239	CD	B-NP	B-protein
kDa	kDa	NN	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O


Protein	Protein	NN	B-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
(	(	(	O	O
PTKs	PTK	NNS	B-NP	B-protein
)	)	)	O	O
are	be	VBP	B-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
growth	growth	NN	I-NP	O
by	by	IN	B-PP	O
virtue	virtue	NN	B-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
frequent	frequent	JJ	I-NP	O
appearance	appearance	NN	I-NP	O
as	as	IN	B-PP	O
products	product	NNS	B-NP	O
of	of	IN	B-PP	O
retroviral	retroviral	JJ	B-NP	B-DNA
oncogenes	oncogene	NNS	I-NP	I-DNA
,	,	,	O	O
as	as	IN	B-SBAR	O
intracellular	intracellular	JJ	B-NP	O
signal	signal	NN	I-NP	O
transducers	transducer	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
as	as	IN	B-PP	O
growth	growth	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
or	or	CC	I-NP	O
components	component	NNS	I-NP	O
thereof	thereof	RB	B-ADVP	O
.	.	.	O	O


The	The	DT	B-NP	O
IA4	IA4	NN	I-NP	B-protein
mAb	mAb	NN	I-NP	I-protein
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
among	among	IN	B-PP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
raised	raise	VBN	B-VP	O
in	in	IN	B-PP	O
BALB	BALB	NN	B-NP	B-protein
/	/	SYM	B-NP	O
c	c	NN	I-NP	O
mice	mouse	NNS	I-NP	O
after	after	IN	B-PP	O
immunization	immunization	NN	B-NP	O
against	against	IN	B-PP	O
a	a	DT	B-NP	O
HLA	HLA	NN	I-NP	B-protein
class	class	NN	I-NP	I-protein
I	I	CD	I-NP	I-protein
-	-	HYPH	B-NP	O
deficient	deficient	JJ	I-NP	O
,	,	,	I-NP	O
lymphokine	lymphokine	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
activated	activate	VBN	B-VP	O
killer	killer	NN	B-NP	O
(	(	(	O	O
LAK	LAK	NN	B-NP	O
)	)	)	O	O
-	-	HYPH	O	O
susceptible	susceptible	JJ	B-NP	O
EBV	EBV	NN	I-NP	O
-	-	HYPH	B-NP	O
B	B	NN	I-NP	O
lymphocyte	lymphocyte	NN	I-NP	O
line	line	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
a	a	DT	B-NP	O
randomized	randomize	VBN	I-NP	O
double	double	JJ	I-NP	O
-	-	HYPH	I-NP	O
blind	blind	JJ	I-NP	B-cell_type
cross	cross	AFX	I-NP	I-cell_type
-	-	HYPH	I-NP	O
over	over	IN	B-PP	O
study	study	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
received	receive	VBD	B-VP	O
theophylline	theophylline	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	SYM	I-NP	O
kg	kg	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
with	with	IN	B-PP	O
omeprazole	omeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
or	or	CC	O	O
identical	identical	JJ	B-NP	O
placebo	placebo	NN	I-NP	O
during	during	IN	B-PP	O
two	two	CD	B-NP	O
periods	period	NNS	I-NP	O
,	,	,	O	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
separated	separate	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
washout	washout	NN	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O


Primer	Primer	NN	B-NP	O
extension	extension	NN	I-NP	O
and	and	CC	O	O
mung	mung	JJ	B-NP	O
bean	bean	NN	I-NP	O
and	and	CC	O	O
S1	S1	NN	B-NP	B-protein
nuclease	nuclease	NN	I-NP	I-protein
mapping	mapping	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
transcription	transcription	NN	I-NP	B-DNA
initiation	initiation	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
and	and	CC	O	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
Northern	Northern	JJ	B-NP	O
analyses	analysis	NNS	I-NP	O
.	.	.	O	O


Two	Two	CD	B-NP	O
variant	variant	JJ	I-NP	O
PRP	PRP	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
precursor	precursor	NN	I-NP	B-DNA
alleles	allele	NNS	I-NP	I-DNA
occur	occur	VBP	B-VP	O
which	which	WDT	B-NP	O
slightly	slightly	RB	B-ADVP	O
differ	differ	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
repeats	repeat	NNS	B-NP	O
in	in	IN	B-PP	O
domain	domain	NN	B-NP	O
C	C	NN	I-NP	O
.	.	.	O	O


Unlike	Unlike	IN	B-PP	O
the	the	DT	B-NP	O
typical	typical	JJ	I-NP	O
enhancer	enhancer	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
,	,	,	O	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
functions	function	VBZ	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
orientation	orientation	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
20	20	CD	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
uses	use	NNS	I-NP	O
of	of	IN	B-PP	O
botulinum	botulinum	NN	B-NP	O
toxin	toxin	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
neurotoxin	neurotoxin	NN	I-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O


Allagille	Allagille	NNP	B-NP	O
'	'	POS	B-NP	O
s	s	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
antenatal	antenatal	JJ	B-NP	O
ascites	ascite	NNS	I-NP	O


Sensitivity	Sensitivity	NN	B-NP	O
and	and	CC	I-NP	O
specificity	specificity	NN	I-NP	O
was	be	VBD	B-VP	O
established	establish	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Pharmacia	Pharmacia	NNP	I-NP	O
CAP	CAP	NNP	I-NP	O
System	System	NNP	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
DPC	DPC	NNP	I-NP	O
AlaSTAT	AlaSTAT	NNP	I-NP	O
System	System	NNP	I-NP	O
by	by	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
results	result	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
skin	skin	NN	I-NP	O
prick	prick	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O


PSI	PSI	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
G	G	NN	I-NP	I-protein
and	and	CC	I-NP	O
PSI	PSI	NN	I-NP	B-protein
-	-	HYPH	O	I-protein
K	K	NN	B-NP	I-protein
probably	probably	RB	B-ADVP	O
have	have	VBP	B-VP	O
evolved	evolve	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
gene	gene	NN	I-NP	O
duplication	duplication	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
ancestral	ancestral	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O


At	At	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
terminus	terminus	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
protein	protein	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
domain	domain	NN	I-NP	O
that	that	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
sequences	sequence	NNS	B-NP	O
very	very	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
breakpoint	breakpoint	NN	I-NP	O
cluster	cluster	NN	I-NP	O
region	region	NN	I-NP	O
gene	gene	NN	I-NP	O
product	product	NN	I-NP	O
,	,	,	O	O
n	n	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
chimerin	chimerin	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
rho	rho	JJ	B-NP	B-protein
GAP	GAP	NN	I-NP	I-protein
,	,	,	O	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
possess	possess	VB	I-VP	O
intrinsic	intrinsic	JJ	B-NP	O
GAP	GAP	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
on	on	IN	B-PP	O
small	small	JJ	B-NP	B-protein
GTPases	GTPas	NNS	I-NP	I-protein
.	.	.	O	O


Site	Site	NN	B-NP	O
-	-	HYPH	B-NP	O
directed	direct	VBN	I-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
two	two	CD	B-NP	O
clusters	cluster	NNS	I-NP	O
of	of	IN	B-PP	O
basic	basic	JJ	B-NP	O
amino	amino	JJ	I-NP	O
acids	acid	NNS	I-NP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
conserved	conserve	VBN	I-NP	B-DNA
basic	basic	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
and	and	CC	O	O
two	two	CD	B-NP	O
amphipathic	amphipathic	JJ	I-NP	O
helices	helix	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
adjacent	adjacent	JJ	I-NP	B-protein
HLH	HLH	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
are	be	VBP	B-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
sequence	sequence	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
and	and	CC	O	O
hetero	hetero	AFX	B-NP	O
-	-	HYPH	I-NP	O
oligomerization	oligomerization	NN	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O


Dimerization	Dimerization	NN	B-NP	O
of	of	IN	B-PP	O
Myf	Myf	NN	B-NP	B-protein
-	-	HYPH	O	I-protein
5	5	CD	B-NP	I-protein
with	with	IN	B-PP	O
the	the	DT	B-NP	O
ubiquitously	ubiquitously	RB	I-NP	O
expressed	express	VBN	I-NP	O
bHLH	bHLH	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
E12	E12	NN	I-NP	B-protein
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
increases	increase	VBZ	B-VP	O
the	the	DT	B-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
DNA	DNA	NN	B-NP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
stimulates	stimulate	VBZ	B-VP	O
transactivation	transactivation	NN	B-NP	O
independently	independently	RB	B-ADVP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
circadian	circadian	JJ	I-NP	O
rhythmicity	rhythmicity	NN	I-NP	O
of	of	IN	B-PP	O
sleep	sleep	NN	B-NP	O
was	be	VBD	B-VP	O
pronounced	pronounce	VBN	I-VP	O
.	.	.	O	O


SEA	SEA	NN	B-NP	B-protein
was	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
with	with	IN	B-PP	O
bidirectional	bidirectional	JJ	B-NP	O
filters	filter	NNS	I-NP	O
at	at	IN	B-PP	O
25	25	CD	B-NP	O
-	-	HYPH	I-NP	O
250	250	CD	I-NP	O
HZ	HZ	NN	I-NP	O
and	and	CC	I-NP	O
40	40	CD	I-NP	O
-	-	HYPH	I-NP	O
250	250	CD	I-NP	O
Hz	Hz	NN	I-NP	O
using	use	VBG	B-VP	O
Simson	Simson	NN	B-NP	O
method	method	NN	I-NP	O
.	.	.	O	O


Neural	Neural	JJ	B-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
,	,	,	O	O
genomic	genomic	JJ	B-NP	O
structure	structure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chromosomal	chromosomal	JJ	B-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
zinc	zinc	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
finger	finger	NN	I-NP	I-protein
transcription	transcription	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
NGFI	NGFI	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
C	C	NN	I-NP	O
.	.	.	O	O


An	An	DT	B-NP	O
experiment	experiment	NN	I-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
gonadotrophin	gonadotrophin	NN	B-NP	O
releasing	release	VBG	B-VP	O
hormone	hormone	NN	B-NP	O
(	(	(	O	O
100	100	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
GnRH	GnRH	NN	I-NP	O
injected	inject	VBN	B-VP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
progestagen	progestagen	NN	B-NP	O
sponge	sponge	NN	I-NP	O
removal	removal	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
season	season	NN	B-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
(	(	(	O	O
autumn	autumn	NN	B-NP	O
v	v	NN	I-NP	O
.	.	.	I-NP	O
spring	spring	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
supplementary	supplementary	JJ	B-NP	O
feeding	feeding	NN	I-NP	O
with	with	IN	B-PP	O
lupin	lupin	NN	B-NP	O
grain	grain	NN	I-NP	O
(	(	(	O	O
in	in	IN	B-PP	O
autumn	autumn	NN	B-NP	O
only	only	RB	B-ADVP	O
,	,	,	O	O
from	from	IN	B-PP	O
12	12	CD	B-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
until	until	IN	B-NP	O
8	8	CD	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
sponge	sponge	NN	B-NP	O
removal	removal	NN	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
ovulation	ovulation	NN	B-NP	O
in	in	IN	B-PP	O
182	182	CD	B-NP	O
mature	mature	JJ	I-NP	O
Merino	Merino	NNP	I-NP	O
ewes	ewe	NNS	I-NP	O
superovulated	superovulate	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
400	400	CD	B-NP	O
I	I	CD	I-NP	O
.	.	.	I-NP	O
U	U	NNP	I-NP	O
.	.	.	I-NP	O
pregnant	pregnant	JJ	I-NP	O
mare	mare	JJ	I-NP	O
serum	serum	NN	I-NP	O
gonadotrophin	gonadotrophin	NN	I-NP	O
(	(	(	O	O
PMSG	PMSG	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
12	12	CD	B-NP	O
mg	mg	NN	I-NP	O
follicle	follicle	NN	I-NP	O
stimulating	stimulate	VBG	B-VP	O
hormone	hormone	NN	B-NP	O
(	(	(	O	O
FSH	FSH	NN	B-NP	O
-	-	HYPH	B-NP	O
P	P	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


Drug	Drug	NN	B-NP	O
-	-	HYPH	I-NP	O
drug	drug	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
are	be	VBP	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	JJ	I-ADJP	O
to	to	TO	B-VP	O
occur	occur	VB	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
receiving	receive	VBG	B-VP	O
multiple	multiple	JJ	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
drugs	drug	NNS	B-NP	O
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
narrow	narrow	JJ	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
window	window	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
sequence	sequence	NN	I-NP	O
data	datum	NNS	I-NP	O
now	now	RB	B-ADVP	O
permit	permit	VBP	B-VP	O
a	a	DT	B-NP	O
detailed	detailed	JJ	I-NP	O
interpretation	interpretation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
X	X	NN	I-NP	B-DNA
-	-	HYPH	B-NP	O
ray	ray	NN	I-NP	O
crystallographic	crystallographic	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
enzyme	enzyme	NN	I-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
cloning	cloning	NN	I-NP	O
and	and	CC	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
clostridial	clostridial	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
will	will	MD	B-VP	O
facilitate	facilitate	VB	I-VP	O
site	site	NN	B-NP	O
-	-	HYPH	O	O
directed	direct	VBN	B-NP	O
mutagenesis	mutagenesis	NN	I-NP	O
.	.	.	O	O


Total	Total	JJ	B-NP	O
body	body	NN	I-NP	O
irradiation	irradiation	NN	I-NP	O
was	be	VBD	B-VP	O
delivered	deliver	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
hyperfractionated	hyperfractionate	VBN	I-NP	O
scheme	scheme	NN	I-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
fractions	fraction	NNS	I-NP	O
given	give	VBN	B-PP	O
three	three	CD	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
5	5	CD	B-NP	O
hr	hr	NN	I-NP	O
apart	apart	RB	B-ADVP	O
for	for	IN	B-PP	O
4	4	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
only	only	RB	I-VP	O
observed	observe	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
142	142	CD	B-NP	O
+	+	SYM	B-ADJP	O
/	/	SYM	O	O
-	-	SYM	O	O
17	17	CD	B-NP	O
/	/	SYM	I-NP	O
86.6	86.6	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	B-NP	O
9.1	9.1	CD	B-NP	O
to	to	TO	I-NP	O
139	139	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
13	13	CD	B-NP	O
/	/	SYM	I-NP	O
82.9	82.9	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
8.9	8.9	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.05	0.05	CD	B-NP	O
for	for	IN	B-PP	O
DBP	DBP	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O


AgMNPV	AgMNPV	NNP	B-NP	O
and	and	CC	I-NP	O
Orgyia	Orgyia	NNP	I-NP	O
pseudotsugata	pseudotsugata	NN	I-NP	O
MNPV	MNPV	NN	I-NP	O
(	(	(	O	O
OpMNPV	OpMNPV	NN	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
promoter	promoter	NN	B-NP	O
structure	structure	NN	I-NP	O
and	and	CC	O	O
polyhedrin	polyhedrin	NN	B-NP	B-DNA
primary	primary	JJ	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
polyhedrin	polyhedrin	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
of	of	IN	B-PP	O
both	both	DT	B-NP	O
viruses	virus	NNS	I-NP	O
is	be	VBZ	B-VP	O
transcribed	transcribe	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
anti	anti	AFX	I-NP	O
-	-	HYPH	I-NP	O
clockwise	clockwise	JJ	I-NP	O
direction	direction	NN	I-NP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
physical	physical	JJ	I-NP	O
maps	map	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
gene	gene	NN	I-NP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Escherichia	Escherichia	FW	I-NP	B-DNA
coli	coli	FW	I-NP	I-DNA
dnaA	dnaA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	O
putida	putida	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
transcription	transcription	NN	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
in	in	IN	B-PP	O
E	E	NN	B-NP	O
.	.	.	O	O
coli	coli	NN	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
P	P	NN	B-NP	O
.	.	.	O	O
putida	putida	NN	B-NP	O
.	.	.	O	O


STP1	STP1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
unessential	unessential	JJ	I-NP	B-DNA
yeast	yeast	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
removal	removal	NN	I-NP	O
of	of	IN	B-PP	O
intervening	intervene	VBG	B-VP	O
sequences	sequence	NNS	B-NP	O
from	from	IN	B-PP	O
some	some	DT	B-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	B-NP	O
all	all	DT	I-NP	O
,	,	,	O	O
families	family	NNS	B-NP	O
of	of	IN	B-PP	O
intervening	intervene	VBG	B-VP	B-DNA
sequence	sequence	NN	B-NP	I-DNA
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
pre	pre	AFX	O	B-DNA
-	-	HYPH	O	O
tRNAs	tRNA	NNS	B-NP	B-RNA
.	.	.	O	O


Using	Use	VBG	B-VP	O
these	these	DT	B-NP	O
antibodies	antibody	NNS	I-NP	B-protein
,	,	,	O	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
define	define	VB	I-VP	O
the	the	DT	B-NP	O
conditions	condition	NNS	I-NP	O
to	to	TO	B-VP	O
completely	completely	RB	I-VP	O
solubilize	solubilize	VB	I-VP	O
the	the	DT	B-NP	O
Cdc25	Cdc25	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


GCR1	GCR1	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
function	function	NN	I-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
high	high	JJ	B-NP	O
-	-	HYPH	I-NP	O
level	level	NN	I-NP	O
glycolytic	glycolytic	JJ	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
Saccharomyces	Saccharomyces	NNP	B-NP	O
cerevisiae	cerevisiae	NNP	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
decay	decay	NN	I-NP	O
curves	curve	NNS	I-NP	O
of	of	IN	B-PP	O
chlorophyll	chlorophyll	NN	B-NP	O
fluorescence	fluorescence	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
superposition	superposition	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
exponentially	exponentially	RB	I-NP	O
decaying	decay	VBG	I-NP	O
components	component	NNS	B-NP	O
with	with	IN	B-PP	O
time	time	NN	B-NP	O
constants	constant	NNS	I-NP	O
of	of	IN	B-PP	O
T1	T1	NN	B-NP	B-protein
=	=	SYM	B-VP	I-protein
100	100	CD	B-NP	I-protein
-	-	HYPH	I-NP	I-protein
200	200	CD	I-NP	I-protein
ps	p	NNS	I-NP	I-protein
,	,	,	O	O
T2	T2	NN	B-NP	O
=	=	SYM	B-VP	O
300	300	CD	B-NP	O
-	-	HYPH	I-NP	O
500	500	CD	I-NP	O
ps	p	NNS	I-NP	O
and	and	CC	I-NP	O
T3	T3	NN	I-NP	O
=	=	SYM	B-VP	O
2.0	2.0	CD	B-NP	O
-	-	HYPH	I-NP	O
3.5	3.5	CD	I-NP	O
ns	n	NNS	I-NP	O
.	.	.	O	O


After	After	IN	B-PP	O
tilting	tilt	VBG	B-VP	O
,	,	,	O	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
fell	fall	VBD	B-VP	O
an	an	DT	B-NP	O
average	average	NN	I-NP	O
of	of	IN	B-PP	O
17	17	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
who	who	WP	B-NP	O
cramped	cramp	VBD	B-VP	O
infrequently	infrequently	RB	B-ADVP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.0031	0.0031	CD	B-NP	O
)	)	)	O	O
but	but	CC	O	O
only	only	RB	B-NP	O
10	10	CD	I-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
frequently	frequently	RB	B-ADVP	O
cramping	cramp	VBG	B-VP	O
patients	patient	NNS	B-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
roles	role	NNS	I-NP	O
that	that	IN	B-NP	O
CCK	CCK	NN	B-NP	B-protein
and	and	CC	I-NP	O
trypsin	trypsin	NN	I-NP	B-protein
inhibitors	inhibitor	NNS	I-NP	O
are	be	VBP	B-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
play	play	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
negative	negative	JJ	I-NP	O
feedback	feedback	NN	I-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
pancreatic	pancreatic	JJ	B-NP	O
exocrine	exocrine	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O


Most	Most	JJS	B-NP	O
apneic	apneic	JJ	I-NP	O
events	event	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
during	during	IN	B-PP	O
Stages	Stage	NNS	B-NP	O
I	I	CD	B-NP	O
and	and	CC	I-NP	O
II	II	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
REM	REM	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
proportion	proportion	NN	I-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
gamma	gamma	NN	I-NP	O
OH	OH	NN	I-NP	O
study	study	NN	I-NP	O
(	(	(	O	O
77.9	77.9	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
8.9	8.9	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
studies	study	NNS	I-NP	O
(	(	(	O	O
92.3	92.3	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
1.9	1.9	CD	B-NP	O
and	and	CC	I-NP	O
95.9	95.9	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
2.2	2.2	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
apneas	apnea	NNS	B-NP	O
occurring	occur	VBG	B-VP	O
even	even	RB	B-ADVP	O
during	during	IN	B-PP	O
SWS	SWS	NN	B-NP	B-protein
with	with	IN	B-PP	O
gamma	gamma	NN	B-NP	O
OH	OH	NN	I-NP	O
.	.	.	O	O
(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-PP	O
250	250	CD	B-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O


Eight	Eight	CD	B-NP	O
rabbits	rabbit	NNS	I-NP	O
were	be	VBD	B-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
0.7	0.7	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
0.4	0.4	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
m3	m3	NN	I-NP	O
Co2	Co2	NN	I-NP	O
+	+	SYM	B-VP	O
as	as	IN	B-PP	O
CoCl2	CoCl2	NN	B-NP	O
and	and	CC	O	O
1.2	1.2	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
0.7	0.7	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
m3	m3	NN	I-NP	B-protein
Cr3	Cr3	NN	I-NP	I-protein
+	+	SYM	B-VP	O
as	as	IN	B-PP	O
Cr	Cr	NN	B-NP	O
(	(	(	O	O
NO3	NO3	NN	B-NP	O
)	)	)	O	O
3	3	CD	B-NP	O
(	(	NN	I-NP	O
group	group	NN	I-NP	O
Co	Co	NN	I-NP	O
+	+	SYM	B-NP	O
Cr	Cr	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
eight	eight	CD	B-NP	O
to	to	TO	B-PP	O
0.6	0.6	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
0.5	0.5	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
m3	m3	NN	I-NP	O
Co2	Co2	NN	I-NP	O
+	+	SYM	B-NP	O
(	(	(	O	O
group	group	NN	B-NP	O
Co	Co	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
eight	eight	CD	B-NP	O
to	to	TO	B-PP	O
filtered	filter	VBN	B-NP	O
air	air	NN	I-NP	O
(	(	(	O	O
control	control	NN	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
for	for	IN	B-PP	O
4	4	CD	B-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
/	/	SYM	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
6	6	CD	B-NP	O
hr	hr	NN	I-NP	O
/	/	SYM	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O


16	16	CD	B-NP	O
women	woman	NNS	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
methadone	methadone	NN	B-NP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
withdrawal	withdrawal	NN	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O


Disruption	Disruption	NN	B-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
CDC14	CDC14	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
essential	essential	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O


Coronary	Coronary	JJ	B-NP	O
flow	flow	NN	I-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
by	by	IN	B-PP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
phosphocreatine	phosphocreatine	NN	I-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
18	18	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
60A	60A	NN	I-NP	B-RNA
transcripts	transcript	NNS	I-NP	I-RNA
and	and	CC	O	O
protein	protein	NN	B-NP	O
are	be	VBP	B-VP	O
first	first	RB	I-VP	O
detected	detect	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
gastrulation	gastrulation	NN	B-NP	O
,	,	,	O	O
primarily	primarily	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mesoderm	mesoderm	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
extending	extend	VBG	I-NP	O
germ	germ	NN	I-NP	O
band	band	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
724	724	CD	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
bp	bp	NN	I-NP	I-DNA
segment	segment	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
flanking	flank	VBG	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	B-DNA
E	E	NN	I-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
box	box	NN	I-NP	I-DNA
flanked	flank	VBN	B-VP	O
upstream	upstream	RB	B-ADVP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
mammalian	mammalian	JJ	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
specific	specific	JJ	I-NP	I-DNA
352	352	CD	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
bp	bp	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
sufficient	sufficient	JJ	B-ADJP	O
for	for	IN	B-PP	O
maximal	maximal	JJ	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activation	activation	NN	I-NP	O
in	in	IN	B-PP	O
postconfluent	postconfluent	JJ	B-NP	B-cell_line
BC3H1	BC3H1	NN	I-NP	I-cell_line
myoblasts	myoblast	NNS	I-NP	I-cell_line
.	.	.	O	O


These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
baculovirus	baculovirus	NN	B-NP	O
-	-	HYPH	B-NP	O
expressed	express	VBN	I-NP	O
TR	TR	NN	I-NP	B-protein
mediates	mediate	VBZ	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
and	and	CC	O	O
repression	repression	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
manner	manner	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O


Influence	Influence	NN	B-NP	O
of	of	IN	B-PP	O
neural	neural	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
on	on	IN	B-PP	O
anti	anti	AFX	B-NP	O
-	-	HYPH	I-NP	O
arrhythmic	arrhythmic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
GABA	GABA	NN	B-NP	B-protein
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O


Recent	Recent	JJ	B-NP	O
investigations	investigation	NNS	I-NP	O
have	have	VBP	B-VP	O
detailed	detail	VBN	I-VP	O
a	a	DT	B-NP	O
selective	selective	JJ	I-NP	O
dye	dye	NN	I-NP	O
release	release	NN	I-NP	O
technique	technique	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
a	a	DT	B-NP	O
pulse	pulse	NN	I-NP	O
of	of	IN	B-PP	O
laser	laser	NN	B-NP	O
light	light	NN	I-NP	O
induces	induce	VBZ	B-VP	O
the	the	DT	B-NP	O
release	release	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
fluorescent	fluorescent	JJ	I-NP	O
dye	dye	NN	I-NP	O
from	from	IN	B-PP	O
temperature	temperature	NN	B-NP	O
-	-	HYPH	B-NP	O
sensitive	sensitive	JJ	I-NP	O
liposomes	liposome	NNS	I-NP	O
circulating	circulate	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
retinal	retinal	JJ	I-NP	O
vasculature	vasculature	NN	I-NP	O
.	.	.	O	O


And	And	CC	O	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	O
barriers	barrier	NNS	I-NP	O
?	?	.	O	O


Three	Three	CD	B-NP	O
pyridoxine	pyridoxine	NN	I-NP	O
derivatives	derivative	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
fresh	fresh	JJ	I-NP	O
stem	stem	NN	I-NP	O
bark	bark	NN	I-NP	O
of	of	IN	B-PP	O
Albizzia	Albizzia	NNP	B-NP	O
julibrissin	julibrissin	NN	I-NP	O
DURAZZ	DURAZZ	NNP	I-NP	O
.	.	.	O	O
.	.	.	O	O


The	The	DT	B-NP	O
serum	serum	NN	I-NP	B-protein
erythropoietin	erythropoietin	NN	I-NP	I-protein
(	(	(	O	O
EPO	EPO	NN	B-NP	B-protein
)	)	)	O	O
concentrations	concentration	NNS	B-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
male	male	JJ	I-NP	O
triathletes	triathlete	NNS	I-NP	O
(	(	(	O	O
26.3	26.3	CD	B-NP	O
U	U	NN	I-NP	O
.	.	SYM	B-NP	O
ml	ml	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
male	male	JJ	I-NP	O
distance	distance	NN	I-NP	O
runners	runner	NNS	I-NP	O
(	(	(	O	O
31.6	31.6	CD	B-NP	O
U	U	NN	I-NP	O
.	.	SYM	B-NP	O
ml	ml	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
coating	coat	VBG	I-NP	O
materials	material	NNS	I-NP	O
were	be	VBD	B-VP	O
poloxamine	poloxamine	NN	B-NP	O
904	904	CD	I-NP	O
,	,	,	O	O
poloxamine	poloxamine	NN	B-NP	O
908	908	CD	I-NP	O
,	,	,	O	O
poloxamine	poloxamine	NN	B-NP	O
1508	1508	CD	I-NP	O
,	,	,	O	O
poloxamer	poloxamer	NN	B-NP	O
338	338	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Brij	Brij	NNP	B-NP	O
35	35	CD	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
eating	eating	NN	I-NP	O
and	and	CC	I-NP	O
drinking	drinking	NN	I-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
pygmy	pygmy	JJ	B-NP	O
goats	goat	NNS	I-NP	O
fed	feed	VBN	B-VP	O
ad	ad	NN	B-NP	O
lib	lib	NN	I-NP	O
and	and	CC	O	O
kept	keep	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
12	12	CD	I-NP	O
h	h	NN	I-NP	O
light	light	NN	I-NP	O
/	/	SYM	B-NP	O
12	12	CD	I-NP	O
h	h	NN	I-NP	O
dark	dark	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
and	and	CC	O	O
analyzed	analyze	VBN	B-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
highlights	highlight	VBZ	B-VP	O
the	the	DT	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
sputum	sputum	NN	B-NP	O
amoxycillin	amoxycillin	NN	I-NP	O
(	(	(	O	O
amoxy	amoxy	NN	B-NP	O
)	)	)	O	O
levels	level	NNS	B-NP	O
when	when	WRB	B-ADVP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
tablet	tablet	NN	I-NP	O
,	,	,	O	O
amoxy	amoxy	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
plus	plus	CC	O	O
bromhexeine	bromhexeine	NN	B-NP	O
8	8	CD	I-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
administered	administer	VBN	I-VP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-VP	O
to	to	TO	B-VP	O
plain	plain	VB	I-VP	O
amoxy	amoxy	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O


His	His	PRP$	B-NP	O
HC	HC	NN	I-NP	B-protein
II	II	CD	I-NP	I-protein
activity	activity	NN	I-NP	O
and	and	CC	I-NP	O
antigen	antigen	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
49	49	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
similar	similar	JJ	B-NP	O
low	low	JJ	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O


Argatroban	Argatroban	NNP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
more	more	RBR	B-ADJP	O
effective	effective	JJ	I-ADJP	O
under	under	IN	B-PP	O
low	low	JJ	B-NP	O
HC	HC	NN	I-NP	O
II	II	CD	B-NP	O
conditions	condition	NNS	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
its	its	PRP$	B-NP	O
potent	potent	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
thrombin	thrombin	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
at	at	IN	B-PP	O
sites	site	NNS	B-NP	O
of	of	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
wall	wall	NN	I-NP	O
damage	damage	NN	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
results	result	NNS	I-NP	O
support	support	VBP	B-VP	O
the	the	DT	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
validity	validity	NN	I-NP	O
of	of	IN	B-PP	O
NFPD	NFPD	NN	B-NP	B-protein
in	in	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
/	/	SYM	O	O
NCA	NCA	NN	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
because	because	IN	B-SBAR	O
such	such	JJ	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
panic	panic	NN	B-NP	O
disorder	disorder	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
classical	classical	JJ	I-NP	O
panic	panic	NN	I-NP	O
disorder	disorder	NN	I-NP	O
presentation	presentation	NN	I-NP	O
.	.	.	O	O


FDA	FDA	NN	B-NP	O
regulations	regulation	NNS	I-NP	O
for	for	IN	B-PP	O
growth	growth	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
and	and	CC	O	O
related	related	JJ	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O


Because	Because	IN	B-SBAR	O
the	the	DT	B-NP	O
adrenergic	adrenergic	JJ	I-NP	O
nervous	nervous	JJ	I-NP	O
system	system	NN	I-NP	O
influences	influence	VBZ	B-VP	O
cardiac	cardiac	JJ	B-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
and	and	CC	O	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
can	can	MD	B-VP	O
directly	directly	RB	I-VP	O
affect	affect	VB	I-VP	O
sympathetic	sympathetic	JJ	B-NP	O
innervation	innervation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sympathetic	sympathetic	JJ	I-NP	O
nervous	nervous	JJ	I-NP	O
system	system	NN	I-NP	O
on	on	IN	B-PP	O
reentry	reentry	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
canine	canine	JJ	I-NP	O
heart	heart	NN	I-NP	O
4	4	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
infarction	infarction	NN	B-NP	O
.	.	.	O	O


DESIGN	DESIGN	NN	B-NP	O
:	:	:	O	O
Serum	Serum	NN	B-NP	O
aldosterone	aldosterone	NN	I-NP	O
and	and	CC	O	O
plasma	plasma	NN	B-NP	O
renin	renin	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
supine	supine	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
and	and	CC	O	O
60	60	CD	B-NP	O
,	,	,	I-NP	O
90	90	CD	I-NP	O
,	,	,	I-NP	O
120	120	CD	I-NP	O
minutes	minute	NNS	I-NP	O
after	after	IN	B-PP	O
oral	oral	JJ	B-NP	O
captopril	captopril	NN	I-NP	O
,	,	,	O	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O


Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
transcripts	transcript	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
size	size	NN	I-NP	O
and	and	CC	O	O
having	have	VBG	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
developmental	developmental	JJ	I-NP	O
profile	profile	NN	I-NP	O
as	as	IN	B-PP	O
those	those	DT	B-NP	O
generated	generate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
wild	wild	JJ	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
type	type	NN	I-NP	I-DNA
E10	E10	NN	I-NP	I-DNA
fragment	fragment	NN	I-NP	I-DNA
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
probes	probe	NNS	B-NP	O
covering	cover	VBG	B-VP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cloned	clone	VBN	I-NP	O
region	region	NN	I-NP	O
.	.	.	O	O


Intravenous	Intravenous	JJ	B-NP	O
amine	amine	NN	I-NP	O
pressor	pressor	NN	I-NP	O
tests	test	NNS	I-NP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
volunteers	volunteer	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
mean	mean	JJ	I-NP	O
minimum	minimum	JJ	I-NP	O
steady	steady	JJ	I-NP	O
-	-	HYPH	I-NP	O
state	state	NN	I-NP	O
concentration	concentration	NN	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
(	(	(	O	O
23	23	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
.	.	.	O	O
l	l	NN	B-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
)	)	)	O	O
was	be	VBD	B-VP	O
78	78	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
intramuscular	intramuscular	JJ	I-NP	O
regime	regime	NN	I-NP	O
(	(	(	O	O
29	29	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
.	.	.	O	O
l	l	NN	B-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
)	)	)	O	O
.	.	.	O	O


In	In	IN	B-PP	O
an	an	DT	B-NP	O
ongoing	ongoing	JJ	I-NP	O
study	study	NN	I-NP	O
the	the	DT	B-NP	O
performance	performance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SMSP	SMSP	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Mini	Mini	NNP	I-NP	O
Speech	Speech	NNP	I-NP	O
Processor	Processor	NNP	I-NP	O
(	(	(	O	O
MSP	MSP	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O


Both	Both	DT	B-NP	O
parents	parent	NNS	I-NP	O
are	be	VBP	B-VP	O
clinically	clinically	RB	B-ADJP	O
normal	normal	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
unrelated	unrelated	JJ	I-ADJP	O
.	.	.	O	O


These	These	DT	B-NP	O
mutant	mutant	JJ	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
retained	retain	VBD	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
competitively	competitively	RB	I-VP	O
inhibit	inhibit	VB	I-VP	O
kappa	kappa	NN	B-NP	B-protein
B	B	NN	I-NP	I-protein
-	-	HYPH	O	I-protein
mediated	mediate	VBN	B-VP	O
transcriptional	transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
immunodeficiency	immunodeficiency	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
long	long	JJ	I-NP	I-DNA
terminal	terminal	JJ	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
but	but	CC	O	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
efficiently	efficiently	RB	I-VP	O
transform	transform	VB	I-VP	O
chicken	chicken	NN	B-NP	B-cell_type
lymphoid	lymphoid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
both	both	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O


The	The	DT	B-NP	O
sequence	sequence	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
HiNF	HiNF	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
D	D	NN	I-NP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
key	key	JJ	I-NP	B-DNA
proximal	proximal	JJ	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
H4	H4	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
FO108	FO108	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
regulated	regulate	VBN	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
diploid	diploid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
J	J	NN	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
and	and	CC	I-VP	O
overcome	overcome	VB	I-VP	O
TI	TI	NN	B-NP	B-DNA
region	region	NN	I-NP	I-DNA
-	-	HYPH	B-NP	O
based	base	VBN	I-NP	O
expression	expression	NN	I-NP	O
problems	problem	NNS	I-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
worthwhile	worthwhile	JJ	B-ADJP	O
to	to	TO	B-VP	O
start	start	VB	I-VP	O
out	out	RP	B-PRT	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
versatile	versatile	JJ	I-NP	O
vector	vector	NN	I-NP	O
containing	contain	VBG	B-VP	O
exhaustive	exhaustive	JJ	B-NP	O
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
periShine	periShine	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
Dalgarno	Dalgarno	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
;	;	:	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
rule	rule	NN	I-NP	O
the	the	DT	B-NP	O
coding	cod	VBG	I-NP	O
MTI	MTI	NN	I-NP	B-DNA
subregion	subregion	NN	I-NP	I-DNA
can	can	MD	B-VP	O
be	be	VB	I-VP	O
kept	keep	VBN	I-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O


Four	Four	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
five	five	CD	I-NP	O
subjects	subject	NNS	I-NP	O
also	also	RB	B-ADVP	O
performed	perform	VBD	B-VP	O
mixed	mixed	JJ	B-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
under	under	IN	B-PP	O
conditional	conditional	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
words	word	NNS	I-NP	O
(	(	(	O	O
e	e	JJ	B-NP	O
.	.	.	I-NP	O
g	g	NN	I-NP	O
.	.	NN	I-NP	O
,	,	,	O	O
A1	A1	NN	B-NP	B-protein
-	-	SYM	B-VP	O
-	-	SYM	B-NP	O
-	-	SYM	B-NP	O
-	-	HYPH	B-NP	O
B2	B2	NN	I-NP	B-protein
-	-	SYM	B-NP	O
-	-	SYM	B-NP	O
-	-	SYM	B-NP	O
-	-	HYPH	B-NP	O
A3	A3	NN	I-NP	B-protein
-	-	SYM	B-NP	O
-	-	SYM	B-NP	O
-	-	SYM	B-NP	O
-	-	HYPH	B-NP	O
B4	B4	NN	I-NP	B-protein
-	-	SYM	B-NP	O
-	-	SYM	B-NP	O
-	-	SYM	I-NP	O
-	-	HYPH	I-NP	O
A5	A5	NN	I-NP	B-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
reversal	reversal	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
verifying	verify	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
stimuli	stimulus	NNS	I-NP	O
which	which	WDT	B-NP	O
occupied	occupy	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
position	position	NN	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
sequence	sequence	NN	I-NP	O
were	be	VBD	B-VP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
class	class	NN	I-NP	O
.	.	.	O	O


UF	UF	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
021	021	CD	I-NP	O
ophthalmic	ophthalmic	JJ	I-NP	O
solution	solution	NN	I-NP	O
(	(	(	O	O
0.03	0.03	CD	B-NP	O
to	to	TO	O	O
0.24	0.24	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
topically	topically	RB	B-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
eyes	eye	NNS	I-NP	O
of	of	IN	B-PP	O
rabbits	rabbit	NNS	B-NP	O
,	,	,	O	O
caused	cause	VBD	B-VP	O
dose	dose	NN	B-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
IOP	IOP	NN	I-NP	O
reduction	reduction	NN	I-NP	O
(	(	(	O	O
2.8	2.8	CD	B-NP	O
to	to	TO	O	O
5.2	5.2	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
without	without	IN	B-PP	O
transient	transient	JJ	B-NP	O
IOP	IOP	NN	I-NP	O
rise	rise	NN	I-NP	O
.	.	.	O	O


While	While	IN	B-SBAR	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
noradrenergic	noradrenergic	JJ	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
assessed	assess	VBN	B-VP	O
as	as	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
urinary	urinary	JJ	B-NP	O
excretion	excretion	NN	I-NP	O
of	of	IN	B-PP	O
norepinephrine	norepinephrine	NN	B-NP	O
,	,	,	O	O
remained	remain	VBD	B-VP	O
unaffected	unaffected	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Pl	Pl	NNP	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
supine	supine	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
and	and	CC	I-NP	O
diastolic	diastolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
resting	rest	VBG	I-NP	O
venous	venous	JJ	I-NP	O
norepinephrine	norepinephrine	NN	I-NP	O
level	level	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
norepinephrine	norepinephrine	NN	I-NP	O
excretion	excretion	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
month	month	NN	I-NP	O
of	of	IN	B-PP	O
dF	dF	NN	B-NP	O
administration	administration	NN	I-NP	O
.	.	.	O	O


Wild	Wild	JJ	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
type	type	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
bound	bind	VBD	B-VP	O
azido	azido	AFX	B-NP	O
-	-	HYPH	I-NP	O
ATP	ATP	NN	I-NP	O
well	well	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
mutants	mutant	NNS	B-NP	O
with	with	IN	B-PP	O
substitutions	substitution	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	O
amino	amino	JJ	I-NP	O
acids	acid	NNS	I-NP	O
were	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
azido	azido	AFX	B-NP	O
-	-	HYPH	I-NP	O
ATP	ATP	NN	I-NP	O
.	.	.	O	O


Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
biopsy	biopsy	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
stoma	stoma	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
missing	miss	VBG	B-VP	O
early	early	JJ	B-NP	O
rejection	rejection	NN	I-NP	O
.	.	.	O	O


Whole	Whole	JJ	B-NP	O
blood	blood	NN	I-NP	O
serotonin	serotonin	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
35	35	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
127	127	CD	B-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
various	various	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
regimen	regimen	NN	I-NP	O
i	i	NN	I-NP	O
.	.	.	O	O
e	e	NN	B-NP	O
.	.	.	O	O
conservative	conservative	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
39	39	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
maintenance	maintenance	NN	B-NP	O
haemodialysis	haemodialysis	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
35	35	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
after	after	IN	B-PP	O
renal	renal	JJ	B-NP	O
transplantation	transplantation	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
53	53	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


Tissues	Tissue	NNS	B-NP	O
and	and	CC	I-NP	O
exudates	exudate	NNS	I-NP	O
contain	contain	VBP	B-VP	O
sufficient	sufficient	JJ	B-NP	O
thymidine	thymidine	NN	I-NP	O
for	for	IN	B-PP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
inhibitory	inhibitory	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
trimethoprim	trimethoprim	NN	B-NP	O
-	-	HYPH	B-NP	O
sulfamethoxazole	sulfamethoxazole	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
homologies	homology	NNS	I-NP	O
between	between	IN	B-PP	O
RAD16	RAD16	NN	B-NP	B-protein
,	,	,	I-NP	O
RAD54	RAD54	NN	I-NP	B-protein
and	and	CC	I-NP	O
SNF2	SNF2	NN	I-NP	B-protein
are	be	VBP	B-VP	O
also	also	RB	I-VP	O
shared	share	VBN	I-VP	O
by	by	IN	B-PP	O
several	several	JJ	B-NP	O
additional	additional	JJ	I-NP	O
,	,	,	I-NP	O
recently	recently	RB	I-NP	O
isolated	isolate	VBN	I-NP	O
yeast	yeast	NN	I-NP	O
and	and	CC	I-NP	O
Drosophila	Drosophila	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O


But	But	CC	O	O
the	the	DT	B-NP	O
application	application	NN	I-NP	O
solutions	solution	NNS	I-NP	O
of	of	IN	B-PP	O
instrument	instrument	NN	B-NP	O
disinfectants	disinfectant	NNS	I-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
longer	long	JJR	B-ADJP	O
than	than	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
the	the	DT	B-NP	O
Rett	Rett	NNP	I-NP	O
syndrome	syndrome	NN	I-NP	O
we	we	PRP	B-NP	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
suspect	suspect	VB	B-VP	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
disturbances	disturbance	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
stem	stem	NN	I-NP	O
functions	function	VBZ	B-VP	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ascending	ascend	VBG	I-NP	O
reticular	reticular	JJ	I-NP	O
activating	activate	VBG	I-NP	O
system	system	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
elevation	elevation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
conscious	conscious	JJ	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
experiment	experiment	NN	I-NP	O
,	,	,	O	O
simultaneous	simultaneous	JJ	B-NP	O
nitrofurazone	nitrofurazone	NN	I-NP	O
administration	administration	NN	I-NP	O
and	and	CC	I-NP	O
S	S	NN	I-NP	O
.	.	.	O	O
enteritidis	enteritidis	NN	B-NP	O
challenge	challenge	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
S	S	NN	B-NP	O
.	.	.	O	O
enteritidis	enteritidis	``	O	O
isolation	isolation	NN	B-NP	O
frequency	frequency	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
agreement	agreement	NN	I-PP	O
with	with	IN	I-PP	O
this	this	DT	B-NP	O
southern	southern	JJ	I-NP	O
blotting	blotting	NN	I-NP	O
of	of	IN	B-PP	O
mouse	mouse	NN	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
with	with	IN	B-PP	O
SmN	SmN	NN	B-NP	B-DNA
probes	probe	NNS	I-NP	I-DNA
reveals	reveal	VBZ	B-VP	O
bands	band	NNS	B-NP	O
,	,	,	O	O
additional	additional	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
pseudogene	pseudogene	NN	I-NP	B-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
characteristic	characteristic	JJ	B-ADJP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
intron	intron	NN	I-NP	B-DNA
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
SmN	SmN	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O


Two	Two	CD	B-NP	O
cDNAs	cDNA	NNS	I-NP	B-DNA
encoding	encode	VBG	B-VP	O
casein	casein	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
yeast	yeast	NN	I-NP	B-DNA
cDNA	cDNA	NN	I-NP	I-DNA
library	library	NN	I-NP	I-DNA
and	and	CC	O	O
termed	term	VBN	B-NP	O
CKI1	CKI1	NN	I-NP	B-protein
and	and	CC	I-NP	O
CKI2	CKI2	NN	I-NP	B-protein
.	.	.	O	O


Incidence	Incidence	NN	B-NP	O
rate	rate	NN	I-NP	O
ranging	range	VBG	B-VP	O
between	between	IN	B-PP	O
122	122	CD	B-NP	O
/	/	SYM	I-NP	O
100	100	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
/	/	SYM	I-NP	O
year	year	NN	I-NP	O
and	and	CC	O	O
190	190	CD	B-NP	O
/	/	SYM	I-NP	O
100	100	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
/	/	SYM	I-NP	O
year	year	NN	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
(	(	(	O	O
minimum	minimum	NN	B-NP	O
,	,	,	O	O
estimated	estimate	VBN	B-NP	O
and	and	CC	I-NP	O
raw	raw	JJ	I-NP	O
datasets	dataset	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
observed	observe	VBN	I-NP	O
sequence	sequence	NN	I-NP	O
variation	variation	NN	I-NP	O
disrupts	disrupt	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
ORF	ORF	NN	I-NP	B-DNA
in	in	IN	B-PP	O
many	many	JJ	B-NP	O
Y	Y	NN	I-NP	O
'	'	''	I-NP	O
s	s	NNS	I-NP	O
while	while	IN	B-SBAR	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
ORF	ORF	NN	I-NP	B-DNA
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	B-DNA
helicase	helicase	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
unaffected	unaffected	JJ	B-ADJP	O
.	.	.	O	O


The	The	DT	B-NP	O
final	final	JJ	I-NP	O
screening	screening	NN	I-NP	O
yielded	yield	VBD	B-VP	O
a	a	DT	B-NP	O
clone	clone	NN	I-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
2	2	CD	I-NP	B-DNA
kilobase	kilobase	NN	I-NP	I-DNA
(	(	(	O	I-DNA
kb	kb	NN	B-NP	I-DNA
)	)	)	O	I-DNA
insert	insert	NN	B-NP	I-DNA
.	.	.	O	O


Lesions	Lesion	NNS	B-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
by	by	IN	B-PP	O
pressure	pressure	NN	B-NP	O
injection	injection	NN	I-NP	O
of	of	IN	B-PP	O
kainic	kainic	JJ	B-NP	O
acid	acid	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
SOC	SOC	NN	I-NP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
stereotaxically	stereotaxically	RB	I-NP	O
positioned	position	VBN	I-NP	O
glass	glass	NN	I-NP	O
micropipette	micropipette	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
38	38	CD	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
bp	bp	NN	I-NP	I-DNA
poly	poly	NN	I-NP	I-DNA
(	(	(	O	I-DNA
dA	dA	NN	B-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
dT	dT	NN	I-NP	I-DNA
)	)	)	O	I-DNA
region	region	NN	B-NP	I-DNA
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
regulator	regulator	NN	I-NP	O
of	of	IN	B-PP	O
Act1	Act1	NN	B-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
activity	activity	NN	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
identified	identify	VBD	B-VP	O
a	a	DT	B-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
termed	term	VBN	B-NP	O
NFIL	NFIL	NN	I-NP	B-protein
-	-	HYPH	O	O
1	1	CD	B-NP	O
beta	beta	SYM	I-NP	O
A	A	NN	I-NP	O
(	(	(	O	O
NF	NF	NN	B-NP	B-protein
beta	beta	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
that	that	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
12	12	CD	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
bp	bp	NN	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
(	(	(	O	O
-	-	SYM	B-NP	B-DNA
49	49	CD	B-NP	I-DNA
to	to	TO	B-PP	I-DNA
-	-	SYM	B-NP	I-DNA
38	38	CD	I-NP	I-DNA
)	)	)	O	O
located	located	JJ	B-ADJP	O
upstream	upstream	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TATA	TATA	NN	I-NP	B-DNA
box	box	NN	I-NP	I-DNA
motif	motif	NN	I-NP	I-DNA
in	in	IN	B-PP	O
both	both	CC	B-NP	O
the	the	DT	I-NP	O
human	human	JJ	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
murine	murine	JJ	I-NP	I-DNA
IL	IL	NN	I-NP	I-DNA
-	-	HYPH	O	I-DNA
1	1	CD	B-NP	I-DNA
beta	beta	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O


We	We	PRP	B-NP	O
tried	try	VBD	B-VP	O
amphotericin	amphotericin	NN	B-NP	O
B	B	NN	I-NP	O
(	(	(	O	O
AmB	AmB	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
remission	remission	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumor	tumor	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O


Cutis	Cutis	NN	B-NP	O
aplasia	aplasia	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
DRF	DRF	NN	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
2	2	CD	I-NP	I-protein
nuclear	nuclear	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
characteristics	characteristic	NNS	B-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
muscle	muscle	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
specific	specific	JJ	I-NP	I-protein
regulatory	regulatory	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
MEF	MEF	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
(	(	(	O	O
Buskin	Buskin	NNP	B-NP	O
and	and	CC	O	O
Hauschka	Hauschka	NNP	B-NP	O
1989	1989	CD	I-NP	O
;	;	:	O	O
Gossett	Gossett	NNP	B-NP	O
et	et	FW	I-NP	O
al	al	FW	I-NP	O
.	.	FW	I-NP	O
,	,	,	I-NP	O
1989	1989	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O


From	From	IN	B-PP	O
the	the	DT	B-NP	O
15	15	CD	I-NP	B-cell_line
-	-	HYPH	I-NP	I-cell_line
kb	kb	NN	I-NP	I-cell_line
clone	clone	NN	I-NP	I-cell_line
a	a	DT	B-NP	O
4	4	CD	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
kb	kb	NN	I-NP	I-DNA
EcoRI	EcoRI	NN	I-NP	I-DNA
fragment	fragment	NN	I-NP	I-DNA
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
two	two	CD	I-NP	O
exons	exon	NNS	I-NP	B-DNA
and	and	CC	O	O
2.6	2.6	CD	B-NP	O
kb	kb	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
flanking	flanking	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
opn	opn	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
sequenced	sequence	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	B-DNA
start	start	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
primer	primer	NN	B-NP	O
extension	extension	NN	I-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	O	O
S1	S1	NN	B-NP	B-protein
nuclease	nuclease	NN	I-NP	I-protein
mapping	mapping	NN	I-NP	O
.	.	.	O	O


Cardiovascular	Cardiovascular	JJ	B-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
standardized	standardized	JJ	B-NP	O
techniques	technique	NNS	I-NP	O
.	.	.	O	O


Production	Production	NN	B-NP	O
costs	cost	NNS	I-NP	O
included	include	VBD	B-VP	O
feed	feed	NN	B-NP	O
,	,	,	O	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
feed	feed	NN	I-NP	O
operating	operating	NN	I-NP	O
,	,	,	O	O
fixed	fix	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
replacement	replacement	NN	B-NP	O
stock	stock	NN	I-NP	O
costs	cost	NNS	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
developing	develop	VBG	B-VP	O
factor	factor	NN	B-NP	O
VII	VII	CD	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
possibly	possibly	RB	B-ADVP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
reaction	reaction	NN	I-NP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	O
administration	administration	NN	I-NP	O
;	;	:	O	O
it	it	PRP	B-NP	O
gave	give	VBD	B-VP	O
rise	rise	NN	B-NP	O
to	to	TO	B-PP	O
fatal	fatal	JJ	B-NP	O
haemorrhage	haemorrhage	NN	I-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
contrast	contrast	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
classical	classical	JJ	I-NP	O
'	'	``	I-NP	O
oxygen	oxygen	NN	I-NP	O
debt	debt	NN	I-NP	O
hypothesis	hypothesis	NN	I-NP	O
'	'	''	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
debt	debt	NN	I-NP	O
and	and	CC	O	O
lactate	lactate	NN	B-NP	O
clearance	clearance	NN	I-NP	O
are	be	VBP	B-VP	O
linked	link	VBN	I-VP	O
.	.	.	O	O


Account	Account	NN	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
of	of	IN	B-PP	O
noncellular	noncellular	JJ	B-NP	O
and	and	CC	I-NP	O
nonhuman	nonhuman	JJ	I-NP	O
elements	element	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
smears	smear	NNS	I-NP	O
;	;	:	O	O
they	they	PRP	B-NP	O
included	include	VBD	B-VP	O
mucus	mucus	NN	B-NP	O
,	,	,	O	O
Charcot	Charcot	NNP	B-NP	O
-	-	HYPH	I-NP	O
Layden	Layden	NNP	I-NP	O
crystals	crystal	NNS	I-NP	O
,	,	,	O	O
pollen	pollen	NN	B-NP	O
grains	grain	NNS	I-NP	O
,	,	,	O	O
vegetal	vegetal	JJ	B-NP	B-DNA
fragments	fragment	NNS	I-NP	I-DNA
and	and	CC	I-NP	O
fungi	fungus	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
carbon	carbon	NN	I-NP	O
-	-	HYPH	B-NP	O
perfused	perfuse	VBN	I-NP	O
areas	area	NNS	I-NP	O
and	and	CC	I-NP	O
MBF	MBF	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
cortex	cortex	NN	I-NP	O
,	,	,	O	O
spleen	spleen	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
small	small	JJ	B-NP	O
intestinal	intestinal	JJ	I-NP	O
serosa	serosa	NN	I-NP	O
(	(	(	O	O
only	only	RB	B-NP	O
MBF	MBF	NN	I-NP	B-protein
)	)	)	O	O
increased	increase	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
5	5	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
CLP	CLP	NN	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
a	a	DT	B-NP	O
greater	great	JJR	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
women	woman	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sweeping	sweeping	JJ	I-NP	O
group	group	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
dilatation	dilatation	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
cm	cm	NN	I-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
vaginal	vaginal	JJ	I-NP	O
examination	examination	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
labour	labour	NN	I-NP	O
ward	ward	NN	I-NP	O
(	(	(	O	O
16	16	CD	B-NP	O
/	/	SYM	O	O
33	33	CD	B-NP	O
(	(	(	O	O
49	49	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
vs	vs	IN	B-PP	O
5	5	CD	B-NP	O
/	/	SYM	I-NP	O
32	32	CD	I-NP	O
(	(	(	O	O
16	16	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
;	;	:	O	O
OR	OR	NN	B-NP	O
4.39	4.39	CD	I-NP	O
;	;	:	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
CI	CI	NN	I-NP	O
1.56	1.56	CD	I-NP	O
to	to	TO	B-PP	O
12.32	12.32	CD	B-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.005	0.005	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


Lewis	Lewis	RB	B-ADVP	O
,	,	,	O	O
N	N	NN	B-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
nine	nine	CD	B-NP	O
women	woman	NNS	I-NP	O
(	(	(	O	O
age	age	NN	B-NP	O
23	23	CD	I-NP	O
-	-	HYPH	O	O
40	40	CD	B-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
contraceptives	contraceptive	NNS	I-NP	O
(	(	(	O	O
Nordette	Nordette	NNP	B-NP	O
-	-	HYPH	B-NP	O
28	28	CD	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
studied	study	VBN	I-VP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
pill	pill	NN	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
accurate	accurate	JJ	I-NP	O
and	and	CC	I-NP	O
rapid	rapid	JJ	I-NP	O
method	method	NN	I-NP	O
makes	make	VBZ	B-VP	O
the	the	DT	B-NP	O
MLPA	MLPA	NNP	I-NP	O
test	test	NN	I-NP	O
logistically	logistically	RB	B-ADJP	O
feasible	feasible	JJ	I-ADJP	O
for	for	IN	B-PP	O
large	large	JJ	B-NP	O
-	-	HYPH	I-NP	O
scale	scale	NN	I-NP	O
screening	screening	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
modalities	modality	NNS	I-NP	O
for	for	IN	B-PP	O
using	use	VBG	B-VP	O
reference	reference	NN	B-NP	O
values	value	NNS	I-NP	O
for	for	IN	B-PP	O
individual	individual	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
for	for	IN	B-PP	O
groups	group	NNS	B-NP	O
are	be	VBP	B-VP	O
then	then	RB	I-VP	O
discussed	discuss	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
main	main	JJ	I-NP	O
points	point	NNS	I-NP	O
of	of	IN	B-PP	O
research	research	NN	B-NP	O
which	which	WDT	B-NP	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
faced	face	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
near	near	JJ	I-NP	O
future	future	NN	I-NP	O
regarding	regard	VBG	B-VP	O
reference	reference	NN	B-NP	O
values	value	NNS	I-NP	O
are	be	VBP	B-VP	O
highlighted	highlight	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
application	application	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
antibody	antibody	NN	I-NP	O
-	-	HYPH	B-VP	O
targeted	target	VBN	B-NP	O
Phthalocyanine	Phthalocyanine	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
patients	patient	NNS	I-NP	O
suffering	suffer	VBG	B-VP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
advanced	advanced	JJ	I-NP	O
ovarian	ovarian	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
(	(	(	O	O
FIGO	FIGO	NN	B-NP	O
III	III	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O


We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
lung	lung	NN	B-NP	O
cancer	cancer	NN	I-NP	O
tissues	tissue	NNS	I-NP	O
of	of	IN	B-PP	O
positive	positive	JJ	B-NP	O
67Ga	67Ga	NN	I-NP	O
scan	scan	NN	I-NP	O
expressed	express	VBD	B-VP	O
TFR	TFR	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
scan	scan	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	O	O
.	.	.	O	O


This	This	DT	B-NP	O
open	open	JJ	I-NP	B-DNA
reading	reading	NN	I-NP	I-DNA
frame	frame	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
the	the	DT	B-NP	O
correct	correct	JJ	I-NP	O
one	one	CD	I-NP	O
by	by	IN	B-PP	O
direct	direct	JJ	B-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
terminal	terminal	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
overproduced	overproduce	VBN	I-NP	O
msgB	msgB	NN	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
product	product	NN	I-NP	I-protein
.	.	.	O	O


In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
purified	purify	VBD	B-VP	O
and	and	CC	O	O
characterized	characterize	VBD	B-VP	O
the	the	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	B-protein
furin	furin	NN	I-NP	I-protein
from	from	IN	B-PP	O
the	the	DT	B-NP	O
conditioned	condition	VBN	I-NP	O
medium	medium	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
virus	virus	NN	I-NP	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
40	40	CD	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
kDa	kDa	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
,	,	,	O	O
tax	tax	NN	B-NP	B-protein
,	,	,	O	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
immortalization	immortalization	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O


However	However	RB	B-ADVP	O
,	,	,	O	O
butyrate	butyrate	NN	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
2	2	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
stimulating	stimulate	VBG	B-VP	O
CAT	CAT	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
fusion	fusion	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
containing	contain	VBG	B-VP	O
upstream	upstream	JJ	B-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
(	(	(	O	O
-	-	SYM	B-NP	B-DNA
834	834	CD	B-NP	I-DNA
to	to	TO	B-PP	I-DNA
-	-	SYM	B-NP	I-DNA
576	576	CD	I-NP	I-DNA
)	)	)	O	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
containing	contain	VBG	B-VP	O
proximal	proximal	JJ	B-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
(	(	(	O	O
-	-	SYM	B-NP	B-DNA
456	456	CD	B-NP	I-DNA
to	to	TO	B-PP	I-DNA
-	-	SYM	B-NP	I-DNA
172	172	CD	I-NP	I-DNA
)	)	)	O	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
two	two	CD	B-NP	O
regions	region	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PSG1	PSG1	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
I	I	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
mediate	mediate	VBP	B-VP	O
the	the	DT	B-NP	O
butyrate	butyrate	NN	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O


An	An	DT	B-NP	O
examination	examination	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
carboxyl	carboxyl	NN	I-NP	B-protein
terminus	terminus	NN	I-NP	I-protein
in	in	IN	B-PP	O
regulating	regulate	VBG	B-VP	O
NGFI	NGFI	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
B	B	NN	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
activity	activity	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
in	in	IN	B-PP	O
accordance	accordance	NN	B-NP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
,	,	,	O	O
mutants	mutant	NNS	B-NP	O
lacking	lack	VBG	B-VP	O
portions	portion	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
carboxyl	carboxyl	NN	I-NP	B-protein
terminus	terminus	NN	I-NP	I-protein
had	have	VBD	B-VP	O
greatly	greatly	RB	I-VP	O
decreased	decrease	VBN	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O


Altogether	Altogether	RB	B-ADVP	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
Syn	Syn	NN	I-NP	O
5	5	CD	I-NP	O
locus	locus	NN	I-NP	O
segregates	segregate	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
specifying	specify	VBG	B-VP	O
gH	gH	NN	B-NP	B-protein
,	,	,	O	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
encompassing	encompass	VBG	B-VP	O
portions	portion	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TK	TK	NN	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
UL	UL	NN	I-NP	I-DNA
24	24	CD	B-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
syn	syn	NN	I-NP	O
mutation	mutation	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
or	or	CC	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
TK	TK	NN	B-NP	B-protein
.	.	.	O	O


Nucleoprotein	Nucleoprotein	NN	B-NP	B-protein
(	(	(	O	O
N	N	NN	B-NP	O
)	)	)	O	O
expressed	express	VBN	B-VP	O
by	by	IN	B-PP	O
both	both	CC	B-NP	O
recombinant	recombinant	JJ	I-NP	O
vaccinia	vaccinia	NN	I-NP	O
virus	virus	NN	I-NP	O
and	and	CC	O	O
TGEV	TGEV	NN	B-NP	B-protein
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
relative	relative	JJ	I-NP	O
molecular	molecular	JJ	I-NP	O
mass	mass	NN	I-NP	O
(	(	(	O	O
Mr	Mr	NN	B-NP	B-protein
)	)	)	O	O
of	of	IN	B-PP	O
47	47	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
susceptible	susceptible	JJ	B-ADJP	O
to	to	TO	B-PP	O
degradation	degradation	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
terminus	terminus	NN	I-NP	I-protein
yielding	yield	VBG	B-VP	O
discrete	discrete	JJ	B-NP	O
breakdown	breakdown	NN	I-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O


Recently	Recently	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
3.6	3.6	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	B-protein
full	full	JJ	I-NP	I-protein
-	-	HYPH	I-NP	I-protein
length	length	NN	I-NP	I-protein
alpha	alpha	SYM	B-NP	I-protein
-	-	HYPH	B-NP	O
GalNAc	GalNAc	NN	I-NP	B-DNA
cDNA	cDNA	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
remarkable	remarkable	JJ	B-NP	O
nucleotide	nucleotide	NN	I-NP	O
and	and	CC	O	O
predicted	predict	VBD	B-VP	O
amino	amino	JJ	B-NP	O
acid	acid	NN	I-NP	O
homology	homology	NN	I-NP	O
(	(	(	O	O
55.8	55.8	CD	B-NP	O
and	and	CC	I-NP	O
46.9	46.9	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
-	-	HYPH	O	O
galactosidase	galactosidase	NN	B-NP	B-protein
A	A	NN	I-NP	I-protein
(	(	(	O	O
alpha	alpha	SYM	B-NP	O
-	-	HYPH	B-NP	O
Gal	Gal	JJ	I-NP	B-protein
A	A	NN	I-NP	I-protein
)	)	)	O	O
cDNA	cDNA	NN	B-NP	O
.	.	.	O	O


Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
enzymatic	enzymatic	JJ	I-NP	O
activity	activity	NN	I-NP	O
below	below	IN	B-PP	O
X	X	SYM	B-NP	B-DNA
-	-	HYPH	O	O
-	-	SYM	B-NP	O
1	1	CD	I-NP	O
manifested	manifest	VBD	B-VP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
IgA	IgA	NN	B-NP	B-protein
,	,	,	I-NP	O
IgG	IgG	NN	I-NP	B-protein
,	,	,	I-NP	O
IgM	IgM	NN	I-NP	B-protein
,	,	,	I-NP	O
T	T	NN	I-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
B	B	NN	I-NP	I-cell_type
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type
,	,	,	B-PP	O
and	and	CC	I-PP	O
of	of	IN	B-PP	O
phagocytic	phagocytic	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
neutrophils	neutrophil	NNS	B-NP	B-cell_type
as	as	IN	B-SBAR	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
patients	patient	NNS	B-NP	O
exhibiting	exhibit	VBG	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
enzymatic	enzymatic	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
reason	reason	NN	I-NP	O
that	that	IN	B-SBAR	O
nitrous	nitrous	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
produce	produce	VB	I-VP	O
hydroxyl	hydroxyl	NN	B-NP	O
radicals	radical	NNS	I-NP	O
readily	readily	RB	B-ADVP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
one	one	CD	I-NP	O
-	-	HYPH	I-NP	O
electron	electron	NN	I-NP	O
reduction	reduction	NN	I-NP	O
proceeds	proceed	VBZ	B-VP	O
through	through	IN	B-PP	O
an	an	DT	B-NP	O
N2O	N2O	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
intermediate	intermediate	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
energetically	energetically	RB	B-ADVP	O
very	very	RB	B-ADJP	O
unfavourable	unfavourable	JJ	I-ADJP	O
:	:	:	O	O
EO	EO	NN	B-NP	O
(	(	(	O	O
N2O	N2O	NN	B-NP	B-protein
/	/	SYM	B-NP	O
N2O	N2O	NN	I-NP	B-protein
-	-	SYM	B-NP	O
)	)	)	O	O
=	=	SYM	B-VP	O
-	-	SYM	O	O
1.1	1.1	CD	B-NP	O
V	V	NN	I-NP	O
.	.	.	O	O


All	All	DT	B-NP	O
mutant	mutant	JJ	I-NP	B-protein
JCV	JCV	NN	I-NP	I-protein
T	T	NN	I-NP	I-protein
antigens	antigen	NNS	I-NP	I-protein
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
JCV	JCV	NN	B-NP	B-protein
and	and	CC	I-NP	O
SV40	SV40	NN	I-NP	O
origins	origin	NNS	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
replication	replication	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
relation	relation	NN	I-NP	O
between	between	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	B-protein
beta	beta	SYM	I-NP	I-protein
-	-	HYPH	I-NP	I-protein
adrenergic	adrenergic	JJ	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
and	and	CC	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-ADJP	O
(	(	(	O	O
LV	LV	NN	B-NP	O
)	)	)	O	O
function	function	NN	B-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
10	10	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
aged	age	VBN	B-VP	O
41	41	CD	B-NP	O
to	to	TO	I-NP	O
61	61	CD	I-NP	O
years	year	NNS	I-NP	O
(	(	(	O	O
average	average	NN	B-NP	O
51	51	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
LV	LV	NN	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	VBD	B-VP	O
mainly	mainly	RB	B-ADVP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
chronic	chronic	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O


Since	Since	IN	B-SBAR	O
each	each	DT	B-NP	O
transcript	transcript	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
encode	encode	VB	I-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
complexity	complexity	NN	I-NP	O
may	may	MD	B-VP	O
reflect	reflect	VB	I-VP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
lineage	lineage	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
or	or	CC	I-NP	O
differentiation	differentiation	NN	I-NP	O
-	-	HYPH	O	O
dependent	dependent	JJ	B-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
expression	expression	NN	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
limited	limited	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
survival	survival	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
alternating	alternate	VBG	I-NP	O
arm	arm	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
superior	superior	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
survival	survival	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CAV	CAV	NN	I-NP	O
arm	arm	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
.	.	.	B-NP	O
014	014	CD	I-NP	O
)	)	)	O	O
or	or	CC	O	O
the	the	DT	B-NP	O
survival	survival	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PE	PE	NN	I-NP	O
arm	arm	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
.	.	.	O	O
023	023	''	O	B-cell_line
)	)	)	O	O
.	.	.	O	O


We	We	PRP	B-NP	O
identify	identify	VBP	B-VP	O
the	the	DT	B-NP	O
"	"	``	I-NP	B-DNA
M	M	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
"	"	''	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
muscle	muscle	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
specific	specific	JJ	I-NP	I-DNA
Xenopus	Xenopus	NN	I-NP	I-DNA
cardiac	cardiac	JJ	I-NP	I-DNA
actin	actin	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
from	from	IN	B-PP	O
-	-	SYM	B-NP	B-DNA
282	282	CD	I-NP	I-DNA
to	to	TO	B-PP	I-DNA
-	-	SYM	B-NP	I-DNA
348	348	CD	I-NP	I-DNA
as	as	RB	I-NP	O
necessary	necessary	JJ	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
embryonic	embryonic	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
actin	actin	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
beta	beta	SYM	I-NP	O
-	-	HYPH	I-NP	O
globin	globin	NN	I-NP	B-DNA
reporter	reporter	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
injected	inject	VBN	B-VP	O
into	into	IN	B-PP	O
fertilized	fertilize	VBN	B-NP	O
eggs	egg	NNS	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
identified	identify	VBN	I-NP	O
and	and	CC	I-NP	O
characterized	characterize	VBN	I-NP	O
attenuator	attenuator	NN	I-NP	O
1	1	CD	I-NP	O
situated	situate	VBD	B-VP	O
93	93	CD	B-NP	B-DNA
nucleotides	nucleotide	NNS	I-NP	I-DNA
downstream	downstream	RB	B-ADVP	I-DNA
from	from	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	B-DNA
late	late	JJ	I-NP	I-DNA
transcription	transcription	NN	I-NP	I-DNA
start	start	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
attenuator	attenuator	NN	I-NP	O
,	,	,	O	O
attenuator	attenuator	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
,	,	,	O	O
situated	situate	VBD	B-VP	O
55	55	CD	B-NP	B-DNA
nucleotides	nucleotide	NNS	I-NP	I-DNA
downstream	downstream	RB	B-ADVP	I-DNA
from	from	IN	B-PP	O
it	it	PRP	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O


EBNA	EBNA	NN	B-NP	B-protein
-	-	HYPH	O	I-protein
2	2	CD	B-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
cis	cis	NN	I-NP	B-DNA
-	-	HYPH	B-VP	I-DNA
acting	act	VBG	B-NP	I-DNA
CD23	CD23	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
increased	increase	VBD	B-VP	O
TK	TK	NN	B-NP	B-RNA
-	-	HYPH	O	I-RNA
promoted	promote	VBN	B-VP	I-RNA
mRNA	mRNA	NN	B-NP	I-RNA
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
alter	alter	VB	I-VP	O
the	the	DT	B-NP	O
herpes	herpes	NN	I-NP	B-DNA
simplex	simplex	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
TK	TK	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
transcription	transcription	NN	I-NP	I-DNA
start	start	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O


These	These	DT	B-NP	O
experiments	experiment	NNS	I-NP	O
delineate	delineate	VBP	B-VP	O
a	a	DT	B-NP	O
186	186	CD	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
bp	bp	NN	I-NP	I-DNA
,	,	,	O	O
EBNA	EBNA	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
responsive	responsive	JJ	I-NP	O
cell	cell	NN	I-NP	O
DNA	DNA	NN	I-NP	O
fragment	fragment	NN	I-NP	O
and	and	CC	O	O
provide	provide	VBP	B-VP	O
firm	firm	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
EBNA	EBNA	NN	B-NP	B-protein
-	-	HYPH	O	I-protein
2	2	CD	B-NP	I-protein
transactivates	transactivate	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O


Plasma	Plasma	NN	B-NP	O
vitamin	vitamin	NN	I-NP	O
E	E	NN	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
lipids	lipid	NNS	I-NP	O
and	and	CC	O	O
myeloperoxidase	myeloperoxidase	NN	B-NP	B-protein
levels	level	NNS	I-NP	O
during	during	IN	B-PP	O
spinal	spinal	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O


Transfecting	Transfecte	VBG	B-VP	O
the	the	DT	B-NP	O
cloned	clone	VBN	I-NP	O
bovine	bovine	JJ	I-NP	O
PBR	PBR	NN	I-NP	O
/	/	SYM	B-NP	O
IBP	IBP	NN	I-NP	B-DNA
cDNA	cDNA	NN	I-NP	I-DNA
into	into	IN	B-PP	O
COS	COS	NN	B-NP	B-cell_line
-	-	HYPH	B-NP	I-cell_line
7	7	CD	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
11	11	CD	I-NP	O
-	-	HYPH	I-NP	O
fold	fold	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
density	density	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
[	[	(	O	O
3H	3H	NN	B-NP	O
]	]	)	O	O
PK	PK	NN	B-NP	B-DNA
11195	11195	CD	I-NP	I-DNA
binding	bind	VBG	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
only	only	RB	B-NP	O
low	low	JJ	I-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
Ro5	Ro5	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
4864	4864	CD	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
initial	initial	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
vascular	vascular	JJ	I-NP	O
permeability	permeability	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
peritoneal	peritoneal	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
and	and	CC	O	O
LTB4	LTB4	NN	B-NP	O
production	production	NN	I-NP	O
was	be	VBD	B-VP	O
dose	dose	NN	B-NP	O
dependently	dependently	RB	B-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	O
-	-	HYPH	I-NP	O
LO	LO	NN	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
phenidone	phenidone	NN	I-NP	O
,	,	,	O	O
BW	BW	NN	B-NP	B-protein
A4C	A4C	NN	I-NP	I-protein
,	,	,	O	O
A63162	A63162	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ICI	ICI	NN	B-NP	B-protein
207	207	CD	I-NP	I-protein
968	968	CD	I-NP	I-protein
but	but	CC	B-PP	O
not	not	RB	B-PP	O
by	by	IN	I-PP	O
dexamethasone	dexamethasone	NN	B-NP	O
or	or	CC	I-NP	O
colchicine	colchicine	NN	I-NP	O
.	.	.	O	O


Discrepant	Discrepant	JJ	B-NP	O
results	result	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
latex	latex	JJ	I-NP	O
agglutination	agglutination	NN	I-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
assessment	assessment	NN	I-NP	O
of	of	IN	B-PP	O
cytomegalovirus	cytomegalovirus	NN	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
status	status	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
donors	donor	NNS	I-NP	O
.	.	.	O	O


Each	Each	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
contained	contain	VBD	B-VP	O
five	five	CD	B-NP	O
or	or	CC	I-NP	O
six	six	CD	I-NP	O
internal	internal	JJ	I-NP	O
uridine	uridine	NN	I-NP	O
residues	residue	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
transcribed	transcribe	VBN	I-VP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
mixture	mixture	NN	I-NP	O
of	of	IN	B-PP	O
UTP	UTP	NN	B-NP	B-protein
and	and	CC	O	O
thio	thio	AFX	B-NP	O
-	-	HYPH	I-NP	O
UTP	UTP	NN	I-NP	B-protein
.	.	.	O	O


We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	I-VP	O
sequenced	sequence	VBN	I-VP	O
two	two	CD	B-NP	O
overlapping	overlap	VBG	I-NP	O
cDNA	cDNA	NN	I-NP	B-DNA
fragments	fragment	NNS	I-NP	I-DNA
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
encode	encode	VB	I-VP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
rat	rat	NN	B-NP	B-protein
testis	testis	NN	I-NP	I-protein
fructose	fructose	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
6	6	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
phosphate	phosphate	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
-	-	HYPH	I-NP	O
kinase	kinase	NN	I-NP	O
:	:	:	O	O
fructose	fructose	NN	B-NP	O
-	-	HYPH	B-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
6	6	CD	I-NP	O
-	-	HYPH	I-NP	O
bisphosphatase	bisphosphatase	NN	I-NP	B-protein
.	.	.	O	O


We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
SWI5	SWI5	NN	B-NP	B-DNA
'	'	''	O	I-DNA
s	s	VBZ	B-VP	O
nuclear	nuclear	JJ	B-NP	O
localization	localization	NN	I-NP	O
signal	signal	NN	I-NP	O
(	(	(	O	O
NLS	NLS	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
confer	confer	VB	I-VP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
nuclear	nuclear	JJ	I-NP	O
entry	entry	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
heterologous	heterologous	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
behavioral	behavioral	JJ	B-NP	O
deviation	deviation	NN	I-NP	O
(	(	(	O	O
the	the	DT	B-NP	O
avoidance	avoidance	NN	I-NP	O
conditioning	conditioning	NN	I-NP	O
lost	lose	VBD	B-VP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
haloperidol	haloperidol	NN	I-NP	O
intrastriatal	intrastriatal	JJ	I-NP	O
microinjections	microinjection	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
DA	DA	NN	I-NP	O
synaptic	synaptic	JJ	I-NP	O
level	level	NN	I-NP	O
in	in	IN	B-PP	O
rostral	rostral	JJ	B-NP	O
neostriatum	neostriatum	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
similar	similar	JJ	B-NP	O
transient	transient	JJ	I-NP	O
transfection	transfection	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
in	in	IN	B-PP	O
HeLa	HeLa	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
overexpression	overexpression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
wt	wt	NN	I-NP	B-protein
human	human	JJ	I-NP	I-protein
retinoblastoma	retinoblastoma	NN	I-NP	I-protein
susceptibility	susceptibility	NN	I-NP	I-protein
gene	gene	NN	I-NP	I-protein
product	product	NN	I-NP	I-protein
,	,	,	O	O
RB	RB	NN	B-NP	B-protein
,	,	,	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
repress	repress	VB	I-VP	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	O
-	-	HYPH	B-VP	O
induced	induce	VBN	B-NP	O
IL	IL	NN	I-NP	B-protein
-	-	HYPH	O	I-protein
6	6	CD	B-NP	I-protein
(	(	(	O	O
-	-	SYM	B-NP	O
225	225	CD	B-NP	O
to	to	TO	B-PP	O
+	+	SYM	B-NP	O
13	13	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
c	c	NN	O	B-DNA
-	-	HYPH	O	I-DNA
fos	fos	NN	B-NP	I-DNA
(	(	(	O	O
-	-	SYM	B-NP	O
711	711	CD	B-NP	O
to	to	TO	B-PP	O
+	+	SYM	B-NP	O
42	42	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
beta	beta	SYM	O	O
-	-	HYPH	O	O
actin	actin	NN	B-NP	B-protein
(	(	(	O	O
-	-	SYM	B-NP	O
3400	3400	CD	B-NP	O
to	to	TO	B-PP	O
+	+	SYM	B-NP	O
912	912	CD	I-NP	O
)	)	)	O	O
promoters	promoter	NNS	B-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
the	the	DT	B-NP	O
PRV	PRV	NN	I-NP	B-protein
-	-	HYPH	B-VP	O
induced	induce	VBN	B-NP	O
IL	IL	NN	I-NP	B-protein
-	-	HYPH	O	I-protein
6	6	CD	B-NP	I-protein
(	(	(	O	O
-	-	SYM	B-NP	O
110	110	CD	B-NP	O
to	to	TO	B-PP	O
+	+	SYM	B-NP	O
13	13	CD	I-NP	O
)	)	)	O	O
or	or	CC	O	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	O
-	-	HYPH	B-VP	O
induced	induce	VBN	B-NP	O
MHC	MHC	NN	I-NP	B-protein
(	(	(	O	O
-	-	SYM	B-NP	O
528	528	CD	B-NP	O
to	to	TO	B-PP	O
-	-	SYM	B-NP	O
38	38	CD	I-NP	O
)	)	)	O	O
promoters	promoter	NNS	B-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
repression	repression	NN	I-NP	O
was	be	VBD	B-VP	O
mediated	mediate	VBN	I-VP	O
through	through	IN	B-PP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
E2	E2	NN	I-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
-	-	HYPH	O	I-DNA
binding	bind	VBG	B-VP	I-DNA
site	site	NN	B-NP	I-DNA
immediately	immediately	RB	B-ADVP	O
upstream	upstream	RB	I-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
P105	P105	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
TATA	TATA	NN	I-NP	I-DNA
box	box	NN	I-NP	I-DNA
and	and	CC	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
abrogated	abrogate	VBN	I-VP	O
by	by	IN	B-PP	O
preincubation	preincubation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HPV	HPV	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
18	18	CD	I-NP	I-DNA
P105	P105	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
template	template	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
extract	extract	NN	I-NP	O
allowing	allow	VBG	B-VP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
preinitiation	preinitiation	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O


We	We	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
detect	detect	VB	I-VP	O
p50	p50	NN	B-NP	B-protein
in	in	IN	B-PP	O
association	association	NN	B-NP	O
with	with	IN	B-PP	O
native	native	JJ	B-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
in	in	IN	B-PP	O
L	L	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
or	or	CC	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
overexpressed	overexpresse	VBN	I-NP	O
glucocorticoid	glucocorticoid	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
in	in	IN	B-PP	O
Chinese	Chinese	JJ	B-NP	B-cell_line
hamster	hamster	NN	I-NP	I-cell_line
ovary	ovary	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O


Two	Two	CD	B-NP	O
putative	putative	JJ	I-NP	O
12	12	CD	I-NP	O
-	-	HYPH	I-NP	O
O	O	NN	I-NP	B-DNA
-	-	HYPH	O	I-DNA
tetradecanoyl	tetradecanoyl	NN	B-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
phorbol	phorbol	NN	I-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
13	13	CD	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
acetate	acetate	NN	I-NP	I-DNA
(	(	(	O	I-DNA
TPA	TPA	NN	B-NP	I-DNA
)	)	)	O	I-DNA
response	response	NN	B-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
,	,	,	O	O
that	that	WDT	B-NP	O
might	might	MD	B-VP	O
serve	serve	VB	I-VP	O
as	as	IN	B-PP	O
binding	bind	VBG	B-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
transcription	transcription	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
AP	AP	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
and	and	CC	O	O
a	a	DT	B-NP	O
consensus	consensus	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
of	of	IN	B-PP	O
a	a	DT	B-NP	O
transforming	transform	VBG	I-NP	B-DNA
growth	growth	NN	I-NP	I-DNA
factor	factor	NN	I-NP	I-DNA
beta	beta	SYM	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
(	(	(	O	I-DNA
TGF	TGF	NN	B-NP	I-DNA
-	-	HYPH	O	I-DNA
beta	beta	SYM	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
)	)	)	O	I-DNA
inhibitory	inhibitory	JJ	B-NP	I-DNA
element	element	NN	I-NP	I-DNA
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
.	.	.	O	O


TPA	TPA	NN	B-NP	O
and	and	CC	I-NP	O
TGF	TGF	NN	I-NP	B-protein
-	-	HYPH	O	O
beta	beta	SYM	B-NP	O
1	1	CD	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
markedly	markedly	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
72	72	CD	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
kDa	kDa	NN	I-NP	I-protein
enzyme	enzyme	NN	I-NP	I-protein
.	.	.	O	O


They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
almost	almost	RB	I-VP	O
regularly	regularly	RB	I-VP	O
excited	excite	VBN	I-VP	O
by	by	IN	B-PP	O
pressure	pressure	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ipsilateral	ipsilateral	JJ	I-NP	O
cornea	cornea	NN	I-NP	O
or	or	CC	B-PP	O
to	to	TO	B-PP	O
both	both	DT	B-NP	O
corneas	cornea	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
strength	strength	NN	I-NP	O
well	well	RB	B-PP	O
above	above	IN	I-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
corneal	corneal	JJ	I-NP	O
pain	pain	NN	I-NP	O
threshold	threshold	NN	I-NP	O
.	.	.	O	O


Feed	Feed	NN	B-NP	O
intake	intake	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
KCl	KCl	NN	I-NP	O
or	or	CC	I-NP	O
NaHCO3	NaHCO3	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
average	average	JJ	B-NP	O
daily	daily	JJ	I-NP	O
gain	gain	NN	I-NP	O
increased	increase	VBD	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
K	K	NN	I-NP	O
and	and	CC	O	O
tended	tend	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
reduced	reduce	VBN	I-VP	O
by	by	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
NaHCO3	NaHCO3	NN	I-NP	O
.	.	.	O	O


Extraction	Extraction	NN	B-NP	O
procedure	procedure	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
measurement	measurement	NN	I-NP	O
of	of	IN	B-PP	O
butyltin	butyltin	NN	B-NP	O
compounds	compound	NNS	I-NP	O
in	in	IN	B-PP	O
biological	biological	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
using	use	VBG	B-VP	O
toluene	toluene	NN	B-NP	O
,	,	,	O	O
HBr	HBr	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
tropolone	tropolone	NN	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
cloned	clone	VBN	I-VP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
that	that	WDT	B-NP	O
complements	complement	VBZ	B-VP	O
the	the	DT	B-NP	O
exoenzyme	exoenzyme	NN	I-NP	O
S	S	NN	I-NP	O
-	-	HYPH	B-NP	O
deficient	deficient	JJ	I-NP	O
phenotype	phenotype	NN	I-NP	O
of	of	IN	B-PP	O
strain	strain	NN	B-NP	B-protein
388	388	CD	I-NP	I-protein
exs1	exs1	NN	I-NP	I-protein
:	:	:	O	O
:	:	:	O	O
Tn1	Tn1	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
chromosomal	chromosomal	JJ	I-NP	O
Tn1	Tn1	NN	I-NP	O
insertional	insertional	JJ	I-NP	O
mutation	mutation	NN	I-NP	O
.	.	.	O	O


axl	axl	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
transforming	transform	VBG	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
myeloid	myeloid	JJ	I-NP	I-cell_type
leukemia	leukemia	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
receptor	receptor	NN	I-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
.	.	.	O	O


Alignment	Alignment	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	B-protein
acid	acid	NN	I-NP	I-protein
sequences	sequence	NNS	I-NP	I-protein
surrounding	surround	VBG	B-VP	O
Tyr	Tyr	NN	B-NP	B-protein
-	-	HYPH	O	O
766	766	CD	B-NP	O
with	with	IN	B-PP	O
corresponding	correspond	VBG	B-VP	O
regions	region	NNS	B-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
FGFRs	FGFR	NNS	I-NP	B-protein
revealed	reveal	VBD	B-VP	O
conserved	conserve	VBN	I-VP	O
tyrosine	tyrosine	NN	B-NP	O
residues	residue	NNS	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
known	know	VBN	I-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
FGFR	FGFR	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
single	single	JJ	I-NP	O
most	most	RBS	I-NP	O
important	important	JJ	I-NP	O
element	element	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
linker	linker	NN	B-NP	O
-	-	HYPH	B-NP	O
scanning	scanning	NN	I-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
10	10	CD	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
bp	bp	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
CCAAT	CCAAT	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
.	.	.	O	O


Capnography	Capnography	NN	B-NP	O
curves	curve	NNS	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
HVS	HVS	NN	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
non	non	AFX	O	O
-	-	HYPH	O	O
HVS	HVS	NN	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
psycho	psycho	AFX	B-NP	O
-	-	HYPH	I-NP	O
somatic	somatic	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
and	and	CC	O	O
26	26	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
controls	control	NNS	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
transcription	transcription	NN	I-NP	B-DNA
initiation	initiation	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
to	to	TO	I-VP	O
occur	occur	VB	I-VP	O
66	66	CD	B-NP	B-DNA
bp	bp	NN	I-NP	I-DNA
upstream	upstream	RB	B-ADVP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
initiating	initiate	VBG	I-NP	O
Met	Met	NNP	I-NP	O
.	.	.	O	O


All	All	DT	B-NP	O
anti	anti	AFX	I-NP	O
-	-	HYPH	I-NP	O
I	I	PRP	B-NP	O
and	and	CC	O	O
anti	anti	AFX	B-NP	O
-	-	HYPH	I-NP	O
i	i	NN	I-NP	O
CA	CA	NN	I-NP	O
were	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
express	express	VB	I-VP	O
VH4	VH4	NN	B-NP	B-protein
heavy	heavy	JJ	I-NP	I-protein
chains	chain	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
14	14	CD	B-NP	O
of	of	IN	B-PP	O
17	17	CD	B-NP	O
CA	CA	NN	I-NP	O
expressed	express	VBD	B-VP	O
a	a	DT	B-NP	O
previously	previously	RB	I-NP	O
described	describe	VBN	I-NP	O
VH4	VH4	NN	I-NP	B-protein
second	second	JJ	I-NP	O
hypervariable	hypervariable	JJ	I-NP	O
region	region	NN	I-NP	O
determinant	determinant	NN	I-NP	O
,	,	,	O	O
termed	term	VBN	B-NP	O
VH4	VH4	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
HV2a	HV2a	NN	I-NP	B-protein
.	.	.	O	O


Intron	Intron	NN	B-NP	B-DNA
K1	K1	NN	I-NP	O
cox1.2	cox1.2	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
S	S	NN	B-NP	O
.	.	.	O	O
cerevisiae	cerevisiae	FW	O	O
and	and	CC	O	O
appears	appear	VBZ	B-VP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
unique	unique	JJ	I-NP	O
location	location	NN	I-NP	O
in	in	IN	B-PP	O
K	K	NN	B-NP	O
.	.	.	O	O
lactis	lactis	NN	B-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
determined	determine	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
mutants	mutant	NNS	I-NP	O
define	define	VBP	B-VP	O
two	two	CD	B-NP	O
complementation	complementation	NN	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
designated	designate	VBN	B-VP	O
cgs1	cgs1	NN	B-NP	B-protein
+	+	SYM	B-NP	O
and	and	CC	O	O
cgs2	cgs2	NN	B-NP	B-protein
+	+	SYM	B-NP	O
(	(	(	O	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
grow	grow	VB	I-VP	O
in	in	IN	B-PP	O
stationary	stationary	JJ	B-ADJP	O
)	)	)	O	O
.	.	.	O	O


However	However	RB	B-ADVP	O
,	,	,	O	O
alterations	alteration	NNS	B-NP	O
in	in	IN	B-PP	O
electrostatic	electrostatic	JJ	B-NP	O
and	and	CC	I-NP	O
hydrophobic	hydrophobic	JJ	I-NP	O
interactions	interaction	NNS	I-NP	O
created	create	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
substitutions	substitution	NNS	I-NP	O
prevent	prevent	VBP	B-VP	O
the	the	DT	B-NP	O
conformational	conformational	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
enzyme	enzyme	NN	I-NP	O
usually	usually	RB	B-VP	O
produced	produce	VBN	I-VP	O
by	by	IN	B-PP	O
calmodulin	calmodulin	NN	B-NP	B-protein
binding	binding	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
induced	induce	VBN	B-NP	O
coexpression	coexpression	NN	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
supported	support	VBN	I-VP	O
by	by	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
FeLV	FeLV	NN	B-NP	O
recombinants	recombinant	NNS	I-NP	O
when	when	WRB	B-ADVP	O
FeLV	FeLV	NN	B-NP	O
-	-	HYPH	B-NP	O
C	C	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
infect	infect	VB	I-VP	O
the	the	DT	B-NP	O
feline	feline	NN	I-NP	B-cell_line
3201B	3201B	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
that	that	WDT	B-NP	O
constitutively	constitutively	RB	B-VP	O
expresses	express	VBZ	I-VP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
FeLV	FeLV	NN	I-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
mRNAs	mRNA	NNS	I-NP	B-RNA
.	.	.	O	O


Recombination	Recombination	NN	B-NP	O
between	between	IN	B-PP	O
feline	feline	NN	B-NP	O
leukemia	leukemia	NN	I-NP	O
virus	virus	NN	I-NP	O
subgroup	subgroup	NN	I-NP	O
B	B	NN	I-NP	O
or	or	CC	O	O
C	C	NN	B-NP	O
and	and	CC	O	O
endogenous	endogenous	JJ	B-NP	B-DNA
env	env	NN	I-NP	I-DNA
elements	element	NNS	I-NP	I-DNA
alters	alter	VBZ	B-VP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
biological	biological	JJ	I-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
viruses	virus	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
at	at	IN	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
and	and	CC	I-NP	I-DNA
3	3	CD	I-NP	I-DNA
'	'	SYM	I-NP	I-DNA
ends	end	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
these	these	DT	B-NP	O
introns	intron	NNS	I-NP	B-DNA
are	be	VBP	B-VP	O
characteristic	characteristic	JJ	B-ADJP	O
of	of	IN	B-PP	O
spliced	splice	VBN	B-NP	O
transcripts	transcript	NNS	I-NP	O
from	from	IN	B-PP	O
eukaryotic	eukaryotic	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
-	-	HYPH	O	O
encoding	encode	VBG	B-VP	O
genes	gene	NNS	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
;	;	:	O	O
i	i	LS	B-LST	O
.	.	.	O	O
e	e	VB	B-VP	O
.	.	.	O	O
,	,	,	O	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
end	end	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LAT	LAT	NN	I-NP	B-DNA
intron	intron	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
GC	GC	NN	B-NP	O
instead	instead	RB	B-CONJP	O
of	of	IN	I-CONJP	O
the	the	DT	B-NP	O
consensus	consensus	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
GT	GT	NN	I-NP	O
.	.	.	O	O


At	At	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
5	5	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
9	9	CD	B-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-SBAR	O
initial	initial	JJ	B-NP	O
isolation	isolation	NN	I-NP	O
of	of	IN	B-PP	O
C	C	NN	B-NP	O
.	.	.	O	O
kutscheri	kutscheri	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
hamsters	hamster	NNS	B-NP	O
were	be	VBD	B-VP	O
euthanatized	euthanatize	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
attempts	attempt	NNS	B-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-PP	O
culture	culture	NN	B-NP	O
C	C	NN	I-NP	O
.	.	.	O	O
kutscheri	kutscheri	NNS	B-NP	O
from	from	IN	B-PP	O
13	13	CD	B-NP	B-DNA
additional	additional	JJ	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O


The	The	DT	B-NP	O
strategy	strategy	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
2.6	2.6	CD	B-NP	O
kilobases	kilobas	NNS	I-NP	O
of	of	IN	B-PP	O
nucleotide	nucleotide	NN	B-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Saccharomyces	Saccharomyces	NNP	I-NP	B-DNA
cerevisiae	cerevisiae	NNP	I-NP	I-DNA
ADE	ADE	NNP	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
locus	locus	NN	I-NP	I-DNA
.	.	.	O	O


Two	Two	CD	B-NP	O
independent	independent	JJ	I-NP	B-DNA
promoters	promoter	NNS	I-NP	I-DNA
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
5	5	CD	B-NP	B-DNA
'	'	SYM	I-NP	I-DNA
untranslated	untranslated	JJ	I-NP	I-DNA
regions	region	NNS	I-NP	I-DNA
regulate	regulate	VBP	B-VP	O
Dd	Dd	NN	B-NP	O
ras	ras	NN	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
Dictyostelium	Dictyostelium	NNP	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
results	result	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
depending	depend	VBG	B-PP	O
upon	upon	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
type	type	NN	I-NP	O
,	,	,	O	O
gene	gene	NN	B-NP	O
cotransfer	cotransfer	NN	I-NP	O
using	use	VBG	B-VP	O
aminoglycoside	aminoglycoside	NN	B-NP	O
resistance	resistance	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
selectable	selectable	JJ	I-NP	O
marker	marker	NN	I-NP	O
may	may	MD	B-VP	O
seriously	seriously	RB	I-VP	O
perturb	perturb	VB	I-VP	O
important	important	JJ	B-NP	O
cellular	cellular	JJ	I-NP	O
control	control	NN	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
PKC	PKC	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O


Transfer	Transfer	NN	B-NP	B-DNA
RNA	RNA	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
from	from	IN	B-PP	O
Dictyostelium	Dictyostelium	NN	B-NP	O
discoideum	discoideum	NN	I-NP	O
are	be	VBP	B-VP	O
frequently	frequently	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
repetitive	repetitive	JJ	B-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
and	and	CC	O	O
contain	contain	VBP	B-VP	O
consensus	consensus	NN	B-NP	B-DNA
boxes	box	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
and	and	CC	I-NP	I-DNA
3	3	CD	I-NP	I-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
flanking	flanking	NN	I-NP	I-DNA
regions	region	NNS	I-NP	I-DNA
.	.	.	O	O


Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
strD	strD	NN	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
strE	strE	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
could	could	MD	B-VP	O
serve	serve	VB	I-VP	O
as	as	IN	B-PP	O
universal	universal	JJ	B-NP	O
probes	probe	NNS	I-NP	O
indicative	indicative	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
biosynthetic	biosynthetic	JJ	B-NP	O
capacity	capacity	NN	I-NP	O
for	for	IN	B-PP	O
6	6	CD	B-NP	O
-	-	HYPH	I-NP	O
deoxyhexose	deoxyhexose	NN	I-NP	O
moieties	moiety	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
two	two	CD	I-NP	O
genes	gene	NNS	I-NP	O
code	code	VBP	B-VP	O
for	for	IN	B-PP	O
polypeptides	polypeptide	NNS	B-NP	O
of	of	IN	B-PP	O
420	420	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
(	(	(	O	O
M	M	NN	B-NP	O
.	.	.	O	O
HgiCI	HgiCI	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
345	345	CD	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
(	(	(	O	O
R	R	NN	B-NP	O
.	.	.	I-NP	O
HgiCI	HgiCI	NN	I-NP	B-protein
)	)	)	O	O
.	.	.	O	O


Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
wt1	wt1	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
via	via	IN	B-PP	O
transient	transient	JJ	B-NP	O
transfection	transfection	NN	I-NP	O
in	in	IN	B-PP	O
COS	COS	NN	B-NP	B-cell_line
-	-	HYPH	B-NP	I-cell_line
1	1	CD	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
52	52	CD	I-NP	B-protein
kDa	kDa	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
immunoprecipitated	immunoprecipitate	VBN	I-VP	O
by	by	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
N	N	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
C	C	NN	I-NP	O
-	-	HYPH	B-NP	O
terminal	terminal	JJ	I-NP	O
-	-	HYPH	I-NP	O
specific	specific	JJ	I-NP	O
antisera	antiserum	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
factor	factor	NN	I-NP	O
which	which	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
TR	TR	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
co	co	AFX	O	O
-	-	HYPH	O	O
sedimented	sedimente	VBN	B-VP	O
with	with	IN	B-PP	O
SV40	SV40	NN	B-NP	B-DNA
chromosomes	chromosome	NNS	I-NP	I-DNA
extracted	extract	VBN	B-VP	O
late	late	RB	B-ADVP	O
in	in	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O


Temafloxacin	Temafloxacin	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
b	b	NN	I-NP	O
.	.	.	O	O
i	i	NN	B-NP	O
.	.	.	I-NP	O
d	d	NN	I-NP	O
.	.	.	O	O
administered	administer	VBN	B-VP	O
orally	orally	RB	B-ADVP	O
for	for	IN	B-PP	O
28	28	CD	B-NP	O
days	day	NNS	I-NP	O
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
safe	safe	JJ	I-NP	O
and	and	CC	I-NP	O
effective	effective	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
prostatitis	prostatitis	NN	I-NP	O
.	.	.	O	O


Its	Its	PRP$	B-NP	O
neuromuscular	neuromuscular	JJ	I-NP	O
effects	effect	NNS	I-NP	O
are	be	VBP	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
ED90	ED90	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
vecuronium	vecuronium	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
prolonged	prolonged	JJ	I-NP	O
fever	fever	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
dissecting	dissect	VBG	B-VP	O
aneurysm	aneurysm	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
aorta	aorta	NN	I-NP	O
in	in	IN	B-PP	O
whom	whom	WP	B-NP	O
pleuropneumonia	pleuropneumonia	NN	B-NP	O
masked	mask	VBD	B-VP	O
the	the	DT	B-NP	O
real	real	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
presented	present	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
resulting	result	VBG	I-NP	O
clone	clone	NN	I-NP	O
pKB11	pKB11	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
1369	1369	CD	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
base	base	NN	I-NP	I-DNA
pair	pair	NN	I-NP	I-DNA
(	(	(	O	I-DNA
bp	bp	NN	B-NP	I-DNA
)	)	)	O	I-DNA
cDNA	cDNA	NN	B-NP	I-DNA
insert	insert	NN	I-NP	I-DNA
,	,	,	O	O
overlapping	overlap	VBG	B-VP	O
pCAD142	pCAD142	NN	B-NP	O
by	by	IN	B-PP	O
781	781	CD	B-NP	O
bp	bp	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
hybridization	hybridization	NN	B-NP	O
methods	method	NNS	I-NP	O
and	and	CC	O	O
sequence	sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
contain	contain	VB	I-VP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
cDNA	cDNA	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CAD	CAD	NN	I-NP	B-protein
polypeptide	polypeptide	NN	I-NP	I-protein
.	.	.	O	O


This	This	DT	B-NP	O
conclusion	conclusion	NN	I-NP	O
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
Northern	Northern	NN	B-NP	O
blotting	blotting	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
flanking	flank	VBG	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O


We	We	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
isolation	isolation	NN	I-NP	O
of	of	IN	B-PP	O
genomic	genomic	JJ	B-NP	O
and	and	CC	I-NP	O
cDNA	cDNA	NN	I-NP	B-DNA
clones	clone	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
light	light	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
independent	independent	JJ	I-NP	I-DNA
Sn	Sn	NN	I-NP	I-DNA
:	:	:	O	I-DNA
bol3	bol3	NN	B-NP	I-DNA
allele	allele	NN	I-NP	I-DNA
.	.	.	O	O


Histamine	Histamine	NN	B-NP	O
-	-	HYPH	I-NP	O
2	2	CD	I-NP	O
blockade	blockade	NN	I-NP	O
in	in	IN	B-PP	O
psoriasis	psoriasis	NN	B-NP	O


Its	Its	PRP$	B-NP	O
clearance	clearance	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
(	(	(	O	O
typically	typically	RB	B-ADVP	O
by	by	IN	B-PP	O
around	around	IN	B-NP	O
25	25	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
often	often	RB	B-ADVP	O
by	by	IN	B-PP	O
far	far	RB	B-NP	O
more	more	JJR	I-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
erythromycin	erythromycin	NN	B-NP	O
,	,	,	O	O
troleandomycin	troleandomycin	NN	B-NP	O
(	(	(	O	O
triacetyloleandomycin	triacetyloleandomycin	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
roxithromycin	roxithromycin	NN	B-NP	O
,	,	,	O	O
enoxacin	enoxacin	NN	B-NP	O
,	,	,	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
,	,	,	O	O
pefloxacin	pefloxacin	NN	B-NP	O
,	,	,	O	O
norfloxacin	norfloxacin	NN	B-NP	O
,	,	,	O	O
ofloxacin	ofloxacin	NN	B-NP	O
,	,	,	O	O
fluoroquinolone	fluoroquinolone	NN	B-NP	O
T	T	NN	I-NP	O
-	-	HYPH	B-NP	O
3262	3262	CD	I-NP	O
,	,	,	O	O
pipemidic	pipemidic	JJ	B-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
cimetidine	cimetidine	NN	B-NP	O
,	,	,	O	O
etintidine	etintidine	NN	B-NP	O
,	,	,	O	O
propranolol	propranolol	NN	B-NP	O
,	,	,	O	O
verapamil	verapamil	NN	B-NP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
,	,	,	O	O
nifedipine	nifedipine	NN	B-NP	O
,	,	,	O	O
furosemide	furosemide	NN	B-NP	O
(	(	(	O	O
frusemide	frusemide	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
some	some	DT	B-NP	O
anovulent	anovulent	JJ	I-NP	O
agents	agent	NNS	I-NP	O
,	,	,	O	O
viloxazine	viloxazine	NN	B-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
,	,	,	O	O
ticlopidine	ticlopidine	NN	B-NP	O
,	,	,	O	O
idrocilamide	idrocilamide	NN	B-NP	O
,	,	,	O	O
thiabendazole	thiabendazole	NN	B-NP	O
,	,	,	O	O
disulfiram	disulfiram	NN	B-NP	O
,	,	,	O	O
influenza	influenza	NN	B-NP	O
-	-	HYPH	B-NP	O
and	and	CC	I-NP	O
BCG	BCG	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
vaccination	vaccination	NN	B-NP	O
,	,	,	O	O
interferon	interferon	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
caffeine	caffeine	NN	B-NP	O
(	(	(	O	O
half	half	NN	B-NP	O
-	-	HYPH	I-NP	O
life	life	NN	I-NP	O
increase	increase	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


A	A	DT	B-NP	O
third	third	JJ	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
partial	partial	JJ	I-NP	O
element	element	NN	I-NP	O
terminating	terminate	VBG	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
probable	probable	JJ	I-NP	B-DNA
internal	internal	JJ	I-NP	I-DNA
restriction	restriction	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
used	use	VBN	B-VP	O
for	for	IN	B-PP	O
cloning	cloning	NN	B-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
enrolled	enrol	VBD	B-VP	O
253	253	CD	B-NP	O
HIV	HIV	NN	I-NP	O
-	-	HYPH	B-NP	O
antibody	antibody	NN	I-NP	O
positive	positive	JJ	I-NP	O
heroin	heroin	NN	I-NP	O
addicts	addict	NNS	I-NP	O
without	without	IN	B-PP	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
81	81	CD	B-NP	O
)	)	)	O	O
or	or	CC	O	O
with	with	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
generalized	generalize	VBN	I-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
172	172	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
study	study	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
clinical	clinical	JJ	B-NP	O
progression	progression	NN	I-NP	O
to	to	TO	B-PP	O
AIDS	AIDS	NNP	B-NP	O
related	related	JJ	I-NP	O
complex	complex	NN	I-NP	O
(	(	(	O	O
ARC	ARC	NN	B-NP	B-protein
)	)	)	O	O
or	or	CC	O	O
AIDS	AIDS	NN	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
factors	factor	NNS	B-NP	O
of	of	IN	B-PP	O
possible	possible	JJ	B-NP	O
prognostic	prognostic	JJ	I-NP	O
relevance	relevance	NN	I-NP	O
.	.	.	O	O


No	No	DT	B-NP	O
homology	homology	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
RNA14	RNA14	NN	B-NP	B-protein
and	and	CC	I-NP	O
RNA15	RNA15	NN	I-NP	B-protein
or	or	CC	B-PP	O
between	between	IN	B-PP	O
RNA14	RNA14	NN	B-NP	B-protein
and	and	CC	O	O
other	other	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
contained	contain	VBN	B-VP	O
in	in	IN	B-PP	O
data	datum	NNS	B-NP	O
banks	bank	NNS	I-NP	O
.	.	.	O	O


Mutations	Mutation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	B-DNA
RNA14	RNA14	NN	I-NP	I-DNA
and	and	CC	I-NP	I-DNA
RNA15	RNA15	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
result	result	VBP	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
mRNA	mRNA	NN	I-NP	O
decay	decay	NN	I-NP	O
rate	rate	NN	I-NP	O
;	;	:	O	O
sequence	sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
reveals	reveal	VBZ	B-VP	O
an	an	DT	B-NP	O
RNA	RNA	NN	I-NP	B-protein
-	-	HYPH	B-PP	I-protein
binding	bind	VBG	B-NP	I-protein
domain	domain	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
RNA15	RNA15	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


Myocardial	Myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
previous	previous	JJ	B-NP	O
bypass	bypass	NN	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
most	most	RBS	I-NP	O
striking	striking	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
birch	birch	NN	I-NP	O
NAD	NAD	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
)	)	)	O	O
H	H	NN	B-NP	O
-	-	HYPH	B-NP	O
NR	NR	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
to	to	TO	B-PP	O
NADH	NADH	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
NR	NR	NN	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	B-DNA
pyridine	pyridine	NN	I-NP	I-DNA
nucleotide	nucleotide	NN	I-NP	I-DNA
binding	binding	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O


A	A	DT	B-NP	O
single	single	JJ	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
C	C	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
terminal	terminal	JJ	I-NP	I-protein
region	region	NN	I-NP	I-protein
influences	influence	VBZ	B-VP	O
dominant	dominant	JJ	B-NP	O
negative	negative	JJ	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	I-NP	O
receptor	receptor	NN	I-NP	O
dimer	dimer	NN	I-NP	O
formation	formation	NN	I-NP	O
.	.	.	O	O


No	No	DT	B-NP	O
such	such	JJ	I-NP	O
benefits	benefit	NNS	I-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
for	for	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
CD4	CD4	NN	B-NP	B-protein
+	+	SYM	I-NP	O
counts	count	NNS	I-NP	O
below	below	IN	B-PP	O
0.2	0.2	CD	B-NP	O
x	x	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
9	9	CD	B-NP	O
)	)	)	O	O
per	per	IN	B-PP	O
liter	liter	NN	B-NP	O
at	at	IN	B-PP	O
entry	entry	NN	B-NP	O
.	.	.	O	O


Because	Because	IN	B-SBAR	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
Antp	Antp	NN	I-NP	I-protein
TATAA	TATAA	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
lymphoid	lymphoid	JJ	I-NP	O
and	and	CC	O	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	B-cell_type
lymphoid	lymphoid	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
we	we	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
homeobox	homeobox	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
has	have	VBZ	B-VP	O
evolved	evolve	VBN	I-VP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
general	general	JJ	I-NP	O
transcriptional	transcriptional	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
higher	high	JJR	B-NP	B-cell_type
eukaryotic	eukaryotic	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O


The	The	DT	B-NP	O
95	95	CD	I-NP	O
%	%	NN	I-NP	O
confidence	confidence	NN	I-NP	O
values	value	NNS	I-NP	O
(	(	(	O	O
2SD	2SD	NN	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
Ros	Ros	NNP	B-NP	O
required	require	VBN	B-VP	O
to	to	TO	B-VP	O
exclude	exclude	VB	I-VP	O
natural	natural	JJ	B-NP	O
variability	variability	NN	I-NP	O
were	be	VBD	B-VP	O
0.39	0.39	CD	B-NP	O
,	,	,	I-NP	O
0.50	0.50	CD	I-NP	O
and	and	CC	I-NP	O
0.53	0.53	CD	I-NP	O
cmH2O	cmH2O	NN	I-NP	O
l	l	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
s	s	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O


Among	Among	IN	B-PP	O
953	953	CD	B-NP	O
infants	infant	NNS	I-NP	O
in	in	IN	B-PP	O
22	22	CD	B-NP	O
neonatal	neonatal	JJ	I-NP	O
care	care	NN	I-NP	O
units	unit	NNS	I-NP	O
studied	study	VBN	B-VP	O
,	,	,	O	O
23	23	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
median	median	JJ	B-NP	O
value	value	NN	I-NP	O
,	,	,	O	O
range	range	NN	B-NP	B-protein
0	0	CD	I-NP	I-protein
-	-	HYPH	B-NP	O
78	78	CD	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
faecally	faecally	RB	I-VP	O
colonized	colonize	VBN	I-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
21	21	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
nosocomial	nosocomial	JJ	I-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
,	,	,	O	O
Klebsiella	Klebsiella	NN	B-NP	O
or	or	CC	I-NP	O
Enterobacter	Enterobacter	NN	I-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O


Biochemical	Biochemical	JJ	B-NP	O
studies	study	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
expected	expect	VBN	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
ChAT	ChAT	NN	B-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
dorsal	dorsal	JJ	I-NP	O
and	and	CC	I-NP	O
ventral	ventral	JJ	I-NP	O
hippocampi	hippocampi	NN	I-NP	O
of	of	IN	B-PP	O
lesioned	lesione	VBN	B-NP	O
animals	animal	NNS	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
norepinephrine	norepinephrine	NN	B-NP	O
(	(	(	O	O
NE	NE	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
dorsal	dorsal	JJ	I-NP	O
hippocampus	hippocampus	NN	I-NP	O
of	of	IN	B-PP	O
MS	MS	NN	B-NP	O
/	/	SYM	B-NP	O
HSI	HSI	NN	I-NP	O
animals	animal	NNS	I-NP	O
.	.	.	O	O
(	(	(	O	O
ABSTRACT	ABSTRACT	NN	B-NP	O
TRUNCATED	TRUNCATED	VBN	B-VP	O
AT	AT	IN	B-PP	O
250	250	CD	B-NP	O
WORDS	WORDS	NNS	I-NP	O
)	)	)	O	O


The	The	DT	B-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
proteoglycan	proteoglycan	NN	I-NP	B-DNA
locus	locus	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
genome	genome	NN	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
availability	availability	NN	I-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
RFLPs	RFLP	NNS	I-NP	B-DNA
provide	provide	VBP	B-VP	O
the	the	DT	B-NP	O
tools	tool	NNS	I-NP	O
for	for	IN	B-PP	O
future	future	JJ	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
HSPG2	HSPG2	NN	I-NP	B-DNA
proteoglycan	proteoglycan	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
suspected	suspect	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
.	.	.	O	O


After	After	IN	B-PP	O
2	2	CD	B-NP	O
min	min	NN	I-NP	O
of	of	IN	B-PP	O
dobutamine	dobutamine	NN	B-NP	O
injection	injection	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
after	after	IN	B-SBAR	O
20	20	CD	B-NP	O
min	min	NN	I-NP	O
of	of	IN	B-PP	O
pimobendan	pimobendan	NN	B-NP	O
injection	injection	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
myocardium	myocardium	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
used	use	VBN	B-VP	O
for	for	IN	B-PP	O
determination	determination	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tissue	tissue	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
metabolites	metabolite	NNS	B-NP	O
of	of	IN	B-PP	O
energy	energy	NN	B-NP	O
and	and	CC	I-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
.	.	.	O	O


During	During	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
contrary	contrary	NN	I-NP	O
,	,	,	O	O
intracoronary	intracoronary	JJ	B-NP	O
procaterol	procaterol	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
dose	dose	NN	I-NP	O
significantly	significantly	RB	B-ADVP	O
deteriorated	deteriorate	VBD	B-VP	O
regional	regional	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
without	without	IN	B-PP	O
changing	change	VBG	B-VP	O
LCX	LCX	NN	B-NP	O
flow	flow	NN	I-NP	O
,	,	,	O	O
global	global	JJ	B-NP	O
hemodynamics	hemodynamic	NNS	I-NP	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	O
lactate	lactate	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
.	.	.	O	O


Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
present	present	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
major	major	JJ	B-NP	O
IE	IE	JJ	I-NP	O
proteins	protein	NNS	I-NP	O
IE86	IE86	NN	I-NP	B-protein
,	,	,	O	O
IE72	IE72	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
IE55	IE55	NN	B-NP	B-protein
are	be	VBP	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
trans	trans	AFX	B-NP	O
-	-	HYPH	I-NP	O
activating	activate	VBG	B-VP	O
the	the	DT	B-NP	O
HIV	HIV	NN	I-NP	B-DNA
LTR	LTR	NN	I-NP	I-DNA
in	in	IN	B-PP	O
a	a	DT	B-NP	O
T	T	NN	I-NP	B-cell_line
-	-	HYPH	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
HUT	HUT	NN	B-NP	B-cell_line
-	-	HYPH	B-NP	I-cell_line
78	78	CD	I-NP	I-cell_line
.	.	.	O	O


In	In	IN	B-PP	O
a	a	DT	B-NP	O
country	country	NN	I-NP	O
where	where	WRB	B-ADVP	O
general	general	JJ	B-NP	O
HIV	HIV	NN	I-NP	O
prevalence	prevalence	NN	I-NP	O
is	be	VBZ	B-VP	O
low	low	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
strategy	strategy	NN	I-NP	O
is	be	VBZ	B-VP	O
cost	cost	AFX	B-ADJP	O
-	-	HYPH	O	O
effective	effective	JJ	B-ADJP	O
for	for	IN	B-PP	O
location	location	NN	B-NP	O
and	and	CC	I-NP	O
counselling	counselling	NN	I-NP	O
of	of	IN	B-PP	O
unknowingly	unknowingly	RB	B-NP	O
seropositive	seropositive	JJ	I-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
cis	cis	NN	I-NP	B-DNA
-	-	HYPH	O	I-DNA
acting	act	VBG	B-VP	I-DNA
element	element	NN	B-NP	I-DNA
mediating	mediate	VBG	B-VP	O
glucocorticoid	glucocorticoid	NN	B-NP	O
inducibility	inducibility	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chicken	chicken	NN	I-NP	B-DNA
glutamine	glutamine	NN	I-NP	I-DNA
synthetase	synthetase	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O


However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
biliary	biliary	JJ	B-NP	O
excretion	excretion	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
compensate	compensate	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
elimination	elimination	NN	I-NP	O
of	of	IN	B-PP	O
bretylium	bretylium	NN	B-NP	O
and	and	CC	O	O
hexylsalicylic	hexylsalicylic	JJ	B-NP	O
acid	acid	NN	I-NP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
kidney	kidney	NN	I-NP	O
.	.	.	O	O


Diagnostic	Diagnostic	JJ	B-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
cerebrospinal	cerebrospinal	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	O
G	G	NN	I-NP	O
(	(	(	O	O
IgG	IgG	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
pediatric	pediatric	JJ	B-NP	O
neurological	neurological	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O


Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
six	six	CD	B-NP	O
genes	gene	NNS	I-NP	O
,	,	,	O	O
ipaB	ipaB	NN	B-NP	B-DNA
,	,	,	O	O
ipaC	ipaC	NN	B-NP	O
,	,	,	O	O
invE	invE	NN	B-NP	O
,	,	,	O	O
invG	invG	NN	B-NP	O
,	,	,	O	O
invJ	invJ	NN	B-NP	B-DNA
,	,	,	O	O
and	and	CC	O	O
invK	invK	NN	B-NP	B-DNA
,	,	,	O	O
was	be	VBD	B-VP	O
apparently	apparently	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
positive	positive	JJ	I-NP	B-protein
regulator	regulator	NN	I-NP	I-protein
virF	virF	NN	I-NP	I-protein
.	.	.	O	O


Inducible	Inducible	JJ	B-NP	O
VT	VT	NN	I-NP	O
was	be	VBD	B-VP	O
suppressed	suppress	VBN	I-VP	O
entirely	entirely	RB	B-ADVP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O


Venkatesan	Venkatesan	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
D	D	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
mature	mature	JJ	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
transcripts	transcript	NNS	I-NP	I-RNA
(	(	(	O	O
3.2	3.2	CD	B-NP	O
-	-	HYPH	I-NP	O
3.5	3.5	CD	I-NP	B-DNA
kilobase	kilobase	NN	I-NP	I-DNA
pairs	pair	NNS	I-NP	I-DNA
(	(	(	O	O
kb	kb	NN	B-NP	O
]	]	)	O	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
by	by	IN	B-PP	O
Northern	Northern	NN	B-NP	O
blot	blot	NN	I-NP	O
hybridization	hybridization	NN	I-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
nuclease	nuclease	NN	I-NP	I-protein
protection	protection	NN	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O


Approximately	Approximately	RB	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ribosomal	ribosomal	JJ	I-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
(	(	(	O	O
rDNA	rDNA	NN	B-NP	B-DNA
)	)	)	O	O
units	unit	NNS	B-NP	O
of	of	IN	B-PP	O
Drosophila	Drosophila	NN	B-NP	O
melanogaster	melanogaster	NN	I-NP	O
are	be	VBP	B-VP	O
inactivated	inactivate	VBN	I-VP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
28	28	CD	I-NP	O
S	S	NN	I-NP	O
RNA	RNA	NN	I-NP	O
ribosomal	ribosomal	JJ	I-NP	O
gene	gene	NN	I-NP	O
insertions	insertion	NNS	I-NP	O
(	(	(	O	O
type	type	NN	B-NP	O
I	I	CD	I-NP	O
and	and	CC	O	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O


Gap	Gap	NN	B-NP	B-protein
b3	b3	NN	I-NP	I-protein
consists	consist	VBZ	B-VP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
chains	chain	NNS	I-NP	O
(	(	(	O	O
Mr	Mr	NN	B-NP	B-protein
=	=	JJ	B-VP	O
110	110	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
and	and	CC	I-NP	O
30	30	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
seem	seem	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
proteolytic	proteolytic	JJ	B-NP	B-protein
cleavage	cleavage	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
connected	connect	VBN	B-VP	O
by	by	IN	B-PP	O
disulfide	disulfide	NN	B-NP	B-protein
bonds	bond	NNS	I-NP	I-protein
from	from	IN	B-PP	O
a	a	DT	B-NP	O
precursor	precursor	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
rtFc	rtFc	NN	I-NP	B-DNA
gamma	gamma	NN	I-NP	I-DNA
R	R	NN	I-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
clone	clone	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
complementary	complementary	JJ	B-ADJP	O
to	to	TO	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
different	different	JJ	I-NP	O
-	-	HYPH	I-NP	O
sized	size	VBN	I-NP	O
mRNAs	mRNA	NNS	I-NP	B-RNA
expressed	express	VBN	B-VP	O
by	by	IN	B-PP	O
CRNK	CRNK	NN	B-NP	B-cell_line
-	-	HYPH	O	I-cell_line
16	16	CD	B-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
contrasting	contrast	VBG	B-VP	O
the	the	DT	B-NP	O
single	single	JJ	I-NP	O
Fc	Fc	NN	I-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
R	R	NN	I-NP	I-protein
-	-	HYPH	B-VP	O
related	relate	VBN	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
species	specie	NNS	I-NP	I-RNA
expressed	express	VBN	B-VP	O
by	by	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
and	and	CC	I-NP	I-cell_type
mouse	mouse	NN	I-NP	I-cell_type
natural	natural	JJ	I-NP	I-cell_type
killer	killer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O


Both	Both	DT	B-NP	O
genes	gene	NNS	I-NP	O
comprise	comprise	VBP	B-VP	O
three	three	CD	B-NP	O
exons	exon	NNS	I-NP	B-DNA
,	,	,	O	O
two	two	CD	B-NP	O
introns	intron	NNS	I-NP	B-DNA
and	and	CC	O	O
an	an	DT	B-NP	O
unusually	unusually	RB	I-NP	O
long	long	JJ	I-NP	B-DNA
3	3	CD	I-NP	I-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
untranslated	untranslated	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
(	(	(	O	O
3.2	3.2	CD	B-NP	B-DNA
kilobase	kilobase	NN	I-NP	I-DNA
pairs	pair	NNS	I-NP	I-DNA
)	)	)	O	O
,	,	,	O	O
specificying	specificye	VBG	B-VP	O
a	a	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
4.1	4.1	CD	I-NP	O
kilobases	kilobas	NNS	I-NP	O
.	.	.	O	O


Stable	Stable	JJ	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chimeric	chimeric	JJ	I-NP	O
alpha	alpha	NN	I-NP	O
i	i	NN	I-NP	O
(	(	(	O	O
54	54	CD	B-NP	O
)	)	)	O	O
/	/	SYM	B-NP	O
s	s	NN	I-NP	O
polypeptide	polypeptide	NN	I-NP	O
in	in	IN	B-PP	O
Chinese	Chinese	JJ	B-NP	B-cell_line
hamster	hamster	NN	I-NP	I-cell_line
ovary	ovary	NN	I-NP	I-cell_line
(	(	(	O	I-cell_line
CHO	CHO	NN	B-NP	I-cell_line
)	)	)	O	I-cell_line
cells	cell	NNS	B-NP	I-cell_line
constitutively	constitutively	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
both	both	CC	O	O
cAMP	cAMP	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
and	and	CC	I-NP	O
cAMP	cAMP	NN	I-NP	O
-	-	HYPH	B-NP	O
dependent	dependent	JJ	I-NP	O
protein	protein	NN	I-NP	O
kinase	kinase	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
exon	exon	NN	I-NP	B-DNA
,	,	,	O	O
here	here	RB	B-ADVP	O
named	name	VBN	B-VP	O
exon	exon	NN	B-NP	B-DNA
0	0	CD	I-NP	I-DNA
,	,	,	O	O
contained	contain	VBD	B-VP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
untranslated	untranslated	JJ	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
N	N	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
terminal	terminal	JJ	I-NP	I-protein
signal	signal	NN	I-NP	I-protein
sequence	sequence	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
.	.	.	O	O


Treatment	Treatment	NN	B-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
myeloid	myeloid	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
HL	HL	NN	B-NP	B-cell_line
-	-	HYPH	O	I-cell_line
60	60	CD	B-NP	I-cell_line
and	and	CC	O	O
U937	U937	NN	B-NP	B-cell_line
with	with	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
12	12	CD	I-NP	O
-	-	HYPH	O	O
myristate	myristate	NN	B-NP	B-protein
13	13	CD	I-NP	I-protein
-	-	HYPH	O	O
acetate	acetate	NN	B-NP	O
(	(	(	O	O
PMA	PMA	NN	B-NP	O
)	)	)	O	O
increased	increase	VBD	B-VP	O
within	within	IN	B-PP	O
2	2	CD	B-NP	O
h	h	NN	I-NP	O
cellular	cellular	JJ	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RNA	RNA	NN	I-NP	O
hybridizable	hybridizable	JJ	B-ADJP	O
to	to	TO	B-PP	O
LD78	LD78	NN	B-NP	B-DNA
cDNA	cDNA	NN	I-NP	I-DNA
.	.	.	O	O


A	A	DT	B-NP	O
new	new	JJ	I-NP	O
,	,	,	I-NP	O
flexible	flexible	JJ	I-NP	O
fiberoptic	fiberoptic	JJ	I-NP	O
ventriculoscope	ventriculoscope	NN	I-NP	O
for	for	IN	B-PP	O
observation	observation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ventricles	ventricle	NNS	I-NP	O
and	and	CC	O	O
major	major	JJ	B-NP	O
cisterns	cistern	NNS	I-NP	O
is	be	VBZ	B-VP	O
reported	report	VBN	I-VP	O
.	.	.	O	O


Isopenicillin	Isopenicillin	NN	B-NP	B-protein
N	N	NN	I-NP	I-protein
isomerase	isomerase	NN	I-NP	I-protein
(	(	(	O	O
epimerase	epimerase	NN	B-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
purified	purify	VBN	I-VP	O
from	from	IN	B-PP	O
Streptomyces	Streptomyce	NNS	B-NP	O
clavuligerus	clavuligerus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
amino	amino	JJ	I-NP	B-protein
acid	acid	NN	I-NP	I-protein
sequence	sequence	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
terminus	terminus	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O


Serum	Serum	NN	B-NP	B-protein
IgG	IgG	NN	I-NP	I-protein
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
in	in	IN	B-PP	O
6	6	CD	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
attained	attain	VBD	B-VP	O
complete	complete	JJ	B-NP	O
remission	remission	NN	I-NP	O
(	(	(	O	O
CR1	CR1	NN	B-NP	B-protein
)	)	)	O	O
with	with	IN	B-PP	O
conventional	conventional	JJ	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
relapsed	relapse	VBD	B-VP	O
14	14	CD	B-NP	O
months	month	NNS	I-NP	O
later	later	RB	B-ADVP	O
.	.	.	O	O


157	157	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
16	16	CD	B-NP	O
mg	mg	NN	I-NP	O
/	/	SYM	B-NP	O
dl	dl	NN	I-NP	O
;	;	:	O	O
NS	NS	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
basal	basal	JJ	B-ADJP	O
(	(	(	O	O
17	17	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
4	4	CD	B-NP	O
vs	v	NNS	I-NP	O
.	.	.	O	O


Platelet	Platelet	NN	B-NP	O
aggregation	aggregation	NN	I-NP	O
and	and	CC	O	O
metabolic	metabolic	JJ	B-NP	O
control	control	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
calcium	calcium	NN	B-NP	O
antagonist	antagonist	NN	I-NP	O
treatment	treatment	NN	I-NP	O
in	in	IN	B-PP	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O


Wnt	Wnt	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
(	(	(	O	O
int	int	NN	B-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
cellular	cellular	JJ	I-NP	B-DNA
oncogene	oncogene	NN	I-NP	I-DNA
often	often	RB	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
insertion	insertion	NN	B-NP	O
of	of	IN	B-PP	O
proviral	proviral	JJ	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O
mammary	mammary	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
virus	virus	NN	I-NP	O
.	.	.	O	O


Induction	Induction	NN	B-NP	O
of	of	IN	B-PP	O
Jurkat	Jurkat	NN	B-NP	B-cell_line
leukemic	leukemic	JJ	I-NP	I-cell_line
T	T	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
with	with	IN	B-PP	O
phorbol	phorbol	NN	B-NP	O
12	12	CD	I-NP	O
-	-	HYPH	O	O
myristate	myristate	NN	B-NP	B-protein
13	13	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
acetate	acetate	NN	I-NP	O
and	and	CC	I-NP	O
ionomycin	ionomycin	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
FKBP	FKBP	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
.	.	.	O	O


GLUT5	GLUT5	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
at	at	IN	B-PP	O
highest	high	JJS	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
small	small	JJ	B-NP	O
intestine	intestine	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
much	much	RB	B-NP	O
lower	low	JJR	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
kidney	kidney	NN	B-NP	O
,	,	,	O	O
skeletal	skeletal	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
adipose	adipose	NN	B-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O


e	e	NN	B-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
speculate	speculate	VBP	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
tumors	tumor	NNS	I-NP	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
congenital	congenital	JJ	B-NP	O
hamartomatous	hamartomatous	JJ	I-NP	O
growths	growth	NNS	I-NP	O
.	.	.	O	O


Identification	Identification	NN	B-NP	O
and	and	CC	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
promoter	promoter	NN	I-NP	B-DNA
for	for	IN	B-PP	O
the	the	DT	B-NP	O
cytotactin	cytotactin	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O


Surprisingly	Surprisingly	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
sequence	sequence	NN	I-NP	O
homology	homology	NN	I-NP	O
between	between	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
Ly	Ly	NN	B-NP	O
-	-	HYPH	B-NP	O
6E	6E	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
established	establish	VBN	I-NP	O
consensus	consensus	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
interferon	interferon	NN	I-NP	B-DNA
-	-	HYPH	B-VP	I-DNA
stimulated	stimulate	VBN	B-NP	I-DNA
response	response	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
functionally	functionally	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
to	to	TO	B-PP	O
all	all	DT	B-NP	O
previously	previously	RB	B-VP	O
characterized	characterize	VBN	I-VP	O
alpha	alpha	SYM	B-NP	O
/	/	SYM	B-VP	O
beta	beta	SYM	B-NP	B-protein
interferon	interferon	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
inducible	inducible	JJ	I-NP	B-DNA
promoters	promoter	NNS	I-NP	I-DNA
.	.	.	O	O


Relatively	Relatively	RB	B-NP	O
large	large	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
rearrangements	rearrangement	NNS	I-NP	O
spanning	span	VBG	B-VP	O
the	the	DT	B-NP	O
region	region	NN	I-NP	O
with	with	IN	B-PP	O
tandem	tandem	JJ	B-NP	B-DNA
direct	direct	JJ	I-NP	I-DNA
repeats	repeat	NNS	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
carboxy	carboxy	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
terminal	terminal	JJ	I-NP	I-protein
histone	histone	NN	I-NP	I-protein
H1	H1	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
like	like	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
AlgP	AlgP	NN	B-NP	B-protein
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
strains	strain	NNS	I-NP	O
upon	upon	IN	B-PP	O
conversion	conversion	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mucoid	mucoid	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
nonmucoid	nonmucoid	JJ	I-NP	O
phenotype	phenotype	NN	I-NP	O
.	.	.	O	O


(	(	(	O	O
1988	1988	CD	B-NP	O
)	)	)	O	O
J	J	NNP	B-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
results	result	NNS	I-NP	O
strongly	strongly	RB	B-VP	O
suggested	suggest	VBD	I-VP	O
that	that	IN	B-SBAR	O
similar	similar	JJ	O	O
,	,	,	O	O
if	if	IN	B-CONJP	O
not	not	RB	I-CONJP	O
identical	identical	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
CArG	CArG	NN	I-NP	B-protein
box	box	NN	I-NP	I-protein
binding	binding	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
functionally	functionally	RB	I-NP	O
different	different	JJ	I-NP	O
promoter	promoter	NN	I-NP	B-DNA
element	element	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
VLC1	VLC1	NN	I-NP	B-protein
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	B-protein
alpha	alpha	SYM	I-NP	I-protein
-	-	HYPH	I-NP	O
actin	actin	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
c	c	NN	O	B-DNA
-	-	HYPH	O	I-DNA
fos	fos	NN	B-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O


Polyadenylation	Polyadenylation	NN	B-NP	O
of	of	IN	B-PP	O
B4	B4	NN	B-NP	B-RNA
RNA	RNA	NN	I-NP	I-RNA
,	,	,	O	O
which	which	WDT	B-NP	O
occurs	occur	VBZ	B-VP	O
very	very	RB	B-ADJP	O
early	early	JJ	I-ADJP	O
during	during	IN	B-PP	O
maturation	maturation	NN	B-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
limited	limit	VBN	I-VP	O
to	to	TO	B-PP	O
150	150	CD	B-NP	B-protein
residues	residue	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
this	this	DT	B-NP	O
number	number	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
polysomal	polysomal	JJ	B-NP	O
recruitment	recruitment	NN	I-NP	O
.	.	.	O	O


Co	Co	AFX	B-NP	B-DNA
-	-	HYPH	I-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	B-DNA
elements	element	NNS	I-NP	I-DNA
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
elements	element	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
AP	AP	NN	I-NP	B-DNA
-	-	HYPH	O	I-DNA
2	2	CD	B-NP	I-DNA
element	element	NN	I-NP	I-DNA
or	or	CC	I-NP	O
CCAAT	CCAAT	NN	I-NP	B-DNA
box	box	NN	I-NP	I-DNA
,	,	,	O	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O


Recently	Recently	RB	B-ADVP	O
,	,	,	O	O
studies	study	NNS	B-NP	O
of	of	IN	B-PP	O
agents	agent	NNS	B-NP	O
that	that	WDT	B-NP	O
disrupt	disrupt	VBP	B-VP	O
collagen	collagen	NN	B-NP	B-protein
synthesis	synthesis	NN	I-NP	O
and	and	CC	I-NP	O
deposition	deposition	NN	I-NP	O
have	have	VBP	B-VP	O
yielded	yield	VBN	I-VP	O
several	several	JJ	B-NP	O
new	new	JJ	I-NP	O
angiogenesis	angiogenesis	NN	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
.	.	.	O	O


Since	Since	IN	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
flanking	flank	VBG	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
this	this	DT	B-NP	O
gene	gene	NN	I-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
hormonal	hormonal	JJ	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
expression	expression	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	O	O
partially	partially	RB	B-VP	O
characterized	characterize	VBD	I-VP	O
an	an	DT	B-NP	O
avian	avian	JJ	I-NP	B-DNA
fatty	fatty	JJ	I-NP	I-DNA
acid	acid	NN	I-NP	I-DNA
synthase	synthase	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O


A	A	DT	B-NP	O
new	new	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
cDNA	cDNA	NN	B-NP	B-DNA
clones	clone	NNS	I-NP	I-DNA
spanning	span	VBG	B-VP	O
approximately	approximately	RB	B-NP	O
3.2	3.2	CD	I-NP	O
kb	kb	NN	I-NP	O
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
lambda	lambda	SYM	I-NP	O
-	-	HYPH	I-NP	O
ZAP	ZAP	NN	I-NP	B-DNA
goose	goose	NN	I-NP	I-DNA
liver	liver	NN	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
library	library	NN	I-NP	I-DNA
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
most	most	JJS	B-NP	I-DNA
exon	exon	NN	I-NP	I-DNA
-	-	HYPH	B-NP	O
containing	contain	VBG	B-VP	O
fragment	fragment	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
most	most	RBS	I-NP	I-DNA
genomic	genomic	JJ	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
clone	clone	NN	I-NP	I-DNA
.	.	.	O	O


Northern	Northern	NN	B-NP	O
blotting	blotting	NN	I-NP	O
analysis	analysis	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genes	gene	NNS	I-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
clones	clone	NNS	I-NP	O
is	be	VBZ	B-VP	O
confined	confine	VBN	I-VP	O
to	to	TO	B-PP	O
pollen	pollen	NN	B-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O


Whereas	Whereas	IN	B-SBAR	O
cDNA	cDNA	NN	B-NP	O
hybridization	hybridization	NN	I-NP	O
to	to	TO	B-PP	O
genomic	genomic	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
blots	blot	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
subfamily	subfamily	NN	I-NP	O
of	of	IN	B-PP	O
G0S19	G0S19	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
simple	simple	JJ	B-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
bands	band	NNS	B-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
most	most	JJS	B-NP	O
cDNAs	cDNA	NNS	I-NP	B-DNA
,	,	,	O	O
including	include	VBG	B-PP	O
G0S30	G0S30	NN	B-NP	B-DNA
cDNA	cDNA	NN	I-NP	I-DNA
,	,	,	O	O
corresponded	correspond	VBD	B-VP	O
to	to	TO	B-PP	O
single	single	JJ	B-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
copy	copy	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O


Lymphoproliferative	Lymphoproliferative	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
arising	arise	VBG	B-VP	O
under	under	IN	B-PP	O
immunosuppression	immunosuppression	NN	B-NP	O
with	with	IN	B-PP	O
FK	FK	NN	B-NP	O
506	506	CD	I-NP	O
:	:	:	O	O
initial	initial	JJ	B-NP	O
observations	observation	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	B-cell_type
transplant	transplant	NN	I-NP	I-cell_type
population	population	NN	I-NP	I-cell_type
.	.	.	O	O


The	The	DT	B-NP	O
Drosophila	Drosophila	NNP	I-NP	O
suppressor	suppressor	NN	I-NP	O
of	of	IN	B-PP	O
sable	sable	JJ	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
with	with	IN	B-PP	O
regions	region	NNS	B-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
RNA	RNA	NN	B-NP	B-protein
-	-	HYPH	B-VP	I-protein
binding	bind	VBG	B-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O


2	2	CD	B-NP	O
:	:	:	O	O
121	121	CD	B-NP	O
-	-	HYPH	I-NP	O
133	133	CD	I-NP	O
,	,	,	I-NP	O
1988	1988	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O


It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
extremely	extremely	RB	B-ADJP	O
homologous	homologous	JJ	I-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
third	third	JJ	I-NP	O
'	'	``	I-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	B-DNA
classical	classical	JJ	I-NP	I-DNA
'	'	''	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
HLA	HLA	NN	B-NP	B-DNA
-	-	HYPH	O	I-DNA
5.4	5.4	CD	B-NP	I-DNA
,	,	,	O	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
chimpanzee	chimpanzee	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
Ch28	Ch28	NN	B-NP	B-DNA
.	.	.	O	O


Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
N13	N13	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
N20	N20	NN	I-NP	O
interpeak	interpeak	NN	I-NP	O
interval	interval	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
parallel	parallel	JJ	I-NP	O
shift	shift	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
2	2	CD	I-NP	O
peaks	peak	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
central	central	JJ	I-NP	O
conduction	conduction	NN	I-NP	O
time	time	NN	I-NP	O
measured	measure	VBN	B-VP	O
from	from	IN	B-PP	O
onset	onset	NN	B-NP	O
latencies	latency	NNS	I-NP	O
of	of	IN	B-PP	O
N11	N11	NN	B-NP	B-protein
and	and	CC	I-NP	O
N20	N20	NN	I-NP	B-protein
significantly	significantly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
.	.	.	O	O


Using	Use	VBG	B-VP	O
avidin	avidin	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
biotin	biotin	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
DNA	DNA	NN	I-NP	O
binding	binding	NN	I-NP	O
assays	assay	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
overlapping	overlap	VBG	B-VP	B-DNA
alpha	alpha	NN	B-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
between	between	IN	B-PP	O
-	-	SYM	B-NP	B-DNA
170	170	CD	I-NP	I-DNA
to	to	TO	I-NP	I-DNA
29	29	CD	I-NP	I-DNA
basepairs	basepair	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
each	each	DT	B-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
GR	GR	NN	B-NP	B-protein
,	,	,	O	O
whereas	whereas	IN	O	O
a	a	DT	B-NP	O
control	control	NN	I-NP	B-protein
GRE	GRE	NN	I-NP	I-protein
avidly	avidly	RB	B-NP	I-protein
bound	bind	VBN	I-NP	I-protein
receptor	receptor	NN	I-NP	I-protein
.	.	.	O	O


Sequence	Sequence	NN	B-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
peptides	peptide	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
Asn120	Asn120	NN	B-NP	O
is	be	VBZ	B-VP	O
glycosylated	glycosylate	VBN	I-VP	O
,	,	,	O	O
Asn65	Asn65	NN	B-NP	B-protein
and	and	CC	I-NP	O
Asn109	Asn109	NN	I-NP	O
glycosylated	glycosylate	VBN	B-VP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
molecules	molecule	NNS	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
others	other	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Asn72	Asn72	NN	B-NP	B-protein
not	not	RB	B-VP	O
glycosylated	glycosylate	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
DNA	DNA	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
conferring	confer	VBG	B-VP	O
AP	AP	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
located	locate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
.	.	.	O	O


The	The	DT	B-NP	O
murine	murine	JJ	I-NP	O
mutation	mutation	NN	I-NP	O
dominant	dominant	JJ	I-NP	O
white	white	JJ	I-NP	O
spotting	spotting	NN	I-NP	O
(	(	(	O	O
W	W	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proto	proto	AFX	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
oncogene	oncogene	NN	I-NP	I-DNA
,	,	,	O	O
c	c	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
kit	kit	NN	I-NP	I-protein
.	.	.	O	O


Isolation	Isolation	NN	B-NP	O
and	and	CC	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	B-DNA
chromosomal	chromosomal	JJ	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
for	for	IN	B-PP	O
a	a	DT	B-NP	O
polypeptide	polypeptide	NN	I-NP	O
(	(	(	O	O
pS1	pS1	NN	B-NP	O
)	)	)	O	O
antigenically	antigenically	RB	B-ADJP	O
related	relate	VBN	I-ADJP	O
to	to	TO	B-PP	O
statin	statin	NN	B-NP	B-protein
.	.	.	O	O


The	The	DT	B-NP	O
proteins	protein	NNS	I-NP	O
differ	differ	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
or	or	CC	I-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
21	21	CD	I-NP	O
-	-	HYPH	I-NP	O
amino	amino	JJ	I-NP	O
-	-	HYPH	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
located	located	JJ	I-NP	O
24	24	CD	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
C	C	NN	I-NP	O
terminal	terminal	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
translational	translational	JJ	I-NP	B-DNA
initiation	initiation	NN	I-NP	I-DNA
codon	codon	NN	I-NP	I-DNA
.	.	.	O	O


Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
also	also	RB	B-ADVP	O
indicate	indicate	VBP	B-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
sequences	sequence	NNS	B-NP	O
downstream	downstream	RB	B-ADVP	O
of	of	IN	B-PP	O
-	-	SYM	B-NP	O
0.11	0.11	CD	I-NP	O
kb	kb	NN	I-NP	O
which	which	WDT	B-NP	O
can	can	MD	B-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
tissue	tissue	NN	B-NP	O
-	-	HYPH	B-NP	O
specific	specific	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
HLA	HLA	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
B7	B7	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
gene	gene	NN	I-NP	O
to	to	TO	B-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
gamma	gamma	NN	B-NP	B-protein
interferon	interferon	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
SH2	SH2	NN	I-NP	B-protein
and	and	CC	I-NP	I-protein
SH3	SH3	NN	I-NP	I-protein
domains	domain	NNS	I-NP	I-protein
of	of	IN	B-PP	O
pp60src	pp60src	NN	B-NP	B-protein
direct	direct	JJ	I-NP	O
stable	stable	JJ	I-NP	O
association	association	NN	I-NP	O
with	with	IN	B-PP	O
tyrosine	tyrosine	NN	B-NP	B-protein
phosphorylated	phosphorylated	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
p130	p130	NN	I-NP	B-protein
and	and	CC	I-NP	O
p110	p110	NN	I-NP	B-protein
.	.	.	O	O


Chem	Chem	NNP	B-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
clones	clone	NNS	I-NP	O
overlapped	overlap	VBD	B-VP	O
and	and	CC	I-VP	O
contained	contain	VBD	I-VP	O
the	the	DT	B-NP	O
structural	structural	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
C5	C5	NN	I-NP	B-protein
alpha	alpha	SYM	O	I-protein
-	-	HYPH	O	O
chain	chain	NN	B-NP	O
and	and	CC	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
beta	beta	SYM	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
C5	C5	NN	I-NP	B-protein
alpha	alpha	SYM	O	I-protein
-	-	HYPH	O	I-protein
chain	chain	NN	B-NP	I-protein
was	be	VBD	B-VP	O
encoded	encode	VBN	I-VP	O
by	by	IN	B-PP	O
49	49	CD	B-NP	O
kilobases	kilobas	NNS	I-NP	O
containing	contain	VBG	B-VP	O
26	26	CD	B-NP	B-DNA
exons	exon	NNS	I-NP	I-DNA
;	;	:	O	O
the	the	DT	B-NP	O
beta	beta	SYM	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
was	be	VBD	B-VP	O
encoded	encode	VBN	I-VP	O
by	by	IN	B-PP	O
29	29	CD	B-NP	O
kilobases	kilobas	NNS	I-NP	O
containing	contain	VBG	B-VP	O
16	16	CD	B-NP	B-DNA
exons	exon	NNS	I-NP	I-DNA
.	.	.	O	O


Heterozygous	Heterozygous	JJ	B-NP	O
mutation	mutation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
G	G	NN	I-NP	O
+	+	SYM	O	O
5	5	CD	B-NP	O
position	position	NN	I-NP	O
of	of	IN	B-PP	O
intron	intron	NN	B-NP	B-DNA
33	33	CD	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pro	pro	AFX	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
alpha	alpha	SYM	I-NP	I-DNA
2	2	CD	I-NP	I-DNA
(	(	(	O	I-DNA
I	I	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
(	(	(	O	O
COL1A2	COL1A2	NN	B-NP	B-DNA
)	)	)	O	O
that	that	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
aberrant	aberrant	JJ	B-NP	O
RNA	RNA	NN	I-NP	O
splicing	splicing	NN	I-NP	O
and	and	CC	O	O
lethal	lethal	JJ	B-NP	O
osteogenesis	osteogenesis	NN	I-NP	O
imperfecta	imperfecta	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
differ	differ	VBP	B-VP	O
at	at	IN	B-PP	O
only	only	RB	B-NP	O
nine	nine	CD	I-NP	O
positions	position	NNS	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
differences	difference	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
protein	protein	NN	I-NP	O
predicted	predict	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
pim	pim	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
proto	proto	AFX	I-NP	O
-	-	HYPH	I-NP	B-DNA
oncogene	oncogene	NN	I-NP	I-DNA
shares	share	VBZ	B-VP	O
extensive	extensive	JJ	B-NP	O
homology	homology	NN	I-NP	O
with	with	IN	B-PP	O
known	know	VBN	B-NP	O
serine	serine	NN	I-NP	O
/	/	SYM	O	O
threonine	threonine	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
kinases	kinase	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
yet	yet	RB	B-ADVP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
Pim	Pim	NNP	I-NP	I-protein
-	-	HYPH	I-NP	I-protein
1	1	CD	I-NP	I-protein
enzyme	enzyme	NN	I-NP	I-protein
has	have	VBZ	B-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	B-VP	O
exhibit	exhibit	VB	I-VP	O
protein	protein	NN	B-NP	B-protein
tyrosine	tyrosine	NN	I-NP	I-protein
kinase	kinase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
both	both	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O


A	A	DT	B-NP	O
full	full	JJ	I-NP	B-DNA
-	-	HYPH	I-NP	I-DNA
length	length	NN	I-NP	I-DNA
human	human	JJ	I-NP	I-DNA
pim	pim	NN	I-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
cDNA	cDNA	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
subcloned	subclone	VBN	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
vector	vector	NN	I-NP	O
pGEX	pGEX	NN	I-NP	O
-	-	HYPH	B-NP	O
2T	2T	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Pim	Pim	NNP	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
1	1	CD	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
expressed	express	VBN	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
fusion	fusion	NN	I-NP	O
product	product	NN	I-NP	O
with	with	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
glutathione	glutathione	NN	I-NP	O
S	S	NN	I-NP	O
-	-	HYPH	O	O
transferase	transferase	NN	B-NP	O
(	(	(	O	O
GST	GST	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O


This	This	DT	B-NP	O
report	report	NN	I-NP	O
substantiates	substantiate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
18	18	CD	I-NP	B-protein
kDa	kDa	NN	I-NP	I-protein
hsps	hsp	NNS	I-NP	I-protein
in	in	IN	B-PP	O
maize	maize	NN	B-NP	O
are	be	VBP	B-VP	O
products	product	NNS	B-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
but	but	CC	I-NP	O
related	related	JJ	I-NP	O
genes	gene	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
10	10	CD	I-NP	B-protein
kDa	kDa	NN	I-NP	I-protein
polypeptide	polypeptide	NN	I-NP	I-protein
was	be	VBD	B-VP	O
phosphorylated	phosphorylate	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
by	by	IN	B-PP	O
incubating	incubate	VBG	B-VP	O
wheat	wheat	NN	B-NP	O
etioplast	etioplast	NN	I-NP	O
membranes	membrane	NNS	I-NP	O
with	with	IN	B-PP	O
[	[	(	B-NP	O
gamma	gamma	NN	I-NP	O
32P	32P	NN	I-NP	O
]	]	)	I-NP	O
ATP	ATP	NN	I-NP	O
.	.	.	O	O


Homology	Homology	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
only	only	RB	B-NP	O
34	34	CD	I-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tandem	tandem	JJ	I-NP	B-DNA
repeat	repeat	NN	I-NP	I-DNA
domain	domain	NN	I-NP	I-DNA
,	,	,	O	O
mainly	mainly	RB	B-ADVP	O
showing	show	VBG	B-VP	O
conservation	conservation	NN	B-NP	O
of	of	IN	B-PP	O
serines	serine	NNS	B-NP	O
and	and	CC	I-NP	O
threonines	threonine	NNS	I-NP	O
,	,	,	O	O
presumed	presume	VBN	B-VP	O
sites	site	NNS	B-NP	O
of	of	IN	B-PP	O
O	O	NN	B-NP	O
-	-	HYPH	O	O
linked	link	VBN	B-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
attachment	attachment	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
targeting	target	VBG	B-VP	O
partially	partially	RB	B-NP	O
assembled	assemble	VBN	I-NP	O
Ti	Ti	NNP	I-NP	O
alpha	alpha	SYM	B-NP	O
-	-	HYPH	B-NP	O
beta	beta	SYM	I-NP	O
CD3	CD3	NN	I-NP	B-protein
gamma	gamma	SYM	I-NP	I-protein
delta	delta	NN	I-NP	I-protein
epsilon	epsilon	NN	I-NP	I-protein
TCR	TCR	NN	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
,	,	,	O	O
CD3	CD3	NN	B-NP	B-protein
zeta	zeta	NN	I-NP	I-protein
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-protein
-	-	HYPH	O	O
2	2	CD	B-NP	O
production	production	NN	I-NP	O
after	after	IN	B-PP	O
TCR	TCR	NN	B-NP	B-protein
stimulation	stimulation	NN	I-NP	O
with	with	IN	B-PP	O
antigen	antigen	NN	B-NP	O
/	/	SYM	B-VP	O
major	major	JJ	B-NP	O
histocompatibility	histocompatibility	NN	I-NP	O
complex	complex	NN	I-NP	O
.	.	.	O	O


When	When	WRB	B-ADVP	O
desipramine	desipramine	NN	B-NP	O
was	be	VBD	B-VP	O
injected	inject	VBN	I-VP	O
16	16	CD	B-NP	O
hrs	hr	NNS	I-NP	O
after	after	IN	B-PP	O
fluoxetine	fluoxetine	NN	B-NP	O
injection	injection	NN	I-NP	O
,	,	,	O	O
brain	brain	NN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
desipramine	desipramine	NN	B-NP	O
were	be	VBD	B-VP	O
no	no	RB	I-VP	O
longer	longer	RBR	I-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O


Opposite	Opposite	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
CYP1	CYP1	NN	B-NP	B-protein
are	be	VBP	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
aerobic	aerobic	JJ	B-NP	O
,	,	,	I-NP	O
heme	heme	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
sufficient	sufficient	JJ	I-NP	O
cells	cell	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
segmental	segmental	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
key	key	JJ	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
HLA	HLA	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
DR1	DR1	NN	I-NP	I-protein
that	that	WDT	B-NP	O
control	control	VBP	B-VP	O
T	T	NN	B-NP	O
cell	cell	NN	I-NP	O
allorecognition	allorecognition	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
transfected	transfecte	VBN	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
expressing	express	VBG	B-VP	O
the	the	DT	B-NP	O
products	product	NNS	I-NP	O
of	of	IN	B-PP	O
recombinant	recombinant	JJ	B-NP	B-protein
DRB	DRB	NN	I-NP	I-protein
/	/	SYM	B-NP	O
H	H	NN	I-NP	O
-	-	HYPH	B-NP	O
2Eb	2Eb	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
paired	pair	VBN	B-VP	O
with	with	IN	B-PP	O
either	either	CC	O	O
DR	DR	NN	B-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
or	or	CC	I-NP	O
H	H	NN	I-NP	O
-	-	HYPH	B-NP	O
2E	2E	NN	I-NP	B-protein
alpha	alpha	NN	I-NP	I-protein
.	.	.	O	O


We	We	PRP	B-NP	O
characterized	characterize	VBD	B-VP	O
cDNA	cDNA	NN	B-NP	B-DNA
clones	clone	NNS	I-NP	I-DNA
specific	specific	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
extracellular	extracellular	JJ	I-NP	B-protein
matrix	matrix	NN	I-NP	I-protein
glycoprotein	glycoprotein	NN	I-NP	I-protein
undulin	undulin	NN	I-NP	I-protein
.	.	.	O	O


Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
some	some	DT	B-NP	O
point	point	NN	I-NP	O
mutations	mutation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Gag	Gag	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
Pol	Pol	NN	I-NP	B-protein
PR	PR	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
inhibited	inhibit	VBD	B-VP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
RT	RT	NN	B-NP	O
in	in	IN	B-PP	O
trans	tran	NNS	B-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
wild	wild	JJ	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
type	type	NN	I-NP	I-protein
PR	PR	NN	I-NP	I-protein
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
correct	correct	JJ	I-NP	O
conformation	conformation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PR	PR	NN	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
in	in	IN	B-PP	O
Gag	Gag	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
Pol	Pol	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
prerequisite	prerequisite	JJ	B-ADJP	O
for	for	IN	B-PP	O
activation	activation	NN	B-NP	O
of	of	IN	B-PP	O
RT	RT	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
alpha	alpha	NN	I-NP	B-DNA
inhibin	inhibin	NN	I-NP	I-DNA
promoter	promoter	NN	I-NP	I-DNA
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
mutated	mutate	VBN	I-NP	O
CRE	CRE	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
regulated	regulate	VBN	I-VP	O
by	by	IN	B-PP	O
forskolin	forskolin	NN	B-NP	O
in	in	IN	B-PP	O
granulosa	granulosa	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
bind	bind	VB	I-VP	O
the	the	DT	B-NP	O
CREB	CREB	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


Regulation	Regulation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alpha	alpha	NN	I-NP	B-DNA
inhibin	inhibin	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
by	by	IN	B-PP	O
cyclic	cyclic	JJ	B-NP	O
adenosine	adenosine	NN	I-NP	O
3	3	CD	I-NP	O
'	'	SYM	B-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
monophosphate	monophosphate	NN	I-NP	O
after	after	IN	B-PP	O
transfection	transfection	NN	B-NP	O
into	into	IN	B-PP	O
rat	rat	NN	B-NP	B-cell_line
granulosa	granulosa	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O


Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
between	between	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
and	and	CC	I-NP	I-DNA
bovine	bovine	JJ	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
similarity	similarity	NN	I-NP	O
extended	extend	VBD	B-VP	O
2400	2400	CD	B-NP	O
bp	bp	NN	I-NP	O
downstream	downstream	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
coding	cod	VBG	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
.	.	.	O	O


Cloning	Cloning	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
cDNA	cDNA	NN	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
CDC2	CDC2	NN	I-NP	B-protein
-	-	HYPH	O	O
related	relate	VBN	B-NP	O
kinase	kinase	NN	I-NP	B-protein
by	by	IN	B-PP	O
complementation	complementation	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
budding	bud	VBG	I-NP	O
yeast	yeast	NN	I-NP	O
cdc28	cdc28	NN	I-NP	O
mutation	mutation	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
and	and	CC	O	O
joint	joint	JJ	B-NP	B-protein
empyema	empyema	NN	I-NP	I-protein
(	(	(	O	I-protein
n	n	NN	B-NP	I-protein
=	=	SYM	B-VP	I-protein
48	48	CD	B-NP	I-protein
)	)	)	O	I-protein
PMN	PMN	NN	B-NP	I-protein
elastase	elastase	NN	I-NP	I-protein
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
77	77	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
only	only	RB	I-VP	O
exceeded	exceed	VBN	I-VP	O
by	by	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
unspecific	unspecific	JJ	I-NP	O
erythrocyte	erythrocyte	NN	I-NP	O
sedimentation	sedimentation	NN	I-NP	O
rate	rate	NN	I-NP	O
(	(	(	O	O
sensitivity	sensitivity	NN	B-NP	O
89	89	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


E	E	NN	B-NP	O
.	.	NN	I-NP	O
,	,	,	O	O
Hession	Hession	NN	B-NP	O
,	,	,	O	O
C	C	NN	B-NP	O
.	.	.	O	O
,	,	,	O	O
Goff	Goff	NNP	B-NP	O
,	,	,	O	O
D	D	NNP	B-NP	O
.	.	.	O	O
,	,	,	O	O
Griffiths	Griffith	NNS	B-NP	O
,	,	,	O	O
B	B	NN	B-NP	O
.	.	NN	I-NP	O
,	,	,	O	O
Tizard	Tizard	NNP	B-NP	O
,	,	,	O	O
R	R	NNP	B-NP	O
.	.	.	O	O
,	,	,	O	O
Newman	Newman	NNP	B-NP	O
,	,	,	O	O
B	B	NNP	B-NP	O
.	.	.	O	O
,	,	,	O	O
Chi	Chi	NNP	B-NP	B-protein
-	-	HYPH	I-NP	O
Rosso	Rosso	NNP	I-NP	O
,	,	,	O	O
G	G	NNP	B-NP	O
.	.	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Lobb	Lobb	NNP	B-NP	O
,	,	,	O	O
R	R	NN	B-NP	O
.	.	NN	I-NP	O
,	,	,	O	O
(	(	(	O	O
1990	1990	CD	B-NP	O
)	)	)	O	O
Cell	Cell	NNP	B-NP	O
63	63	CD	I-NP	O
,	,	,	I-NP	O
1349	1349	CD	I-NP	O
-	-	HYPH	I-NP	O
1356	1356	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
above	above	JJ	I-NP	O
results	result	NNS	I-NP	O
mean	mean	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
alpha	alpha	SYM	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
adrenergic	adrenergic	JJ	I-NP	I-protein
receptors	receptor	NNS	I-NP	I-protein
makes	make	VBZ	B-VP	O
the	the	DT	B-NP	O
prostate	prostate	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
already	already	RB	I-VP	O
hypertrophied	hypertrophy	VBN	I-VP	O
,	,	,	O	O
less	less	RBR	B-ADJP	O
elastic	elastic	JJ	I-ADJP	O
,	,	,	O	O
inhibiting	inhibit	VBG	B-VP	O
external	external	JJ	B-NP	O
urinary	urinary	JJ	I-NP	O
sphincter	sphincter	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O


An	An	DT	B-NP	O
approximately	approximately	RB	I-NP	O
2	2	CD	I-NP	B-RNA
-	-	HYPH	I-NP	I-RNA
kilobase	kilobase	NN	I-NP	I-RNA
B2	B2	NN	I-NP	I-RNA
transcript	transcript	NN	I-NP	I-RNA
was	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
alfalfa	alfalfa	NN	I-NP	O
organs	organ	NNS	I-NP	O
tested	test	VBN	B-VP	O
.	.	.	O	O


These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
sulfhydryl	sulfhydryl	NN	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
certain	certain	JJ	B-NP	O
angiotensin	angiotensin	NN	I-NP	O
converting	convert	VBG	B-VP	O
enzyme	enzyme	NN	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
can	can	MD	B-VP	O
potentiate	potentiate	VB	I-VP	O
their	their	PRP$	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
endogenous	endogenous	JJ	I-NP	B-protein
nitrovasodilator	nitrovasodilator	NN	I-NP	I-protein
EDRF	EDRF	NN	I-NP	I-protein
.	.	.	O	O


Pharmacokinetics	Pharmacokinetic	NNS	B-NP	O
of	of	IN	B-PP	O
FK	FK	NN	B-NP	O
506	506	CD	I-NP	O
in	in	IN	B-PP	O
transplant	transplant	NN	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
second	second	JJ	I-NP	O
even	even	RB	I-NP	O
more	more	RBR	I-NP	O
significant	significant	JJ	I-NP	O
match	match	NN	I-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
E	E	NN	I-NP	B-DNA
.	.	.	O	I-DNA
coli	coli	NN	B-NP	I-DNA
region	region	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
retroviral	retroviral	JJ	I-NP	O
ribonuclease	ribonuclease	NN	I-NP	B-protein
H	H	NN	I-NP	I-protein
(	(	(	O	I-protein
RNase	RNase	NN	B-NP	I-protein
H	H	NN	I-NP	I-protein
)	)	)	O	I-protein
domain	domain	NN	B-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
corresponds	correspond	VBZ	B-VP	O
precisely	precisely	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
aligned	align	VBN	I-VP	O
by	by	IN	B-PP	O
previous	previous	JJ	B-NP	O
investigators	investigator	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
E	E	NN	I-NP	O
.	.	.	O	O
coli	coli	NNP	B-NP	O
RNase	RNase	NNP	I-NP	B-protein
H	H	NNP	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
Pol	Pol	NN	B-NP	O
I	I	CD	I-NP	O
helices	helix	NNS	I-NP	O
O	O	NN	I-NP	O
and	and	CC	I-NP	O
P	P	NN	I-NP	O
are	be	VBP	B-VP	O
homologous	homologous	JJ	B-ADJP	O
to	to	TO	B-PP	O
helices	helix	NNS	B-NP	O
A	A	NN	I-NP	O
and	and	CC	I-NP	O
D	D	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
RNase	RNase	NN	I-NP	B-protein
H	H	NN	I-NP	O
crystal	crystal	NN	I-NP	O
structure	structure	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O


Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
deduced	deduce	VBN	I-NP	O
amino	amino	JJ	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
CHIP28	CHIP28	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
contains	contain	VBZ	B-VP	O
six	six	CD	B-NP	O
bilayer	bilayer	NN	I-NP	B-protein
-	-	HYPH	O	I-protein
spanning	span	VBG	B-VP	I-protein
domains	domain	NNS	B-NP	I-protein
,	,	,	O	O
two	two	CD	B-NP	O
exofacial	exofacial	JJ	I-NP	O
potential	potential	JJ	I-NP	O
N	N	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
glycosylation	glycosylation	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
intracellular	intracellular	JJ	B-NP	O
N	N	NN	I-NP	O
and	and	CC	I-NP	O
C	C	NN	I-NP	B-protein
termini	terminus	NNS	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
qualitative	qualitative	JJ	I-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
HCG	HCG	NN	B-NP	B-protein
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
37.5	37.5	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
F	F	NN	B-NP	O
absorption	absorption	NN	I-NP	O
and	and	CC	O	O
slower	slow	JJR	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	B-protein
F	F	NN	I-NP	I-protein
concentration	concentration	NN	I-NP	O
accompanying	accompany	VBG	B-VP	O
delayed	delay	VBN	B-NP	O
gastric	gastric	JJ	I-NP	O
emptying	emptying	NN	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
passage	passage	NN	B-NP	O
of	of	IN	B-PP	O
F	F	NN	B-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
intestine	intestine	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
factor	factor	NN	I-NP	O
in	in	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
F	F	NN	I-NP	O
absorption	absorption	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	B-protein
lipase	lipase	NN	I-NP	I-protein
and	and	CC	I-NP	O
amylase	amylase	NN	I-NP	B-protein
distinctly	distinctly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
h	h	NN	I-NP	O
and	and	CC	O	O
went	go	VBD	B-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
maximum	maximum	NN	I-NP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
injection	injection	NN	B-NP	O
of	of	IN	B-PP	O
Na	Na	NN	B-NP	O
-	-	HYPH	B-NP	O
Tc	Tc	NN	I-NP	O
.	.	.	O	O


They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
for	for	IN	B-PP	O
anti	anti	AFX	B-NP	O
-	-	HYPH	I-NP	O
HCV	HCV	NN	I-NP	O
(	(	(	O	O
anti	anti	AFX	O	O
-	-	HYPH	B-NP	B-protein
C100	C100	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
3	3	CD	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
HCV	HCV	NN	B-NP	O
EIA	EIA	NN	I-NP	O
kit	kit	NN	I-NP	O
(	(	(	O	O
Abbott	Abbott	NNP	B-NP	O
Lab	Lab	NNP	I-NP	B-protein
.	.	.	O	O
,	,	,	O	O
North	North	NNP	B-NP	O
Chicago	Chicago	NNP	I-NP	O
,	,	,	O	O
IL	IL	NNP	B-NP	O
)	)	)	O	O
.	.	.	O	O


Diltiazem	Diltiazem	NNP	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
epicardial	epicardial	JJ	B-NP	O
diameter	diameter	NN	I-NP	O
(	(	(	O	O
+	+	SYM	B-NP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
;	;	:	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
blood	blood	NN	I-NP	O
flow	flow	NN	I-NP	O
(	(	(	O	O
CBF	CBF	NN	B-NP	B-protein
)	)	)	O	O
(	(	(	O	O
+	+	SYM	O	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
;	;	:	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.0001	0.0001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
first	first	JJ	I-NP	O
transfusion	transfusion	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
platelet	platelet	NN	I-NP	O
increment	increment	NN	I-NP	O
to	to	TO	B-PP	O
32	32	CD	B-NP	O
Gpt	Gpt	NN	I-NP	B-protein
/	/	SYM	B-NP	O
l	l	NN	B-NP	O
(	(	(	O	O
CCI	CCI	NN	B-NP	B-DNA
11	11	CD	I-NP	I-DNA
)	)	)	O	O
.	.	.	O	O


These	These	DT	B-NP	O
risk	risk	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
can	can	MD	B-VP	O
be	be	VB	I-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
2	2	CD	B-NP	O
groups	group	NNS	I-NP	O
:	:	:	O	O
local	local	JJ	B-NP	O
vessel	vessel	NN	I-NP	O
wall	wall	NN	I-NP	O
-	-	HYPH	O	O
related	relate	VBN	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
local	local	JJ	O	B-protein
(	(	(	O	I-protein
focal	focal	JJ	B-NP	I-protein
action	action	NN	I-NP	I-protein
)	)	)	O	I-protein
systemic	systemic	JJ	B-NP	I-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O


Epidemiology	Epidemiology	NN	B-NP	O
and	and	CC	I-NP	O
prevention	prevention	NN	I-NP	O
of	of	IN	B-PP	O
hospital	hospital	NN	B-NP	O
infections	infection	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Local	Local	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
of	of	IN	B-PP	O
Sassari	Sassari	NNP	B-NP	O
:	:	:	O	O
profile	profile	NN	B-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
and	and	CC	O	O
antimicrobial	antimicrobial	JJ	B-NP	O
agents	agent	NNS	I-NP	O
of	of	IN	B-PP	O
large	large	JJ	B-NP	O
usage	usage	NN	I-NP	O
.	.	.	O	O


PRDII	PRDII	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
BF1	BF1	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
derived	derive	VBN	I-NP	O
cDNAs	cDNA	NNS	I-NP	B-DNA
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
of	of	IN	B-PP	O
either	either	CC	B-NP	O
basal	basal	JJ	I-NP	O
or	or	CC	I-NP	O
tat	tat	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
induced	induce	VBN	I-NP	O
activated	activate	VBN	I-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O


Vaccinia	Vaccinia	NN	B-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
VV	VV	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
immunogen	immunogen	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
VV	VV	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
yet	yet	RB	I-VP	O
known	know	VBN	I-VP	O
.	.	.	O	O


Max	Max	NN	B-NP	B-protein
:	:	:	O	O
functional	functional	JJ	B-NP	O
domains	domain	NNS	I-NP	O
and	and	CC	O	O
interaction	interaction	NN	B-NP	O
with	with	IN	B-PP	O
c	c	NN	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
Myc	Myc	NN	I-NP	I-protein
.	.	.	O	O


86	86	CD	B-NP	O
:	:	:	O	O
3199	3199	CD	B-NP	O
-	-	HYPH	I-NP	O
3203	3203	CD	I-NP	O
)	)	)	O	O
or	or	CC	O	O
G1	G1	NN	B-NP	O
to	to	TO	B-PP	O
S	S	NN	B-NP	O
phase	phase	NN	I-NP	O
(	(	(	O	O
Reilly	Reilly	NNP	B-NP	O
,	,	,	O	O
C	C	NNP	B-NP	O
.	.	.	O	O


Substitutions	Substitution	NNS	B-NP	O
introduced	introduce	VBN	B-VP	O
at	at	IN	B-PP	O
bases	base	NNS	B-NP	O
surrounding	surround	VBG	B-VP	O
the	the	DT	B-NP	O
ICR2	ICR2	NN	I-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
yielded	yield	VBD	B-VP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
pRNA	pRNA	NN	B-NP	O
replication	replication	NN	I-NP	O
that	that	WDT	B-NP	O
differed	differ	VBD	B-VP	O
,	,	,	O	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
maintenance	maintenance	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
5	5	CD	I-NP	O
'	'	SYM	I-NP	O
stem	stem	NN	I-NP	O
-	-	HYPH	B-NP	O
loop	loop	NN	I-NP	O
structure	structure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
positive	positive	JJ	I-NP	O
strand	strand	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
viral	viral	JJ	I-NP	B-DNA
genome	genome	NN	I-NP	I-DNA
.	.	.	O	O


Zn	Zn	NN	B-NP	B-protein
(	(	(	O	I-protein
II	II	CD	B-NP	I-protein
)	)	)	O	I-protein
coordination	coordination	NN	B-NP	I-protein
domain	domain	NN	I-NP	I-protein
mutants	mutant	NNS	I-NP	I-protein
of	of	IN	B-PP	O
T4	T4	NN	B-NP	B-protein
gene	gene	NN	I-NP	I-protein
32	32	CD	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


Zn	Zn	NN	B-NP	B-protein
(	(	(	O	I-protein
II	II	CD	B-NP	I-protein
)	)	)	O	I-protein
coordination	coordination	NN	B-NP	I-protein
domain	domain	NN	I-NP	I-protein
mutants	mutant	NNS	I-NP	I-protein
of	of	IN	B-PP	O
T4	T4	NN	B-NP	B-protein
gene	gene	NN	I-NP	I-protein
32	32	CD	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
tissue	tissue	NN	I-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
gene	gene	NN	B-NP	O
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
identical	identical	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
described	describe	VBN	B-VP	O
previously	previously	RB	B-ADVP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
CaMV	CaMV	NN	I-NP	B-DNA
35S	35S	NN	I-NP	I-DNA
domain	domain	NN	I-NP	I-DNA
B	B	NN	I-NP	I-DNA
enhancer	enhancer	NN	I-NP	I-DNA
element	element	NN	I-NP	I-DNA
.	.	.	O	O


The	The	DT	B-NP	O
pathophysiology	pathophysiology	NN	I-NP	O
and	and	CC	O	O
clinical	clinical	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
brain	brain	NN	I-NP	O
injury	injury	NN	I-NP	O
in	in	IN	B-PP	O
infancy	infancy	NN	B-NP	O
and	and	CC	I-NP	O
childhood	childhood	NN	I-NP	O
are	be	VBP	B-VP	O
presented	present	VBN	I-VP	O
using	use	VBG	I-VP	O
acute	acute	JJ	B-NP	O
traumatic	traumatic	JJ	I-NP	O
brain	brain	NN	I-NP	O
injury	injury	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
model	model	NN	I-NP	O
.	.	.	O	O


Transcripts	Transcript	NNS	B-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
POU	POU	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
domain	domain	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
Oct	Oct	NN	B-NP	B-DNA
-	-	HYPH	I-NP	O
25	25	CD	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
oocytes	oocyte	NNS	B-NP	O
and	and	CC	O	O
early	early	RB	B-NP	O
embryos	embryo	NNS	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
dramatically	dramatically	RB	I-VP	O
upregulated	upregulate	VBN	I-VP	O
during	during	IN	B-PP	O
early	early	JJ	B-NP	O
gastrulation	gastrulation	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
some	some	DT	B-NP	O
early	early	JJ	I-NP	B-cell_type
B	B	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
Abelson	Abelson	NN	B-NP	O
murine	murine	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
virus	virus	NN	I-NP	O
-	-	HYPH	O	O
transformed	transform	VBN	B-VP	B-cell_line
pre	pre	AFX	B-NP	I-cell_line
-	-	HYPH	B-NP	I-cell_line
B	B	NN	I-NP	I-cell_line
-	-	HYPH	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
,	,	,	O	O
LT	LT	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
is	be	VBZ	B-VP	O
constitutively	constitutively	RB	I-VP	O
expressed	express	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
genome	genome	NN	I-NP	O
of	of	IN	B-PP	O
Thogoto	Thogoto	NNP	B-NP	O
virus	virus	NN	I-NP	O
comprises	comprise	VBZ	B-VP	O
six	six	CD	B-NP	O
segments	segment	NNS	I-NP	O
of	of	IN	B-PP	O
single	single	JJ	B-NP	O
-	-	HYPH	I-NP	O
stranded	stranded	JJ	I-NP	O
,	,	,	I-NP	O
negative	negative	JJ	I-NP	O
sense	sense	NN	I-NP	O
RNA	RNA	NN	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
tumors	tumor	NNS	I-NP	O
were	be	VBD	B-VP	O
classified	classify	VBN	I-VP	O
into	into	IN	B-PP	O
three	three	CD	B-NP	O
broad	broad	JJ	I-NP	O
groups	group	NNS	I-NP	O
:	:	:	O	O
I	I	NN	B-NP	O
,	,	,	O	O
cystadenoma	cystadenoma	NN	B-NP	B-DNA
;	;	:	O	I-DNA
II	II	CD	B-NP	I-DNA
,	,	,	O	O
cystadenocarcinoma	cystadenocarcinoma	NN	B-NP	O
;	;	:	O	O
and	and	CC	O	O
III	III	CD	B-NP	O
,	,	,	O	O
adenocarcinoma	adenocarcinoma	NN	B-NP	O
with	with	IN	B-PP	O
mucin	mucin	NN	B-NP	O
production	production	NN	I-NP	O
or	or	CC	O	O
an	an	DT	B-NP	O
associated	associate	VBN	I-NP	O
cyst	cyst	NN	I-NP	O
.	.	.	O	O


Immunostaining	Immunostaining	NN	B-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
transfected	transfecte	VBN	B-VP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
constructs	construct	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
both	both	CC	O	O
the	the	DT	B-NP	O
myristoylated	myristoylate	VBN	I-NP	O
and	and	CC	I-NP	O
nonmyristoylated	nonmyristoylate	VBN	I-NP	O
mutants	mutant	NNS	I-NP	O
were	be	VBD	B-VP	O
localized	localize	VBN	I-VP	O
in	in	IN	B-PP	O
nuclei	nucleus	NNS	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
wild	wild	JJ	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
type	type	NN	I-NP	I-protein
PKC	PKC	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
was	be	VBD	B-VP	O
primarily	primarily	RB	B-ADJP	O
cytoplasmic	cytoplasmic	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
perinuclear	perinuclear	JJ	I-ADJP	O
.	.	.	O	O


We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
partially	partially	RB	I-VP	O
sequenced	sequence	VBN	I-VP	O
the	the	DT	B-NP	O
RAP74	RAP74	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
from	from	IN	B-PP	O
purified	purify	VBN	B-NP	O
HeLa	HeLa	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
cloned	clone	VBN	B-VP	O
its	its	PRP$	B-NP	O
complementary	complementary	JJ	I-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
and	and	CC	O	O
shown	show	VBN	B-VP	O
that	that	IN	B-SBAR	O
its	its	PRP$	B-NP	O
translation	translation	NN	I-NP	B-protein
product	product	NN	I-NP	I-protein
can	can	MD	B-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
RAP30	RAP30	NN	B-NP	B-protein
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O


Effects	Effect	NNS	B-NP	O
of	of	IN	B-PP	O
thromboxane	thromboxane	NN	B-NP	B-protein
synthetase	synthetase	NN	I-NP	I-protein
inhibition	inhibition	NN	I-NP	O
on	on	IN	B-PP	O
postburn	postburn	JJ	B-NP	O
mesenteric	mesenteric	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
porcine	porcine	JJ	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
primary	primary	JJ	I-NP	O
pancreatic	pancreatic	JJ	I-NP	O
insult	insult	NN	I-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
unaffected	unaffected	JJ	B-ADJP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
because	because	IN	B-SBAR	O
neither	neither	CC	O	O
the	the	DT	B-NP	O
rise	rise	NN	I-NP	O
in	in	IN	B-PP	O
plasma	plasma	NN	B-NP	B-protein
lipase	lipase	NN	I-NP	I-protein
nor	nor	CC	O	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
ascites	ascite	NNS	B-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
extension	extension	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pancreatic	pancreatic	JJ	I-NP	O
necrosis	necrosis	NN	I-NP	O
were	be	VBD	B-VP	O
diminished	diminish	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mutant	mutant	JJ	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
unprocessed	unprocessed	JJ	I-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	O
precursor	precursor	NN	I-NP	O
(	(	(	O	O
pre	pre	AFX	O	B-DNA
-	-	HYPH	B-NP	O
super	super	NN	I-NP	O
-	-	HYPH	O	O
pro	pro	AFX	O	B-DNA
-	-	HYPH	O	O
PrB	PrB	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
as	as	IN	B-SBAR	O
detected	detect	VBN	B-VP	O
in	in	IN	B-PP	O
sec61	sec61	NN	B-NP	O
mutants	mutant	NNS	I-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
translocation	translocation	NN	B-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
endoplasmic	endoplasmic	JJ	I-NP	O
reticulum	reticulum	NN	I-NP	O
is	be	VBZ	B-VP	O
blocked	block	VBN	I-VP	O
.	.	.	O	O


Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
-	-	HYPH	I-NP	O
site	site	NN	I-NP	O
mutation	mutation	NN	I-NP	O
prevents	prevent	VBZ	B-VP	O
the	the	DT	B-NP	O
wild	wild	JJ	I-NP	O
-	-	HYPH	I-NP	O
type	type	NN	I-NP	O
processing	processing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
N	N	NN	I-NP	B-protein
-	-	HYPH	B-VP	I-protein
glycosylated	glycosylate	VBN	I-VP	I-protein
73	73	CD	B-NP	I-protein
-	-	HYPH	I-NP	I-protein
kDa	kDa	NN	I-NP	I-protein
precursor	precursor	NN	I-NP	I-protein
of	of	IN	B-PP	O
PrB	PrB	NN	B-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
41.5	41.5	CD	I-NP	B-RNA
kDa	kDa	NN	I-NP	I-RNA
pro	pro	AFX	O	O
-	-	HYPH	O	O
PrB	PrB	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
endoplasmic	endoplasmic	JJ	I-NP	O
reticulum	reticulum	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
predicted	predict	VBN	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
sequence	sequence	NN	I-NP	O
exhibited	exhibit	VBD	B-VP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
identity	identity	NN	I-NP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
Bacillus	Bacillus	NN	B-NP	O
stearothermophilus	stearothermophilus	NN	I-NP	O
TyrTS	TyrTS	NN	I-NP	O
and	and	CC	O	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
identity	identity	NN	I-NP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
E	E	NN	B-NP	O
.	.	.	O	O
coli	coli	NNP	B-NP	O
TyrTS	TyrTS	NNP	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
identity	identity	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
cryptic	cryptic	JJ	I-NP	O
B	B	NN	I-NP	O
.	.	.	O	O
subtilis	subtilis	JJ	B-NP	O
TyrTS	TyrTS	NN	I-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
designated	designate	VBN	B-VP	O
tyrZ	tyrZ	NN	B-NP	B-DNA
,	,	,	O	O
was	be	VBD	B-VP	O
only	only	RB	B-NP	O
27	27	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O


Heat	Heat	NN	B-NP	O
-	-	HYPH	I-NP	O
inducible	inducible	JJ	I-NP	O
CAT	CAT	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
detectable	detectable	JJ	B-ADJP	O
when	when	WRB	B-ADVP	O
additional	additional	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
native	native	JJ	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
containing	contain	VBG	B-VP	O
three	three	CD	B-NP	O
CCAAT	CCAAT	NN	I-NP	B-DNA
boxes	box	NNS	I-NP	I-DNA
and	and	CC	O	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
HSE	HSE	NN	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
constructions	construction	NNS	I-NP	O
.	.	.	O	O


SETTING	SETTING	NN	B-NP	O
-	-	HYPH	B-NP	O
-	-	SYM	I-NP	O
Women	Woman	NNS	B-NP	O
,	,	,	O	O
Infants	Infant	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Children	Children	NNP	B-NP	O
clinics	clinic	NNS	I-NP	O
in	in	IN	B-PP	O
Minneapolis	Minneapolis	NNP	B-NP	O
,	,	,	O	O
Minn	Minn	NNP	B-NP	O
.	.	.	O	O


Testosterone	Testosterone	NN	B-NP	O
,	,	,	O	O
free	free	JJ	B-NP	O
testosterone	testosterone	NN	I-NP	O
,	,	,	O	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
sex	sex	NN	B-NP	B-protein
hormone	hormone	NN	I-NP	I-protein
-	-	HYPH	O	I-protein
binding	bind	VBG	B-NP	I-protein
globulin	globulin	NN	I-NP	I-protein
-	-	HYPH	B-PP	O
bound	bind	VBN	B-NP	O
testosterone	testosterone	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
free	free	JJ	B-NP	O
androgen	androgen	NN	I-NP	O
index	index	NN	I-NP	O
:	:	:	O	O
which	which	WDT	B-NP	O
testosterone	testosterone	NN	I-NP	O
measurement	measurement	NN	I-NP	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADJP	O
relevant	relevant	JJ	I-ADJP	O
to	to	TO	B-PP	O
reproductive	reproductive	JJ	B-NP	O
and	and	CC	I-NP	O
sexual	sexual	JJ	I-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
men	man	NNS	B-NP	O
with	with	IN	B-PP	O
epilepsy	epilepsy	NN	B-NP	O
?	?	.	O	O


BACKGROUND	BACKGROUND	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
effectiveness	effectiveness	NN	I-NP	O
of	of	IN	B-PP	O
monoamine	monoamine	NN	B-NP	O
oxidase	oxidase	NN	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
(	(	(	O	O
MAOIs	MAOI	NNS	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
tricyclic	tricyclic	JJ	B-NP	O
resistant	resistant	JJ	I-NP	O
depression	depression	NN	I-NP	O
has	have	VBZ	B-VP	O
received	receive	VBN	I-VP	O
surprisingly	surprisingly	RB	B-NP	O
little	little	JJ	I-NP	O
systematic	systematic	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
upstream	upstream	JJ	I-NP	B-DNA
delta	delta	NN	I-NP	I-DNA
-	-	HYPH	B-NP	I-DNA
alpha	alpha	NN	I-NP	I-DNA
breakpoint	breakpoint	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
flanked	flank	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
direct	direct	JJ	I-NP	O
repeats	repeat	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
acceptor	acceptor	NN	I-NP	B-DNA
splice	splice	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
down	down	RB	I-NP	O
-	-	HYPH	I-NP	O
stream	stream	NN	I-NP	O
alpha	alpha	SYM	O	O
-	-	HYPH	O	O
delta	delta	SYM	O	O
breakpoint	breakpoint	NN	B-NP	O
is	be	VBZ	B-VP	O
located	locate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
adjacent	adjacent	JJ	I-NP	B-DNA
intron	intron	NN	I-NP	I-DNA
.	.	.	O	O


Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
PDDAT	PDDAT	NN	I-NP	O
were	be	VBD	B-VP	O
impaired	impair	VBN	I-VP	O
on	on	IN	B-PP	O
all	all	DT	B-NP	O
serial	serial	JJ	I-NP	O
positions	position	NNS	I-NP	O
for	for	IN	B-PP	O
both	both	CC	B-NP	O
spatial	spatial	JJ	I-NP	O
order	order	NN	I-NP	O
and	and	CC	O	O
spatial	spatial	JJ	B-NP	O
recognition	recognition	NN	I-NP	O
memory	memory	NN	I-NP	O
.	.	.	O	O


Bone	Bone	NN	B-NP	O
and	and	CC	I-NP	O
bones	bone	NNS	I-NP	O
.	.	.	O	O


One	One	CD	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
plasma	plasma	NN	B-NP	B-protein
C	C	NN	I-NP	I-protein
-	-	HYPH	O	O
peptide	peptide	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
3	3	CD	B-NP	O
pM	pM	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
excluded	exclude	VBN	I-VP	O
from	from	IN	B-PP	O
analysis	analysis	NN	B-NP	O
.	.	.	O	O


Complex	Complex	JJ	B-NP	O
repetitive	repetitive	JJ	I-NP	O
discharges	discharge	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
muscles	muscle	NNS	B-NP	O
of	of	IN	B-PP	O
mdx	mdx	NN	B-NP	O
mice	mouse	NNS	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
complex	complex	JJ	I-NP	O
repetitive	repetitive	JJ	I-NP	O
discharges	discharge	NNS	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
muscles	muscle	NNS	B-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
control	control	NN	I-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O


Management	Management	NN	B-NP	O
often	often	RB	B-ADVP	O
involves	involve	VBZ	B-VP	O
beta	beta	SYM	B-NP	O
-	-	HYPH	B-ADJP	O
and	and	CC	O	O
calcium	calcium	NN	B-NP	O
channel	channel	NN	I-NP	O
blocking	block	VBG	B-VP	O
drugs	drug	NNS	B-NP	O
or	or	CC	I-NP	O
type	type	NN	I-NP	O
IC	IC	NN	I-NP	O
antiarrhythmic	antiarrhythmic	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O


To	To	TO	B-VP	O
overcome	overcome	VB	I-VP	O
this	this	DT	B-NP	O
problem	problem	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
overexpressed	overexpresse	VBN	I-VP	O
Kex2p	Kex2p	NN	B-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
baculovirus	baculovirus	NN	I-NP	O
/	/	SYM	B-NP	O
insect	insect	NN	I-NP	O
cell	cell	NN	I-NP	O
expression	expression	NN	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O


J	J	NNP	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
major	major	JJ	I-NP	B-protein
49	49	CD	I-NP	I-protein
-	-	HYPH	I-NP	I-protein
kDa	kDa	NN	I-NP	I-protein
core	core	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
HSPG	HSPG	NN	I-NP	O
preparation	preparation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
antibody	antibody	NN	I-NP	O
that	that	WDT	B-NP	O
specifically	specifically	RB	B-ADVP	O
recognizes	recognize	VBZ	B-VP	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
of	of	IN	B-PP	O
fibroglycan	fibroglycan	NN	B-NP	O
.	.	.	O	O


While	While	IN	B-SBAR	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	B-protein
transmembrane	transmembrane	NN	I-NP	I-protein
regions	region	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
,	,	,	O	O
several	several	JJ	B-NP	O
short	short	JJ	I-NP	O
hydrophobic	hydrophobic	JJ	I-NP	O
amino	amino	NN	I-NP	O
acid	acid	NN	I-NP	O
stretches	stretch	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
localized	localize	VBN	I-VP	O
in	in	IN	B-PP	O
and	and	CC	I-PP	O
around	around	IN	I-PP	O
the	the	DT	B-NP	O
Pro	Pro	NN	I-NP	B-DNA
II	II	CD	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
,	,	,	O	O
and	and	CC	O	O
these	these	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
attachment	attachment	NN	B-NP	O
of	of	IN	B-PP	O
precursors	precursor	NNS	B-NP	O
to	to	TO	B-PP	O
membranes	membrane	NNS	B-NP	O
.	.	.	O	O


Toxicity	Toxicity	NN	B-NP	O
was	be	VBD	B-VP	O
mild	mild	JJ	B-ADJP	O
,	,	,	O	O
mainly	mainly	RB	B-ADVP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
emesis	emesis	NN	B-NP	O
(	(	(	O	O
81	81	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
;	;	:	O	O
66	66	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
courses	course	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
leukopenia	leukopenia	NN	B-NP	O
of	of	IN	B-PP	O
World	World	NNP	B-NP	O
Health	Health	NNP	I-NP	O
Organization	Organization	NNP	I-NP	O
(	(	(	O	O
WHO	WHO	WP	B-NP	O
)	)	)	O	O
grade	grade	NN	B-NP	O
1	1	CD	I-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
(	(	(	O	O
47	47	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
;	;	:	O	O
18	18	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
courses	course	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
thrombocytopenia	thrombocytopenia	NN	B-NP	O
(	(	(	O	O
12	12	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
;	;	:	O	O
3	3	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
courses	course	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O


W	W	NNP	B-NP	O
.	.	.	I-NP	O
G	G	NNP	I-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
study	study	NN	I-NP	O
confirms	confirm	VBZ	B-VP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
individual	individual	JJ	B-NP	O
reaction	reaction	NN	I-NP	O
is	be	VBZ	B-VP	O
remarkably	remarkably	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
,	,	,	O	O
transportation	transportation	NN	B-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
stressor	stressor	NN	I-NP	O
for	for	IN	B-PP	O
Beagle	Beagle	NNP	B-NP	O
dogs	dog	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
mouse	mouse	NN	I-NP	B-DNA
brain	brain	NN	I-NP	I-DNA
beta	beta	SYM	O	I-DNA
-	-	HYPH	O	O
spectrin	spectrin	NN	B-NP	O
of	of	IN	B-PP	O
cDNA	cDNA	NN	B-NP	B-DNA
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
lambda	lambda	SYM	I-NP	B-DNA
Gt11	Gt11	NN	I-NP	I-DNA
expression	expression	NN	I-NP	I-DNA
library	library	NN	I-NP	I-DNA
using	use	VBG	B-VP	O
an	an	DT	B-NP	O
antibody	antibody	NN	I-NP	B-protein
which	which	WDT	B-NP	O
specifically	specifically	RB	B-ADVP	O
binds	bind	VBZ	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
235	235	CD	I-NP	B-protein
kDa	kDa	NN	I-NP	I-protein
spectrin	spectrin	NN	I-NP	I-protein
beta	beta	SYM	B-VP	I-protein
-	-	HYPH	O	I-protein
subunit	subunit	NN	B-NP	I-protein
.	.	.	O	O


RESULTS	RESULTS	NNS	B-NP	O
:	:	:	O	O
Plasma	Plasma	NN	B-NP	O
AVP	AVP	NN	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
osmotic	osmotic	JJ	B-NP	O
stimulation	stimulation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
non	non	AFX	B-NP	O
-	-	HYPH	I-NP	O
osmotic	osmotic	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
by	by	IN	B-PP	O
drinking	drinking	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
compulsive	compulsive	JJ	B-NP	O
water	water	NN	I-NP	O
drinking	drinking	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
fragments	fragment	NNS	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
region	region	NN	I-NP	O
were	be	VBD	B-VP	O
amplified	amplify	VBN	I-VP	O
by	by	IN	B-PP	O
polymerase	polymerase	NN	B-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
and	and	CC	O	O
analyzed	analyze	VBN	B-VP	O
by	by	IN	B-PP	O
gel	gel	NN	B-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
to	to	TO	B-VP	O
detect	detect	VB	I-VP	O
single	single	JJ	B-NP	O
-	-	HYPH	I-NP	O
strand	strand	NN	I-NP	O
conformation	conformation	NN	I-NP	O
polymorphism	polymorphism	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
csbA	csbA	NN	I-NP	O
fusion	fusion	NN	I-NP	O
was	be	VBD	B-VP	O
maximally	maximally	RB	I-VP	O
expressed	express	VBN	I-VP	O
during	during	IN	B-PP	O
early	early	JJ	B-NP	O
stationary	stationary	JJ	I-NP	O
phase	phase	NN	I-NP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
grown	grow	VBN	B-VP	O
in	in	IN	B-PP	O
Luria	Luria	NNP	B-NP	O
broth	broth	CC	O	O
containing	contain	VBG	B-VP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
glucose	glucose	NN	I-NP	O
and	and	CC	O	O
0.2	0.2	CD	B-NP	O
%	%	NN	I-NP	O
glutamine	glutamine	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
constraints	constraint	NNS	I-NP	O
of	of	IN	B-PP	O
primase	primase	NN	B-NP	B-DNA
recognition	recognition	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
,	,	,	O	O
nucleotide	nucleotide	NN	B-NP	O
substrate	substrate	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
additional	additional	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
on	on	IN	B-PP	O
oligoribonucleotide	oligoribonucleotide	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
63	63	CD	I-NP	B-protein
-	-	HYPH	I-NP	I-protein
kDa	kDa	NN	I-NP	I-protein
gene	gene	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
examined	examine	VBN	I-VP	O
using	use	VBG	B-VP	O
templates	template	NNS	B-NP	O
of	of	IN	B-PP	O
defined	define	VBN	B-NP	O
sequence	sequence	NN	I-NP	O
.	.	.	O	O


Thrombolytic	Thrombolytic	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
in	in	IN	B-PP	O
spontaneous	spontaneous	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
dissection	dissection	NN	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
trial	trial	NN	I-NP	O
was	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
in	in	IN	B-PP	O
156	156	CD	B-NP	O
unselected	unselected	JJ	I-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
41	41	CD	B-NP	O
men	man	NNS	I-NP	O
,	,	,	O	O
mean	mean	JJ	B-NP	O
age	age	NN	I-NP	O
67.5	67.5	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
115	115	CD	B-NP	O
women	woman	NNS	I-NP	O
,	,	,	O	O
mean	mean	JJ	B-NP	O
age	age	NN	I-NP	O
71.4	71.4	CD	B-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
undergone	undergo	VBN	I-VP	O
total	total	JJ	B-NP	O
hip	hip	NN	I-NP	O
joint	joint	NN	I-NP	O
replacement	replacement	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
degenerative	degenerative	JJ	B-NP	O
or	or	CC	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
or	or	CC	I-NP	O
fracture	fracture	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
neck	neck	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
femur	femur	NN	I-NP	O
.	.	.	O	O


When	When	WRB	B-ADVP	O
both	both	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
were	be	VBD	B-VP	O
complete	complete	JJ	B-NP	O
lateral	lateral	JJ	I-NP	O
hemisections	hemisection	NNS	I-NP	O
in	in	IN	B-PP	O
weanling	weanle	VBG	B-NP	O
operates	operate	NNS	I-NP	O
,	,	,	O	O
little	little	JJ	B-NP	O
behavioral	behavioral	JJ	I-NP	O
recovery	recovery	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
,	,	,	O	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
spinal	spinal	JJ	B-NP	O
cord	cord	NN	I-NP	O
transection	transection	NN	I-NP	O
(	(	(	O	O
N	N	NN	B-NP	O
=	=	SYM	B-VP	O
3	3	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


Human	Human	JJ	B-NP	B-protein
SRF	SRF	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
related	relate	VBN	I-NP	O
proteins	protein	NNS	I-NP	O
:	:	:	O	O
DNA	DNA	NN	B-NP	O
-	-	HYPH	O	O
binding	bind	VBG	B-NP	O
properties	property	NNS	I-NP	O
and	and	CC	O	O
potential	potential	JJ	B-NP	O
regulatory	regulatory	JJ	I-NP	O
targets	target	NNS	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
isolated	isolate	VBN	I-VP	O
cDNAs	cDNA	NNS	B-NP	B-DNA
for	for	IN	B-PP	O
a	a	DT	B-NP	O
gene	gene	NN	I-NP	O
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
G	G	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
subunit	subunit	NN	I-NP	I-protein
from	from	IN	B-PP	O
tomato	tomato	NN	B-NP	O
(	(	(	O	O
Lycopersicon	Lycopersicon	NN	B-NP	O
esculentum	esculentum	NN	I-NP	O
,	,	,	O	O
cv	cv	NN	B-NP	O
.	.	.	O	O


Growth	Growth	NN	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
causes	cause	VBZ	B-VP	O
the	the	DT	B-NP	O
phosphorylation	phosphorylation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
c	c	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
Myc	Myc	NN	I-NP	I-protein
transcriptional	transcriptional	JJ	I-NP	I-protein
activation	activation	NN	I-NP	I-protein
domain	domain	NN	I-NP	I-protein
at	at	IN	B-PP	O
Ser62	Ser62	NN	B-NP	B-protein
within	within	IN	B-PP	O
a	a	DT	B-NP	O
proline	proline	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
rich	rich	JJ	I-NP	I-protein
region	region	NN	I-NP	I-protein
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
highly	highly	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
among	among	IN	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Myc	Myc	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
(	(	(	O	O
Alvarez	Alvarez	NNP	B-NP	O
,	,	,	O	O
E	E	NNP	B-NP	O
.	.	.	O	O
,	,	,	O	O
Northwood	Northwood	NNP	B-NP	O
,	,	,	O	O
I	I	NNP	B-NP	O
.	.	.	I-NP	O
C	C	NNP	I-NP	O
.	.	.	O	O
,	,	,	O	O
Gonzalez	Gonzalez	NNP	B-NP	O
,	,	,	O	O
F	F	NNP	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
authors	author	NNS	I-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
for	for	IN	B-PP	O
thrombotic	thrombotic	JJ	B-NP	O
complications	complication	NNS	I-NP	O
arising	arise	VBG	B-VP	O
from	from	IN	B-PP	O
implantation	implantation	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
ventricular	ventricular	JJ	I-NP	O
assist	assist	NN	I-NP	O
device	device	NN	I-NP	O
(	(	(	O	O
Sarns	Sarn	VBZ	B-VP	O
/	/	SYM	B-NP	B-protein
3M	3M	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
VAD	VAD	NN	I-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
calves	calf	NNS	I-NP	O
.	.	.	O	O


Cardiac	Cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
(	(	(	O	O
CO	CO	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.0005	0.0005	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MBBF	MBBF	NN	I-NP	B-protein
group	group	NN	I-NP	O
.	.	.	O	O


Amino	Amino	NN	B-NP	B-protein
acid	acid	NN	I-NP	I-protein
residues	residue	NNS	I-NP	I-protein
147	147	CD	B-NP	I-protein
-	-	HYPH	I-NP	O
167	167	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
reported	report	VBN	I-NP	O
sequence	sequence	NN	I-NP	O
are	be	VBP	B-VP	O
replaced	replace	VBN	I-VP	O
by	by	IN	B-PP	O
new	new	JJ	B-NP	O
residues	residue	NNS	I-NP	O
147	147	CD	B-NP	O
to	to	TO	B-PP	O
150	150	CD	B-NP	O
.	.	.	O	O


Transcriptional	Transcriptional	JJ	B-NP	O
activation	activation	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
HIV	HIV	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
Tat	Tat	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
requires	require	VBZ	B-VP	O
specific	specific	JJ	B-NP	O
residues	residue	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hexanucleotide	hexanucleotide	NN	I-NP	O
loop	loop	NN	I-NP	O
and	and	CC	I-NP	O
trinucleotide	trinucleotide	NN	I-NP	O
bulge	bulge	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TAR	TAR	NN	I-NP	O
RNA	RNA	NN	I-NP	O
stem	stem	NN	I-NP	O
-	-	HYPH	B-NP	O
loop	loop	NN	I-NP	O
structure	structure	NN	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
-	-	HYPH	I-NP	I-DNA
untranslated	untranslated	JJ	I-NP	I-DNA
leader	leader	NN	I-NP	I-DNA
of	of	IN	B-PP	O
all	all	DT	B-NP	O
viral	viral	JJ	I-NP	B-RNA
transcripts	transcript	NNS	I-NP	I-RNA
.	.	.	O	O


We	We	PRP	B-NP	O
obtained	obtain	VBD	B-VP	O
quantitative	quantitative	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
coding	coding	NN	I-NP	O
of	of	IN	B-PP	O
interaural	interaural	JJ	B-NP	O
time	time	NN	I-NP	O
differences	difference	NNS	I-NP	O
(	(	(	O	O
ITDs	ITD	NNS	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
click	click	NN	B-NP	O
stimuli	stimulus	NNS	I-NP	O
by	by	IN	B-PP	O
40	40	CD	B-NP	O
single	single	JJ	I-NP	O
neurons	neuron	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
auditory	auditory	JJ	I-NP	O
cortex	cortex	NN	I-NP	O
of	of	IN	B-PP	O
anesthetized	anesthetize	VBN	B-NP	O
albino	albino	NN	I-NP	O
rats	rat	NNS	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
results	result	NNS	I-NP	O
strongly	strongly	RB	B-VP	O
suggest	suggest	VBP	I-VP	O
that	that	IN	B-SBAR	O
locally	locally	RB	B-ADVP	O
-	-	HYPH	I-ADVP	O
applied	apply	VBN	B-NP	O
TTC	TTC	NN	I-NP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
FDBA	FDBA	NN	B-NP	B-protein
enhances	enhance	VBZ	B-VP	O
new	new	JJ	B-NP	O
bone	bone	NN	I-NP	O
formation	formation	NN	I-NP	O
in	in	IN	B-PP	O
experimental	experimental	JJ	B-NP	O
alveolar	alveolar	JJ	I-NP	O
bone	bone	NN	I-NP	O
defects	defect	NNS	I-NP	O
.	.	.	O	O


As	As	IN	B-PP	O
an	an	DT	B-NP	O
initial	initial	JJ	I-NP	O
step	step	NN	I-NP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
replicative	replicative	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
polymerases	polymeras	NNS	I-NP	O
of	of	IN	B-PP	O
trypanosomes	trypanosome	NNS	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
cloned	clone	VBN	I-VP	O
,	,	,	O	O
sequenced	sequence	VBN	B-VP	O
and	and	CC	I-VP	O
examined	examine	VBN	I-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Trypanosoma	Trypanosoma	NN	I-NP	B-DNA
(	(	(	O	I-DNA
Trypanozoon	Trypanozoon	NN	B-NP	I-DNA
)	)	)	O	I-DNA
brucei	brucei	NN	B-NP	I-DNA
brucei	brucei	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
that	that	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
polymerase	polymerase	NN	I-NP	O
alpha	alpha	NN	I-NP	O
catalytic	catalytic	JJ	I-NP	O
core	core	NN	I-NP	O
(	(	(	O	O
pol	pol	NN	B-NP	O
alpha	alpha	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O


In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
postdexamethasone	postdexamethasone	NN	B-NP	O
cortical	cortical	JJ	I-NP	O
concentrations	concentration	NNS	I-NP	O
with	with	IN	B-PP	O
age	age	NN	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.01	0.01	CD	B-NP	O
;	;	:	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
0.31	0.31	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


Pulmonary	Pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
or	or	CC	B-PP	O
without	without	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
arterial	arterial	JJ	I-NP	O
narrowing	narrowing	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
condition	condition	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
isolated	isolate	VBN	B-NP	O
atrial	atrial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
volume	volume	NN	I-NP	O
fraction	fraction	NN	I-NP	O
(	(	(	O	O
Vv	Vv	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
number	number	NN	B-NP	O
/	/	SYM	O	O
mm2	mm2	NN	B-NP	O
(	(	(	O	O
Na	Na	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
capillaries	capillary	NNS	I-NP	O
(	(	(	O	O
perfused	perfuse	VBN	B-VP	O
and	and	CC	I-VP	O
nonperfused	nonperfuse	VBN	I-VP	O
)	)	)	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
given	give	VBN	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
brain	brain	NN	B-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
after	after	IN	B-PP	O
staining	stain	VBG	B-VP	O
for	for	IN	B-PP	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
.	.	.	O	O


Airway	Airway	NN	B-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
air	air	NN	B-NP	O
flow	flow	NN	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
endotracheal	endotracheal	JJ	I-NP	O
tube	tube	NN	I-NP	O
in	in	IN	B-PP	O
13	13	CD	B-NP	O
children	child	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
ventilators	ventilator	NNS	B-NP	O
.	.	.	O	O


Appl	Appl	NNP	B-NP	O
.	.	.	O	O


Issues	Issue	NNS	B-NP	O
of	of	IN	B-PP	O
distribution	distribution	NN	B-NP	O
of	of	IN	B-PP	O
kinetic	kinetic	JJ	B-NP	O
energy	energy	NN	I-NP	O
of	of	IN	B-PP	O
traumatizing	traumatize	VBG	B-VP	O
object	object	NN	B-NP	O
in	in	IN	B-PP	O
direct	direct	JJ	B-NP	O
contact	contact	NN	I-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
head	head	NN	B-NP	O
during	during	IN	B-PP	O
impact	impact	NN	B-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
from	from	IN	B-PP	O
position	position	NN	B-NP	O
of	of	IN	B-PP	O
biomechanics	biomechanic	NNS	B-NP	O
.	.	.	O	O


CONCLUSION	CONCLUSION	NN	B-NP	O
:	:	:	O	O
Monitoring	Monitor	VBG	B-VP	O
SpO2	SpO2	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
nasal	nasal	JJ	I-NP	B-DNA
septum	septum	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
more	more	RBR	B-ADJP	O
reliable	reliable	JJ	I-ADJP	O
than	than	IN	B-PP	O
monitoring	monitor	VBG	B-VP	O
it	it	PRP	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
finger	finger	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
hypothermic	hypothermic	JJ	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O


Diltiazem	Diltiazem	NNP	B-NP	O
decreased	decrease	VBD	B-VP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
body	body	NN	I-NP	O
clearance	clearance	NN	I-NP	O
from	from	IN	B-PP	O
34.0	34.0	CD	B-NP	O
+	+	SYM	B-ADJP	O
/	/	SYM	O	O
-	-	SYM	O	O
8.0	8.0	CD	B-NP	O
to	to	TO	B-PP	O
28.6	28.6	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
6.1	6.1	CD	B-NP	O
mL	mL	NN	I-NP	O
/	/	SYM	B-NP	O
min	min	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
.	.	.	B-NP	O
01	01	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
prolonged	prolong	VBD	B-VP	O
the	the	DT	B-NP	O
elimination	elimination	NN	I-NP	O
half	half	NN	I-NP	O
-	-	HYPH	I-NP	O
life	life	NN	I-NP	O
from	from	IN	B-PP	O
12.6	12.6	CD	B-NP	O
+	+	SYM	B-ADJP	O
/	/	SYM	O	O
-	-	SYM	O	O
3.0	3.0	CD	B-NP	O
to	to	TO	B-PP	O
14.3	14.3	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	B-NP	O
-	-	SYM	O	O
2.5	2.5	CD	B-NP	O
hours	hour	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
.	.	.	B-NP	O
01	01	CD	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
antipyrine	antipyrine	NN	B-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
volume	volume	NN	B-NP	O
of	of	IN	B-PP	O
distribution	distribution	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
granules	granule	NNS	I-NP	O
grew	grow	VBD	B-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
melted	melted	JJ	I-NP	O
material	material	NN	I-NP	O
immersed	immerse	VBN	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
void	void	JJ	I-NP	O
space	space	NN	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
adhered	adhered	JJ	I-NP	O
particles	particle	NNS	I-NP	O
.	.	.	O	O


Hence	Hence	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
uPA	uPA	NN	I-NP	B-DNA
promoter	promoter	NN	I-NP	I-DNA
contains	contain	VBZ	B-VP	O
multiple	multiple	JJ	B-NP	B-DNA
weak	weak	JJ	I-NP	I-DNA
cis	cis	NN	I-NP	I-DNA
-	-	HYPH	O	I-DNA
acting	act	VBG	B-VP	I-DNA
elements	element	NNS	B-NP	I-DNA
distributed	distribute	VBN	B-VP	O
over	over	IN	B-NP	O
7.0	7.0	CD	I-NP	O
kb	kb	NN	I-NP	O
5	5	CD	I-NP	O
'	'	SYM	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
translation	translation	NN	I-NP	B-DNA
start	start	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O


Substituting	Substitute	VBG	B-VP	O
a	a	DT	B-NP	O
Ser	Ser	NN	I-NP	O
for	for	IN	B-PP	O
Gly69	Gly69	NN	B-NP	B-protein
or	or	CC	O	O
a	a	DT	B-NP	O
Glu	Glu	NN	I-NP	B-protein
for	for	IN	B-PP	O
Lys	Lys	NNP	B-NP	B-protein
71	71	CD	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
conserved	conserve	VBN	I-NP	O
TGEK	TGEK	NN	I-NP	O
tetrapeptide	tetrapeptide	NN	I-NP	O
in	in	IN	B-PP	O
finger	finger	NN	B-NP	O
II	II	CD	I-NP	O
of	of	IN	B-PP	O
TFIIIA	TFIIIA	NN	B-NP	B-protein
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
binding	binding	NN	I-NP	O
.	.	.	O	O


P	P	NN	B-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
one	one	CD	B-NP	O
,	,	,	O	O
exploratory	exploratory	JJ	B-NP	O
behavior	behavior	NN	I-NP	O
(	(	(	O	O
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
hole	hole	NN	B-NP	O
pokes	poke	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
locomotion	locomotion	NN	B-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
10	10	CD	I-NP	O
-	-	HYPH	I-NP	O
min	min	NN	I-NP	O
test	test	NN	I-NP	O
session	session	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
model	model	NN	I-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
anticipate	anticipate	VB	I-VP	O
why	why	WRB	B-ADVP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
fluoridation	fluoridation	NN	I-NP	O
on	on	IN	B-PP	O
caries	cary	NNS	B-NP	O
prevalence	prevalence	NN	I-NP	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADJP	O
pronounced	pronounced	JJ	I-ADJP	O
when	when	WRB	B-ADVP	O
caries	cary	NNS	B-NP	O
is	be	VBZ	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
at	at	IN	B-PP	O
cavity	cavity	NN	B-NP	O
level	level	NN	I-NP	O
.	.	.	O	O


12	12	CD	B-NP	O
-	-	HYPH	I-NP	O
O	O	NN	I-NP	O
-	-	HYPH	O	O
Tetradecanoylphorbol	Tetradecanoylphorbol	NN	B-NP	B-protein
13	13	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
acetate	acetate	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
inhibit	inhibit	VB	I-VP	O
rapidly	rapidly	RB	B-ADVP	O
and	and	CC	I-ADVP	O
potently	potently	RB	I-ADVP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
mRNAs	mRNA	NNS	B-NP	B-RNA
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
myogenic	myogenic	JJ	I-NP	O
regulators	regulator	NNS	I-NP	O
CMD1	CMD1	NN	I-NP	B-protein
and	and	CC	I-NP	O
myogenin	myogenin	NN	I-NP	B-protein
.	.	.	O	O


In	In	IN	B-PP	O
Xenopus	Xenopus	NNP	B-NP	O
laevis	laevis	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
elongation	elongation	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
-	-	HYPH	O	O
alpha	alpha	SYM	O	O
variant	variant	NN	B-NP	O
EF	EF	NN	I-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
alpha	alpha	SYM	I-NP	O
O	O	NN	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
O	O	NN	B-NP	O
stands	stand	VBZ	B-VP	O
for	for	IN	B-PP	O
oocyte	oocyte	NN	B-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
oocytes	oocyte	NNS	B-NP	B-cell_type
and	and	CC	O	O
early	early	JJ	B-NP	O
embryos	embryo	NNS	I-NP	O
.	.	.	O	O


These	These	DT	B-NP	O
introns	intron	NNS	I-NP	B-DNA
belong	belong	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
nuclear	nuclear	JJ	B-NP	O
pre	pre	AFX	I-NP	O
-	-	HYPH	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
introns	intron	NNS	I-NP	O
and	and	CC	O	O
contain	contain	VBP	B-VP	O
typical	typical	JJ	B-NP	O
5	5	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
and	and	CC	I-NP	O
3	3	CD	I-NP	O
'	'	SYM	I-NP	O
-	-	HYPH	I-NP	O
consensus	consensus	NN	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
unique	unique	JJ	B-NP	O
features	feature	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
identified	identify	VBN	B-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
human	human	JJ	I-NP	B-cell_type
and	and	CC	O	I-cell_type
rat	rat	NN	B-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-RNA
clathrin	clathrin	NN	I-NP	I-RNA
clone	clone	NN	I-NP	I-RNA
revealed	reveal	VBD	B-VP	I-RNA
transcripts	transcript	NNS	B-NP	I-RNA
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
6.5	6.5	CD	I-NP	O
kb	kb	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
predicted	predict	VBN	I-NP	O
180	180	CD	I-NP	O
kDa	kDa	NN	I-NP	O
molecular	molecular	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
clathrin	clathrin	NN	I-NP	B-protein
heavy	heavy	JJ	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
.	.	.	O	O


In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
almost	almost	RB	B-NP	O
6	6	CD	I-NP	O
kb	kb	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
presented	present	VBN	I-VP	O
,	,	,	O	O
including	include	VBG	B-PP	O
1251	1251	CD	B-NP	O
bp	bp	NN	I-NP	O
5	5	CD	B-NP	O
'	'	SYM	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
,	,	,	O	O
over	over	IN	B-NP	O
4	4	CD	I-NP	O
kb	kb	NN	I-NP	O
of	of	IN	B-PP	O
exon	exon	NN	B-NP	B-DNA
and	and	CC	I-NP	O
exon	exon	NN	I-NP	B-DNA
-	-	HYPH	B-NP	O
intron	intron	NN	I-NP	O
junctions	junction	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
583	583	CD	B-NP	O
bp	bp	NN	I-NP	O
3	3	CD	B-NP	O
'	'	SYM	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
.	.	.	O	O


An	An	DT	B-NP	O
8	8	CD	I-NP	O
-	-	HYPH	I-NP	O
h	h	NN	I-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
DMEA	DMEA	NN	I-NP	O
/	/	SYM	B-NP	O
m3	m3	NN	I-NP	O
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
postexposure	postexposure	NN	I-NP	O
plasma	plasma	NN	I-NP	O
concentration	concentration	NN	I-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
-	-	HYPH	I-NP	O
h	h	NN	I-NP	O
postexposure	postexposure	NN	I-NP	O
urinary	urinary	JJ	I-NP	O
excretion	excretion	NN	I-NP	O
of	of	IN	B-PP	O
4.9	4.9	CD	B-NP	O
mumol	mumol	NN	I-NP	O
/	/	SYM	B-NP	O
l	l	NN	I-NP	O
and	and	CC	O	O
75	75	CD	B-NP	O
mmol	mmol	NN	I-NP	O
/	/	SYM	B-NP	O
mol	mol	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O


Antibodies	Antibody	NNS	B-NP	B-protein
specific	specific	JJ	B-ADJP	O
to	to	TO	B-PP	O
rE12	rE12	NN	B-NP	O
and	and	CC	I-NP	O
rNFIL	rNFIL	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
6	6	CD	I-NP	O
disrupt	disrupt	NN	I-NP	O
nucleoprotein	nucleoprotein	NN	I-NP	O
complexes	complex	NNS	I-NP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
DNA	DNA	NN	I-NP	B-DNA
-	-	HYPH	O	I-DNA
binding	bind	VBG	B-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
,	,	,	O	O
confirming	confirm	VBG	B-VP	O
the	the	DT	B-NP	O
interaction	interaction	NN	I-NP	O
of	of	IN	B-PP	O
native	native	JJ	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
factors	factor	NNS	I-NP	O
.	.	.	O	O


A	A	DT	B-NP	O
method	method	NN	I-NP	O
is	be	VBZ	B-VP	O
described	describe	VBN	I-VP	O
for	for	IN	B-PP	O
detecting	detect	VBG	B-VP	O
targeted	target	VBN	B-NP	O
events	event	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
mu	mu	NN	I-NP	B-DNA
heavy	heavy	JJ	I-NP	I-DNA
chain	chain	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
which	which	WDT	B-NP	O
relies	rely	VBZ	B-VP	O
on	on	IN	B-PP	O
co	co	AFX	B-NP	O
-	-	HYPH	I-NP	O
conversion	conversion	NN	I-NP	O
(	(	(	O	O
or	or	CC	O	O
co	co	AFX	O	O
-	-	HYPH	O	O
exchange	exchange	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
point	point	NN	I-NP	O
mutation	mutation	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
selectable	selectable	JJ	I-NP	O
marker	marker	NN	I-NP	O
contained	contain	VBN	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
replacement	replacement	NN	I-NP	O
vector	vector	NN	I-NP	O
.	.	.	O	O


Allergenic	Allergenic	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
allergen	allergen	NN	B-NP	O
extract	extract	NN	I-NP	O
Ambrosia	Ambrosia	NN	I-NP	O
elatior	elatior	NN	I-NP	O
(	(	(	O	O
AE	AE	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
in	in	IN	B-PP	O
fifteen	fifteen	CD	B-NP	O
volunteers	volunteer	NNS	I-NP	O
extremely	extremely	RB	B-ADJP	O
sensitive	sensitive	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
allergen	allergen	NN	I-NP	O
.	.	.	O	O


This	This	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
aimed	aim	VBN	I-VP	O
at	at	IN	B-PP	O
assessing	assess	VBG	B-VP	O
whether	whether	IN	B-SBAR	O
c	c	NN	B-NP	O
-	-	HYPH	I-NP	O
DDP	DDP	NN	I-NP	O
administration	administration	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
before	before	IN	B-PP	O
radiotherapy	radiotherapy	NN	B-NP	O
could	could	MD	B-VP	O
increase	increase	VB	I-VP	O
frequency	frequency	NN	B-NP	O
and	and	CC	I-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
objective	objective	JJ	B-NP	O
responses	response	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
survival	survival	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
affected	affect	VBN	B-VP	O
with	with	IN	B-PP	O
locally	locally	RB	B-NP	O
advanced	advance	VBN	I-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
squamous	squamous	JJ	B-NP	O
carcinomas	carcinoma	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
.	.	.	O	O


Two	Two	CD	B-NP	O
potential	potential	JJ	I-NP	B-DNA
regulatory	regulatory	JJ	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
DNA	DNA	NN	B-NP	B-protein
binding	binding	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
non	non	AFX	I-NP	O
-	-	HYPH	I-NP	B-DNA
coding	cod	VBG	B-VP	I-DNA
5	5	CD	B-NP	I-DNA
'	'	SYM	I-NP	I-DNA
region	region	NN	I-NP	I-DNA
:	:	:	O	O
a	a	DT	B-NP	O
HAP2	HAP2	NN	I-NP	B-protein
/	/	SYM	B-NP	O
HAP3	HAP3	NN	I-NP	B-DNA
consensus	consensus	NN	I-NP	I-DNA
recognition	recognition	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
at	at	IN	B-PP	O
nucleotide	nucleotide	NN	B-NP	O
-	-	HYPH	O	O
154	154	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
BAF1	BAF1	NN	I-NP	B-DNA
consensus	consensus	NN	I-NP	I-DNA
recognition	recognition	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
at	at	IN	B-PP	O
nucleotide	nucleotide	NN	B-NP	B-DNA
-	-	HYPH	O	I-DNA
136	136	CD	B-NP	I-DNA
.	.	.	O	O


Marked	Mark	VBN	B-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
,	,	,	O	O
depletion	depletion	NN	B-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	B-protein
fibrinogen	fibrinogen	NN	I-NP	I-protein
and	and	CC	O	O
prolonged	prolong	VBD	B-VP	O
prothrombin	prothrombin	NN	B-NP	B-protein
and	and	CC	O	O
activated	activate	VBN	B-VP	O
partial	partial	JJ	B-NP	O
thromboplastin	thromboplastin	NN	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
to	to	TO	I-NP	O
10	10	CD	I-NP	O
and	and	CC	I-NP	O
30	30	CD	I-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
minutes	minute	NNS	I-NP	O
after	after	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
envenomation	envenomation	NN	I-NP	O
.	.	.	O	O


We	We	PRP	B-NP	O
exploit	exploit	VBP	B-VP	O
the	the	DT	B-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
LexA	LexA	NN	B-NP	B-protein
fusion	fusion	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
to	to	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
dimerization	dimerization	NN	I-NP	B-protein
and	and	CC	I-NP	I-protein
DNA	DNA	NN	I-NP	I-protein
-	-	HYPH	O	I-protein
contacting	contact	VBG	B-VP	I-protein
domains	domain	NNS	B-NP	I-protein
of	of	IN	B-PP	O
cRel	cRel	NN	B-NP	B-protein
.	.	.	O	O


Plasma	Plasma	NN	B-NP	O
lipid	lipid	NN	I-NP	O
and	and	CC	I-NP	O
lipoprotein	lipoprotein	NN	I-NP	O
profiles	profile	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
in	in	IN	B-PP	O
elderly	elderly	JJ	B-NP	O
female	female	JJ	I-NP	O
runners	runner	NNS	I-NP	O
(	(	(	O	O
RU	RU	NN	B-NP	O
:	:	SYM	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
15	15	CD	B-NP	O
,	,	,	O	O
aged	age	VBN	B-VP	O
66	66	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
5	5	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
body	body	NN	B-NP	O
fat	fat	VBP	B-VP	O
20	20	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
4	4	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
training	train	VBG	B-VP	O
distance	distance	NN	B-NP	O
35	35	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	B-protein
-	-	SYM	O	I-protein
15	15	CD	B-NP	I-protein
km	km	NN	I-NP	I-protein
week	week	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
VO2max	VO2max	NN	B-NP	O
36	36	CD	I-NP	O
+	+	SYM	B-NP	O
/	/	SYM	I-NP	B-protein
-	-	SYM	I-NP	I-protein
4	4	CD	I-NP	I-protein
ml	ml	NN	I-NP	I-protein
kg	kg	NN	I-NP	I-protein
-	-	HYPH	O	I-protein
1	1	CD	B-NP	I-protein
min	min	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
mean	mean	NN	B-NP	O
+	+	SYM	B-VP	O
/	/	SYM	B-NP	O
-	-	HYPH	B-NP	O
SD	SD	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
age	age	NN	B-NP	O
-	-	HYPH	O	O
matched	match	VBN	B-VP	O
untrained	untrained	JJ	B-NP	O
women	woman	NNS	I-NP	O
(	(	(	O	O
UT	UT	NN	B-NP	O
:	:	SYM	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
28	28	CD	B-NP	O
,	,	,	O	O
66	66	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
4	4	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
body	body	NN	B-NP	O
fat	fat	NN	I-NP	O
26	26	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
6	6	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
VO2max	VO2max	NN	B-NP	O
26	26	CD	I-NP	O
+	+	SYM	O	O
/	/	SYM	O	B-protein
-	-	SYM	O	I-protein
3	3	CD	B-NP	I-protein
ml	ml	NN	I-NP	I-protein
kg	kg	NN	I-NP	I-protein
-	-	HYPH	O	I-protein
1	1	CD	B-NP	I-protein
min	min	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O


Auditory	Auditory	JJ	B-NP	O
threshold	threshold	NN	I-NP	O
shifts	shift	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
auditory	auditory	JJ	I-NP	O
evoked	evoke	VBN	I-NP	O
brainstem	brainstem	NN	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
4	4	CD	I-NP	O
,	,	,	I-NP	O
8	8	CD	I-NP	O
,	,	,	I-NP	O
12	12	CD	I-NP	O
,	,	,	I-NP	O
16	16	CD	I-NP	O
,	,	,	I-NP	O
20	20	CD	I-NP	O
and	and	CC	I-NP	O
24	24	CD	I-NP	O
kHz	kHz	NN	I-NP	O
.	.	.	O	O


Fundamental	Fundamental	JJ	B-NP	O
and	and	CC	I-NP	O
clinical	clinical	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
equilibrium	equilibrium	NN	B-NP	O
dialysis	dialysis	NN	I-NP	O
-	-	HYPH	O	O
-	-	HYPH	B-NP	O
radioimmunoassay	radioimmunoassay	NN	I-NP	O
system	system	NN	I-NP	O
for	for	IN	B-PP	O
measurement	measurement	NN	B-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	O
free	free	JJ	I-NP	O
thyroxine	thyroxine	NN	I-NP	O


We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
TA	TA	NN	B-NP	B-protein
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
AGD	AGD	NN	B-NP	O
on	on	IN	B-PP	O
GD	GD	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
largely	largely	RB	I-VP	O
reversed	reverse	VBN	I-VP	O
by	by	IN	B-PP	O
PCD	PCD	NN	B-NP	B-DNA
23	23	CD	I-NP	I-DNA
.	.	.	O	O


When	When	WRB	B-ADVP	O
examined	examine	VBN	B-VP	O
as	as	IN	B-PP	O
adults	adult	NNS	B-NP	O
(	(	(	O	O
8	8	CD	B-NP	O
weeks	week	NNS	I-NP	O
old	old	JJ	B-ADJP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
external	external	JJ	I-NP	O
genitalia	genitalia	NN	I-NP	O
of	of	IN	B-PP	O
TA	TA	NN	B-NP	B-protein
-	-	HYPH	O	O
exposed	expose	VBN	B-NP	O
offspring	offspring	NN	I-NP	O
were	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O


After	After	IN	B-PP	O
PTCA	PTCA	NN	B-NP	B-protein
,	,	,	O	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
54	54	CD	B-NP	O
+	+	SYM	B-ADJP	O
/	/	SYM	O	O
-	-	SYM	O	O
8	8	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-PP	O
59	59	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
8	8	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
regional	regional	JJ	B-NP	O
function	function	NN	I-NP	O
improved	improve	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
(	(	(	O	O
maximal	maximal	JJ	B-NP	O
standard	standard	JJ	I-NP	O
deviation	deviation	NN	I-NP	O
before	before	IN	B-PP	O
PTCA	PTCA	NN	B-NP	O
:	:	:	O	O
2.8	2.8	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
0.8	0.8	CD	B-NP	O
;	;	:	O	O
after	after	IN	B-PP	O
PTCA	PTCA	NN	B-NP	O
:	:	:	O	O
1.9	1.9	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	B-NP	O
-	-	SYM	B-NP	O
0.9	0.9	CD	I-NP	O
-	-	HYPH	I-NP	O
segments	segment	NNS	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
standard	standard	JJ	I-NP	O
deviation	deviation	NN	I-NP	O
before	before	IN	B-PP	O
PTCA	PTCA	NN	B-NP	O
:	:	:	O	O
31	31	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
16	16	CD	B-NP	O
;	;	:	O	O
after	after	IN	B-PP	O
PTCA	PTCA	NN	B-NP	O
:	:	:	O	O
19	19	CD	B-NP	O
+	+	SYM	O	O
/	/	SYM	O	O
-	-	SYM	O	O
17	17	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O


The	The	DT	B-NP	O
alcoholic	alcoholic	JJ	I-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
work	work	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
subjectivity	subjectivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
period	period	NN	I-NP	O


These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
combined	combined	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
thromboxane	thromboxane	NN	I-NP	B-protein
synthetase	synthetase	NN	I-NP	I-protein
inhibitor	inhibitor	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
thromboxane	thromboxane	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
antagonist	antagonist	NN	I-NP	O
provides	provide	VBZ	B-VP	O
a	a	DT	B-NP	O
better	good	JJR	I-NP	O
protection	protection	NN	I-NP	O
against	against	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
intoxication	intoxication	NN	I-NP	O
than	than	IN	B-PP	O
with	with	IN	B-PP	O
either	either	DT	B-NP	O
agent	agent	NN	I-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O


A	A	DT	B-NP	O
330	330	CD	I-NP	O
-	-	HYPH	I-NP	O
kb	kb	NN	I-NP	O
YAC	YAC	NN	I-NP	O
,	,	,	O	O
A148A7	A148A7	NN	B-NP	B-protein
,	,	,	O	O
spanned	span	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
HLA	HLA	NN	I-NP	B-DNA
-	-	HYPH	B-NP	I-DNA
DQA1	DQA1	NN	I-NP	I-DNA
locus	locus	NN	I-NP	I-DNA
through	through	IN	B-PP	O
the	the	DT	B-NP	O
Y3	Y3	NN	I-NP	B-DNA
/	/	SYM	B-VP	I-DNA
Ring	Ring	NN	B-NP	I-DNA
4	4	CD	I-NP	I-DNA
locus	locus	NN	I-NP	I-DNA
and	and	CC	O	O
extended	extend	VBD	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
130	130	CD	I-NP	O
kb	kb	NN	I-NP	O
centromeric	centromeric	JJ	B-ADJP	O
of	of	IN	B-PP	O
YAC	YAC	NN	B-NP	B-protein
B1D12	B1D12	NN	I-NP	I-protein
.	.	.	O	O


Interspecific	Interspecific	JJ	B-NP	O
backcross	backcross	NN	I-NP	O
analysis	analysis	NN	I-NP	O
using	use	VBG	B-VP	O
progeny	progeny	NN	B-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
matings	mating	NNS	B-NP	O
of	of	IN	B-PP	O
(	(	(	O	O
C57BL	C57BL	NN	B-NP	O
/	/	SYM	B-NP	O
6J	6J	NN	I-NP	O
x	x	SYM	I-NP	O
Mus	Mus	NN	I-NP	O
spretus	spretus	NN	I-NP	O
)	)	)	O	O
F1	F1	NN	B-NP	O
x	x	SYM	B-NP	O
C57BL	C57BL	NN	I-NP	O
/	/	SYM	B-NP	O
6J	6J	NN	B-NP	O
mice	mouse	NNS	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
thrombospondin	thrombospondin	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
tightly	tightly	RB	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Fshb	Fshb	NN	I-NP	B-protein
,	,	,	O	O
Actcl	Actcl	NN	B-NP	O
,	,	,	O	O
Ltk	Ltk	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
B2M	B2M	NN	B-NP	B-DNA
loci	locus	NNS	I-NP	I-DNA
on	on	IN	B-PP	O
murine	murine	JJ	B-NP	B-DNA
chromosome	chromosome	NN	I-NP	I-DNA
2	2	CD	I-NP	I-DNA
.	.	.	O	O


Adverse	Adverse	JJ	B-NP	O
foetal	foetal	JJ	I-NP	O
outcome	outcome	NN	I-NP	O
in	in	IN	B-PP	O
specific	specific	JJ	B-NP	O
IgM	IgM	NN	I-NP	B-protein
positive	positive	JJ	I-NP	O
Chlamydia	Chlamydia	NN	I-NP	O
trachomatis	trachomatis	NN	I-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
.	.	.	O	O


Using	Use	VBG	B-VP	O
an	an	DT	B-NP	O
image	image	NN	I-NP	O
-	-	HYPH	B-NP	O
processing	process	VBG	I-NP	O
computer	computer	NN	I-NP	O
,	,	,	O	O
regional	regional	JJ	B-NP	O
LV	LV	NN	I-NP	O
time	time	NN	I-NP	O
-	-	HYPH	B-NP	O
density	density	NN	I-NP	O
curves	curve	NNS	I-NP	O
were	be	VBD	B-VP	O
constructed	construct	VBN	I-VP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
cardiac	cardiac	JJ	I-NP	O
cycle	cycle	NN	I-NP	O
.	.	.	O	O


In	In	IN	B-PP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
patient	patient	NN	I-NP	O
the	the	DT	B-NP	O
VT	VT	NN	I-NP	O
became	become	VBD	B-VP	O
nonsustained	nonsustained	JJ	B-ADJP	O
.	.	.	O	O


If	If	IN	B-SBAR	O
delay	delay	NN	B-NP	O
has	have	VBZ	B-VP	O
occurred	occur	VBN	I-VP	O
between	between	IN	B-PP	O
centrifugation	centrifugation	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
measurement	measurement	NN	I-NP	O
,	,	,	O	O
causing	cause	VBG	B-VP	O
substantial	substantial	JJ	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
CO2	CO2	NN	B-NP	B-protein
,	,	,	O	O
equilibration	equilibration	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
sample	sample	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
gas	gas	NN	I-NP	O
mixture	mixture	NN	I-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
PCO2	PCO2	NN	B-NP	B-protein
=	=	SYM	B-VP	O
5.3	5.3	CD	B-NP	O
kPa	kPa	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
measurement	measurement	NN	I-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
.	.	.	O	O


The	The	DT	B-NP	O
possible	possible	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
underlying	underlie	VBG	B-VP	O
differences	difference	NNS	B-NP	O
in	in	IN	B-PP	O
post	post	AFX	B-NP	O
-	-	HYPH	I-NP	O
tetanic	tetanic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
from	from	IN	B-PP	O
muscle	muscle	NN	B-NP	O
and	and	CC	O	O
cutaneous	cutaneous	JJ	B-NP	O
afferents	afferent	NNS	I-NP	O
in	in	IN	B-PP	O
adults	adult	NNS	B-NP	O
and	and	CC	I-NP	O
neonates	neonate	NNS	I-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
.	.	.	O	O


We	We	PRP	B-NP	O
examined	examine	VBD	B-VP	O
behavioral	behavioral	JJ	B-NP	O
alterations	alteration	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
brown	brown	JJ	I-NP	O
cockroach	cockroach	NN	I-NP	O
,	,	,	O	O
Periplaneta	Periplaneta	NNP	B-NP	O
brunnea	brunnea	NN	I-NP	O
,	,	,	O	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
acanthocephalan	acanthocephalan	NN	I-NP	O
,	,	,	O	O
Moniliformis	Moniliformis	NNP	B-NP	O
moniliformis	moniliformis	NNP	I-NP	O
.	.	.	O	O


First	First	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
finding	finding	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
monomeric	monomeric	JJ	I-NP	O
Alu	Alu	NN	I-NP	O
family	family	NN	I-NP	O
repeat	repeat	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
junction	junction	NN	I-NP	O
between	between	IN	B-PP	O
nonhomology	nonhomology	JJ	B-NP	O
block	block	NN	I-NP	O
I	I	CD	I-NP	O
and	and	CC	O	O
homology	homology	NN	B-NP	O
block	block	VBP	B-VP	O
Y	Y	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alpha	alpha	SYM	I-NP	B-DNA
2	2	CD	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
-	-	HYPH	O	O
containing	contain	VBG	B-VP	O
unit	unit	NN	B-NP	O
in	in	IN	B-PP	O
rhesus	rhesus	NN	B-NP	O
macaque	macaque	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
dimeric	dimeric	JJ	I-NP	B-DNA
Alu	Alu	NN	I-NP	I-DNA
family	family	NN	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
,	,	,	O	O
Alu	Alu	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
orthologous	orthologous	JJ	I-NP	O
position	position	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
was	be	VBD	B-VP	O
generated	generate	VBN	I-VP	O
by	by	IN	B-PP	O
insertion	insertion	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
monomeric	monomeric	JJ	I-NP	O
Alu	Alu	NN	I-NP	O
family	family	NN	I-NP	O
repeat	repeat	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
3	3	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
end	end	NN	I-NP	I-DNA
of	of	IN	B-PP	O
another	another	DT	B-NP	O
preexisting	preexist	VBG	I-NP	O
Alu	Alu	NN	I-NP	O
family	family	NN	I-NP	O
repeat	repeat	NN	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
repressor	repressor	NN	I-NP	B-DNA
locus	locus	NN	I-NP	I-DNA
,	,	,	O	O
c	c	NN	B-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Streptomyces	Streptomyces	NNP	I-NP	O
temperate	temperate	JJ	I-NP	O
phage	phage	NN	I-NP	O
,	,	,	O	O
phi	phi	NN	B-NP	O
C31	C31	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
to	to	TO	B-VP	O
contain	contain	VB	I-VP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	B-DNA
reading	reading	NN	I-NP	I-DNA
frame	frame	NN	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
a	a	DT	B-NP	O
74	74	CD	I-NP	B-protein
kDa	kDa	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O


The	The	DT	B-NP	O
EPO	EPO	NN	I-NP	B-protein
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
distinctly	distinctly	RB	I-VP	O
increased	increase	VBN	I-VP	O
before	before	IN	B-PP	O
transfusion	transfusion	NN	B-NP	O
;	;	:	O	O
they	they	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
change	change	VB	I-VP	O
just	just	RB	B-ADVP	O
after	after	IN	B-PP	O
transfusion	transfusion	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
subsequently	subsequently	RB	B-VP	O
decreased	decrease	VBD	I-VP	O
.	.	.	O	O


This	This	DT	B-NP	O
differential	differential	JJ	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
DB	DB	NN	B-NP	B-protein
,	,	,	O	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
DB	DB	NN	B-NP	B-protein
which	which	WDT	B-NP	O
caused	cause	VBD	B-VP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
righting	righting	NN	B-NP	O
in	in	IN	B-PP	O
LS	LS	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
equal	equal	JJ	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
-	-	HYPH	B-NP	O
soluble	soluble	JJ	I-NP	O
barbiturate	barbiturate	NN	I-NP	O
brain	brain	NN	I-NP	O
distribution	distribution	NN	I-NP	O
and	and	CC	I-NP	O
elimination	elimination	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
lines	line	NNS	I-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
threshold	threshold	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
,	,	,	O	O
above	above	IN	B-PP	O
which	which	WDT	B-NP	O
certain	certain	JJ	B-NP	O
phenomena	phenomenon	NNS	I-NP	O
may	may	MD	B-VP	O
occur	occur	VB	I-VP	O
,	,	,	O	O
strengthens	strengthen	VBZ	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
sentinels	sentinel	NNS	B-NP	O
.	.	.	O	O


